货号:A188772 同义名: Sch-39720 dihydrate;Ceftibuten (hydrate)
Ceftibuten Dihydrate a semisynthetic, β-lactamase-stable, third-generation cephalosporin with antibacterial activity.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Ceftibuten (Dihydrate), an oral expanded-spectrum cephalosporin, has a broad spectrum of activity against many gram-negative and selected gram-positive organisms. Ceftibuten is stable to hydrolysis by many common beta-lactamases[3]. Ceftibuten displayed high activity against Haemophilus influenzae and Branhamella catarrhalis. There was reduced activity against Streptococcus pneumoniae (MIC90 16 mg/l). The protein binding of ceftibuten was 77% and the primary target site PBP3[4]. Moreover, the synergistic combination of ceftibuten plus amoxicillin-clavulanic acid may be an option for oral treatment of UTIs (urinary tract infection) caused by ESBL (extended-spectrum β-lactamase) producing E. coli or K. pneumoniae[5]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01604824 | Hypercholesterolemia | Phase 2 | Unknown | September 2016 | United States, Utah ... 展开 >> Salt Lake City, Utah, United States France Lille, Cedex, France Nante, Cedex, France Paris, France 收起 << |
NCT02746510 | Schizophrenia | Not Applicable | Recruiting | August 2019 | France ... 展开 >> CH Le Vinatier Recruiting BRON Cedex, Rhône-Alpes, France, 69678 Contact: POISSON ALICE, PH 0437915163 alice.poisson@ch-le-vinatier.fr Contact: VIAL VERONIQUE 0437915531 veronique.vial@ch-le-vinatier.fr 收起 << |
NCT02899676 | Neural Bases of Arithmetic Pro... 展开 >>cessing 收起 << | Not Applicable | Unknown | May 2017 | France ... 展开 >> Médecine nucléaire, Groupement Hospitalier Est Recruiting BRON cedex, France, 69677 Contact: Christian SCHEIBER, MD, PhD +33 4 72 68 49 61 christian.scheiber@chu-lyon.fr Principal Investigator: Christian SCHEIBER, MD, PhD 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.24mL 0.45mL 0.22mL |
11.20mL 2.24mL 1.12mL |
22.40mL 4.48mL 2.24mL |
CAS号 | 118081-34-8 |
分子式 | C15H18N4O8S2 |
分子量 | 446.455 |
别名 | Sch-39720 dihydrate;Ceftibuten (hydrate);SCH 39720 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,2-8°C |
溶解度 |
DMSO: 105 mg/mL(235.19 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
Tags: Ceftibuten dihydrate | 118081-34-8 | Sch-39720 dihydrate | Beta-lactamase | Anti-infection | Beta-lactamase | Bacterial | Antibiotic | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Ceftibuten dihydrate 纯度/质量文件 | Ceftibuten dihydrate 生物活性 | Ceftibuten dihydrate 临床数据 | Ceftibuten dihydrate 参考文献 | Ceftibuten dihydrate 实验方案 | Ceftibuten dihydrate 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01604824 | Hypercholesterolemia | Phase 2 | Unknown | September 2016 | United States, Utah ... 展开 >> Salt Lake City, Utah, United States France Lille, Cedex, France Nante, Cedex, France Paris, France 收起 << |
NCT02746510 | Schizophrenia | Not Applicable | Recruiting | August 2019 | France ... 展开 >> CH Le Vinatier Recruiting BRON Cedex, Rhône-Alpes, France, 69678 Contact: POISSON ALICE, PH 0437915163 alice.poisson@ch-le-vinatier.fr Contact: VIAL VERONIQUE 0437915531 veronique.vial@ch-le-vinatier.fr 收起 << |
NCT02899676 | Neural Bases of Arithmetic Pro... 展开 >>cessing 收起 << | Not Applicable | Unknown | May 2017 | France ... 展开 >> Médecine nucléaire, Groupement Hospitalier Est Recruiting BRON cedex, France, 69677 Contact: Christian SCHEIBER, MD, PhD +33 4 72 68 49 61 christian.scheiber@chu-lyon.fr Principal Investigator: Christian SCHEIBER, MD, PhD 收起 << |
NCT03071939 | Schizophrenia | Not Applicable | Not yet recruiting | February 15, 2019 | France ... 展开 >> Centre Hospitalier Le Vinatier Not yet recruiting Bron Cedex, France, 69678 Contact: Thierry D'AMATO, PH 04 37 91 51 00 thierry.damato@ch-le-vinatier.fr 收起 << |
NCT03217357 | Schizophrenia | Not Applicable | Not yet recruiting | March 31, 2019 | France ... 展开 >> Centre Hospitalier Le Vinatier Bron Cedex, France, 69678 收起 << |
NCT03656211 | - | Completed | - | France ... 展开 >> Rennes University Hospital Rennes cedex, France, 350033 收起 << | |
NCT01440413 | Breast Cancer | Not Applicable | Active, not recruiting | December 2018 | France ... 展开 >> Centre Georges François Leclerc DIJON Cedex, France, 21079 Centre Leon Berard LYON Cedex 08, France, 69373 收起 << |
NCT03657979 | Aortic Aneurysm, Abdominal | Phase 4 | Completed | - | France ... 展开 >> Cardiovascular and thoracic surgery unit, CHU Dijon Dijon Cedex, France, 21079 收起 << |
NCT02270489 | Multiple System Atrophy ... 展开 >> Neurodegenerative Diseases 收起 << | Phase 1 | Completed | - | France ... 展开 >> University Hospital Bordeaux (Pellegrin Hospital) Bordeaux Cedex, France, 33076 University Hospital Toulouse Toulouse Cedex 9, France, 31059 收起 << |
NCT00713427 | Biliary Strictures Caused by M... 展开 >>alignant Neoplasms 收起 << | Not Applicable | Completed | - | Belgium ... 展开 >> ULB Erasme Hospital Brussels, Belgium, 1070 France Hopital Edouard Herriot Lyon, Cedex 3, France, 69437 Germany EVK Krankenhaus der Universitat Dusseldorf Dusseldorf, Germany, D-40217 India Asian Institute of Gastroenterology Hyderabaad, India, 500082 Italy Università Cattolica del Sacro Cuore Rome, Italy, 00168 Netherlands Academisch Medisch Centrum Universiteit van Amsterdam Amsterdam, AZ, Netherlands, 1105 收起 << |
NCT01955174 | Nutcracker Oesophagus | Phase 2 | Completed | - | France ... 展开 >> Service d'Hépato-Gastro-Entérologie et Oncologie Digestive- Hôpital Haut Lévêque - CHU de Bordeaux Bordeaux Cedex, France, 33075 Service d'Exploration Fonctionnelle Digestive - Hôpital Edouard Herriot Pavillon H 5 - Hospices Civils de Lyon LYON Cedex 03, France, 69437 收起 << |
NCT00285103 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | United States, Iowa ... 展开 >> Holden Comprehensive Cancer Center, Univ. of Iowa Iowa City, Iowa, United States, 52242 Denmark Rigshospitalet Copenhagen, Denmark, 2100 KAS Herlev Herlev, Denmark, 2730 Vejle Sygehus Vejle, Denmark, 7100 France Service d'HématologieCentre Hospitalier Lyon-Syd Lyon, Cedex, France, 69495 Bruno Cazin Lille, France, 59037 Mauricette Michellet Lyon, France, 69437 Centre Henri Becquerel Rouen, France, 76038 United Kingdom Leeds General Infirmary Leeds, United Kingdom, LS1 3EX MRC Toxicology Unit, University of Leicester Leicester, United Kingdom, LE1 9HN Christie Hospital NHS Trust Manchester, United Kingdom, M20 4BX The Royal Marsden NHS Foundation Trust Surrey, United Kingdom, SM2 5PT 收起 << |
NCT01326845 | Myelodysplastic Syndrome ... 展开 >> Transfusional Iron Overload 收起 << | Phase 4 | Terminated(The trial was termi... 展开 >>nated due to insufficient enrollment.) 收起 << | - | France ... 展开 >> Novartis Investigative Site Caen, Cedex, France, 14033 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Limoges cedex, France, 87042 Novartis Investigative Site Pessac Cedex, France, 33604 Novartis Investigative Site Vandoeuvre les Nancy, France, 54511 Italy Novartis Investigative Site Alessandria, AL, Italy, 15100 Novartis Investigative Site Torino, TO, Italy, 10126 Novartis Investigative Site Roma, Italy, 00133 South Africa Novartis Investigative Site Bloemfontein, South Africa, 901 Spain Novartis Investigative Site Madrid, Spain, 28033 收起 << |
NCT02099240 | Osteomyelitis | Early Phase 1 | Recruiting | September 2019 | United States, Kentucky ... 展开 >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD 502-852-1148 jarami01@louisville.edu Contact: David Seligson, MD 502-852-0923 d0seli01@louisville.edu Sub-Investigator: Forest Arnold, DO Sub-Investigator: Timothy Wiemkwn, PhD Sub-Investigator: Robert Kelley, PhD Sub-Investigator: James Summersgill, PhD Sub-Investigator: Ruth Carrico, PhD Sub-Investigator: Julie Harting, PharmD Sub-Investigator: Paula Peyrani, MD Principal Investigator: David Seligson, MD Sub-Investigator: Craig Roberts, MD Principal Investigator: Julio Ramirez, MD 收起 << |
NCT01326845 | - | Terminated(The trial was termi... 展开 >>nated due to insufficient enrollment.) 收起 << | - | - | |
NCT01803893 | - | Unknown | - | United States, Connecticut ... 展开 >> Yale Women and Children's Center for Blood Disorders & Yale Fertility Center New Haven, Connecticut, United States, 06511 France Poissy St Germain Hospital Poissy, Cedex, France, 78303 Lab Clement - Seine St. Denis Hospital, Le Blanc Mesnil Paris, France, 93150 Versailles St. Quentin University Poissy, France, 2493 Greece Helena Venizelou Hospital Athens, Greece, 11521 收起 << | |
NCT03492970 | Smith Magenis Syndrome | Not Applicable | Recruiting | December 30, 2020 | France ... 展开 >> CH Le Vinatier Recruiting BRON Cedex, Rhône-Alpes, France, 69678 Contact: POISSON ALICE, PH 0437915163 alice.poisson@ch-le-vinatier.fr Contact: VIAL VERONIQUE 0437915531 veronique.vial@ch-le-vinatier.fr 收起 << |
NCT01805102 | - | Unknown | - | United States, Connecticut ... 展开 >> Yale Women and Children's Center for Blood Disorders & Yale Fertility Center New Haven, Connecticut, United States, 06511 France Poissy St Germain Hospital Poissy, Cedex, France, 78303 Lab Clement - Seine St Denis Hospital, Le Blanc Mesnil Paris, France, 93150 Versailles St Quentin University Poissy, France, 2493 Greece Helena Venizelou Hospital Athens, Greece, 115 21 收起 << | |
NCT02940704 | Pulpitis | Not Applicable | Completed | - | Egypt ... 展开 >> Endodontic Department - Faculty of Oral and Dental Medicine - Cairo University Cairo, Egypt 收起 << |
NCT03453216 | Behavior and Behavior Mechanis... 展开 >>ms 收起 << | Not Applicable | Not yet recruiting | September 30, 2023 | France ... 展开 >> CH Le Vinatier BRON Cedex, Rhône-Alpes, France, 69678 收起 << |
NCT01098656 | Lymphoma | Phase 3 | Terminated(recruitment prematu... 展开 >>rely halted following company's decision to stop financial support to the study) 收起 << | - | Austria ... 展开 >> Medical University of Graz Graz, Austria, 8036 Medical University Vienna - General Hospital Vienna, Austria, 1090 Belgium Cliniques Universitaires St. Luc Brussels, Belgium Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium U.Z. Leuven - Campus Gasthuisberg Leuven, Belgium Finland Helsinky University Central Hospital - Skin & Allergy Hospital Helsinki, Finland, 00029 France Nouvel Hopital Estaing Clermont-Ferrand, Cedex 1, France, 66003 Chu de Bordeaux - Hopital Du Haut Leveque Bordeaux, Pessac Cedex, France, 33604 Chu Lyon - Centre Hospitalier Lyon Sud Lyon, Pierre-Benite Cedex, France, 69495 Chu Amiens - Hopital Sud Amiens, France, 80054 Hopital Saint-Louis Paris, France, 75475 CHU de Reims - Hôpital Robert Debré Reims, France, 51092 Germany Charite - Universitaetsmedizin Berlin - Campus Mitte Berlin, Germany Johannes Gutenberg Universitaetskliniken Mainz, Germany Johannes Wesling Klinikum Minden Minden, Germany Spain Csu de Bellvitge (Institut Catala D'Oncologia) L'Hospitalet De Llobregat, Spain, 08907 Hospital Universitario 12 De Octubre Madrid, Spain Switzerland UniversitaetsSpital Zurich - Division of Oncology Zurich, Switzerland United Kingdom NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre Glasgow, United Kingdom Guy'S and St Thomas' Nhs - St Thomas Hospital London, United Kingdom, SE1 7EH Christie Nhs Foundation Trust Manchester, United Kingdom, M20 4BX Nottingham University Hospitals NHS Trust - City Hospital campus Nottingham, United Kingdom 收起 << |
NCT02166606 | - | Completed | - | - | |
NCT01717612 | Ulcer, on Gastric Varices ... 展开 >> Rebleeding From Gastric Varices 收起 << | Phase 3 | Unknown | - | Taiwan ... 展开 >> E-DA Hospital Recruiting Kaohsiung, Taiwan, 824 Contact: Gin-Ho Lo, M.D 886-7-6150011 ext 1629 ghlo@kimo.com Principal Investigator: Gin-Ho Lo, M.D. 收起 << |
NCT00979745 | Erythropoietic Protoporphyria | Phase 3 | Completed | - | Finland ... 展开 >> HUS:n Iho-ja allergiasairaala (Skin and Allergy Hospital) Helsinki, Finland France Centre Français des Porphyries, Hôpital Louis Mourier Colombes, Cedex, France, 92701 Germany Department of Dermatology , Heinrich-Heine-University Duesseldorf Duesseldorf, Germany, 40225 Ireland Beaumont Hospital, Department of Dermatology Dublin, Ireland, 9 Netherlands Academisch Ziekenhuis Maastricht Maastricht, Netherlands Erasmus Medical Center Rotterdam, Netherlands United Kingdom St Woolos Hospital Newport, Wales, United Kingdom Photobiology Unit - Hope Hospital, University of Manchester Manchester, United Kingdom, M6 8HD 收起 << |
NCT02861885 | - | Recruiting | December 24, 2019 | France ... 展开 >> Hôpital Estaing, CHU Clermont Ferrand, NHE Service d'Hépato-gastroentérologie, 1 place Lucie Aubrac Not yet recruiting Clermont-ferrand, France, 63003 Contact: Julien SCANZI, MD jscanzi@chu-clermontferrand.fr Hospices Civils de Lyon, Hôpital de la Croix Rousse, Service d'hépato-gastroentérologie, 103 Grande-Rue de la Croix Rousse Recruiting LYON cedex 04, France, 69317 Contact: Jean-Christophe SOUQUET, Pr Contact jean-christophe.souquet@chu-lyon.fr Centre Hospitalier Saint JOSEPH Saint Luc, Service d'hépato-gastroentérologie, 20 quai Claude Bernard Not yet recruiting Lyon, France, 69004 Contact: Denis PÉRÉ-VERGÉ, MD dpereverge@ch-stjoseph-stluc-lyon.fr Hospices Civils de Lyon, Hôpital E Herriot, Service d'hépatogastroentérologie, 5 place d'Arsonval Recruiting Lyon, France, 69437 Contact: Christine CHAMBON-AUGOYARD, MD (0)472 110 130 ext +33 christine.chabom-augoyard@chu-lyon.fr Contact: Laurent MAGAUD, Clinical project manager (0)472 112 805 ext +33 laurent.magaud@chu-lyon.fr Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'hépato-gastroentérologie, Chemin Grand Revoyet Recruiting Pierre Benite, France, 69310 Contact: Marion CHAUVENET, MD marion.chauvenet@chu-lyon.fr Centre Hospitalier Villefranche sur Saône, Service d'Hépato-gastroentérologie, Plateux d'Ouilly Gleize Not yet recruiting Villefranche Sur Saone, France, 69655 Contact: Fabien PETIT-LAURENT, MD fpetitlaurent@lhopitalnordouest.fr 收起 << | |
NCT00354133 | Parkinson Disease | Phase 4 | Active, not recruiting | March 2022 | France ... 展开 >> Michallon Hospital, CHU Grenoble, Service de Neurologie, BP217 Grenoble Cedex, France, 38043 Service de Neurologie C, Hôpital Neurologique et neurochirurgical Pierre Wertheimer , 59 Bd Pinel 69677 BRON Cedex Lyon, France, 69677 Centre hospitalier La Timone, Service de neurologie et pathologie du mouvement,Boulevard Jean Moulin Marseille, France, 13005 "Hôpital Nord Laënnec Boulevard Jacques-Monod - Saint-Herblain Nantes, France, 44093 CIC, CHU Pitié-Salpêtrière, 47-83 Bd de l'Hôpital Paris Cedex 13, France, 75651 Hôpital La Milétrie, Tour Jean Bernard, 350 Av Jacques Cœur, BP 577 Poitiers, France, 86021 Centre Hospitalo-Universitaire de Rouen, Charles Nicolle, bat. DV, 1 rue de Germont Rouen, France, 76031 Centre d'investigation Clinique, Pavillon Riser, Hôpital Purpan,Place du Dr Baylac TSA 40031 Toulouse, France, 31059 Germany Klinik und Poliklinik für Neurologie, Charite Berlin, Germany Neurologische Klinik der Universität, Moorenstr. 5 Duesseldorf, Germany, 40225 Neurologische Universitätsklinik Freiburg, Breisacher Str. 64 Freiburg, Germany, 79106 Paracelsus-Elena-Klinik, Kassel, Klinikstrasse 16 Kassel, Germany, 34128 Klinik für Neurologie, Universitätsklinikum Schleswig-Holstein, Schittenhelmstr. 10 Kiel, Germany, 24105 Klinik und Poliklinik für Neurologie Köln, Germany, 50924 Klinikum der Universität München Neurologische Klinik und Poliklinik - Großhadern, Marchioninistr. 15 München, Germany, 81377 Universitätsklinikum Tübingen, Klinik für Neurochirurgie, Hoppe-Seyler-Str.3 Tübingen, Germany, 72076 收起 << |
NCT02614833 | Adenocarcinoma Breast Stage IV | Phase 2 | Recruiting | December 2020 | Belgium ... 展开 >> AZ Sint-Jan Burgge-Oostende Recruiting Brugge, Belgium, 8000 Cliniques universitaires Saint-Luc - Institut Roi Albert II - Cancérologie et Hématologie Oncologie clinique Recruiting Brussel, Belgium, 1200 AZ Sint-Maarten Recruiting Duffel, Belgium, 2570 Universitair Ziekenhuis Antwerpen Breast and Gynecological Oncology Unit Recruiting Edegem, Belgium, 2650 UZ Leuven, campus Gasthuisberg Department of General Medical Oncology and Multidisciplinary Breast Centre Recruiting Leuven, Belgium, 3000 Centre Hospitalier Universitaire Sart Tilman Oncologie médicale Recruiting Liège, Belgium, 4000 Clinique Sainte-Elisabeth Recruiting Namur, Belgium, 5000 GZA Ziekenhuizen campus Sint-Augustinus Oncologische Research Recruiting Wilrijk, Belgium, 2610 France Institut de Cancérologie de la Loire Recruiting Saint Priest en Jarez, France, 42271 Institut Curie / Centre René Huguenin Recruiting Saint-Cloud, France, 92210 Institut Claudius Regaud - IUC Toulouse - Oncopôle Recruiting Toulouse Cedex 9, France, 31059 Germany HELIOS Klinikum Berlin-Buch Gynecologic Oncology and Obstetrics, Head of the Interdisciplinary, Breast Cancer Center Withdrawn Berlin, Germany, 13125 KEM- Brustzentrum der Kliniken Essen-Mitte Recruiting Essen, Germany, 45136 Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus Centrum für Hämatologie und Onkologie Recruiting Frankfurt, Germany, 60389 NCT - Nationales Centrum für Tumorerkrankungen Recruiting Heidelberg, Germany, 69120 UFKT - Universitäts-Frauenklinik Tübingen Recruiting Tübingen, Germany, 72076 UFU - Universitätsfrauenklinik Ulm Recruiting Ulm, Germany, 89081 Hungary Szent Margit Kórház Onkológiai Osztály Recruiting Budapest, Hungary, 1032 MH Egészségügyi Központ Onkológiai Osztály Recruiting Budapest, Hungary, 1062 DE KK Onkológiai Klinika Recruiting Debrecen, Hungary, 4032 Somogy Megyei Kaposi Mór Oktató Kórház Klinikai Onkológiai Centrum Kaposvár Withdrawn Kaposvár, Hungary, 7400 Netherlands VU University Medical Center Recruiting Amsterdam, Netherlands, 1081 Reinier de Graaf Gasthuis Recruiting Delft, Netherlands, 2625 Zuyderland MC Recruiting Geleen, Netherlands, 6162 UMCG Medisch Centrum Groningen Recruiting Groningen, Netherlands, 9700 MUMC Medical Oncology department Recruiting Maastricht, Netherlands, 6202 Erasmus MC Recruiting Rotterdam, Netherlands, 3075 VieCuri Medisch Centrum Recruiting Venlo, Netherlands, 5912 BL Poland Kierownik Oddziału Onkologii i Radioterapii Szpital Morski im. PCK w Gdyni Recruiting Gdynia, Poland, 81 - 519 University Centre for Ophthalmology and Oncology Recruiting Katowice, Poland, PL-40-514 Specjalistyczna Praktyka Recruiting Warsaw, Poland, 02-954 Military Institute of Medicine, Oncology Dept Withdrawn Warsaw, Poland, 04-141 United Kingdom St James' Institute of Oncology Recruiting Leeds, West Yorkshire, United Kingdom, LS9 7TF The Christie NHS Foundation Trust The Christie Clinic - Medical Oncology Recruiting Manchester, United Kingdom, M20 4BX Nottingham University Hospitals NHS Trust Recruiting Nottingham, United Kingdom, NG5 1PB 收起 << |
NCT01117818 | Alzheimer's Disease | Phase 2 | Completed | - | Austria ... 展开 >> Landeskrankenhaus Hall Gedächtnisambulanz Hall in Tirol, Austria, 6060 LNK Wagner-Jauregg, Dept. of geriatrics Linz, Austria, 4020 Christian Doppler Klinik, Univ. Klinik f. Neurologie Salzburg, Austria, 5020 Studienzentrum der PROSENEX, Ambulatoriumbetriebsges.m.b.H an der Confraternität - Privatklinik Josefstadt Vienna, Austria, 1080 MUW Klin. Pharmakologie und Klinik für Neurologie Vienna, Austria, 1090 MUW, Klin.Abt.f. Biolog. Psychiatrie Vienna, Austria, 1090 SMZ-Ost, Psychiatric Dep. Vienna, Austria, 1220 Croatia Klinčki Bolnički Centar Rijeka, Klinika za Psihijatriju Rijeka, Croatia, 51000 Opća bolnica Varaždin, Klinika za Neurologiju Varaždin, Croatia, 42000 "BONIFARM" Poliklinika za kliničku farmakologiju i toksikologiju Zagreb, Croatia, 10000 Klinčki Bolnički Centar Zagreb (REBRO), Klinika za Neurologiju Zagreb, Croatia, 10000 Psihijatrijska Bolnica Vrapče Zagreb, Croatia, 10090 Czech Republic University Thomayer Hospital Praha 4, Czech Republic, 149 50 University Hospital Motol, Clinic of Neurology Praha 5, Czech Republic, 150 06 France CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard Bordeaux Cedex, France, 33076 Hôpital Neurologique Pierre Wertheimer Bron, France, 69500 Centre Hospitalier Universitaire (CHU) de Dijon Dijon, France, 21033 Centre Mémoire de Ressources et de Recherche, Service de Neurologie Montpellier Cedex 05, France, 34295 Hôpital de la Pitié-Salpêtrière Paris, France, 75651 CHU de rennes Site Hôtel Dieu RENNES Cedex, France, 35064 Hopital La Grave Toulouse, France, 31059 Germany Charite Universitätsmedizin Berlin, Klinik u. Hochschulambulanz f. Psychiatrie u. Psychotherapie Berlin, Germany, 14050 Universitätsklinikum Hamburg-Eppendorf, Klinik für Psychiatrie und Psychotherapie Hamburg, Germany, 20251 Arzneimittelforschung Leipzig GmbH, Studienzentrum Leipzig, Germany, 04107 Zentralinstitut für Seelische Gesundheit, Abt. Gerontopsychiatrie Mannheim, Germany, 68159 Klinik u. Poliklinik f. Psychiatrie u. Psychotherapie der TU München Munich, Germany, 81675 Studienzentrum PD Dr. Steinwachs Nürnberg, Germany, 90402 Klinikum Nürnberg Nord, Klinik f. Psychiatrie u. Psychotherapie Nürnberg, Germany, 90419 NeuroPoint GmbH Ulm/Donau, Germany, 89073 Slovakia EPAMED, s.r.o. Kosice, Slovakia, 040 17 Psychiatric Hospital Michalovce Michalovce, Slovakia, 071 01 收起 << |
NCT02565147 | - | Terminated(Futility at the int... 展开 >>erim analysis.) 收起 << | - | - | |
NCT01373502 | Stable Angina ... 展开 >> Unstable Angina Documented Silent Ischemia 收起 << | Not Applicable | Completed | - | Belgium ... 展开 >> Academisch Ziekenhuis Middelheim Antwerpen, Belgium Ziekenhuis Oost Limburg Genk, Belgium France Clinique les Franciscaines Nimes, France Institut Mutualiste Montsouris Paris, France Clinique Saint-Hilaire Rouen, France Hôpital de Rangueil Toulouse Cedex 4, France Germany Medizinisches Versorgungszentrum Hamburg, Germany Krankenhaus der Barmherzigen Brüder Trier, Germany Italy Azienda Ospedaliera Careggi Firenze, Italy Istituto di Fisiologia Clinica del CNR Massa, Italy Ospedale S. Camillo Roma, Italy 收起 << |
NCT03300453 | Sanfilippo Syndrome B | Phase 1 Phase 2 | Active, not recruiting | November 2019 | France ... 展开 >> Hopitaux Universitaires Paris-Sud Paris, Le Kremlin-Bicetre Cedex, France, 94275 收起 << |
NCT00227097 | - | Terminated | - | France ... 展开 >> Cardiovascular Departement - University Hospital of Grenoble - BP 217 La tronche, Grenoble Cédex 9, France, 38700 收起 << | |
NCT02565147 | Acute Myocardial Infarction | Phase 3 | Terminated(Futility at the int... 展开 >>erim analysis.) 收起 << | - | France ... 展开 >> Hopital Ambroise Paré Boulogne Cedex, France, 92104 Hospital Lariboisière Paris, France, 75010 Netherlands VUMC Amsterdam Amsterdam, Netherlands, 1117 HV Erasmus Medical Center Rotterdam, Netherlands, 3015 CE 收起 << |
NCT01237483 | Head and Neck Cancer Squamous ... 展开 >>Cell 收起 << | Phase 2 | Completed | - | France ... 展开 >> Hôpital Bretonneau Tours Cedex 09, France, 37044 收起 << |
NCT00839670 | Stroke | Phase 3 | Terminated(departure of the in... 展开 >>vestigator coordinator into other country) 收起 << | - | France ... 展开 >> Service de Médecine Physique et de Réadaptation - Hôpital BICHAT Paris, Paris Cedex 18, France, 75877 收起 << |
NCT02008513 | Alzheimer´s Disease | Phase 2 | Terminated(Study AFF006A was e... 展开 >>arly terminated by the sponsor based on the results of study AFF006.) 收起 << | - | Austria ... 展开 >> Landeskrankenhaus Hall Gedächtnisambulanz Hall in Tirol, Austria, 6060 LNK Wagner-Jauregg, Dept. of geriatrics Linz, Austria, 4020 Christian Doppler Klinik, Univ. Klinik f. Neurologie Salzburg, Austria, 5020 MUW Klin. Pharmakologie und Klinik für Neurologie Vienna, Austria, 1090 MUW, Klin.Abt.f. Biolog. Psychiatrie Vienna, Austria, 1090 SMZ-Ost, Psychiatric Dep. Vienna, Austria, 1220 Croatia Klinčki Bolnički Centar Rijeka, Klinika za Psihijatriju Rijeka, Croatia, 51000 Opća bolnica Varaždin, Klinika za Neurologiju Varaždin, Croatia, 42000 "BONIFARM" Poliklinika za kliničku farmakologiju i toksikologiju Zagreb, Croatia, 10000 Psihijatrijska Bolnica Vrapče Zagreb, Croatia, 10090 Czech Republic University Thomayer Hospital Praha, Czech Republic, 14950 University Hospital Motol, Clinic of Neurology Praha, Czech Republic, 15006 France CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard Bordeaux Cedex, France, 33076 Hôpital Neurologique Pierre Wertheimer Bron, France, 69500 Centre Hospitalier Universitaire (CHU) de Dijon Dijon, France, 21033 Centre Mémoire de Ressources et de Recherche, Service de Neurologie Montpellier Cedex, France, 34295 Hôpital de la Pitié-Salpêtrière Paris, France, 75651 CHU de Rennes Site Hôtel Dieu Rennes Cedex, France, 35064 Hopital La Grave Toulouse, France, 31059 Germany Charite Universitätsmedizin Berlin, Klinik u. Hochschulambulanz f. Psychiatrie u. Psychotherapie Berlin, Germany, 14050 Universitätsklinikum Hamburg-Eppendorf, Klinik für Psychiatrie und Psychotherapie Hamburg, Germany, 20251 Arzneimittelforschung Leipzig GmbH, Studienzentrum Leipzig, Germany, 04107 Zentralinstitut für Seelische Gesundheit, Abt. Gerontopsychiatrie Mannheim, Germany, 68159 Klinik u. Poliklinik f. Psychiatrie u. Psychotherapie der TU München Munich, Germany, 81675 Studienzentrum PD Dr. Steinwachs Nürnberg, Germany, 90402 NeuroPoint GmbH Ulm/Donau, Germany, 89073 Slovakia EPAMED, s.r.o. Kosice, Slovakia, 04017 收起 << |
NCT00213460 | - | Completed | - | France ... 展开 >> CHU Rouen Rouen, Rouen Cedex, France, 76031 收起 << | |
NCT00505622 | - | Terminated(Study stopped due t... 展开 >>o lack of efficacy.) 收起 << | - | - | |
NCT00505622 | Parkinson's Disease | Phase 3 | Terminated(Study stopped due t... 展开 >>o lack of efficacy.) 收起 << | - | France ... 展开 >> Centre d'Investigation Clinique, Hospital Purpan Toulouse, Toulouse Cedex, France, 31059 收起 << |
NCT03769571 | Autism Spectrum Disorder | Not Applicable | Recruiting | November 7, 2021 | France ... 展开 >> Service de pédopsychiatrie Sainte-Marguerite Recruiting Marseille, Marseille Cedex 09, France, 13274 Contact: Clarisse Chatel, PH 0491745771 clarisse.chatel@ap-hm.fr 收起 << |
NCT00213525 | - | Completed | - | France ... 展开 >> Rouen University Hospital Rouen, Rouen Cedex, France, 76031 收起 << | |
NCT02017899 | Shigellosis | Phase 1 | Completed | - | France ... 展开 >> Centre d'Investigation Clinique en Vaccinologie Cochin-Pasteur (CIC1417) Paris, Paris cedex 14, France, 75679 收起 << |
NCT00143312 | - | Completed | - | - | |
NCT00143312 | Prophylaxis Of Invasive Fungal... 展开 >> Infections 收起 << | Phase 4 | Completed | - | Belgium ... 展开 >> Pfizer Investigational Site Leuven, Belgium, 3000 France Pfizer Investigational Site Marseille, Cedex 09, France, 13273 Pfizer Investigational Site Creteil, France, 94010 Pfizer Investigational Site Nantes, France, 44035 cedex Pfizer Investigational Site Pessac, France, 33600 Pfizer Investigational Site Strasbourg, France, 67098 Germany Pfizer Investigational Site Koeln, Germany, 50937 Pfizer Investigational Site Mainz, Germany, 55101 Pfizer Investigational Site Wuerzburg, Germany, 97070 Portugal Pfizer Investigational Site Lisboa, Portugal, 1099-023 Spain Pfizer Investigational Site Barcelona, Spain, 08025 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Madrid, Spain, 28006 Sweden Pfizer Investigational Site Stockholm, Sweden, 141 86 Switzerland Pfizer Investigational Site CH-4031 Basel, Switzerland United Kingdom Pfizer Investigational Site London, United Kingdom, W12 0NN Pfizer Investigational Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT02514616 | GERD | Not Applicable | Terminated(Early termination d... 展开 >>ue to a suspension of financial support) 收起 << | - | Belgium ... 展开 >> Gastroenterology Department, Erasme University Hospital Brussels, Belgium, 1070 France Hôpital Edouard Herriot, Service d'Explorations Fonctionnelles Digestives, Pavillons H et L, 5 Place d'Arsonval Lyon, Lyon Cedex 3, France, 69437 收起 << |
NCT02570724 | Intracranial Hypotension | Not Applicable | Completed | - | France ... 展开 >> Service Anesthésie Réanimation Chirurgicale Hôpitaux Universitaires de Strasbourg, 1 avenue Molière Strasbourg, Strasbourg Cedex, France, 67098 收起 << |
NCT00202644 | - | Completed | - | - | |
NCT00429013 | PARAPLEGIA | Phase 2 | Terminated(principal criteria ... 展开 >>was achieved with the intermediate statistical analysis) 收起 << | - | France ... 展开 >> University Hospital of Grenoble Grenoble, Cedex 09, France, 38043 收起 << |
NCT02574468 | Vital Pulp Therapy | Phase 4 | Completed | - | - |
NCT00294320 | Actinic Keratosis | Phase 3 | Completed | - | France ... 展开 >> Hopital L'Archet 2 Nice, Cedex 3, France 收起 << |
NCT00603096 | Obesity-Hypoventilation Syndro... 展开 >>me (OHS) 收起 << | Not Applicable | Unknown | June 2008 | France ... 展开 >> Laboratoire d'Explorations Fonctionnelles Cardio-Respiratoires - CHU Grenoble Recruiting Grenoble, Cedex 9, France, 38043 Contact: Jean-Louis Pepin, Pr JLPepin@chu-grenoble.fr Contact: Jean-Christian Borel JCBorel@chu-grenoble.fr 收起 << |
NCT00202644 | Thrombocythemia, Hemorrhagic | Phase 4 | Completed | - | Bulgaria ... 展开 >> University Multiprofile Hospital for Active Treatment ''Dr Georgi Stranski'' - Pleven Pleven, Bulgaria, 5800 University Multiprofile Hospital for active Treatment ''Alexandrovska'' Clinic of Haematology Sofia, Bulgaria, 1303 University Multiprofile Hospital for Active Treament ''Sv. Marina'' - Varna Haematology Clinic Varna, Bulgaria, 9010 France CHU Angers Services des Maladies du Sang Angers, Cedex 09, France, 49933 Hopital Saint Louis - Centre d'Investigation Clinique Paris, France Hungary University of Debrecen Medical and Health Science Centre Debrecen, Hungary, 4012 Petz Aladar County Teaching Hospital Gyor, Hungary, 9024 Pandy Kalman Hospital of Bekes County Gyula, Hungary, 5700 Kaposi Mor Teaching Hospital Kaposvar, Hungary, 7400 Poland Uniwersyteckie Centrum Kliniczne Katedra i Klinika Hematologii i Transplantologii Gdansk, Poland, 80-952 Samodzielny Publiczny Szpital Kliniczny Nr 1 Lublin, Poland, 21-081 Katedra i Klinika Onkologii i Chorob Wewnetrznych Akademii Medycznej Warsaw, Poland, 02-097 Klinika Hematologii Instytut Hematologii i Transfuzjologi Warsaw, Poland, 02-776 Portugal Hospitals da Universidade de Coimbra Coimbra, Portugal, 3000-076 Serbia Institute for Haematology of Clinical Centre of Serbia Belgrade, Serbia, 11000 收起 << |
NCT00827749 | Swallowing Disorders | Early Phase 1 | Completed | - | France ... 展开 >> University Hospital of Grenoble Grenoble, Cedex 09, France 收起 << |
NCT01742949 | Obstructive Sleep Apnea | Not Applicable | Completed | - | France ... 展开 >> Hôpital Bichat-Claude Bernard Paris, Paris Cedex, France, 75877 Hôpital Henri Mondor Paris, France Hôpital La Pitie Salpetriere Paris, France Hôpital Louis Mourier Paris, France 收起 << |
NCT03765853 | Lower Back Pain | Not Applicable | Recruiting | October 30, 2020 | France ... 展开 >> Service de Gynécologie Obstétrique - Hôpital Nord Recruiting Marseille, Marseille Cedex, France, 13915 Contact: Florence Bretelle 33(0)4 91 96 46 72 florence.bretelle@ap-hm.fr 收起 << |
NCT00152685 | Severe Head Injury | Phase 2 Phase 3 | Unknown | - | France ... 展开 >> Surgical intensive care. CHU Recruiting Angers, Cedex 9, France, 49993 Contact: ter Minassian Aram, MD, PhD 33 (0)2 4135 39 51 arterminassian@chu-angers.fr Principal Investigator: Ter Minassian Aram, MD, PhD Neurosurgical intensive care. CHU Le Kremlin Bicêtre Not yet recruiting Le Kremlin Bicêtre, France, 94275 Contact: Vigue Bernard 33 (0)1 45213441 bernard.vigue@bct.ap-hop-paris.fr Principal Investigator: Vigue Bernard, MD, PhD Neurosurgical intensive care. CHU de Nancy Recruiting Nancy, France, 54035 Contact: Audibert Gérard, MD, PhD 33 (0)3 83 85 14 03 g.audibert@chu-nancy.fr Principal Investigator: Audibert Gérard, Md, PhD 收起 << |
NCT00931567 | Dupuytren's Contracture | Phase 2 Phase 3 | Completed | - | France ... 展开 >> CHU Hôpital de la Timone Marseille, Cedex 05, France, 13385 Centre Hospitalier Universitaire de Nice Hôpital de Cimiez Nice, France, 06000 收起 << |
NCT01757522 | - | Unknown | December 2016 | France ... 展开 >> University Hospital of Grenoble Recruiting Grenoble, Cedex 09, France, 38043 Contact: Carole SCHWEBEL, PU/PH 33-476768779 cschwebel@chu-grenoble.fr Contact: Cyrielle CLAPE, CRA 33-476767109 cclape@chu-grenoble.fr Principal Investigator: Carole SCHWEBEL, PU/PH Sub-Investigator: Agnes BONADONA, PH Sub-Investigator: Rebecca HAMIDFAR, PH Sub-Investigator: Clemence MINET, PH Sub-Investigator: Claire ARA SOMOHANO, PH Sub-Investigator: Patrice FAURE, PU/PH Sub-Investigator: Bertrand TOUSSAINT, PU/PH Sub-Investigator: Carole SAUNIER, PH Sub-Investigator: Nicolas TERZI, PU/PH 收起 << | |
NCT01176942 | Metabolic Endotoxemia ... 展开 >> Metabolic Syndrome 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU Toulouse Hospital Toulouse, Cedex 9, France 收起 << |
NCT00925509 | Upper Digestive Tract Cancer | Not Applicable | Terminated(Insufficient recrui... 展开 >>tment, too much selective inclusion criteria, feasibility problems) 收起 << | December 2011 | France ... 展开 >> Centre Léon Bérard Service de Chirurgie-Stomatologie Lyon, Cedex 08, France, 69373 CHU Hôtel-Dieu Service d'Odontologie Clermont-ferrand, France, 63 000 Hospices Civils de Lyon Service de Consultations et Traitements Dentaires Lyon, France, 69007 Centre Hospitalier Lyon Sud Service de Stomatologie et Chirurgie Maxillo-Faciale Pierre Benite, France, 69495 收起 << |
NCT01977053 | Non-metastatic Patients With B... 展开 >>reast Cancer Non-metastatic Patients With Colon Cancer Non-metastatic Patients With Rectal Cancer Patients Undergoing Adjuvant Chemotherapy 收起 << | Not Applicable | Active, not recruiting | December 2018 | France ... 展开 >> Centre Antoine Lacassagne Nice, Cedex 2, France, 06189 Polyclinique St Jean Cagnes sur Mer, France, 06800 收起 << |
NCT02111837 | Infant Growth | Not Applicable | Completed | - | France ... 展开 >> CHU de Caen Caen, Cedex 9, France, 14033 Hôpital Bretonneau - UPM Tours, Cedex 9, France, 37044 Groupe Hospitalier Pellegrin Bordeaux, France, 33076 Italy Istituto di Ostetricia e Ginecologia Neonatalogia Palermo, Italy, 90127 收起 << |
NCT00234637 | Alzheimer's Disease | Phase 4 | Completed | - | France ... 展开 >> Département de Gérontologie Clinique Limoges, Cedex, France, 87042 收起 << |
NCT00596804 | Non-Hodgkin's Lymphoma ... 展开 >> Lymphoma, Diffuse Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Service Des Maladies Du Sang Lille, Cedex, France, 59037 Centre hospitalier Lyon Lyon, Pierre Benite Cedex, France, 69495 United Kingdom University of Leicester Leicester, United Kingdom, LE1 9HN 收起 << |
NCT02331498 | Glioblastoma Multiforme | Phase 1 Phase 2 | Recruiting | December 2018 | France ... 展开 >> Centre Antoine Lacassagne Recruiting Nice, Cedex 2, France, 06189 Contact: Esma SAADA BOUZID, Md +33492031618 esma.saada-bouzid@nice.unicancer.fr Contact: Christine LOVERA +33492031618 christine.lovera@nice.unicancer.fr Principal Investigator: Esma SAADA BOUZID, Dr Sub-Investigator: Jérôme BARRIERE, Pr. Sub-Investigator: Pierre Yves BONDIAU, Dr. 收起 << |
NCT02012985 | Primary Hyperoxaluria | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Hôpital Robert-Debré, Néphrologie Pédiatrique Paris, Cedex 19, France, 75945 Hôpital des Enfants, Centre de référence maladies rénales rares du Sud-Ouest (SORARE), CHU de Bordeaux Bordeaux, France, 33076 Hôpital Femme Mère Enfant, Lyon - Paediatric Dept Lyon, France, 69677 Bron Hôpital Necker-Enfants Malades,Centre de référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA) Paris, France, 75015 Germany Universitätsklinikum Bonn, Dept of Paediatric Nephrology Bonn, Germany, DE-53113 United Kingdom Birmingham Children's Hospital NHS Foundation Trust - Dept of Nephrology Birmingham, United Kingdom, B4 6NH Royal Free Hospital -UCL Centre for Nephrology London, United Kingdom, NW3 2QG Great Ormond Street Hospital for Children NHS Trust London, United Kingdom, WCIN 3JH 收起 << |
NCT00526487 | Aortic Dissection Involving th... 展开 >>e Descending Thoracic Aorta 收起 << | Not Applicable | Completed | - | Australia ... 展开 >> St. Vincent's Hospital Melbourne Melbourne, Australia, VIC 3065 Czech Republic St. Anne's Universtiy Hospital Brno Brno, Czech Republic, 656 91 France CHRU de Lille Lille, Cedex, France, 59037 Germany Hannover Medical School Hannover, Germany, 30625 Heart Center Leipzig / Park Hospital Leipzig, Germany, 04289 Clinic of Internal Medicine, University Hospital Rostock Rostock, Germany, 18057 Italy Hospital San Raffaele Milan, Italy, 20129 IRCCS Policlinico San Matteo Pavia, Italy, 27100 收起 << |
NCT03068663 | Non Small Cell Lung Cancer | Not Applicable | Recruiting | November 30, 2019 | France ... 展开 >> Centre Jean Perrin Recruiting Clermont Ferrand, Cedex 1, France, 63003 Contact: Marc Filaire, Professor 0473278121 marc.filaire@clermont.unicancer.fr 收起 << |
NCT02821156 | - | Completed | - | Belgium ... 展开 >> Cliniques Universitaires ST Luc Bruxelles, Belgium, 1200 CHU Sart TILMAN Liège, Belgium France Hôpital Pitié-Salpêtrière Paris, Cedex 13, France, 75651 Hôpital Necker-Enfants Malades Paris, Paris cedex, France, 75743 Hôpital Haut-Lévèque Bordeaux, France, 33604 Hôpital du Bocage Central Dijon, France, 21079 CHU Montpellier - Hôpital Arnaud de Villeneuve Montpellier, France, 34295 Hôpital Arnaud de Villeneuve Montpellier, France, 34295 CHU de Nantes - Hôpital Laennec Nantes, France, 44093 Hôpital Hôtel Dieu Nantes, France, 44093 Hôpital Trousseau Paris, France, 75012 Hôpital Necker-Enfants Malades Paris, France, 75015 American Memorial Hospital Reims, France, 51092 Clinique Pasteur Toulouse, France, 31076 收起 << | |
NCT00957788 | Tinnitus | Phase 1 | Terminated | May 2013 | Belgium ... 展开 >> Cliniques Universitaries U.C.L. Mont-Godinne, Belgium France Hôpital Avicenne Bobigny, Cedex, France, 93009 收起 << |
NCT03367208 | - | Completed | - | France ... 展开 >> Centre Antoine Lacassagne Nice, Cedex 2, France, 06189 收起 << | |
NCT03706677 | Persistent Atrial Fibrillation... 展开 >> Atrial Arrhythmia 收起 << | Not Applicable | Not yet recruiting | July 31, 2022 | France ... 展开 >> Clinique Pasteur Toulouse Not yet recruiting Toulouse, Cedex 3, France, 31076 Contact: Serge Boveda, Dr Germany Herz-Zentrum Bad Krozingen Not yet recruiting Bad Krozingen, Germany, 79189 Contact: Thomas Arentz, Prof. Dr. Cardioangiologisches Centrum Bethanien CCB Not yet recruiting Frankfurt am Main, Germany, 60431 Contact: KR Julian Chun, PD Dr. Asklepios St. Georg Not yet recruiting Hamburg, Germany, 20099 Contact: Andreas Rillig, PD Dr. 收起 << |
NCT01998854 | - | Terminated(Investigational dev... 展开 >>ice changes) 收起 << | - | France ... 展开 >> Le Centre Hospitalier Regional et Universitaire de Tours - Hôpital Bretonneau Tours, Cedex, France, 37044 Assistance Publique Hôpitaux de Paris - Hôpital Bicêtre Paris, France, 75475 收起 << | |
NCT01718886 | - | Completed | - | Belgium ... 展开 >> Department of Gastroenterology, Erasme Hospital Brussels, Belgium, 6B1070 France Service D'exploration Functionelle Digestive, Hospital Edouard Harriot Lyon, Cedex, France, 69473 收起 << | |
NCT01284894 | Dysphagia | Not Applicable | Completed | - | France ... 展开 >> Unité d'Exploration Fonctionnelle Digestive - Hopital Edouard Herriot - 69437 LYON Cedex 03 Lyon, France, 69437 收起 << |
NCT00421395 | NHL B-Cell NH... 展开 >>L Non-Hodgkins Lymphoma 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Research Unit 463 INSERM Nantes, Cedex, France, 44035 Service des Maladies du Sang Lille, France, 59037 Germany University Hospital Dresden Dresden, Germany, 01307 Klinikum der Georg-August-Universitat Gottingen Gottingen, Germany, 37075 Universitatsklinikum University of Saarland Homburg/Saar, Germany, D-66421 收起 << |
NCT00323895 | Coronary Artery Disease | Phase 4 | Completed | - | France ... 展开 >> Centre Cardiologique du Nord Saint Denis, France Unite de Cardiologie Interventionelle Toulouse Cedex 3, France, 4131076 收起 << |
NCT01899196 | Hiv Infection | Not Applicable | Completed | - | France ... 展开 >> Hospital St Antoine Paris, France, 75012 收起 << |
NCT01835938 | Chronic Hepatitis C Infection ... 展开 >> HCV Genotype 1b 收起 << | Phase 1 Phase 2 | Unknown | May 2015 | France ... 展开 >> Service d'Hépatogastroentérologie, NHC1, place de l'hôpital Not yet recruiting Strasbourg Cedex, Alsace, France, BP n°426 Principal Investigator: Pr. Michel DOFFOEL, MD, PhD 收起 << |
NCT00969683 | Anesthesia | Not Applicable | Completed | - | France ... 展开 >> Service d'Anesthésie, Hôpital Foch Suresnes, France, 92150 收起 << |
NCT02973776 | Psoriasis Vulgaris | Phase 1 | Completed | - | France ... 展开 >> CPCAD Nice, Cedex, France, 06202 收起 << |
NCT00996255 | Advanced/Metastatic Solid Tumo... 展开 >>rs 收起 << | Phase 1 | Terminated | - | France ... 展开 >> Institut Gustave-Roussy Villejuif Cedex, France, 94805 United Kingdom St. James University Hospital Leeds, United Kingdom, LS9 7TF 收起 << |
NCT01523743 | Neurogenic Bladder Dysfunction... 展开 >> Nos 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> PrivatHospitalet Danmark, privat hospital, Charlottenlund, Denmark Rigshospitalet, Urology clinic, Copenhagen, Denmark CCBR Vejle, Clinical research site, Vejle, Denmark France Hôpital Tenon, Neuro-Urology and perineal explorations department, Paris, Cedex 20, France Hôpital Raymond Poincaré, Urology clinic Garches, France, 92350 Hôpital Léon Berard, Rehabilitation clinic, Hyères cedex, France Hôpital Henry Gabrielle, Urology clinic, Saint Genis Laval, France Germany University Heidelberg, Neuro-Urology clinic, Heidelberg, Germany Norway St. Olavs Hospital HF, Neurologi clinic, Trondheim, Norway Sweden Gävle sjukhus, Urology clinic, Gävle, Sweden Rehab Station Stockholm, Stockholm, Sweden 收起 << |
NCT01523743 | - | Completed | - | - | |
NCT02633800 | Head and Neck Neoplasms | Phase 2 | Completed | - | Belgium ... 展开 >> Institut Jules Bordet Brussels, Belgium, 1000 Univeristair Ziekenhuis Antwerpen Edegem, Belgium, 2650 UZ Leuven Leuven, Belgium, 3000 France Institut Curie Paris, Cedex, France, 75248 Institut de Cancerologie de l'Ouest Angers cedex 02, France, 49055 Centre Hospitalier de Bordeaux - Hôpital Saint André Bordeaux, France, 33075 Hopital Croix-Rousse Lyon, France, 69004 Centre Leon Berard Lyon, France, 69373 CHU Hopital de la Timone Marseille, France, 13005 Hopital Saint Joseph Marseille, France, 13008 Centre de Cancerologie du Grand Montpellier Montpellier, France, 34070 Institut de Cancerologie de l'Ouest Saint-Herblain Cedex, France, 44805 Gustave Roussy Villejuif, France, 94805 Germany Charite Universitatsmedizin Berlin Berlin, Germany, 12200/12203 Medizinische Hochschule Hannover Hannover, Germany, 30625 Klinikum der Universitat Munchen München, Germany, 81377 Hungary Orszagos Onkologiai Intezet Budapest, Hungary, 1122 Debreceni Egyetem Orvos-es Egeszsegtudomanyi Centrum Debrecen, Hungary, 4032 Bacs-Kiskun Megyei Korhaz Kecskemet, Hungary, 6000 Borsod Abauj Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz Miskolc, Hungary, 3526 Josa Andras Oktatokorhaz Nyíregyháza, Hungary, 4400 Poland Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy Bydgoszcz, Poland, 85-796 Przychodnia Lekarska "KOMED" Konin, Poland, 62-500 Regionalny Osrodek Onkologiczny Szpital im. M. Kopernika w Lodzi Lodz, Poland, 93-513 Romania Medisprof SRL Cluj-Napoca, Romania, 400058 Centrul de Oncologie Sfantul Nectarie Craiova, Romania, 200347 Institutul Regional de Oncologie Iasi Iasi, Romania, 700483 United Kingdom University College London Hospitals NHS Foundation Trust - University College Hospital London, United Kingdom, NW1 2PG Guy's and St Thomas' NHS Foundation Trust - St Thomas' Hospital London, United Kingdom, SE1 7EH The Royal Marsden NHS Foundation Trust London, United Kingdom, SW3 6JJ Weston Park Hospital Sheffield, United Kingdom, S10 2SJ The Shrewsbury and Telford Hospital NHS Trust Shrewsbury, United Kingdom, SY3 8XQ Southampton General Hospital Southampton, United Kingdom, SO16 6YD The Royal Marsden NHS Foundation Trust Sutton, United Kingdom, SM2 5PT 收起 << |
NCT01256073 | Acute Myeloid Leukemia | Phase 1 | Completed | - | France ... 展开 >> Institut Paoli-Calmettes Marseille, Marseille Cedex 09, France, 13273 Hopital Dupuytren LIMOGES Cedex, France, 87042 C.H.R.U. de Nantes - Hotel Dieu NANTES Cedex 1, France, 44093 Centre Hospitalier Lyon Sud - Hospices Civils de Lyon Pierre-Bénite, France, 69495 Hopital de Purpan Toulouse Cedex 9, France, 31059 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT01551524 | Hematologic Malignancies | Phase 1 | Completed | - | France ... 展开 >> Centre Henri Becquerel Rouen, Cedex, France, 76038 Hôpital Henri Mondor Créteil, France, 94010 Hôpitaux du CHU de Nantes Nantes, France Hospices Civils de Lyon Pierre-Bénite, France, 69495 Institut Claudius Regaud Toulouse, France, 31052 收起 << |
NCT00159822 | Aspergillosis | Phase 2 Phase 3 | Completed | - | France ... 展开 >> Pfizer Investigational Site Nantes, Cedex, France, 44093 Pfizer Investigational Site Angers Cedex, France, 49033 Pfizer Investigational Site Bobigny, France, 93000 Pfizer Investigational Site Brest Cedex, France, 29609 Pfizer Investigational Site Bris Sous Forges, France, 94640 Pfizer Investigational Site Caen Cedex, France, 14033 Pfizer Investigational Site Dinan Cedex, France, 22101 Pfizer Investigational Site Grenoble Cedex 09, France, 38043 Pfizer Investigational Site Lille Cedex, France, 59037 Pfizer Investigational Site Lyon Cedex, France, 69394 Pfizer Investigational Site Montpellier Cedex 5, France, 34295 Pfizer Investigational Site Paris Cedex 18, France, 75877 Pfizer Investigational Site Paris Cedex 20, France, 75970 Pfizer Investigational Site Paris, France, 75010 Pfizer Investigational Site Poitiers Cedex, France, 86021 Pfizer Investigational Site Reims Cedex, France, 51092 Pfizer Investigational Site Rouen Cedex, France, 76031 Pfizer Investigational Site Suresnes, France, 92150 收起 << |
NCT03262857 | Local Anesthesia | Phase 2 | Active, not recruiting | September 21, 2018 | - |
NCT01934452 | - | Recruiting | April 15, 2020 | France ... 展开 >> CHU de la Timone Recruiting Marseille, Cedex 5, France, 13335 CHRU HOTEL DIEU - Service Urologie Recruiting Angers Cedex, France, 49933 C.H.U Morvan Recruiting Brest, France, 29000 Clinique Victor Hugo Recruiting Le Mans, France, 72015 Institut Paoli-Calmettes Recruiting Marseille Cedex 09, France, 13273 Institut Paoli-Calmettes / Hôpital de jour Recruiting Marseille Cedex 9, France, 13273 Cedex 9 Hopital Timone Adultes Recruiting Marseille Cedex, France, 13385 CRLC Val d'Aurelle Recruiting Montpellier cedex 05, France, 34295 Hopital Europeen Georges Pompidou Recruiting Paris Cedex 15, France, 75908 Centre Hospitalier Lyon Sud Recruiting Pierre Bénite Cedex, France, 69495 Clinique Chirurgicale de l'Orangerie, Chiliotherapie Recruiting Strasbourg, France, 67010 Centre Alexis Vautrin Recruiting Vandoeuvre les Nancy, France, 54511 Institut Gustave Roussy Active, not recruiting Villejuif Cedex, France, 94805 收起 << | |
NCT01827254 | - | Completed | - | France ... 展开 >> CHU de la Timone Marseille, Cedex 5, France, 13335 Hopital albert Michalon Grenoble, Cedex 9, France, 38043 Centre Paul Papin Angers, France, 49100 Hôpital Saint-André Bordeaux Cedex, France, 33075 Centre Catalan Urologie Andrologie Cabestany, France, 66330 Centre Oscar Lambret - Cancérologie Urologie Digestive Lille Cedex, France, 59020 clinique de la Louvière Lille Cedex, France, 59042 Hopital Dupuytren - Oncologie Medicale Limoges Cedex, France, 87042 Centre Leon Berard, Service d'Oncologie Medicale Lyon Cedex 08, France, 69373 Institut Paoli-Calmettes / Hôpital de jour Marseille Cedex 9, France, 13273 Cedex 9 Hopital Timone Adultes Marseille Cedex, France, 13385 Hopital Europeen Georges Pompidou Paris Cedex 15, France, 75908 Centre Eugene Marquis Rennes, France, 35042 CHU Charles Nicolle ROUEN Cedex, France, 76031 Departement d'Oncologie Medicale-Institut de Cancerologie de la Loire Saint Priest en Jarez Cedex, France, 42271 Centre Rene Gauducheau - Service Oncologie Medicale St Herblain Cedex, France, 44805 Institut Claudius Regaud Toulouse, France, 31000 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 收起 << | |
NCT00835068 | - | Completed | - | - | |
NCT01827254 | - | Completed | - | - | |
NCT00159822 | - | Completed | - | - | |
NCT00835068 | - | Completed | - | France ... 展开 >> Pfizer Investigational Site Chamberry, Cedex, France, 73011 Pfizer Investigational Site Le Chesnay, Cedex, France, 78157 Pfizer Investigational Site Caen Cedex 9, France, 14033 Pfizer Investigational Site Clermont Ferrand, France, 63003 Pfizer Investigational Site Dijon Cedex, France, 21070 Pfizer Investigational Site leKremlin-Bicetre, France, 94275 Pfizer Investigational Site Lyon, France, 69003 Pfizer Investigational Site Marseille Cedex 05, France, 13385 Pfizer Investigational Site Montmorency, France, 95160 Pfizer Investigational Site Montpellier Cedex 5, France, 34 34295 Pfizer Investigational Site Nantes cedex 1, France, 44093 Pfizer Investigational Site Paris, France, 75014 Pfizer Investigational Site Paris, France, F-75015 Pfizer Investigational Site Rouen, France, 76031 Pfizer Investigational Site Saint Priest en Jarez, France, 42277 Pfizer Investigational Site Tours, France, 37044 Pfizer Investigational Site Vandoeuvre Les Nancy Cedex, France, 54511 收起 << | |
NCT01079143 | Renal Interstitial Fibrosis | Phase 3 | Completed | - | France ... 展开 >> Novartis Investigative Site Caen, Cedex, France, 14033 Novartis Investigative Site Amiens cedex1, France, 80054 Novartis Investigative Site Angers, France, 49 033 Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Lyon, France, 69 437 Novartis Investigative Site Nice Cedex 1, France, 06602 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Paris, France, 75475 Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Pierre Benite Cedex, France, 69495 Novartis Investigative Site Poitiers, France, 86000 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site St Priest en Jarez Cedex, France, 42277 Novartis Investigative Site Strasbourg, France, 67091 Novartis Investigative Site Suresnes, France, 92150 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Novartis Investigative Site Tours Cedex, France, 37044 Novartis Investigative Site Vandoeuvre Les Nancys, France, 54511 收起 << |
NCT01728532 | Root Canal Obturation | Not Applicable | Completed | - | France ... 展开 >> Cabinet dentaire privé - 21, rue Fabre d'Églantine Paris, France Service d'endodontie de la Pitié Salpêtrière Hôpital de la Pitié Salpêtrière Paris, France United Kingdom School of Dentistry Cardiff University Cardiff, United Kingdom 收起 << |
NCT02187042 | - | Completed | - | France ... 展开 >> CHU de la Timone Marseille, Cedex 5, France, 13335 CHU Strasbourg Strasbourg, Cedex, France, 67091 Centre Hospitalier d'Annecy Annecy Cedex, France, 74011 Centre Catalan Urologie Andrologie Cabestany, France, 66330 Centre hospitalier de Chambery Chambery, France, 73000 Hopital prive La Louviere Lille, France, 59042 Clinique Claude Bernard Chimiotherapie Ambulatoire Metz, France, 57000 CRLC Val d'Aurelle Montpellier cedex 05, France, 34295 Polyclinique Gentilly Nancy, France, 54000 Polyclinique de Gentilly Service Oncologie Médicale Nancy, France, 54100 CHI de Cornouailles - Oncologie hospitalisation Quimper Cedex, France, 29107 Hopital Jean BERNARD - Tours - 7eme etage Valenciennes, France, 59300 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 收起 << | |
NCT02598154 | - | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT00998790 | Stress Urinary Incontinence | Not Applicable | Completed | - | Belgium ... 展开 >> Universitaire Ziekenhuisen Leuven Leuven, Belgium France Clinique Jules Verne Nantes, Cedex 3, France, 44314 Hopital Edouard Herriot Lyon Cedex 03, France, 69435 收起 << |
NCT00998790 | - | Completed | - | - | |
NCT01079143 | - | Completed | - | - | |
NCT01070537 | Carcinoma | Phase 2 | Completed | - | France ... 展开 >> Centre Léon Bérard Lyon Cedex 08, France, 69373 收起 << |
NCT00812864 | Breast Cancer ... 展开 >> Colorectal Cancer 收起 << | Phase 4 | Completed | - | France ... 展开 >> CHU Limoges Limoges Cedex, Province, France, 87042 收起 << |
NCT02156362 | Thyroid Cancer | Not Applicable | Recruiting | May 2023 | France ... 展开 >> Hospices Civils de Lyon-Centre de Médecine Nucléaire Groupement Hospitalier Est 59 boulevard Pinel Recruiting Bron cedex, France, 69677 Contact: Claire BOURNAUD, MD +33472356999 claire.bournaud-salinas@chu-lyon.fr Contact: Françoise BORSON-CHAZOT, PHD,MD +33472119319 francoise.borson-chazot@chu-lyon.fr Principal Investigator: Claire BOURNAUD, MD 收起 << |
NCT01737229 | Tooth Injury | Not Applicable | Completed | - | France ... 展开 >> Cabinet de Chirurgie Dentaire rue Saint Didier Paris, France Service d'endodontie de la Pitié Salpêtrière Hôpital de la Pitié Salpêtrière Paris, France Service d'Odontologie Hôpital Rothschild Paris, France 收起 << |
NCT01919957 | Epilepsy, Unspecified, Pharmac... 展开 >>ologically Resistant Memory Impairment 收起 << | Not Applicable | Recruiting | December 2022 | France ... 展开 >> INSERM - Plateau IRM du CENIR, CR-ICM Hôpital Pitié-Salpêtrière, 47/83 Boulevard de l'Hôpital Recruiting Paris, Cedex 13, France, 75651 Contact: Sophie Dupont, MD, PhD 01 42 17 85 23 ext +33 sophie.dupont@psl.aphp.fr Contact: Virginie Lambrecq, MD vlambrecq@hotmail.fr Principal Investigator: Sophie Dupont, MD, PhD Sub-Investigator: Virginie Lambrecq, MD Sub-Investigator: Véra Dinkelacker, MD Sub-Investigator: Stéphane Lehéricy, MD, PhD Sub-Investigator: Lionel Thivard, MD, PhD Sub-Investigator: Claude Adam, MD, PhD 收起 << |
NCT02550106 | CHRONIC SPONTANEOUS URTICARIA | Phase 4 | Completed | - | France ... 展开 >> Novartis Investigative Site Paris, Cedex 10, France, 75475 Novartis Investigative Site Angers, France, 49033 Novartis Investigative Site Argenteuil, France, 95107 Novartis Investigative Site Besancon Cedex, France, 25030 Novartis Investigative Site Bobigny Cedex, France, 93009 Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Chalons-en-Champagne, France, 51005 Novartis Investigative Site Clermont Ferrand cedex 1, France, 63003 Novartis Investigative Site Dijon, France, 21034 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site LILLE Cedex, France, 59037 Novartis Investigative Site Lille, France, 59000 Novartis Investigative Site Limoges cedex, France, 87042 Novartis Investigative Site Lyon cedex 04, France, 69317 Novartis Investigative Site Marseille Cedex 05, France, 13885 Novartis Investigative Site Montpellier cedex 5, France, 34295 Novartis Investigative Site Nantes, France, 44035 Novartis Investigative Site Nice, France, 06202 Novartis Investigative Site Nimes Cedex, France, 30029 Novartis Investigative Site Paris, France, 75014 Novartis Investigative Site Paris, France, 75877 Novartis Investigative Site Quimper, France, 29000 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Rennes Cedex 9, France, 35033 Novartis Investigative Site Rouen, France, 76031 Novartis Investigative Site Saint-Etienne, France, 42055 Novartis Investigative Site Toulon Cedex 9, France, 83800 Novartis Investigative Site Toulouse Cedex, France, 31400 Novartis Investigative Site Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT00724256 | Pyelonephritis | Phase 3 | Terminated(other upcoming stud... 展开 >>ies; patients refusal of invasive follow up (DMSA)) 收起 << | - | Italy ... 展开 >> Institute for Child Health Burlo Garofolo Triest, Italy, 34137 收起 << |
NCT01837576 | Psoriasis Vulgaris | Phase 1 | Completed | - | France ... 展开 >> Centre de harmacologie Clinique Appliquée à la Dermatologie (CPCAD) Nice, Nice Cedex 3, France, 06202 收起 << |
NCT01910090 | Healthy | Phase 1 | Completed | - | Jordan ... 展开 >> Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit Amman, Jordan, 00962 收起 << |
NCT01577511 | - | Active, not recruiting | October 2017 | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << | |
NCT01589575 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT02253186 | Lymphedema | Not Applicable | Completed | - | France ... 展开 >> CHU Montpellier - Hôpital St Eloi - Service Maladies Vasculaires Montpellier Cedex 5, France, 34295 收起 << |
NCT01647815 | Healthy Volunteers | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT01647802 | Mobility Limitation | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT01644760 | Collapsibility of the Inferior... 展开 >> Vena Cava 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT01331772 | Breast Cancer ... 展开 >> Adequate Physical Condition 收起 << | Not Applicable | Completed | - | France ... 展开 >> Centre Leon Berard Lyon Cedex 08, France, 69373 收起 << |
NCT03357302 | - | Completed | - | France ... 展开 >> Olivier MAILLARD Saint Pierre Cedex, Reunion, France, 97448 收起 << | |
NCT01649401 | Asthma | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT02381639 | Anorexia Nervosa | Not Applicable | Completed | - | France ... 展开 >> CHU de Nantes, Service d'Addictologie Nantes, France 收起 << |
NCT00403520 | Alzheimer's Disease | Phase 4 | Completed | - | France ... 展开 >> CHU Gui de Chauliac Montpellier cedex, France 收起 << |
NCT01403168 | Breast Cancer | Not Applicable | Terminated(Recruitment difficu... 展开 >>lties) 收起 << | - | France ... 展开 >> Centre Leon Berard LYON Cedex 08, France, 69373 收起 << |
NCT01743105 | Respiratory Distress Syndrome,... 展开 >> Adult 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01746433 | Supine Position ... 展开 >> Elderly 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01590511 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT02495090 | Hypospadias | Not Applicable | Unknown | November 2016 | France ... 展开 >> Hôpital Lapeyronie Montpellier Cedex 5, France, 34295 收起 << |
NCT01785368 | Emergency Department Admission... 展开 >> Imaging Techniques 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT01405534 | - | Completed | - | France ... 展开 >> Centre Léon Bérard LYON Cedex 08, France, 69373 收起 << | |
NCT01789801 | Radial Artery ... 展开 >> Ultrasonography 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01795443 | Back Pain | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01750944 | Good Health | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT01800084 | SPECT-CT | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01664572 | - | Completed | - | France ... 展开 >> University Hospital Angers cedex 9, France, 49933 收起 << | |
NCT01469975 | Sarcoma, Synovial | Phase 1 | Terminated(Too slow accrual.) | - | France ... 展开 >> Centre Léon Bérard LYON Cedex 08, France, 69373 收起 << |
NCT01685645 | Knee Surgery ... 展开 >>Arthroplasty 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << |
NCT01707602 | Influenza | Phase 1 Phase 2 | Completed | - | France ... 展开 >> GH Cochin - Broca - Hôtel-Dieu CIC BT505 PARIS Cedex 14, France, 75679 收起 << |
NCT02482467 | Ovarian Cyst | Not Applicable | Unknown | November 2017 | France ... 展开 >> Hôpital Lapeyronie Recruiting Montpellier cedex 5, France, 34295 Contact: Nicolas KALFA, MD, PhD 04 67 33 87 82 ext 0033 n-kalfa@chu-montpellier.fr Contact: Françoise PARIS, MD, PhD 04 67 33 83 28 ext 0033 f-paris@chu-montpellier.fr 收起 << |
NCT01739426 | Zenker Diverticulum | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << |
NCT00221767 | Spinal Cord Injuries ... 展开 >> Neurogenic Bladder Disorder Paraplegia Quadriplegia 收起 << | Not Applicable | Completed | - | France ... 展开 >> Neurochirurgie A - Hôpital Pellegrin , Place Amélie Raba-Léon Bordeaux Cedex, France, 33076 收起 << |
NCT01736826 | - | Active, not recruiting | June 2019 | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT02883803 | Septic Shock | Not Applicable | Not yet recruiting | November 2022 | France ... 展开 >> Service de Réanimation Médicale, Hôpital Bocage Not yet recruiting Dijon, France Sub-Investigator: Pierre-Emmanuel Charles Service de Réanimation Médicale, Hôpital Central Not yet recruiting Nancy, France Sub-Investigator: Pierre Edouard Bollaert UTCT, Hôpital Brabois Not yet recruiting Vandoeuvre-les-Nancy, France Sub-Investigator: Danièle Bensoussan Sub-Investigator: Véronique Decot 收起 << |
NCT01580527 | Pancreatic Disease | Not Applicable | Unknown | March 2014 | France ... 展开 >> Unité de Chirurgie Hépatobiliaire et Pancréatique Hopital Edouard Herriot Recruiting LYON cedex 03, France, 69437 Principal Investigator: Mustapha ADHAM, Professor 收起 << |
NCT02509390 | Major Trauma | Not Applicable | Unknown | December 2015 | France ... 展开 >> Department of Anesthesiology and critical care, Lapeyronie University Hospital Recruiting Montpellier Cedex 5, France, 34295 Contact: Pauline PD DERAS, MD +334 67 33 82 56 p-deras@chu-montpellier.fr 收起 << |
NCT01804868 | New Educational Technologies | Not Applicable | Completed | - | France ... 展开 >> Centre d'Epidémiologie Clinique, hôpital Hôtel Dieu, Assistance Publique-Hôpitaux de Paris Paris Cedex 04, France, 75181 收起 << |
NCT01806896 | Huntington's Disease | Phase 2 | Completed | - | France ... 展开 >> Centre d'Investigation Clinique (CIC)/ Institut du Cerveau et de la Möelle Epinière (ICM) Paris Cedex 13, France, 75651 收起 << |
NCT01818882 | Dyspnea | Not Applicable | Terminated(Inclusion curve too... 展开 >> slow.) 收起 << | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << |
NCT02062086 | Sarcopenia | Not Applicable | Recruiting | July 2018 | France ... 展开 >> Gerontopôle - CHU La Grave Casselardit - Serv. de Médecine Interne & de Gérontologie Clinique - 170 av de Casselardit - TSA 40031 Recruiting Toulouse cedex 9, France, 31059 Contact: Gabor Abellan Van Kan, MD 33-5 61 77 64 05 abellan.g@chu-toulouse.fr Principal Investigator: Gabor Abellan Van Kan, MD 收起 << |
NCT01781416 | - | Completed | - | France ... 展开 >> Research Site PARIS Cedex 15, France 收起 << | |
NCT01822782 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT01838798 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT01479803 | Pancreatic Tumor ... 展开 >> Fine Needle Aspiration Endoscopic Ultrasonography 收起 << | Phase 3 | Completed | - | France ... 展开 >> Hôpital L'Archet 2, CHU Nice, BP 3079 Nice Cedex 3, France, 06202 收起 << |
NCT01696630 | Colorectal Cancer | Phase 2 | Completed | - | France ... 展开 >> Centre Léon Bérard LYON Cedex 08, France, 69373 收起 << |
NCT01806896 | - | Completed | - | - | |
NCT00479557 | Alzheimer Disease | Phase 2 | Completed | - | France ... 展开 >> Groupe Hospitalier Pitie-Salpetriere Paris, Cedex 13 (MRI), France, 75651 Hôpital Pitié-Salpétrière Paris Cedex 13, Paris, France, 75651 Hopital Pellegrin-Centre Mémoire de Recherche et de Ressources Bordeaux, France, 33076 CHRU de Lille Lille (MRI), France, 59037 CHRU de Lille Lille, France, 59037 Hôpital Sainte-Marguerite MARSEILLE cedex 5, France, 13385 CHU Hôpital Gui de Chaulliac Montpellier, France, 34295 Groupe Hospitalier Broca-La Rochefoucauld Paris, France, 75013 Clinique de L'Union St JEAN, France, 31240 Hôpital LA GRAVE TOULOUSE Cedex 9, France, 31059 Chru Purpan Toulouse, France, 31300 Clinique PASTEUR Toulouse, France, 31300 Germany Unversitätsklinikum Freiburg Freiburg, Baden- Württemberg, Germany, 79106 Klinik fuer Psychiatrie und Psychotherapie, Charite Universitaetsmedizin Berlin Berlin, Germany, 14050 Zentralinstitut fuer Seelische Gesundheit Frankenthal, Germany, 67227 Klinik fuer Psychiatrie und Psychotherapie Goettingen, Germany, 37075 Zentralinstitut fuer Seelische Gesundheit Mannheim, Germany, 68159 Universitaetsklinikum Muenster Muenster, Germany, 48149 Universitaetsklinikum Muenster Muenster, Germany, 48165 Technische Universitaet Muenchen, Klinikum rechts der Isar München, Germany, 81675 Spain Hospital del Mar Barcelona, Spain, 08003 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clinico y Provincial Barcelona, Spain, 08036 Hospital Universitario Clinico San Carlos Madrid, Spain, 28040 收起 << |
NCT01738217 | Liver Neoplasms | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Centre Léon Bérard Lyon Cedex 08, France, 69373 收起 << |
NCT00306436 | Diabetic Nephropathies | Not Applicable | Unknown | May 2008 | France ... 展开 >> Service de Néphrologie-Hémodialyse du Pr C.Combe, Hôpital Pellegrin, Place Amélie Raba-Léon Recruiting Bordeaux cedex, France, 33076 Contact: Catherine Lasseur, Doctor 33 (0) 5 56 79 55 37 catherine.lasseur@chu-bordeaux.fr 收起 << |
NCT02062528 | Hot Flashes F... 展开 >>atty Acids Menopause 收起 << | Not Applicable | Completed | - | France ... 展开 >> Centre d'investigation clinique CIC1406 GRENOBLE cedex9, France, 38043 收起 << |
NCT02310516 | Brain Awake Surgery | Not Applicable | Unknown | - | France ... 展开 >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille cedex 5, France, 13354 Contact: Mathieu CECCALDI mathieu.ceccaldi@ap-hm.fr 收起 << |
NCT02893605 | - | Completed | - | France ... 展开 >> CHU de Montpellier - Hôpital Gui de Chauliac Montpellier Cedex 5, France, 34295 收起 << | |
NCT02898363 | - | Completed | - | France ... 展开 >> IURC - Laboratoire de Biostatistique d'Epidémiologie et de Recherche Clinique Montpellier Cedex 5, France, 34093 收起 << | |
NCT01956539 | - | Recruiting | December 2025 | France ... 展开 >> Hopital Lariboisiere Recruiting PARIS Cedex 10, France, 75475 Contact: Damien LOGEART Principal Investigator: Damien LOGEART 收起 << | |
NCT00360308 | Parkinson's Disease | Phase 3 | Terminated(Study stopped due t... 展开 >>o lack of efficacy.) 收起 << | - | France ... 展开 >> Pavillon Riser- Hopital Purpan Toulouse Cedex, France, 31059 收起 << |
NCT01780012 | Osteoporosis With Current Frag... 展开 >>ility Fracture 收起 << | Not Applicable | Completed | - | France ... 展开 >> Pôle IMER, Hospices Civils de Lyon LYON cedex 03, France, 69424 收起 << |
NCT00360308 | - | Terminated(Study stopped due t... 展开 >>o lack of efficacy.) 收起 << | - | - | |
NCT01976897 | - | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT00479557 | - | Completed | - | - | |
NCT02116439 | - | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT02011243 | - | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT02183779 | Raynaud Disease ... 展开 >> Hyperemia Cold 收起 << | Not Applicable | Unknown | June 2017 | France ... 展开 >> Centre d'investigation clinique CIC1406 Recruiting GRENOBLE cedex9, France, 38043 Contact: Jean-Luc CRACOWSKI, MD-PhD 33476769260 JLCracowski@chu-grenoble.fr Contact: PARIS Adeline, PharmD-PhD 33476767383 AParis@chu-grenoble.fr Principal Investigator: Jean-Luc CRACOWSKI, MD-PhD 收起 << |
NCT02822807 | Q Fever Auto-... 展开 >>Immunity 收起 << | Not Applicable | Recruiting | January 2019 | France ... 展开 >> Assistance Publique - Hôpitaux de Marseille Recruiting Marseille Cedex 05, France, 13385 Contact: Didier RAOULT, Pr 04 91 38 55 14 ext +33 didier.raoult@gmail.com Contact: Alexandra GIULIANI 04 91 38 28 70 alexandra.giuliani@ap-hm.fr 收起 << |
NCT02855372 | - | Unknown | April 2018 | France ... 展开 >> Assistance Publique Hôpitaux de Marseille, Hôpital Nord Not yet recruiting Marseille Cedex 01, France, 13915 收起 << | |
NCT00169468 | B Cell Lymphoma | Phase 2 | Completed | - | France ... 展开 >> Hôpital Saint-Louis Paris, Paris 10, France, 75475 Institut Gustave Roussy Villejuif, Villejuif Cedex, France, 94805 Hôpital Henri Mondor Créteil, France, 94010 Hôpital Lyon Sud Pierre Bénite, France, 69310 收起 << |
NCT02126930 | Infection | Not Applicable | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT02273700 | - | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT02021539 | - | Terminated | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT02829424 | Psoriasis | Phase 4 | Recruiting | October 2020 | France ... 展开 >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille Cedex 05, France, 13385 Contact: Marie RICHARD, Pr +33 4 91 387 991 ext +33 mrichard@ap-hm.fr Contact: Jean DHORNE 04 91 38 14 75 ext +33 jean.dhorne@ap-hm.fr 收起 << |
NCT02903550 | - | Recruiting | March 2018 | France ... 展开 >> Hôpital de La Timone - Assistance Publique Hôpitaux de Marseille Recruiting Marseille Cedex 05, France, 13385 Contact: Arthur VAROQUAUX arthur.varoquaux@ap-hm.fr 收起 << | |
NCT02739477 | Ebola Virus Survivor | Phase 2 | Terminated(End date of epidemi... 展开 >>c) 收起 << | - | Guinea ... 展开 >> Conakry Conakry, Guinea Nzérékoré Nzérékoré, Guinea 收起 << |
NCT02269020 | Carcinoma, Squamous Cell | Phase 1 | Unknown | April 2018 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Benjiman Lallemant, MD, PhD 收起 << |
NCT00438035 | Pain Postoper... 展开 >>ative 收起 << | Not Applicable | Completed | - | France ... 展开 >> Service de Neurochirurgie A, hôpital Pellegrin Bordeaux Cedex, Place Amélie Raba-Léon, France, 33076 收起 << |
NCT02408354 | Alternating Hemiplegia of Chil... 展开 >>dhood 收起 << | Phase 2 | Active, not recruiting | December 2017 | France ... 展开 >> Groupe hospitalier Pitié Salpêtrière Paris, France, 75013 收起 << |
NCT02373800 | - | Recruiting | December 2018 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Vincent Letouzey, MD Sub-Investigator: Eve Mousty, MD Sub-Investigator: Renaud de Tayrac, MD, PhD Sub-Investigator: Pierre Marès, MD, PhD Sub-Investigator: Arnaud Corille, MD Sub-Investigator: Frédéric Grosjean, MD 收起 << | |
NCT00209404 | Coronary Artery Disease | Phase 4 | Completed | - | France ... 展开 >> Amersham Health S.A. Velizy Cedex, France, 78457 收起 << |
NCT00437762 | Tennis Elbow | Phase 3 | Completed | - | France ... 展开 >> Unité de médecine orthopédique- Hôpital Pellegrin RDC aile 2. Bordeaux cedex, France, 330076 收起 << |
NCT02420002 | Wounds, Nonpenetrating | Phase 4 | Recruiting | October 2019 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Philippe Fournier, MD Sub-Investigator: Tu Anh Tran, MD, PhD 收起 << |
NCT02839642 | Progressive Supranuclear Palsy... 展开 >> (PSP) 收起 << | Phase 3 | Recruiting | November 2019 | France ... 展开 >> Service de Neurologie et Pathologie du Mouvement Hôpital de La Timone Recruiting Marseille Cedex 5, France, 13385 Contact: Alexandre EUSEBIO, Dr 04.91.38.43.33 ext +33 alexandre.eusebio@ap-hm.fr 收起 << |
NCT02427009 | Post-Dural Puncture Headache | Not Applicable | Terminated(no inclusion) | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT02262494 | Deep Vein Thrombosis | Not Applicable | Terminated(No recruitment) | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << |
NCT02392390 | Leg Ulcer | Not Applicable | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT01935869 | Psoriasis Vulgaris | Phase 1 | Completed | - | France ... 展开 >> CPCAD, Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Hôpital de l'Archet 2 Nice Cedex 3, France, 06202 收起 << |
NCT02075424 | Physiological Stress ... 展开 >> Psychological Stress 收起 << | Not Applicable | Completed | - | France ... 展开 >> Centre Hospitalier Régional Metz Thionville Metz cedex 03, France, 57085 收起 << |
NCT02597413 | - | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT00790322 | Head and Neck Cancer ... 展开 >> Oral Mucositis 收起 << | Phase 3 | Completed | - | France ... 展开 >> Institute Gustave Roussy Villejuif Cédex, France, 94805 收起 << |
NCT02598141 | Bacterial Infection | Not Applicable | Recruiting | November 2018 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Nicolas Cellier, MD Sub-Investigator: Olivier Marès, MD Sub-Investigator: Catherine Lechiche, MD Sub-Investigator: Jean-Philippe Lavigne, MD, PhD Sub-Investigator: Nicole Bouziges, MD 收起 << |
NCT02609191 | Osteodensitometry | Not Applicable | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT02599233 | - | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT02614638 | Hospitalization | Not Applicable | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT02610452 | Palliative Care | Not Applicable | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT02636829 | Multiple Sclerosis ... 展开 >> Rheumatoid Arthritis 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT02865525 | - | Unknown | December 2017 | France ... 展开 >> Grenoble University Hospital Recruiting Grenoble cedex 9, France, 38043 Contact: Audrey Lehmann, PharmD, PHD student 0033476769209 alehmann@chu-grenoble.fr Contact: Benoit Allenet, PharmD PHD 0033476765497 ballenet@chu-grenoble.fr Principal Investigator: Audrey Lehmann, PharmD, PHD student Sub-Investigator: Carine Meslot, PHD Student Principal Investigator: Benoît Allenet, PharmD, PHD Sub-Investigator: Aurelie Gauchet, PHD Sub-Investigator: Matthieu Roustit, PharmD, PHD Sub-Investigator: Pierrick Bedouch, PharmD, PHD Sub-Investigator: Jean-Luc Bosson, MD, PHD 收起 << | |
NCT01988480 | Edentulous | Not Applicable | Active, not recruiting | September 2018 | France ... 展开 >> Hospices Civils de Lyon - Service de Consultations et Traitements Dentaires Lyon cedex 07, France, 69365 收起 << |
NCT02683304 | Headache | Not Applicable | Recruiting | July 2018 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Romain Genre Grandpierre, MD Sub-Investigator: Xavier Bobbia, MD Sub-Investigator: Rémi Perrin-Bayard, MD Sub-Investigator: Stéphane Pommet, MD Sub-Investigator: Alexandre Moreau, MD Sub-Investigator: Pierre-Géraud Claret, MD Sub-Investigator: Yan Bodin, MD 收起 << |
NCT03336814 | Septic Shock | Phase 4 | Recruiting | June 1, 2019 | France ... 展开 >> Assistance Publique - Hôpitaux de Marseille Recruiting Marseille Cedex 05, France, 13354 Contact: Duclos Gary gary.duclos@ap-hm.fr 收起 << |
NCT02740491 | - | Recruiting | September 2018 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Luc Duwig, MD Sub-Investigator: Luc Farcy, MD Sub-Investigator: Nadine Houédé, MD, PhD Sub-Investigator: Sylvie Van Hulst, MD Sub-Investigator: Miruna Timar-David, MD Sub-Investigator: Florence Lai Tiong, MD Sub-Investigator: Catherine Ferrer, MD Sub-Investigator: Françoise Bons, MD Sub-Investigator: Marie-Pierre Farcy Jaquet, MD Sub-Investigator: Charles Debrigode, MD Sub-Investigator: Philippe Lang, MD 收起 << | |
NCT03157141 | - | Recruiting | June 2020 | France ... 展开 >> Centre Hospitalier Lyon-Sud Recruiting Pierre-Bénite, France, 69495 Contact: Jean-Luc BESSE, Dr +33 4 78 86 28 28 jean-luc.besse@chu-lyon.fr Contact: Laurence CHEZE, Prof. +33 4 72 44 80 98 laurence.cheze@univ-lyon1.fr 收起 << | |
NCT02746094 | Erectile Dysfunction | Not Applicable | Withdrawn(Change strategy) | April 2019 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT00122629 | Hepatitis C, Chronic | Phase 3 | Terminated | - | France ... 展开 >> Service d’Hépato-Gastroentérologie Hopital Hotel Dieu Lyon Cedex, France, 69288 收起 << |
NCT00445055 | Nausea Vomiti... 展开 >>ng 收起 << | Phase 4 | Terminated | - | France ... 展开 >> Département d'Anesthésie-Réanimation II ; Groupe Hospitalier Sud, CHU de Bordeaux PESSAC Cedex, France, 33604 收起 << |
NCT02234349 | Pancreas-kidney Transplantatio... 展开 >>n Kidney Transplantation 收起 << | Not Applicable | Completed | - | France ... 展开 >> Hôpital Edourad Herriot - Pavillon P LYON cedex 03, France, 69437 收起 << |
NCT02369718 | Hard of Hearing | Not Applicable | Completed | - | France ... 展开 >> Pavillon ORL (U) - Hôpital Edouard Herriot LYON cedex 03, France, 69437 收起 << |
NCT02614651 | Retinitis Pigmentosa ... 展开 >> Glaucoma 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémea Nîmes Cedex 09, France, 30029 收起 << |
NCT02742025 | Preoperative Anxiety | Not Applicable | Not yet recruiting | January 2019 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Not yet recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Guillaume Cayla, MD, PhD Sub-Investigator: Patrick Messner, MD, PhD 收起 << |
NCT00454259 | Pain, Postoperative | Phase 4 | Completed | - | France ... 展开 >> CHU de Bordeaux Département d'Anesthésie-Réanimation II PESSAC Cedex, Hôpital cardiologique, France, 33604 收起 << |
NCT00875277 | Psoriasis Vulgaris | Phase 2 | Completed | - | France ... 展开 >> LEO Pharma site St Quentin Yvelines Cedex, France 收起 << |
NCT00948883 | - | Completed | - | France ... 展开 >> Hôpital Bicêtre - Assistance Publique-Hôpitaux de Paris Le Kremlin Bicetre Cedex, France, 94275 收起 << | |
NCT01022476 | HIV Infection ... 展开 >> Liver Failure Evidence of Liver Transplantation 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Service de Médecine Interne, Hôpital de Bicêtre LE KREMLIN-BICETRE cedex, France, 94275 收起 << |
NCT00295438 | Abdominal Injuries ... 展开 >> Thoracic Injuries High Energy Trauma 收起 << | Not Applicable | Terminated(No diagnosis of vis... 展开 >>ceral lesion was placed on 18 included patients. The study is thus stopped prematurely for ethical reasons.) 收起 << | - | France ... 展开 >> University Hospital Grenoble, France, 38000 收起 << |
NCT00845481 | Psoriasis Vulgaris | Phase 2 | Completed | - | France ... 展开 >> LEO Pharma site St Quentin Yvelines Cedex, France, 78054 收起 << |
NCT01245374 | Growth Hormone Disorder ... 展开 >> Growth Hormone Deficiency in Children Foetal Growth Problem Small for Gestational Age Genetic Disorder Turner Syndrome Chronic Kidney Disease Chronic Renal Insufficiency Delivery Systems 收起 << | Phase 4 | Completed | - | France ... 展开 >> Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 收起 << |
NCT01226966 | - | Completed | - | France ... 展开 >> Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 收起 << | |
NCT00845481 | - | Completed | - | - | |
NCT01285089 | - | Completed | - | France ... 展开 >> Paris La défense cedex, France, 92932 收起 << | |
NCT01245374 | - | Completed | - | - | |
NCT00560352 | Multiple Myeloma | Phase 1 | Terminated | - | United States, Florida ... 展开 >> Orlando Health, Inc. M.D. Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Georgia Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 France Local Institution Nantes, Cedex 1, France, 44093 Local Institution Lille Cedex, France, 59037 Italy Local Institution Bari, Italy, 70124 Local Institution Bologna, Italy, 40138 Spain Local Institution Salamanca, Spain, 37007 收起 << |
NCT01327924 | - | Completed | - | France ... 展开 >> Paris La défense cedex, France, 92932 收起 << | |
NCT00163150 | Cerebrovascular Accident ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Completed | - | France ... 展开 >> Pfizer Investigational Site Paris, Cedex 18, France, 75877 收起 << |
NCT00179621 | Myelodysplastic Syndromes | Phase 3 | Completed | - | - |
NCT00560352 | - | Terminated | - | - | |
NCT03624920 | Parkinson Disease | Phase 2 | Recruiting | August 2019 | Czechia ... 展开 >> Neurologická klinika 1.LF UK a VFN v Praze Recruiting Praha, Czechia, 12821 Contact: Hana Brožová, MD, PhD France ICM Centre d'Investigation Clinique Hôpital Pitié Salpêtrière Active, not recruiting Paris, France, 75013 Germany Neurologische Praxis Dipl. med. Cristian Oehlwein Recruiting Gera, Germany, 07551 Contact: Christian Oehlwein, MD +491719333192 chr.oehlwein@online.de Praxis Dr. med. Arnfin Bergmann Not yet recruiting Neuburg, Germany, 86633 Contact: Arnfin Bergmann, MD +49843145899 abergmann@neurotransdata.com Gemeinschaftspraxis Dr. med. Joachim Springub / Wolfgang Schwarz, Studienzentrum Nord-West Recruiting Westerstede, Germany, 26655 Contact: Joachim Springub, MD +49448872999 joachim.springub@ewetel.net Hungary Nyírő Gyula Országos Pszichiátriai és Addiktológiai Intézet, Neurológiai Osztály Recruiting Budapest, Hungary Contact: Magdolna Bokor, MD +3614512678 Debreceni Egyetem Kenézy Gyula Egyetemi Kórház Neurológiai Osztály Recruiting Debrecen, Hungary, 4031 Contact: Julianna Lajtos, MD 收起 << |
NCT00239174 | Obesity | Phase 2 | Completed | - | Argentina ... 展开 >> Sanofi-Aventis Administrative Office Buenos Aires, Argentina Australia sanofi-aventis Australia & New Zealand administrative office Macquarie Park, Australia Finland Sanofi-Aventis Administrative Office Helsinki, Finland France Sanofi-Aventis Administrative Office Paris, France Spain Sanofi-Aventis Administrative Office Barcelona, Spain 收起 << |
NCT01580488 | - | Completed | - | - | |
NCT01628341 | - | Completed | - | France ... 展开 >> Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 收起 << | |
NCT03422328 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Enrolling by invitation | May 2, 2021 | France ... 展开 >> Service de pneumologie et Réanimation Respiratoire, CHU de Bicêtre Le Kremelin-Bicêtre Cedex, France, 94275 收起 << |
NCT01607853 | Psoriasis Vulgaris | Phase 2 | Completed | - | France ... 展开 >> Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD) Nice, France, 06202 收起 << |
NCT00179621 | - | Completed | - | - | |
NCT01607853 | - | Completed | - | - | |
NCT00458770 | Cluster Headache | Not Applicable | Terminated | - | France ... 展开 >> Pôle de Neurosciences Cliniques CHU Timone Marseille, France, 13005 收起 << |
NCT01347255 | Psoriasis Vulgaris | Phase 2 | Completed | - | France ... 展开 >> Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD) Nice, France, Cedex 3 收起 << |
NCT01580488 | Psoriasis Vulgaris | Phase 1 | Completed | - | France ... 展开 >> Centre de Pharmacologie Clinique Appliquée à la Dermatologie (CPCAD) - Hôpital l'Archet 2, 151 route Saint-Antoine de Ginestière Nice, France, 06202 收起 << |
NCT02252497 | Hip Arthroplasty | Phase 4 | Completed | - | France ... 展开 >> CHU de Saint-Etienne SAINT-ETIENNE cedex 2, France, 42055 收起 << |
NCT01234363 | Renal Transplant | Not Applicable | Unknown | September 2013 | France ... 展开 >> Service de Radiologie, Pavillon P Radio, Hôpital Edouard Herriot Recruiting Lyon, France, 69437 Contact: ROUVIERE Olivier, Pr 4 72 11 09 51 ext +33 olivier.rouviere@netcourrier.com Principal Investigator: ROUVIERE Olivier, Pr 收起 << |
NCT01347255 | - | Completed | - | - | |
NCT02833259 | - | Recruiting | March 31, 2019 | France ... 展开 >> Grenoble University Hospital CS10217 Grenoble Cedex 9 Recruiting Grenoble, France, 38043 Contact: Patrice François, MD, PhD +33 476 768 767 pfrancois@chu-grenoble.fr Contact: Raouf Zouglech, MDS +33 476 765 805 rzouglech@chu-grenoble.fr Principal Investigator: Patrice François, MD, PhD Sub-Investigator: José Labarère, MD, PhD Sub-Investigator: Jérome Fauconnier, MD, MSc Sub-Investigator: Patricia Pavese, MD, MSc Sub-Investigator: Boubou Camara, MD Centre Hospitalier Annecy Genevois,1 avenue de l'hôpital, Epagny Metz-Tessy,BP 90074 Recruiting Pringy, France, 74374 Contact: Xavier Courtois, MD +33 450 636027 xcourtois@ch-annecygenevois.fr Contact: Pascaline Levrard, BSc +33 450 637 019 plevrard@ch-annecygenevois.fr Principal Investigator: Xavier Courtois, MD Sub-Investigator: Jacques Gaillat, MD Sub-Investigator: Virginie Vitrat, MD 收起 << | |
NCT01226550 | Peritoneal Carcinosis (PC) | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Service de Chirurgie Générale et Thoracique, Centre Hospitalier Lyon-Sud Pierre Bénite Cedex, France, 69495 收起 << |
NCT02130648 | - | Unknown | April 2016 | France ... 展开 >> Centre hospitalier Universitaire de Montpellier Recruiting Montpellier, France, 34295 Contact: Anne VERCHERE 33467330812 a-verchere@chu-montpellier.fr Contact: Sandrine BARBAS 33467330813 s-barbas@chu-montpellier.fr Principal Investigator: Mireille CLAUSTRES 收起 << | |
NCT02384876 | Intraoperative Arterial Hypote... 展开 >>nsion Infant, Newborn 收起 << | Phase 2 | Recruiting | June 2019 | France ... 展开 >> Hôpital d'Estaing Recruiting Clermont-Ferrand, France, 63003 Contact: Jean-Etienne BAZIN Principal Investigator: Jean-Etienne BAZIN Hospices Civils de Lyon Recruiting Lyon, France Contact: Mathilde DE QUEIROZ SIQUEIRA, MD 0472129756 ext +33 mathilde.de-queiroz-siqueira@chu-lyon.fr Hôpital Nord Recruiting Saint Etienne, France, 42055 Contact: Serge Moliex Principal Investigator: Serge Moliex 收起 << |
NCT00824967 | ALZHEIMER Disease | Not Applicable | Terminated | - | France ... 展开 >> CHU de Nice - 4 avenue Reine Victoria Nice, Alpes-Maritimes, France, 06001 收起 << |
NCT00927290 | Chronic Hepatitis C ... 展开 >> Insulin Resistance 收起 << | Phase 3 | Terminated(Suspension of use o... 展开 >>f medicine containing Pioglitazone by French regulatory agency) 收起 << | - | France ... 展开 >> Hôpital Pitié Salpêtrière, Service d'hépatogastroentérologie Paris, France, 75013 收起 << |
NCT00955617 | Peripheral Arterial Disease | Phase 4 | Completed | - | France ... 展开 >> Guerbet Roissy CDG Cedex, France 收起 << |
NCT03080675 | Cognitive Decline | Not Applicable | Recruiting | November 2023 | France ... 展开 >> CHU Toulouse Recruiting Toulouse, France, 31059 Contact: Bruno Pr. Vellas +33 5 61 77 70 47 收起 << |
NCT00955617 | - | Completed | - | - | |
NCT00572806 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | France ... 展开 >> Novo Nordisk Investigational Site MONTPELLIER cedex 5, France, 34295 收起 << |
NCT01143350 | Alzheimer's Disease | Not Applicable | Terminated | - | France ... 展开 >> Robert Nice, Alpes-Maritimes, France, 06001 收起 << |
NCT01416012 | Disease Alzheimer | Not Applicable | Unknown | September 2013 | Australia ... 展开 >> The University of Queensland Recruiting St Lucia, Australia Contact: Nitz Jennifer, PhD nitz@uq.edu.au Principal Investigator: Nitz Jennifer, PhD France CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez Recruiting Nice, Alpes-Maritimes, France, 06001 Contact: ROBERT Philippe, PU-PH +33492034770 robert.p@chu-nice.fr Contact: Dechamps Arnaud +33492034770 dechamps.a@chu-nice.fr Netherlands Radboud University Nijmegen Medical Centre Recruiting Nijmegen, Netherlands Contact: Kessels Roy, PhD +31 24 3666196 ext +31 24 3617408 r.kessels@mps.umcn.nl Principal Investigator: Kessels Roy, PhD 收起 << |
NCT02583373 | Pneumonia Pne... 展开 >>umococcal Infections 收起 << | Phase 1 | Completed | - | Belgium ... 展开 >> St Luc University Hospital Brussels, Belgium University Hospital Brussels Brussels, Belgium Clinique St Pierre Ottignies, Belgium France CHU Jean Minjoz Besancon, France CHD Les Oudairies La Roche-sur-Yon, France Hôpital Mignot Le Chesnay, France CHU Dupuytren Limoges, France Centre Hospitalier Régional d'ORLEANS Orléans, France CH Yves Le Foll Saint-Brieuc, France CHRU de Tours Tours, France 收起 << |
NCT01092052 | Advanced/Metastatic Solid Tumo... 展开 >>rs 收起 << | Phase 1 | Terminated(Discontinuation of ... 展开 >>clinical investigation with NMS-1116354) 收起 << | - | France ... 展开 >> Institut Gustave-Roussy (IGR) Villejuif, Cedex, France 收起 << |
NCT01128725 | Alzheimer Disease | Not Applicable | Unknown | December 2012 | France ... 展开 >> Robert Recruiting Nice, Alpes-Maritimes, France, 06001 Contact: Philippe ROBERT, PhD +33492034770 ext +33492034772 robert.p@chu-nice.fr Principal Investigator: Philippe ROBERT, PhD 收起 << |
NCT00390273 | Hyperlactatemia | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Centre Hospitalier Universitaire de Grenoble Grenoble cedex 9, France, 38043 收起 << |
NCT00745875 | Non Small Cell Lung Cancer ... 展开 >> Lung Cancer 收起 << | Phase 2 | Completed | - | Bulgaria ... 展开 >> research Site Pleven, Bulgaria Research Site Sofia, Bulgaria Research Site Varna, Bulgaria Czech Republic Research Site Jicin, Czech Republic Research Site Prague, Czech Republic France Research Site Cedex, France Research Site Strasbourg, France Romania Research Site Bucharest, Romania Research Site Cluj-Napoca, Romania Ukraine Research Site Chernivtsi, Ukraine Research Site Kiev, Ukraine Research Site Sumy, Ukraine Research Site Uzngorod, Ukraine 收起 << |
NCT02425995 | Chronic Knee Instability | Not Applicable | Completed | - | France ... 展开 >> Hospices Civils de Lyon Lyon, France 收起 << |
NCT00236301 | Healthy Symptomatic Menopausal... 展开 >> Women 收起 << | Phase 3 | Terminated(terminated) | - | France ... 展开 >> CIC, Saint Antoine Hospital Paris cedex 12, France, 75571 收起 << |
NCT00199238 | Urticaria | Phase 2 | Terminated | - | France ... 展开 >> Hospital Saint Louis Paris Cedex 10, France, 75475 收起 << |
NCT00245479 | Nocturnal Enuresis | Phase 4 | Completed | - | France ... 展开 >> Foundation Hospital Saint Joseph, 185, rue Raymond Losserand Paris Cedex 14, France, 75674 收起 << |
NCT00231075 | Ovarian Cancer | Phase 2 | Completed | - | France ... 展开 >> Centre Hosptalier Emile Roux Eaubonne, France, 95600 Centre Hospitalier Lyon-sud Pierre-Bénite, France, 69495 收起 << |
NCT00574652 | Cryoglobulinemia Vasculitis | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Hôpital de la Pitié Paris, France, 75651 收起 << |
NCT01591538 | - | Completed | - | France ... 展开 >> Centre d'épidémiologie et de santé publique des armées Saint Mandé cedex, France, 94163 收起 << | |
NCT00140933 | Pain | Phase 3 | Terminated | - | France ... 展开 >> Laboratoires Merck Sharp & Dohme - Chibret Paris Cedex 8, France, 75114 收起 << |
NCT02788006 | Colorectal Adenocarcinoma | Phase 2 | Unknown | May 2018 | France ... 展开 >> CHU SUD - Service Oncologie Médicale Recruiting Amiens, France Contact: Bruno CHAUFFERT chauffert.bruno@chu-amiens.fr Principal Investigator: Bruno CHAUFFERT Sub-Investigator: Roxana FOURNIER Sub-Investigator: Sanaa HANNAT CH Victor Dupouy Recruiting Argenteuil, France Contact: Malika BOUDRAOUI malika_boudraoui@yahoo.fr Principal Investigator: Malika BOUDRAOUI Sub-Investigator: Radu VANICA Sub-Investigator: Arnaud BOUTANT-LAROZE Sub-Investigator: Laëticia JOLY Sub-Investigator: Julie BOISSET Sub-Investigator: Djamel GHEBRIOU Hôpital privé Les Bonnettes Recruiting Arras, France Contact: Bruno HUGUENIN drbhuguenin@orange.fr Principal Investigator: Bruno HUGUENIN Sub-Investigator: Anne-Sophie BLANC CH Recruiting Auch, France Contact: Karine SALIGNON K.Salignon@ch-auch.fr Principal Investigator: Karine SALIGNON CH Recruiting Auxerre, France Contact: Anne-Laure VILLING alvilling@ch-auxerre.fr Principal Investigator: Anne-Laure VILLING Clinique Tivoli Ducos Recruiting Bordeaux, France Contact: Nathalie BONICHON-LAMICHHANE bonichon-lamichhane@wanadoo.fr Principal Investigator: Nathalie BONICHON-LAMICHHANE Polyclinique Nord Recruiting Bordeaux, France Contact: Cédric LECAILLE lecail@hotmail.com Principal Investigator: Cédric LECAILLE Sub-Investigator: Xavier MONCOUCY Sub-Investigator: Regis MANNANT Sub-Investigator: Iris DEVAURE Sub-Investigator: Laure DUPONT KAZMA CH Dubois Recruiting Brive La Gaillarde, France Contact: Laure VAYRE laure.vayre@ch-brive.fr Principal Investigator: Laure VAYRE Centre François Bacless Recruiting Caen, France Contact: Aurélie PARZY a.parzy@baclesse.unicancer.fr Principal Investigator: Aurélie PARZY Hôpital privé Sainte Marie Recruiting Chalon sur Saone, France Contact: Adrien MELIS melisadrien@yahoo.fr Principal Investigator: Adrien MELIS Sub-Investigator: Erika VIEL Sub-Investigator: André VANOLI Sub-Investigator: Léa PERRON Centre Oncologie et Radiothérapie Recruiting Dijon, France Contact: Ariane DARUT JOUVE ariane.jouve@orange.fr Principal Investigator: Ariane DARUT JOUVE Sub-Investigator: Genevieve BOILLEAU-JOLIMOY Sub-Investigator: Marie-Christine BONE-LEPINOY Sub-Investigator: Edouard LAGNEAU CHI Recruiting Elbeuf, France Contact: Anne-Marie QUEUNIET anne-marie.queuniet@chi-elbeuf-louviers.fr Principal Investigator: Anne-Marie QUEUNIET CH Marne La Vallée Recruiting Jossigny, France Contact: Christine LE FOLL clefoll@ch-lagny77.fr Principal Investigator: Christine LE FOLL Sub-Investigator: Tamar KUTATELADZE CHD Les Oudairies Recruiting La Roche sur Yon, France Contact: Roger FAROUX roger.faroux@chd-vendee.fr Principal Investigator: Roger FAROUX Sub-Investigator: Morgane AMIL Sub-Investigator: Lucile BAUGUION Sub-Investigator: Cécile GARCEAU Sub-Investigator: Carelle KOUDOUGOU Sub-Investigator: Vincent MACE Sub-Investigator: Matthieu SCHNEE Sub-Investigator: Véronique GIRRE Sub-Investigator: Tifenn L'HARIDON Sub-Investigator: Frank PRIOU Sub-Investigator: Jean-François RAMEE Sub-Investigator: Thierry CHARLOIS Sub-Investigator: Elodie MENAGER TABOUREL Clinique du Cap d'Or Recruiting La Seyne Sur Mer, France Contact: Mounira EL DEMERY oncocco2@gmail.com Principal Investigator: Mounira EL DEMERY Caluire et Cuire - Infirmerie Protestante de Lyon Recruiting Lyon, France Contact: Johannes HARTWIG johannes.hartwig@infirmerie-protestante.com Principal Investigator: Johannes HARTWIG Sub-Investigator: David TAVAN CH Lyon Sud (HCL) - Pierre Benite Recruiting Lyon, France Contact: Claire FALANDRY claire.falandry@chu-lyon.fr Principal Investigator: Claire FALANDRY Sub-Investigator: Marion CHAUVENET Sub-Investigator: Benoît YOU Hôpital privé Jean Mermoz Recruiting Lyon, France Contact: Jérôme DESRAME jerome.desrame@orange.fr Principal Investigator: Jérôme DESRAME Sub-Investigator: Pascal ARTRU Sub-Investigator: Gérard LLEDO Hôpital Européen Recruiting Marseille, France Contact: Yves RINALDI y.rinaldi@hopital-europeen.fr; yrinaldi@wanadoo.fr Principal Investigator: Yves RINALDI Sub-Investigator: Julie GIGOUT Sub-Investigator: Cécile JULIEN CH Recruiting Meaux, France Contact: Christophe LOCHER c-locher@ch-meaux.fr Principal Investigator: Christophe LOCHER Sub-Investigator: Laurence THOMAS-MARQUES Sub-Investigator: Marc PRIETO Sub-Investigator: Hatem SALLOUM CHRU - Hôpital Saint Eloi Recruiting Montpellier, France Contact: Eric ASSENAT e-assenat@chu-montpellier.fr;e.assenat@gmail.com Principal Investigator: Eric ASSENAT Sub-Investigator: Christophe CARENCO Sub-Investigator: Thibault MAZARD Sub-Investigator: Marc YCHOU Sub-Investigator: Catherine GUILLEMARE Clinique d'Occitanie Recruiting Muret, France Contact: Jean-Marie VANTELON jmvantelon@gmail.com Principal Investigator: Jean-Marie VANTELON Hôpital Américain Recruiting Neuilly sur Seine, France Contact: Lionel VEDRINE lionelvedrine@orange.fr Principal Investigator: Lionel VEDRINE Sub-Investigator: Hanah LAMALLEM Sub-Investigator: Marc BOLLET Sub-Investigator: Alain TOLEDANO CHR - Service HGE Recruiting Orléans, France Contact: Barbara DAUVOIS barbara.dauvois@chr-orleans.fr Principal Investigator: Barbara DAUVOIS Sub-Investigator: Jean-Paul LAGASSE Sub-Investigator: Sofia HERRMANN Sub-Investigator: Belinda TCHOUNJEU Saint Joseph Recruiting Paris, France Contact: Nabil BABA HAMED nbaba-hamed@hpsj.fr Principal Investigator: Nabil BABA HAMED Sub-Investigator: Robert SVERDLIN Sub-Investigator: Francesco SAVINELLI Sub-Investigator: Michel GATINEAU Sub-Investigator: Lionel STAUDACHER Sub-Investigator: Eric RAYMOND CH Recruiting Perpignan, France Contact: Faiza KHEMISSA AKOUZ faiza.khemissa@ch-perpignan.fr Principal Investigator: Faiza KHEMISSA AKOUZ Hôpital Haut Leveque Recruiting Pessac, France Contact: Eric TERREBONNE eric.terrebonne@chu-bordeaux.fr Principal Investigator: Eric TERREBONNE Sub-Investigator: Pierre GROUSSEAU Sub-Investigator: Denis SMITH Centre Cario - HPCA Recruiting Plérin, France Contact: Pierre Luc ETIENNE pl.etienne@cario-sante.fr ; pl.etienne@wanadoo.fr Principal Investigator: Pierre Luc ETIENNE Sub-Investigator: Dominique BESSON Sub-Investigator: ANNE-CLAIRE HARDY-BESSARD CH Annecy Genevois Recruiting Pringy, France Contact: Emmanuel MAILLARD emaillard@ch-annecygenevois.fr Principal Investigator: Emmanuel MAILLARD Sub-Investigator: Mathieu BACONNIER Sub-Investigator: Aude MONTCHAUD Sub-Investigator: Laëtitia STEFANI Sub-Investigator: Oana POP CHU Recruiting Saint-Etienne, France Contact: Jean-Marc PHELIP j.marc.phelip@chu-st-etienne.fr Principal Investigator: Jean-Marc PHELIP Sub-Investigator: Nadia BOUARIOUA Sub-Investigator: Léa CLAVEL CHP Recruiting Saint-Grégoire, France Contact: Laurent MIGLIANICO lmiglianico@cpa-sante.com Principal Investigator: Laurent MIGLIANICO Sub-Investigator: Anne MERCIER-BLAS Sub-Investigator: Jerome CHAMOIS Sub-Investigator: Romuald LE SCODAN Centre Paul Strauss Recruiting Strasbourg, France Contact: Meher BEN ABDELGHANI mbenabdelghani@strasbourg.unicancer.fr Principal Investigator: Meher BEN ABDELGHANI Sub-Investigator: Pascal PIEDBOIS Sub-Investigator: Christian BOREL Sub-Investigator: Christine BELLETIER CHI Les Hôpitaux de Léman Recruiting Thonon Les Bains, France Contact: Ahmed BEDJAOUI a-bedjaoui@ch-hopitauxduleman.fr Principal Investigator: Ahmed BEDJAOUI Sub-Investigator: Maria DIAZ-GHANEM Hôpital privé Recruiting Villeneuve D'Ascq, France Contact: Olivier ROMANO romanoolivier@yahoo.fr Principal Investigator: Olivier ROMANO Sub-Investigator: Nathalie LEMOINE 收起 << |
NCT00794261 | Lymphoma Myel... 展开 >>oma 收起 << | Phase 2 | Completed | - | France ... 展开 >> CHU Angers Angers, France, 49000 CHU Brest Brest, France, 29609 Centre Leon Berard Lyon, France, 69008 Hopital Edouard Herriot Lyon, France, 69008 Hôpital Lapeyronnie Montpellier, France, 34295 CHU Nantes Nantes, France, 44000 Centre Hospitalier Lyon Sud Pierre Bénite, France, 69495 Centre Henri Becquerel Rouen, France, 76038 CHU Toulouse - Hôpital Purpam Toulouse, France, 31000 CHU Tours - Hôpital Bretonneau Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT01423799 | Gastrointestinal Cancer | Phase 3 | Completed | - | France ... 展开 >> Centre Hospitalier Régional Universitaire de Lille Lille, France, 59037 收起 << |
NCT02193802 | Crohn's Disease | Not Applicable | Suspended(Lack of enrollment, ... 展开 >>amendment to colon capsule) 收起 << | January 2017 | France ... 展开 >> Hôpital Beaujon Clichy, France, 92 110 Hôpital Huriez Lille, France, 59000 Hôpital Brabois Nancy, France, 54000 Hôpital Hôtel Dieu Nantes, France, 44093 Hôpital Archet 2 Nice, France, 06200 Hôpital St Louis Paris, France, 75010 Spain Hospital Clinic Barcelona, Spain, 08036 收起 << |
NCT00745875 | - | Completed | - | - | |
NCT01062373 | Premature | Not Applicable | Terminated(difficulties of rec... 展开 >>ruitement) 收起 << | - | France ... 展开 >> Service de Médecine néonatale, Hôpital de la Conception Marseille Cedex 05, France, 13385 收起 << |
NCT02785328 | Sleep Apnea T... 展开 >>emporo-central Epilepsy Narcolepsy High Intellectual Potential Healthy Subject 收起 << | Not Applicable | Unknown | February 2018 | France ... 展开 >> Service d'exploration et pathologie du sommeil, Hôpital Femme Mère Enfant, 59 Bd Pinel Recruiting Lyon, Auvergne-Rhône-Alpes, France, 69677 Contact: Patricia FRANCO, MD PHD 4 27 85 60 52 ext +33 Patricia.franco@chu-lyon.fr 收起 << |
NCT01638403 | Treatment of Excessive Daytime... 展开 >> Sleepiness in Narcolepsy 收起 << | Phase 3 | Completed | - | France ... 展开 >> Evelyne DESCHAMPS DE PAILLETTE Paris, France, 75002 收起 << |
NCT00696202 | Medicated Intrauterine Devices... 展开 >> Contraception 收起 << | Phase 4 | Completed | - | France ... 展开 >> Amiens Cedex 01, France, 80054 收起 << |
NCT01991249 | Pediatric Acute Leukemia | Not Applicable | Unknown | January 2017 | France ... 展开 >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: John Boudjarane john.boudjarane@ap-hm.fr 收起 << |
NCT01789398 | Narcolepsy | Phase 3 | Completed | - | France ... 展开 >> CHU Montpellier Montpellier, France, 34000 收起 << |
NCT01201343 | Multiple Sclerosis, Relapsing,... 展开 >> Remitting 收起 << | Phase 4 | Completed | - | - |
NCT01775046 | - | Active, not recruiting | December 2021 | France ... 展开 >> CHU Amiens Picardie, Hôpital Sud Amiens, France, 80054 CHU de Bordeaux, Groupe Hospitalier Pellegrin Bordeaux, France, 33000 Hôpital Henri Mondor Créteil, France, 94010 CHU Grenoble, Hôpital A. Michallon La Tronche, France, 38700 Hôpital Privé de Parly 2 Le Chesnay, France, 78150 Centre Chirurgical Marie Lannelongue Le Plessis-Robinson, France, 92350 CHU de Limoges Limoges, France, 87042 Clinique de la Sauvegarde Lyon, France, 69009 Hôpital Privé Résidence du Parc Marseille, France, 13010 Hôpital de la Timone Marseille, France, 13385 Hôpital Nord Marseille, France, 13915 Hôpital Européen Georges Pompidou Paris, France, 75015 Hôpital Pitié Salpêtrière Paris, France, 75651 CHU de Saint-Etienne, Hôpital Nord Saint Priest en Jarez, France, 42270 Clinique Belledonne Saint-Martin-d'Hères, France, 38400 CHU Rangueil Toulouse, France, 31059 Clinique Pasteur Toulouse, France, 31076 Clinique Saint-Joseph Trélazé, France, 49800 Clinique du Tonkin Villeurbanne, France, 69626 收起 << | |
NCT02038361 | Acute Leukemia | Not Applicable | Unknown | January 2017 | France ... 展开 >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: Cornel POPOVICI cornel.popovici@ap-hm.fr 收起 << |
NCT00973492 | - | Unknown | December 2009 | France ... 展开 >> Service de Diabétologie du Pr Halimi, CHU Grenoble Cedex 9, France, 38043 收起 << | |
NCT01017965 | - | Terminated(intermediary analys... 展开 >>is was performed and significant results were found for the main objective) 收起 << | - | France ... 展开 >> Service de Diabétologie du Pr Halimi, CHU Grenoble Cedex 9, France, 38043 收起 << | |
NCT01201343 | - | Completed | - | - | |
NCT02627638 | Cancer Patients | Not Applicable | Completed | - | France ... 展开 >> Médecine palliative - Groupement Hospitalier Lyon Sud- Hospices Civils de Lyon Pierre-Bénite Cedex, France, 69495 收起 << |
NCT02847156 | Cystic Fibrosis ... 展开 >> Respiratory Viral Infection 收起 << | Not Applicable | Completed | - | France ... 展开 >> Cystic Fibrosis Pediatric Reference Centrer, Hospices Civils de Lyon Bron, France, 69677 收起 << |
NCT02403245 | Dementia Soci... 展开 >>al Interactions 收起 << | Not Applicable | Completed | - | - |
NCT01906151 | Glaucoma | Not Applicable | Withdrawn | - | France ... 展开 >> CHNO des Quinze-Vingts, 28 rue Charenton Paris, France, 75571 收起 << |
NCT00932087 | - | Completed | - | France ... 展开 >> Fédération d'Endocrinologie-Diabétologie-Maladies métaboliques-Nutrition - Hôpital Cardiovasculaire et Pneumologique Lyon Cedex 03, France, 69394 收起 << | |
NCT03218865 | End Stage Renal Disease ... 展开 >> Inflammation 收起 << | Not Applicable | Recruiting | December 24, 2018 | France ... 展开 >> AIDER Recruiting Montpellier, Occitanie, France, 34295 Contact: Jean Paul Cristol, Professor +33 4 67 33 83 15 jp-cristol@chu-montpellier.fr Contact: Laetitia Barbe +33 6 30 17 80 37 laetitia.barbe@hemotech.fr 收起 << |
NCT01095874 | - | Completed | - | France ... 展开 >> Hôpital Saint-Louis Paris Cedex 10, France, 75475 收起 << | |
NCT00943969 | Obesity | Phase 4 | Completed | - | France ... 展开 >> Unit of Therapeutic Research, Department of Internal Medicine, Lariboisière Hospital Paris cedex 10, France, 75475 收起 << |
NCT01594112 | - | Completed | - | - | |
NCT01321866 | Arteriovenous Fistula ... 展开 >> Fistula 收起 << | Not Applicable | Terminated(Inclusion curve too... 展开 >> slow.) 收起 << | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT02323243 | Detrusor Striated Sphincter Dy... 展开 >>ssynergia (DSSD) 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Service de Chirurgie-Urologie - Centre Hospitalier Lyon Sud Pierre Bénite cedex, France, 69495 收起 << |
NCT02885090 | Rett Syndrome | Not Applicable | Completed | - | France ... 展开 >> Handicaps de l'Enfant - Pavillon Ste Marie, CHU St Jacques Besançon, France Service de Neuropédiatrie, Hôpital St Jacques, CHU de Besançon Besançon, France Unité de génétique, Groupe hospitalier Hôpital Flaubert Caen, France Centre de Génétique Hôpital d'Enfants, CHU de Dijon Dijon, France Service de neuropédiatrie, CHU Hôpital Gui de Chauliac Montpellier, France Laboratoire de Génétique chromosomique, CHU Hôpital l'Archet 2 Nice, France Service de génétique médicale, CHU Hôpital Purpan Nice, France Service de génétique médicale, CHU Hôpital Purpan, CHU de Toulouse Toulouse, France Laboratoire de Génétique, Hôpitaux de Brabois, CHU de Nancy Vandoeuvre les Nancy, France 收起 << |
NCT01323049 | Anesthesia, General | Not Applicable | Completed | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT00998972 | Brain Death C... 展开 >>hronic Renal Insufficiency 收起 << | Phase 3 | Completed | - | France ... 展开 >> CHU de Nice NICE cedex 01, Alpes Maritimes, France, 06000 收起 << |
NCT01377129 | Anterior Cruciate Ligament Inj... 展开 >>ury 收起 << | Not Applicable | Terminated(Patient enrolment p... 展开 >>roved to be more difficult than foreseen and was stopped at 46 inclusions.) 收起 << | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01320813 | Thyroid Nodule ... 展开 >> Goiter Thyroiditis Graves Disease 收起 << | Not Applicable | Terminated(Unable to find enou... 展开 >>gh patients who accept randomization of surgical procedures.) 收起 << | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01956721 | Heart Failure | Not Applicable | Terminated(Difficulty of inclu... 展开 >>sion) 收起 << | March 2017 | France ... 展开 >> physiologie clinique, hopital Arnaud de Villeneuve, 371 avenue du Doyen G;Giraud Montpellier Cedex 5, France, 34295 收起 << |
NCT01321970 | Coronary Artery Disease ... 展开 >> Coronary Disease 收起 << | Not Applicable | Withdrawn(Impossible to start ... 展开 >>to the study.) 收起 << | December 2015 | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01402765 | Chronic Immobile Patients | Not Applicable | Completed | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01402791 | - | Completed | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << | |
NCT02018718 | Marathoners | Not Applicable | Completed | - | France ... 展开 >> University Hospital of Montpellier Montpellier Cedex 5, France, 34295 收起 << |
NCT01323127 | - | Completed | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << | |
NCT01403909 | Major Abdominal Surgery | Not Applicable | Withdrawn(We need somebody to ... 展开 >>replace the principal inestigator.) 收起 << | December 2015 | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01404819 | Carotid Endarterectomy | Not Applicable | Completed | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01194843 | Hepatectomy P... 展开 >>ain Metastasis 收起 << | Not Applicable | Completed | - | France ... 展开 >> Centre Léon Bérard LYON Cedex 08, France, 69373 收起 << |
NCT01403220 | Renal Failure, Acute | Not Applicable | Completed | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01325636 | Cytomegalovirus Infections ... 展开 >> Adenovirus Infections 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Biotherapy department, Hôpital Necker - Enfants Malades Paris Cedex 15, France, 75743 收起 << |
NCT01543360 | Central Venous Catheterization | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT03155022 | Myocardial Infarction, Acute | Not Applicable | Recruiting | October 2021 | France ... 展开 >> Hopital Louis Pradel Recruiting Bron, France Contact: Michel Ovize, Pr Principal Investigator: Michel Ovize 收起 << |
NCT01541059 | Third Molar Extraction | Phase 4 | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT02904850 | - | Unknown | December 2016 | France ... 展开 >> Service de Pneumologie Nouvel Hôpital Civil Recruiting Strasbourg, Alsace, France, 67091 Sub-Investigator: Bertrand MENNECIER Sub-Investigator: Alain DUCOLONE Sub-Investigator: Nathalie PRIM Sub-Investigator: Cesar MATAU Sub-Investigator: Ashok PUROHIT 收起 << | |
NCT01548976 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << | |
NCT01930903 | Coronary Artery Disease ... 展开 >> High Bleeding Risk Patients 收起 << | Not Applicable | Unknown | December 2015 | France ... 展开 >> Chu Toulouse Toulouse, France 收起 << |
NCT01559155 | - | Terminated(recruitment difficu... 展开 >>lties) 收起 << | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT01545089 | Patient Comfort | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << |
NCT01559207 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT01566058 | Stress Disorders, Post-Traumat... 展开 >>ic Anxiety 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT01548989 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 收起 << | |
NCT01595958 | Non Shockable Out of Hospital ... 展开 >>Cardiac Arrest 收起 << | Phase 3 | Completed | - | France ... 展开 >> Medical intensive care unit, Edouard Herriot Hospital Lyon, France, 69003 收起 << |
NCT00707304 | Non Small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT02014727 | Malaria, Falciparum | Phase 1 | Completed | - | Burkina Faso ... 展开 >> CNRFP Ouagadougou, Burkina Faso France CIC BT 505 de vaccinologie Cochin Pasteur Hôpital Cochin Bâtiment Lavoisier 27 rue du faubourg St Jacqu, Paris, France, 75014 收起 << |
NCT00942058 | - | Terminated(Difficult for recru... 展开 >>iting) 收起 << | - | France ... 展开 >> Centre Jean Perrin CLERMONT-FERRAND Cedex 01, France, 63011 Institut Cancérologique de la Loire Saint Priest En Jarez, France, 42270 CHU de Saint-Etienne SAINT-ETIENNE Cedex 2, France, 42055 收起 << | |
NCT01386580 | Brain Metastases ... 展开 >> Lung Cancer Breast Cancer Melanoma Malignant Glioma 收起 << | Phase 1 Phase 2 | Completed | - | United States, North Carolina ... 展开 >> UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Belgium Universitair Ziekenhuis Antwerpen Antwerp, Belgium, B-2650 Jules Bordet Institute Brussels, Belgium, B-1000 France Institut Curie Paris, Paris Cedex 05, France, 75248 Institut Gustave Roussy Villejuif, Val de Marne, France, 94805 Netherlands Antoni van Leeuwenhoek Ziekenhuis Amsterdam, Netherlands, 1066 CX Vrije Universiteit medisch centrum (Vumc) Amsterdam, Netherlands, 1081 HV Leids Universitair Medisch Centrum (LUMC) Leiden, Netherlands, 2333 CA Maastricht Universitair Medisch Centrum Maastricht, Netherlands, 6229 HX Erasmus MC Rotterdam, Netherlands, 3075 EA 收起 << |
NCT02126475 | - | Unknown | October 2016 | France ... 展开 >> ICM-IHU Not yet recruiting Paris, France, 75013 Sub-Investigator: ilhame AMEQRANE, PhD ICM Recruiting Paris, France, 75013 Contact: bertrand degos, MD-PhD bertrand.degos@psl.aphp.fr Sub-Investigator: ilhame ameqrane, PhD 收起 << | |
NCT01207336 | Acute Ischaemic Stroke | Phase 2 Phase 3 | Unknown | - | France ... 展开 >> Centre d' Investigation Clinique de Toulouse et Hopitaux de Toulouse ( Purpan) Recruiting Toulouse, France, 31059 Contact: Fabienne Calvas, MD 0033561772407 fabienne.calvas@inserm.fr Principal Investigator: Marion SIMONETTA-MOREAU, MDPhD Sub-Investigator: Claire THALAMAS, MD Sub-Investigator: Angélique GERDELAT-MAS, MD Sub-Investigator: Fabienne CALVAS, MD Sub-Investigator: François CHOLLET, MDPhD Sub-Investigator: Jean-François ALBUCHER, MD Sub-Investigator: Nicolas RAPOSO, MD Sub-Investigator: Isabelle Loubinoux, PhD 收起 << |
NCT00219726 | Chronic Myeloid Leukemia | Phase 2 | Completed | - | France ... 展开 >> University Hospital Poitiers, France, 86021 收起 << |
NCT00556283 | Gastric Outlet Obstruction ... 展开 >> Rectocele Intussusception Anismus 收起 << | Phase 4 | Completed | - | France ... 展开 >> Chirurgie Proctologique Besancon, France, 25000 Clinique des Cèdres Cornebarrieu, France, 31700 Groupe Hospitalier Diaconesses Croix Saint-Simon Paris, France, 75012 Hopital Bagatelle Talence, France, 33401 CHU Purpan Toulouse, France, 31055 Italy Ospedale S. Giuseppe Milan, Italy, 20123 Ospedale "Franchini" di Montecchio Emilia Montecchio Emilia, Italy, 42027 Ospedale Santa Maria degli Angeli Pordenone, Italy, 33170 United Kingdom Royal Liverpool University Hospital Liverpool, United Kingdom, L7 8XP 收起 << |
NCT00190151 | Healthy Volunteers | Not Applicable | Terminated(terminated) | - | France ... 展开 >> Hôpital Bichat Claude Bernard, 46 rue Henri Huchard Paris, France, 75877 收起 << |
NCT00219752 | Chronic Myeloid Leukemia | Phase 2 | Completed | - | France ... 展开 >> University Hospital Poitiers, France, 86021 收起 << |
NCT01065038 | Essential Thrombocythaemia | Phase 3 | Completed | - | Austria ... 展开 >> Center Innsbruck Innsbruck, Tirol, Austria, 6020 Center AKH Vienna, Austria, 1090 Center Hanusch Vienna, Austria, 1140 Czech Republic Center Brno Brno, Czech Republic, 62500 Center Olomouc Olomouc, Czech Republic, 77520 Center Praha Prague, Czech Republic, 12808 France Center Paris Paris, CLICHY Cedex, France, 92118 Germany Center Munich Munich, Bavaria, Germany, 80331 Center Berlin Berlin, Germany, 12200 Center Halle Halle, Germany, 06111 Center Saarbrücken Saarbrücken, Germany, 66113 Center Ulm Ulm, Germany, 89081 Hungary Center Budapest Budapest, Hungary, 1097 Italy Center Modena Modena, Italy, 41100 Center Pavia Pavia, Italy, 27100 Lithuania Center Vilnius Vilnius, Lithuania, 2600 Poland Center Gdansk Gdansk, Poland, 80-211 Center Katowice Katowice, Poland, 40-027 Center Krakow Krakow, Poland, 31-501 Center Lodz Lodz, Poland, 93-510 Center Lublin Lublin, Poland, 20-079 Center Warszawa Warszawa, Poland, 02-097 Singapore Center Singapore Singapore, Singapore, 169608 Slovenia Center Ljubljana Ljubljana, Slovenia 收起 << |
NCT01055873 | - | Completed | - | - | |
NCT00122551 | HIV Infections | Phase 3 | Terminated | - | France ... 展开 >> Service des Maladies Infectieuses Paris, France, 75010 Service des Maladies Infectieuses et Tropicales Hopital Purpan Toulouse Cedex 9, France, 31059 收起 << |
NCT00001671 | - | Completed | - | United States, California ... 展开 >> University of California, San Francisco San Francisco, California, United States, 94143 United States, District of Columbia Childrens National Medical Center Washington, D.C., District of Columbia, United States France Institut National de la Sante' et de la Recherche Medicale Clermont-Ferrand, Cedex, France, 63001 Israel Tel Aviv University Tel Aviv, Israel Netherlands Academiseh Ziuekenhuis Vrije Universiteit Amsterdam, Netherlands 收起 << | |
NCT01058174 | Liver Transplantation ... 展开 >> Mycoses 收起 << | Phase 3 | Completed | - | - |
NCT00496457 | Diabetic Neuropathy | Phase 2 | Completed | - | Croatia ... 展开 >> Univerity Hospital OSIJEK, Department for Diabetes and Endocrinology, J.Huttlera 4 Osijek, Croatia, 31 000 Genaral Hospital "Josip Bencevic", Internal Medicine Department-Unit for Diabetes, Andrije Stampara 42 Slavonski Brod, Croatia, 35 000 General Hospital Varazdin, Internal Medicine Department-Unit for Diabetes, Ivana Mestrovica bb Varazdin, Croatia, 42 000 University Hospital "Dubrava", University Department for Internal Medicine, Institut for Diabetes, Endocrinology and Metabolic diseases, Avenija Gojka Suska 6 Zagreb, Croatia, 10 000 Germany Diabetes Zentrum Mergentheim - Theodor-Klotzbücher-Straße 12 Bad Mergentheim, Germany, 97980 Diabetologische Schwerpunktpraxis - Wilhelminenstr. 22 Dinslaken-Bruch, Germany, 46537 Deutsches Diabetes Center, Institut für Klinische Diabetologie, Leibniz-Zentrum an der Heinrich-Heine Universität - Auf'm Hennekamp 65 Duesseldorf, Germany, 40225 Klinikum Region Hannover GmbH - Klinikum Hannover Nordstadt - Diabetes Schwerpunktklinik -Medizinische Klinik - Haltenhoffstr. 41 Hannover, Germany, 30167 Universitätsklinikum Heidelberg - Abteilung Innere Medizin I und klinische Chemie - Im Neuenheimer Feld 410 Heidelberg, Germany, 69120 Pro scientia med - Osterweide 10 Lübeck, Germany, 23562 IKFE GmbH - Institut für klinische Forschung und Entwicklung - Parcusstr. 8 Mainz, Germany, 55116 Diabetes Schwerpunktpraxis - Gesundheitszentrum Potsdam GmbH - Hebbelstr. 1A Potsdam, Germany, 14467 Diabetes Schwerpunktpraxis - Gesundheitszentrum Potsdam GmbH, Hebbelstr. 1A Potsdam, Germany, 14467 Sophien- und Hufeland-Klinikum gGmbH - Klinik für Neurologie und Klinische Neurophysiologie - Henry-van-de-Velde-Str. 2 Weimar, Germany, 99425 Latvia Daugavpils Regional Hospital - Vasarnicu street 20 Daugavpils, Latvia, LV-5420 Zemgale's Diabetes Centre SIA - Zemgales boulevard 15 Jelgava, Latvia, LV-3000 Doctor's Practice in Endocrinology - Meža prospekts 9, 2nd floor, 41.kabinets Ogre, Latvia, LV-5001 Clinical Research Centre "Riga" - Katrinas dambis 16 Riga, Latvia, LV-1045 Talsu Hospital - Rugena street 7 Talsi, Latvia, LV-3201 Poland NZOZ Specjalistyczny Ośrodek, Internistyczno-Diabetologiczny, ul Zamenhofa 10/20 Białystok, Poland, 15-435 Centrum Neurologii Klinicznej - Ul. Dwernickiego 8 Kraków, Poland, 31-530 NZOZ Special-Med. Ul. Weteranów 46 Lublin, Poland, 20-044 NZOZ MEDICA, ul. Jutrzenki 4 Lublin, Poland, 20-538 NZOZ Beta-Med., Plac Wolności 17 Rzeszów, Poland, 35-073 Adamiec Rajmund Gabinet Lekarski, ul. Żelazna 34 Wrocław, Poland, 53-428 Serbia Centre of Neurology, Clinical Hospital Centre "Dr Dragisa Misovic" Belgrade, Serbia, 11000 Clinic for Neurology and Psychiatry, Clinical Hospital Centre "Zvezdara" Belgrade, Serbia, 11000 Institute for Endocrinology, Clinical Centre Serbia Belgrade, Serbia, 11000 Neurology Clinic, Military Medical Academy Belgrade, Serbia, 11000 Neurology Department, Clinical Hospital Zemun Belgrade, Serbia, 11000 Center for Neurology, Clinical Centre "Kragujevac" Kragujevac, Serbia, 34000 收起 << |
NCT01086904 | Renal Transplant Recipients ... 展开 >> Immunosuppression 收起 << | Phase 2 | Completed | - | France ... 展开 >> Centre hospitalier Lyon Sud, service de néphrologie transplantation Pierre-Bénite cedex, Lyon, France, 69495 Hôpital E. Herriot , Service de néphrologie, transplantation et immunologie clinique Lyon cedex 3, France, 69437 Service d'urologie, GH Pitié Salpêtrière Paris, France, 75013 收起 << |
NCT02556359 | - | Recruiting | September 2019 | France ... 展开 >> Saint Louis hospital Recruiting Paris, France, 75010 Contact: Claire Fieschi, MD PhD +33 1 42 49 45 83 claire.fieschi@aphp.fr 收起 << | |
NCT01322698 | - | Completed | - | France ... 展开 >> CHU de Nîmes Nimes, Gard, France, 30029 CHU de Montpellier Montpellier Cedex 05, France, 34090 收起 << | |
NCT02098200 | Tricuspid Regurgitation | Phase 1 | Completed | - | France ... 展开 >> Bichat Hospital Paris, Paris Cedex 18, France, 75877 Hospices Civils de Lyon Lyon, France Clinique Pasteur Toulouse, France, 31076 Germany Universitatsklinikum Bonn Bonn, Germany, 53127 CardioVasculares Centrum Frankfurt Frankfurt am Main, Germany, 60389 UKE Heart Center Hamburg, Germany Italy Monzino Hospital Milan, Lombardy, Italy, 20121 University Hospital Pisa Pisa, Tuscany, Italy, 56124 Ferrarotto Hospital Catania, Italy, 95124 Fondazione Toscana G. Monasterio Ospedale del Cuore G. Pasquinucci Massa, Italy, 54100 San Raffaele Hospital Milano, Italy, 20129 Azienda Ospedaliera di Padova Padova, Italy, 35128 Fondazione PTV Policlinico Tor Vergata Roma, Italy Netherlands St. Antonius Ziekenhuis Nieuwegein, Netherlands, 3430EM 收起 << |
NCT00432419 | HIV Infections ... 展开 >> Lymphoma, Non-Hodgkin 收起 << | Phase 1 Phase 2 | Terminated(only one patient en... 展开 >>rolled) 收起 << | - | France ... 展开 >> Servide d'Immunologie Clinique Creteil, France, 94010 收起 << |
NCT00265642 | Hepatitis C, Chronic | Phase 3 | Completed | - | France ... 展开 >> CHU Angers, Service d'hépato-gastroentérologie Angers, France, 49933 cedex 09 收起 << |
NCT00462462 | Congenital Venous Malformation | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins Medical Institutions Baltimore, Maryland, United States, 21287 France Hôpital Bretonneau Service de neuroradiologie Tours Cedex 1, France, 37044 收起 << |
NCT00462462 | - | Completed | - | - | |
NCT00528060 | HIV Infections | Phase 2 | Completed | - | France ... 展开 >> Hopital du Kremlin Bicêtre Service de médecine interne Kremlin Bicëtre, France, 94275 Hopital Bichat CIC Paris cedex 18, France, 75877 收起 << |
NCT01577836 | - | Active, not recruiting | September 2019 | France ... 展开 >> APHM - Hôpital de la Conception Marseille Cedex 5, France, 13385 Clinique Beau Soleil Montpellier, France, 34070 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT01323075 | - | Completed | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 Hôpital Lapeyronnie CHU de Montpellier Montpellier Cedex 05, France, 34295 Hôpital Privé Claude Galien Quincy-sous-Sénart, France, 91480 收起 << | |
NCT01961310 | - | Active, not recruiting | December 31, 2018 | France ... 展开 >> CHRU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 Unité U1047 "Bacterial virulence and infectious diseases", UFR de Médecine Nîmes Cedex 2, France, 30908 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT00322374 | Metastatic Breast Cancer | Phase 1 | Completed | - | France ... 展开 >> Local Institution Toulouse Cedex 3, France, 31052 Italy Local Institution Milano, Italy, 20133 收起 << |
NCT00480792 | HIV Infections | Phase 3 | Completed | - | France ... 展开 >> Hopital Cochin CIC de vaccinologie Paris, France, 75014 收起 << |
NCT00935051 | Diabetic Foot Ulcer | Early Phase 1 | Completed | - | France ... 展开 >> Diabetology department Grenoble, Isere, France, 38043 Service de Diabétologie du Pr Halimi, CHU Grenoble Grenoble Cedex 9, France, 38043 收起 << |
NCT00324116 | - | Completed | - | - | |
NCT02380820 | Pressure Ulcer | Not Applicable | Completed | - | France ... 展开 >> EHPAD La Chimotaie Cugan Montaigu Cedex, France, 85610 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 EHPAD Notre Dame des Pins Saint Privat des Vieux, France, 30340 收起 << |
NCT00324116 | Macular Degeneration | Phase 4 | Completed | - | France ... 展开 >> Pfizer Investigational Site Angers, Cedex 09, France, 49933 Pfizer Investigational Site Lyon, Cedex 4, France, 69317 Pfizer Investigational Site Besancon, Cedex, France, 25030 Pfizer Investigational Site Creteil, Cedex, France, 94010 Pfizer Investigational Site Macon, Cedex, France, 71018 Pfizer Investigational Site Poitiers, Cedex, France, 86021 Pfizer Investigational Site Bayonne, France, 64100 Pfizer Investigational Site Belfort Cedex, France, 90016 Pfizer Investigational Site Bordeaux, France, 33076 Pfizer Investigational Site Bordeaux, France, 33100 Pfizer Investigational Site Brest, France, 29200 Pfizer Investigational Site DIJON Cedex, France, 21033 Pfizer Investigational Site La Rochefoucauld, France, 16110 Pfizer Investigational Site La Tronche, France, 38700 Pfizer Investigational Site Lille, France, 59800 Pfizer Investigational Site Limoges Cedex 1, France, 87042 Pfizer Investigational Site Lyon, France, 69003 Pfizer Investigational Site Marseille, France, 13008 Pfizer Investigational Site Montpellier, France, 34000 Pfizer Investigational Site Montpellier, France, 34070 Pfizer Investigational Site MULHOUSE Cedex 1, France, 68070 Pfizer Investigational Site Nancy, France, 54000 Pfizer Investigational Site Nantes Cedex 1, France, 44093 Pfizer Investigational Site Paris cedex 12, France, 75557 Pfizer Investigational Site PARIS Cedex 19, France, 75940 Pfizer Investigational Site Paris, France, 75006 Pfizer Investigational Site Paris, France, 75015 Pfizer Investigational Site Rives, France, 38140 Pfizer Investigational Site Rouen, France, 76000 Pfizer Investigational Site Saint-Herblain, France, 44819 Pfizer Investigational Site Strasbourg Cedex, France, 67091 Pfizer Investigational Site Strasbourg, France, 67000 Pfizer Investigational Site Toulouse, France, 31054 Pfizer Investigational Site Toulouse, France, 31200 收起 << |
NCT01104610 | Obesity Hypoventilation Syndro... 展开 >>me 收起 << | Not Applicable | Withdrawn(Stopped by the spons... 展开 >>or) 收起 << | - | France ... 展开 >> CHU Grenoble, France GH Pitié-Salpétrière - Service de pneumologie et réanimation Paris cedex 13, France, 75651 收起 << |
NCT02328742 | - | Withdrawn(Feasibility issues r... 展开 >>equire solutions.) 收起 << | May 2018 | France ... 展开 >> Institut des Biomolécules Max Mousseron Montpellier Cedex 05, France, 34093 CHRU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT01128855 | Muscular Dystrophies | Phase 1 | Completed | - | United States, Ohio ... 展开 >> GSK Investigational Site Columbus, Ohio, United States, 43205 France GSK Investigational Site Paris cedex 13, France, 75651 收起 << |
NCT01388907 | Uterine Fibroids ... 展开 >> Fertility Disorders 收起 << | Phase 4 | Completed | - | France ... 展开 >> University Hospital Angers, France, 49933 Clinique du Tondu Bordeaux, France, 33000 Béclère Hospital (Public Assistance of Paris Hospital) Clamart, France, 92141 UNIVERSITY HOSPITAL Estaing Clermont-ferrand, France, 63003 University Carémeau Hospital Nimes, France, 30029 TENON Hospital (Public Assistance of Paris Hospital) Paris, France, 75020 TROUSSEAU Hospital (Public Assistance of Paris Hospital) Paris, France, 75571 Bichat Hospital - Claude Bernard (Public Assistance of Paris Hospital) Paris, France, 75877 South University Hospital Rennes, France, 35023 Centre Hospitalier des quatre villes Sevres, France, 92317 Versailles Hospital Versailles, France, 78157 收起 << |
NCT01388907 | - | Completed | - | - | |
NCT00606359 | Influenza Ort... 展开 >>homyxoviridae Infections 收起 << | Phase 2 | Completed | - | France ... 展开 >> Lyon, Cedex, France Lyon, France 收起 << |
NCT00322374 | - | Completed | - | - | |
NCT01905644 | Delivery, Obstetric | Not Applicable | Completed | - | France ... 展开 >> CHU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 CHU de Poitiers Poitiers Cedex, France, 86021 收起 << |
NCT01558349 | - | Recruiting | December 2017 | France ... 展开 >> CHU de Montpellier - Hôpital Saint-Eloi Not yet recruiting Montpellier, France, 34295 Sub-Investigator: Catherine Alix-Panabières, MD CHU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Laurent Meunier, MD 收起 << | |
NCT02293733 | - | Completed | - | France ... 展开 >> Centre Hospitalier D Argenteuil Argenteuil, Val D'oise, France, 95100 Site 12 Aix En Provence, France, 13100 Centre Hospitalier Universitaire Angers, France, 49033 Centre Hospitalier du Morvan Brest, France, 29200 Centre François Baclesse Caen, France, 14000 Centre Hospitalier René Dubos Cergy-pontoise, France, 95301 Site 33 Creteil, France, 94010 Site 07 Draguignan, France, 83300 Site 32 Elbeuf, France, 76503 Site 04 GAP, France, 05000 Centre Hospitalier Les Oudairies La Roche Sur Yon, France, 85000 Hospital du Cluzeau Limoges, France, 87042 Site 00 Limoges, France Centre Hospitalier Régional Longjumeau, France, 91160 Site 25 Mantes La Jolie, France, 78200 Site 06 Marseille, France, 13274 Site 01 Meaux, France, 77108 Site 19 Perigueux, France, 24019 Site 20 Rennes, France, 35033 Site 18 Rouen, France, 76031 Site 17 Rouen, France, 76233 Hôpital Yves Le Foll Saint Brieuc, France, 22023 Site 14 Toulon, France, 83800 Site 11 Villefranche Sur Saone, France, 69655 收起 << | |
NCT02763644 | Transplant Associated Microang... 展开 >>iopathy TAM 收起 << | Phase 2 | Terminated | - | United States, North Carolina ... 展开 >> Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599 United States, Ohio Novartis Investigative Site Columbus, Ohio, United States, 43210 France Novartis Investigative Site Paris, Cedex 10, France, 75475 Novartis Investigative Site Marseille, France, 13273 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Heidelberg, Germany, 69120 收起 << |
NCT02329626 | - | Completed | - | France ... 展开 >> CHRU de Montpellier - Hôpital Gui de Chauliac Montpellier Cedex 5, France, 34295 CHRU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT00460551 | Non Small Cell Lung Cancer | Phase 2 | Terminated(Due to consideratio... 展开 >>ns regarding the appropriate therapeutic regimen for these patients.) 收起 << | - | United States, Maryland ... 展开 >> Towson, Maryland, United States, 21204 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213-2967 Belgium UZ Gent Gent, Belgium, 9000 CHR La Citadelle Liege, Belgium, 4000 CHU Sart-Tilman Domaine Universitaire du Sart-Tilman Liege, Belgium, 4000 France CHRU Reims, Hospital Maison Blanche Reims, Cedex, France, 51092 Netherlands VU Medisch Centrum (VUMC) Amsterdam, Netherlands, 1004MB United Kingdom The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom, SM2 5PT 收起 << |
NCT01577576 | - | Terminated(Inclusion curve too... 展开 >> slow.) 收起 << | - | France ... 展开 >> Université d'Avignon, Faculté des Sciences Avignon, France, 84000 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT01558024 | - | Completed | - | France ... 展开 >> CHU de Montpellier - Hôpital Saint-Eloi Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT00221650 | HIV Infections ... 展开 >> Hepatitis C, Chronic Treatment Failure 收起 << | Phase 2 | Completed | - | France ... 展开 >> Hôpital Pellegrin, Federation des Maladies Infectieuses, Pr RAGNAUD Bordeaux, France, 33076 收起 << |
NCT01685658 | Renal Colic A... 展开 >>cute Renal Colic 收起 << | Phase 4 | Suspended(same study already p... 展开 >>ublished) 收起 << | March 2018 | France ... 展开 >> CH d'Alès Alès, France, 30103 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << |
NCT00460551 | - | Terminated(Due to consideratio... 展开 >>ns regarding the appropriate therapeutic regimen for these patients.) 收起 << | - | - | |
NCT01082471 | Postoperative Pain | Phase 3 | Completed | - | Czech Republic ... 展开 >> Teaching Hospital Bulovka, Department of Urology Prague, Czech Republic, 180 00 France Anaesthetisia - Resuscitation Department, Tenon Hospital Paris, Cedex 20, France, 75970 Germany Universitätsklinikum Bonn, Klinik und Poliklinik f. Anaesthesiologie Bonn, Germany, 53105 Netherlands Department of Anaesthesiology, Leiden University Medical Centre Leiden, Netherlands, 2300 RC Poland Ii Klinika Anestezjologii i It Lublin, Poland, 20-081 United Kingdom Intensive Care Unit, Level 5, Western Infirmary, Glasgow, Renfrewshire, United Kingdom, G11 6NT St John's Hospital Livingston, West Lothian, United Kingdom, EH54 6PP 收起 << |
NCT01544244 | Shoulder Tend... 展开 >>inopathy 收起 << | Not Applicable | Terminated(Inclusion curve too... 展开 >> slow.) 收起 << | - | France ... 展开 >> CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << |
NCT01109147 | - | Completed | - | - | |
NCT02116426 | - | Completed | - | France ... 展开 >> CHRU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT01909258 | - | Completed | - | France ... 展开 >> CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT01109147 | Schizophrenia, Undifferentiate... 展开 >>d Type 收起 << | Phase 4 | Completed | - | France ... 展开 >> Hôpital de la Conception - Service du Pr Dassa -147, boulevard Baille Marseille cedex 5, France, 13385 Sainte-Marguerite Hospital - Psychiatric service -Service du Pr Azorin - 270 boulevard de Sainte Marguerite Marseille, France, 13009 收起 << |
NCT02059746 | - | Completed | - | France ... 展开 >> CHRU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT02805725 | Soft-tissue Sarcomas | Phase 1 Phase 2 | Recruiting | December 2019 | France ... 展开 >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD Principal Investigator: Antoine ITALIANO, MD,PhD Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Jean-Yves BLAY Principal Investigator: Jean-Yves BLAY, MD,PhD Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Contact: Sarah DUMONT, MD Principal Investigator: Sarah DUMONT, MD 收起 << |
NCT00889720 | Smoking Cessation | Phase 4 | Completed | - | France ... 展开 >> Pfizer Investigational Site Paris Cedex 13, France, 75651 Italy Pfizer Investigational Site Pisa, Italy, 56124 收起 << |
NCT02116387 | Lower Back Pain | Not Applicable | Active, not recruiting | May 2018 | France ... 展开 >> CHRU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << |
NCT00985413 | - | Terminated(The company DNage i... 展开 >>s in receivership and no longer functional) 收起 << | - | United States, Massachusetts ... 展开 >> Harvard medical School, Children's Hospital Boston, Division of Genetics & Metabolism Boston, Massachusetts, United States, 02115 United States, New York New York University Medical Center New York, New York, United States, 10016 France Hopitaux Universitaires de Strasbourg, Service de Pédiatrie 1 Strasbourg, Cedex, France, 67098 United Kingdom St. Mary's Hospital, Genetic Medicine, 6th Floor, Oxford Road Manchester, United Kingdom, M13 9 WL 收起 << | |
NCT01322256 | Diabetic Foot ... 展开 >> Osteoarthritis 收起 << | Not Applicable | Terminated(The study has prove... 展开 >>n to be infeasible.) 收起 << | - | France ... 展开 >> Centre Hospitalier Universitaire de Nîmes Nîmes Cedex 09, Gard, France, 30029 CHU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi Le Grau du Roi, France, 30240 收起 << |
NCT02426970 | - | Recruiting | December 2018 | France ... 展开 >> CHRU de Montpellier - Hôpital Lapeyronie Recruiting Montpellier, France, 34295 Principal Investigator: Isabelle Tavares, MD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Claire de Labachelerie, MD Sub-Investigator: Arnaud Dupeyron, MD, PhD 收起 << | |
NCT02325063 | Epicondylitis, Lateral Humeral... 展开 >> Tennis Elbow 收起 << | Not Applicable | Terminated(Stop production PRB... 展开 >> kit) 收起 << | - | France ... 展开 >> CHRU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT00889720 | - | Completed | - | - | |
NCT01271777 | Insulin Resistance ... 展开 >> Abdominal Obesity 收起 << | Phase 2 | Completed | - | France ... 展开 >> Site n°1 Nantes Cedex 1, France, 44093 Site n°2 Pierre Bénite, France, 69310 收起 << |
NCT02664623 | Multiple Sclerosis | Not Applicable | Recruiting | July 2018 | France ... 展开 >> CH d'Alès Not yet recruiting Alès, France, 30103 Principal Investigator: Eric Thouvenot, MD, PhD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Eric Thouvenot, MD, PhD Sub-Investigator: Sandrine Fiorella, dietician Sub-Investigator: Giovanni Castelnovo, MD 收起 << |
NCT01495247 | Inoperable Locally Advanced Br... 展开 >>east Cancer Metastatic Breast Cancer (MBC) 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Novartis Investigative Site Dijon Cedex, France, 21034 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Spain Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 收起 << |
NCT02317133 | - | Recruiting | December 2018 | France ... 展开 >> CHRU de Montpellier - Hôpital Lapeyronie Recruiting Montpellier, France, 34295 Principal Investigator: Eric Jeziorski, MD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Tu Anh Tran, MD, PhD Sub-Investigator: Anne Filleron, MD Sub-Investigator: Jean Philippe Lavigne, MD, PhD Sub-Investigator: Catherine Dunyach-Remy, PhD 收起 << | |
NCT02805049 | Septic Shock ... 展开 >>Peritonitis 收起 << | Phase 4 | Recruiting | January 2019 | Australia ... 展开 >> Royal Brisbane Women's Hospital Active, not recruiting Herston, Australia, 4029 France CHU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Claire Roger, MD Sub-Investigator: Jean-Yves Lefrant, MD, PhD Sub-Investigator: Guillaume Louart, MD Sub-Investigator: Benjamin Louart, MD Sub-Investigator: Caroline Boutin, MD Sub-Investigator: Saber Barbar, MD Sub-Investigator: Laurent Muller, MD Sub-Investigator: Pablo Massenet, MD Sub-Investigator: Aurélien Daurat, MD 收起 << |
NCT01536301 | Arthroplasty, Replacement, Hip | Phase 4 | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 APHP - Groupe Hospitalier Pitié-Salpetrière Paris, France, 75013 收起 << |
NCT01405430 | Colorectal Cancer ... 展开 >> Metastasis 收起 << | Not Applicable | Completed | - | France ... 展开 >> Centre Léon Bérard LYON Cedex 08, France, 69373 Hôpital Privé Jean Mermoz Lyon, France, 69008 收起 << |
NCT01563653 | Urinary Incontinence, Stress | Not Applicable | Terminated(Not enough inclusio... 展开 >>ns.) 收起 << | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 CH de Dignes les Bains Digne-les-Bains, France, 04000 收起 << |
NCT01234701 | - | Completed | - | United States, Massachusetts ... 展开 >> Harvard Medical School, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02117-0825 United States, Missouri St. Louis University, Liver Center Saint Louis, Missouri, United States, 63110-0250 France University Hospital Strasbourg Strasbourg, Cedex, France, 67098 Germany University Hospital Essen Essen, Germany, 45147 New Zealand Auckland City Hospital Auckland, New Zealand, 9 Switzerland University Hospital Zurich, Department of Interventional and Diagnostic Radiology Zurich, Switzerland, 8091 University Hospital Zurich, Department of Visceral and Transplant Surgery, Swiss Hepato-Pancreato-Biliary (HPB) Center Zurich, Switzerland, 8091 United Kingdom The Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom, LS9 7TF University College London Hospitals NHS Foundation Trust London, United Kingdom, NW1 2PG Imperial College, Hammersmith Hospital London, United Kingdom, W12 0HS 收起 << | |
NCT02114749 | Motor Activity | Not Applicable | Completed | - | France ... 展开 >> TIMC - pavillon Taillefer - CHU GRENOBLE cedex 9, France, 38043 University Hospital Grenoble, France, 38043 收起 << |
NCT02751827 | - | Recruiting | February 2019 | France ... 展开 >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD Principal Investigator: Antoine ITALIANO, MD,PhD Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Jean-Yves BLAY, MD, PhD Principal Investigator: Jean-Yves BLAY, MD, PhD 收起 << | |
NCT02420158 | Irritable Bowel Syndrome | Not Applicable | Active, not recruiting | August 2018 | France ... 展开 >> Clinique Universitaire d'Hépato-Gastroentérologie - CHU de Grenoble Grenoble, France, 38043 Service d'Exploration Fonctionnelle Digestive - Hôpital Edouard Herriot - Hospices Civils de Lyon LYON Cedex 03, France, 69437 收起 << |
NCT02273687 | Respiratory Distress Syndrome,... 展开 >> Adult 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 CH de Perpignan - Hôpital Saint Jean Perpignan, France, 66046 收起 << |
NCT03643224 | Persistent Atrial Fibrillation... 展开 >> Atrial Fibrillation 收起 << | Not Applicable | Recruiting | April 15, 2020 | United States, Mississippi ... 展开 >> Jackson Heart Clinic Recruiting Jackson, Mississippi, United States, 39216 Contact: Rose Cheatham, RN 601-982-7850 Principal Investigator: Judson Colley, MD France Clinique Pasteur Recruiting Toulouse, Cedex 3, France, 31076 Contact: Juliette Goutner, RN (+336)1373-1838 Principal Investigator: Jean Paul Albenque, MD Clinique du Tonkin Recruiting Villeurbanne, Lyon, France, 69100 Contact: Rafik Stiti, RN (+33) (0)4 37 48 48 05 Principal Investigator: Herve Poty, MD Sub-Investigator: Durand Dubief 收起 << |
NCT02806258 | Radiation Therapy, Breast Canc... 展开 >>er, Sequential Partial Breast Irradiation Intermediate and High-risk Luminal and Triple Negative Breast Cancer 收起 << | Phase 1 Phase 2 | Recruiting | March 2025 | France ... 展开 >> CHU de Grenoble Recruiting Grenoble Cedex 09, France, 38043 Contact: Christophe Mendoza +33 4.76.76.94.81 ChMendoza@chu-grenoble.fr AP-HP Henri mondor Not yet recruiting Paris, France Contact: Yazid BELKACEMI, MD, PhD 收起 << |
NCT00560456 | Sleep Deprivation | Not Applicable | Completed | - | France ... 展开 >> University Hospital Bordeaux, Groupe Hospitalier Pellegrin Bordeaux cedex, France, 33076 Laboratoire d'Imagerie et de Neurosciences Cognitives (LINC) Strasbourg, France, 67000 收起 << |
NCT02400151 | Obesity | Phase 4 | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 Institut Saint Pierre Palavas-Les-Flots, France, 34250 收起 << |
NCT02664571 | Amyloid Cerebral Angiopathy ... 展开 >> Alzheimer Disease 收起 << | Not Applicable | Not yet recruiting | January 2020 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Not yet recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Dimitri Renard, MD Sub-Investigator: Laurent Collombier, MD Sub-Investigator: Benjamin Chambert, MD CH de Perpignan - Hôpital Saint Jean Not yet recruiting Perpignan, France, 66046 Principal Investigator: Denis Sablot, MD 收起 << |
NCT02739880 | Menopause Dys... 展开 >>pareunia 收起 << | Not Applicable | Active, not recruiting | December 2018 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 Centre Médical KARIS Perpignan, France, 66000 收起 << |
NCT02737540 | - | Recruiting | October 2019 | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Marilyn Wyart, MD Sub-Investigator: Fabrice Jollant, MD Sub-Investigator: Mocrane Abbar, MD Clinique Les Sophoras Not yet recruiting Nîmes, France, 30000 Sub-Investigator: Stéphane Torres, MD Sub-Investigator: Guillaume Collin, MD 收起 << | |
NCT02540291 | Tumors | Phase 1 | Terminated(Terminated due to, ... 展开 >>licensing agreement granting exclusive rights of research, development, manufacture and marketing of Eisai's E7046 to Adlai Nortye Biopharma.) 收起 << | - | United States, Massachusetts ... 展开 >> Boston, Massachusetts, United States United States, Texas Houston, Texas, United States France Villejuif, Cedex, France 收起 << |
NCT02698579 | - | Enrolling by invitation | November 2033 | United States, California ... 展开 >> Mattel Children's Hospital-UCLA Los Angeles, California, United States, 90095 United States, Massachusetts Boston Children's Hospital/Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Argentina Fundación Investigar Buenos Aires, Argentina Australia Women's and Children's Hospital North Adelaide, Australia France Hôpital Bicêtre Le Kremlin-Bicêtre, Cedex, France, 94275 United Kingdom Great Ormond Street Hospital London, United Kingdom 收起 << | |
NCT02884609 | - | Unknown | July 2018 | France ... 展开 >> CHR Metz-Thionville Recruiting Metz Cedex 03, France, 57087 Contact: Benoît LEHEUP, MD 0033382558826 b.leheup@chr-metz-thionville.fr Principal Investigator: Benoît LEHEUP, MD GH Diaconesses Croix Saint Simon Recruiting Paris, France, 75012 Contact: Stéphane PICARD, MD 0033144742802 SPicard@hopital-dcss.org Principal Investigator: Stéphane PICARD, MD 收起 << | |
NCT00741949 | Respiratory Insufficiency | Phase 3 | Completed | - | France ... 展开 >> University Hospital Bordeaux, Groupe Hospitalier Pellegrin Bordeaux cedex, France, 33076 Centre hospitalier Libourne Libourne, France, 33505 收起 << |
NCT02020577 | Neoplasms | Phase 1 | Completed | - | France ... 展开 >> 1200.122.33001 Boehringer Ingelheim Investigational Site Villejuif Cedex, France Spain 1200.122.34001 Boehringer Ingelheim Investigational Site Madrid, Spain 收起 << |
NCT03594955 | Leukaemia | Phase 1 Phase 2 | Recruiting | July 2021 | France ... 展开 >> Investigational Site Number 2500001 Recruiting Paris, France, 75010 Investigational Site Number 2500003 Recruiting Villejuif Cedex, France, 94805 收起 << |
NCT02020577 | - | Completed | - | - | |
NCT02150174 | Schizophrenia ... 展开 >> Episodic Memory Deficits 收起 << | Not Applicable | Completed | - | France ... 展开 >> Centre Psychothérapique de Nancy Laxou Cedex, France, 54521 Service de psychiatrie - Hôpital Civil - CHRU Strasbourg Strasbourg, France, 67091 Cedex 收起 << |
NCT01118624 | - | Completed | - | - | |
NCT02118259 | Geriatrics Re... 展开 >>sidence for Dependent Elderly Health Services for the Aged 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 CHRU de Nîmes - Centre de Gérontologie de Serre Cavalier Nîmes, France, 30029 收起 << |
NCT01215058 | - | Withdrawn | April 2011 | - | |
NCT01626950 | - | Completed | - | France ... 展开 >> IURC - Laboratoire de Biostatistique d'Epidémiologie et de Recherche Clinique Montpellier Cedex 5, France, 34093 Equipe Démographie Santé Montpellier Cedex 5, France, 34298 Registre Tumeurs de l'Hérault Montpellier Cedex 5, France, 34298 收起 << | |
NCT01118624 | Breast Cancer ... 展开 >> Breast Tumors Neoplasms, Breast Cancer of the Breast Human Mammary Carcinoma 收起 << | Phase 2 | Completed | - | United States, Oregon ... 展开 >> Providence Cancer Center Portland, Oregon, United States, 97213 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Czech Republic Fakultní nemocnice Olomouc Olomouc, Czech Republic, 775 20 Multiscan, s.r.o. Pardubice, Czech Republic, 532 03 Fakultní nemocnice Královské Vinohrady - FNKV Praha, Czech Republic, 100 34 France Centre Lutte Contre le Cancer Val d'Aurelle (CRLC) Montpellier, Cedex 5, France, 34298 Centre Régional de Lutte Contre le Cancer Alexis Vautrin Vandoeuvre, les Nancy Cedex, France, 54511 Centre Georges François Leclerc Dijon Cedex, France, 21079 Centre Léon Bérard Lyon Cedex, France, 69373 Institut Paoli Calmettes Marseille, France, 13273 Institut Jean-Godinot Reims Cedex 09, France, 51056 Hungary University of Debrecen Medical and Health Science Center Debrecen, Hajdú-Bihar, Hungary, 4032 Semmelweis University Budapest Budapest, Hungary, H-1082 National Health Centre of Hungary Budapest, Hungary, H-1145 收起 << |
NCT01211652 | - | Completed | - | - | |
NCT00207012 | HER2 or EGFR Expressing Advanc... 展开 >>ed Solid Malignancies 收起 << | Phase 1 | Completed | - | France ... 展开 >> Local Institution Villejuif Cedex, France Spain Local Institution Barcelona, Spain 收起 << |
NCT01596062 | Renal Transplantation | Phase 2 | Completed | - | France ... 展开 >> Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Tours Cedex, France, 37044 收起 << |
NCT02648737 | Parkinson's Disease ... 展开 >> Generalized Anxiety Disorder Social Phobia 收起 << | Not Applicable | Recruiting | December 2019 | France ... 展开 >> Neurology and Movement Disorders Unit, Lille University Hospital Recruiting Lille Cedex, France, 59037 Contact: Kathy Dujardin, Professor (+33) 320 446 752 kathy.dujardin@univ-lille2.fr Principal Investigator: Kathy Dujardin, Professor Netherlands Maastricht University Medical Centre Recruiting Maastricht, Netherlands, 6202 AZ Contact: Anja JH Moonen + 31 43 3877443 anja.moonen@maastrichtuniversity.nl Contact: Albert FG Leentjens, MD, PhD + 31 43 3877443 a.leentjens@maastrichtuniversity.nl Principal Investigator: Anja JH Moonen Principal Investigator: Albert FG Leentjens, MD, PhD 收起 << |
NCT02404584 | - | Recruiting | September 2018 | France ... 展开 >> CHRU de Montpellier - Hôpital Saint-Eloi Recruiting Montpellier cedex 5, France, 34295 Principal Investigator: Délphine Topart, MD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Nadine Houédé, MD, PhD Sub-Investigator: Alexandre Evard, Pharmd, PhD Sub-Investigator: Jean-Christophe Boyer, MD, PhD Institut de Cancérologie du Gard (ICG) Recruiting Nîmes Cedex 9, France, 30029 Principal Investigator: Angélique Chapellie, MD 收起 << | |
NCT00143130 | Seizures | Phase 3 | Completed | - | - |
NCT00958516 | Atopic Dermatitis | Phase 1 | Completed | - | France ... 展开 >> LEO Pharma site St Quentin en Yvelines Cedex, France, 78054 收起 << |
NCT01407133 | Chronic Tinnitus | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Département d'ORL et de Chirurgie Cervico-Maxillo-Faciale, Hôpital Edouard Herriot LYON Cedex 03, France, 69437 Service d'Audiologie et Explorations Orofaciales, Centre Hospitalier Lyon Sud PIERRE-BÉNITE Cedex, France, 69495 Service d'Oto-Rhino-Laryngologie, Centre Hospitalier Lyon-Sud PIERRE-BÉNITE Cedex, France, 69495 收起 << |
NCT03492177 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 2 | Recruiting | December 30, 2025 | France ... 展开 >> HOSP ARNAUD DE VILLENEUVE - PAED DEPT (Montpellier) Recruiting Montpellier, France, 34295 Contact: Principal Investigator + 33 4 67 33 67 33 p-amedro@chu-montpellier.fr HOSP NECKER _CARDIOLOGY PEDIATRY DEPT (Paris) Recruiting Paris, France, 75015 Contact: Principal Investigator +33 1 44 49 43 44 damien.bonnet@nck.aphp.fr HOSP DES ENFANTS_CARDIOLOGY DEPT (Toulouse Cedex 9) Recruiting Toulouse Cedex 9, France, 31059 Contact: Principal Investigator + 33 5 61 77 22 33 dulac.y@chu-toulouse.fr Hungary Gottsegen Gyorgy National Card Inst - Pediatric Card Recruiting Budapest, Hungary, 1096 Contact: Principal Investigator +36 1 215 1220 ablonczyl@kardio.hu 收起 << |
NCT01596062 | - | Completed | - | - | |
NCT03584711 | Metastatic Colorectal Cancer | Phase 2 | Recruiting | December 2020 | France ... 展开 >> Clinique Trenel Recruiting Sainte Colombe, Lyon, France, 69560 Contact: Ivan GRABER, Dr graber.trenel@gmail.com Clinique Claude Bernard Recruiting Albi, France, 81030 Contact: Yann Berge, Dr berge@claude-bernard-albi.com Hopital Sud Recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, Dr hautefeuille.vincent@chu-amiens.fr Clinique de L'Europe Recruiting Amiens, France, 80090 Contact: Michel Gozy, Dr michelgozy@gmail.com Chu D'Angers Recruiting Angers CEDEX 9, France, 49933 Contact: Carole VITELLIUS, Dr carole.vitellius@chu-angers.fr; carole.vitellius@wanadoo.fr; cvitellius@gmail.com Hopital Prive D'Antony Recruiting Antony, France, 92166 Contact: Anne THIROT BIDAULT, Dr a.t.bidault@gmail.com Hopital Les Bonnettes Recruiting Arras CEDEX, France, 62012 Contact: Bruno HUGUENIN, Dr drbhuguenin@orange.fr Centre Marie Curie Recruiting Arras, France, 62000 Contact: Anne-Sophie BLANC-GUERINEAU drblanc@radiopole-artois.com Ch Cote Basque Recruiting Bayonne CEDEX, France, 64109 Contact: Franck AUDEMAR, Dr faudemar@ch-cotebasque.fr Ch de Beauvais Recruiting Beauvais, France, 60021 Contact: Fayçal HOCINE, Dr f.hocine@ch-beauvais.fr ; fayoncologie@yahoo.fr Polyclinique Saint Privat Recruiting Boujan-sur-Libron, France, 34760 Contact: Michaël HUMMELSBERGER, Dr michael.hummelsberger@orange.fr Cmco Cote D'Opale Recruiting Boulogne-sur-Mer, France, 62222 Contact: Laurent GASNAULT, Dr laurent.gasnault@sfr.fr Hopital Duchenne Recruiting Boulogne-sur-Mer, France, 62321 Contact: Vincent BOURGEOIS, Dr vincebourgeois@hotmail.com Hopital Morvan - Chu Recruiting Brest, France, 29609 Contact: Jean-Philippe METGES, Dr jean-philippe.metges@chu-brest.fr Ch de Beziers Cedex Recruiting Béziers, France, 34525 Contact: Mohamed RAMDANI, Dr mohamed.ramdani@ch-beziers.fr Centre Francois Baclesse Recruiting Caen, France, 14076 Contact: Stéphane CORBINAIS, Dr s.corbinais@baclesse.unicancer.fr Ch Cahors Recruiting Cahors, France, 46000 Contact: Nadia LEVASSEUR, Dr nadia.levasseur@ch-cahors.fr Ch de Cholet Recruiting Cholet, France, 49325 Contact: Frédérique ALABERT, Dr frederique.alabert@ch-cholet.fr Centre Hospitalier General Recruiting Châlons-en-Champagne, France, 51005 Contact: ROCH ANICET OSSENDZA, Dr rochossendza@yahoo.fr Hopitaux Civils de Colmar Recruiting Colmar, France, 68024 Contact: Gilles BREYSACHER, Dr gilles.breysacher@ch-colmar.fr Service de Medecine Recruiting Digne-les-Bains, France, 04000 Contact: Gilbert BORDES, Dr gbordes@ch-digne.fr CH Recruiting Dunkerque CEDEX 01, France, 59385 Contact: Tatiana CEBAN RUDIC, Dr tatiana.ceban@ch-dunkerque.fr Hopital Jacques Monod Recruiting Flers CEDEX, France, 61104 Contact: Pierre-Emmanuel HENNERESSE, Dr pierre-emmanuel.henneresse@ch-flers.fr ; netpeh@orange.fr; p.e.henneresse@wanadoo.fr Chi de Frejus Saint-Raphael Recruiting Fréjus, France, 83600 Contact: Bruno VALENZA, Dr valenza-b@chi-frejus-saint-raphael.fr;oncologie-sec@chi-fsr.fr; brunovalenza@msn.com Polyclinique de Blois - 3Eme Etage Recruiting La Chaussee St Victor, France, 41260 Contact: Philippe LAPLAIGE, Dr dr.laplaige@wanadoo.fr Chd Vendee Recruiting La Roche-sur-Yon, France, 85925 Contact: Roger FAROUX, Dr roger.faroux@chd-vendee.fr Ch Du Mans Recruiting Le Mans CEDEX 9, France, 72037 Contact: Oana COJOCARASU, Dr ocojocarasu@ch-lemans.fr; oanaalexa@hotmail.com Centre Hospitalier Schaffner Recruiting Lens, France, 62307 Contact: Alice PHAM-BECKER, Dr apham@ch-lens.fr Chru Hopital Claude Huriez 4Eme Est Recruiting Lille, France, 59037 Contact: Anthony TURPIN, Dr turpin.anth@yahoo.fr; anthony.turpin@chru-lille.fr Ch St Joseph-St Luc Recruiting Lyon, France, 69365 Contact: Denis PERE VERGE, Dr dpereverge@ch-stjoseph-stluc-lyon.fr; fannydenis@sfr.fr Hopital Europeen Marseille Recruiting Marseille, France, 13331 Contact: Yves RINALDI, Dr y.rinaldi@hopital-europeen.fr; yrinaldi@wanadoo.fr Ch de Meaux Recruiting Meaux, France, 77100 Contact: Christophe LOCHER, Dr c-locher@ch-meaux.fr Hopital Layne Recruiting Mont-de-Marsan, France, 40024 Contact: Jérôme DAUBA, Dr jerome.dauba@ch-mt-marsan.fr Polyclinique de Gentilly Recruiting Nancy, France, 54100 Contact: Fabien BROCARD, Dr f.brocard@oncog.fr Hopital Prive Du Confluent Sas Recruiting Nantes, France, 44277 Contact: Benjamin LINOT, Dr benjamin.linot@groupeconfluent.fr Ch de Niort - Sce D'Oncologie Recruiting Niort CEDEX, France, 79021 Contact: Albert ALEBA, Dr albert.aleba@ch-niort.fr Groupe Hospitalier Pitie-Salpetriere Recruiting Paris CEDEX 13, France, 75651 Contact: Jean-Baptiste BACHET, Dr jean-baptiste.bachet@aphp.fr Chu Cochin Recruiting Paris, France, 75014 Contact: Romain CORIAT, Pr romain.coriat@aphp.fr Groupe Hospitalier Pitie-Salpetriere Recruiting Paris, France Contact: Jean-Baptiste Bachet, Pr Polyclinique de Courlancy Recruiting Reims, France, 51100 Contact: Karinne PRULHIER-CORVIOLE, Dr kpulhiere@iccreims.fr Centre Hospitalier Recruiting Saint-Quentin CEDEX, France, 02321 Contact: Innocenti DADAMESSI, Dr I.dadamessi@ch-stquentin.fr;dadamessi@gmail.com Clinique Ste Anne Recruiting Strasbourg, France, 67000 Contact: Louis-Marie DOURTHE, Dr lm.dourthe@solcrr.org Centre Paul Strauss Recruiting Strasbourg, France, 67065 Contact: Meher BEN ABDELGHANI, Dr mbenabdelghani@strasbourg.unicancer.fr Polyclinique de L'Ormeau Recruiting Tarbes, France, 65000 Contact: Philippe AYELA, Dr Payela@ch-lourdes.fr ; philippe.ayela@sfr.fr ; nathaliemonteiro@wanadoo.fr Clinique Pasteur Recruiting Toulouse, France, 31076 Contact: Mathilde MARTINEZ, Dr m.martinez@clinique-pasteur.com Martinique Chu de Fort de France Recruiting Fort-de-France, Martinique, 97261 Contact: Nathalie GROSSAT BERNADOU, Dr nathalie.grossat-bernadou@chu-martinique.fr 收起 << |
NCT02245737 | Alzheimer´s Disease | Phase 2 Phase 3 | Terminated(An independent asse... 展开 >>ssment concluded the trial was not likely to meet the primary endpoint upon completion and therefore, trial stopped for futility) 收起 << | - | - |
NCT01201356 | Relapsing Forms of Multiple Sc... 展开 >>lerosis 收起 << | Phase 3 | Completed | - | - |
NCT01651780 | Severe Aortic Stenosis ... 展开 >> Transcatheter Aortic Valve Replacement Aortic Valve Replacement 收起 << | Phase 3 | Completed | - | Canada, Quebec ... 展开 >> Montreal Heart Institute Montreal, Quebec, Canada, H1T 1C8 Canada St. Paul´s Hospital Providence Health Care Vancouver, Canada, V6Z1Y6 France Clinique Pasteur, Unité de Cardiologie Interventionnelle Toulouse, Cedex 3, France, 31076 CHU de Toulouse Toulouse, Cedex 9, France, 31059 CHU Jean Minjoz, Service de Cardiologie Besançon, France, 25000 Centre Hospitalier de Lyon Bron, France, 69500 Department of Cardiology, CHRU Lille Lille, France, 59037 Institut Hospitalier Jacques Cartier Massy, France, 91300 Service de Cardiologie, Centre Hospitalo-Universitaire, Hôpital Charles-Nicolle Rouen, France, 76031 Germany University Heart Centre, Clinic of Inner Medicine 1 Cardiology Jena, Lobeda Ost, Germany, 07747 Universitätsklinikum Bonn Bonn, Germany, 53105 Klinikum links der Weser Bremen Bremen, Germany, 28277 Elisabeth-Krankenhaus Essen Essen, Germany, 45257 Freiburg University Freiburg, Germany, 79106 Asklepios St. Georg Hamburg Hamburg, Germany, 20099 Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universität Leipzig - Herzzentrum GmbH Leipzig, Germany, 04289 Universitätsmedizin der Johannes Gutenberg-Universitat Mainz Mainz, Germany, 55131 LMU Munich, Klinikum der Universität München Munich, Germany, 81377 Deutsches Herzzentrum München München, Germany, 80636 Helios Heart Center Siegburg Siegburg, Germany, 53721 Italy Ferraroto Hospital, University of Catania Catania, Italy, 95123 Ospedale San Raffaele U.O. Cardiologia Interventistica Milano, Italy, 20132 Azienda Ospedaliero-Universitaria Pisana Pisa, Italy, 56124 Azienda Ospedaliera San Camillo-Forlanini Roma, Italy, 00151 Policlinico Umberto I, Università La Sapienza Roma, Italy Netherlands St. Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Switzerland Cardiology University Hospital Basel Basel, Switzerland, CH-4031 Universitätsklinik Bern Bern, Switzerland, 3010 United Kingdom The Royal Sussex County Hospital Brighton, East Sussex, United Kingdom, BN2 5BE Hammersmith Hospital London, United Kingdom, W12 0HS 收起 << |
NCT01651780 | - | Completed | - | - | |
NCT02892149 | Anemia in Subjects With DD-CKD | Phase 3 | Recruiting | January 2020 | - |
NCT03670810 | Migraine | Phase 3 | Not yet recruiting | March 2, 2021 | - |
NCT02967692 | Melanoma | Phase 3 | Recruiting | February 13, 2020 | - |
NCT00141245 | Seizure Disorder, Partial | Phase 3 | Completed | - | - |
NCT03447769 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | September 15, 2025 | - |
NCT03334396 | Atopic Dermatitis | Phase 3 | Recruiting | August 15, 2019 | - |
NCT03428100 | Atopic Dermatitis | Phase 3 | Recruiting | March 1, 2021 | - |
NCT02064868 | Acute Heart Failure (AHF) | Phase 3 | Terminated(Study was terminate... 展开 >>d based on results from pivotal adult AHF study CRLX030A2301) 收起 << | - | - |
NCT02684006 | Renal Cell Cancer | Phase 3 | Active, not recruiting | April 30, 2021 | - |
NCT00048230 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT03524092 | Ulcerative Colitis | Phase 3 | Recruiting | March 22, 2022 | - |
NCT03518086 | Ulcerative Colitis | Phase 3 | Recruiting | December 29, 2021 | - |
NCT03155997 | Breast Cancer | Phase 3 | Recruiting | June 10, 2027 | - |
NCT00368745 | Generalized Anxiety Disorder | Phase 3 | Completed | - | Costa Rica ... 展开 >> Pfizer Investigational Site San Pedro de Montes de Oca, San José, Costa Rica, 00 Czech Republic Pfizer Investigational Site Plzen, Czech Republic, 301 00 Pfizer Investigational Site Praha 10, Czech Republic, 100 00 Pfizer Investigational Site Praha 6, Czech Republic, 163 00 Pfizer Investigational Site Praha 7, Czech Republic, 170 00 Pfizer Investigational Site Praha-Bubenec, Czech Republic, 170 00 France Pfizer Investigational Site Paris, Cedex 12, France, 75571 Pfizer Investigational Site Arcachon, France, 33120 Pfizer Investigational Site Caen, France, 14000 Pfizer Investigational Site Elancourt, France, 78990 Pfizer Investigational Site Nantes-Orvault, France, 44700 Guatemala Pfizer Investigational Site Guatemala, Guatemala Italy Pfizer Investigational Site L'Aquila, Italy, 67100 Pfizer Investigational Site Milan, Italy, 20157 Mexico Pfizer Investigational Site Tepic, Nayarit, Mexico, 63000 Pfizer Investigational Site Mexico D.f., Mexico, 03740 Pfizer Investigational Site San Luis Potosi, Mexico, 78216 Spain Pfizer Investigational Site Langreo, Asturias, Spain, 33900 Pfizer Investigational Site Barcelona, Spain, 08025 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Zamora, Spain, 49021 收起 << |
NCT02792218 | Relapsing Multiple Sclerosis | Phase 3 | Active, not recruiting | May 16, 2019 | - |
NCT00368745 | - | Completed | - | - | |
NCT01483027 | Colorectal Cancer Metastatic | Phase 3 | Recruiting | September 2019 | - |
NCT02422615 | Advanced Breast Cancer | Phase 3 | Active, not recruiting | February 19, 2020 | - |
NCT03132636 | Carcinoma, Basal Cell | Phase 2 | Recruiting | May 4, 2021 | - |
NCT01956812 | Metastatic Pancreatic Cancer ... 展开 >> Pancreatic Cancer 收起 << | Phase 3 | Terminated(The DSMB conducted ... 展开 >>an interim analysis on overall survival, which showed that the treatment arm did not demonstrate a sufficient improvement in OS vs. placebo.) 收起 << | March 2017 | - |
NCT02422615 | - | Active, not recruiting | - | - | |
NCT02752776 | Moderate to Severe Plaque Psor... 展开 >>iasis 收起 << | Phase 4 | Completed | - | - |
NCT03551626 | Malignant Melanoma | Phase 3 | Recruiting | October 22, 2021 | - |
NCT01859481 | Migraine Without Aura ... 展开 >> Migraine With Aura 收起 << | Phase 3 | Completed | - | - |
NCT00268983 | Lymphoma, Non-Hodgkin | Phase 3 | Completed | - | United States, Washington ... 展开 >> GSK Investigational Site Walla Walla, Washington, United States, 99362 France GSK Investigational Site Pierre-Benite Cedex, France, 69495 United Kingdom GSK Investigational Site Manchester, Lancashire, United Kingdom 收起 << |
NCT00926731 | Acute Myeloid Leukemia | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Research Site Cleveland, Ohio, United States United States, Texas Research Site Houston, Texas, United States France Research Site Le Chesnay Cedex, France Research Site Villejuif Cedex, France 收起 << |
NCT00268983 | - | Completed | - | - | |
NCT01176968 | Myocardial Infarction | Phase 4 | Completed | - | - |
NCT03379727 | Acute Myeloid Leukemia | Phase 3 | Recruiting | December 30, 2021 | - |
NCT03148795 | Prostate Cancer | Phase 2 | Recruiting | March 3, 2022 | - |
NCT02721966 | Axial Psoratic Arthritis | Phase 3 | Recruiting | June 11, 2019 | - |
NCT01176968 | - | Completed | - | - | |
NCT00098722 | HIV Infections | Phase 2 Phase 3 | Completed | - | - |
NCT02278120 | Advanced Metastatic Breast Can... 展开 >>cer 收起 << | Phase 3 | Active, not recruiting | September 27, 2019 | - |
NCT01884350 | Non-valvular Atrial Fibrillati... 展开 >>on 收起 << | Phase 4 | Completed | - | - |
NCT01307501 | Metastatic Lung Cancer | Not Applicable | Active, not recruiting | September 2018 | United States, California ... 展开 >> Ronald Regan UCLA Medical Center Los Angeles, California, United States, 90095 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester Rochester, Minnesota, United States, 55905 France Institut Gustave Roussy Villejuif, Cedex, France, 94805 收起 << |
NCT01251653 | - | Completed | - | France ... 展开 >> 1200.93.33002 Boehringer Ingelheim Investigational Site Dijon, France 1200.93.33001 Boehringer Ingelheim Investigational Site Saint-Herblain cedex, France 1200.93.33003 Boehringer Ingelheim Investigational Site Toulouse, France 收起 << | |
NCT01257633 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes, Gard, France, 30029 CHU de Montpellier - Hôpital Gui de Chauliac Montpellier, France, 34295 CHRU de Toulouse - Hôpital de Rangueil Toulouse Cedex 9, France, 31059 收起 << | |
NCT00955773 | Cancer | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 France GSK Investigational Site Paris Cedex 20, France, 75970 收起 << |
NCT01649271 | - | Completed | - | - | |
NCT02055729 | - | Active, not recruiting | December 2018 | France ... 展开 >> Centre Mutualiste Neurologique Propara Montpellier, France, 34090 Unité U1047 "Bacterial virulence and infectious diseases", UFR de Médecine Nîmes Cedex 2, France, 30908 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 Laboratoire d'Etude et de Recherche en Environnement et Santé, Unité Biodiagnostic, UNIMES Nîmes, France, 30000 收起 << | |
NCT01251653 | - | Completed | - | - | |
NCT01649271 | Breast Neoplasms ... 展开 >> Stomach Neoplasms 收起 << | Phase 1 | Completed | - | France ... 展开 >> CTR Georges-François Leclerc Dijon, France, 21079 CTR René Gauducheau, Onco, St Herblain Saint Herblain Cedex, France, 44805 INS Claudius Regaud Toulouse, France, 31059 收起 << |
NCT00143143 | Epilepsies, Partial ... 展开 >> Epilepsy, Complex Partial 收起 << | Phase 3 | Completed | - | - |
NCT01121822 | Influenza | Phase 3 | Completed | - | France ... 展开 >> Gieres, France, 38610 MONTPELLIER Cedex 5, France, 34094 Rouffach, France, 68250 收起 << |
NCT01894425 | - | Completed | - | France ... 展开 >> CHU de Montpellier - Hôpital Saint-Eloi Montpellier cedex 5, France, 34295 CHU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier, France, 34295 CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT00063726 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00098722 | - | Completed | - | - | |
NCT02517918 | Solid Tumor O... 展开 >>steosarcoma 收起 << | Phase 1 | Recruiting | October 2019 | France ... 展开 >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Maud Toulmonde, Doctor Centre Léon Bérard Not yet recruiting Lyon, France, 69008 Contact: Jean-Yves BLAY, Professor Institut Curie Not yet recruiting Paris Cedex 05, France, 75248 Contact: Sophie PIPERNO-NEUMANN, Doctor Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Contact: Julien DOMONT, Doctor 收起 << |
NCT00722566 | Multiple Myeloma | Phase 3 | Completed | - | Belgium ... 展开 >> UZ Brussel Department Medical Oncology Laarbeeklaan 101 Brussel, Belgium, 1090 France Hôtel DIEU, Service D'Hématologie Place Alexis RICORDEAU NANTES Cedex 01, France, 44093 Germany Universitätsklinikum Münster Onkologische Ambulanz West Albert-Schweitzer-Str. 33 Münster, Germany, 48129 收起 << |
NCT01650467 | - | Withdrawn(Funding is late, unf... 展开 >>orseeable.) 收起 << | June 2017 | France ... 展开 >> Clinique du Parc Castelnau Le Lez, France, 34170 CHU de Montpellier - Hôpital Saint-Eloi Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT00722566 | - | Completed | - | - | |
NCT02938611 | - | Not yet recruiting | April 2019 | France ... 展开 >> AIDER - Unité de Dialyse d'Alès Not yet recruiting Alès, France, 30100 Principal Investigator: Anne Wuillai, MD Sub-Investigator: Médérick Mohajer, MD Sub-Investigator: Farid Bellahsene, MD AIDER - Unité de Dialyse de Nîmes, CHU Carémeau Not yet recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Laure Patrier, MD Sub-Investigator: Emilie Pambrun, MD CHU de Nîmes - Hôpital Universitaire Carémeau Not yet recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Olivier Moranne, MD, PhD Sub-Investigator: Pascal Reboul, MD Sub-Investigator: Sylvain Cariou, MD Sub-Investigator: Sophie Renaud, MD Sub-Investigator: Louis Marie Vernier, MD Sub-Investigator: Frédérique Vecina, MD Gardialyse Not yet recruiting Nîmes, France, 30900 Principal Investigator: Samir Boubenider, MD Sub-Investigator: Philippe Rousseau, MD 收起 << | |
NCT00661180 | Chronic Myelogenous Leukemia | Phase 2 | Completed | - | United States, Oregon ... 展开 >> Portland, Oregon, United States, 97239 France Lyon Cedex, France, 69437 Paris, France, 75010 Poitiers Cedex, France, 86021 收起 << |
NCT01688882 | Bullous Pemphigoid | Phase 2 | Terminated(This study was stop... 展开 >>ped after Part 1 completed and was terminated because the predefined criteria of efficacy was not reached ( >50% better then placebo)) 收起 << | - | United States, Iowa ... 展开 >> Novartis Investigative Site Iowa City, Iowa, United States, 52242 United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 Austria Novartis Investigative Site Vienna, Austria, A 1040 France Novartis Investigative Site Rouen, Cedex, France, 76031 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Freiburg, Germany, 79104 Novartis Investigative Site Marburg, Germany, 35039 Japan Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-8582 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 收起 << |
NCT02056262 | - | Unknown | March 2017 | France ... 展开 >> CHRU de Montpellier - Centre de Soins, d'Enseignement et de Recherche Dentaires Recruiting Montpellier, France, 34295 Sub-Investigator: Jean-Christophe Chazel, MD, PhD Sub-Investigator: Pierre Michailesco, MD, PhD Sub-Investigator: Estelle Moulis, MD, PhD Sub-Investigator: Paul Tramini, MD, PhD Sub-Investigator: Jean Valcarcel, MD, PhD Sub-Investigator: Paula Vintan, MD CHRU de Montpellier - Hôpital La Colombière Not yet recruiting Montpellier, France, 34295 Sub-Investigator: Estelle Jumas-Bilak, MD, PhD CHRU de Nîmes - Hôpital Universitaire Carémeau Not yet recruiting Nîmes Cedex 9, France, 30029 Principal Investigator: Hervé Léon, MD Sub-Investigator: Jean-Albert Triay, MD Sub-Investigator: Bernard Delarbre, MD 收起 << | |
NCT00346034 | Fibromyalgia | Phase 3 | Completed | - | - |
NCT00346034 | - | Completed | - | - | |
NCT02735135 | Pressure Ulcer | Not Applicable | Not yet recruiting | August 2019 | France ... 展开 >> CH de Beziers Not yet recruiting Béziers, France, 34525 Sub-Investigator: Nadine Mitermite, MD Clinique de Soins de suite et réadaptation Saint Basile Not yet recruiting Mougins, France, 06250 Sub-Investigator: Bernard Gioanni, MD CHRU de Nîmes - Hôpital Universitaire Carémeau Not yet recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Emilie Viollet, MD Sub-Investigator: Arnaud Dupeyron, MD, PhD Sub-Investigator: Nouvel Fabrice, Ergotherapist Sub-Investigator: Mylène Blot, Ergotherapist 收起 << |
NCT00910728 | Primary Myelofibrosis (PMF) ... 展开 >> Post-Polycythaemia Vera Essential Thrombocythaemia Myelofibrosis 收起 << | Phase 1 | Completed | - | United States, New York ... 展开 >> Research Site New York, New York, United States United States, Texas Research Site Houston, Texas, United States France Research Site Villejuif Cedex, France 收起 << |
NCT00879905 | Advanced Solid Malignancies | Phase 1 | Completed | - | Canada, Ontario ... 展开 >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Toulouse Cedex 3, France, 31052 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 收起 << |
NCT00531479 | Aspergillosis | Phase 3 | Completed | - | - |
NCT00910728 | - | Completed | - | - | |
NCT02610647 | Healthy Volunteers | Not Applicable | Completed | - | France ... 展开 >> Laboratoire Movement to Health (M2H), Euromov, Université Montpellier 1 Montpellier, France, 34090 CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT02109302 | Premature Ejaculation | Not Applicable | Unknown | - | France ... 展开 >> Polyclinique de Blois Not yet recruiting La Chaussée Saint Victor, France, 41260 Contact: Benoît Vogt, MD benoitvogt@free.fr Principal Investigator: Benoît Vogt, MD Hôpital Saint Joseph Not yet recruiting Marseille Cedex 08, France, 13285 Contact: Robert Porto, MD robert.porto@worldonline.fr Principal Investigator: Robert Porto, MD Hôpital Necker Not yet recruiting Paris, France, 75015 Contact: Alexandre Alcaïs, MD alexandre.alcais@inserm.fr Principal Investigator: Alexandre Alcaïs, MD 收起 << |
NCT01357655 | Leukemia | Phase 2 | Terminated(No participants enr... 展开 >>olled in this trial could receive the SMO antagonist as a recommended phase 2 dose was not determined by a different, concurrently-run trial.) 收起 << | - | United States, New Jersey ... 展开 >> John Theurer Cancer Center Hackensack, New Jersey, United States, 07601 United States, Tennessee Tennessee Oncology Pllc Nashville, Tennessee, United States, 37203 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Argentina Local Institution San Miguel De Tucuman, Tucuman, Argentina, 4000 Belgium Local Institution Antwerpen, Belgium, 2060 Local Institution Brugge, Belgium, B-8000 Canada, Alberta Local Institution Edmonton, Alberta, Canada, T6G 1Z2 Finland Local Institution Helsinki, Finland, 00290 France Local Institution Nantes, Cedex, France, 44000 Local Institution Bordeaux, France, 33076 Local Institution Le Chesnay, France, 78150 Local Institution Lille, France, 59037 Local Institution Paris Cedex 10, France, 75475 Local Institution Strasbourg Cedex, France, 67091 Local Institution Toulouse Cedex 09, France, 31059 Poland Local Institution Chorzow, Poland, 41-500 Local Institution Gdansk, Poland, 80-952 Local Institution Krakow, Poland, 30-510 Local Institution Lodz, Poland, 93-513 Local Institution Wroc#aw, Poland, 50-367 Spain Local Institution Madrid, Spain, 28006 Local Institution Madrid, Spain, 28034 Local Institution Oviedo, Spain, 33006 Local Institution Pamplona, Spain, 31008 收起 << |
NCT01830738 | Hysterectomy | Not Applicable | Terminated(Inclusion curve too... 展开 >> poor.) 收起 << | - | France ... 展开 >> APHM - Hôpital de la Conception Marseille, France, 13385 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 CHU de Saint Etienne - Hôpital Nord Saint-Priest en Jarez, France, 42270 收起 << |
NCT01357655 | - | Terminated(No participants enr... 展开 >>olled in this trial could receive the SMO antagonist as a recommended phase 2 dose was not determined by a different, concurrently-run trial.) 收起 << | - | - | |
NCT00531479 | - | Completed | - | - | |
NCT02373956 | Pressure Ulcer | Not Applicable | Recruiting | December 2019 | France ... 展开 >> Centre Mutualiste Neurologique Propara Recruiting Montpellier, France, 34090 Contact: Anthony GELIS CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Jean-Philippe Lavigne, MD, PhD Sub-Investigator: Catherine Dunyach-Rémy, PhD Sub-Investigator: Albert Sotto, MD, PhD Sub-Investigator: Benoît de Wasières, MD, PhD Sub-Investigator: Arnaud Dupeyron, MD,PhD CHRU de Nîmes - Centre de Gérontologie de Serre Cavalier Recruiting Nîmes, France, 30029 Sub-Investigator: Sabine Rouvière, MD 收起 << |
NCT02055781 | Primary Myelofibrosis ... 展开 >> Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis 收起 << | Phase 3 | Terminated | - | - |
NCT01222078 | Diabetes Mellitus, Type 1 | Phase 2 | Terminated(A Phase 3 study rec... 展开 >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) 收起 << | - | France ... 展开 >> GSK Investigational Site Paris Cedex 18, France, 75877 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 收起 << |
NCT01222078 | - | Terminated(A Phase 3 study rec... 展开 >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) 收起 << | - | - | |
NCT02370979 | HIV-1 Infection | Phase 4 | Unknown | July 2017 | France ... 展开 >> Centre hospitalier de Belfort-Montbéliard Active, not recruiting Belfort, France, 90000 Centre hospitalier de Colmar Recruiting Colmar, France, 68024 Contact: Martin MARTINOT, MD martin.martinot@ch-colmar.fr Centre hospitalier de Mulhouse Recruiting Mulhouse Cedex, France, 68070 Contact: Geneviève BECK WIRTH, MD beck-wirthg@ch-mulhouse.fr Hôpitaux Universitaire de Strasbourg Recruiting Strasbourg Cedex, France, 67091 Contact: David REY, PhD david.rey@chru-strasbourg.fr 收起 << |
NCT02916732 | - | Recruiting | January 2019 | France ... 展开 >> CH Andrée Rosemon (CHAR) Recruiting Cayenne Cedex, France, 97306 CHU de Martinique Recruiting Fort de France Cedex, France, 97261 CHU de Pointe à Pitre/Les Abymes Recruiting Pointe A Pitre, France, 97139 CH de l'Ouest Guyanais Franck Joly (CHOG) Recruiting Saint-laurent-du-maroni, France, 97320 收起 << | |
NCT01163253 | Psoriasis | Phase 3 | Terminated | - | - |
NCT02738411 | - | Recruiting | September 2021 | France ... 展开 >> CHRU de Montpellier - Hôpital Arnaud de Villeneuve Recruiting Montpellier, France, 34295 Principal Investigator: Gilles Cambonie, MD, PhD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Anne Filleron, MD, PhD Sub-Investigator: Tu-Anh Tran, MD, PhD Sub-Investigator: Catherine Dunyach-Remy, PhD Sub-Investigator: Pierre Corbeau, MD, PhD Réseau GRANDIR EN LANGUEDOC-ROUSILLON Active, not recruiting Saint Gely Du Fesc, France, 34980 收起 << | |
NCT02583997 | Wisdom Tooth Avulsion | Not Applicable | Completed | - | France ... 展开 >> CHRU de Montpellier - Hôpital Gui de Chauliac Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 CH de Perpignan - Hôpital Saint Jean Perpignan, France, 66046 收起 << |
NCT01804647 | - | Completed | - | France ... 展开 >> Hospices civils de Lyon - Service de Neurologie A - 59 Boulevard Pinel Bron cedex, France, 69677 CHU Timone - Service de Neurologie et CRMBM CNRS 7339 - 264, rue Saint Pierre Marseille Cedex 5, France, 13385 Spain Hospital Universitari and Research Institute Vall d'Hebron - Servicio de Neuroimunologia de Nuestro Centro - Pg. Vall d'Hebron 119-129 Barcelona, Cataluna, Spain, 08035 Switzerland Centre Hospitalier Universitaire Vaudois - Dpt of Clinical Neurosciences - Neurology /Batiment 10-131 - Rue du Bugnon 46 - Lausanne, Switzerland, CH-1011 收起 << | |
NCT01137682 | Acromegaly | Phase 3 | Completed | - | - |
NCT02575781 | Neoplasm Malignant | Phase 1 | Completed | - | Denmark ... 展开 >> Investigational Site Number 2080001 København Ø, Denmark, 2100 France Investigational Site Number 2500001 Villejuif Cedex, France, 94805 Spain Investigational Site Number 7240001 Barcelona, Spain, 08035 收起 << |
NCT01137682 | - | Completed | - | - | |
NCT00718341 | Fragile X Syndrome | Phase 2 | Completed | - | France ... 展开 >> Novartis Investigator Site Bron cedex, France, 69677 Italy Novartis Investigator Site Rome, Italy, 00168 Switzerland Novartis Investigator Site Lausanne, Switzerland, 1011 收起 << |
NCT02784314 | Prostate Cancer | Not Applicable | Completed | - | France ... 展开 >> Service d'Urologie - Clinique St Augustin Bordeaux, France, 33074 Service d'Urologie et Chirurgie de la Transplantation - Hôpital Edouard Herriot -Hospices Civils de Lyon Lyon cedex 03, France, 69437 Service d'Urologie - Institut Mutualiste Montsouris Paris, France, 75014 收起 << |
NCT01163253 | - | Terminated | - | - | |
NCT00333866 | Fibromyalgia | Phase 3 | Completed | - | - |
NCT01688882 | - | Terminated(This study was stop... 展开 >>ped after Part 1 completed and was terminated because the predefined criteria of efficacy was not reached ( >50% better then placebo)) 收起 << | - | - | |
NCT01464112 | Multiple Myeloma | Phase 1 | Completed | - | France ... 展开 >> Lille Cedex, France Nantes, France Tours, France 收起 << |
NCT01277601 | - | Completed | - | - | |
NCT00333866 | - | Completed | - | - | |
NCT02334748 | Systemic Juvenile Idiopathic A... 展开 >>rthritis Hereditary Periodic Fevers 收起 << | Phase 3 | Active, not recruiting | December 24, 2018 | France ... 展开 >> Novartis Investigative Site Bron Cedex, France, 69677 Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Paris, France, 75015 收起 << |
NCT00163202 | Coronary Arteriosclerosis ... 展开 >> Hypercholesterolemia 收起 << | Phase 4 | Completed | - | - |
NCT01598831 | Severe Sepsis ... 展开 >> Coagulopathy 收起 << | Phase 3 | Active, not recruiting | July 2019 | - |
NCT01277601 | Chronic Hepatitis B | Phase 4 | Completed | - | - |
NCT00655668 | T-cell Non-Hodgkin's Lymphoma | Phase 2 | Terminated(Decision not to pur... 展开 >>sue as single agent in the study population.) 收起 << | - | - |
NCT00130897 | - | - | - | - | |
NCT01558882 | - | Terminated(Trouble with recrut... 展开 >>ing) 收起 << | - | France ... 展开 >> APHP - Hôpital Antoine Beclere Clamart Cedex, France, 92141 APHP - Centre Hospitalier Universitaire de Bicêtre Le Kremlin Bicêtre Cedex, France, 94275 CHRU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT00471497 | - | Active, not recruiting | - | - | |
NCT00471497 | Myelogenous Leukemia, Chronic | Phase 3 | Active, not recruiting | November 12, 2018 | - |
NCT00655668 | - | Terminated(Decision not to pur... 展开 >>sue as single agent in the study population.) 收起 << | - | - | |
NCT01061177 | - | Completed | - | - | |
NCT01839448 | - | Completed | - | France ... 展开 >> CH d'Arles - Hôpital Joseph Imbert Arles Cedex, France, 13637 CHU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier Cedex 5, France, 34295 CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 收起 << | |
NCT02021370 | Anemia Renal ... 展开 >>Insufficiency, Chronic 收起 << | Phase 2 | Completed | - | - |
NCT01061177 | CML in Chronic Phase | Phase 4 | Completed | - | - |
NCT02972658 | Alzheimer's Disease | Phase 3 | Terminated(An independent asse... 展开 >>ssment concluded the trial was not likely to meet the primary endpoint upon completion and therefore, trial stopped for futility.) 收起 << | - | - |
NCT01151826 | - | Unknown | August 2012 | France ... 展开 >> Service de Chirurgie thoracique - Nouvel Hôpital Civil - 1, Place de l'hôpital Recruiting Strasbourg Cedex, France, 67091 Contact: Gilbert MASSARD, MD 33 3 69 55 07 98 Gilbert.Massard@chru-strasbourg.fr Principal Investigator: Gilbert MASSARD, MD Sub-Investigator: Pierre-Emmanuel FALCOZ, MD Sub-Investigator: Nicola SANTELMO, MD Service de Physiologie et d'Explorations fonctionnelles - Nouvel Hôpital Civil - 1, Place de l'hôpital Recruiting Strasbourg Cedex, France, 67091 Contact: Bernard GENY, MD 33 3 69 55 08 79 Bernard.Geny@chru-strasbourg.fr Principal Investigator: Bernard GENY, MD Sub-Investigator: Anne CHARLOUX, MD Service de Pneumologie - Nouvel Hôpital Civil -1, Place de l'hôpital Recruiting Strasbourg Cedex, France, 67091 Contact: Romain KESSLER, MD 33 3 69 55 06 45 Romain.Kessler@chru-strasbourg.fr Principal Investigator: Romain Kessler, MD Sub-Investigator: Armelle SCHULLER, MD Sub-Investigator: Matthieu CANUET, MD Sub-Investigator: Sandrine HIRSCHI, MD Service d'Anesthésie-Réanimations chirurgicales - Nouvel Hôpital Civil - Hôpitaux Universitaires de Strasbourg Recruiting Strasbourg, France, 67091 Contact: Julien Pottecher, MD 33 3 69 55 04 44 julien.pottecher@chru-strasbourg.fr Principal Investigator: Julien Pottecher, MD Sub-Investigator: Jean-Pierre DUPEYRON, MD Sub-Investigator: Olivier HELMS, MD Sub-Investigator: Jean-Gustave HENTZ, MD Sub-Investigator: François LEVY, MD Sub-Investigator: Jean-Claude RIGOLOT, MD Sub-Investigator: Anne-Claude ROCHE, MD Sub-Investigator: Régine CUNY, MD Sub-Investigator: Marie-Odile LEBOUBE, MD 收起 << | |
NCT01345630 | HIV-1 | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01751126 | Vernal Keratoconjunctivitis | Phase 3 | Completed | - | - |
NCT01345630 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00426660 | HIV Infections | Phase 3 | Completed | - | - |
NCT00428220 | Metastatic Breast Cancer [F] ... 展开 >> Advanced Breast Cancer Metastatic Castration Resistant Prostate Cancer Metastatic Renal Cell Cancer Non-Small Cell Lung Cancer Thyroid Cancer Advanced/Metastatic Non-Small Cell Lung Cancer Advanced Gastric Cancer Gastrointestinal Stromal Tumor Hepatocellular Carcinoma Pancreatic Islet Cell Carcinoma Pancreatic Neuroendocrine Tumor 收起 << | Not Applicable | Completed | - | - |
NCT00232180 | Heart Failure | Phase 3 | Completed | - | - |
NCT00428220 | - | Completed | - | - | |
NCT00141427 | Seizures | Phase 4 | Completed | - | - |
NCT00232180 | - | Completed | - | - | |
NCT02389933 | - | - | - | - | |
NCT00730665 | Gastroesophageal Reflux Diseas... 展开 >>e 收起 << | Phase 2 | Terminated(This study has been... 展开 >> placed on clinical hold by the sponsor due to operational reasons.) 收起 << | - | - |
NCT01743989 | Leukemia, Myeloid, Ph1-Positiv... 展开 >>e 收起 << | Phase 3 | Recruiting | May 28, 2020 | - |
NCT03232073 | Multiple Sclerosis | Phase 3 | Enrolling by invitation | April 2, 2022 | - |
NCT00426660 | - | Completed | - | - | |
NCT02273375 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | - | - |
NCT02555644 | Head and Neck Neoplasms | Phase 1 | Recruiting | February 28, 2019 | United States, Alabama ... 展开 >> University of Alabama at Birmingham Medical Center Recruiting Birmingham, Alabama, United States, 35249 Contact 205-934-2762 Principal Investigator: Eddy Yang United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact 713-792-6363 Principal Investigator: Mehmet Altan France Centre Leon Berard Recruiting Lyon, France, 69008 Contact 33478785103 Principal Investigator: Jérôme Fayette Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Contact 33142114931 Principal Investigator: Eric Deutsch 收起 << |
NCT00327691 | Cardiovascular Disease ... 展开 >> Cerebrovascular Accident Coronary Heart Disease 收起 << | Phase 4 | Completed | - | - |
NCT00636168 | High Risk Stage III Melanoma | Phase 3 | Active, not recruiting | December 31, 2018 | - |
NCT00716859 | - | Completed | - | - | |
NCT00716859 | Glaucoma | Phase 3 | Completed | - | - |
NCT00667810 | Alzheimer Disease | Phase 3 | Terminated(The study was termi... 展开 >>nated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns.) 收起 << | - | - |
NCT00636168 | - | Active, not recruiting | - | - | |
NCT02081378 | Chronic Myelogenous Leukemia ... 展开 >> Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia 收起 << | Phase 1 | Recruiting | December 20, 2022 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Hematology / Oncology Recruiting Boston, Massachusetts, United States, 02215 Contact: Shannon Milillo 617-632-6840 shannon_milillo@dfci.harvard.edu Principal Investigator: Daniel J. DeAngelo United States, Michigan University of Michigan Comprehensive Cancer Center SC Recruiting Ann Arbor, Michigan, United States, +1 48109 0944 Contact: Shelagh L. Elliott 734-232-0759 shelagh@med.umich.edu Principal Investigator: Moshe Talpaz United States, New York Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Recruiting New York, New York, United States, 10065 Contact: Michael Mauro J. Mauro, MD 212-639-3107 maurom@mskcc.org Principal Investigator: Michael J. Mauro United States, Oregon Oregon Health and Science University SC-6 Recruiting Portland, Oregon, United States, 97239 Contact: Bianca Gille 503-494-4603 gille@ohsu.edu Principal Investigator: Michael J. Heinrich United States, Texas University of Texas/MD Anderson Cancer Center UT MD Anderson Recruiting Houston, Texas, United States, 77030-4009 Contact: Jorge E Cortes, MD 713-794-5783 Jcortes@mdanderson.org Principal Investigator: Jorge E. Cortes United States, Utah Huntsman Cancer Institute SC Recruiting Salt Lake City, Utah, United States, 84112 Contact: Aaron Ernst aaron.ernst@hci.utah.edu Principal Investigator: Michael W. Deininger Australia, South Australia Novartis Investigative Site Recruiting Adelaide, South Australia, Australia, 5000 France Novartis Investigative Site Recruiting Paris Cedex 10, Cedex 10, France, 75475 Novartis Investigative Site Recruiting Bordeaux, France, 33076 Germany Novartis Investigative Site Recruiting Berlin, Germany, 13353 Novartis Investigative Site Recruiting Frankfurt, Germany, 60590 Novartis Investigative Site Recruiting Jena, Germany, 07740 Italy Novartis Investigative Site Recruiting Roma, RM, Italy, 00161 Japan Novartis Investigative Site Recruiting Kobe-shi, Hyogo, Japan, 650-0017 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Seocho-gu, Korea, Republic of, 06591 Netherlands Novartis Investigative Site Recruiting Amsterdam, Netherlands, 1081 HV Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169608 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28006 收起 << |
NCT02411448 | Metastatic Non-Small Cell Lung... 展开 >> Cancer 收起 << | Phase 3 | Active, not recruiting | September 1, 2022 | - |
NCT01345318 | - | Completed | - | - | |
NCT02435849 | Lymphoblastic Leukemia ... 展开 >> Acute Childhood 收起 << | Phase 2 | Active, not recruiting | November 28, 2022 | - |
NCT01492374 | Alzheimer's Disease | Phase 1 | Completed | - | - |
NCT02889523 | Lymphoma, Large B-Cell, Diffus... 展开 >>e 收起 << | Phase 1 Phase 2 | Suspended(Waiting for more inf... 展开 >>ormation regarding a lymphoblastic T lymphoma in one patient receiving tazemetostat in another study) 收起 << | May 2023 | France ... 展开 >> CHRU Lille - Hôpital Claude Huriez Lille Cedex, France, 59037 CHU de Nantes - Hôtel Dieu Nantes, France, 44093 CHU Lyon Sud Pierre-Bénite Cedex, France, 69495 Centre Henri Becquerel Rouen, France, 76000 Institut Gustave Roussy Villejuif, France, 94085 收起 << |
NCT00279422 | Ulcerative Colitis | Phase 2 Phase 3 | Terminated(DMC recommendation,... 展开 >> no efficacy) 收起 << | - | - |
NCT03189719 | Esophageal Neoplasms | Phase 3 | Recruiting | August 22, 2021 | - |
NCT00667810 | - | Terminated(The study was termi... 展开 >>nated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns.) 收起 << | - | - | |
NCT03559257 | Migraine | Phase 3 | Recruiting | October 31, 2019 | - |
NCT03259074 | Ankylosing Spondylitis | Phase 3 | Recruiting | January 20, 2022 | - |
NCT02937272 | Solid Tumor | Phase 1 | Recruiting | May 3, 2021 | United States, California ... 展开 >> University of California, San Francisco Recruiting San Francisco, California, United States, 94115 Contact 415-514-6568 Principal Investigator: Pamela Munster United States, Kentucky University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact 502-562-4158 Principal Investigator: Rebecca Redman United States, New York NYU Clinical Cancer Center Not yet recruiting New York, New York, United States, 10016 Contact 212-263-2441 Principal Investigator: Dimitris Placantonakis Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact 646-962-6137 Principal Investigator: Howard Fine United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact 713-563-5844 Principal Investigator: Timothy Yap Australia, New South Wales Calvary Mater Newcastle Recruiting Newcastle, New South Wales, Australia, 2298 Contact 61243401581 Principal Investigator: Andre van der Westhuizen St Vincent's Hospital Recruiting Sydney, New South Wales, Australia, 2010 Contact 6193555655 Principal Investigator: Anthony Joshua Australia, Queensland Greenslopes Private Hospital Recruiting Greenslopes, Queensland, Australia, 4120 Contact 61733947111 Principal Investigator: Victoria Atkinson Canada, Ontario Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact 4169462277 Principal Investigator: Warren P Mason France Hopital Saint-Louis Recruiting Paris, Cedex 10, France, 75475 Contact 33171207466 Principal Investigator: Antoine Carpentier CHRU de Lille- Hôpital Roger Salengro Recruiting Lille, France, 59037 Contact 33662688717 Principal Investigator: Emilie Le Rhun Hôpital Saint Joseph Recruiting Paris, France, 75014 Contact 330144127456 Principal Investigator: ERIC RAYMOND Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Contact 33142114338 Principal Investigator: Christophe Massard Germany Universitätsklinikum Würzburg Recruiting Würzburg, Bayern, Germany, 97080 Contact 4993120140160 Principal Investigator: Mario Löhr Universitätsklinikum Essen Recruiting Essen, Nordrhein-Westfalen, Germany, 45122 Contact 492017232024 Principal Investigator: Jörg Hense Charité Universitätsmedizin Berlin Recruiting Berlin, Germany, 12203 Contact 493084452648 Principal Investigator: Sebastian Ochsenreither Italy Istituto Clinico Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact 390282244080 Principal Investigator: Armando Santoro Ospedale Policlinico Giambattista Rossi, Borgo Roma Recruiting Verona, Italy, 37134 Contact 390458128148 Principal Investigator: Davide Melisi Japan National Cancer Center Hospital Not yet recruiting Chuo-Ku, Tokyo, Japan, 104-0045 Contact 81120360605 Principal Investigator: Shunsuke Kondo Spain Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact 34934894374 Principal Investigator: Elena Garralda Cabanas Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact 34913908000 Principal Investigator: Juan Manuel Sepúlveda Sánchez Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46010 Contact 34961973528 Principal Investigator: Andres Cervantes Ruiperez Switzerland Ospedale Regionale di Bellinzona e Valli - Bellinzona Recruiting Bellinzona, Ticino, Switzerland, 6500 Contact 41918118931 Principal Investigator: Anastasios Stathis Universitätsspital Zürich Recruiting Zürich, Switzerland, 8091 Contact 41442552214 Principal Investigator: Christian Britschgi 收起 << |
NCT03284424 | Squamous Cell Carcinoma | Phase 2 | Recruiting | April 26, 2022 | - |
NCT01345318 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01938443 | Cancer | Phase 1 | Completed | - | France ... 展开 >> GSK Investigational Site Villejuif Cedex, France, 94805 United Kingdom GSK Investigational Site London, United Kingdom, W12 0HS GSK Investigational Site London, United Kingdom, W1G 6AD GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 << |
NCT01034163 | - | Completed | - | - | |
NCT01985191 | Neoplasm Malignant | Phase 1 | Completed | - | France ... 展开 >> Investigational Site Number 250001 Villejuif Cedex, France, 94805 Netherlands Investigational Site Number 528001 Amsterdam, Netherlands, 1066 CX Investigational Site Number 528003 Rotterdam, Netherlands, 3075 EA Investigational Site Number 528002 Utrecht, Netherlands, 3584 CX 收起 << |
NCT03158948 | Shock, Septic | Phase 2 | Completed | - | Belgium ... 展开 >> Cliniques Universitaires Saint-Luc (there may be other sites in this country) Brussels, Belgium France Inserm Clinical Investigational Center, CHU Dupuytren (there may be other sites in this country) Limoges Cedex, France Netherlands Radboudumc (there may be other sites in this country) Nijmegen, Netherlands Spain Hospital Clínico San Carlos, Medicina Intensiva (there may be other sites in this country) Madrid, Spain 收起 << |
NCT01370798 | Hypospadias | Phase 3 | Completed | - | France ... 展开 >> Service de Chirurgie Pédiatrique Uro-génitale, Hopital femme Mere Enfant Bron Cedex, France, 69677 Hôpital Mère-Enfant Nantes, France, 44093 Hôpital Robert Debré Paris, France, 72015 Hôpital NECKER Paris, France, 75015 收起 << |
NCT01193595 | Neoplasms, Malignant | Phase 1 | Completed | - | France ... 展开 >> Investigational Site Number 250001 Villejuif Cedex, France, 94805 Italy Investigational Site Number 380002 Milano, Italy, 20132 Investigational Site Number 380001 Milano, Italy, 20133 United Kingdom Investigational Site Number 826001 Sutton, United Kingdom, SM2 5PT 收起 << |
NCT03466359 | Pediatric Obesity | Not Applicable | Recruiting | December 2018 | France ... 展开 >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr Principal Investigator: Yves BOIRIE Sub-Investigator: David THIVEL 收起 << |
NCT03040973 | Advanced Solid Tumors Which Ar... 展开 >>e cMET-dependent 收起 << | Phase 4 | Recruiting | May 20, 2019 | Denmark ... 展开 >> Novartis Investigative Site Recruiting Copenhagen, Denmark, DK-2100 France Novartis Investigative Site Recruiting Dijon Cedex, Cote D Or, France, 21034 Germany Novartis Investigative Site Recruiting Hannover, Germany, 30625 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28040 收起 << |
NCT01034163 | Hodgkin's Lymphoma | Phase 3 | Completed | - | - |
NCT03742622 | Pediatric Obesity | Not Applicable | Recruiting | February 15, 2019 | France ... 展开 >> Chu Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Lise LACLAUTRE 04 73 75 49 63 drci@chu-clermontferrand.fr Principal Investigator: Yves BOIRIE 收起 << |
NCT01402154 | - | Active, not recruiting | December 2017 | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 CHU de Montpellier - Hôpital Lapeyronie - Plateforme LCCRH Montpellier Cedex 05, France, 34295 CHU de Montpellier - Hôpital Lapeyronie Montpellier Cedex 05, France, 34295 Clinique Beau Soleil Montpellier, France, 34070 Centre Regional de Lutte Contre le Cancer - Val d'Aurelle - Paul Lamarque Montpellier, France, 34298 收起 << | |
NCT00997204 | Hereditary Angioedema | Phase 3 | Completed | - | Argentina ... 展开 >> Hospital Britanico Unidad de Alergia Buenos Aires, Argentina, C1035AAT Austria Universitätsklinik für Dermatologie und Venerologie Graz, Austria, 8036 Denmark Odense Universitetshospital-OUH Odense, I og Alergicentret, Denmark France Centre Hospitalier Universitaire/ Service de Dermatologie Angers, Angers Cedex 09, France, 49933 Hospital Edouaed Herriot Lyon, Cedex 03, France, 69437 Clinique Universitaire de Medicine/ Centre National de reference Grenoble, Grenoble Cedex 09, France, 38043 Hopital Claude Huriex/ Service de medicine interne Lille, Lille Cedex, France, 59037 Hopital Europeen Georges Pompidou Immunologie Clinique Paris, Paris Cedex 15, France, 75015 Germany Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie, Charité Berlin, Germany, 10117 Universitäts-Hals-Nasen-Ohren-Klinik Essen, Universität Duisburg-Essen Essen, Germany, 45127 Klinkum der Johann Wolfgang Goethe-Universitat Frankfurt am Main, Germany, 60590 Hautklinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Germany, 55101 Israel Bnai-Zion M.C. Clinical Immunology and Allergy Division Haifa, Israel, 31048 Tel Aviv Sourasky Medical Center - Allergy Unit Tel Aviv, Israel, 64239 The Chaim Sheba Medical Center, The Allergy and Clinical Immunology Unit Tel Hashomer, Israel, 52621 Italy Ospedale Luigi Sacco Milano, Italy, 20157 Universita degli Studi di Napoli 'Federico II' Napoli,, Italy, 80131 Spain Hospital Universitario Vall de Hebrón / Sección de Alergia, Escola Infermeria Barcelona, Spain, 08035 Hospital General Universitario Gregorio Maranon Madrid, Spain, 28007 Hospital Universitario La Paz, Servicio de Alergia Madrid, Spain, 28046 Hospital Universitario La Fe, Servicio de Alergia Valencia, Spain, 46009 Switzerland Luzerner Kantonsspital Luzern, Switzerland Universitätsspital Zürich / Dermatologische Klinik Zurich, Switzerland, 8091 United Kingdom Southmead Hospital, Department of Immunology Bristol, United Kingdom, BS10 5NB Barts & The London NHS Trust, Pathology and Pharmacy Building London, United Kingdom, E1 2ES Derriford Combined Laboratory, Department of Clinical Immunology & Allergy Plymouth, United Kingdom, PL6 8DH 收起 << |
NCT00997204 | - | Completed | - | - | |
NCT02771379 | - | Recruiting | February 2021 | Austria ... 展开 >> Universitaetsklinikum Graz Recruiting Graz, Austria, 8036 Principal Investigator: Mona Schneider, MD Medical University of Vienna Recruiting Vienna, Austria Principal Investigator: Berthold Pemp, MD France CHU de Nîmes - Hôpital Carémeau Recruiting Nîmes, Gard, France, 30029 Principal Investigator: Luc Jeanjean, MD CHU Angers - Hôpital Hôtel Dieu Recruiting Angers, Maine Et Loire, France, 49033 Principal Investigator: Christophe Verny, MD Hopital Roger Salengro - CHU Lille Recruiting Lille, Nord, France, 59037 Principal Investigator: Sabine Defoort Delemmes, MD Hôpital Européen Georges Pompidou Recruiting Paris, Paris Cedex 15, France, 75908 Principal Investigator: Christophe Orssaud, MD CHU Amiens - Centre Saint Victor Recruiting Amiens, Somme, France, 80054 Principal Investigator: Solange Milazzo, MD Hopital Neurologique Pierre Wertheimer Recruiting Lyon Cedex, France, 69677 Principal Investigator: Damien Biotti, MD Hospices Civils de Lyon Recruiting Lyon, France, 69002 Principal Investigator: Caroline Tilikete, MD Centre Hospitalier National d'Ophtalmologie (CHNO) des Quinze-Vingts Recruiting Paris, France, 75012 Principal Investigator: Catherine Vignal, MD Fondation Ophtalmologique Adolphe de Rothschild Recruiting Paris, France, 75019 Principal Investigator: Rabih Hage, MD Germany Julius Maximilians University Recruiting Wuerzburg, Baden Wuerttemberg, Germany, 97070 Principal Investigator: Thomas Ach, MD Charite - Campus Virchow-Klinikum Recruiting Berlin, Germany, 13353 Principal Investigator: Uwe Pleyer, MD Universitaetsklinikum Essen Recruiting Essen, Germany Principal Investigator: Michael Oeverhaus, MD Universitaetsklinikum Freiburg Recruiting Freiburg, Germany Principal Investigator: Wolf Lagreze Universitaetsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Principal Investigator: Martin Spitzer, MD Universitaetsklinikum Heidelberg Recruiting Heidelberg, Germany Principal Investigator: Klaus Rohrschneider, MD Friedrich-Baur-Institut Recruiting Munich, Germany Principal Investigator: Thomas Klopstock Universitaetsklinikum Muenster Recruiting Munster, Germany Principal Investigator: Nicole Eter, MD Universitaetsklinikum Neubrandenburg Recruiting Neubrandenburg, Germany Principal Investigator: Herbert Jaegle, MD Universitaetsklinikum Regensburg Recruiting Regensburg, Germany Principal Investigator: Helmut Hoeh, MD Greece Athens Ophthalmological Center Recruiting Athens, Greece, 11528 Principal Investigator: Agathi Kouri, MD Italy Università di Bologna-Clinica Neurologica-Dipartimento di Scienze Neurologiche Not yet recruiting Bologna, Italy, 40123 Principal Investigator: Valerio Carelli, MD Ospedale San Raffaele Recruiting Milano, Italy, 20132 Principal Investigator: Francesco Maria Bandello, MD Azienda Ospedaliera S. Camillo Forlanini Not yet recruiting Rome, Italy, 00152 Principal Investigator: Anna De Negri, MD Netherlands Universitair Medisch Centrum Groningen Recruiting Groningen, Netherlands, 9713 GZ Principal Investigator: Jan-Willem Pott, MD Maastricht University Medical Center Not yet recruiting Maastricht, Netherlands, 6211 LK Principal Investigator: Noël Bauer, MD 收起 << | |
NCT01649479 | Antiphospholipid Syndrome | Not Applicable | Terminated(Impossible to inclu... 展开 >>de patients at a correct rate; patients don't want to come back so they refuse participation.) 收起 << | - | France ... 展开 >> APHM - Hôpital Nord Marseille Cedex 20, France, 13915 APHM - Hôpital de la Conception Marseille Cedex 5, France, 13385 APHM - Hôpital La Timone Adultes Marseille cedex 5, France, 13385 CHU de Montpellier - Hôpital Saint-Eloi Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << |
NCT00084266 | Methicillin Resistant Staphylo... 展开 >>coccus Aureus (MRSA) 收起 << | Phase 4 | Completed | - | - |
NCT02811861 | Renal Cell Carcinoma | Phase 3 | Recruiting | February 2021 | - |
NCT00084266 | - | Completed | - | - | |
NCT00708214 | - | Completed | - | - | |
NCT00957580 | Leukemia, Myeloid, Acute ... 展开 >> Hematologic Neoplasms 收起 << | Phase 2 | Terminated(The trial has been ... 展开 >>terminated due to an estimated low probability of clinical benefit based on limited anti-leukemic effects observed in safety run-in (Part 1)) 收起 << | - | United States, Illinois ... 展开 >> Northwestern University Chicago, Illinois, United States United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States Dana Farber Cancer Institute Boston, Massachusetts, United States United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States France Hospital Hotel Dieu, Service D'Hematologie Nantes, Cedex, France Hospital Edouard Herriot, Service d'Hematologie Clinique Lyon Cedex, France Hospital Saint Louis, Service des Maladies du Sang Paris, France CHU du Haut-Leveque, Service des Maladies du Sang Unite de Recherche Clinique Pessac, France 收起 << |
NCT00957580 | - | Terminated(The trial has been ... 展开 >>terminated due to an estimated low probability of clinical benefit based on limited anti-leukemic effects observed in safety run-in (Part 1)) 收起 << | - | - | |
NCT00289991 | Antifungal Prophylaxis of Inva... 展开 >>sive Fungal Infections 收起 << | Phase 3 | Completed | - | - |
NCT00708214 | Breast Neoplasms | Phase 2 | Completed | - | France ... 展开 >> 1200.5.3306A Boehringer Ingelheim Investigational Site Caen Cedex, France 1200.5.3304A Boehringer Ingelheim Investigational Site Nice Cedex 2, France 1200.5.3301A Boehringer Ingelheim Investigational Site Paris Cedex 10, France 1200.5.3305A Boehringer Ingelheim Investigational Site Paris Cedex 20, France 1200.5.3302A Boehringer Ingelheim Investigational Site Saint Cloud, France 收起 << |
NCT00289991 | - | Completed | - | - | |
NCT01265719 | - | Completed | - | - | |
NCT00481312 | Continuous Sedation in Initial... 展开 >>ly Sedated Adults in ICU 收起 << | Phase 3 | Completed | - | - |
NCT00289640 | Melanoma | Phase 2 | Completed | - | - |
NCT01265719 | - | Completed | - | - | |
NCT01244542 | Pain Schizoph... 展开 >>renia 收起 << | Not Applicable | Terminated(recruitment difficu... 展开 >>lties) 收起 << | - | France ... 展开 >> Service de Psychiatrie Adulte2, Place Saint-Jacques - ZA 481, Centre Hospitalier Saint-Jacques Besançon Cedex, France, 25030 Service de Psychiatrie Adulte, Secteur G11, Centre Hospitalier de Erstein, 13 route de Krafft Erstein Cedex, France, 67152 Centre d'évaluation et de traitement de la douleur, Hôpitaux Universitaires de Strasbourg Strasbourg Cedex, France, 67 091 Centre d'Investigation Clinique - Hôpitaux Universitares de Strasbourg Strasbourg Cedex, France, 67091 Service de Psychiatrie - Hôpitaux Universitaires de Strasbourg Strasbourg cedex, France, 67091 收起 << |
NCT01027949 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Active, not recruiting | December 2020 | - |
NCT00890890 | Alzheimer's Disease | Phase 2 | Terminated | - | - |
NCT03588299 | Hemophilia A | Phase 1 Phase 2 | Recruiting | August 30, 2025 | United States, Arkansas ... 展开 >> Arkansas Children's Hospital Not yet recruiting Little Rock, Arkansas, United States, 72202-3500 United States, California Loma Linda Children's Hospital Not yet recruiting San Bernardino, California, United States, 92408 United States, Michigan C.S. Mott Children's Hospital Recruiting Ann Arbor, Michigan, United States, 48109 United States, Ohio University Hospitals Cleveland Medical Center Not yet recruiting Cleveland, Ohio, United States, 44106-2602 United States, Wisconsin University of Wisconsin - Madison Not yet recruiting Madison, Wisconsin, United States, 53792 Bulgaria SHATHD Spec. Hospi. for Active Treatm. of Haematol. Dis. EAD Not yet recruiting Sofia, Bulgaria, 1756 France Hôpital Calmette - Lille Cedex Not yet recruiting Lille Cedex, France, 59037 Hôpital de la Timone - Marseille Not yet recruiting Marseille, France, 13005 Hopital Necker les enfants malades - Paris Not yet recruiting Paris, France, 75015 Hôpital Pontchaillou Not yet recruiting Rennes Cedex, France, 35033 Germany Universitätsklinikum der Johann Wolfgang Goethe Universität Not yet recruiting Frankfurt, Hessen, Germany, 60596 Universitätsklinikum des Saarlandes Not yet recruiting Homburg, Saarland, Germany, 66421 Vivantes Klinikum im Friedrichshain Not yet recruiting Berlin, Germany, 10249 Netherlands Academisch Medisch Centrum (AMC) Not yet recruiting Amsterdam, Netherlands, 1105 AZ Universitair Medisch Centrum Groningen Not yet recruiting Groningen, Netherlands, 9713 GZ Erasmus Medisch Centrum Not yet recruiting Rotterdam, Netherlands, 3015 CE University Medical Center Utrecht Not yet recruiting Utrecht, Netherlands, 3584 CX Spain Hospital Central de Asturias Not yet recruiting Oviedo, Asturias, Spain, 33011 Ciutat Sanitària i Universitaria de la Vall d'Hebron Not yet recruiting Barcelona, Spain, 08035 Hospital de la Santa Creu i de Sant Pau Not yet recruiting Barcelona, Spain, 08041 Hospital Universitario "La Paz" Not yet recruiting Madrid, Spain, 28046 Hospital Regional de Málaga Not yet recruiting Málaga, Spain, 29010 Hospital Universitari i Politècnic La Fe Not yet recruiting Valencia, Spain, 46026 United Kingdom St Thomas' Hospital Not yet recruiting London, United Kingdom, SE1 7EH Manchester Royal Infirmary Not yet recruiting Manchester, United Kingdom, M13 9WL 收起 << |
NCT00763971 | ADHD | Phase 3 | Completed | - | - |
NCT00607256 | Fibromyalgia | Phase 3 | Terminated | - | - |
NCT00428597 | Carcinoma, Islet Cell ... 展开 >> Carcinoma, Pancreas 收起 << | Phase 3 | Terminated(Refer to Detailed D... 展开 >>escription.) 收起 << | - | - |
NCT00763971 | - | Completed | - | - | |
NCT02213263 | Follicular Lymphoma | Phase 3 | Completed | - | - |
NCT02658175 | Familial Chylomicronemia Syndr... 展开 >>ome Lipoprotein Lipase Deficiency Hyperlipoproteinemia Type 1 收起 << | Phase 3 | Active, not recruiting | October 2020 | - |
NCT00389181 | Arteriovenous Malformations, C... 展开 >>erebral 收起 << | Phase 3 | Completed | - | - |
NCT00428597 | - | Terminated(Refer to Detailed D... 展开 >>escription.) 收起 << | - | - | |
NCT02213263 | - | Completed | - | - | |
NCT01479244 | Breast Cancer With Low to Inte... 展开 >>rmediate HER2 Expression 收起 << | Phase 3 | Completed | - | - |
NCT00954616 | - | Completed | - | France ... 展开 >> CHU Rouen Rouen, Bois guillaume, France, 76 230 CHU Bordeaux Pessac, Bordeaux, France, 33 604 CH Le Mans Le Mans, Le Mans Cedex 1, France, 72 037 CHU Montpellier Montpellier, Montpellier Cedex 5, France, 34 295 APHP Charles Foix Ivry sur Seine, Paris, France, 94 205 CHU Saint Etienne Saint Etienne, France, 42 055 收起 << | |
NCT03085758 | Septic Shock | Phase 2 | Recruiting | September 2019 | Belgium ... 展开 >> Clinique Universitaire Saint-Luc (UCL Bruxelles) Recruiting Brussels, Belgium, 1200 Contact: Pierre-Francois Laterre, Prof : +32 (0)2 764 27 33 pierre-francois.laterre@uclouvain.be Contact: Xavier Wittebole, Dr. +32 (0)2 764 27 26 Xavier.wittebole@uclouvain.be Antwerp University Hospital (UZA), Critical Care Medicine Recruiting Edegem, Belgium, 2650 Contact: Philippe Jorens, Prof +32 (0) 3 821 36 39 Philippe.jorens@uza.be Contact: Karolien Dams, Dr. +32 (0) 3 821 51 75 karolien.dams@uza.be Groupe Jolimont, Hospitalier de Jolimont Recruiting Haine Saint Paul, Belgium, 7100 Contact: Vincent Huberlant, Dr. +32 (0) 64 23 49 49 vincent.huberlant@jolimont.be Contact: Pierre Henin, Dr. +32 (0) 64 23 49 49 pierre.henin@jolimont.be Clinique St. Pierre, Intensive Care Recruiting Ottignies, Belgium, 1340 Contact: Thierry Dugernier, Dr. +32 (0) 10 43 73 43 thierry.dugernier@cspo.be Contact: Nicolas De Schryver, Dr. +32 (0) 10 43 77 34 nicolas.deschryver@cspo.be France Medical Intensive Care Medicine, Centre hospital - universitaire Recruiting Angers, Cedex, France, 49933 Contact: Pierre Asfar, Dr. +33 (0)2 41 35 36 37 PiAsfar@chu-angers.fr CH Victor Dupouy Recruiting Argenteuil, Cedex, France, 95107 Contact: Gaetan Plantefeve, Dr. +33 (0) 1 34 23 14 45 gaetan.plantefeve@ch-argenteuil.fr Contact: Hervé Mentec, Dr. +33 (0) 1 34 23 24 57 herve.mentec@ch-argenteuil.fr Hopital Beaujon; Anesthesie Reanimation Recruiting Clichy, Cedex, France, 92118 Contact: Emmanuel Weiss, Dr. +33(0) 603 0041 93 emmanuel.weiss@aphp.fr Contact: Catherine Paugam-Burtz, Prof +33(0) 140 87 5911 catherine.paugam@aphp.fr CHU de Limoges Recruiting Limoges, Cedex, France, 87042 Contact: Bruno Francois, Dr. +33 (0) 555056254 bruno.francois@chu-limoges.fr Contact: Philippe Vignon, Dr. +33 (0) 555058835 philippe.vignon@chu-limoges.fr CHU de Nantes; Medicine Intensive Reanimation Recruiting Nantes, Cedex, France, 44093 Contact: Jean-Baptiste Lascarrou, Dr. +33 (0)2 4008 7365 jeanbaptiste.lascarrou@chu-nantes.fr Contact: Jean Reignier, Prof +33 (0)2 4008 7369 jean.reignier@chu-nantes.fr CHRU Bretonneau, Medecine Intensive Réanimation Recruiting Tours, Cedex, France, 37044 Contact: Emmanuelle Mercier, Dr. +33 (0)2 47 47 38 55 emercier@med.univ-tours.fr Contact: Pierre Francois Dequin, Dr. +33 (0)2 47 47 38 55 pierre-francois.dequin@univ-tours.fr University Hospital of Clermont-Ferrand, Dept. of Perioperative Medicine Recruiting Clermont-Ferrand, France, 63003 Contact: Jean-Michel Constantin, Prof +33 (0) 473750541 jmconstantin@chu-clermontferrand.fr Contact: Sophie Cayot, Dr. +33 (0) 73750501 scayot@chu-clermontferrand.fr AP-HP, Hopital Louis Mourier, Réanimation Médicale Recruiting Colombes, France, 92700 Contact: Stéphane Gaudry, Dr. +33 (0)1 47 60 61 62 stephanegaudry@gmail.com Contact: Nicolas Bénichou, Dr. +33 (0)1 47 60 61 62 CHD-Vendée Recruiting La Roche Sur Yon, France, 85000 Contact: Jean-Claude Lacherade, Dr. +33(0)2 51 44 60 87 jean-claude.lacherade@chd-vendee.fr Contact: Gwenhaël Colin, Dr. Hôpital de Bicêtre, Service d'anesthésie-réanimation chirurgicale Recruiting Le Kremlin-Bicêtre, France, 94270 Contact: Jacques Duranteau, Prof +33 (0)1 45 21 24 19 Jacques.duranteau@aphp.fr Contact: Guillaume Dubreuil, Dr. +33 (0)1 45 21 24 19 Guillaume.Dubreuil@aphp.fr Hôpital Lariboisière, Dept. d'Anesthesie Recruiting Paris, France, 75010 Contact: Alexandre Mebazaa, Prof +33 (0)1 4995 8071 Alexandre.mebazaa@aphp.fr Contact: Etienne Gayat, Dr. +33 (0)1 4995 8084 etienne.gayat@aphp.fr Hôpital Lariboisière, Réanimation Médicale et Traumatologique Recruiting Paris, France, 75010 Contact: Nicolas Deye, Dr. +33 (0)1 49 95 63 47 nicolas.deye@aphp.fr Contact: Nicolas Péron, Dr. +33 (0)1 49 95 90 30 nicolas.peron@aphp.fr Hôpital Saint-Louis, Service d'Anesthésie-Réanimation Recruiting Paris, France, 75010 Contact: Matthieu Legrand, Dr. +33 (0)1 42 49 94 25 matthieu.legrand@aphp.fr Contact: Haikel Oueslati, Dr. +33 (0)1 42 49 94 25 oueslatihaikel007@yahoo.fr Hôpital Européen Georges Pompidou, Service d'Anesthésie-Réanimation Chirurgicale, Université Paris Descartes Recruiting Paris, France, 75015 Contact: Romain Pirracchio, Prof +33 (0)1 56 09 25 13 Romain.pirracchio@aphp.fr Nouvel Hopital Civil Recruiting Strasbourg, France, 67091 Contact: Ferhat Meziani, Prof +33 (0) 369 5510 21 ferhat.meziani@chru-strasbourg.fr Contact: Julie Boisrame-Helms, dr. +33 (0) 369 5513 69 julie.boisrame-helms@chru-strasbourg.fr Hôpital de Hautepierre , Hôpitaux Universitaires de Strasbourg, Unité de Réanimation Chirurgicale, Service d'Anesthésie-Réanimation Chirurgicale Recruiting Strasbourg, France, 67200 Contact: Julien Pottecher, Prof +33 (0)3 88 12 70 95 julien.pottecher@chru-strasbourg.fr Contact: . Jean-Pierre Rameau, Dr. +33 (0)3 88 12 70 65 jean-pierre.rameau@chru-strasbourg.fr Germany Universitätsklinikum Aachen, Klinik für Operative Intensivmedizin Recruiting Aachen, Germany, 52074 Contact: Gernot Marx, Prof +49 (0)241 80 80444 gmarx@ukaachen.de Contact: Tim-Philipp Simon, Dr. +49 (0)241 80 35184 tsimon@ukaachen.de Universitätsklinikum Hamburg-Eppendorf Klinik für Intensivmedizin Recruiting Hamburg, Germany, 20246 Contact: Stefan Kluge, Prof +49 (0)40 7410 57010 s.kluge@uke.de Contact: Axel Nierhaus, Dr. +49 (0)40 7410 57010 nierhaus@uke.de Universitätsklinikum Jena Klinik für Anästhesiologie und Intensivmedizin Recruiting Jena, Germany, 07747 Contact: Michael Bauer, Prof +49 (0)3641 9323101 michael.bauer@med.uni-jena.de Contact: Frank Bloos, PD +49 (0)3641 9323283 frank.bloos@med.uni-jena.de Universitätsklinikum Münster Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie Recruiting Muenster, Germany, 48149 Contact: Alexander Zarbock, Prof +49 (0)251 83 47251 zarbock@uni-muenster.de Contact: Thomas Ermert, Dr +49 (0)251 83 47255 ermert@anit.uni-muenster.de Universitätsmedizin Rostock Klinik und Poliklinik für Anästhesiologie und Intensivtherapie Recruiting Rostock, Germany, 18057 Contact: Tobias Schuerholz, Prof +49 (0)381 494 6481 tobias.schuerholz@med.uni-rostock.de Contact: Martin Sauer, PD +49 (0)381 494 6409 martin.sauer@uni-rostock.de Netherlands Gelderse Vallei Hospital, Department of Intensive Care Recruiting Ede, Netherlands, 6716 RP Contact: Arthur van Zanten, Dr. +31 (0)318 434115 ZantenA@zgv.nl Medisch Spectrum Twente, Department of Intensive Care Not yet recruiting Enschede, Netherlands, 7512 KZ Contact: Albertus Beishuizen, Dr. +31 (0)53 48 72 000 ext 7403 b.beishuizen@mst.nl Contact: S. Papendorp, Dr. s.papendorp@mst.nl Zuyderland Medical Center, Department of Intensive Care Recruiting Heerlen, Netherlands, 6401 CX Contact: Tom Dormans, Dr. +31 (0)455767220 t.dormans@zuyderland.nl Contact: A. Janssen, Dr. +31 (0) 455767220 g.janssen@zuyderland.nl Radboud UMC Intensive Care Recruiting Nijmegen, Netherlands, 6525 GA Contact: Peter Pickkers, Prof +31 24 36 65 010 peter.pickkers@radboudumc.nl Contact: Hans van der Hoeven, Prof +31 (0)24 36 14170 Hans.vanderHoeven@radboudumc.nl Canisius-Wilhelmina-Ziekenhuis (CWZ), Intensive Care Recruiting Nijmegen, Netherlands, 6532 SZ Contact: Oscar Hoiting, Dr. ++31 (0)24 365 7560 .o.hoiting@cwz.nl 收起 << |
NCT00435409 | Breast Neoplasms | Phase 3 | Completed | - | - |
NCT02797951 | Episodic Cluster Headache ... 展开 >> Chronic Cluster Headache 收起 << | Phase 3 | Enrolling by invitation | August 24, 2020 | - |
NCT02544451 | Cystic Fibrosis | Phase 3 | Active, not recruiting | November 2019 | - |
NCT01419171 | Atherosclerosis ... 展开 >> Coronary Artery Disease 收起 << | Not Applicable | Completed | - | - |
NCT00232661 | Breast Cancer | Phase 3 | Completed | - | - |
NCT02243800 | Rheumatoid Arthritis ... 展开 >> Vitamin D Deficiency 收起 << | Phase 3 | Unknown | August 2016 | France ... 展开 >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr 收起 << |
NCT00759174 | - | Completed | - | - | |
NCT01419171 | - | Completed | - | - | |
NCT00435409 | - | Completed | - | - | |
NCT02283853 | Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 3 | Recruiting | May 30, 2025 | - |
NCT01950819 | End Stage Renal Disease (ESRD)... 展开 >> Chronic Kidney Disease (CKD) Hemodialysis Renal Replacement Therapy Renal Transplantation 收起 << | Phase 4 | Completed | - | - |
NCT00605280 | Macular Edema Associated With ... 展开 >>Diabetes Mellitus 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT01191060 | Myeloma | Phase 3 | Active, not recruiting | September 2020 | - |
NCT00759174 | - | Completed | - | - | |
NCT00605280 | - | Completed | - | - | |
NCT00630812 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT00688688 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
NCT01395017 | Pancreatic Cancer | Phase 2 | Completed | - | - |
NCT02654990 | Multiple Myeloma | Phase 2 | Recruiting | December 15, 2022 | - |
NCT01395017 | - | Completed | - | - | |
NCT01332227 | HIV, Combination Therapy | Phase 4 | Completed | - | - |
NCT00878709 | - | Active, not recruiting | - | - | |
NCT00688688 | - | Completed | - | - | |
NCT01332227 | - | Completed | - | - | |
NCT02792231 | Relapsing Multiple Scelrosis | Phase 3 | Recruiting | May 15, 2019 | - |
NCT00878709 | Breast Cancer | Phase 3 | Active, not recruiting | November 2020 | - |
NCT02712983 | Non-cystic Fibrosis Bronchiect... 展开 >>asis 收起 << | Phase 2 | Recruiting | October 16, 2019 | - |
NCT02540954 | Macular Degeneration | Phase 3 | Recruiting | January 12, 2021 | - |
NCT00673049 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00673049 | Carcinoma, Large Cell ... 展开 >> Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma, Adenosquamous Cell 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT03445533 | Metastatic Melanoma | Phase 3 | Recruiting | June 2022 | - |
NCT01241591 | Psoriasis | Phase 3 | Completed | - | - |
NCT01241591 | - | Completed | - | - | |
NCT03102320 | Neoplasms | Phase 1 | Recruiting | July 28, 2021 | - |
NCT01784068 | Chronic Myelogenous Leukemia | Phase 2 | Recruiting | February 28, 2025 | - |
NCT00474786 | Renal Cell Carcinoma | Phase 3 | Completed | - | - |
NCT00282971 | Diabetes Mellitus Type 2 | Phase 3 | Terminated(Terminated as marke... 展开 >>ting of this product will be discontinued) 收起 << | - | - |
NCT00474786 | - | Completed | - | - | |
NCT00373425 | Non-small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT00678392 | Kidney Neoplasms | Phase 3 | Completed | - | - |
NCT00481247 | Myeloid Leukemia, Chronic | Phase 3 | Completed | - | - |
NCT00282971 | - | Terminated(Terminated as marke... 展开 >>ting of this product will be discontinued) 收起 << | - | - | |
NCT00035035 | Pancreatic Neoplasms ... 展开 >> Metastases, Neoplasm 收起 << | Phase 3 | Completed | - | - |
NCT02228382 | Previously Treated PH + CML | Phase 4 | Active, not recruiting | September 18, 2021 | - |
NCT00610714 | - | Completed | - | - | |
NCT00481247 | - | Completed | - | - | |
NCT03435250 | Advanced Solid Tumors ... 展开 >> Lymphoma 收起 << | Phase 1 | Recruiting | October 2020 | United States, Connecticut ... 展开 >> New Haven Recruiting New Haven, Connecticut, United States, 06519 United States, Massachusetts Boston Recruiting Boston, Massachusetts, United States, 02114 United States, New York New York Recruiting New York, New York, United States, 10065 United States, Tennessee Nashville Recruiting Nashville, Tennessee, United States, 37203 France Villejuif Cedex Not yet recruiting Villejuif Cedex, France, 94805 Spain Barcelona Not yet recruiting Barcelona, Spain, 08035 收起 << |
NCT00678392 | - | Completed | - | - | |
NCT03512197 | Acute Myeloid Leukemia (AML) | Phase 3 | Recruiting | April 20, 2026 | - |
NCT00610714 | Ovarian Neoplasms ... 展开 >> Ovarian Cancer 收起 << | Phase 2 | Completed | - | - |
NCT01544595 | Moderate to Severe Plaque-type... 展开 >> Psoriasis 收起 << | Phase 3 | Completed | - | - |
NCT01563354 | Neuroendocrine Carcinoma of th... 展开 >>e Lung and Thymus 收起 << | Phase 2 | Active, not recruiting | June 28, 2019 | - |
NCT00373425 | - | Completed | - | - | |
NCT01920711 | Heart Failure With Preserved E... 展开 >>jection Fraction 收起 << | Phase 3 | Active, not recruiting | May 31, 2019 | - |
NCT01665144 | Secondary Progressive Multiple... 展开 >> Sclerosis 收起 << | Phase 3 | Active, not recruiting | September 22, 2023 | - |
NCT01035255 | Heart Failure With Reduced Eje... 展开 >>ction Fraction 收起 << | Phase 3 | Terminated(Early termination w... 展开 >>as approved due to compelling efficacy of LCZ696 in patients with HF & reduced EF after final pre-specified interim analysis 28-Mar-2014.) 收起 << | - | - |
NCT02038036 | Polycythemia Vera | Phase 3 | Active, not recruiting | April 8, 2020 | - |
NCT01035255 | - | Terminated(Early termination w... 展开 >>as approved due to compelling efficacy of LCZ696 in patients with HF & reduced EF after final pre-specified interim analysis 28-Mar-2014.) 收起 << | - | - | |
NCT01665144 | - | Active, not recruiting | - | - | |
NCT01794793 | Cushing's Disease ... 展开 >> Acromegaly Neuroendocrine Tumors Pituitary Tumors Ectopic ACTH Secreting (EAS) Tumors Dumping Syndrome Prostate Cancer Melanoma Negative for bRAF Melanoma Negative for nRAS 收起 << | Phase 4 | Recruiting | June 12, 2023 | - |
NCT01568866 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT01568866 | - | Completed | - | - | |
NCT00719264 | Carcinoma Ade... 展开 >>nocarcinoma Renal Cell Nephroid Carcinoma Hypernephroid 收起 << | Phase 2 | Completed | - | - |
NCT02598297 | Early Myelofibrosis With High ... 展开 >>Molecular Risk Mutations 收起 << | Phase 3 | Completed | - | - |
NCT01909453 | Melanoma | Phase 3 | Active, not recruiting | March 31, 2019 | - |
NCT03334435 | Atopic Dermatitis | Phase 3 | Recruiting | August 27, 2021 | - |
NCT00719264 | - | Completed | - | - | |
NCT02292446 | Polycythemia Vera | Phase 3 | Completed | - | - |
NCT01763164 | Metastatic or Unresectable Cut... 展开 >>aneous Melanoma 收起 << | Phase 3 | Active, not recruiting | July 31, 2019 | - |
NCT02655419 | Complicated Intra-Abdominal In... 展开 >>fections, cIAIs 收起 << | Phase 2 | Completed | - | France ... 展开 >> Nouveau CHU Amiens Picardie AMIENS Cedex, France, 80054 CHU de Clermont-Ferrand Clermont-Ferrand, France, 63003 University Hospital C. Lille Cedex, France, 59037 CHU Limoges Limoges cedex, France, 87042 CHU de la Miletrie POITIERS Cedex, France, 86021 Germany Universitaetsklinikum Freiburg, Department Chirurgie Freiburg, Germany, 79106 Universitaetsklinikum Koeln Innere Medizin I Koeln, Germany, 50937 Universitaetsklinikum Schleswig-Holstein, Klinik fuer Infektiologie und Mikrobiologie, DZIF-CTU Luebeck, Germany, 23538 Klinikum rechts der Isar der Technischen Universitaet Muenchen Muenchen, Germany, 81675 Universitaetsklinikum Regensburg Klinik und Poliklinik fuer Chirurgie Regensburg, Germany, 93053 Spain Hospital Universitario Cruces Barakaldo, Bizkaia, Spain, 48903 Hospital Universitario Son Espases Palma de Mallorca, ISLA Baleares, Spain, 07010 Hospital Universitari del Mar Barcelona, Spain, 08003 Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Clinic de Barcelona Barcelona, Spain, 08036 Servicio Andaluz de Salud- Reina Sofia University Hospital Cordoba, Spain, 14004 Hospital Universitario Virgen Macarena Sevilla, Spain, 41009 Hospital Universitario Virgen del Rocio Sevilla, Spain, 41013 University Hospital Mutua Terrassa, Spain, 08221 Hospital Clinico Universitario Zaragoza Zaragoza, Spain, 50012 收起 << |
NCT01994902 | Stoma Ileostomy | Not Applicable | Completed | - | Denmark ... 展开 >> TFS Søborg, Denmark France Hopital du bocage Dijon cedex, France, 21079 Hopital Robert Boulin Libourne cedex, France, 33505 Hopital Claude Huriez Lille cedex, France, 59037 Hopital Nord Marseille, France, 13015 Hopital Cochin Paris, France, 75014 Hopital Tenon Paris, France, 75020 Hopital de Haut Levêque Pessac cedex, France, 33604 CHRU La Milétrie Poitiers Cedex, France, 86021 Germany BB medica medizinisches Aachen, Germany Sanitätshause reinhold hilscher e.K. Augsburg, Germany Patientenberatung Strack e.K. Bad Staffelstein, Germany Pro-samed Santitätshaus Berlin, Germany SIEWA coloplast Homecare Burgdorf, Germany SIEWA Coloplast Homecare Freising, Germany SIEWA Coloplast homecare Leinfelden-echterdingen, Germany Schürmaier GmbH &Co Leipzig, Germany Sanitätshaus Fürst GmbH Passau, Germany SIEWA Coloplast Homecare Saulgrub, Germany Sanitäts- und gesundheitshaus Carqueville GmbH Töppeln, Germany Alippi GmbH Zwickau, Germany Norway Sykpleierklinikken Larvik, Norway United Kingdom Pilgrim Hospital Boston, United Kingdom Addenbrookes Cambridge, United Kingdom, CB20QQ Cheltenham General Hospital Gloucestershire, United Kingdom, GL53/AI Lincon Country hospital Lincoln, United Kingdom, LN25QY Charing Cross Hospital London, United Kingdom, W68RF Kettering General hospital Northamptonshire, United Kingdom, NN168UZ west Suffolk Hospital Suffolk, United Kingdom, IP332QZ 收起 << |
NCT01011439 | Thymic Carcinoma | Phase 2 | Active, not recruiting | December 2018 | United States, Arizona ... 展开 >> TGen Clinical Research Services at Scottsdale Healthcare Scottsdale, Arizona, United States, 85258 United States, Maryland NIH, Center for Cancer Research, Medical Oncology Bethesda, Maryland, United States, 20892 France Hopital Larrey Toulouse Cedex, France, 31059 Institut de cancerologie Gustave Roussy Villejuif Cedex, France, 94805 Italy Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Milano, (mi), Italy, 20133 Azienda Ospedaliera San Luigi Gonzaga Orbassano, Italy, 10043 收起 << |
NCT01318525 | Liver Failure, Acute | Phase 2 | Unknown | September 2012 | France ... 展开 >> CHU de Besançon Not yet recruiting Besançon Cedex, France, 25030 Principal Investigator: Vincent Di Martino CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand Cedex 1, France, 63003 Principal Investigator: Armand Abergel Hôpital Beaujon Recruiting Clichy, France, 92110 Principal Investigator: François Durand CHU de Grenoble Recruiting Grenoble Cedex 9, France, 38043 Principal Investigator: Vincent Leroy Hôpital Claude Huriez Not yet recruiting Lille cedex, France, 59037 Principal Investigator: Philippe Mathurin Hôpital Croix-Rousse Recruiting Lyon, France, 69004 Principal Investigator: Si Nafa Si Ahmed Hôpital Conception Not yet recruiting Marseille Cedex 5, France, 13385 Principal Investigator: Danielle Botta Fridlund Hôpital Saint-Eloi Recruiting Montpellier Cedex 5, France, 34295 Principal Investigator: Dominique Larrey Hôpital de l'Archet 2 Not yet recruiting Nice, France, 06202 Principal Investigator: Jean Gugenheim Hôpital Saint Antoine Recruiting Paris Cedex 12, France, 75571 Principal Investigator: Nicolas Carbonell Hôpital La Pitié Salpétrière Recruiting Paris Cedex 13, France, 75651 Principal Investigator: Marika Rudler Centre Hépatobiliaire Paul Brousse Recruiting Villejuif Cedex, France, 94804 Principal Investigator: Didier Samuel 收起 << |
NCT01011439 | - | Active, not recruiting | - | - | |
NCT01994902 | - | Completed | - | - | |
NCT01460186 | Breast Cancer ... 展开 >> Metastasis 收起 << | Not Applicable | Active, not recruiting | December 2023 | France ... 展开 >> Hôpital Jean Minjoz - CHU Besançon BESANCON Cedex, France, 25030 Institut Bergonié Bordeaux, France, 33000 Centre François Baclesse Caen, France, 14000 Centre Georges François Leclerc DIJON Cedex, France, 21079 Institut Daniel Hollard Grenoble, France, 38028 Hôpital Dupuytren LIMOGES Cedex, France, 87042 Centre Léon Bérard LYON Cedex 08, France, 69373 Institut Paoli Calmettes Marseille, France, 13009 Val d'Aurelle Montpellier, France, 34000 Centre Antoine Lacassagne Nice, France, 06000 Institut Curie PARIS Cedex 05, France, 75248 Institut Jean Godinot Reims, France, 51100 Centre René Gauducheau SAINT HERBLAIN Cedex, France, 44805 Centre Paul Strauss Strasbourg, France, 67065 Institut Claudius Regaud TOULOUSE Cedex, France, 31052 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT02355379 | Colonic Adenocarcinoma | Phase 3 | Recruiting | August 2025 | - |
NCT02985190 | MDS Systemic ... 展开 >>Autoimmune Diseases 收起 << | Phase 2 | Recruiting | October 2021 | - |
NCT03201003 | Peanut Allergy | Phase 3 | Active, not recruiting | February 2019 | France ... 展开 >> Unité de dermatologie Pédiatrique, Hôpital Pellegrin-Enfants, place Amélie Raba-Léon Bordeaux Cedex, France, 33076 Hopital Saint Vincent de Paul, Service d'Allergologie Lille Cedex, France, 59020 Paediatric Allergy and Pulmonology Center, Jeanne de Flandre Hospital, Lille University Hospital Lille cedex, France, 59037 Service d'Allergologie Nouvel Hôpital Civil Hôpitaux Univesitaires de Strasbourg Strasbourg Cedex, France, 67091 Germany Charité Universitaetsmedizin Berlin, Klinik für Pädiatrie mit Schwerpunkt Pneumologie und Immunologie Berlin, Germany, 13353 University of Frankfurt, Klinik für Kinder- und Jugendmedizin, Pädiatrische Allergologie, Pneumologie und Mukoviszidose Frankfurt am Main, Germany, 60590 Ireland UCC Dept. of Paediatrics and Child, Cork University Hospital Cork, Ireland National Children's Research Centre, Our Lady's Children's Hospital Crumlin Dublin, Ireland, D12 V004 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Spain Hospital General Universitario Gregorio Marañón, C/Manuel Esquerdo 46 Madrid, Spain, 28007 H. Infantil Universitario Niño Jesús, Servicio de Alergia Madrid, Spain, 28009 Hospital Clinico San Carlos, Madrid Hospital Clinico San Carlos Madrid, Spain, 28040 Sweden Sachsska Children and Youth Hospital Stockholm, Sweden, 118 83 United Kingdom James Paget University Hospital Gorleston-on-Sea, Norfolk, United Kingdom, NR31 6LA Guy & St Thomas' Hospital, NHS Foundation Trust London, United Kingdom, SE1 7EH St. Mary's Hospital London, United Kingdom, W2 1NY Royal Manchester Children's Hospital Manchester, United Kingdom, M13 9WL University Hospitals Southampton Foundation NHS Trust Southampton, United Kingdom, SO16 6YD 收起 << |
NCT03139513 | - | Active, not recruiting | December 31, 2018 | France ... 展开 >> Centre Hospitalier d'Albi Albi Cedex 9, France, 81013 Hopital Prive D Antony; Dermatologie Antony, France, 92166 Chic Cote Basque Bayonne; Medecine II Bayonne, France, 64109 CHU Besançon - Hôpital Jean Minjoz Besançon Cedex, France, 25030 Hopital Avicenne; Dermatologie Bobigny, France, 93009 CH Fleyriat Bourg en Bresse, France, 01000 CH Metropole de Savoie CHAMBERY Cedex, France, 73011 Chu Estaing; Dermatologie Clermont Ferrand, France, 63003 Hopital Louis Pasteur; Sce Dermatologie Colmar, France, 68024 Centre Georges Francois Leclerc Dijon, France, 21000 Chu Site Du Bocage;Dermatologie Dijon, France, 21079 Centre Hospitalier Le Mans; Dermatologie Le Mans, France, 72037 Hopital Claude Huriez; Sce Dermatologie Lille, France, 59037 CHU de Limoges - Hôpital Dupuytren Limoges, France, 87042 Hopital Timone Adultes; Dermatologie Marseille, France, 13385 Hopital Jacques Monod; Dermatologie Montivilliers, France, 76290 Hopital Saint Eloi; CHU de Montpellier; Svc de Dermatologie Montpellier, France, 34295 CH de Mulhouse Hôpital Emile Muller Mulhouse, France, 68070 Hopital l Archet 2; Ginestriere, Service de; Dermatologie Nice cedex 3, France, 06200 Hopital Cochin; Dermatologie Paris, France, 75006 Groupe Hospitalier Bichat Claude Bernard Paris, France, 75018 CENTRE HOSPITALIER ANNECY-GENEVOIS; Dematologie Pringy, France Centre Eugene Marquis Centre Regional de Lutte Contre Le Cancer Rennes, France, 35000 CHU Rouen - CH C. Nicolle - Clinique dermatologique Rouen, France, 76031 CHU de Saint-Etienne - Hopital Nord Saint Etienne, France, 42055 CHI de Poissy St Germain Saint Germain, France, 07810 Hopital Broussais St Malo Cedex, France, 35403 Pole de Cancerologie Prive Strasbourgeois Strasbourg, France, 67000 Hopital Bel Air Thionville Cedex, France, 57126 Hia Sainte Anne; Medecine Interne Oncologie Toulon, France, 83041 CHU de Toulouse - Hôpital Larrey Toulouse, France, 31059 Centre Hospitalier Valence Valence, France, 26953 Institut Gustave Roussy; Dermatologie Villejuif, France, 94805 收起 << | |
NCT01625377 | - | Completed | - | - | |
NCT01105325 | - | Terminated(due to poor patient... 展开 >> recruitment) 收起 << | March 2011 | - | |
NCT01625377 | Liver Transplantation | Phase 3 | Completed | - | France ... 展开 >> Novartis Investigative Site Besancon cedex, France, 25030 Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Chambray les Tours, France, 37044 Novartis Investigative Site Clichy, France, 92110 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Marseille, France, 13385 Novartis Investigative Site Montpellier, France, 34295 Novartis Investigative Site Nice, France, 06202 Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Rennes Cedex, France, 35033 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Novartis Investigative Site Villejuif, France, 94800 收起 << |
NCT00948389 | Glioblastoma | Phase 1 Phase 2 | Terminated(Inability to meet p... 展开 >>rotocol objectives) 收起 << | - | France ... 展开 >> Local Institution Paris Cedex, France, 75013 Italy Local Institution Bologna, Italy, 40139 Netherlands Local Institution Nijmegen, Netherlands, 6525 GA Local Institution Rotterdam, Netherlands, 3075 EA Switzerland Local Institution Lausanne, Switzerland, 1011 收起 << |
NCT00948389 | - | Terminated(Inability to meet p... 展开 >>rotocol objectives) 收起 << | - | - | |
NCT02595970 | Psoriasis | Phase 3 | Completed | - | France ... 展开 >> Novartis Investigative Site Limoges cedex, Haute Vienne, France, 87000 Novartis Investigative Site Amiens cedex 1, France, 80054 Novartis Investigative Site Antony, France, 92160 Novartis Investigative Site Argenteuil, France, 95107 Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Brest, France, 29609 Novartis Investigative Site La Rochelle, France, 17019 Novartis Investigative Site Le Mans Cedex 09, France, 72037 Novartis Investigative Site Marseille Cedex 05, France, 13885 Novartis Investigative Site Martigues, France, 13500 Novartis Investigative Site Metz, France, 57077 Novartis Investigative Site Nice, France, 06202 Novartis Investigative Site Paris, France, 75014 Novartis Investigative Site Paris, France, 75877 Novartis Investigative Site Rouen, France, 76031 Novartis Investigative Site Toulon Cedex 9, France, 83800 Novartis Investigative Site Toulouse Cedex, France, 31400 收起 << |
NCT02789384 | Soft-tissue Sarcomas | Not Applicable | Recruiting | January 2021 | France ... 展开 >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD Principal Investigator: ITALIANO Antoine, MD,PhD Centre Georges François Leclerc Not yet recruiting Dijon Cedex, France, 21079 Principal Investigator: ISAMBERT Nicolas, MD Centre Oscar Lambret Not yet recruiting Lille Cedex, France, 59020 Principal Investigator: PENEL Nicolas, MD Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Principal Investigator: BLAY Jean-Yves, MD,PhD AP-HM _ Hôpital de la Timone Not yet recruiting Marseille Cedex 05, France, 13385 Principal Investigator: DUFFAUD Florence, MD,PhD Institut Paoli Calmettes Not yet recruiting Marseille Cedex 9, France, 13273 Principal Investigator: BERTUCCI François, MD,PhD Institut de Cancérologie de l'Ouest Not yet recruiting Nantes, France, 44805 Principal Investigator: BOMPAS Emmanuel, MD Institut Curie Not yet recruiting Paris Cedex, France, 75005 Principal Investigator: PIPERNO-NEUMANN Sophie, MD Institut Claudius Regaud - IUCT-0 Not yet recruiting Toulouse Cedex 9, France, 31052 Principal Investigator: CHEVREAU Christine, MD Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Principal Investigator: LECESNE Axel, MD 收起 << |
NCT02967237 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT01632839 | - | Completed | - | France ... 展开 >> APHP - Hôpital Antoine Beclere Clamart Cedex, France, 92141 CHU de Clermont Ferrand - Hôpital Estaing Clermont Ferrand, France, 63003 G.C.S. Flandre Maritime - site Polyclinique de Grande-Synthe Grande Synthe, France, 59760 CH de la Rochelle La Rochelle Cedex, France, 17019 APHP - Centre Hospitalier Universitaire de Bicêtre Le Kremlin Bicêtre Cedex, France, 94275 CHRU de Lille - Hôpital Jeanne de Flandre Lille Cedex, France, 59037 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 APHP - Hôpital Bichat - Claude Bernard Paris Cedex 18, France, 75877 Groupe Hospitalier Dioconesses - Site Reuilly Paris, France, 75012 CHU de Poitiers Poitiers Cedex, France, 86021 CH de la Région d'Annecy Pringy Cedex, France, 74374 CH de Poissy - Saint-Germain-en-Laye Saint-Germain-en-Laye, France, 78100 CHRU de Strasbourg - Hôpital de Hautepierre Strasbourg, France, 67098 Hôpital Foch Suresnes, France, 92151 收起 << | |
NCT03186326 | Metastatic Colorectal Cancer ... 展开 >> MSI 收起 << | Phase 2 | Recruiting | March 31, 2025 | - |
NCT03006432 | OESOPHAGO-GASTRIC CARCINOMA | Phase 3 | Recruiting | August 2022 | - |
NCT02837406 | - | Unknown | June 2018 | France ... 展开 >> Agences Régionales de Santé Bourgogne Chalon-sur-Saône, France, 71100 Agence régionale de santé de Rhône Alpes LYON cedex, France, 69418 Agences Régionales de Santé Aquitaine Mont de Marsan, France, 40100 Agence Régionale de Santé (ARS) Ile-de-France Paris, France, 75019 Agence Régionale Santé Océan Indien Saint-Denis, France, 97743 收起 << | |
NCT01777074 | - | Completed | - | - | |
NCT02093741 | - | Completed | - | France ... 展开 >> CHRU Pellegrin, Hématologie - CRTH BORDEAUX Cedex, France, 33076 Centre Hospitalier Générale, CTH Chambery Cedex, France, 73011 CRTH Laboratoire d'Hématologie CHRU - Hôpital du Bocage Dijon Cedex, France, 21034 American Memorial Hospital, Service de Pédiatrie REIMS Cedex, France, 51092 CHU de Rennes Hôpital Pontchaillou Rennes Cedex 09, France, 35033 Hôpital Nord, Pédiatrie Saint Priest En Jarez, France, 42270 CHRU Purpan, CRTH - Pavillon Sénac TOULOUSE Cedex 9, France, 31059 CHU de Nancy - Hôpital de Brabois- CRTH - Laboratoire Hémato-Hémostase VANDOEUVRE-LES-NANCY Cedex, France, 54511 Germany Universitätskliniken des Saarlandes, Klinik für pädiatrische Onkologie und Hämatologie Homburg, Saarland, Germany, 66421 Klinikum Stuttgart, Olgahospital, Pädiatrie 5 Stuttgart, Germany, 70176 Hungary Heim Pál Children's Hospital, Department of Oncology Budapest, Hungary, 1131 Borsod-Abaúj-Zemplén County Hospital, Pediatric Dep Miskolc, Hungary, 3629 Mohacsi Korhaz, Department of Pediatrics Mohacs, Hungary, 7700 Josa Andras Egyetemi Oktatokorhaz, Department of Pediatrics Nyiregyhaza, Hungary, 4400 United Kingdom Leeds General Infirmary Leeds, West Yorkshire, United Kingdom, LS1 3EX Birmingham Children's Hospital NHS Trust Birmingham, United Kingdom, B4 6NH Great Ormond Street Hospital for Children NHS Trust London, United Kingdom, WC1N 3JH 收起 << | |
NCT02902900 | - | Recruiting | September 30, 2020 | - | |
NCT02803489 | Chronic Diseases | Not Applicable | Terminated(inclusion rate too ... 展开 >>low & investigators enable to recruit new patients rapidly) 收起 << | - | France ... 展开 >> Cabinet Privé de Cardiologie - 2, rue jean jaurès Annecy, France, 74000 Cabinet Privé de Pneumologie - 7 rue gabriel de mortillet Annecy, France, 74000 Centre Hospitalier d'Annecy Genevois - service cardiologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy PRINGY Cedex, France, 74374 Centre Hospitalier d'Annecy Genevois - service pneumologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy Pringy cedex, France, 74374 Cabinet privé de pneumologie - 28 avenue de Genève Saint Julien en Genevois, France, 74160 cabinet privé de médecine générale - 18, rue Louis Haase Thones, France, 74230 收起 << |
NCT02416232 | - | - | - | France ... 展开 >> GSK Investigational Site Amiens Cedex, France, 80054 GSK Investigational Site Angers, France, 49100 GSK Investigational Site Bayonne cedex, France, 64109 GSK Investigational Site Besancon cedex, France, 25030 GSK Investigational Site Bobigny, France, 93000 GSK Investigational Site Bordeaux, France, 33075 GSK Investigational Site Boulogne-Billancourt, France, 92100 GSK Investigational Site Brest cedex, France, 29609 GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Chambray-Les-Tours, France, 37170 GSK Investigational Site Clermont-Ferrand cedex 1, France, 63003 GSK Investigational Site Creteil, France, 94010 GSK Investigational Site Dijon Cedex, France, 21079 GSK Investigational Site Grenoble cedex 9, France, 38043 GSK Investigational Site La Rochelle cedex 1, France, 17019 GSK Investigational Site Le Havre, France, 76083 GSK Investigational Site Le Mans, France, 72000 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Limoges cedex, France, 87042 GSK Investigational Site Lorient, France, 56322 GSK Investigational Site Lyon Cedex 08, France, 69373 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Montpellier cedex 5, France, 34295 GSK Investigational Site Montpellier Cedex 5, France, 34298 GSK Investigational Site Mulhouse, France, 68100 GSK Investigational Site Nantes Cedex 1, France, 44093 GSK Investigational Site Nice, France, 06202 GSK Investigational Site Nimes, France, 30029 cedex 9 GSK Investigational Site Orleans Cedex 2, France, 45067 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Paris, France, 75006 GSK Investigational Site Pau, France, 64000 GSK Investigational Site Pierre-Benite cedex, France, 69495 GSK Investigational Site Poitiers, France, 86021 GSK Investigational Site Pringy Cedex, France, 74374 GSK Investigational Site Reims Cedex, France, 51092 GSK Investigational Site Rennes Cedex, France, 35042 GSK Investigational Site Rouen, France, 76031 GSK Investigational Site Saint-Pierre, France, 97448 GSK Investigational Site Saint-Priest en Jarez, France, 42270 GSK Investigational Site Strasbourg Cedex, France, 67091 GSK Investigational Site Thionville, France, 57126 Cedex 1 GSK Investigational Site Toulouse Cedex 9, France, 31059 GSK Investigational Site Valence Cedex 9, France, 26953 GSK Investigational Site Vandoeuvre-Les-Nancy, France, 54511 GSK Investigational Site Villejuif cedex, France, 94805 收起 << | |
NCT00931723 | Acute Mania | Phase 4 | Completed | - | - |
NCT00931723 | - | Completed | - | - | |
NCT03415035 | - | Recruiting | March 30, 2022 | - | |
NCT00066170 | Narcolepsy | Phase 3 | Completed | - | - |
NCT03378388 | - | Recruiting | December 31, 2021 | France ... 展开 >> Centre Hospitalier Cote Basque Recruiting BAYONNE Cedex, France Ch de Blois Recruiting Blois Cedex, France Clinique du palais Recruiting Grasse, France Ghef Ch Marne La Vallee Recruiting Jossigny, France Hopital Edouard Herriot Recruiting Lyon Cedex 03, France Ctre Hosp St Joseph Et St Luc Recruiting Lyon Cedex 07, France Hopital Saint Eloi-Chru Montpellier Recruiting Montpellier Cedex 5, France Ch Lyon Sud Recruiting Pierre Benite Cedex, France Polyclinique Cote Basque Sud Recruiting St Jean de Luz Cedex, France HOPITAL NORD-CHU de SAINT-ETIENNE Recruiting St Priest En Jarez Cedex, France Clinique Ambroise Pare Recruiting Toulouse, France HOPITAUX DE BRABOIS-CHRU de NANCY Recruiting Vandoeuvre Les Nancy Cedex, France Gh mutualiste les portes du sud Recruiting Venissieux Cedex, France 收起 << | |
NCT00637377 | Macular Degeneration | Phase 3 | Completed | - | - |
NCT01012973 | Retinal Vein Occlusion | Phase 3 | Completed | - | - |
NCT01012973 | - | Completed | - | - | |
NCT00066170 | - | Completed | - | - | |
NCT00228553 | Excessive Daytime Sleepiness ... 展开 >> Narcolepsy Obstructive Sleep Apnea/Hypopnea Syndrome Chronic Shift Work Sleep Disorder 收起 << | Phase 3 | Completed | - | - |
NCT00228553 | - | Completed | - | - | |
NCT00099879 | Non-small Cell Lung Cancer | Phase 2 | Terminated | - | United States, California ... 展开 >> Local Institution Sacramento, California, United States United States, Connecticut Local Institution New Haven, Connecticut, United States United States, Georgia Local Institution Atlanta, Georgia, United States United States, Illinois Local Institution Maywood, Illinois, United States United States, Michigan Local Institution Detroit, Michigan, United States United States, Pennsylvania Local Institution Pittsburgh, Pennsylvania, United States United States, Tennessee Local Institution Nashville, Tennessee, United States Belgium Local Institution Brussels, Belgium Local Institution Leuven, Belgium France Local Institution Besancon, Cedex, France Local Institution Saint-Herblain, Cedex, France Local Institution Belfort, France Italy Local Institution Parma, Italy Local Institution Roma, Italy Netherlands Local Institution Amsterdam, Netherlands Local Insitution Groningen, Netherlands Spain Local Institution Barcelona, Spain Local Institution Madrid, Spain United Kingdom Local Institution Shefield, Yorkshire, United Kingdom Local Institution Manchester, United Kingdom 收起 << |
NCT00036543 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT02382016 | - | Active, not recruiting | - | - | |
NCT00637377 | - | Completed | - | - | |
NCT00162266 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT00133731 | Angioplasty, Transluminal, Per... 展开 >>cutaneous Coronary 收起 << | Phase 2 | Completed | - | - |
NCT01412502 | - | Terminated(no recruitment) | - | France ... 展开 >> Hôpital Beaujon -APHP Clichy, France Assistance Publique - Hopitaux de Marseille Marseille, France CHU Lapeyronie Montpellier Cedex 05, France, 34295 Hôpital Gui De Chauliac (CHU de Montpellier) Montpellier cedex 5, France, 34295 Centre Hospitalier Universitaire de Nîmes Nîmes cedex 09, France, 30029 Hôpital Kremlin Bicêtre - APHP Paris, France 收起 << | |
NCT00989261 | Acute Myeloid Leukemia | Phase 2 | Completed | - | - |
NCT00887978 | Pulmonary Hypertension | Phase 3 | Completed | - | - |
NCT00801060 | Chronic Lymphocytic Leukemia | Phase 2 | Terminated | - | - |
NCT00162266 | - | Completed | - | - | |
NCT02382016 | Portopulmonary Hypertension | Phase 4 | Active, not recruiting | January 1, 2019 | - |
NCT02680574 | Anemia Non-di... 展开 >>alysis-dependent Chronic Kidney Disease 收起 << | Phase 3 | Recruiting | August 2020 | - |
NCT01510184 | Diffuse Large B-cell Lymphoma ... 展开 >> Follicle Center Lymphoma 收起 << | Phase 3 | Terminated | June 2018 | - |
NCT02735902 | Transcatheter Aortic Valve Rep... 展开 >>lacement 收起 << | Phase 4 | Recruiting | April 2020 | France ... 展开 >> Clinique du Millénaire Recruiting Montpellier cedex 2, France, 34960 Sub-Investigator: Christophe Piot, MD, PhD Sub-Investigator: Gilles Levy, MD Sub-Investigator: François Rivalland, MD CHRU de Montpellier - Hôpital Arnaud de Villeneuve Recruiting Montpellier, France, 34295 Principal Investigator: Florence Leclercq, MD, PhD Sub-Investigator: Jean-Christophe Macia, MD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Guillaume Cayla, MD, PhD Sub-Investigator: Laurent Schmutz, MD Hôpital Privé les Franciscaines Not yet recruiting Nîmes Cedex 1, France, 30032 Sub-Investigator: Eric Maupas, MD Clinique Saint-Pierre Recruiting Perpignan, France, 66000 Sub-Investigator: Gabriel Robert, MD CH de Perpignan - Hôpital Saint Jean Recruiting Perpignan, France, 66046 Sub-Investigator: Frédéric Targosz, MD Sub-Investigator: Delphine Delseny, MD 收起 << |
NCT03154333 | Epidermolysis Bullosa Simplex | Phase 2 | Terminated(An independent data... 展开 >> monitoring committee suggested that the study will not meet statistical objectives.) 收起 << | - | - |
NCT03191487 | Colorectal Neoplasms | Not Applicable | Withdrawn(no Financial agreeme... 展开 >>nt) 收起 << | November 2019 | France ... 展开 >> Institut Sainte Catherine Avignon Cedex 9, France, 84918 Institut de Cancérologie Montpellier Montpellier Cedex 5, France, 34298 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes, France, 30029 CHRU de Strasbourg - Hôpital de Hautepierre Strasbourg, France, 67098 CHRU de Toulouse - Hôpital de Rangueil Toulouse Cedex 9, France, 31059 IUCT-Oncopole Toulouse, France, 31100 收起 << |
NCT00887978 | - | Completed | - | - | |
NCT02598115 | Aged Patient ... 展开 >>Admission Hospitalization 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU de Grenoble - Hôpital Albert Michallon Grenoble Cedex 9, France, 38043 CHU de Nice - Hôpitaux L'Archet 1 et 2 Nice, France, 06202 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 CHU de Rouen - Hôpital Charles Nicolle Rouen, France, 76031 CHRU de Strasbourg - Hôpital de Hautepierre Strasbourg, France, 67098 CHRU de Toulouse - Hôpital Paule de Viguier Toulouse Cedex 9, France, 31059 收起 << |
NCT02156843 | Diabetic Nephropathy ... 展开 >> Diabetic Kidney Disease 收起 << | Phase 3 | Terminated | March 2018 | - |
NCT02843867 | - | Recruiting | September 2026 | France ... 展开 >> CHU de Besançon Recruiting Besançon, France, 25000 Contact: Didier Ducloux, Pr. CHU Clermont-Ferrand, 58 rue Montalembert, 63003 Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick Detex, Pr. CHU Dijon, Hôpital du Bocage, 2 Bd du Maréchal de Lattre de Tassigny, 21079 Dijon cedex Recruiting Dijon, France, 21079 Contact: Christiane Mousson, Pr. Hôpital du Kremlin Bicêtre 78, rue du Général Leclerc, 94275 Le Kremlin-Bicêtre Cedex Recruiting Le Kremlin-Bicêtre, France, 94275 Contact: Antoine Durrbach, Pr. CHU Brabois, et Vandoeuvre les Nancy Active, not recruiting Nancy, France CHU Reims, 45 rue Cognacq-Jay 51092 Reims Cedex Active, not recruiting Reims, France, 51092 Hôpital Civil- 1, place de l'hôpital BP426 ; 67091 Strasbourg Cedex Active, not recruiting Strasbourg, France, 67091 收起 << | |
NCT01027884 | Muscular Dystrophy, Duchenne ... 展开 >> Ambulatory Care 收起 << | Phase 3 | Completed | - | - |
NCT02378493 | - | Recruiting | June 2019 | France ... 展开 >> CHU de Clermont-Ferrand - Hôpital Gabriel-Montpied Not yet recruiting Clermont Ferrand, France, 63003 Principal Investigator: Richard Bonnet, MD, PhD Sub-Investigator: Olivier Lesens, MD, PhD CHU de Lyon - Hôpital de la Croix-Rousse Recruiting Lyon Cedex 4, France, 69317 Sub-Investigator: Frédéric Laurent, MD Sub-Investigator: Jean Philippe Rasigade, MD CHU Not yet recruiting Nantes, France Contact: David BOUTOILLE CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Jean Philippe Lavigne, MD, PhD Sub-Investigator: Albert Sotto, MD, PhD CHU de Lyon - Centre Hospitalier Lyon Sud Recruiting Pierre Benite, France, 69310 Sub-Investigator: Gérad Lina, MD, PhD Sub-Investigator: Julien Vouillarmet, MD Sub-Investigator: Paul Michon, MD CHRU de Strasbourg - Hôpital Civil Not yet recruiting Strasbourg Cedex, France, 67091 Principal Investigator: Laurence Kessler, MD 收起 << | |
NCT00002390 | HIV Infections | Phase 2 | Completed | - | France ... 展开 >> Group Hospier Pitie-Salpetriere / Maladies Infec et Trop Paris Cedex 13, France Groupe Hospitalier Bichat-Claude Bernard Paris Cedex 18, France Hopital de Purpan / CHU de Rangueil / Medecine Interue Toulouse Cedex, France Hopital de Purpan / Service du Professeur Auvergnat Toulouse Cedex, France Germany Universitat Erlangen Erlangen, Germany Universitatsklinikurn Frankfurt Frankfurt, Germany 收起 << |
NCT01027884 | - | Completed | - | - | |
NCT02302547 | HIV | Phase 3 | Completed | - | France ... 展开 >> Unité des Maladies Infectieuses, CHU de CAEN Caen, France, 14033 Service des Maladies Infectieuses, CHR Orléans La Source, ORLEANS CEDEX 2 CHR d'ORLEANS, France, 45067 Service d'Immunologie Clinique centre de Vaccination anti- VIH ANRS Hopital Henri- Mondor Creteil, France, 94010 Service de Médecine Interne et Maladies Infectieuses, Groupe Hospitalier La Rochelle, Cedex 01 La Rochelle, France, 17019 Service de Pneumologie, centre Hospitalier Fontenoy, CH de CHARTRES Le Coudray, France, 28630 CHU de NANCY Nancy, France, 54035 Service des maladies Infectieuses et tropicales, CH GEORGES RENON Niort, France, 79021 Service des Maladies Infectieuses et tropicales, APHP SAINT LOUIS Paris, France, 75475 Hospital Tenon Paris, France, 75970 Centre de diagnostic et thérapeutique, Hopital Hotel Dieu Paris, France, 94010 Consultation Maladies Infectieuses, Chu de Poitiers, Cedex Poitiers, France, 86021 Maladies Infectieuses, CHU de ROUEN Rouen, France, 76031 Service de Médecine Interne, CH de SAINTONGE- BP 326 Saintes, France, 17108 Médecine Interne, Hôpital FOCH Suresnes, France, 92151 Service Universitaire des Maladies Infectieuses et du Voyageur, CH DRON Tourcoing, France, 59200 Service de Medecine Interne et Maladies Infectieuses, CHRU BRETONNEAU, TOURS CEDEX9 Tours, France, 37044 收起 << |
NCT00043966 | HIV Infections | Phase 3 | Completed | - | - |
NCT01558856 | Urinary Bladder, Overactive | Not Applicable | Unknown | November 2017 | France ... 展开 >> Clinique Beau Soleil Recruiting Montpellier, France, 34070 Sub-Investigator: Antoine Faix, MD CHU de Nantes - Hôtel Dieu Recruiting Nantes Cedex 1, France, 44093 Sub-Investigator: Loïc Le Normand, MD CHU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Laurent Wagner, MD Sub-Investigator: Stéphane Droupy, MD PhD Sub-Investigator: Pierre Costa, MD PhD APHP - Groupe Hospitalier Pitié-Salpetrière Not yet recruiting Paris Cedex 13, France, 75651 Sub-Investigator: Emmanuel Chartier-Kastler, MD, PhD CHU de Rouen - Hôpital Charles Nicolle Not yet recruiting Rouen, France, 76031 Sub-Investigator: Jean Nicolas Cornu, MD, PhD CHRU de Toulouse - Hôpital de Rangueil Recruiting Toulouse Cedex 9, France, 31059 Sub-Investigator: Xavier Game, MD 收起 << |
NCT03042611 | Gastric Cancer ... 展开 >> Gastric Adenocarcinoma 收起 << | Phase 3 | Active, not recruiting | March 31, 2019 | - |
NCT00121901 | Pancreatitis | Phase 3 | Completed | - | Denmark ... 展开 >> Department of Medical and Surgical Gastroenterology, KAS Glostrup Copenhagen, Glostrup, Denmark, 2600 Dept. of Medical Gastroenterology F, KAS Gentofte Copenhagen, Hellerup, Denmark, 2900 Gastroenheden, Hvidovre Hospital Copenhagen, Hvidovre, Denmark, 2650 Rigshospitalet Copenhagen, København Ø, Denmark, 2100 Køge County Hospital Køge, Denmark, 4600 Dept of Medical Gastroenterology S, Odense Universitetshospital Odense, Denmark, 5000 France Serv Gastroenterologie Hopital Sainte Marguerite Marseille, Marseille Cedex 09, France, F-13274 North Hospital Marseille, France Norway Div of Gastroenterology, dept. of Int Medicine Affiliated Hospital University of Oslo, Østfold Fredrikstad Fredrikstad, Norway, N-1603 Helse Fonna HF Haugesund Sjukehus Kirurgisk - vest blokk gastro Haugesund, Norway, 5504 Ullevål Hospital Oslo, Norway Stavanger Hospital Stavanger, Norway Sweden Halmstad Hospital Halmstad, Sweden Dept of Surgery, University Hospital Malmö Malmö, Sweden, S-205 02 收起 << |
NCT02810210 | - | Unknown | September 2018 | France ... 展开 >> CH de la Basse Terre Recruiting Basse-terre Cedex, France, 97109 Contact: Jean-Christophe HEBERT j.hebert@ch-labasseterre.fr CH Andrée Rosemon (CHAR) Active, not recruiting Cayenne Cedex, France, 97306 CHU de Martinique Recruiting Fort de France Cedex, France, 97261 Contact: Olivier FLECHELLES Olivier.flechelles@chu-fortdefrance.fr CHU de Pointe à Pitre/Les Abymes Recruiting Pointe A Pitre, France, 97139 Contact: Aude Abrial aude.abrial@chu-guadeloupe.fr CH LC Fleming Active, not recruiting Saint Martin Cedex, France, 97054 CH de l'Ouest Guyanais Franck Joly (CHOG) Active, not recruiting Saint-laurent-du-maroni, France, 97320 收起 << | |
NCT00324155 | Melanoma | Phase 3 | Completed | - | - |
NCT03358472 | Head and Neck Cancer | Phase 3 | Active, not recruiting | June 2020 | - |
NCT02246127 | Neuroendocrine Tumors | Phase 3 | Recruiting | June 2020 | - |
NCT00051844 | Human Immunodeficiency Virus | Phase 2 | Completed | - | - |
NCT02853370 | Marginal Zone B-cell Lymphoma | Phase 2 | Active, not recruiting | April 2020 | France ... 展开 >> Créteil (Hôpital Henri Mondor) Creteil, France Dijon (CHU de Dijon - Hôpital d'Enfants) Dijon, France Grenoble cedex 9 (CHU Michallon) Grenoble, France Le Kremlin Bicêtre (Hôpital Bicêtre) Le Kremlin Bicetre, France Le Mans (C.H. Le Mans) Le Mans, France Lille cedex (CHRU Lille - Hôpital Claude Huriez) Lille, France Pierre Bénite Lyon Sud, France Vandoeuvre-les-Nancy cedex (CHU Brabois) Nancy, France Nantes cedex 01 (CHU de Nantes - Hôtel Dieu) Nantes, France Paris cedex 10 (Hôpital Saint-Louis) Paris, France Pessac cedex (Centre François Magendie) Pessac, France Rouen (Centre Henri Becquerel) Rouen, France Italy Ospedale Civile Ss. Antonio E Biagio Alessandria, Italy A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona Ancona, Italy Ospedale Armando Businco Cagliari, Italy A.O. Universitaria S. Martino Di Genova Genova, Italy Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Sede Di Meldola (Fc) Meldola, Italy Irccs Fondazione Centro S. Raffaele Del Monte Tabor Milano, Italy A.O. Universitaria Policlinico Di Modena Modena, Italy A.O. "V. Cervello" Palermo, Italy A.O. Universitaria Policlinico Giaccone Palermo, Italy A.O. Universitaria Di Parma Parma, Italy Ausl Di Piacenza Piacenza, Italy Ospedale S. Maria Delle Croci Di Di Ravenna Ravenna, Italy Ospedale Bianchi - Melacrino - Morelli Reggio Calabria, Italy Ospedale Di S. Maria Nuova-Irccs Reggio Emilia, Italy Irccs Centro Di Riferimento Oncologico Di Basilicata (Crob) Rionero, Italy Irccs Istituto Dermatologico S. Gallicano (Ifo) Roma, Italy Azienda Ospedaliera "S. Maria" Terni, Italy Ospedale Di Circolo E Fondazione Macchi Varese, Italy 收起 << |
NCT00796731 | Lymphoma Non-... 展开 >>Hodgkin 收起 << | Phase 1 | Completed | - | France ... 展开 >> Sanofi-Aventis Investigational Site Number 250004 Creteil Cedex, France, 94010 Sanofi-Aventis Investigational Site Number 250006 Lille Cedex, France, 59037 Sanofi-Aventis Investigational Site Number 250001 Pierre Benite Cedex, France, 69495 Sanofi-Aventis Investigational Site Number 250005 Rennes, France, 35033 Sanofi-Aventis Investigational Site Number 250003 Rouen Cedex, France, 76038 Sanofi-Aventis Investigational Site Number 250002 Villejuif Cedex, France, 94805 收起 << |
NCT00147602 | Cardiovascular Disease | Phase 4 | Completed | - | - |
NCT00036556 | Prostatic Neoplasms | Phase 3 | Completed | - | - |
NCT00986440 | Colorectal Cancer | Phase 2 | Completed | - | - |
NCT01868269 | Opsoclonus Myoclonus Syndrome ... 展开 >> Neuroblastoma 收起 << | Phase 3 | Recruiting | April 2031 | Austria ... 展开 >> St. Anna Kinderkrebsforschung e.V. CHILDREN'S CANCER RESEARCH INSTITUTE Recruiting Wien, Austria, 1090 Principal Investigator: Ruth LADENSTEIN, Dr. France Chu de Bicetre Recruiting Le Kremlin-Bicêtre, LE Kremlin Bicetre, France, 94275 Contact: DEIVA Kumaran, dr Principal Investigator: DEIVA Kumaran, DR Centre Oscar Lambret Recruiting Lille, Lille Cedex, France, 59020 Contact: DESFACHELLES THOMASSIN Anne-Sophie, DR Principal Investigator: DESFACHELLES THOMASSIN Anne-Sophie, DR Centre Leon Berard Recruiting Lyon, LYON Cedex 08, France, 69373 Contact: FAURE CONTER Cécile, DR Principal Investigator: FAURE CONTER Cécile, DR Hopita D'Enfants de La Timone Recruiting Marseille, Marseille Cedex 5, France, 13385 Contact: COZE CAROLE, DR Principal Investigator: COZE Carole, DR Hopital Arnaud de Villeneuve Not yet recruiting Montpellier, Montpellier Cedex 4, France, 34295 Contact: HAOUY Stéphanie, DR Principal Investigator: HAOUY Stéphanie, DR Chr de Nantes Recruiting Nantes, Nantes Cedex01, France, 44093 Contact: THEBAUD Estelle, DR Principal Investigator: THEBAUD Estelle, DR Chu de Nice Archet 2 Recruiting Nice, NICE Cedex 03, France, 06202 Contact: BENADIBA Joy, dr Principal Investigator: BENADIBA Joy, DR Ch Trousseau Recruiting Paris, Paris Cedex 12, France, 75571 Contact: PETIT Arnaud, dr Principal Investigator: PETIT Arnaud, dr Chu Hopital Sud Not yet recruiting Rennes, Rennes Cedex 02, France, 35056 Contact: TAQUE Sophie, dr Principal Investigator: TAQUE Sophie, dr Chu de Rouen Not yet recruiting Rouen, Rouen Cedex, France, 76031 Contact: SCHNEIDER Pascale, DR Principal Investigator: SCHNEIDER Pascale, DR CHU DE STRASBOURG HOPITAL Hautepierre Not yet recruiting Strasbourg, Strasbourg Cedex, France, 67098 Contact: Natacha ENTZ-WERLE, MD Principal Investigator: Natacha ENTZ-WERLE, MD Chu Toulouse Hopital Des Enfants Recruiting Toulouse, Toulouse Cedex 9, France, 31059 Contact: Marion GAMBART, dr Principal Investigator: Marion GAMBART, dr Chu Amiens Not yet recruiting Amiens, France, 80054 Contact: DEVOLDERE Catherine, DR Principal Investigator: DEVOLDERE Catherine, DR Chu Angers Not yet recruiting Angers, France, 49933 Contact: PELLIER Isabelle, DR Principal Investigator: PELLIER Isabelle, DR Hopital Jean Minjoz Not yet recruiting Besancon, France, 25030 Contact: KLEIN Stéphane, DR Principal Investigator: KLEIN Stéphane, DR Chr Pellegrin Recruiting Bordeaux, France, 33076 Contact: BOUYN-ICHER Céline, DR Principal Investigator: BOUYN-ICHER Céline, DR CHU CAEN Not yet recruiting Caen, France, 14033 Contact: MINCKES ODILE, DR Principal Investigator: MINCKES Odile, DR Chu D'Estaing Not yet recruiting Clermont Ferrand, France, 63003 Contact: KANOLD Justina, DR Principal Investigator: KANOLD Justina, DR Chu Dijon Recruiting Dijon, France, 21079 Contact: DESPLANTES Claire, DR Principal Investigator: DESPLANTES Claire, DR Chu de Grenoble Recruiting Grenoble, France, 38045 Contact: PLANTAZ Dominique, DR Principal Investigator: PLANTAZ Dominique, DR Chu de Limoges Recruiting Limoges, France, 87042 Contact: PIGUET Christophe, DR Principal Investigator: PIGUET Christophe, DR Institut Curie Recruiting Paris, France, 75005 Contact: Schleiermacher Gudrun, dr Principal Investigator: Schleiermacher Gudrun, dr Chu de Poitiers Not yet recruiting Poitiers, France, 86021 Contact: MILLOT Frédéric, DR Principal Investigator: MILLOT Frédéric, dr Chu de Reims Not yet recruiting Reims, France, 51092 Contact: PLUCHART Claire, DR Principal Investigator: PLUCHART Claire, dr CHU LA REUNION Site Félix Guyon Recruiting Saint-denis, France, 97400 Principal Investigator: Yves REGUERRE, MD Chu Saint Etienne Not yet recruiting Saint-Étienne, France, 42055 Contact: STEPHAN Jean-Louis, DR Principal Investigator: STEPHAN Jean-Louis, dr Chu Tours Hopital Clocheville Not yet recruiting Tours, France, 37044 Contact: BLOUIN Pascale, dr Principal Investigator: BLOUIN Pascale, dr Hopital Nancy Brabois Recruiting Vandoeuvre Les Nancy, France, 54500 Contact: CHASTAGNER PASCAL, DR Principal Investigator: CHASTAGNER Pascal, DR Institut de Cancerologie Gustave Roussy Recruiting Villejuif, France, 94805 Contact: VALTEAU COUANNET Dominique, dr Principal Investigator: VALTEAU COUANNET Dominique, DR Italy G. Gaslini Institut Recruiting Genova, Italy, 16148 Contact: DE GRANDIS ELISA, DR Principal Investigator: DE GRANDIS Elisa, dr Spain The Fundación para la Formación e Investigación Sanitarias de la Región de Murcia Recruiting El Palmar, Spain, 30120 Principal Investigator: Mar Bermúdez Cortés, Dr. Sweden University Hospital Lund Recruiting Lund, Sweden, 22185 Contact: ORA Ingrid, dr Principal Investigator: ORA Ingrid, dr Switzerland Universitätskinderklinik Recruiting Bern, Switzerland, CH 3010 Principal Investigator: Maja STEINLIN, DR Kinderspital Zurich Recruiting Zurich, Switzerland, 8032 Principal Investigator: Andrea KLEIN United Kingdom John Radcliffe Hospital Recruiting Oxford, United Kingdom, 0X3 9DU Contact: PIKE Michael, dr Principal Investigator: PIKE Michael, dr 收起 << |
NCT00060554 | Myocardial Infarction ... 展开 >> Coronary Disease 收起 << | Phase 2 | Withdrawn(Drug sold to Sanofi-... 展开 >>Aventis who sold it to GSK; OBS no longer owns study and does not have data.) 收起 << | - | - |
NCT00050973 | Non-small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT00169156 | Untreated T-cell Angioimmunobl... 展开 >>astic Lymphoma 收起 << | Phase 2 | Completed | - | France ... 展开 >> Hôpital Henri Mondor Créteil, France Hôpital Saint Louis Paris, France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Henri Becquerel Rouen, France 收起 << |
NCT00324155 | - | Completed | - | - | |
NCT01196208 | - | - | - | - | |
NCT00731263 | Solid Tumors | Phase 1 | Completed | - | United States, New York ... 展开 >> Research Site New York, New York, United States, 10065 United States, Texas Research Site Houston, Texas, United States France Research Site Clichy, France United Kingdom Research Site Sutton, Surrey, United Kingdom 收起 << |
NCT00479583 | Cancer | Phase 1 | Completed | - | United States, Alabama ... 展开 >> University Of Alabama At Birmingham Birmingham, Alabama, United States, 35294 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 France Local Institution Saint-Herblain Cedex, France, 44805 Local Institution Villejuif, France, 94805 收起 << |
NCT02146430 | Pain Associated With Fibromyal... 展开 >>gia 收起 << | Phase 3 | Completed | - | - |
NCT02118896 | Kidney Transplantation ... 展开 >> Liver Transplantation Heart Transplantation 收起 << | Phase 3 | Completed | - | - |
NCT00251433 | Neoplasms, Breast | Phase 1 | Active, not recruiting | December 31, 2019 | United States, Tennessee ... 展开 >> Novartis Investigative Site Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Paris Cedex 10, France, 75475 Novartis Investigative Site Paris Cedex 5, France, 75248 Ireland Novartis Investigative Site Dublin, Ireland, 4 Novartis Investigative Site Dublin, Ireland, 8 收起 << |
NCT02348723 | - | Completed | - | - | |
NCT00136591 | Follicular Lymphoma | Phase 2 | Terminated(An arm closed due t... 展开 >>o lack of efficacy) 收起 << | - | Belgium ... 展开 >> Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France 收起 << |
NCT01192347 | - | Completed | - | France ... 展开 >> GH Pitie Salpetriere Paris, Cedex 13, France, 75651 CH DU Pays D Aix Aix En Provence, Cedex 1, France, 13616 Hopital Dupuytren Limoges, Cedex 1, France, 87042 Hopital Emile Muller Mulhouse, Cedex 1, France, 68070 Hopital Hotel Dieu Et Hme Nantes, Cedex 1, France, 44093 Hopital Tenon Paris, Cedex 20, France, 75970 Nouvelles Cliniques Nantaises Nantes, Cedex 2, France, 44277 Hopital Hautepierre Strasbourg, Cedex 2, France, 67098 Hopital De L Archet Nice, Cedex 3, France, 6202 Clinique Du Parc Caen, Cedex 4, France, 14052 Hotel Dieu Angers, Cedex 9, France, 49933 CH Departemental Des Oudairies La Roche Sur Yon, Cedex 9, France, 85925 Hopital Pontchaillou Rennes, Cedex 9, France, 35033 Hia Sainte Anne Toulon, Cedex 9, France, 83041 Ch D Arras Arras, Cedex, France, 62022 Hopital Robert Ballanger Aulnay Sous Bois, Cedex, France, 93602 CH De Blois Blois, Cedex, France, 41016 Ch De Fleyriat Bourg En Bresse, Cedex, France, 1012 CME Brest, Cedex, France, 29609 Hopital Augustin Morvan Brest, Cedex, France, 29609 Ch De Brive La Gaillarde Brive La Gaillarde, Cedex, France, 19312 Hopital Henri Mondor Creteil, Cedex, France CH De Bicetre Le Kremlin Bicetre, Cedex, France, 94275 CHRU Lille - Hopital Huriez Lille, Cedex, France, 59037 Hopital Saint Philibert Lomme, Cedex, France, 59462 Hopital Edouard Herriot Lyon, Cedex, France, 69437 Institut J Paoli Calmettes Marseille, Cedex, France, 13273 Hopital N D Bon Secours Metz, Cedex, France, 57038 Clinique Pont de Chaume Montauban, Cedex, France, 82017 Hopital Saint Antoine Paris, Cedex, France, 41016 GH Pitie Salpetriere Paris, Cedex, France, 75651 Hopital Saint Jean Perpignan, Cedex, France, 66046 Hopital De Haut Leveque Pessac, Cedex, France, 33604 CHI Poissy Saint German en Laye Poissy, Cedex, France, 78303 Chi De Cornouaille Quimper, Cedex, France, 29107 Hopital de La Maison Blanche Reims, Cedex, France, 51092 Institut de Cancerologie de la Loire Saint Priest En Jarez, Cedex, France, 42271 Hopital Font Pre Toulon, Cedex, France, 83056 Hopitaux de Brabois Vandoeuvre Les Nancy, Cedex, France, 54511 Ch De Vendome Vendome, Cedex, France, 41106 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33300 Hopital Robert Boulin Libourne, France, 33505 CHU Nord - Chemin Des Bourrely Marseille, France, 13015 CHRA Metz Tessy, France, 74370 Cabinet D'Hematologie Perpignan, France, 66000 Centre De Radiotherapie Strasbourg, France, 67000 收起 << | |
NCT01192347 | - | Completed | - | - | |
NCT00560391 | Multiple Myeloma | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Arizona Scottsdale, Arizona, United States, 85259 Australia, Victoria Local Institution Prahran, Victoria, Australia, 3181 France Local Institution Toulouse Cedex 03, France, 31059 Local Institution Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT01214018 | - | Terminated(No recruitment) | - | France ... 展开 >> CH Henry Duffaut Avignon, France, 84902 Centre Hospitalier Général Beziers, France, 34525 Hôpital Guy de Chauliac, CHU de Montpellier Montpellier Cedex 05, France, 34295 Centre Hospitalier Universitaire de Nîmes Nimes, France, 30029 收起 << | |
NCT01890993 | - | Completed | - | France ... 展开 >> Paris La défense cedex, France, 92932 Germany Mainz, Germany, 55127 Spain Madrid, Spain, 28033 United Kingdom Crawley, United Kingdom, RH11 9RT 收起 << | |
NCT00560391 | - | Completed | - | - | |
NCT00083889 | Carcinoma, Renal Cell | Phase 3 | Completed | - | - |
NCT02118896 | - | Completed | - | - | |
NCT02983045 | Melanoma Rena... 展开 >>l Cell Carcinoma Non Small Cell Lung Cancer Urothelial Carcinoma Triple Negative Breast Cancer 收起 << | Phase 1 Phase 2 | Recruiting | June 2021 | - |
NCT02348723 | Atrial Fibrillation | Phase 4 | Completed | - | - |
NCT00137449 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Pfizer Investigational Site Boston, Massachusetts, United States, 02115 France Pfizer Investigational Site Lyon Cedex 08, France, 69373 Pfizer Investigational Site Villejuif, France, 94805 Italy Pfizer Investigational Site Milano, Italy, 20133 收起 << |
NCT01021436 | Pneumonia | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Birminghan, Alabama, United States, 35233 United States, Ohio Cincinnati, Ohio, United States, 45267 United States, Tennessee Memphis, Tennessee, United States, 38163 United States, Texas Houston, Texas, United States, 77030 France Paris, Cedex 13, France, 75651 Limoges, Cedex, France, 87046 收起 << |
NCT00257205 | Melanoma | Phase 3 | Completed | - | - |
NCT01544231 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHU de Nice - Hôpital St-Roch Nice, France, 06006 APHP - Groupe Hospitalier Pitié-Salpetrière Paris Cedex 13, France, 75651 Hôpital Interarmées Sainte Anne Toulon, France, 83800 收起 << | |
NCT03464344 | Cerebral Amyloid Angiopathy | Not Applicable | Recruiting | October 2022 | France ... 展开 >> Pellegrin Hospital Not yet recruiting Bordeaux, France Contact: Igor SIBON Gui de Chauliac Hospital Not yet recruiting Montpellier, France Contact: Caroline ARQUIZAN Lariboisière Hospital Not yet recruiting Paris, France Contact: Eric JOUVENT CHU Purpan. Hôpital Pierre-Paul Riquet Recruiting Toulouse cedex 9, France, 31059 Contact: Nicolas RAPOSO, MD Sub-Investigator: Christophe Cognard, PHD Sub-Investigator: Jacques Izopet, PHD Sub-Investigator: Claire Thalamas, MD 收起 << |
NCT00886782 | Advanced Solid Cancers ... 展开 >> Metastatic Cancer 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Canada, Ontario Local Institution Toronto, Ontario, Canada, M5G 2M9 France Local Institution Villejuif Cedex, France, 94800 收起 << |
NCT00083889 | - | Completed | - | - | |
NCT00137449 | - | Completed | - | - | |
NCT01213069 | - | Completed | - | France ... 展开 >> AP-HM Hôpital Nord Marseille, France, 13915 Hôpital Guy de Chauliac, CHU de Montpellier Montpellier Cedex 05, France, 34295 Hôpital Cimiez, CHU de Nice Nice, France, 06003 Centre Hospitalier Universitaire de Nîmes Nimes, France, 30029 收起 << | |
NCT01191801 | - | Completed | - | - | |
NCT01191801 | Acute Myeloid Leukemia | Phase 3 | Completed | - | - |
NCT03597022 | Hemophilia A and B | Phase 2 | Recruiting | May 29, 2020 | - |
NCT01232556 | Lymphoma, Non-Hodgkin | Phase 3 | Terminated(The study was termi... 展开 >>nated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified.) 收起 << | - | - |
NCT01232556 | - | Terminated(The study was termi... 展开 >>nated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified.) 收起 << | - | - | |
NCT00659438 | Prostate Cancer | Phase 2 | Completed | - | France ... 展开 >> Research Site Bordeaux Cedex, France Research Site Creteil, France Research Site Paris, France Research Site Reims Cedex, France Research Site Villejuif, France 收起 << |
NCT03316885 | Cataract | Not Applicable | Active, not recruiting | July 2021 | Australia, Victoria ... 展开 >> Alcon Investigative Site Footscray, Victoria, Australia, 3011 Alcon Investigative Site Mornington, Victoria, Australia, 3931 Australia Alcon Investigative Site Sydney, Australia, 2067 France Alcon Investigative Site Brest, Cedex, France, 29609 Alcon Investigative Site Lyon, France, 69003 Alcon Investigative Site Paris, France, 75014 Germany Alcon Investigative Site Frankfurt, Germany, 60590 Alcon Investigative Site Heidelberg, Germany, 69120 Italy Alcon Investigative Site Perugia, Italy, 06129 Alcon Investigative Site Pisa, Italy, 56124 Netherlands Alcon Investigative Site Amsterdam, Netherlands, 1105AZ Spain Alcon Investigative Site Jerez De La Frontera, Cadiz, Spain, 11408 Alcon Investigative Site Alcalá De Henares, Spain, 28805 Alcon Investigative Site Oviedo, Spain, 33012 Alcon Investigative Site San Sebastián, Spain, 20014 Alcon Investigative Site Valencia, Spain, 46015 United Kingdom Alcon Investigative Site Sutton, Carshalton, United Kingdom, SM5 1AA Alcon Investigative Site Brighton, United Kingdom, BN2 5BF Alcon Investigative Site London, United Kingdom, EC1V2PD 收起 << |
NCT00441155 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 France Novartis Investigative Site Lyon Cedex, France, 69373 Italy Novartis Investigative Site Milano, MI, Italy, 20133 收起 << |
NCT00254579 | Refractory Melanoma | Phase 2 | Completed | - | - |
NCT01552629 | Atopic Dermatitis | Phase 2 | Completed | - | Austria ... 展开 >> Novartis Investigative Site Vienna, Austria France Novartis Investigative Site Nice Cedex 3, France, 06202 Germany Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Kiel, Germany, 24105 收起 << |
NCT00261443 | - | Completed | - | - | |
NCT00659438 | - | Completed | - | - | |
NCT00261443 | Bipolar Disorder | Phase 4 | Completed | - | - |
NCT03028740 | Nonalcoholic Steatohepatitis | Phase 3 | Recruiting | July 31, 2024 | - |
NCT01167803 | Obesity | Phase 4 | Completed | - | France ... 展开 >> CHU de Clermont Ferrand - Hôpital Estaing Clermont Ferrand, France, 63000 CHRU de Lille - Hôpital Claude Huriez Lille, France, 59037 CHU de Montpellier - Hôpital Saint-Eloi Montpellier Cedex 5, France, 34295 CHU de Nice - Hôpitaux L'Archet 1 et 2 Nice, France, 06202 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes, France, 30029 CHU de Poitiers Poitiers Cedex, France, 86021 收起 << |
NCT02281318 | Asthma | Phase 3 | Completed | - | - |
NCT03343613 | Solid Tumor N... 展开 >>on Small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck Urothelial Carcinoma Brain Metastasis 收起 << | Phase 1 | Recruiting | December 7, 2020 | United States, Indiana ... 展开 >> IU Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact 317-278-8845 Principal Investigator: Bert H O'Neil United States, Tennessee Sarah Cannon Research Institute SCRI Recruiting Nashville, Tennessee, United States, 37203 Contact 615-329-7615 Principal Investigator: SMO Sarah Cannon Research Inst. Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact 6153297274 Principal Investigator: Johanna Chock Bendell Belgium Institut Jules Bordet Recruiting Brussel, Belgium, 1000 Contact 3225412739 Principal Investigator: Sandrine ASPESLAGH France Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Contact 33142114338 Principal Investigator: Christophe Massard 收起 << |
NCT02281318 | - | Completed | - | - | |
NCT02641392 | Crohn's Disease | Phase 3 | Terminated(Study terminated by... 展开 >> Sponsor following a recommendation from external DMC based on lack of emerging benefit; there were no new emergent safety findings) 收起 << | - | - |
NCT00696527 | - | Completed | - | - | |
NCT02869789 | Lung Cancer | Phase 4 | Recruiting | November 17, 2021 | - |
NCT00163215 | Endocrine System Diseases | Phase 3 | Completed | - | France ... 展开 >> Pfizer Investigational Site Annemasse Cedex, France, 74107 Pfizer Investigational Site Besancon, France, 25030 Pfizer Investigational Site Bordeaux, France, 33000 Pfizer Investigational Site Bordeaux, France, 33076 Pfizer Investigational Site Bron Cedex, France, 69677 Pfizer Investigational Site Dijon, France, 21000 Pfizer Investigational Site Grenoble Cedex, France, 38043 Pfizer Investigational Site Lorient, France, 56100 Pfizer Investigational Site Lyon Cedex 05, France, 69322 Pfizer Investigational Site Marseille, France, 13385 Pfizer Investigational Site Montpellier, France, 34059 Pfizer Investigational Site Paris, France, 75015 Pfizer Investigational Site Paris, France, 75019 Pfizer Investigational Site Paris, France, 75571 Pfizer Investigational Site Paris, France, 75674 Cedex Pfizer Investigational Site PRINGY Cedex, France, 74374 Pfizer Investigational Site Toulouse Cedex, France, 31026 Pfizer Investigational Site Vandoeuvre Les Nancy Cedex, France, 54511 收起 << |
NCT01231295 | - | Completed | - | France ... 展开 >> CHU d'Amiens - Hôpital Sud Amiens Cedex 1, France, 80054 CHU d'Angers - Hôtel-Dieu Angers, France, 49933 CHU de Besançon - Hôpital Jean Minjoz Besançon, France, 25030 CHU de Bordeaux - Groupe Hospitalier Pellegrin Bordeaux, France, 33076 APHP - Hôpital Albert Chenevier Creteil Cedex, France, 94010 APHP - Hôpital Charles Foix Ivry Sur Seine Cedex, France, 94205 CHRU de Lille - Hôpital Claude Huriez Lille, France, 59037 CHRU de Lille - Hôpital Roger Salengro Lille, France, 59037 APHP - Hôpital Emile Roux Limeil Brevannes Cedex, France, 94456 APHM - Hôpital La Timone Adultes Marseille cedex 5, France, 13385 CHU de Montpellier - Hôpital Gui de Chauliac Montpellier Cedex 5, France, 34295 CHU de Nancy - Hôpital Central Nancy, France, 54035 CHU de Nice - Hôpitaux L'Archet 1 et 2 Nice, France, 06202 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 APHP - Groupe Hospitalier Pitié-Salpetrière Paris cedex 13, France, 75651 APHP - Hôpital Lariboisière Paris, France, 75010 APHP - Hôpital Broca Paris, France, 75013 Groupe Hospitalier Paris Saint-Joseph Paris, France, 75014 CHU de Poitiers Poitiers, France, 86021 CHU de Reims - Hôpital Maison Blanche Reims, France, 51092 CHU de Rouen - Hôpital Charles Nicolle Rouen, France, 76031 CHRU de Strasbourg - Hôpital de Hautepierre Strasbourg, France, 67098 CHRU de Toulouse - Hôpital Garonne Toulouse cedex 9, France, 31059 CHRU de Toulouse - Hôpital Purpan Toulouse Cedex 9, France, 31059 CHRU de Tours - Hôpital Bretonneau Tours, France, 37044 收起 << | |
NCT02293265 | Asthma | Phase 3 | Completed | - | - |
NCT00163215 | - | Completed | - | - | |
NCT02907177 | Multiple Sclerosis | Phase 3 | Recruiting | March 31, 2020 | - |
NCT02715804 | Stage IV Pancreatic Ductal Ade... 展开 >>nocarcinoma 收起 << | Phase 3 | Recruiting | December 31, 2019 | - |
NCT03053297 | - | Terminated(Cancelled due to ch... 展开 >>anges in the scientific landscape. Decision was made after thorough evaluation of of pros&cons, ethical as well as regulatory consideration) 收起 << | - | - | |
NCT03189875 | - | Recruiting | June 30, 2022 | - | |
NCT03404726 | Leukemia | Phase 1 | Recruiting | December 14, 2020 | United States, New York ... 展开 >> Montefiore Medical Center Recruiting Bronx, New York, United States, 10467-2490 Memorial Sloan-Kettering Cancer Center Recruiting New York, New York, United States, 10065 United States, Pennsylvania Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Vanderbilt University Medical Center Not yet recruiting Nashville, Tennessee, United States, 37232 France Institut Gustave Roussy Recruiting Villejuif Cedex, France, 94805 收起 << |
NCT02555787 | - | Active, not recruiting | March 2023 | - | |
NCT02516241 | Urothelial Cancer | Phase 3 | Recruiting | September 23, 2019 | - |
NCT01528085 | Philadelphia Chromsome Positiv... 展开 >>e Acute Lymphoblastic Leukemia 收起 << | Phase 2 | Unknown | November 2018 | - |
NCT02258542 | Asthma | Phase 3 | Completed | - | - |
NCT02465515 | Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT03112603 | Graft-versus-host Disease (GVH... 展开 >>D) 收起 << | Phase 3 | Recruiting | January 2022 | - |
NCT03123393 | Diffuse Large B-cell Lymphoma | Phase 2 | Recruiting | August 31, 2021 | - |
NCT02808819 | Asthma | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT02746146 | Kidney Failure, Chronic | Not Applicable | Recruiting | April 5, 2019 | France ... 展开 >> Clinique Claude Bernard Not yet recruiting Albi, France, 81000 Sub-Investigator: Aleandra Duhem, MD AIDER - Unité de Dialyse d'Alès Not yet recruiting Alès, France, 30100 Sub-Investigator: Médérick Mohajer, MD CH d'Auch Not yet recruiting Auch, France, 32008 Sub-Investigator: Djelaleddine Benyakoub, MD Centre d'Hemodialyse Languedoc Méditérranéen Not yet recruiting Béziers, France, 34500 Sub-Investigator: Alexandre Dumoulin, MD Medipole Grand Sud St Roch Not yet recruiting Cabestany, France, 66330 Sub-Investigator: Hugo Weclawiak, MD CH de Cahors Not yet recruiting Cahors, France Contact: GOURMALA Asma CH de Carcassonne Not yet recruiting Carcasonne, France, 11000 Sub-Investigator: Charles Cartou, MD NephroCare Not yet recruiting Castelnau le Lez, France, 34170 Sub-Investigator: Sébastien Deleuze, MD AAIR Midi-Pyrénées Not yet recruiting Colomiers, France Contact: PILLET Adéle Centre Hospitalier Intercommunal du Val d'Ariège Not yet recruiting Foix Cedex, France, 09017 Sub-Investigator: Mamadou Cellou Balde, MD Clinique du Pont de Chaume Not yet recruiting Montauban, France, 82017 Sub-Investigator: Anne-Gaëlle Gosse, MD AIDER de Montpellier Not yet recruiting Montpellier, France, 34295 Contact: TURC-BARON Cécile CHRU de Montpellier - Hôpital Lapeyronie Not yet recruiting Montpellier, France, 34295 Sub-Investigator: Georges Mourad, MD, PhD Sub-Investigator: Leila Chenine, MD Sub-Investigator: Hélène Leray Moragues, MD Clinique de l'Occitanie Recruiting Muret Cedex, France, 31603 Sub-Investigator: Emilie Girardot, MD Polyclinique Le Languedoc Not yet recruiting Narbonne, France, 11000 Sub-Investigator: François de Cornelissen, MD CHRU de Nîmes - Hôpital Universitaire Carémeau Not yet recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Olivier Moranne, MD, PhD Sub-Investigator: Emilie Pambrun, MD Sub-Investigator: Benoit De Wazière, MD, PhD AIDER - Unité de Dialyse de Nîmes Recruiting Nîmes Cedex 9, France, 30029 Sub-Investigator: Laure Patrier, MD Gardialyse Not yet recruiting Nîmes, France, 30900 Sub-Investigator: Philippe Rousseau, MD CH de Perpignan - Hôpital Saint Jean Not yet recruiting Perpignan, France, 66046 Sub-Investigator: Carlos Vela, MD Centre Hospitalier Jacques Puel Not yet recruiting Rodez, France, 12000 Sub-Investigator: Mustapha Amirou, MD CH de Bigorre Not yet recruiting Tarbes Cedex 9, France, 65013 Sub-Investigator: Michèle Hemery, MD Clinique Néphrologique Saint-Exupéry Not yet recruiting Toulouse Cedex 4, France, 31077 Sub-Investigator: Olivier Milioto, MD CHRU de Toulouse - Hôpital de Rangueil Not yet recruiting Toulouse Cedex 9, France, 31059 Sub-Investigator: Nassim Kamar, MD, PhD CHRU de Toulouse - Hôpital Larrey Not yet recruiting Toulouse Cedex 9, France, 31059 Sub-Investigator: Bruno Seigneuric, MD CHRU de Toulouse - Hôptal Casselardit Not yet recruiting Toulouse Cedex 9, France, 31059 Sub-Investigator: Laurent Balardy, MD 收起 << |
NCT02116413 | - | Completed | - | France ... 展开 >> CHU d'Amiens - Hôpital Nord Amiens Cedex 1, France, 80054 CHU de Besançon - Hôpital Jean Minjoz Besançon, France, 25030 CHU de Caen - Hôpital Côte de Nacre Caen Cedex 9, France, 14033 CHU de Clermont Ferrand - Hôpital Estaing Clermont Ferrand, France, 63003 CHU de Clermont Ferrand - Hôpital Gabriel-Montpied Clermont Ferrand, France, 63003 APHM - Hôpital Nord Marseille Cedex 20, France, 13915 CHU de Nantes - Hôpital Guillaume et René Laennec Nantes, France, 44093 CHU de Nice - Hôpital St-Roch Nice Cedex 1, France, 06001 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 收起 << | |
NCT02625610 | Unresectable, Locally Advanced... 展开 >> or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction 收起 << | Phase 3 | Active, not recruiting | March 11, 2024 | - |
NCT02603432 | Urothelial Cancer | Phase 3 | Recruiting | July 24, 2020 | - |
NCT02517398 | Solid Tumors | Phase 1 | Recruiting | July 1, 2019 | - |
NCT02428543 | Acute Myeloid Lukemia | Phase 1 Phase 2 | Recruiting | September 2020 | France ... 展开 >> Dr Abdelaziz CHAIB Recruiting Aix-en-Provence, France, 13600 Contact: Abdelaziz CHAIB achaib@ch-aix.fr Principal Investigator: Abdelaziz CHAIB Chu Amiens Recruiting Amiens, France, 80054 Contact: MAROLLEAU Jean Pierre Principal Investigator: MAROLLEAU Jean Pierre CHU d'Angers Recruiting Angers, France, 49033 Contact: Martine GARDEMBAS Magardembas@chu-angers.fr Principal Investigator: Martine GARDEMBAS Hôpital VICTOR DUPOUY Recruiting Argenteuil, France, 95107 Contact: AL JIJAKLI Ahmad ahmad.aljijakli@ch-argenteuil.fr Principal Investigator: AL JIJAKLI Ahmad Dr Edouard RANDIAMALALA Recruiting Bayonne, France, 64100 Contact: Edouard RANDIAMALALA erandiamalala@ch-cotebasque.fr Principal Investigator: Edouard RANDIAMALALA CHU de Besançon Recruiting Besançon, France, 25030 Contact: Fabrice LAROSA flarosa@chu-besançon.fr Principal Investigator: Fabrice LAROSA Dr Thorsten BRAUN Recruiting Bobigny, France, 93000 Contact: Thorsten BRAUN thorsten.braun@aphp.fr Principal Investigator: Thorsten BRAUN CHU Boulogne Sur Mer Recruiting Boulogne Sur Mer cedex, France, 62321 Contact: CHOUFI Bachra b.choufi@ch-boulogne.fr Principal Investigator: CHOUFI Bachra Chr Clemenceau Recruiting Caen Cedex, France, 14033 Contact: REMAN Oumédaly reman-o@chu-caen.fr Principal Investigator: REMAN Oumédaly Hôpital d'Instruction des Armées PERCY Recruiting Clamart, France, 92141 Contact: Jean Valère MALFUSSON jvmalf@free.fr Principal Investigator: Jean Valère MALFUSSON Dr Stéphanie HAÏAT Recruiting Corbeil-essonnes, France, 91100 Contact: Stéphanie HAÏAT Principal Investigator: Stéphanie HAÏAT Hôpital Henri Mondor Recruiting Créteil, France, 94010 Contact: PAUTAS Cécile cecile.pautas@hmn.aphp.fr Principal Investigator: PAUTAS Cécile CHU de Dijon Not yet recruiting Dijon, France, 21079 Contact: CAILLOT Denis denis.caillot@chu-dijon.fr Principal Investigator: CAILLOT Denis Centre hospitalier de Versailles Recruiting Le Chesnay cedex, France, 78157 Contact: Rousselot Philippe 003339638622 phrousselot@ch-versailles.fr Principal Investigator: Rousselot Philippe Hôpital Claude Huriez Recruiting Lille cedex, France, 59037 Contact: QUESNEL Bruno bquesnel@chru-lille.fr Principal Investigator: QUESNEL Bruno CHRU Dupuytren Not yet recruiting Limoges cedex, France, 87042 Contact: TURLURE Pascal pascal.turlure@chu-limoges.fr Principal Investigator: TURLURE Pascal Hôpital Edouard Herriot Recruiting Lyon cedex 03, France, 69437 Contact: THOMAS Xavier xavier.thomas@chu-lyon.fr Principal Investigator: THOMAS Xavier Dr Regis COSTELLO Recruiting Marseille, France, 13000 Contact: Regis COSTELLO regis.costello@ap-hm.fr Principal Investigator: Regis COSTELLO Centre Hospitalier de Meaux Recruiting Meaux, France, 77104 Contact: FRAYFER Jamilé j-frayfer@ch-meaux.fr Principal Investigator: FRAYFER Jamilé Dr Mario OJEDA-URIBE Recruiting Mulhouse, France, 68000 Contact: Mario OJEDA-URIBE ojedam@ch-mulhouse.fr Principal Investigator: Mario OJEDA-URIBE Dr Jacques DELAUNAY Recruiting Nantes, France, 44000 Contact: Jacques DELAUNAY jacques.delaunay@chu-nantes.fr Principal Investigator: Jacques DELAUNAY CHU Nice, Hôpital Archet 1 Recruiting Nice cedex 3, France, 06202 Contact: MANNONE Lionel mannone.l@chu-nice.fr Principal Investigator: MANNONE Lionel CHU de Nîmes Recruiting Nîmes, France, 30029 Contact: Eric JOURDAN eric.jourdan@chu-nimes.fr Principal Investigator: Eric Jourdan Hôpital Saint Antoine Recruiting Paris cedex 12, France, 75751 Contact: ISNARD Françoise francoise.isnard@sat.aphp.fr Principal Investigator: ISNARD Françoise Hôpital Necker Enfants Malades Recruiting Paris cedex 15, France, 75743 Contact: SUAREZ Felipe felipe.suarez@nck.aphp.fr Principal Investigator: SUAREZ Felipe Hôpital Saint Louis Recruiting Paris, France, 75010 Contact: RAFFOUX Emmanuel emmanuel.raffoux@sls.ap-hop-paris.fr Principal Investigator: RAFFOUX Emmanuel Hôpital La Pitié Salpêtrière Recruiting Paris, France, 75013 Contact: UZUNOV Madalina madalina.uzunov@psl.aphp.fr Principal Investigator: UZUNOV Madalina Dr Laurence SANHES Suspended Perpignan, France, 66000 Dr Arnaud PIGNEUX Recruiting Pessac, France, 33604 Contact: Arnaud PIGNEUX arnaud.pigneux@chu-bordeaux.fr Principal Investigator: Arnaud PIGNEUX Centre Hospitalier René Dubos Recruiting Pontoise Cedex, France, 95303 Contact: VAIDA Iona Dana ioana.vaida@ch-pontoise.fr Principal Investigator: VAIDA Iona Dana Marc BERNARD Recruiting Rennes, France, 35000 Contact: Marc BERNARD marc.bernard@chu-rennes.fr Principal Investigator: Marc BERNARD Dr Emilie LEMASLE Recruiting Rouen, France, 76000 Contact: Emilie LEMASLE emilie.lemasle@chb.unicancer.fr Principal Investigator: Emilie LEMASLE Centre Hospitalier René Huguenin Suspended Saint Cloud, France, 92210 Institut de Cancérologie de la Loire Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Emmanuelle TAVERNIER-TARDY emmanuelle.tavernier@icloire.fr Principal Investigator: Emmanuelle TAVERNIER-TARDY Dr Réda GARIDI Recruiting Saint-Quentin, France, 02100 Contact: Réda GARIDI Principal Investigator: Réda GARIDI Dr Christian RECHER Recruiting Toulouse, France, 31000 Contact: Christian RECHER Principal Investigator: Christian RECHER Centre Hospitalier de Valenciennes Recruiting Valenciennes, France, 59322 Contact: FERNANDES José fernandes-j@ch-valenciennes.fr Principal Investigator: FERNANDES José 收起 << |
NCT02576574 | First Line Non-Small Cell Lung... 展开 >> Cancer 收起 << | Phase 3 | Active, not recruiting | September 5, 2024 | - |
NCT00933296 | - | Completed | - | France ... 展开 >> CHU de Besançon Service de Dermatologie Besancon, France Service de DermatologieCHU Morvan5 avenue Foch BREST Cedex, France, 29609 Centre Hospitalier Général Bd Yves du Manoir DAX, France Service de Rhumatologie Centre Hospitalier du Mans Le Mans Cedex 9, France, 72037 Service de Médecine Interne Hôpital Claude-Huriez Lille, France Service de DermatologieHôtel Dieu LYON Cedex 02, France, 69288 Service médecine interne et thérapeutique Hôpital sainte marguerite Marseille Cedex 09, France, 13274 Service de Dermatologie Hôpital Saint Eloi 80 avenue A Fliche MONTPELLIER cedex 5, France, 34295 Service de dermatologie CHU Hôtel Dieu1 place Alexis Ricordeau Nantes, France, 44093 Unité de médecine interne Centre Hospitalier G. Renon Niort, France, 79021 Service de médecine interne Hôpital Tenon4, rue de la Chine PARIS Cedex 20, France, 75970 Service d'immuno-hématologie Hôpital St-Louis 1 av Claude Vellefaux Paris, France, 75010 Service de dermatologieCHU GUERIN2 rue de la Milétrie POITIERS Cedex, France, 86021 BOYE Thierry Toulon, France, 83041 Service de médecine interne-néphrologie Centre Hospitalier Valenciennes Valenciennes, France, 59322 Italy Azienda Ospedaliero Universitaria Policlinico Bari, Italy, 70122 Clinica DermatologicaUnivesité de GênesVialle Benedetto Genova, Italy, 716132 收起 << | |
NCT01457768 | - | Completed | - | - | |
NCT02483416 | - | Terminated(Poor recruitment) | - | France ... 展开 >> CLI Dr Calabet, Oncolgie, Agen Agen, France, 47000 HOP Centre Hospitalier Pays d'Aix, Pneumo, Aix en Provence Aix en Provence cedex 1, France, 13616 CLI Polyclinique du Parc Rambot, Pneumo, Aix en Provence Aix en Provence, France, 13617 HOP Centre Marie Curie, Onco, Arras Arras, France, 62000 CLI Bordeaux Nord Aquitaine Bordeaux, France, 33000 CLI Tivoli Bordeaux, France, 33000 CH, Oncologie, Brive la Gaillarde, Brive La Gaillarde cedex, France, 19312 HOP Louis Pradel Bron cedex, France, 69677 HOP Centre Hospitalier de Béziers, Pneumo, Béziers Béziers, France, 34500 CLI du Parc, Pneumo, Castelnau le Lez Castelnau le lez, France, 34170 Centre médical N de Pontoux, Oncologie, Chalon sur Saône Chalons Sur Saône, France, 71100 HOP de Chauny Chauny, France, 02303 Centre Hospitalier Intercommunal, Oncolgie, Crétail Creteil cedex, France, 94010 HOP La Dracénie, Onco, Draguignan Draguignan, France, 83300 HOP CHD La Roche sur Yon - Montaigu - Luçon, Pneumo La Roche Sur Yon cedex, France, 85925 HOP CH Emile Roux Le Puy, Pneumo, Le puy en Velay Le Puy en Velay, France, 43000 HOP Hôpital Robert Boulin, Pneumo, Libourne Libourne, France, 33500 HOP Saint Joseph et Saint Luc, Pneumo, Lyon Lyon cedex 07, France, 69365 Hopital Privé Jean Mermoz Lyon, France, 69008 CHG, Oncologie, Meaux Meaux cedex, France, 77104 CLI Clémentville Montpellier, France, 34070 HOP Centre Hospitalier de Mulhouse, Pneumo, Mulhouse Mulhouse, France, 68100 CTR d'Oncologie de Gentilly, Onco, Nancy Nancy, France, 54100 CLI Polyclinique le Languedoc, Narbonne Narbonne cedex, France, 11108 CLI Polyclinique le Languedoc, Narbonne Narbonne, France, 11100 CLI Saint-Pierre, Oncologie, Perpignan Perpignan, France, 66000 CHR d'Annecy, Oncologie, Annecy Pringy, France, 74374 HOP Cornouaille, Pneumo, Quimper Quimper, France, 29000 CLI Les Bleuets, Pneumologie, Reims Reims, France, 51100 HOP Centre Hospitalier de Saint Quentin, Pneumo, St-Quentin Saint-Quentin cedex, France, 02321 HOP Hôpitaux du Léman Thonon les Bains, France, 74203 HOP HIA Saint-Anne Toulon, France, 83800 CLI Pasteur Toulouse, France, 31076 CLI Pasteur Toulouse, France, 31300 Centre de Radiothérapie Marie Curie Valence, France, 26000 HOP Nord Ouest de Villefranche, oncologie, Gleize Villefranche sur Saône Cedex, France, 69655 收起 << | |
NCT00987506 | - | Completed | - | - | |
NCT02476006 | Hypercholesterolemia | Phase 3 | Active, not recruiting | March 27, 2019 | - |
NCT02733042 | Lymphoma Leuk... 展开 >>emia, Lymphocytic, Chronic, B-Cell 收起 << | Phase 1 Phase 2 | Active, not recruiting | July 8, 2022 | - |
NCT02140736 | - | Completed | - | - | |
NCT02565914 | Cystic Fibrosis | Phase 3 | Enrolling by invitation | September 2019 | - |
NCT01457755 | - | Completed | - | - | |
NCT02932618 | Von Willebrand Disease | Phase 3 | Recruiting | May 29, 2020 | - |
NCT02596893 | Crohn Disease | Phase 3 | Terminated(Study terminated by... 展开 >> Sponsor following a recommendation from external DMC based on lack of emerging benefit; there were no new emergent safety findings) 收起 << | - | - |
NCT02369731 | - | Recruiting | April 2022 | Austria ... 展开 >> Krankenhaus der Barmherzigen Schwestern Linz Recruiting Linz, Austria, 4010 Principal Investigator: Veronika Pilshofer, Dr Preyer Children Hospital Recruiting Wien, Austria, 1100 Principal Investigator: Guenther Bernert, Pr France CHU Brest, hôpital Morvan Recruiting Best, France, 29609 Principal Investigator: Ropars Juliette, Dr CHU Bordeaux Pelgrin Recruiting Bordeaux Cedex, France, 33076 Principal Investigator: Caroline Espil-Taris L'Escale Hôpital Femme Mère Enfant- Hospices Civils de Lyon Recruiting Bron, France, 69500 Principal Investigator: Carole Vuillerot, Dr CHU Clermont-Ferrand, hôpital Estaing Recruiting Clermont-Ferrand, France, 63003 Principal Investigator: Catherine Sarret, Dr CHU de Martinique - Hôpital P. Zobda-Quitman Recruiting Fort De France Cedex, France, 97261 Principal Investigator: Rémi Bellance, Dr CHRU de Lille Recruiting Lille Cedex, France, 59037 Principal Investigator: Jean-Marie Cuisset, Dr CHU Marseille Hôpital de la Timone Recruiting Marseille Cedex 5, France, 13385 Principal Investigator: Brigitte Chabrol, Pr CHU Nantes Recruiting Nantes, France, 44000 Principal Investigator: Yan Pereon, Pr Hôpital Armand Trousseau Recruiting Paris, France, 75012 Principal Investigator: Gidaro Teresa, Dr Hôpital Necker Recruiting Paris, France, 75015 Principal Investigator: Isabelle Desguerre, Pr CHU Reims Recruiting Reims, France, 51100 Principal Investigator: Pascal Sabouraud, Dr CHU Saint-Etienne MPR pédiatrique Hôpital Bellevue Recruiting Saint Etienne Cedex, France, 42055 Principal Investigator: Stéphane Chabrier, Dr CHU de la Réunion - GHSR - GH Sud-Réunion Recruiting Saint Pierre, France, 97448 Principal Investigator: Renouil Michel, Dr CHU Strasbourg Recruiting Strasbourg Cedex, France, 67098 Principal Investigator: Vincent Laugel, Pr CHU Toulouse Recruiting Toulouse, France, 31059 Principal Investigator: Pascal Cintas, Dr Hôpital d'enfants Gatien de Clocheville Recruiting Tours Cedex 9, France, 37044 Principal Investigator: Lagrue Emmanuelle, Dr CHU Nancy Hôpital de Brabois-Enfants Rue du Morvan Recruiting Vandoeuvre-les-Nancy, France, 54500 Principal Investigator: Emmanuel Raffo, Pr Germany Klinikum Bayreuth GmbH Recruiting Bayreuth, Germany, 95445 Principal Investigator: Almut Hirsch, Dr Charité Universitätsmedizin Berlin Recruiting Berlin, Germany, 13353 Principal Investigator: Claudia Weiss, Dr Universitätsklinikum Erlangen Recruiting Erlangen, Germany, 91054 Principal Investigator: Regina Trollmann, Pr Universitaetsklinikum Essen (AoR) Recruiting Essen, Germany, 45147 Principal Investigator: Ulrike Schara, Pr SPZ Frankfurt Mitte Recruiting Frankfurt am Main, Germany, 60316 Principal Investigator: Jurgen Seeger, Dr Universitaetsklinikum Freiburg Recruiting Freiburg, Germany, 79106 Principal Investigator: Janbernd Kirschner, Pr UKE, Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Principal Investigator: Jessica Johannsen, Dr Israel Hadassah Medical Center Recruiting Jerusalem, Israel, 91120 Principal Investigator: Talya Dor, Dr Chaim Sheba Medical Center Ramat Gan, Neuromuscle clinic Recruiting Ramat Gan, Israel, 52621 Principal Investigator: Amir Dori, Dr Sweden Queen Silvia Children's Hospital Recruiting Goteborg, Sweden, 41685 Principal Investigator: Mar Tulinius, Pr 收起 << | |
NCT03188965 | Neoplasms | Phase 1 | Recruiting | January 24, 2020 | - |
NCT01551940 | Sialorrhea Am... 展开 >>yotrophic Lateral Sclerosis 收起 << | Phase 2 | Completed | - | France ... 展开 >> Département de Neurologie, Hôpital de l'Hôtel-Dieu, CHU d'Angers Angers cedex 9, France, 49933 Centre SLA, Groupement Hospitalier Est, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon Bron, France, 69677 Service de Neurologie Vastel, Hôpital Côte de Nacre, CHU de Caen Caen cedex 9, France, 14033 Service de Neurologie, Hôpital Gabriel Montpied, CHU de Clermont-Ferrand Clermont-Ferrand cedex 1, France, 63003 Centre SLA, Service de Neurologie A et pathologies du mouvement, Hôpital Roger Salengro, CHU de Lille Lille, France, 59037 Service de Neurologie, Hôpital Dupuytren, CHU de Limoges Limoges, France, 87042 Service de Neurologie, Hôpital de la Timone, CHU de Marseille Marseille cedex 5, France, 13385 Service de Neurologie, Hôpital Central, CHU de Nancy Nancy, France, 54035 Centre de Référence maladies Neuromusculaires, Service de Médecine Physique et Réadaptation, Hôpital de l'Archet 1, CHU de Nice Nice cedex 3, France, 06202 Fédération des Maladies du Système Nerveux, Groupement Hospitalier Pitié Salpêtrière, AP-HP Paris cedex 13, France, 75651 Service de Neurologie, CHU de Saint-Etienne Saint-Etienne cedex 2, France, 42055 Département de Neurologie, Hôpital de Hautepierre, CHRU de Strasbourg Strasbourg, France, 67091 Service d'Explorations Fonctionelles Neuro-Musculaires, Hôpital Rangueil, CHU de Toulouse Toulouse, France, 31059 收起 << |
NCT01559168 | Pelvic Organ Prolapse | Not Applicable | Completed | - | France ... 展开 >> CH Camille Guérin Châtellerault Cedex, France, 86106 CHU de Clermont Ferrand - Hôpital Estaing Clermont Ferrand, France, 63003 CH de Dunkerque Dunkerque, France, 59385 CH de Gonesse Gonesse, France, 95500 CHRU de Lille - Hôpital Jeanne de Flandre Lille Cedex, France, 59037 CHRU de Lyon - Hôpital de la Croix Rousse Lyon Cedex 4, France, 69317 APHM - Hôpital de la Conception Marseille Cedex 5, France, 13385 Clinique Beau Soleil Montpellier, France, 34070 CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 CH Louis Giorgi Orange, France, 84106 CHU de Poitiers Poitiers, France, 86021 Hôpital Foch Suresnes, France, 92150 收起 << |
NCT03158688 | Relapsed or Refractory Multipl... 展开 >>e Myeloma 收起 << | Phase 3 | Active, not recruiting | July 21, 2022 | - |
NCT02913261 | Corticosteroid Refractory Acut... 展开 >>e Graft vs Host Disease 收起 << | Phase 3 | Recruiting | March 8, 2021 | - |
NCT03345823 | Crohn's Disease | Phase 3 | Enrolling by invitation | March 22, 2023 | - |
NCT03345836 | Crohn's Disease | Phase 3 | Recruiting | April 15, 2020 | - |
NCT02974322 | Crohn Disease | Phase 3 | Withdrawn(Sponsor decision not... 展开 >> to start trial) 收起 << | December 24, 2018 | - |
NCT02673047 | - | Completed | - | - | |
NCT03185897 | - | Active, not recruiting | April 30, 2022 | United States, California ... 展开 >> Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States, 90007 United States, Colorado University of Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States, 80045 United States, Michigan Michigan State University East Lansing, Michigan, United States, 48824 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, South Carolina Medical University of South Carolina (MUSC) Charleston, South Carolina, United States, 29425 United States, Texas Gulf States Hemophilia and Thrombophilia Center Houston, Texas, United States, 77030 United States, Washington University of Washington Seattle, Washington, United States, 98104 Austria AKH - Medizinische Universität Wien Vienna, Austria, 1090 France Hôpital Morvan Brest Cedex, France, 29609 Groupement Hospitalier Est- Hôpital Louis Pradel Bron cedex, France, 69677 Groupement Hospitalier Sud - Hôpital Bicêtre Le Kremlin Bicêtre cedex, France, 94275 Hopital Jeanne de Flandre - CHU Lille Lille Cedex, France, 59037 Hôpital de la Timone Marseille Cedex 05, France, 13385 CHU de Nantes Site Hotel Dieu Nantes Cedex 1, France, 44093 Germany Vivantes Klinikum im Friedrichshain Berlin, Germany, 10249 Klinikum der Johann Wolfgang Goethe-Universitaet Frankfurt, Germany, 60590 Italy Presidio Ospedaliero di Castelfranco Veneto Castelfranco Veneto, Italy, 31033 Azienda Ospedaliera Universitaria Careggi Firenze, Italy, 50134 Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico Milano, Italy, 20122 Ospedale San Bortolo di Vicenza Vicenza, Italy, 36100 Spain Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Regional Universitario de Malaga Malaga, Spain, 29010 Hospital Universitario de Salamanca Salamanca, Spain, 37007 收起 << | |
NCT03556202 | Psoriasis | Phase 3 | Recruiting | May 16, 2024 | - |
NCT02785900 | Acute Myeloid Leukemia | Phase 3 | Terminated(Due to safety; spec... 展开 >>ifically a higher rate of deaths, including fatal infections, in the SGN33A arm versus the control arm) 收起 << | - | - |
NCT02785900 | - | Terminated(Due to safety; spec... 展开 >>ifically a higher rate of deaths, including fatal infections, in the SGN33A arm versus the control arm) 收起 << | - | - | |
NCT02541383 | Multiple Myeloma | Phase 3 | Active, not recruiting | August 2024 | - |
NCT03562637 | Triple Negative Breast Cancer | Phase 3 | Recruiting | November 30, 2025 | - |
NCT03535194 | Psoriasis | Phase 3 | Recruiting | April 9, 2020 | - |
NCT03091127 | - | Recruiting | March 17, 2020 | - | |
NCT02454530 | - | Completed | - | - | |
NCT02738125 | - | Recruiting | November 20, 2028 | - | |
NCT03056755 | Breast Cancer | Phase 2 | Recruiting | April 10, 2020 | - |
NCT01901432 | Polycythemia Vera | Phase 1 Phase 2 | Completed | - | France ... 展开 >> CHU Amiens - Hôpital Sud Amiens Cedex 1, France, 80054 Hôpital Morvan - CHRU de Brest Brest Cedex, France, 29609 Hopital Saint Vincent de Paul - GHICL Lille Lille cedex, France, 59020 Hôpital Saint-Louis (AP-HP), Centre Investigations Cliniques Paris Cedex 10, France, 75475 Germany Charite Research Organisation GmbH Berlin, Germany, 10117 Universitaetsklinikum Carl Gustav Carus TU Dresden Dresden, Germany, 01307 Universitaetsklinikum Freiburg Freiburg, Germany, 79106 Universitaetsklinikum Koeln Koeln, Germany, 50937 Italy Azienda ospedaliero universitaria Consorziale Policlinico di Bari Bari, BA, Italy, 70124 Azienda Ospedaliera Papa Giovanni XXIII Bergamo, BG, Italy, 24127 Azienda Ospedaliero-Universitaria Careggi, Florence Florence, FI, Italy, 50134 Fondazione IRCCS Policlinico San Matteo Pavia, PV, Italy, 27100 Istituto Tumori Giovanni Paolo II - IRCCS Ospedale Oncologico di Bari Bari, Italy, 70124 Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico Milano, Italy Università degli Studi di Napoli Federico II, Facoltà di Medicina e Chirurgia Napoli, Italy, 80131 Ospedale Civile dello Spirito Santo Pescara, Italy Azienda Ospedaliero Universitaria Pisana Pisa, Italy, 56126 Azienda Ospedaliera "Bianchi-Melacrino-Morelli" Reggio Calabria, Italy, 89125 Università Campus Bio-Medico di Roma Rome, Italy Ospedale San Bortolo di Vicenza Vicenza, Italy, 36100 Poland SP ZOZ Zespol Szpitali Miejskich w Chorzowie Chorzow, Poland, 41-500 Uniwersyteckie Centrum Kliniczne Gdansk, Poland, 80-952 United Kingdom Belfast City Hospital Belfast, United Kingdom, BT9 7BL Royal London Hospital London, United Kingdom, E1 1BB Royal Cornwall Hospital Truro, United Kingdom, TR1 3LJ 收起 << |
NCT02998476 | Lymphoma | Phase 2 | Active, not recruiting | July 2020 | - |
NCT03170271 | Asthma | Phase 3 | Recruiting | August 13, 2020 | - |
NCT02929329 | Heart Failure | Phase 3 | Recruiting | January 27, 2021 | - |
NCT01305122 | OMS Grade II Glioma | Not Applicable | Active, not recruiting | February 2019 | France ... 展开 >> CH Amiens-Picardie Amiens, France, 80054 Institut de Cancérologie de l'Ouest Angers, France, 49933 Hôpital Jean Minjoz BESANCON Cedex, France, 25030 Hôpital Saint André Bordeaux, France, 33000 Hôpital Neurologique BRON Cedex, France, 69677 Centre Georges François Leclerc DIJON Cedex, France, 21079 Centre Oscar Lambret LILLE Cedex, France, 59037 CHRU de Lille LILLE Cedex, France, 59037 Hôpital d'instruction des armées Desgenettes LYON Cedex 03, France, 69275 Centre Léon Bérard LYON Cedex 08, France, 69373 Hôpital Guy de Chauliac MONTPELLIER Cedex 5, France, 34295 Hôpital Central de Nancy NANCY Cedex, France, 54035 Centre Antoine Lacassagne NICE Cedex 2, France, 06189 Hôpital Pasteur Nice, France, 06000 Hôpital Pitié Salpêtrière PARIS Cedex 13, France, 75651 Centre Hospitalier Lyon Sud Pierre Benite, France, 69310 Hôpital Maison Blanche REIMS Cedex, France, 51092 Centre Henri Becquerel ROUEN Cedex 1, France, 76038 CHU Charles NICOLLE Rouen, France, 76031 Centre René Gauducheau Saint Herblain, France CH Valenciennes Valenciennes, France, 59322 Centre Alexis Vautrin VANDOEUVRE LES NANCY Cedex, France, 54511 收起 << |
NCT00679640 | - | Completed | - | - | |
NCT02967224 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT03376321 | Influenza A | Phase 3 | Recruiting | May 1, 2020 | - |
NCT03084471 | Advanced Solid Malignancies | Phase 3 | Recruiting | March 26, 2023 | - |
NCT03286842 | HER2-ve Metastatic Breast Canc... 展开 >>er Germline BRCA1/2 Mutations Somatic BRCA1/2 Mutations 收起 << | Phase 3 | Recruiting | November 30, 2020 | - |
NCT03354429 | Acute Ischaemic Stroke ... 展开 >> Transient Ischaemic Attack 收起 << | Phase 3 | Recruiting | December 16, 2019 | - |
NCT03347279 | Asthma | Phase 3 | Recruiting | September 18, 2020 | - |
NCT03449758 | Rheumatoid Arthritis | Phase 4 | Recruiting | July 31, 2019 | France ... 展开 >> Investigational Site Number 250007 Recruiting Argenteuil, France Investigational Site Number 250006 Recruiting Besancon, France, 25030 Investigational Site Number 250027 Recruiting Bobigny, France, 93000 Investigational Site Number 250016 Recruiting Bordeaux, France, 33076 Investigational Site Number 250014 Recruiting Caen, France, 14033 Investigational Site Number 250019 Recruiting Cannes, France, 06414 Investigational Site Number 250013 Recruiting Cholet, France, 49325 Investigational Site Number 250002 Recruiting Clermont Ferrand, France, 63003 Investigational Site Number 250009 Recruiting Echirolles, France, 38434 Investigational Site Number 250005 Recruiting La Roche Sur Yon, France, 85025 Investigational Site Number 250004 Recruiting Lille Cedex, France, 59037 Investigational Site Number 250012 Recruiting Limoges Cedex, France, 87000 Investigational Site Number 250021 Recruiting Lyon, France, 69495 Investigational Site Number 250018 Recruiting Montivilliers, France Investigational Site Number 250029 Recruiting MONTPELLIER Cedex 5, France, 34295 Investigational Site Number 250025 Recruiting NANTES Cedex 1, France, 44035 Investigational Site Number 250026 Recruiting Nice cedex 1, France, 06001 Investigational Site Number 250020 Recruiting Paris Cedex 10, France, 75475 Investigational Site Number 250011 Recruiting PARIS Cedex 13, France, 75013 Investigational Site Number 250010 Recruiting Paris, France, 75012 Investigational Site Number 250015 Recruiting Paris, France, 75014 Investigational Site Number 250028 Recruiting Paris, France, 75015 Investigational Site Number 250031 Recruiting Poitiers, France, 86021 Investigational Site Number 250023 Recruiting Pontoise, France, 95300 Investigational Site Number 250017 Recruiting RENNES Cedex, France, 35022 Investigational Site Number 250008 Recruiting Rouen, France, 76000 Investigational Site Number 250001 Recruiting St Etienne, France, 42055 Investigational Site Number 250022 Recruiting Toulouse, France, 31200 Investigational Site Number 250003 Recruiting Tours, France, 37000 收起 << |
NCT02264665 | - | Recruiting | June 5, 2019 | - | |
NCT00843492 | - | Completed | - | - | |
NCT03330847 | Metastatic Triple Negative Bre... 展开 >>ast Cancer 收起 << | Phase 2 | Recruiting | January 20, 2021 | - |
NCT03383458 | Hepatocellular Carcinoma ... 展开 >> Liver Cancer 收起 << | Phase 3 | Recruiting | June 7, 2025 | - |
NCT01908816 | Choroidal Neovascularization ... 展开 >> Macular Edema Glaucoma, Neovascular Diabetic Retinopathy 收起 << | Phase 3 | Completed | - | France ... 展开 >> Novartis Investigative Site Amiens Cedex 1, France, 80054 Novartis Investigative Site Angers, France, 49044 Novartis Investigative Site Bobigny, France, 93009 Novartis Investigative Site Bordeaux, France, 33000 Novartis Investigative Site Bordeaux, France, 33100 Novartis Investigative Site Caen, France, 14050 Novartis Investigative Site Créteil, France, 94000 Novartis Investigative Site Ecully, France Novartis Investigative Site Grenoble, France, 38000 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Lille, France, 59000 Novartis Investigative Site Lyon Cedex 04, France, 69317 Novartis Investigative Site Lyon, France, 69275 Novartis Investigative Site Mantes la jolie, France, 78201 Novartis Investigative Site Marseille Cedex 8, France, 13008 Novartis Investigative Site Marseille, France, F-13008 Novartis Investigative Site Melun, France, 77000 Novartis Investigative Site Montauban, France, 82000 Novartis Investigative Site Montpellier, France, 34000 Novartis Investigative Site Mulhouse cedex, France, 68070 Novartis Investigative Site Nantes Cedex 1, France, 44093 Novartis Investigative Site Nice, France, 06000 Novartis Investigative Site Paris cedex 10, France, 75010 Novartis Investigative Site Paris Cedex 19, France, 75940 Novartis Investigative Site Paris, Cedex 12, France, F-75571 Novartis Investigative Site Paris, France, 75006 Novartis Investigative Site Paris, France, 75007 Novartis Investigative Site Paris, France, 75013 Novartis Investigative Site Paris, France, 75014 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Poitiers, France, 86021 Novartis Investigative Site Rouen, France, 76100 Novartis Investigative Site Saint-Jean, France, 31240 Novartis Investigative Site Saitnt Herblain, France, 44819 Novartis Investigative Site St-Priest-en-Jarez, France, 42270 Novartis Investigative Site Strasbourg Cedex, France, 67091 Novartis Investigative Site Toulouse, France, 31077 Novartis Investigative Site Tours, France, 37000 Novartis Investigative Site Tours, France, 37044 Novartis Investigative Site Vannes, France, 56000 收起 << |
NCT00843492 | Thrombosis, Venous | Phase 3 | Completed | - | - |
NCT03303599 | - | Recruiting | June 22, 2020 | - | |
NCT03468426 | Non-squamous, Non-Small-Cell L... 展开 >>ung Cancer 收起 << | Phase 1 | Recruiting | February 17, 2021 | France ... 展开 >> CTR Georges-François Leclerc Recruiting Dijon, France, 21079 Contact: Nicolas Isambert +33 (0)3 80 73 75 06 nisambert@cgfl.fr HOP Timone Recruiting Marseille Cedex 5, France, 13385 Contact: Fabrice Barlesi +33 (0)4 91 38 56 28 fabrice.barlesi@ap-hm.fr INS Curie Recruiting Paris, France, 75005 Contact: Nicolas Girard +33 (0)1 44 32 46 06 nicolas.girard2@curie.fr Germany Kommunalunternehmen Klinikum Augsburg Recruiting Augsburg, Germany, 86156 Contact: Björn Hackanson +49 (821) 4002729 bjoern.hackanson@klinikum-augsburg.de Universitätsmedizin der Johannes Gutenberg-Universität Mainz Recruiting Mainz, Germany, 55131 Contact: Jürgen Alt 496131176924 juergen.alt@unimedizin-mainz.de 收起 << |
NCT02941926 | Breast Cancer | Phase 3 | Active, not recruiting | November 22, 2019 | - |
NCT02082977 | Cancer | Phase 1 | Terminated(The maximal dose an... 展开 >>d schedule attained with GSK2816126 has shown insufficient evidence of clinical activity, and does not justify further clinical investigation) 收起 << | - | United States, Illinois ... 展开 >> GSK Investigational Site Chicago, Illinois, United States, 60611 United States, New York GSK Investigational Site New York, New York, United States, 10021 France GSK Investigational Site Villejuif cedex, France, 94805 United Kingdom GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT GSK Investigational Site Southampton, United Kingdom, SO16 6YD 收起 << |
NCT01822795 | Emphysema | Phase 3 | Active, not recruiting | December 2019 | France ... 展开 >> CHU d'Amiens AMIENS Cedex 1, France, 80054 CHU de Grenoble GRENOBLE Cedex 9, France, 38043 AP-HM Marseille, France, 13015 CHU de Montpellier MONTPELLIER Cedex 5, France, 34295 CHU de Nice Nice, France, 06002 AP-HP - Hôpital Bichat PARIS Cedex 18, France, 75877 CHU de Rouen ROUEN Cedex, France, 76031 CHU de Saint-Etienne Saint-priest-en-jarez, France, 42270 Hôpitaux Universitaires de Strasbourg STRASBOURG Cedex, France, 67091 收起 << |
NCT01937442 | Multiple Myeloma | Phase 1 | Completed | - | France ... 展开 >> Hopital Augustin Morvan Brest Cedex, France, 29609 CHU Grenoble Grenoble Cedex 09, France, 38043 CHRU-Hopital Claude Huriez Lille, France, 59037 CHRU Hopital Bretonneau Tours cedex, France, 37044 CHRU Hopital Brabois Vandoeuvre cedex, France, 54511 United Kingdom Christie Hospital NHS Foundation Trust Manchester, United Kingdom, M20 4BX Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT 收起 << |
NCT01689389 | - | Completed | - | France ... 展开 >> Research Site Argenteuil Cedex, France Research Site Belley, France Research Site Castelmaurou, France Reserach Site Cavaillon, France Research Site Les Mureaux, France Research Site Lille, France Research Site Marseille, France Research Site Montpellier, France Research Site Nimes Cedex, France Research SIte Obernai, France Research Site Paris, France Research Site Rennes, France Research Site Saintes Cedex, France Research Site Sens, France research Site St Dizier, France Research Site St Egreve Cedex, France Research Site Toulouse, France Research Site Tours, France Research Site Ussel Cedex, France 收起 << | |
NCT01817166 | Multiple Sclerosis | Phase 3 | Recruiting | January 2022 | France ... 展开 >> CHU d'Amiens - Hôpital Nord Not yet recruiting Amiens Cedex 1, France, 80054 Sub-Investigator: Olivier Godefroy, MD, PhD Sub-Investigator: Abdullatif Al Khedr, MD CHU de Lyon - Hôpital Pierre Wertheimer Recruiting Bron, France, 69677 Sub-Investigator: Christian Confavreux, MD, PHD Sub-Investigator: Sandra Vukusic, MD, PhD CHU de Caen - Hôpital Côte de Nacre Recruiting Caen Cedex 9, France, 14033 Sub-Investigator: Gilles Defer, MD, PhD Sub-Investigator: Nathalie Derache Belpalme, MD CHU de Clermont Ferrand - Hôpital Gabriel-Montpied Recruiting Clermont Ferrand, France, 63003 Sub-Investigator: Pierre Clavelou, MD, PhD Sub-Investigator: Frédéric Thaite, MD CH Sud Francilien Recruiting Corbeil-Essonnes, France, 91100 Sub-Investigator: Ivania Patry, MD Clinique des Cèdres - Capio Not yet recruiting Cornebarrieu, France, 31700 Sub-Investigator: Claude Mekies, MD CHU de Dijon Recruiting Dijon, France, 21079 Sub-Investigator: Thibault Moreau, MD, PhD CHU de Martinique - Hôpital Pierre Zobda-Quitman Not yet recruiting Fort-de-France, France, 97261 Sub-Investigator: Philippe Cabre, MD CHU de Grenoble - Hôpital A Michallon Recruiting Grenoble, France, 38043 Sub-Investigator: Olivier Casez, MD CHRU de Lille - Hôpital Roger Salengro Recruiting Lille, France, 59037 Sub-Investigator: Patrick Vermersch, MD, PhD Sub-Investigator: Hélène Zephyr, MD Sub-Investigator: Olivier Outteryck, MD CHU de Limoges - Hôpital Dupuytren Recruiting Limoges, France, 87042 Sub-Investigator: Laurent Magy, MD, PhD Sub-Investigator: Alexis Montcuquet, MD Groupe Hospitalier de l'Institut Catholique de Lille Recruiting Lomme Cedex, France, 59462 Sub-Investigator: Patrick Hautecoeur, MD Sub-Investigator: Cécile Donzé-Parret, MD CHU de Montpellier - Hôpital Gui de Chauliac Recruiting Montpellier, France, 34295 Sub-Investigator: William Camu, MD, PhD Sub-Investigator: Bertrand Carlander, MD Sub-Investigator: Mahmoud Charif, MD Sub-Investigator: Pierre Labauge, MD, PhD CHU de Nancy - Hôpital Central Recruiting Nancy, France, 54035 Sub-Investigator: Marc Debouverie, MD, PhD Sub-Investigator: Sophie Pittion-Vouyovitch, MD CHU de Nantes - Hôtel-Dieu Recruiting Nantes, France, 44093 Sub-Investigator: Sandrine Wiertlewski, MD Sub-Investigator: David Laplaud, MD CHU de Nice - Hôpital Pasteur Recruiting Nice, France, 06002 Sub-Investigator: Christine Lebrun-Fresnay, MD CHU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 9, France, 30029 Principal Investigator: Eric Thouvenot, MD, PhD Sub-Investigator: Giovanni Castelnovo, MD APHP - Hôpital Saint-Antoine Not yet recruiting Paris Cedex 12, France, 75571 Sub-Investigator: Bruno Stankoff, MD, PhD Sub-Investigator: Claire Giannesini, MD MAILLART Elisabeth - La Pitié Salpétrière Not yet recruiting Paris, France, 75013 Contact: MAILLART Elisabeth, PH Fondation Ophtalmologique Adolphe Rothschild Recruiting Paris, France, 75019 Sub-Investigator: Olivier Gout, MD CH de Pau Not yet recruiting Pau, France, 64000 Sub-Investigator: Mickaël Bonnan, MD CH de Perpignan - Hôpital Saint Jean Recruiting Perpignan, France, 66046 Sub-Investigator: Nicolas Gaillard, MD Sub-Investigator: Anais Dutray, MD CH de Cornouaille - Site Quimper - Hôpital Laennec Recruiting Quimper, France, 29107 Sub-Investigator: Marc Coustans, MD CHU de Reims - Hôpital Maison Blanche Recruiting Reims, France, 51092 Sub-Investigator: Ayman Tourbah, MD CHU de Rennes - Hôpital PontChaillou Recruiting Rennes, France, 35033 Sub-Investigator: Gilles Edan, MD, PhD Sub-Investigator: Emmanuelle Le Page, MD Sub-Investigator: Véronique Deburghgraeve, MD CHU de Rouen - Hôpital Charles Nicolle Recruiting Rouen, France, 76031 Sub-Investigator: Didier Hannequin, MD, PhD Sub-Investigator: Bertrand Bourre, MD CH de Poissy - Saint-Germain-en-Laye Recruiting Saint-Germain-en-Laye, France, 78100 Sub-Investigator: Olivier Heinzlef, MD CH de Saumur Recruiting Saumur Cedex, France, 49403 Sub-Investigator: Richard Devy, MD CHRU de Strasbourg - Hôpital Civil Recruiting Strasbourg Cedex, France, 67091 Sub-Investigator: Jérôme De Sèze, MD, PhD CHRU de Toulouse - Hôpital Purpan Recruiting Toulouse Cedex 9, France, 31059 Sub-Investigator: David Brassat, MD, PhD CHRU de Tours - Hôpital Bretonneau Recruiting Tours, France, 37044 Sub-Investigator: Philippe Corcia, MD, PhD Sub-Investigator: Anne-Marie Guennoc, MD CH de Versailles - Hôpital Mignot Recruiting Versailles, France, 78000 Sub-Investigator: Fernando Pico, MD, PhD Sub-Investigator: Chantal Nifle, MD CH de Vichy - Jacques Larin Not yet recruiting Vichy, France, 03207 Sub-Investigator: Renato Colamarino, MD 收起 << |
NCT02444429 | Renal Transplantation | Phase 3 | Recruiting | June 2020 | France ... 展开 >> Service de Néphrologie,Transplantation, Dialyse I - Hôpital Pellegrin - CHU Bordeaux Recruiting Bordeaux, France, 33000 Contact: Pierre MERVILLE, MD 556 795 538 ext +33 pierre.merville@chu-bordeaux.fr Principal Investigator: Pierre MERVILLE, MD Service de Néphrologie, Hémodialyse, Transplantations Rénales - Hôpital de la Cavale Blanche - CHU de Brest Recruiting BREST Cedex, France, 29609 Contact: Yannick LE MEUR, MD 298 347 074 ext +33 yannick.lemeur@chu-brest.fr Principal Investigator: Yannick LE MEUR, MD Service de Néphrologie - Hôpital Claude Huriez - CHU de Lille Recruiting Lille, France, 59037 Contact: Marc HAZZAN, MD 320 446 770 ext +33 marc.hazzan-2@univ-lille2.fr Principal Investigator: Marc HAZZAN, MD Service de Néphrologie, Transplantation et Immunologie Clinique - Hôpital Edouard Herriot - Hospices Civils de Lyon Recruiting LYON Cedex 03, France, 69437 Contact: Olivier THAUNAT, MD 472 110 150 ext +33 olivier.thaunat@chu-lyon.fr Principal Investigator: Olivier THAUNAT, MD Sub-Investigator: Emmanuel MORELON, MD Sub-Investigator: Valérie HERVIEU, MD Institut de Transplantation, Urologie et Néphrologie (ITUN) - CHU de Nantes Recruiting NANTES cedex 01, France, 44093 Contact: Gilles BLANCHO, MD 240 087 410 ext +33 gilles.blancho@chu-nantes.fr Principal Investigator: Gilles BLANCHO, MD Unité de Transplantation Rénale - Hôpital Pasteur - CHU de Nice Recruiting Nice, France, 06202 Contact: Elisabeth CASSUTO, MD 492 037 910 ext +33 cassuto.e@chu-nice.fr Principal Investigator: Elisabeth CASSUTO, MD Service de Néphrologie et Transplantation - Hôpital Saint-Louis Recruiting PARIS Cedex 10, France, 75475 Contact: Denis GLOTZ, MD 142 499 630 ext +33 denis.glotz@sls.aphp.fr Principal Investigator: Denis GLOTZ, MD Service de Transplantation - Hôpital Universitaire Necker Recruiting Paris, France, 75015 Contact: Dany ANGLICHEAU, MD 144 495 355 ext +33 dany.anglicheau@nck.aphp.fr Principal Investigator: Dany ANGLICHEAU, MD Service Urgences Néphrologiques et Transplantation Rénale - Hôpital Tenon Recruiting Paris, France, 75020 Contact: Alexandre HERTIG, MD 156 016 510 ext +33 alexandre.hertig@tnn.aphp.fr Principal Investigator: Alexandre HERTIG, MD Service de Néphrologie et Transplantation - Nouvel Hôpital Civil - CHRU Strasbourg Recruiting Strasbourg, France, 67091 Contact: Sophie CAILLARD OHLMANN, MD Principal Investigator: Sophie CAILLARD OHLMANN, MD Département de Néphrologie et Transplantation d'Organes - Hôpital Rangueil - CHU de Toulouse Recruiting TOULOUSE Cedex 9, France, 31059 Contact: Nassim KAMAR, MD 561 322 335 ext +33 kamar.n@chu-toulouse.fr Principal Investigator: Nassim KAMAR, MD 收起 << |
NCT02417285 | Lymphoma, Large B-Cell, Diffus... 展开 >>e Lymphoma, Non-Hodgkin 收起 << | Phase 1 | Recruiting | September 27, 2019 | France ... 展开 >> Institut Bergonie Recruiting Borddeaux Cedex, France, 33076 Institut Paoli Calmettes Recruiting Marseille cedex, France, 13273 Centre hospitalier Lyon Sud Hematologie Recruiting Pierre-Bénite cedex, France, 69495 Institut Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Italy Institute of Hematology and Medical Oncology L. and A. Seragnoli Recruiting Bologna, Italy, 40138 Azienda Ospedaliera Citta della Salute e della Scienza di Torino Recruiting Torino, Italy, 10126 Netherlands Academisch Medisch Centrum Recruiting Amsterdam, Netherlands, 1105 Erasmus Medical Center - Daniel den Hoed Recruiting Rotterdam, Netherlands, 3075 EA 收起 << |
NCT02618928 | - | Completed | - | - | |
NCT00911300 | Fibrillation, Atrial | Phase 2 | Completed | - | France ... 展开 >> GSK Investigational Site Albi, France, 81000 GSK Investigational Site Antony cedex, France, 92166 GSK Investigational Site Brest Cedex, France, 29609 GSK Investigational Site Créteil, France, 94000 GSK Investigational Site Evecquemont, France, 78740 GSK Investigational Site Montpellier Cedex 5, France, 34295 GSK Investigational Site Paris cedex 12, France, 75571 GSK Investigational Site Paris cedex 13, France, 75651 GSK Investigational Site Pau, France, 64046 GSK Investigational Site Pessac cedex, France, 33604 GSK Investigational Site Poitiers cedex, France, 86021 GSK Investigational Site Rennes Cedex 9, France, 35033 GSK Investigational Site Toulouse Cedex 09, France, 31059 GSK Investigational Site Toulouse cedex 3, France, 31076 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Aschaffenburg, Bayern, Germany, 63739 GSK Investigational Site Bad Toelz, Bayern, Germany, 83646 GSK Investigational Site Simbach a. Inn, Bayern, Germany, 84359 GSK Investigational Site Potsdam, Brandenburg, Germany, 14467 GSK Investigational Site Frankfurt, Hessen, Germany, 60488 GSK Investigational Site Kassel, Hessen, Germany, 34121 GSK Investigational Site Kassel, Hessen, Germany, 34125 GSK Investigational Site Hagenow, Mecklenburg-Vorpommern, Germany, 19230 GSK Investigational Site Bielefeld, Nordrhein-Westfalen, Germany, 33604 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53115 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Duisburg-Huckingen, Nordrhein-Westfalen, Germany, 47259 GSK Investigational Site Unna, Nordrhein-Westfalen, Germany, 59423 GSK Investigational Site Wesel, Nordrhein-Westfalen, Germany, 46483 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39120 GSK Investigational Site Pirna, Sachsen, Germany, 01796 GSK Investigational Site Berlin, Germany, 10249 GSK Investigational Site Berlin, Germany, 10405 GSK Investigational Site Berlin, Germany, 13353 收起 << |
NCT02664753 | Severe Sepsis ... 展开 >> Shock, Septic Acute Kidney Injury 收起 << | Phase 3 | Recruiting | September 2020 | France ... 展开 >> CHU de Caen Not yet recruiting Caen Cedex 9, France, 14033 Sub-Investigator: Thierry Lobbedez, MD, PhD Principal Investigator: Damien Ducheyron, MD, PhD CH de Chartres Not yet recruiting Chartres, France Contact: Pierre Kalfon Principal Investigator: pierre kalfon CHU de Clermont Ferrand Recruiting Clermont Ferrand, France, 63003 Principal Investigator: Bertrand Souweine, MD, PhD Sub-Investigator: Anne-Elizabeth Heng, MD CHU de Dijon Not yet recruiting Dijon, France, 21079 Principal Investigator: Jean-Pierre Quenot, MD Sub-Investigator: Jean-Michel Rebibou, MD APHM - Hôpital Nord Not yet recruiting Marseille Cedex 20, France, 13915 Principal Investigator: Marc Leone, MD, PhD APHM - Hôpital de la Conception Not yet recruiting Marseille, France, 13385 Sub-Investigator: Stéphane Burtey, MD, PhD Principal Investigator: Marion SALLEE APHM - Hôpital de la Timone Adultes Not yet recruiting Marseille, France, 13385 Principal Investigator: Nicolas Bruder, MD, PhD CHU de Montpellier - St Eloi Recruiting Montpellier cedex 5, France, 34295 Principal Investigator: Samir Jaber, MD, PhD CHU de Montpellier - Lapeyronie Recruiting Montpellier, France, 34295 Principal Investigator: Kada Klouche, MD, PhD Sub-Investigator: Olivier Jonquet, MD, PhD Sub-Investigator: Georges Mourad, MD, PhD CHU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Laurent Muller, MD, PhD Sub-Investigator: Saber Barbar, MD Sub-Investigator: Jean-Yves Lefrant, MD, PhD Sub-Investigator: Olivier Moranne, MD, PhD Sub-Investigator: Serge Lumbroso, MD, PhD Sub-Investigator: David-Paul de Brauwère, MD CHU de Poitiers Not yet recruiting Poitiers Cedex, France, 86021 Sub-Investigator: claire DAHYOT-FIZELIER, MD, PhD Sub-Investigator: Frank Bridoux, MD, PhD Principal Investigator: thibaut papet Sub-Investigator: marc bauwens CHU de St Etienne Not yet recruiting Saint-Priest en Jarez, France, 42270 Principal Investigator: Eric Alamartine, MD, PhD Sub-Investigator: Christophe Mariat, MD, PhD CHU de Toulouse - Hôpital Rangueil Recruiting Toulouse Cedex 9, France, 31059 T Sub-Investigator: Dominique Chauveau, MD, PhD Sub-Investigator: Olivier Cointault, MD Sub-Investigator: nassim kamar Principal Investigator: stanislas faguer 收起 << |
NCT01840319 | - | Completed | - | France ... 展开 >> Pfizer Investigational Site Amiens Cedex 1, France, 80054 Pfizer Investigational Site Argenteuil, France, 95100 Pfizer Investigational Site Ars Laquenexy, France, 57530 Pfizer Investigational Site Besancon cedex, France, 25030 Pfizer Investigational Site Bordeaux Cedex, France, 33076 Pfizer Investigational Site Bordeaux, France, 33000 Pfizer Investigational Site Clermont Ferrand Cedex, France, 63003 Pfizer Investigational Site Clermont-Ferrand, France, 63003 Pfizer Investigational Site La Tronche, France, 38700 Pfizer Investigational Site Le Chesnay cedex, France, 78157 Pfizer Investigational Site Le Kremlin Bicetre, France, 94275 Pfizer Investigational Site Marseille Cedex 20, France, 13915 Pfizer Investigational Site Marseille, France, 13385 Pfizer Investigational Site Montpellier, France, 34295 Pfizer Investigational Site Nantes Cedex 1, France, 44093 Pfizer Investigational Site Nice cedex 1, France, 06006 Pfizer Investigational Site Paris Cedex 18, France, 75877 Pfizer Investigational Site Rennes Cedex 9, France, 35033 Pfizer Investigational Site Rouen Cedex, France Pfizer Investigational Site Saint Etienne Cedex 02, France, 42055 Pfizer Investigational Site Strasbourg, France, 67200 Pfizer Investigational Site Toulouse, France 收起 << | |
NCT01420055 | Multiple Sclerosis, Relapsing-... 展开 >>Remitting 收起 << | Phase 4 | Completed | - | France ... 展开 >> Novartis Investigative Site Agen Cedex 9, France, 47923 Novartis Investigative Site Amiens Cedex 1, France, 80054 Novartis Investigative Site Angers Cedex 1, France, 49033 Novartis Investigative Site Auxerre, France, 89000 Novartis Investigative Site Avignon, France, 84000 Novartis Investigative Site Bayonne, France, 64109 Novartis Investigative Site Beziers, France, 34525 Novartis Investigative Site Bobigny Cedex, France, 93009 Novartis Investigative Site Brest, France, 29240 Novartis Investigative Site Calais, France, 62107 Novartis Investigative Site Castelnau-le-Lez, France, 34170 Novartis Investigative Site Chambray les Tours, France, 37175 Novartis Investigative Site Cherbourg, France, 50100 Novartis Investigative Site Clermont-Ferrand Cedex 1, France, 63003 Novartis Investigative Site Créteil, France, 94010 Novartis Investigative Site Dijon, France, 21034 Novartis Investigative Site Epinal, France, 88021 Novartis Investigative Site Grenoble Cedex 9, France, 38042 Novartis Investigative Site Hagueneau, France, 67500 Novartis Investigative Site La Rochelle cedex 1, France, 17019 Novartis Investigative Site La Seyne sur mer, France, 83500 Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Le Mans Cedex 09, France, 72037 Novartis Investigative Site Limoges, France Novartis Investigative Site Lyon, France, 69275 Novartis Investigative Site Marseille, France, 13008 Novartis Investigative Site Marseille, France, 13012 Novartis Investigative Site Metz, France, 57085 Novartis Investigative Site Montpellier, France, 34000 Novartis Investigative Site Montpellier, France, 34295 Novartis Investigative Site Nimes, France, 32900 Novartis Investigative Site Orsay, France, 91401 Novartis Investigative Site Paris, France, 75005 Novartis Investigative Site Poitiers, France, 86021 Novartis Investigative Site Pontoise, France, F-95300 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Rennes Cedex, France, 35033 Novartis Investigative Site Roanne, France, 42328 Novartis Investigative Site Saint Aubin sur Scie, France, 76550 Novartis Investigative Site Saint Jean, France, 31243 Novartis Investigative Site Sainte Foy les Lyon, France, 69110 Novartis Investigative Site Saumur, France, 49400 Novartis Investigative Site Strasbourg Cedex, France, 67091 Novartis Investigative Site Talant, France, 21240 Novartis Investigative Site Toulouse, France, 31059 Novartis Investigative Site Tourcoing, France, 59200 Novartis Investigative Site Tours Cedex, France, 37044 收起 << |
NCT02925338 | - | Recruiting | December 31, 2020 | - | |
NCT01840319 | - | Completed | - | - | |
NCT00911300 | - | Completed | - | - | |
NCT01786824 | Acute Kidney Injury ... 展开 >> Renal Insufficiency 收起 << | Phase 3 | Terminated(Patient pathway has... 展开 >> become infeasible due to pressure for shorter hospital stays. Not enough inclusions.) 收起 << | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 CHU d'Angers - Hôtel-Dieu Angers, France, 49933 CH d'Avignon - Centre Hospitalier Henri Duffaut Avignon, France, 84902 CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CH de Perpignan - Hôpital Saint Jean Perpignan, France, 66046 收起 << |
NCT01073605 | - | Completed | - | - | |
NCT01470456 | Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | - | Austria ... 展开 >> Investigational Site Number 040002 Graz, Austria, 8036 France Investigational Site Number 250004 Creteil Cedex, France, 94010 Investigational Site Number 250009 Dijon, France, 21000 Investigational Site Number 250006 Lille Cedex, France, 59037 Investigational Site Number 250011 Marseille Cedex 9, France, 13273 Investigational Site Number 250010 Montpellier, France, 34295 Investigational Site Number 250008 Nantes Cedex 01, France, 44093 Investigational Site Number 250007 Paris Cedex 10, France, 75475 Investigational Site Number 250001 Pierre Benite Cedex, France, 69495 Investigational Site Number 250005 Rennes, France, 35033 Investigational Site Number 250003 Rouen Cedex, France, 76038 Investigational Site Number 250002 Villejuif Cedex, France, 94805 Norway Investigational Site Number 578001 Oslo, Norway, 0440 收起 << |
NCT01073605 | Growth Disorders ... 展开 >> Intrauterine Growth Retardation 收起 << | Phase 3 | Completed | - | France ... 展开 >> Pfizer Investigational Site Amiens, France, 80030 Pfizer Investigational Site Angers cedex, France, 49933 Pfizer Investigational Site Besancon Cedex, France, 25030 Pfizer Investigational Site Bordeaux Cedex, France, 33076 Pfizer Investigational Site Bordeaux, France, 33000 Pfizer Investigational Site Boulogne, France, 92100 Pfizer Investigational Site Brest, France, 29200 Pfizer Investigational Site Bron Cedex, France, 69677 Pfizer Investigational Site Clermont Ferrand, France, 63000 Pfizer Investigational Site Dijon, France, 21034 Pfizer Investigational Site Grenoble, France, 38043 Pfizer Investigational Site Hyères, France, 83407 Pfizer Investigational Site Lille, France, 59000 Pfizer Investigational Site Lille, France, 59037 Pfizer Investigational Site Marseille cedex 5, France, 13385 Pfizer Investigational Site Montpellier, France, 34059 Pfizer Investigational Site Nantes Cedex 1, France, 44093 Pfizer Investigational Site Nice, France, 06202 Pfizer Investigational Site Paris, France, 75019 Pfizer Investigational Site Paris, France, 75571 Pfizer Investigational Site Paris, France, 75674 Pfizer Investigational Site Reims, France, 51092 Pfizer Investigational Site Rennes, France, 35033 Pfizer Investigational Site Rouen, France, 76000 Pfizer Investigational Site Saint Priest en Jarez, France, 42277 Pfizer Investigational Site Strasbourg Cedex 2, France, 67098 Pfizer Investigational Site Tarbes, France Pfizer Investigational Site Toulouse Cedex, France, 31026 Pfizer Investigational Site Tours, France, 37044 Pfizer Investigational Site Vandoeuvre Les Nancy Cedex, France, 54511 收起 << |
NCT00715403 | Neoplasms | Phase 1 | Completed | - | France ... 展开 >> 1199.16.3306A Boehringer Ingelheim Investigational Site Bordeaux cedex, France 1199.16.3311A Boehringer Ingelheim Investigational Site Clichy Cedex, France 1199.16.3311B Boehringer Ingelheim Investigational Site Clichy Cedex, France 1199.16.3313A Boehringer Ingelheim Investigational Site Paris Cedex 10, France 1199.16.3313E Boehringer Ingelheim Investigational Site Paris Cedex 10, France 1199.16.3302A Boehringer Ingelheim Investigational Site Paris cedex 15, France 1199.16.3312A Boehringer Ingelheim Investigational Site Paris, France Germany 1199.16.49001 Boehringer Ingelheim Investigational Site Freiburg/Breisgau, Germany 1199.16.49004 Boehringer Ingelheim Investigational Site Grosshansdorf, Germany 1199.16.49008 Boehringer Ingelheim Investigational Site Tübingen, Germany 1199.16.49005 Boehringer Ingelheim Investigational Site Wiesbaden, Germany 收起 << |
NCT00715403 | - | Completed | - | - | |
NCT03589105 | Multiple Sclerosis | Phase 4 | Recruiting | September 15, 2021 | - |
NCT01930708 | Relapsing-Remitting Multiple S... 展开 >>clerosis Multiple Sclerosis 收起 << | Phase 4 | Active, not recruiting | April 30, 2019 | - |
NCT01946204 | Prostatic Neoplasms | Phase 3 | Active, not recruiting | November 30, 2021 | - |
NCT01757535 | Leukemia, Myeloid, Acute | Phase 3 | Active, not recruiting | April 30, 2019 | - |
NCT02348489 | Leukemia, Myeloid, Acute | Phase 3 | Completed | - | - |
NCT01946204 | - | Active, not recruiting | - | - | |
NCT02899299 | Mesothelioma | Phase 3 | Active, not recruiting | September 28, 2021 | - |
NCT02711553 | Biliary Tract Cancer ... 展开 >> Metastatic Cancer Advanced Cancer 收起 << | Phase 2 | Active, not recruiting | May 31, 2020 | - |
NCT01708603 | Moderate to Severe Plaque Psor... 展开 >>iasis 收起 << | Phase 3 | Terminated(Sponsor decision) | August 2015 | - |
NCT02914600 | Crohn's Disease | Phase 3 | Enrolling by invitation | October 2022 | - |
NCT01543334 | - | Completed | - | France ... 展开 >> CH du Pays d'Aix Aix en Provence, France, 13616 CHU d'Amiens - Hôpital Nord Amiens Cedex 1, France, 80054 CHU d'Angers - Hôtel-Dieu Angers, France, 49933 CHU de Clermont Ferrand - Hôpital Estaing Clermont Ferrand, France, 63003 CHU de Grenoble - Hôpital A Michallon Grenoble, France, 38043 APHM - Hôpital Nord Marseille Cedex 20, France, 13915 CHU de Montpellier - Hôpital Saint-Eloi Montpellier, France, 34295 CHU de Nice - Hôpital St-Roch Nice, France, 06006 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 APHP - Hôpital Bichat - Claude Bernard Paris Cedex 18, France, 75877 CHU de Bordeaux - Hôpital Haut-Lévêque Pessac Cedex, France, 33604 CHU de Rennes - Hôpital PontChaillou Rennes, France, 35033 CHRU de Strasbourg - Hôpital Civil Strasbourg Cedex, France, 67091 收起 << | |
NCT02021409 | Anemia Renal ... 展开 >>Insufficiency, Chronic 收起 << | Phase 2 | Completed | - | - |
NCT02160145 | Chronic Kidney Disease ... 展开 >> Autosomal Dominant Polycystic Kidney Disease 收起 << | Phase 3 | Completed | - | - |
NCT02467270 | Myeloid Leukemia, Chronic, Chr... 展开 >>onic Phase 收起 << | Phase 2 | Recruiting | December 31, 2022 | - |
NCT02319044 | Recurrent/Metastatic Squamous ... 展开 >>Cell Carcinoma of Head & Neck 收起 << | Phase 2 | Active, not recruiting | September 28, 2018 | - |
NCT02160145 | - | Completed | - | - | |
NCT01650805 | - | Terminated(Study terminated ba... 展开 >>sed on evaluation of safety data.) 收起 << | - | - | |
NCT02319044 | - | Active, not recruiting | - | - | |
NCT00135005 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19111-2497 France Novartis Investigative Site Lyon Cedex, France, 69373 Germany Novartis Investigative Site Berlin, Germany, 13125 Italy Novartis Investigative Site Milano, MI, Italy, 20133 收起 << |
NCT01650805 | Chronic Myeloid Leukemia | Phase 3 | Terminated(Study terminated ba... 展开 >>sed on evaluation of safety data.) 收起 << | - | - |
NCT02446418 | Asthma | Phase 3 | Completed | - | - |
NCT02577406 | Leukemia, Myeloid ... 展开 >> Isocitrate Dehydrogenase 收起 << | Phase 3 | Recruiting | July 28, 2022 | - |
NCT01975389 | - | Terminated(See Detailed Descri... 展开 >>ption) 收起 << | - | - | |
NCT01969838 | Primary Myelofibrosis ... 展开 >> Post-Polycythemia Vera Myelofibrosis Post-Essential Thrombocythemia Myelofibrosis 收起 << | Phase 3 | Active, not recruiting | March 2019 | - |
NCT03201965 | Amyloidosis | Phase 3 | Recruiting | October 30, 2025 | - |
NCT01206205 | Multiple Myeloma | Phase 2 | Completed | - | France ... 展开 >> Centre François Baclesse Caen, cedex 5, France, 14076 University Hospital of Dijon, Hôpital des Enfants Dijon, France, 21000 University Hospital of Grenoble, Hôpital A.Michallon, BP 217 X Grenoble Cedex 09, France, 38043 University Hospital Of Lille, Hôpital Claude Huriez Lille Cedex, France, 59037 Institut Paoli Calmette Marseille Cedex, France, 13273 University Hospital of Bordeaux, "Hôpital du Haut Lévêque " Pessac, France, 33604 University Hospital of Toulouse, Purpan Toulouse, France, 31059 Hôpital Bretonneau, Tours Tours Cedex, France, 37044 Hôpitaux de Brabois Nancy Vandoeuvre cedex, France, 54511 收起 << |
NCT02540993 | Diabetic Kidney Disease | Phase 3 | Active, not recruiting | May 25, 2020 | - |
NCT01975389 | Cardiovascular Disease | Phase 3 | Terminated(See Detailed Descri... 展开 >>ption) 收起 << | - | - |
NCT02178475 | - | Completed | - | - | |
NCT02236637 | - | Completed | - | - | |
NCT01459653 | - | Completed | - | - | |
NCT01459653 | - | Completed | - | - | |
NCT02178475 | - | Completed | - | - | |
NCT03427814 | Advanced or Inoperable Gastric... 展开 >> Cancer 收起 << | Phase 3 | Recruiting | September 1, 2021 | - |
NCT02064439 | - | Completed | - | - | |
NCT03345407 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Active, not recruiting | January 10, 2019 | - |
NCT02392234 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02555878 | Neoplasms | Phase 3 | Completed | - | - |
NCT02392234 | - | Completed | - | - | |
NCT01610284 | Breast Cancer | Phase 3 | Active, not recruiting | December 31, 2018 | - |
NCT02064439 | Pulmonary Embolism ... 展开 >> Thromboembolism Thrombosis Venous Thrombosis Venous Thromboembolism 收起 << | Phase 3 | Completed | - | - |
NCT02425111 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT02155647 | Carcinoma, Merkel Cell | Phase 2 | Active, not recruiting | April 30, 2023 | - |
NCT02057484 | - | Completed | - | - | |
NCT03298451 | Hepatocellular Carcinoma | Phase 3 | Recruiting | January 29, 2021 | - |
NCT02425111 | - | Completed | - | - | |
NCT03390504 | Urothelial Cancer | Phase 3 | Recruiting | February 1, 2021 | - |
NCT02734004 | Ovarian Breas... 展开 >>t SCLC Gastric Cancers 收起 << | Phase 1 Phase 2 | Recruiting | October 15, 2021 | - |
NCT01755767 | Hepatocellular Carcinoma | Phase 3 | Completed | - | - |
NCT02065791 | Diabetes Mellitus, Type 2 ... 展开 >> Diabetic Nephropathy 收起 << | Phase 3 | Active, not recruiting | June 28, 2019 | - |
NCT02783573 | Alzheimer's Disease | Phase 3 | Terminated(An independent asse... 展开 >>ssment concluded the trial was not likely to meet the primary endpoint upon completion and therefore, trial stopped for futility.) 收起 << | - | - |
NCT02125461 | Non-Small Cell Lung Cancer | Phase 3 | Active, not recruiting | July 9, 2019 | - |
NCT03117621 | - | Recruiting | February 22, 2022 | - | |
NCT02284009 | Diabetes Mellitus, Type 1 | Phase 2 | Completed | - | France ... 展开 >> GSK Investigational Site Amiens Cedex 1, France, 80054 GSK Investigational Site Bois-Guillaume, France, 76230 GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Lille Cedex, France, 59037 GSK Investigational Site Strasbourg cedex, France, 67091 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80804 GSK Investigational Site Frankfurt, Hessen, Germany, 60590 GSK Investigational Site Duesseldorf, Nordrhein-Westfalen, Germany, 40225 GSK Investigational Site Dresden, Sachsen, Germany, 01307 Italy GSK Investigational Site Latina, Lazio, Italy, 04100 GSK Investigational Site Milano, Lombardia, Italy, 20132 GSK Investigational Site Roma, Italy, 00128 Spain GSK Investigational Site Alzira/Valencia, Spain, 46600 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Barcelona, Spain, 08036 GSK Investigational Site Granada, Spain, 18012 GSK Investigational Site Hospitalet de Llobregat, Spain, 08907 GSK Investigational Site Lleida, Spain, 25198 GSK Investigational Site Madrid, Spain, 28006 GSK Investigational Site Málaga, Spain, 29010 GSK Investigational Site Pama de Mallorca, Spain, 07010 GSK Investigational Site San Juan (Alicante), Spain, 03550 GSK Investigational Site Sevilla, Spain, 41014 United Kingdom GSK Investigational Site Ayr, United Kingdom, KA6 6DX GSK Investigational Site Birmingham, United Kingdom, B9 5SS GSK Investigational Site Bristol, United Kingdom, BS2 8HW GSK Investigational Site Cardiff, United Kingdom, CF14 4XN GSK Investigational Site Darlington, United Kingdom, DL3 6HX GSK Investigational Site Dundee, United Kingdom, DD1 9SY GSK Investigational Site Durham, United Kingdom, DH1 5TW GSK Investigational Site Glasgow, United Kingdom, G31 2ER GSK Investigational Site Liverpool, United Kingdom, L7 8XP GSK Investigational Site London, United Kingdom, E1 2AT GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP GSK Investigational Site Sheffield, United Kingdom, S5 7AU 收起 << |
NCT01764633 | Dyslipidemia | Phase 3 | Completed | - | - |
NCT01480063 | - | Active, not recruiting | December 31, 2018 | - | |
NCT01951586 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT01791361 | - | Completed | - | - | |
NCT02962414 | Tuberous Sclerosis Complex | Phase 3 | Recruiting | July 8, 2027 | - |
NCT02285062 | Lymphoma, Large B-Cell, Diffus... 展开 >>e 收起 << | Phase 3 | Active, not recruiting | August 3, 2022 | - |
NCT01764633 | - | Completed | - | - | |
NCT02072434 | Atrial Fibrillation | Phase 3 | Completed | - | - |
NCT02047097 | - | Recruiting | February 28, 2024 | - | |
NCT02319837 | Hormone Sensitive Prostate Can... 展开 >>cer Prostate Cancer Cancer of the Prostate 收起 << | Phase 3 | Active, not recruiting | July 31, 2023 | - |
NCT01843348 | Kidney Transplantation ... 展开 >> Renal Transplantation 收起 << | Phase 3 | Completed | - | France ... 展开 >> Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Dijon, France, 21079 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Nantes, France, 44035 Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Poitiers, France, 86000 Novartis Investigative Site St Priest en Jarez Cedex, France, 42277 Novartis Investigative Site Strasbourg, France, 67091 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Germany Novartis Investigative Site Aachen, Germany, 52074 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Bochum, Germany, 44892 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Erlangen, Germany, 91052 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Tübingen, Germany, 72076 收起 << |
NCT01951586 | - | Completed | - | - | |
NCT01994720 | Acute Ischaemic Stroke ... 展开 >> Transient Ischaemic Attack 收起 << | Phase 3 | Completed | - | - |
NCT00163189 | Growth Hormone Deficiency | Phase 3 | Completed | - | France ... 展开 >> Hôpital Nord Amiens, France, 80030 Centre Hospitalier Intercommunal d'Annemasse-Bonneville, Service de Pédiatrie et Néonatologie Annemasse Cedex, France, 74107 Hôpital Saint Jacques Besancon Cedex, France, 25030 Groupe hospitalier Est- Hôpital Femme, Mère, Enfant Bron, France, 69677 Groupe hospitalier Est-Hôpital Femme, Mère, Enfant Bron, France, 69677 CHU d'Estaing Clermont-Ferrand Cedex 1, France, 63003 CHU de Grenoble, Hôpital Couple enfant. Grenoble Cedex 9, France, 38043 CHU Timone Enfants Marseille Cedex 5, France, 13385 Hôpital Arnaud De Villeneuve Montpellier, France, 34059 CHU de Nantes, Hôpital Mère Enfant Nantes cedex 1, France, 44093 Hôpital Lenval Nice, France, 06200 Groupe Hospitalier Necker - Enfants Malades Paris cedex 15, France, 75743 Hôpital Robert Debré Paris, France, 75019 Hôpital Armand Trousseau Paris, France, 75571 Centre de Perharidy Roscoff Cedex, France, 29684 CHU Charles Nicolle Rouen Cedex, France, 76031 Service de Pédiatrie- Centre Hospitalier Intercommunal Saint Germain-en-Laye Cedex, France, 78105 Hôpital des Enfants Toulouse Cedex 9, France, 31059 CHU Tours - Centre Pediatrique Gatien de Cocheville Tours Cedex 1, France, 37044 收起 << |
NCT03466411 | Crohn's Disease | Phase 3 | Recruiting | October 23, 2024 | - |
NCT01843348 | - | Completed | - | - | |
NCT00163189 | - | Completed | - | - | |
NCT02660359 | Urinary Incontinence ... 展开 >> Overactive Bladder 收起 << | Phase 3 | Active, not recruiting | June 30, 2019 | - |
NCT01994720 | - | Completed | - | - | |
NCT02314143 | Melanoma | Phase 2 | Completed | - | France ... 展开 >> GSK Investigational Site Bordeaux, France, 33075 GSK Investigational Site Marseille cedex 5, France, 13385 GSK Investigational Site Reims Cedex, France, 51092 GSK Investigational Site Rennes Cedex, France, 35042 GSK Investigational Site Villejuif cedex, France, 94805 Spain GSK Investigational Site Barcelona, Spain, 08036 GSK Investigational Site Madrid, Spain, 28041 收起 << |
NCT02001272 | Ovarian Cancer | Phase 2 | Recruiting | May 2020 | - |
NCT03409107 | Anaemia | Phase 3 | Recruiting | November 5, 2020 | - |
NCT02381574 | - | Recruiting | December 2020 | - | |
NCT02927769 | Hodgkin Disease | Phase 2 | Recruiting | March 27, 2022 | - |
NCT02477826 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | December 31, 2020 | - |
NCT02436668 | Metastatic Pancreatic Adenocar... 展开 >>cinoma 收起 << | Phase 3 | Active, not recruiting | April 2019 | - |
NCT01958021 | Advanced, Metastatic Breast Ca... 展开 >>ncer 收起 << | Phase 3 | Active, not recruiting | July 26, 2019 | - |
NCT03281876 | Respiratory Disorders | Phase 2 | Recruiting | February 24, 2020 | - |
NCT02034110 | Cancer | Phase 2 | Active, not recruiting | June 29, 2020 | - |
NCT02760329 | - | Recruiting | May 31, 2021 | - | |
NCT02239666 | - | Completed | - | - | |
NCT02032823 | Breast Cancer | Phase 3 | Recruiting | November 27, 2028 | - |
NCT01895335 | - | Completed | - | - | |
NCT01928771 | Asthma | Phase 3 | Completed | - | - |
NCT03080935 | Dyslipidemia | Phase 3 | Active, not recruiting | December 4, 2022 | - |
NCT01895335 | Multiple Sclerosis | Phase 4 | Completed | - | - |
NCT02207530 | Recurrent or Metastatic PD-L1-... 展开 >>positive Squamous Cell Carcinoma of the Head and Neck 收起 << | Phase 2 | Active, not recruiting | September 28, 2018 | - |
NCT02207530 | - | Active, not recruiting | - | - | |
NCT01958021 | - | Active, not recruiting | - | - | |
NCT02367456 | Myelodysplastic Syndrome ... 展开 >> Acute Myeloid Leukemia 收起 << | Phase 2 | Recruiting | October 10, 2021 | - |
NCT02164513 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT03312907 | Systemic Lupus Erythematosus | Phase 3 | Recruiting | June 9, 2021 | - |
NCT03106987 | Epithelial Ovarian Cancer | Phase 3 | Recruiting | May 7, 2021 | - |
NCT00561795 | Primary Peritoneal Carcinoma ... 展开 >> Tumor Epithelial Ovarian Cancer Uterine Disease Cervix Diseases Neoplasms, Ovarian Cancer 收起 << | Phase 2 | Completed | - | France ... 展开 >> GSK Investigational Site Lyon Cedex 08, France, 69373 GSK Investigational Site Strasbourg, France, 67085 Germany GSK Investigational Site Marburg, Hessen, Germany, 35043 GSK Investigational Site Wiesbaden, Hessen, Germany, 65199 GSK Investigational Site Essen, Nordrhein-westfalen, Germany, 45122 收起 << |
NCT00561795 | - | Completed | - | - | |
NCT02497469 | Colitis, Ulcerative | Phase 3 | Active, not recruiting | March 12, 2019 | - |
NCT02987543 | Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 << | Phase 3 | Recruiting | February 5, 2021 | - |
NCT01928771 | - | Completed | - | - | |
NCT00478985 | Myeloid Leukemia, Chronic | Not Applicable | Completed | - | France ... 展开 >> University Hospital Angers Angers Cedex 01, Angers, France, 49033 Hôpital Henri-Mondor Creteil, Créteil, France, 94000 Hôpital Saint Louis PARIS Cedex, Paris, France, 75475 Institut Bergonié BORDEAUX Cedex, France, 33076 University Hospital Bordeaux, Groupe Hospitalier Pellegrin Bordeaux cedex, France, 33076 Hôpital Morvan Brest, France, 29285 CHU de Grenoble Grenoble, France, 38043 Centre hospitalier-service de médecine interne Onco-Hématologique La Roche sur Yon, France, 85025 Hôpital André Mignot Le Chesnay Cedex, France, 78157 Hôpital Bicêtre, AP-HP Le Kremlin-bicetre, France, 94275 Hôpital Claude Huriez Lille, France, 59037 Hôpital Edouard Herriot Lyon, France, 69374 Institut Paoli Calmet Marseille Cedex 9, France, 13273 CHR de Metz-Thionville Metz Cedex 01, France, 57038 University Hospital Hôtel-Dieu Nantes, France, 44035 Centre Hospitalier de Nevers Nevers, France, 58033 University Hospital Nice Nice, France, 06202 Hôpital Necker-Enfants Malades Paris, France, 75743 Haut Lévêque Hospital Pessac, France, 33604 University Hospital Poitiers Poitiers, France, 86021 University Hospital Strasbourg, Hôpital Civil Strasbourg, France, 67000 University Hospital Toulouse, Purpan Toulouse, France, 31059 University Hospital Brabois Vandoeuvre Les Nancy, France, 54500 Centre Hospitalier Bretagne Atlantique Vannes, France, 56 017 收起 << |
NCT02973087 | Von Willebrand Disease | Phase 3 | Recruiting | May 20, 2019 | United States, Florida ... 展开 >> University of Florida College of Medicine Recruiting Gainesville, Florida, United States, 32610 United States, Illinois Bleeding and Clotting Disorders Institute Recruiting Peoria, Illinois, United States, 61615 United States, Indiana University of Colorado Health Recruiting Aurora, Indiana, United States, 80045 Indiana Hemophilia and Thrombosis Center Recruiting Indianapolis, Indiana, United States, 46260 United States, North Carolina Comprehensive Cancer Center of Wake Forest Unversity Recruiting Winston-Salem, North Carolina, United States, 27157 France Hôpital Morvan Recruiting Brest Cedex, Finistere, France, 29609 Groupement Hospitalier Est- Hôpital Louis Pradel Recruiting Bron cedex, France, 69677 CHU CAEN - Hôpital de la Côte de Nacre Recruiting Caen cedex 9, France, 14033 CHU Dijon - Hopital du Bocage Recruiting Dijon cedex, France, 21079 Hopital Cardiologique - CHU Lille Recruiting Lille Cedex, France, 59037 Germany Coagulation Research Centre GmbH Recruiting Duisburg, Germany, 47051 Werlhof-Institut GmbH Recruiting Hannover, Germany, 30159 Medizinische Hochschule Hannover Recruiting Marburg, Germany, 30625 Italy Ospedale Pediatrico Bambino Gesù Recruiting Rome, Roma, Italy, 165 Azienda Ospedaliera Universitaria Careggi Recruiting Firenze, Italy, 50134 Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico Recruiting Milano, Italy, 20122 Netherlands Erasmus Medisch Centrum Recruiting Rotterdam, Netherlands, 3015 CE Russian Federation SAIH "Kemerovo Regional Clinical Hospital" Recruiting Kemerovo, Russian Federation, 650066 FSBI of Science "Kirov Scientific and Research Institute of Hematology and Blood Transfusion of FMBA Recruiting Kirov, Russian Federation, 610027 Spain Hospital General Universitario de Alicante Recruiting Alicante, Spain, 3010 Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Hospital Universitari i Politecnic La Fe Recruiting Valencia, Spain, 46026 Turkey Istanbul University Cerrahpasa Medical Faculty Recruiting Istanbul, Turkey, 34098 Ege University Medical Faculty Recruiting Izmir, Turkey, 35040 Ege University Medical Faculty Recruiting Izmir, Turkey, 35100 Ondokuz Mayis Univ. Med. Fac. Recruiting Samsun, Turkey, 55139 收起 << |
NCT02864992 | Advanced (Stage IIIB/IV) Non-s... 展开 >>mall Cell Lung Cancer With MET Exon 14 (METex14) Skipping Alterations or MET Amplification 收起 << | Phase 2 | Recruiting | December 31, 2019 | - |
NCT02003924 | Nonmetastatic Castration-Resis... 展开 >>tant Prostate Cancer Prostate Cancer Cancer of the Prostate 收起 << | Phase 3 | Active, not recruiting | May 31, 2020 | - |
NCT02952586 | Squamous Cell Carcinoma of the... 展开 >> Head and Neck 收起 << | Phase 3 | Recruiting | May 18, 2022 | - |
NCT02252172 | Multiple Myeloma | Phase 3 | Active, not recruiting | November 22, 2022 | - |
NCT00813397 | Adhesion Prevention | Not Applicable | Completed | - | France ... 展开 >> CHU Amiens Nord Amiens Cedex 1, France, 80054 Hopital Avicenne Bobingy, France, 93009 Hopital Beaujon Clichy, France, 92110 Centre Hospitalier Simone Veil Eaubonne Cedex, France, 95602 Hopital Nord Marseille cedex 20, France, 13915 CHR Nantes-Hopital Hotel Dieu Nantes Cedex 1, France, 44093 CHU Hopital de le'Archet Nice, France, 06200 Institut Mutualiste Montsouris Paris, France, 75014 CHU Bordeaux-Hopital du Haut Leveque Pessac Cedex, France, 33604 CHU Lyon Sud Pierre Benite, France, 69495 Centre Hospitalier Intercommunal de Poissy Saint-German Poissy, France, 78300 CHU Charles Nicolle Rouen Cedex, France, 76031 CHU Bordeaux Saint Andre Talence Cedex 1, France, 33404 Hopital Purpan Toulouse Cedex 9, France, 31509 CHU Hopital Trousseau Tours, France, 37044 收起 << |
NCT01156870 | Neoplasm Malignant | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Investigational Site Number 840002 Cincinnati, Ohio, United States, 45267-0542 United States, Texas Investigational Site Number 840001 San Antonio, Texas, United States, 78229 France Investigational Site Number 250001 Toulouse Cedex, France, 31052 Spain Investigational Site Number 724002 Madrid, Spain, 28040 Investigational Site Number 724001 Madrid, Spain, 28050 收起 << |
NCT02927431 | - | Terminated(The study was stopp... 展开 >>ed early due to lack of enrollment.) 收起 << | - | - | |
NCT02239120 | Stroke Second... 展开 >>ary Prevention 收起 << | Phase 3 | Completed | - | - |
NCT02782741 | Glycogen Storage Disease Type ... 展开 >>II-Pompe's Disease 收起 << | Phase 3 | Recruiting | February 4, 2022 | - |
NCT02799602 | Prostatic Neoplasms | Phase 3 | Active, not recruiting | August 1, 2022 | - |
NCT02200614 | Prostate Cancer Non-Metastatic... 展开 >> Castration-Resistant 收起 << | Phase 3 | Active, not recruiting | June 30, 2020 | - |
NCT00123474 | Myeloid Leukemia, Chronic, Chr... 展开 >>onic-Phase 收起 << | Phase 3 | Completed | - | - |
NCT02112175 | Multiple Myeloma | Phase 3 | Active, not recruiting | October 12, 2020 | - |
NCT02003924 | - | Active, not recruiting | - | - | |
NCT02927431 | Virus Diseases | Phase 2 | Terminated(The study was stopp... 展开 >>ed early due to lack of enrollment.) 收起 << | - | - |
NCT02164513 | - | Completed | - | - | |
NCT02184416 | - | Recruiting | July 20, 2019 | - | |
NCT02437318 | Breast Cancer | Phase 3 | Active, not recruiting | April 15, 2020 | - |
NCT02674308 | - | Recruiting | June 30, 2022 | - | |
NCT00123474 | - | Completed | - | - | |
NCT02559284 | Polyp of Ethmoidal Sinus ... 展开 >> Surgery 收起 << | Not Applicable | Completed | - | France ... 展开 >> Service d'Oto-rhino-laryngologie - Clinique Saint-Augustin Bordeaux, Gironde, France, 33074 Service d'Oto-rhino-laryngologie et Chirurgie cervico-faciale - Hôpital Pellegrin Bordeaux, Gironde, France, 33076 ORL et Chirurgie Cervico-faciale - Pôle Voies Respiratoires - CHU Toulouse Toulouse cedex 9, Haute-Garonne, France, 31059 Service d'ORL et Chirurgie cervico faciale - CHRU Tours Tours cedex 1, Indre-et-Loire, France, 37044 Service d'oto-rhino-laryngologie - CHU de Nantes Nantes Cedex 1, Loire-Atlantique, France, 44093 Service ORL et Chirurgie Cervico-faciale - CHRU Nancy Nancy CEDEX, Meurthe-et-Moselle, France Service ORL et Chirurgie cervico-faciale - CHRU Lille Lille cedex, Nord, France, 59037 ORL et Chirurgie Cervico-faciale - Centre Hospitalier Intercommunal (CHI) de Créteil Créteil cedex, Val-de-Marne, France, 94010 收起 << |
NCT01241396 | - | Completed | - | - | |
NCT02286362 | - | Completed | - | - | |
NCT01843374 | Unresectable Pleural or Perito... 展开 >>neal Malignant Mesothelioma 收起 << | Phase 2 | Active, not recruiting | April 2, 2019 | - |
NCT02184195 | Germline BRCA1/2 Mutations and... 展开 >> Metastatic Adenocarcinoma of the Pancreas 收起 << | Phase 3 | Recruiting | July 31, 2019 | - |
NCT01843374 | - | Active, not recruiting | - | - | |
NCT03528694 | Non-muscle-invasive Bladder Ca... 展开 >>ncer 收起 << | Phase 3 | Recruiting | November 25, 2024 | - |
NCT02178956 | Gastric Cancer ... 展开 >> Gastroesophageal Junction Cancer 收起 << | Phase 3 | Active, not recruiting | June 2019 | - |
NCT00695266 | - | Completed | - | - | |
NCT01298531 | Axial Spondyloarthritis | Phase 4 | Completed | - | France ... 展开 >> Institut Calot - Fondation Hopale Berck-sur-Mer, France, 62608 Hopital Pellegrin Bordeaux Cedex, France, 33076 Centre Hospitalier, Service de Rhumatologie Cahors, France, 46000 CHU Hopital Gabriel Montpied Clermont-Ferrand, France, 63003 Centre Hospitalier Sud Francilien Corbeil Essonnes, France, 91100 Hopital Bicetre LE KREMLIN-BICETRE Cedex, France, 94275 CH Le Mans Le Mans, France, 72037 Chu Dupuytren, Rhumatologie et Therapeutique Limoges, France, 87042 CHU Lapeyronie, Immuno-Rhumatologie Montpellier, France, 34000 Hopital de l'Archet Nice, France, 06202 Hopital Porte Madeleine Orleans Cedex 1, France, 45032 H�al Saint-Antoine Paris, France, 75012 Hopital Cochin Paris, France, 75014 Hopital Saint Joseph - Service de Rhumatologie Paris, France, 75014 Hopital Bichat Paris, France, 75018 Service de Rhumatologie Paris, France, 75651 Cedex 13 CHU Bois Guillaume - Service de Rhumatologie Rouen, France, 76031 CHU de Saint Etienne, Hopital Nord Saint Etienne Cedex 2, France, 42055 Hopital Purpan Toulouse Cedex 09, France, 31059 收起 << |
NCT02079246 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT02310269 | - | Recruiting | September 27, 2023 | - | |
NCT02079246 | - | Completed | - | - | |
NCT01298531 | - | Completed | - | - | |
NCT01392079 | Chronic Lymphocytic Leukemia | Phase 2 | Unknown | December 2016 | Austria ... 展开 >> Hanuschkrankenhaus Wien Wien, Austria University Hospital Wien, Austria France Centre Hospitalier de la Côte Basque Bayonne, France Hopital Avicenne Bobigny Cedex, France, 93009 CHU Estaing Clermont-Ferrand, France Hôpital Henri Mondor, Creteil -APHP CRETEIL Cedex, France CHU de Grenoble Grenoble, France CHU Claude Huriez Lille, France Hôpital Edouard Herriot Lyon Lyon, France CHU de Nancy NANCY Cedex, France CHU Nantes Nantes, France Hôpital Pitié Salpêtrière Paris-APHP Paris, France Hôpital Saint-Louis Paris -APHP Paris, France Centre Hospitalier Marechal Joffre Hôpital Saint-Jean Perpignan PERPIGNAN Cedex, France CHU de Poitiers POITIERS Cedex, France CHU Robert-Debre Reims, France, 51092 CHU de Tours Tours, France Germany Charité CBF Berlin Berlin, Germany University of Cologne Cologne, Germany Dresden Universtiy Hospital Dresden, Germany Essen University Essen, Germany Freiburg University Freiburg, Germany Goettingen University Goettingen, Germany LMU Munich Grosshadern, Germany AK St. Georg Hamburg Hamburg, Germany Hannover medical school (MHH) Hannover, Germany Heidelberg University Heidelberg, Germany Homburg/Saar University Homburg/Saar, Germany Dr. Soeling Kassel Kassel, Germany Kiel University Kiel, Germany Mainz University Mainz, Germany TU Munich Munich, Germany Nuernberg University Hospital Nuernberg, Germany OncoProGbR Regensburg Regensburg, Germany Universtiy of Tuebingen Tuebingen, Germany University of ulm Ulm, Germany, 89081 Dr. Schlag Wuerzburg Wuerzburg, Germany University Hospital Wuerzburg Wuerzburg, Germany 收起 << |
NCT01204749 | Fallopian Tube Cancer ... 展开 >> Ovarian Cancer Primary Peritoneal Cancer 收起 << | Phase 3 | Completed | - | - |
NCT01007734 | - | Completed | - | - | |
NCT01235962 | Cancer | Phase 3 | Active, not recruiting | April 15, 2019 | - |
NCT01721954 | Colorectal Cancer Metastatic | Phase 3 | Active, not recruiting | December 2019 | - |
NCT02580058 | Ovarian Cancer | Phase 3 | Active, not recruiting | December 19, 2018 | - |
NCT01121406 | - | Completed | - | - | |
NCT01631214 | Postmenopausal Women With Oste... 展开 >>oporosis 收起 << | Phase 3 | Completed | - | - |
NCT01313689 | Leukaemia | Phase 3 | Completed | - | - |
NCT00379366 | Renal Insufficiency, Chronic ... 展开 >> Graft Occlusion, Vascular Thrombosis Intimal Hyperplasia 收起 << | Phase 2 Phase 3 | Terminated(lack of patients) | - | France ... 展开 >> Clinc Delay Bayonne, France, 64100 Côte Basque Hospital Bayonne, France, 64109 Service de Chirurgie Vasculaire, Hôpital Pellegrin-tripode, CHU de Bordeaux Bordeaux cedex, France, 33076 Clinic Saint Augustin Bordeaux, France, 33000 Clinic Francheville Perigueux, France, 24000 收起 << |
NCT01441596 | Breast Neoplasms ... 展开 >> Neoplasm Metastasis 收起 << | Phase 2 | Completed | - | - |
NCT01121406 | Ovarian Neoplasms | Phase 2 | Completed | - | Belgium ... 展开 >> 1230.18.32003 Boehringer Ingelheim Investigational Site Brussel, Belgium 1230.18.32004 Boehringer Ingelheim Investigational Site Edegem, Belgium 1230.18.32002 Boehringer Ingelheim Investigational Site Gent, Belgium 1230.18.32001 Boehringer Ingelheim Investigational Site Leuven, Belgium France 1230.18.3321A Boehringer Ingelheim Investigational Site Angers Cedex 9, France 1230.18.3307A Boehringer Ingelheim Investigational Site Bordeaux cedex, France 1230.18.3301A Boehringer Ingelheim Investigational Site Caen, France 1230.18.3322A Boehringer Ingelheim Investigational Site Lille Cedex, France 1230.18.3313A Boehringer Ingelheim Investigational Site Lyon, France 1230.18.3312A Boehringer Ingelheim Investigational Site Nantes cedex 02, France 1230.18.3308A Boehringer Ingelheim Investigational Site Nice cedex, France 1230.18.3314A Boehringer Ingelheim Investigational Site Paris Cedex 20, France 1230.18.3302A Boehringer Ingelheim Investigational Site Paris, France 1230.18.3309A Boehringer Ingelheim Investigational Site Pierre-Bénite cedex, France 1230.18.3305A Boehringer Ingelheim Investigational Site Reims cedex, France 1230.18.3320A Boehringer Ingelheim Investigational Site Saint-Brieuc cedex, France 1230.18.3311A Boehringer Ingelheim Investigational Site Strasbourg, France 1230.18.3310A Boehringer Ingelheim Investigational Site Toulouse Cedex 9, France 1230.18.3315A Boehringer Ingelheim Investigational Site Vandoeuvre les Nancy cedex, France Slovakia 1230.18.42101 Boehringer Ingelheim Investigational Site Bratislava, Slovakia 1230.18.42103 Boehringer Ingelheim Investigational Site Poprad, Slovakia Spain 1230.18.34006 Boehringer Ingelheim Investigational Site Badalona, Spain 1230.18.34001 Boehringer Ingelheim Investigational Site Barcelona, Spain 1230.18.34005 Boehringer Ingelheim Investigational Site Barcelona, Spain 1230.18.34007 Boehringer Ingelheim Investigational Site Girona, Spain 1230.18.34004 Boehringer Ingelheim Investigational Site L'Hospitalet de Llobregat, Spain 1230.18.34002 Boehringer Ingelheim Investigational Site Madrid, Spain 1230.18.34003 Boehringer Ingelheim Investigational Site Madrid, Spain Sweden 1230.18.46005 Boehringer Ingelheim Investigational Site Linköping, Sweden 1230.18.46001 Boehringer Ingelheim Investigational Site Stockholm, Sweden 1230.18.46003 Boehringer Ingelheim Investigational Site Uppsala, Sweden 收起 << |
NCT01441596 | - | Completed | - | - | |
NCT01313689 | - | Completed | - | - | |
NCT01448044 | Hepatitis C | Phase 3 | Completed | - | United States, California ... 展开 >> Scti Research Foundation San Clemente, California, United States, 92673 United States, Massachusetts Umass Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, Rhode Island University Gastroenterology Providence, Rhode Island, United States, 02905 United States, Virginia Metropolitan Research Annandale, Virginia, United States, 22003 France Local Institution Bondy Cedex, France, 93143 Local Institution Creteil, France, 94000 Local Institution La Roche-Sur-Yon Cedex 9, France, 85925 Local Institution Marseille Cedex 08, France, 13285 Local Institution Nice Cedex 03, France, 06202 Local Institution Orleans Cedex 2, France, 45067 Local Institution Paris, France, 75013 Local Institution Paris, France, 75475 Local Institution Strasbourg Cedex, France, 67091 Local Institution Toulouse Cedex 09, France, 31059 Local Institution Villejuif, France, 94804 Greece Local Institution Thesaloniki, Greece, 54639 Italy Local Institution Roma, Italy, 00149 Local Institution Torino, Italy, 10126 Puerto Rico Local Institution San Juan, Puerto Rico, 00927 Spain Local Institution A Coruna, Spain, 15706 Local Institution Barcelona, Spain, 08003 Local Institution Barcelona, Spain, 08035 Local Institution Madrid, Spain, 28046 United Kingdom Local Institution London, Greater London, United Kingdom, SE5 9RS Local Institution London, Greater London, United Kingdom, SW17 0QT Local Institution London, Greater London, United Kingdom, W2 1NY 收起 << |
NCT01448044 | - | Completed | - | - | |
NCT00537095 | Thyroid Neoplasms | Phase 2 | Active, not recruiting | December 31, 2019 | Belgium ... 展开 >> Research Site Brussels, Belgium Denmark Research Site Odense, Denmark France Research Site Angers Cedex 9, France Research Site Angers Cedex, France Research Site Bordeaux Cedex, France Research Site Caen Cedex 5, France Research Site Caen Cedex, France Research Site Lyon Cedex, France Research Site Lyon, France Research Site Marseille Cedex 9, France Research Site Marseille Cedex, France Research Site Paris Cedex 10, France Research Site Paris Cedex 13, France Research Site Paris, France Research Site Villejuif Cedex, France Research Site Villejuif, France Norway Research Site Oslo, Norway Spain Research Site L'Hospitalet de Llobregat, Spain Research Site Madrid, Spain Sweden Research Site Lund, Sweden Research Site Stockholm, Sweden Switzerland Research Site Bern, Switzerland 收起 << |
NCT01244191 | Non Squamous, Non-small-cell L... 展开 >>ung Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00537095 | - | Active, not recruiting | - | - | |
NCT01492504 | - | Completed | - | - | |
NCT02257736 | Prostatic Neoplasms | Phase 3 | Active, not recruiting | August 24, 2021 | - |
NCT01631214 | - | Completed | - | - | |
NCT01428063 | Hepatitis C Virus Infection | Phase 2 | Completed | - | - |
NCT03112174 | Mantle-Cell Lymphoma | Phase 3 | Recruiting | September 2022 | - |
NCT00312754 | HIV Infections | Phase 4 | Terminated(insufficient enroll... 展开 >>ment) 收起 << | - | France ... 展开 >> Local Institution Bobigny, France, 93009 Local Institution Le Kremlin Bicetre, France, 94270 Local Institution Paris Cedex 15, France, 75908 Local Institution Paris Cedex 20, France, 75970 Local Institution Paris, France, 75651 Local Institution Paris, France, 75877 收起 << |
NCT02414139 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Recruiting | September 30, 2022 | - |
NCT01345019 | Cancer Hemato... 展开 >>logic Malignancies Multiple Myeloma Oncology Bone Metastases Multiple Myeloma Bone Lesions 收起 << | Phase 3 | Active, not recruiting | July 12, 2019 | - |
NCT01272362 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 4 | Completed | - | - |
NCT01345019 | - | Active, not recruiting | - | - | |
NCT03078036 | - | Active, not recruiting | September 30, 2018 | - | |
NCT01428063 | - | Completed | - | - | |
NCT02951052 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Active, not recruiting | February 8, 2022 | - |
NCT01930786 | - | Completed | - | - | |
NCT01347580 | Myocardial Infarction ... 展开 >> Segment Elevation Myocardial Infarction (STEMI) 收起 << | Phase 4 | Completed | - | - |
NCT01122472 | Lymphoma Diff... 展开 >>use Large B-cell Lymphoma 收起 << | Phase 3 | Active, not recruiting | September 2019 | - |
NCT02631538 | Sjogren's Syndrome | Phase 2 | Active, not recruiting | August 26, 2020 | - |
NCT01347580 | - | Completed | - | - | |
NCT02654145 | Asthma | Phase 4 | Completed | - | - |
NCT02654145 | - | Completed | - | - | |
NCT02325739 | HCC | Phase 1 Phase 2 | Active, not recruiting | July 15, 2020 | - |
NCT01294020 | Intestine Transplantation ... 展开 >> Kidney Transplantation Lung Transplantation Liver Transplantation Heart Transplantation 收起 << | Phase 2 | Active, not recruiting | May 2026 | Belgium ... 展开 >> Site BE21 Brussels, Belgium, 1020 Site BE22 Brussels, Belgium, 1200 Czechia Site CZ42 Prague 5, Czechia, 150 06 France Site FR34 Bron Cedex, France, 69677 Site FR35 BRON Cedex, France, 69677 Site FR31 Paris Cedex 15, France, 75743 Site FR32 Paris Cedex 15, France, 75743 Site FR33 Paris Cedex 15, France, 75908 Germany Site DE41 Heidelberg, Germany, 69120 Italy Site IT74 Bergamo, Italy, 24127 Site IT75 Palermo, Italy, 90127 Poland Site PL51 Warsaw, Poland, 04-730 Site PL52 Warsaw, Poland, 04-730 United Kingdom Site GB62 Birmingham, United Kingdom, B4 6NH Site GB64 London, United Kingdom, WC1 3JH Site GB61 Manchester, United Kingdom, M27 4HA 收起 << |
NCT01835236 | Metastatic Breast Cancer | Phase 2 | Active, not recruiting | November 30, 2019 | - |
NCT00317941 | Relapsing-remitting Multiple S... 展开 >>clerosis 收起 << | Phase 4 | Completed | - | - |
NCT01732822 | - | Completed | - | - | |
NCT01223027 | - | Completed | - | - | |
NCT01732822 | Peripheral Artery Disease | Phase 3 | Completed | - | - |
NCT00317941 | - | Completed | - | - | |
NCT02118584 | Ulcerative Colitis | Phase 3 | Recruiting | April 8, 2025 | - |
NCT01663402 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT02924727 | Acute Myocardial Infarction | Phase 3 | Recruiting | April 27, 2020 | - |
NCT01818752 | - | Completed | - | - | |
NCT01223027 | Metastatic Renal Cell Carcinom... 展开 >>a 收起 << | Phase 3 | Completed | - | - |
NCT02576509 | Hepatocellular Carcinoma | Phase 3 | Active, not recruiting | July 14, 2020 | - |
NCT02145468 | - | Completed | - | - | |
NCT02145468 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT02364284 | - | Completed | - | Brazil ... 展开 >> Research Site Belo Horizonte, Brazil Research Site Campinas, Brazil Research Site Porto Alegre, Brazil France Research Site Argenteuil, France Research Site Bordeaux Cedex, France Research Site Creteil cedex, France Research Site Limoges cedex, France Research Site Lyon Cedex 03, France Research Site Nantes Cedex 1, France Greece Research Site Athens, Greece Research Site Heraklion, Greece Research Site Patras, Greece Research Site Thessaloniki, Greece Italy Research Site Bologna, Italy Research Site Brescia, Italy Research Site Monza, Italy Research Site Roma, Italy Research Site Vicenza, Italy Russian Federation Research Site Moscow, Russian Federation Research Site Novosibirsk, Russian Federation Research Site Saint-Petersburg, Russian Federation Research Site Sestroretsk, St. Petersburg, Russian Federation Spain Research Site Badalona, Spain Research Site Barcelona, Spain Research Site Oviedo, Spain Research Site Sevilla, Spain Research Site Terrassa, Spain 收起 << | |
NCT01818752 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT01363817 | Lymphoblastic Leukemia, Acute ... 展开 >>T-cell Precursor T-Cell Lymphoblastic Lymphoma 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Texas The University Of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 France Local Institution Marseille Cedex 9, France, 13273 Local Institution Paris Cedex 10, France, 75475 Germany Johann Wolfgang Goethe Universitaet Frankfurt/main, Germany, 60590 收起 << |
NCT01345682 | Head and Neck Neoplasms ... 展开 >> Carcinoma, Squamous Cell 收起 << | Phase 3 | Completed | - | - |
NCT01957436 | Metastatic Prostate Cancer | Phase 3 | Recruiting | December 2030 | - |
NCT01769196 | - | Terminated(The Study was termi... 展开 >>nated due to lack of efficacy.) 收起 << | - | - | |
NCT01618370 | Prostatic Neoplasms | Phase 3 | Completed | - | - |
NCT00558025 | - | Completed | - | - | |
NCT01769196 | Idiopathic Pulmonary Fibrosis | Phase 2 | Terminated(The Study was termi... 展开 >>nated due to lack of efficacy.) 收起 << | - | - |
NCT01345682 | - | Completed | - | - | |
NCT01376752 | Ovarian Epithelial Cancer Recu... 展开 >>rrent 收起 << | Phase 3 | Recruiting | December 2020 | Belgium ... 展开 >> Institut Jules Bordet Recruiting Brussels, Belgium Principal Investigator: Gabriel LIBERALE France CHU d'AMIENS Recruiting Amiens, France Principal Investigator: Sophie SANGUIN Centre Paul Papin Recruiting Angers Cedex 9, France, 49933 Contact: Gérard LORIMIER, Doctor g.lorimier@angers.fnclcc.fr Principal Investigator: Romuald WERNERT Centre Hospitaleir Universitaire Jean Minjoz Not yet recruiting Besancon, France, 25000 Contact: Elsa KALBACHER, Dr ekalbacher@gmail.com Principal Investigator: Elsa KALBACHER Institut Bergonie Recruiting Bordeaux Cedex, France, 33076 Contact: Frédéric GUYON, Doctor guyon@bergonie.org Principal Investigator: Frédéric GUYON Centre Francois Baclesse Not yet recruiting Caen Cedex 3, France, 14076 Contact: Jean-Marc GUILLOIT, Doctor jm.guilloit@baclesse.fr Principal Investigator: Jean-Marc GUILLOIT Centre Jean Perrin Recruiting Clermont-ferrand Cedex 1, France, 63011 Contact: Christian POMEL, Pr Christophe.POMEL@cjp.fr Principal Investigator: Christian POMEL Centre hospitalier de Dijon Recruiting Dijon, France Principal Investigator: Jean-Marc ROUSSELET CHU Grenoble Not yet recruiting Grenoble, France, 38043 Contact: Fabien PETITPERRIN FPetitperrin@chu-grenoble.fr Principal Investigator: Fabien PETITPERRIN CHU de Grenoble Recruiting Grenoble, France Principal Investigator: Cristina COSTAN Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Eric LEBLANC, Dr e-leblanc@o-lambret.fr Principal Investigator: Eric LEBLANC Centre Hospitalier Universitaire Dupuytren Recruiting Limoges, France, 87042 Contact: Sylvaine DURAND-FONTANIER, Doctor sylvainedurand-fontanier@voila.fr Principal Investigator: Sylvaine DURAND-FONTANIER Centre Leon Berard Recruiting Lyon Cedex 08, France, 69373 Contact: Pierre MEEUS, Doctor MEEUS@lyon.fnclcc.fr Principal Investigator: Pierre MEEUS Institut Paoli Calmettes Recruiting Marseille Cedex 9, France, 13273 Contact: Gilles HOUVENAEGHEL, Pr houvenaeghelg@marseille.fnclcc.fr Principal Investigator: Gilles HOUVENAEGHEL AP-HM - Hôpital de la Timone Recruiting Marseille, France Principal Investigator: Aubert AGOSTINI CRLC Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: François QUENET francois.quenet@montpellier.unicancer.fr Principal Investigator: François QUENET Centre Hospitalier Universitaire Nice - Hopital L'Archet 2 Not yet recruiting Nice Cedex 3, France, 06202 Contact: Jean-Marc BEREDER, Dr ber224@chu-nice.fr Principal Investigator: Jean-Marc BEREDER Hopital Lariboisiere Not yet recruiting Paris, France, 75010 Contact: Marc POCARD marc.pocard@lrb.aphp.fr Principal Investigator: Marc POCARD Hopital Tenon Not yet recruiting Paris, France, 75020 Contact: Valeria LOI, Dr valeria.loi@tnn.aphp.fr Principal Investigator: Valeria LOI Hôpital Européen Georges Pompidou Recruiting Paris, France Principal Investigator: Fabrice LECURU Institut Curie Recruiting Paris, France Principal Investigator: Pascale MARIANI Institute Curie Recruiting Paris, France Contact: Bernard BARANGER bernard.baranger@curie.net Principal Investigator: Bernard BARANGER Centre Hopsitalier Lyon Sud Recruiting Pierre-benite Cedex, France, 69495 Contact: Olivier GLEHEN, Professor olivier.glehen@chu-lyon.fr Principal Investigator: Olivier GLEHEN CHU - Hôpital de la Milétrie Recruiting Poitiers, France Principal Investigator: Cédric NADEAU Centre Jean Godinot Not yet recruiting Reims Cedex, France, 51056 Contact: David KERE, Dr david.kere@reims.fnclcc.fr Principal Investigator: David KERE Centre Hospitalier Universitaire Saint Etienne- Hopital Nord Not yet recruiting Saint-etienne, France, 42055 Contact: Karine ABBOUD, Dr abboud_go@yahoo.fr Principal Investigator: Karine ABBOUD Ico-Centre Rene Gauducheau Recruiting Saint-herblain Cedex, France, 44805 Contact: Jean-Marc CLASSE, Professor jm-classe@nantes.fnclcc.fr Principal Investigator: Jean-Marc CLASSE CHU Hautepierre Not yet recruiting Strasbourg, France, 67098 Contact: Cécile BRIGAND cecile.brigand@chru-strasbourg.fr Principal Investigator: Cécile BRIGAND Institut Claudius Regaud Recruiting Toulouse Cedex, France, 31052 Contact: Gwenaël FERRON, Doctor ferron.gwenael@claudiusregaud.fr Principal Investigator: Gwenaël FERRON Centre Alexis Vautrin Recruiting Vandoeuvre-les-nancy Cedex, France, 54511 Contact: Frédéric MARCHAL, Pr f.marchal@nancy.fnclcc.fr Principal Investigator: Frédéric MARCHAL Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Sébastien GOUY, Doctor sebastien.gouy@igr.fr Principal Investigator: Sébastien GOUY Spain Hospital Universitari Germans Trias I Pujol Recruiting Badalona, Spain Principal Investigator: Juan José TORRENT 收起 << |
NCT00558025 | Parkinson Disease | Phase 3 | Completed | - | France ... 展开 >> 248.636.3303A Boehringer Ingelheim Investigational Site Aix en Provence, France 248.636.3303B Boehringer Ingelheim Investigational Site Aix en Provence, France 248.636.3303C Boehringer Ingelheim Investigational Site Aix en Provence, France 248.636.3307C Boehringer Ingelheim Investigational Site Bron cedex, France 248.636.3309B Boehringer Ingelheim Investigational Site Clermont Ferrand, France 248.636.3305A Boehringer Ingelheim Investigational Site Créteil, France 248.636.3305B Boehringer Ingelheim Investigational Site Créteil, France 248.636.3313A Boehringer Ingelheim Investigational Site Dijon cedex, France 248.636.3304A Boehringer Ingelheim Investigational Site Evreux, France 248.636.3308B Boehringer Ingelheim Investigational Site Lille cedex, France 248.636.3308C Boehringer Ingelheim Investigational Site Lille cedex, France 248.636.3308D Boehringer Ingelheim Investigational Site Lille cedex, France 248.636.3308E Boehringer Ingelheim Investigational Site Lille cedex, France 248.636.3302A Boehringer Ingelheim Investigational Site Marseille cedex 5, France 248.636.3302B Boehringer Ingelheim Investigational Site Marseille cedex 5, France 248.636.3306B Boehringer Ingelheim Investigational Site Montpellier, France 248.636.3312A Boehringer Ingelheim Investigational Site Rouen, France 248.636.3312B Boehringer Ingelheim Investigational Site Rouen, France 248.636.3311A Boehringer Ingelheim Investigational Site Strasbourg, France 248.636.3301A Boehringer Ingelheim Investigational Site Toulouse cedex, France 248.636.3301B Boehringer Ingelheim Investigational Site Toulouse cedex, France 248.636.3301D Boehringer Ingelheim Investigational Site Toulouse cedex, France Germany 248.636.49006 Boehringer Ingelheim Investigational Site Achim bei Bremen, Germany 248.636.49003 Boehringer Ingelheim Investigational Site Berlin-Steglitz, Germany 248.636.49004 Boehringer Ingelheim Investigational Site Berlin, Germany 248.636.49007 Boehringer Ingelheim Investigational Site Berlin, Germany 248.636.49008 Boehringer Ingelheim Investigational Site Berlin, Germany 248.636.49002 Boehringer Ingelheim Investigational Site Gera, Germany 248.636.49001 Boehringer Ingelheim Investigational Site Karlsruhe, Germany 248.636.49005 Boehringer Ingelheim Investigational Site Unterhaching, Germany Netherlands 248.636.31005 Boehringer Ingelheim Investigational Site `s-hertogenbosch, Netherlands 248.636.31002 Boehringer Ingelheim Investigational Site Geldrop, Netherlands 248.636.31003 Boehringer Ingelheim Investigational Site Helmond, Netherlands 248.636.31006 Boehringer Ingelheim Investigational Site Maastricht, Netherlands 248.636.31004 Boehringer Ingelheim Investigational Site Nijmegen, Netherlands 248.636.31001 Boehringer Ingelheim Investigational Site Sittard, Netherlands 收起 << |
NCT02313909 | Stroke | Phase 3 | Terminated(Study halted early ... 展开 >>due to no efficacy improvement over aspirin at an interim analysis and very little chance of showing overall benefit if study were completed) 收起 << | - | - |
NCT01511913 | - | Active, not recruiting | November 28, 2020 | - | |
NCT02234323 | Hemophilia A | Phase 3 | Active, not recruiting | June 2019 | - |
NCT01991795 | Diabetes Mellitus, Type 2 | Phase 3 | Active, not recruiting | December 28, 2018 | - |
NCT01813721 | - | Completed | - | - | |
NCT01697072 | Gastric Cancer | Phase 3 | Terminated(All Amgen sponsored... 展开 >> AMG102 clinical studies were terminated following a pre-planned Data Monitoring Committee safety review of study 20070622.) 收起 << | - | - |
NCT01444456 | - | Completed | - | - | |
NCT01813721 | - | Completed | - | - | |
NCT02187848 | Neoplasm Malignant | Phase 1 Phase 2 | Recruiting | February 17, 2021 | Canada ... 展开 >> Investigational Site Number 124001 Recruiting Toronto, Canada, M5G 2M9 France Investigational Site Number 250003 Recruiting Bordeaux Cedex, France, 33076 Investigational Site Number 250006 Recruiting Dijon, France, 21079 Investigational Site Number 250004 Recruiting Marseille Cedex 5, France, 13385 Investigational Site Number 250007 Recruiting Rennes, France, 35000 Investigational Site Number 250005 Recruiting Saint Mande, France, 94163 Investigational Site Number 250002 Recruiting Toulouse Cedex 9, France, 31059 Investigational Site Number 250001 Recruiting Villejuif Cedex, France, 94805 Korea, Republic of Investigational Site Number 410002 Recruiting Seoul, Korea, Republic of, 03080 Investigational Site Number 410003 Recruiting Seoul, Korea, Republic of, 06351 Investigational Site Number 410004 Recruiting Seoul, Korea, Republic of, 07061 Investigational Site Number 410001 Recruiting Seoul, Korea, Republic of, 138-736 Spain Investigational Site Number 724001 Recruiting Barcelona, Spain, 08035 Investigational Site Number 724004 Recruiting Madrid, Spain, 28040 Investigational Site Number 724003 Recruiting Madrid, Spain, 28050 Investigational Site Number 724002 Recruiting Majadahonda, Spain, 28222 收起 << |
NCT01444456 | - | Completed | - | - | |
NCT01975376 | - | Terminated(See Detailed Descri... 展开 >>ption) 收起 << | - | - | |
NCT01538680 | - | - | - | - | |
NCT01358747 | Hodgkin's Lymphoma | Phase 3 | Completed | - | - |
NCT01761266 | Hepatocellular Carcinoma (HCC) | Phase 3 | Active, not recruiting | March 2019 | - |
NCT02819635 | Ulcerative Colitis (UC) | Phase 3 | Recruiting | February 17, 2022 | - |
NCT01975376 | Cardiovascular Disease | Phase 3 | Terminated(See Detailed Descri... 展开 >>ption) 收起 << | - | - |
NCT02495974 | - | Active, not recruiting | March 2019 | - | |
NCT01761266 | - | Active, not recruiting | - | - | |
NCT02790138 | Colitis, Ulcerative | Phase 4 | Recruiting | March 9, 2019 | - |
NCT02087423 | - | Active, not recruiting | - | - | |
NCT01972841 | Urinary Bladder Overactive ... 展开 >> Urinary Bladder Diseases\Urologic Diseases Overactive Bladder Urgency Incontinence 收起 << | Phase 3 | Completed | - | - |
NCT02087423 | Non-Small Cell Lung Cancer | Phase 2 | Active, not recruiting | December 31, 2018 | - |
NCT01732926 | Indolent Non-Hodgkin's Lymphom... 展开 >>as 收起 << | Phase 3 | Terminated | - | - |
NCT01732926 | - | Terminated | - | - | |
NCT01828112 | Non-Small Cell Lung Cancer | Phase 3 | Active, not recruiting | February 15, 2021 | - |
NCT01387698 | - | Completed | - | - | |
NCT02607865 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01777152 | Anaplastic Large-Cell Lymphoma... 展开 >> Non-Hodgkin Lymphoma T-Cell Lymphoma 收起 << | Phase 3 | Active, not recruiting | December 2019 | - |
NCT01480245 | Muscular Dystrophies | Phase 3 | Terminated(The study was forma... 展开 >>lly terminated given that GSK is not submitting an application for regulatory approval for drisapersen in Duchenne Muscular Dystrophy.) 收起 << | - | - |
NCT03298412 | High-risk Diffuse Large B-cell... 展开 >> Lymphoma 收起 << | Phase 2 | Recruiting | May 31, 2021 | - |
NCT01828112 | - | Active, not recruiting | - | - | |
NCT01972841 | - | Completed | - | - | |
NCT02024646 | Psoriatic Arthritis | Phase 3 | Completed | - | - |
NCT01405820 | Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 2 | Completed | - | - |
NCT02352948 | Non - Small Cell Lung Cancer N... 展开 >>SCLC 收起 << | Phase 3 | Active, not recruiting | December 31, 2018 | - |
NCT02504216 | Peripheral Artery Disease | Phase 3 | Active, not recruiting | October 14, 2019 | - |
NCT01590589 | - | Completed | - | - | |
NCT02104245 | Non Cystic Fibrosis Bronchiect... 展开 >>asis 收起 << | Phase 3 | Completed | - | - |
NCT02100696 | Ulcerative Colitis | Phase 3 | Recruiting | December 26, 2020 | - |
NCT01633060 | Metastatic Breast Cancer | Phase 3 | Completed | - | - |
NCT00528073 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01405820 | - | Completed | - | - | |
NCT02039947 | Melanoma and Brain Metastases | Phase 2 | Completed | - | - |
NCT02092922 | Advanced Multiple Myeloma | Phase 2 | Completed | - | - |
NCT02562443 | Myelodysplastic Syndrome ... 展开 >> MDS Refractory Anemia With Excess Blasts RAEB 收起 << | Phase 3 | Recruiting | September 2019 | - |
NCT02872714 | UC (Urothelial Cancer) | Phase 2 | Recruiting | January 2020 | - |
NCT02365597 | Urothelial Cancer | Phase 2 | Enrolling by invitation | December 31, 2019 | - |
NCT01682083 | Melanoma | Phase 3 | Active, not recruiting | November 30, 2030 | - |
NCT02545049 | Diabetic Kidney Disease | Phase 3 | Active, not recruiting | July 21, 2021 | - |
NCT01682083 | - | Active, not recruiting | - | - | |
NCT01753349 | - | Completed | - | - | |
NCT03410693 | Carcinoma, Transitional Cell | Phase 2 Phase 3 | Recruiting | April 25, 2022 | - |
NCT01231620 | Influenza, Human | Phase 3 | Completed | - | - |
NCT02425644 | Multiple Sclerosis | Phase 3 | Active, not recruiting | May 15, 2019 | - |
NCT00478660 | Ankylosing Spondylitis | Phase 3 | Completed | - | - |
NCT00882128 | - | Completed | - | - | |
NCT00846807 | - | Completed | - | - | |
NCT01808092 | Nosocomial Pneumonia (NP) ... 展开 >> Ventilator-associated Pneumonia (VAP) 收起 << | Phase 3 | Completed | - | - |
NCT01231620 | - | Completed | - | - | |
NCT01018511 | - | Completed | - | - | |
NCT02343406 | Glioblastoma Multiforme | Phase 2 | Recruiting | December 13, 2020 | - |
NCT02013167 | Relapsed/Refractory B-precurso... 展开 >>r Acute Lymphoblastic Leukemia 收起 << | Phase 3 | Terminated | - | - |
NCT01808092 | - | Completed | - | - | |
NCT00908752 | Hepatocellular Carcinoma | Phase 3 | Completed | - | - |
NCT00846807 | - | Completed | - | - | |
NCT00825955 | Liver Cancer | Phase 3 | Terminated(Efficacy endpoint m... 展开 >>et, however, overall experimental dosing regimen is not considered optimal to support further clinical development in this patient population) 收起 << | - | - |
NCT01018511 | Benign Prostatic Hyperplasia ... 展开 >> Lower Urinary Tract Symptoms 收起 << | Phase 3 | Completed | - | - |
NCT01362140 | MDS | Phase 3 | Completed | - | - |
NCT01154140 | Non Squamous Lung Cancer | Phase 3 | Completed | - | - |
NCT01362140 | - | Completed | - | - | |
NCT01874353 | Platinum Sensitive ... 展开 >> BRCA Mutated Relapsed Ovarian Cancer Following Complete or Partial Response to Platinum Based Chemotherapy 收起 << | Phase 3 | Active, not recruiting | June 2, 2021 | - |
NCT02013167 | - | Terminated | - | - | |
NCT00749190 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT00749190 | - | Completed | - | - | |
NCT01828099 | Non-Small Cell Lung Cancer | Phase 3 | Active, not recruiting | April 11, 2022 | - |
NCT01828099 | - | Active, not recruiting | - | - | |
NCT01525810 | - | Completed | - | - | |
NCT01870778 | Acute Heart Failure | Phase 3 | Completed | - | - |
NCT01336634 | Cancer | Phase 2 | Active, not recruiting | December 1, 2020 | - |
NCT00717470 | Kidney Transplantation | Phase 4 | Completed | - | - |
NCT01154140 | - | Completed | - | - | |
NCT01336634 | - | Active, not recruiting | - | - | |
NCT00695656 | - | Completed | - | - | |
NCT01874353 | - | Active, not recruiting | - | - | |
NCT00910091 | - | Completed | - | - | |
NCT02029495 | Psoriatic Arthritis | Phase 3 | Terminated(Sponsor Decision) | - | - |
NCT00960661 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00960661 | - | Completed | - | - | |
NCT01870778 | - | Completed | - | - | |
NCT00801294 | Colorectal Neoplasms | Phase 2 | Completed | - | France ... 展开 >> 1239.2.3305A clinique Saint Jean Lyon, France 1239.2.3305B Cabinet Médical Lyon, France 1239.2.3301A Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301B Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301C Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301D Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301E Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301F Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301G Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301H Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301I Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301J Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3301K Hôpital Saint Antoine Paris Cedex 12, France 1239.2.3302A Hôpital Tenon Paris Cedex 20, France 1239.2.3302B Hôpital Tenon Paris Cedex 20, France 1239.2.3304A Hôpital Robert Debré Reims Cedex, France 1239.2.3304B Hôpital Robert Debré Reims Cedex, France 1239.2.3304C Hôpital Robert Debré Reims Cedex, France 1239.2.3303A Institut Gustave Roussy Villejuif Cedex, France 1239.2.3303B Institut Gustave Roussy Villejuif Cedex, France 1239.2.3303C Institut Gustave Roussy Villejuif Cedex, France 1239.2.3303D Institut Gustave Roussy Villejuif Cedex, France 1239.2.3303E Institut Gustave Roussy Villejuif Cedex, France 1239.2.3303F Institut Gustave Roussy Villejuif Cedex, France 收起 << |
NCT01308372 | - | Completed | - | - | |
NCT00910091 | Endometrial Cancer | Phase 2 | Completed | - | - |
NCT01055353 | - | Completed | - | - | |
NCT00689936 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT01639339 | Lupus Nephritis | Phase 3 | Active, not recruiting | February 5, 2020 | - |
NCT02029495 | - | Terminated(Sponsor Decision) | - | - | |
NCT00689936 | - | Completed | - | - | |
NCT00695175 | - | Completed | - | - | |
NCT00881530 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01933932 | - | Active, not recruiting | - | - | |
NCT02527200 | Metabolism and Nutrition Disor... 展开 >>der Obesity 收起 << | Phase 3 | Recruiting | August 10, 2020 | - |
NCT02369874 | Recurrent or Metastatic PD-L1-... 展开 >>positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN 收起 << | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT01933932 | Locally Advanced or Metastatic... 展开 >> Non Small Cell Lung Cancer Stage IIIb - IV 收起 << | Phase 3 | Active, not recruiting | December 31, 2018 | - |
NCT00864253 | Malignant Melanoma | Phase 3 | Completed | - | - |
NCT00881530 | - | Completed | - | - | |
NCT00864253 | - | Completed | - | - | |
NCT00866697 | Ovarian Cancer | Phase 3 | Completed | - | - |
NCT00831909 | - | Completed | - | - | |
NCT02626481 | Multiple Myeloma | Phase 2 | Active, not recruiting | January 2021 | Belgium ... 展开 >> AZ ST Jan hematology department Bruges, Belgium, 8000 Hematologie Laarbeeklaan Brussel, Belgium, 101 - 1090 Jules Bordet Institute Brussel, Belgium, B - 1000 CHU Dinant Godinne | UCL Namur asbl Yvoir, Belgium, 1 - 5530 France CHRU - Hôpital du Bocage (Amiens) Amiens, France, 49033 CHRU-Hôpital Sud d'Amiens Amiens, France, 80054 Hôpital Avicenne Bobigny, France, 93009 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33300 Hôpital du Haut Lévêque Centre François Magendie Bordeaux, France, 33604 Clinique - ICH CHU de Brest Hôpital Morvan Brest, France, 29609 CHRU Côte de Nacre Caen, France, 14033 Centre Hospitalier William Morey Chalon-sur-Saône, France, 71100 Hôpital d'instruction des armées Percy Clamart, France, 92141 Hématologie Clinique CHU DIJON Dijon, France, 21000 Centre Hospitalier Général Dunkerque, France, 59 385 CHRU, Hôpital A.Michallon Grenoble, France, 38043 Médecine interne Centre hospitalier départemental La Roche sur Yon, France, 85025 Service d'Hématologie CHV André Mignot Le Chesnay Cedex, France, 78157 CHRU , Hôpital Claude Huriez Lille, France Sce Hématologie Thérapie Cellulaire CHU Limoges Limoges, France, 87000 Institut Paoli Calmette Marseille, France, 13273 Hopital J Monod Sce Rhumato Nord Montivilliers, France, 76290 Service Hématologie CHRU Montpellier Montpellier, France, 34090 Hopital E Muller Mulhouse, France, 68100 Maladies du sang CHRU Hôtel Dieu Nantes, France, 44035 Hôpital Saint-Louis PARIS cedex 10, France, 75475 CHU - Hôpital St Antoine PARIS cedex 12, France, 75571 URC/CIC Paris Descartes Necker-Cochin Paris, France, 75015 Centre Hospitalier Lyon sud Pierre - Bénite, France, 69495 CHU de la milétrie Poitiers, France, 86000 Unité de Recherche Clinique - CH Périgueux Périgueux, France, 24019 Hôpital R.Debré Reims, France, 51032 Hôpital de Pontchaillou Rennes, France, 35033 Service d'Hématologie Clinique Institut de Cancérologie Lucien Neuwirth Saint Priest en Jarez, France, 42270 Service Hématologie Centre Hospitalier Yves le Foll Saint-Brieuc, France, 22000 Département d'Hématologie et Oncologie Hôpitaux Universitaires de Strasbourg Strasbourg, France, 67091 Hématologie CHRU IUCT Oncopole Toulouse cedex 9, France, 31100 Onco-hématologie CHRU Hôpital Bretonneau Tours cedex, France, 37044 Hôpitaux de Brabois Vandœuvre-lès-Nancy, France, 54511 service hématologie CH Bretagne Atlantique Vannes, France, 56017 Curie Institut ¨Paris, France, 75248 收起 << |
NCT00695838 | - | Completed | - | - | |
NCT01774344 | - | Active, not recruiting | - | - | |
NCT01062607 | - | Completed | - | - | |
NCT00866697 | - | Completed | - | - | |
NCT00799903 | - | Completed | - | - | |
NCT00799903 | Atherosclerosis | Phase 3 | Completed | - | - |
NCT01316939 | Crohn's Disease | Phase 3 | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - |
NCT02823574 | Head and Neck Cancer | Phase 2 | Active, not recruiting | January 30, 2024 | - |
NCT01330316 | - | Completed | - | - | |
NCT01318993 | Crohn's Disease | Phase 3 | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - |
NCT01316939 | - | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - | |
NCT01330316 | Hepatitis C | Phase 3 | Completed | - | - |
NCT01318993 | - | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - | |
NCT01774344 | Carcinoma, Hepatocellular | Phase 3 | Active, not recruiting | February 28, 2019 | - |
NCT02336451 | ALK-positive Non-small Cell Lu... 展开 >>ng Cancer 收起 << | Phase 2 | Recruiting | November 22, 2018 | - |
NCT01713946 | - | Completed | - | - | |
NCT00803049 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT00904839 | Colorectal Neoplasms | Phase 2 | Completed | - | - |
NCT01363752 | Kidney Transplantation | Phase 4 | Completed | - | - |
NCT01225562 | - | Completed | - | - | |
NCT00803049 | - | Completed | - | - | |
NCT01713946 | Tuberous Sclerosis Complex-ass... 展开 >>ociated Refractory Seizures 收起 << | Phase 3 | Completed | - | - |
NCT01225562 | Myocardial Infarction ... 展开 >> Cardiovascular Death Atherothrombosis Stroke 收起 << | Phase 3 | Completed | - | - |
NCT01087723 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT02752035 | Acute Myeloid Leukemia (AML) ... 展开 >> Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation 收起 << | Phase 2 Phase 3 | Recruiting | December 2021 | - |
NCT02207634 | - | Completed | - | - | |
NCT00904839 | - | Completed | - | - | |
NCT02207634 | Dyslipidemia | Phase 3 | Completed | - | - |
NCT01087723 | - | Completed | - | - | |
NCT00804167 | - | Completed | - | - | |
NCT01015118 | Ovarian Neoplasms ... 展开 >> Peritoneal Neoplasms 收起 << | Phase 3 | Completed | - | - |
NCT00737100 | - | Completed | - | - | |
NCT02255994 | Cystocele | Not Applicable | Completed | - | France ... 展开 >> Clinique Champeau Béziers, France, 34500 APHP - Hôpital Antoine Beclere Clamart Cedex, France, 92141 CHU de Clermont Ferrand - Hôpital Estaing Clermont Ferrand, France, 63003 APHP - Hôpital Beaujon Clichy, France, 92110 CH d'Issoire - Centre Hospitalier Paul Ardier Issoire, France, 63503 CH de la Rochelle La Rochelle Cedex, France, 17019 CH de Chartres - Hôpital Louis Pasteur Le Coudray, France, 28630 APHP - Centre Hospitalier Universitaire de Bicêtre Le Kremlin Bicêtre Cedex, France, 94275 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 CH d'Orange - Hôpital Louis Giorgi Orange, France, 84106 Clinique Mutualiste La Sagesse Rennes, France, 35000 CHU de Rouen - Hôpital Charles Nicolle Rouen, France, 76031 收起 << |
NCT01015118 | - | Completed | - | - | |
NCT00812357 | - | Completed | - | - | |
NCT01842607 | Asthma | Phase 3 | Completed | - | - |
NCT01587755 | Mild to Moderate Psoriasis | Phase 4 | Completed | - | - |
NCT03006068 | Ulcerative Colitis (UC) | Phase 3 | Enrolling by invitation | July 20, 2024 | - |
NCT01014988 | Influenza, Human | Phase 2 | Completed | - | - |
NCT01777256 | Systemic Lupus Erythematosus | Phase 2 | Terminated(This study met a pr... 展开 >>otocol defined futility criterion and will be terminated following completion of the Follow Up Visit on the last subject randomised.) 收起 << | - | - |
NCT01842607 | - | Completed | - | - | |
NCT01039376 | Leukaemia, Lymphocytic, Chroni... 展开 >>c 收起 << | Phase 3 | Completed | - | - |
NCT01894243 | Solid Tumours | Phase 1 | Completed | - | Czech Republic ... 展开 >> Research Site Brno, Czech Republic France Research Site Bordeaux Cedex, France Research Site Bordeaux, France Research Site Dijon, France Research Site Grenoble cedex 9, France Research Site Lyon Cedex 8, France Research Site Paris Cedex 13, France Korea, Republic of Research Site Seoul, Korea, Republic of Netherlands Research Site Amsterdam, Netherlands Research Site Maastricht, Netherlands United Kingdom Research Site London, United Kingdom Research Site Sutton, United Kingdom 收起 << |
NCT02051751 | Neoplasms, Breast Neoplasms, H... 展开 >>ead and Neck Neoplasms 收起 << | Phase 1 | Completed | - | United States, Arkansas ... 展开 >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Indiana Horizon Oncology Center BioAdvance Lafayette, Indiana, United States, 47905 France Novartis Investigative Site Toulouse Cedex 9, France, 31059 Italy Novartis Investigative Site Milano, MI, Italy, 20141 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 收起 << |
NCT01610414 | Herpes Zoster | Phase 3 | Completed | - | - |
NCT01039376 | - | Completed | - | - | |
NCT01036438 | Venous Leg Ulcers ... 展开 >> Mixed Leg Ulcers 收起 << | Phase 4 | Completed | - | - |
NCT01014988 | - | Completed | - | - | |
NCT00737100 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT01610414 | - | Completed | - | - | |
NCT02263508 | Melanoma | Phase 3 | Active, not recruiting | April 28, 2023 | - |
NCT01036438 | - | Completed | - | - | |
NCT01035229 | Carcinoma | Phase 3 | Completed | - | - |
NCT01035229 | - | Completed | - | - | |
NCT01045603 | - | Completed | - | - | |
NCT01021423 | - | Terminated(Terminated by spons... 展开 >>or due to new unpublished data that rendered the current design of the study no longer clinically relevant. There were no safety concerns.) 收起 << | - | - | |
NCT01458574 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT02296320 | Staphylococcus Aureus Pneumoni... 展开 >>a 收起 << | Phase 2 | Active, not recruiting | December 3, 2018 | - |
NCT02135692 | Asthma | Phase 3 | Completed | - | - |
NCT00455767 | Fibrosis Lung... 展开 >> Disease Respiratory Disorders Respiratory Distress Syndrome, Adult Acute Respiratory Distress Syndrome Pulmonary Fibrosis Inflammation 收起 << | Phase 2 | Completed | - | France ... 展开 >> Alain Mercat Angers, France, 49933 Yves Castaing Bordeaux, France, 33076 Laurent Brochard Créteil Cedex, France, 94010 Jean-François Timsit Grenoble Cedex 09, France, 38043 Claude Guerin Lyon, France, 69004 Samir Jaber Montpellier Cedex 05, France, 34295 Jean-Yves Fagon Paris Cedex 15, France, 75908 Jean-Daniel Chiche Paris Cedex, France, 75679 Jean-Jacques Rouby Paris, France, 75651 Jean-Christophe Richard Rouen Cedex, France, 76031 Jean-Michel Arnal Toulon, France, 83100 Italy Massimo Antonelli Roma, Italy, 00168 Spain Jordi Mancebo D. Barcelona, Spain, 08025 Tunisia Fekri Abroug Monastir, Tunisia 收起 << |
NCT02116582 | Metastatic Castration-Resistan... 展开 >>t Prostate Cancer 收起 << | Phase 4 | Completed | - | - |
NCT01458574 | - | Completed | - | - | |
NCT03043872 | Small Cell Lung Carcinoma Exte... 展开 >>nsive Disease 收起 << | Phase 3 | Recruiting | September 30, 2020 | - |
NCT01730534 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent High Risk for Cardiovascular Event 收起 << | Phase 3 | Completed | - | - |
NCT02116582 | - | Completed | - | - | |
NCT01064310 | Carcinoma, Renal Cell | Phase 3 | Completed | - | - |
NCT01277666 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT01064310 | - | Completed | - | - | |
NCT01732796 | Hepatitis C, Chronic | Phase 3 | Completed | - | - |
NCT01021423 | Mantle Cell Lymphoma ... 展开 >> Non-Hodgkin's Lymphoma 收起 << | Phase 3 | Terminated(Terminated by spons... 展开 >>or due to new unpublished data that rendered the current design of the study no longer clinically relevant. There were no safety concerns.) 收起 << | - | - |
NCT02155660 | Moderate to Very Severe Chroni... 展开 >>c Obstructive Pulmonary Disease 收起 << | Phase 3 | Completed | - | - |
NCT01732796 | - | Completed | - | - | |
NCT01104714 | - | Completed | - | France ... 展开 >> CH d'Alès Alès, France, 30103 CHU de Bordeaux - Groupe Hospitalier Saint-André Bordeaux, France, 33075 CHU de Bordeaux - Groupe Hospitalier Pellegrin Bordeaux, France, 33076 CHU de Grenoble Grenoble cedex 09, France, 38043 Centre de Lutte Contre le Cancer - Centre Oscar Lambret Lille Cedex, France, 59020 CHU de Montpellier - Hôpital Gui de Chauliac Montpellier cedex 5, France, 34295 Centre Regional de Lutte Contre le Cancer - Val d'Aurelle - Paul Lamarque Montpellier cedex 5, France, 34298 Centre Antoine Lacassagne Nice cedex 2, France, 06189 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes, France, 30029 CHRU de Toulouse - Hôpital Purpan Toulouse Cedex 9, France, 31059 Centre de Lutte Contre le Cancer - Institut Claudius Regaud Toulouse Cedex, France, 31052 Pharmacologie Clinique, expérim. des anticancéreux, CLCC Claudius Regaud Toulouse, France, 31052 CHRU de Toulouse - Hôpital de Rangueil Toulouse, France, 31059 CHRU de Toulouse - Hôpital Larrey Toulouse, France, 31059 收起 << | |
NCT00925470 | - | Completed | - | - | |
NCT01980628 | Marginal Zone Lymphoma ... 展开 >> B-cell Lymphoma 收起 << | Phase 2 | Completed | - | - |
NCT02631070 | Myelodysplastic Syndromes | Phase 3 | Active, not recruiting | November 5, 2020 | - |
NCT01980628 | - | Completed | - | - | |
NCT03319667 | Plasma Cell Myeloma | Phase 3 | Recruiting | January 2025 | - |
NCT00833573 | - | Completed | - | - | |
NCT01277666 | - | Completed | - | - | |
NCT00974311 | Castration-Resistant Prostate ... 展开 >>Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00322062 | Colonoscopy | Phase 3 | Completed | - | France ... 展开 >> Hôpital Jean Minjoz Besancon, France, 25030 Hôpital Mourier Colombes, France, 92700 Hôpital Huriez Lille cedex, France, 59037 Hôpital Dupuytren Limoges, France, 87000 Hôpital Edouard Herriot Lyon, France, 69003 Hôpital Nord Marseille Nord cedex 20, France, 13915 Centre Hospitalier Montelimar cedex, France, 26216 Centre Hospitalier Intercommunal Montfermeil, France, 93370 Centre Hospitalier De Montpellier Hôpital St Eloi Montpellier, France, 34000 Hôpital De L'Archet Nice cedex 3, France, 06202 Unité Endoscopies Digestives, Hôpital Lariboisière, 2 rue Ambroise Paré Paris cedex 10, France, 75475 Hôpital Cochin Paris cedex 14, France, 75379 Hôpital Bichat Claude Bernard Paris, France, 75018 Hôpital Croix Saint Simon Paris, France, 75020 Hôpital Civil / Clinique Medical B Strasbourg cedex, France, 67091 Hôpital Rangueil Toulouse, France, 31403 Hôpital Trousseau CHRU Tours, France, 37000 CHU De Brabois Vandoeuvre Les Nancy Cedex, France, 54511 收起 << |
NCT02083653 | Metastatic Colorectal Cancer | Phase 2 | Completed | - | - |
NCT01599754 | Clear Cell Renal Carcinoma | Phase 3 | Terminated(Primary endpoint di... 展开 >>d not reach statistical significance) 收起 << | - | - |
NCT02135692 | - | Completed | - | - | |
NCT01597908 | Melanoma | Phase 3 | Active, not recruiting | March 18, 2019 | - |
NCT01363466 | Stage IB2 Cervical Cancer ... 展开 >> Stage II Cervical Cancer Adenocarcinoma Squamous Cell Carcinoma Adenosquamous Carcinoma 收起 << | Phase 3 | Terminated(low recruitment) | - | France ... 展开 >> Clinique Axium Aix-en-Provence, France, 13100 Polyclinique du Parc Rambot Aix-en-Provence, France, 13100 Clinique Sainte Thérèse de l'enfant Jésus Amiens, France, 80039 Centre Hospitalier Universitaire Amiens, France, 80054 Centre Paul Papin Angers, France, 49033 Centre Hospitalier de Beauvais Beauvais, France, 60021 Institut Bergonié Bordeaux, France, 33076 Centre Hospitalier Nord Deux-Sèvres Bressuire Cedex, France, 79302 Centre Hospitalier Universitaire de Brest Brest, France, 29609 Centre Hospitalier Intercommunal Créteil, France, 94010 Centre Georges-François Leclerc Dijon, France, 21034 Centre Hospitalier de Fontainebleau Fontainebleau, France, 77305 Hôpital Hotel-Dieu Lyon Cedex 02, France, 69288 Centre Hospitalier Edouard Herriot Lyon, France, 69437 Centre Hospitalier Lyon Sud Lyon, France, 69495 Institut paoli Calmettes Marseille Cedex 09, France, 13273 Hôpital de la conception Marseille cedex 5, France, 13385 Centre Hospitalier Régional Universitaire La Timone Marseille, France, 13385 Centre Hospitalier Régional Universitaire Hôpital Nord Marseille, France, 13915 Centre Hospitalier Universitaire - Hôpital Arnaud de Villeneuve Montpellier, France, 34295 Centre Val d'Aurelle-Paul Lamarque Montpellier, France, 34298 Centre hospitalier des Pays de Morlaix Morlaix, France, 29205 Centre René Gauducheau Nantes, France, 44805 Hôpital de la Source Orléans, France, 45067 Hôpital des Diaconnesses Paris Cedex 12, France, 75571 Hôpital Européen Georges Pompidou Paris Cedex 15, France, 75908 Centre Hospitalier Universitaire Jean Bernard Poitiers Cedex, France, 86021 Polyclinique de Courlancy Reims, France, 51100 Clinique Mutualiste de la Sagesse Rennes Cedex, France, 35013 Centre Universitaire Hospitalier- Hôpital Sud Rennes, France, 35203 Centre Henri Becquerel Rouen, France, 76038 Centre René Huguenin Saint-Cloud, France, 92210 Institut Claudius Régaud Toulouse Cedex, France, 31052 Centre Hospitalier Bretonneau Tours, France, 37044 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT01597908 | - | Active, not recruiting | - | - | |
NCT03220425 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | - |
NCT01980173 | Postpartum Hemorrhage | Not Applicable | Terminated(recruitment difficu... 展开 >>lties) 收起 << | - | France ... 展开 >> CHU d'Angers - Hôtel-Dieu Angers, France, 49933 APHP - Hôpital Antoine Beclere Clamart Cedex, France, 92141 APHP - Centre Hospitalier Universitaire de Bicêtre Le Kremlin Bicêtre Cedex, France, 94275 APHM - Hôpital Nord Marseille Cedex 20, France, 13915 CHRU de Montpellier - Hôpital Arnaud de Villeneuve Montpellier, France, 34295 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 CHU de Saint Etienne - Hôpital Nord Saint-Priest en Jarez, France, 42270 收起 << |
NCT00974311 | - | Completed | - | - | |
NCT00801242 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT02696031 | Non-radiographic Spondyloarthr... 展开 >>itis 收起 << | Phase 3 | Recruiting | December 16, 2020 | - |
NCT01528345 | Metastatic Breast Cancer | Phase 2 | Terminated(Slow and low enroll... 展开 >>ment) 收起 << | - | - |
NCT01528345 | - | Terminated(Slow and low enroll... 展开 >>ment) 收起 << | - | - | |
NCT00440193 | Venous Thrombosis | Phase 3 | Completed | - | - |
NCT00440193 | - | Completed | - | - | |
NCT00490139 | Neoplasms, Breast | Phase 3 | Active, not recruiting | July 1, 2021 | - |
NCT00475605 | - | Active, not recruiting | August 2022 | - | |
NCT00490139 | - | Active, not recruiting | - | - | |
NCT00858871 | Hepato Cellular Carcinoma (HCC... 展开 >>) 收起 << | Phase 3 | Completed | - | - |
NCT01638000 | Urologic Diseases ... 展开 >> Urinary Bladder, Overactive Urinary Bladder Diseases 收起 << | Phase 3 | Completed | - | - |
NCT01231516 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Active, not recruiting | June 30, 2019 | - |
NCT01876784 | Differentiated Thyroid Cancer | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT01231516 | - | Active, not recruiting | - | - | |
NCT01638000 | - | Completed | - | - | |
NCT01876784 | - | Active, not recruiting | - | - | |
NCT03215706 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | May 20, 2020 | - |
NCT01564784 | Acute Lymphoblastic Leukemia | Phase 3 | Completed | - | - |
NCT00882336 | - | Completed | - | - | |
NCT00665366 | Bipolar Disorder Mania | Phase 3 | Completed | - | - |
NCT01564784 | - | Completed | - | - | |
NCT03599622 | Granulomatous Colitis ... 展开 >> Crohn's Disease Crohn's Enteritis Granulomatous Enteritis 收起 << | Phase 2 | Recruiting | September 28, 2021 | - |
NCT02966834 | Cholestasis | Phase 2 | Recruiting | April 1, 2020 | - |
NCT02395172 | - | Active, not recruiting | - | - | |
NCT01625338 | Chronic Hepatitis C | Phase 3 | Completed | - | - |
NCT02395172 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Active, not recruiting | January 16, 2023 | - |
NCT01342913 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT01125566 | Breast Neoplasms | Phase 3 | Completed | - | - |
NCT03138512 | Renal Cell Carcinoma | Phase 3 | Recruiting | July 7, 2023 | - |
NCT01625338 | - | Completed | - | - | |
NCT01566695 | Myelodysplastic Syndrome | Phase 3 | Active, not recruiting | August 31, 2021 | - |
NCT00665366 | - | Completed | - | - | |
NCT01125566 | - | Completed | - | - | |
NCT01342913 | - | Completed | - | - | |
NCT02022098 | Squamous Cell Carcinoma of the... 展开 >> Head and Neck 收起 << | Not Applicable | Active, not recruiting | April 2019 | France ... 展开 >> Centre Hospitalier de Bretagne Sud - HÔPITAL DU SCORFF Lorient, Bp 2233, France, 56322 C.H.U. Sud Amiens Amiens, France, 80054 ICO Paul Papin Angers Cedex 02, France, CS 10059 Institut Sainte-Catherine Avignon Cedex 9, France, 84918 CHU Côte de Nacre CAEN Cedex 09, France, CS30001 Centre Jean Perrin Clermont-Ferrand Cedex 01, France, BP 392 Centre Georges François Leclerc Dijon, France, 21079 CHU Grenoble Grenoble, France, BP 217 CHD Vendée La Roche Sur Yon cedex 9, France, F- 85925 Centre Guillaume le Conquérant Le Havre, France, 76600 Centre Jean Bernard Le Mans, France Centre Léon Berard Lyon, France Hôpital Nord Franche-Comté Montbéliard, France, 25200 ICM - Val D'Aurelle Montpellier, France, 34298 Institut Curie Paris, France, 75248 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancérologie de l'Ouest (ICO) René Gauducheau Saint-Herblain, France, BP 217 Institut de Cancérologie Lucien Neuwirth (ICLN) Saint-Priest en Jarez, France, BP 60008 Institut Claudius Regaud Toulouse, France, 31052 L'Institut de Cancérologie de Lorraine (ICL) Alexis Vautrin Vandoeuvre-lès-Nancy, France, CS 30519 Institut Gustave Roussy Villejuif, France, 94000 Switzerland Inselspital Bern, Universitätsklinik für Radio-Onkologie, Freiburgstrasse 4 Bern, Switzerland, 3010 Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland, 1011 收起 << |
NCT02362503 | HIV Infections | Phase 3 | Active, not recruiting | April 15, 2020 | - |
NCT02362503 | - | Active, not recruiting | - | - | |
NCT02536300 | Follicular Lymphoma | Phase 3 | Recruiting | May 2023 | - |
NCT01140581 | Atrial Fibrillation | Phase 4 | Completed | - | - |
NCT01767467 | Herpes Zoster | Phase 3 | Completed | - | - |
NCT03162055 | Chronic Obstructive Pulmonary ... 展开 >>Disease COPD 收起 << | Phase 3 | Completed | - | - |
NCT00866671 | - | Completed | - | Denmark ... 展开 >> GSK Investigational Site Aahur N, Denmark GSK Investigational Site Aalborg, Denmark, DK-9100 GSK Investigational Site Koebenhavn Oe, Denmark, 2100 GSK Investigational Site Odense C, Denmark France GSK Investigational Site Bordeaux cedex, France, 33076 GSK Investigational Site Lille Cedex, France, 59037 GSK Investigational Site Nantes Cedex 1, France, 44093 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Paris cedex 12, France, 75571 GSK Investigational Site Paris Cedex 19, France, 75935 GSK Investigational Site Vandoeuvre-Les-Nancy, France, 54511 Germany GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Hamburg, Germany, 20246 Israel GSK Investigational Site Beer-Sheva, Israel, 84101 GSK Investigational Site Haifa, Israel, 31096 GSK Investigational Site Petach-Tikva, Israel GSK Investigational Site Ramat Gan, Israel, 52621 Italy GSK Investigational Site Bologna, Emilia-Romagna, Italy, 40137 Netherlands GSK Investigational Site Rotterdam, Netherlands, 3015 GJ Poland GSK Investigational Site Bydgoszcz, Poland GSK Investigational Site Lublin, Poland, 20-093 GSK Investigational Site Warszawa, Poland, 00-576 GSK Investigational Site Warszawa, Poland, 02-781 GSK Investigational Site Wroclaw, Poland, 50-345 Russian Federation GSK Investigational Site Krasnodar, Russian Federation, 350007 GSK Investigational Site Moscow, Russian Federation, 117997 GSK Investigational Site Moscow, Russian Federation, 119049 Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Boadilla del Monte (Madrid), Spain, 28660 GSK Investigational Site Madrid, Spain, 28009 GSK Investigational Site Madrid, Spain, 28047 收起 << | |
NCT01970865 | ALK-positive Non Small Cell Lu... 展开 >>ng Cancer (NSCLC) and ROS1-positive NSCLC 收起 << | Phase 2 | Active, not recruiting | February 19, 2019 | - |
NCT02304679 | Erectile Dysfunction | Not Applicable | Recruiting | December 2019 | France ... 展开 >> CHU de Bordeax - Hôpital Pellegrin Recruiting Bordeaux, France, 33000 Sub-Investigator: Ludovic Ferretti, MD Sub-Investigator: Grégoire Robert, MD, PhD Sub-Investigator: Jean-Marie Ferriere, MD, PhD APHP - Hôpital Raymond-Poincaré Recruiting Garches, France, 92380 Principal Investigator: François Giuliano, MD, PhD Clinique Beau Soleil Recruiting Montpellier, France, 34070 Principal Investigator: Antoine Faix, MD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Stéphane Droupy, MD, PhD CHU de Lyon - Centre Hospitalier Lyon Sud Recruiting Pierre Benite, France, 69310 Principal Investigator: Nicolas Morel-Journel, MD 收起 << |
NCT01767467 | - | Completed | - | - | |
NCT01492426 | - | Completed | - | - | |
NCT01492426 | Hepatitis C | Phase 3 | Completed | - | - |
NCT00856986 | - | Completed | - | - | |
NCT01374906 | - | Completed | - | - | |
NCT00701402 | - | Completed | - | - | |
NCT00963105 | Relapsed or Refractory Chronic... 展开 >> Lymphocytic Leukemia 收起 << | Phase 2 | Completed | - | - |
NCT00734591 | - | Completed | - | - | |
NCT00734591 | - | Completed | - | - | |
NCT00963105 | - | Completed | - | - | |
NCT00856986 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00574249 | Chronic Plaque Psoriasis | Phase 3 | Completed | - | - |
NCT01374906 | Cushing's Disease | Phase 3 | Completed | - | - |
NCT02724020 | Clear-cell Metastatic Renal Ce... 展开 >>ll Carcinoma 收起 << | Phase 2 | Active, not recruiting | May 30, 2019 | - |
NCT01471210 | Cancer - Solid Tumors and B-Ce... 展开 >>ll Non-Hodgkin's Lymphoma 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States, 90095 Stanford University Medical Center Stanford, California, United States, 94305 United States, Illinois University Of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New Jersey John Theurer Cancer Center Hackensack, New Jersey, United States, 07601 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Oregon Providence Portland Med Ctr Portland, Oregon, United States, 97213 United States, Pennsylvania Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Hospital Of The University Of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Virginia University Of Virginia Health System Charlottesville, Virginia, United States, 22908 France Local Institution Creteil Cedex, France, 94010 Local Institution Lille Cedex, France, 59037 Local Institution Paris, France, 75475 Local Institution Pessac, France, 33604 Local Institution Pierre Benite Cedex, France, 69495 Local Institution Rennes Cedex 9, France, 35033 Local Institution Rouen, France, F-76038 Local Institution Villejuif Cedex, France, 94805 Germany Local Institution Essen, Germany, 45147 Spain Hospital Universitari Vall D'Hebron Barcelona, Spain, 08035 Fundacion Jimenez Diaz Madrid, Spain, 28040 Local Institution Pamplona, Spain, 31192 收起 << |
NCT00574249 | - | Completed | - | - | |
NCT02709109 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT01970865 | - | Active, not recruiting | - | - | |
NCT00694382 | Venous Thromboembolism ... 展开 >> Cancer 收起 << | Phase 3 | Completed | - | - |
NCT03274492 | Diffuse Large B-Cell Lymphoma | Phase 3 | Recruiting | April 15, 2023 | - |
NCT01276509 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT00847301 | - | Completed | - | - | |
NCT00847301 | - | Completed | - | - | |
NCT01658878 | Hepatocellular Carcinoma | Phase 1 Phase 2 | Active, not recruiting | December 26, 2019 | - |
NCT01276509 | - | Completed | - | - | |
NCT02617589 | Brain Cancer | Phase 3 | Recruiting | October 1, 2019 | - |
NCT03470922 | Melanoma | Phase 2 Phase 3 | Recruiting | March 16, 2022 | - |
NCT01004224 | Advanced Solid Tumors With Alt... 展开 >>erations of FGFR1, 2 and or 3 Squamous Lung Cancer With FGFR1 Amplification Bladder Cancer With FGFR3 Mutation or Fusion Advanced Solid Tumors With FGFR1 Amplication Advanced Solid Tumors With FGFR2 Amplication Advanced Solid Tumors With FGFR3 Mutation 收起 << | Phase 1 | Completed | - | - |
NCT01179347 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01668784 | - | Active, not recruiting | - | - | |
NCT01691521 | - | Completed | - | - | |
NCT01684423 | Venous Thrombosis | Phase 2 | Completed | - | - |
NCT01668784 | Advanced or Metastatic (Medica... 展开 >>lly or Surgically Unresectable) Clear-cell Renal Cell Carcinoma 收起 << | Phase 3 | Active, not recruiting | September 28, 2018 | - |
NCT02549170 | Chronic Inflammatory Demyelina... 展开 >>ting Polyradiculoneuropathy 收起 << | Phase 3 | Recruiting | December 31, 2021 | - |
NCT00622700 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT01691521 | Asthma | Phase 3 | Completed | - | - |
NCT00622700 | - | Completed | - | - | |
NCT01458951 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT01430494 | - | Completed | - | - | |
NCT00561925 | HIV Infections | Phase 3 | Completed | - | - |
NCT01179347 | - | Completed | - | - | |
NCT01732913 | Indolent Non-Hodgkin's Lymphom... 展开 >>as 收起 << | Phase 3 | Terminated | - | - |
NCT01458951 | - | Completed | - | - | |
NCT03417037 | Lung Cancer N... 展开 >>on-Small Cell Lung Cancer 收起 << | Phase 3 | Withdrawn(Business objectives ... 展开 >>have changed.) 收起 << | August 20, 2025 | - |
NCT01684423 | - | Completed | - | - | |
NCT01335477 | Pulmonary Fibrosis | Phase 3 | Completed | - | - |
NCT01732913 | - | Terminated | - | - | |
NCT01479465 | Colorectal Cancer | Phase 2 | Completed | - | - |
NCT00561925 | - | Completed | - | - | |
NCT01335477 | - | Completed | - | - | |
NCT02626455 | Lymphoma, Non-Hodgkin | Phase 3 | Recruiting | December 31, 2024 | - |
NCT03052608 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Recruiting | December 30, 2023 | - |
NCT01194882 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | Belgium ... 展开 >> Investigational Site Number 056-001 Leuven, Belgium, 3000 France Investigational Site Number 250-004 Corbeil Essonnes, France, 91100 Investigational Site Number 250-008 Dijon, France, 21000 Investigational Site Number 250-003 Dommartin Les Toul, France, 54200 Investigational Site Number 250-012 Le Mans Cedex 9, France, 72037 Investigational Site Number 250-009 LILLE Cedex, France, 59037 Investigational Site Number 250-007 Marseille, France, 13385 Investigational Site Number 250-001 MONTPELLIER Cedex 5, France, 34295 Investigational Site Number 250-005 Paris, France, 75014 Investigational Site Number 250-010 Pessac Cedex, France, 33604 Investigational Site Number 250-011 ST PRIEST EN JAREZ Cedex, France, 42277 Investigational Site Number 250-002 Strasbourg, France, 67091 Investigational Site Number 250-006 TOULOUSE Cedex 9, France, 31059 Netherlands Investigational Site Number 528003 Den Haag, Netherlands, 2512VA Investigational Site Number 528002 Roermond, Netherlands, 6043CV Investigational Site Number 528001 Zwolle, Netherlands, 8025AB Sweden Investigational Site Number 752-001 Stockholm, Sweden 收起 << |
NCT00626548 | Prostate Cancer | Phase 3 | Terminated(early efficacy revi... 展开 >>ew by the Independent Data Monitoring Committee indicated it was unlikely to meet its primary efficacy endpoints) 收起 << | - | - |
NCT00626548 | - | Terminated(early efficacy revi... 展开 >>ew by the Independent Data Monitoring Committee indicated it was unlikely to meet its primary efficacy endpoints) 收起 << | - | - | |
NCT01313637 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT01696396 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT02230969 | - | Active, not recruiting | January 24, 2022 | - | |
NCT00699374 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00601523 | Parkinson Disease | Phase 3 | Completed | - | - |
NCT00699374 | Carcinoma, Hepatocellular | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01955161 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT01313637 | - | Completed | - | - | |
NCT00463866 | Asthma | Phase 4 | Completed | - | - |
NCT01955161 | - | Completed | - | - | |
NCT00601523 | - | Completed | - | - | |
NCT00463866 | - | Completed | - | - | |
NCT02347657 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01101906 | Advanced Hepatocellular Carcin... 展开 >>oma (HCC) 收起 << | Phase 2 | Terminated(Company decided not... 展开 >> to pursue the development of this drug in this patient population at this time) 收起 << | - | - |
NCT00679224 | - | Completed | - | - | |
NCT00580216 | Atrial Fibrillation | Phase 3 | Terminated(early discontinuati... 展开 >>on based on strategic sponsor decision not driven by any safety concern) 收起 << | - | - |
NCT01753076 | Amyotrophic Lateral Sclerosis | Phase 2 | Completed | - | - |
NCT01520818 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02347657 | - | Completed | - | - | |
NCT00623623 | Myocardial Infarction | Phase 3 | Completed | - | - |
NCT01308567 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT00879333 | Advanced Gastric Cancer | Phase 3 | Completed | - | - |
NCT01315275 | Visual Impairment ... 展开 >> Macular Edema 收起 << | Phase 4 | Completed | - | France ... 展开 >> Novartis Investigative Site Amiens, France, 80054 Novartis Investigative Site Angers, France, 49044 Novartis Investigative Site Besançon cedex, France, 25030 Novartis Investigative Site Bobigny, France, 93009 Novartis Investigative Site Bordeaux, France, 33000 Novartis Investigative Site Bordeaux, France, 33100 Novartis Investigative Site Caen, France, 14050 Novartis Investigative Site Cesson Sevigne, France, 35510 Novartis Investigative Site Clermont-ferrand, France, 63014 Novartis Investigative Site Créteil, France, 94000 Novartis Investigative Site Grenoble, France, 38000 Novartis Investigative Site Lille, France, 59037 Novartis Investigative Site Lyon Cedex 04, France, 69317 Novartis Investigative Site Lyon, France, 69007 Novartis Investigative Site Lyon, France, 69275 Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Mantes la joile, France, 78201 Novartis Investigative Site Marseille cedex 05, France, 13385 Novartis Investigative Site Marseille, France, 13008 Novartis Investigative Site Melun, France, 77000 Novartis Investigative Site Montpellier, France, 34000 Novartis Investigative Site Montpellier, France, 34295 Novartis Investigative Site Nice, France, 06000 Novartis Investigative Site Nimes, France, 30029 Novartis Investigative Site Osny, France, 95520 Novartis Investigative Site Paris Cedex 19, France, 75940 Novartis Investigative Site Paris, Cedex 12, France, F-75571 Novartis Investigative Site Paris, France, 75006 Novartis Investigative Site Paris, France, 75007 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Puilboreau, France, 17138 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Rouen, France, 76100 Novartis Investigative Site Saint Brieuc, France, 22015 Novartis Investigative Site Saint Etienne, France, 42000 Novartis Investigative Site Saitnt Herblain, France, 44819 Novartis Investigative Site St Jean, France, 31240 Novartis Investigative Site St-Priest-en-Jarez, France, 42270 Novartis Investigative Site Strasbourg, France, 67000 Novartis Investigative Site Toulouse, France, 31077 Novartis Investigative Site Tours, France, 37044 Novartis Investigative Site Vandoeuvre les Nancy, France, 54511 Novartis Investigative Site Vannes, France, 56000 收起 << |
NCT00879333 | - | Completed | - | - | |
NCT01308567 | - | Completed | - | - | |
NCT00567502 | - | Completed | - | - | |
NCT00567502 | - | Completed | - | - | |
NCT01753076 | - | Completed | - | - | |
NCT00770250 | - | Completed | - | - | |
NCT01848561 | - | Recruiting | April 6, 2027 | - | |
NCT03767244 | Prostatic Neoplasms | Phase 3 | Not yet recruiting | December 28, 2027 | - |
NCT01734928 | Multiple Myeloma | Phase 3 | Active, not recruiting | May 1, 2022 | - |
NCT01220128 | - | Terminated(Study termination d... 展开 >>ue to negative Ph III of another study product from same technology platform.) 收起 << | - | - | |
NCT02555371 | Asthma | Phase 3 | Recruiting | April 25, 2019 | - |
NCT02047110 | Spondylitis, Ankylosing | Phase 2 | Completed | - | - |
NCT01220128 | Neoplasms, Breast | Phase 2 | Terminated(Study termination d... 展开 >>ue to negative Ph III of another study product from same technology platform.) 收起 << | - | - |
NCT00801242 | - | Completed | - | - | |
NCT00493298 | - | Recruiting | December 28, 2028 | - | |
NCT03153111 | Heart Failure With Preserved E... 展开 >>jection Fraction 收起 << | Phase 2 | Recruiting | May 18, 2020 | - |
NCT01107886 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT01170962 | Hepatitis C Virus | Phase 2 | Completed | - | - |
NCT02008890 | Palmoplantar Pustular Psoriasi... 展开 >>s 收起 << | Phase 3 | Completed | - | - |
NCT00699959 | - | Completed | - | - | |
NCT01107886 | - | Completed | - | - | |
NCT01170962 | - | Completed | - | - | |
NCT00934544 | Myelofibrosis | Phase 3 | Completed | - | - |
NCT02393859 | Leukemia, Acute Lymphoblastic | Phase 3 | Recruiting | July 25, 2023 | - |
NCT02136069 | Ulcerative Colitis | Phase 3 | Recruiting | March 30, 2023 | - |
NCT00934544 | - | Completed | - | - | |
NCT00069836 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00457002 | Venous Thrombosis ... 展开 >> Pulmonary Embolism 收起 << | Phase 3 | Completed | - | - |
NCT00875667 | Mantle Cell Lymphoma ... 展开 >> Lymphoma, Mantle-Cell 收起 << | Phase 2 | Active, not recruiting | July 5, 2019 | - |
NCT00694941 | Amyotrophic Lateral Sclerosis ... 展开 >>(ALS) 收起 << | Phase 2 | Completed | - | Belgium ... 展开 >> Prof. Maloteaux, UCL Saint-Luc Brussels, Belgium Prof. Wim Robberecht, UZ Leuven Leuven, Belgium France Prof. Alain Destee, Hopital Roger Salengro - Clinique Neurologique, Neurologie A Lille Cedex, France Prof. Philippe Couratier, Hopital Duruytren Limoges Cedex, France Prof. Jan Pouget, Hopital de la Timone Marseille, France Prof. William Camu, Hopital de Chauliac Montpellier cedex 5, France Prof. Claude Desnuelle, Hopital 1-Archet 1 Nice cedex 3, France Prof. Vincent Meininger, Hopital LaPitie Salpetriere Paris, France Germany Dr. Thomas Meyer, Charite Campus Virchow, ALS Ambulanz Berlin, Germany Prof. Torsten Grehl, Neurologische Ambulanz Universitatsklinik Bergmannsheil Bochum, Germany Professor Dieter Heuss, Poliklinik der Universitat Erlangen-Nurnberg, Neurologische Klinik Erlangen, Germany Prof. Stephan Zierz, Martin Luther Universitat Halle-Wittenberg, Klinikum der Medizinischen Fakultat, Universitatsklinik und Poliklinik fur Neurologie Halle, Germany Prof. Reinhard Dengler, Medizinische Hochschule Hannover, Neurologische Klinik Hannover, Germany Prof Gian Domenico Borasio, Interdisziplinares Zentrum fur Palliativmedizin Munchen, Germany Prof. Albert Ludolph, Klinik und Poliklinikfur Neurologie der Universitat Ulm-Univeritatsklinikum Ulm Ulm, Germany Dr. Berthold Schrank, Deutsche Klinik fur Diagnostik, Fachbereich Neurologie Wiesbarden, Germany Italy Prof. Vincenzo Silani, Dipartimento di Neurologia e Laboratorio di Neuroscienze - Universita di Milano - IRCCS - Istituto Auxologico Italiano Milano, Italy Dr. Gabriele Mora, Divisione di Neuroriabilitazione II - Fondazione Salvatore Maugeri - IRCCS Pavia, Italy Prof. Adriano Chio, Dipartimento di Neuroscienze - Divisione di Neurologia II - Azienda Ospedaliera S. Giovanni Battista - Molinette Torino, Italy Netherlands Prof Marianne de Visser, Academic Medical Centre (AMC) Amsterdam - Dept of Neurology Amsterdam, Netherlands Prof. Leonard H Van Den Berg, University Medical Center Utrecht Utrecht, Netherlands Switzerland Dr. Markus Weber, Kantonsspital St. Gallen, Muskelzentrum/ALS Clinic St. Gallen, Switzerland United Kingdom Prof. Nigel Leigh, Academic Neuroscience Centre London, United Kingdom Prof. Douglas Mitchell, Royal Preston Hospital Preston, United Kingdom Dr. Chris McDermott, Royal Hallamshire Hospital Sheffield, United Kingdom 收起 << |
NCT00903201 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT00903201 | - | Completed | - | - | |
NCT03301220 | Smoldering Multiple Myeloma | Phase 3 | Recruiting | December 31, 2025 | - |
NCT01997229 | Refractory Generalized Myasthe... 展开 >>nia Gravis 收起 << | Phase 3 | Completed | - | - |
NCT00751738 | Arrhythmias | Phase 3 | Completed | - | - |
NCT00195507 | - | Completed | - | - | |
NCT01997229 | - | Completed | - | - | |
NCT00410124 | Metastatic Renal Cell Carcinom... 展开 >>a 收起 << | Phase 3 | Completed | - | - |
NCT03138655 | Ulcerative Colitis ... 展开 >> Crohn's Disease 收起 << | Phase 2 | Recruiting | December 3, 2020 | - |
NCT00831441 | Acute Coronary Syndrome | Phase 3 | Terminated | - | - |
NCT00195507 | Psoriasis | Phase 4 | Completed | - | - |
NCT00571649 | Venous Thromboembolism | Phase 3 | Completed | - | - |
NCT00410124 | - | Completed | - | - | |
NCT00434148 | Cushing's Disease | Phase 3 | Completed | - | - |
NCT01483755 | Myocardial Reperfusion Injury | Phase 2 | Completed | - | France ... 展开 >> Service de Cardiologie, CHU d'Angers Angers, France, 49933 Service d'explorations Fonctionnelles Cardiovasculaires, Hôpital Cardiologique Louis Pradel Bron, France, 69677 Service de Cardiologie, Hôpital Arnaud de Villeneuve Montpellier Cedex 5, France, 34295 Service de Cardiologie, Hôpital Emile Müller Mulhouse, France, 68051 Service de Cardiologie, Hôpital Rangueil Toulouse, France, 31059 收起 << |
NCT00434148 | - | Completed | - | - | |
NCT00831441 | - | Terminated | - | - | |
NCT00571649 | - | Completed | - | - | |
NCT00157261 | Heart Arrest | Phase 3 | Terminated | - | - |
NCT01673867 | - | Active, not recruiting | - | - | |
NCT00726479 | Pulmonary Disease, Chronic Obs... 展开 >>tructive Bronchitis, Chronic 收起 << | Phase 2 | Withdrawn | - | United States, Alabama ... 展开 >> 1219.4.01001 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States United States, Arizona 1219.4.01007 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States United States, Colorado 1219.4.01006 Boehringer Ingelheim Investigational Site Fort Collins, Colorado, United States United States, Connecticut 1219.4.01002 Boehringer Ingelheim Investigational Site Stamford, Connecticut, United States United States, Georgia 1219.4.01008 Boehringer Ingelheim Investigational Site Rincon, Georgia, United States United States, South Carolina 1219.4.01003 Boehringer Ingelheim Investigational Site Greenville, South Carolina, United States 1219.4.01004 Boehringer Ingelheim Investigational Site Spartanburg, South Carolina, United States 1219.4.01005 Boehringer Ingelheim Investigational Site Union, South Carolina, United States France 1219.4.3306A Boehringer Ingelheim Investigational Site Bethune Cedex, France 1219.4.3306B Boehringer Ingelheim Investigational Site Bethune Cedex, France 1219.4.3302A Boehringer Ingelheim Investigational Site Marseille, France 1219.4.3303A Boehringer Ingelheim Investigational Site Montpellier, France 1219.4.3308A Boehringer Ingelheim Investigational Site Nice Cedex 1, France 1219.4.3307A Boehringer Ingelheim Investigational Site Nimes, France 1219.4.3307B Boehringer Ingelheim Investigational Site Nimes, France 1219.4.3301A Boehringer Ingelheim Investigational Site Paris Cedex 04, France 1219.4.3305A Boehringer Ingelheim Investigational Site Toulouse Cedex, France 1219.4.3305B Boehringer Ingelheim Investigational Site Toulouse Cedex, France Germany 1219.4.49003 Boehringer Ingelheim Investigational Site Eisenach, Germany 1219.4.49004 Boehringer Ingelheim Investigational Site Hamburg, Germany 1219.4.49001 Boehringer Ingelheim Investigational Site Hannover, Germany 1219.4.49006 Boehringer Ingelheim Investigational Site Mainz, Germany 1219.4.49005 Boehringer Ingelheim Investigational Site Rodgau-Dudenhofen, Germany 1219.4.49002 Boehringer Ingelheim Investigational Site Ruedersdorf, Germany 收起 << |
NCT03196427 | Ulcerative Colitis ... 展开 >> Crohn's Disease 收起 << | Phase 2 | Recruiting | June 14, 2025 | - |
NCT01673867 | Non-Squamous Cell Non-small Ce... 展开 >>ll Lung Cancer 收起 << | Phase 3 | Active, not recruiting | December 21, 2018 | - |
NCT02468661 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Recruiting | March 31, 2020 | - |
NCT02296138 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT02473952 | Myasthenia Gravis, Generalized | Phase 2 | Completed | - | - |
NCT02296138 | - | Completed | - | - | |
NCT01830543 | - | Completed | - | - | |
NCT00510068 | Advanced Neuroendocrine Tumors... 展开 >> of Pancreatic Origin 收起 << | Phase 3 | Completed | - | - |
NCT03381196 | Influenza A | Phase 3 | Recruiting | October 29, 2019 | - |
NCT02496767 | Amyotrophic Lateral Sclerosis | Phase 3 | Completed | - | - |
NCT01009593 | Hepatocellular Carcinoma Non-r... 展开 >>esectable Hepatocellular Carcinoma Recurrent Carcinoma, Hepatocellular Liver Diseases Neoplasms by Histologic Type Digestive System Neoplasms Carcinoma Liver Neoplasms Neoplasms Neoplasms by Site Digestive System Diseases Adenocarcinoma Neoplasms, Glandular and Epithelial 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description) 收起 << | - | - |
NCT01830543 | Atrial Fibrillation ... 展开 >> Percutaneous Coronary Intervention 收起 << | Phase 3 | Completed | - | - |
NCT00510068 | - | Completed | - | - | |
NCT00393471 | Active Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT02085993 | - | Completed | - | Austria ... 展开 >> Research Site Innsbruck, Austria, 6020 Research Site Leoben, Austria, 8700 Belgium Research Site Brugge, Belgium, 8000 Research Site Ghent, Belgium, 9000 France Research Site Créteil Cedex, France, 94010 Research Site Limoges Cedex, France, 87042 Research Site Montpellier, France, 34395 Research Site Paris cedex 12, France, 75571 Research Site Pessac Cedex, France, 33604 Germany Research Site Berlin, Germany, 12200 Research Site Kronach, Germany, 96317 Greece Research Site Athens, Greece, 11527 Research Site Kalamata, Greece, 24100 Research Site Thessaloniki, Greece, 54636 Netherlands Research Site Den Haag, Netherlands, 2545 CH Research Site Veldhoven, Netherlands, 5504 DB Spain Research Site Avila, Castilla León, Spain, 05004 Research Site Majadahonda, Madrid, Spain, 28222 Research Site Madrid, Spain, 28031 Research Site Madrid, Spain, 28041 United Kingdom Research Site Leicester, United Kingdom, LE1 5WW Research Site London, United Kingdom, E1 1BB 收起 << | |
NCT00240331 | Renal Failure | Phase 3 | Completed | - | - |
NCT00643201 | - | Completed | - | - | |
NCT00643201 | Venous Thrombosis | Phase 3 | Completed | - | - |
NCT02443324 | Gastric Adenocarcinoma ... 展开 >> Adenocarcinoma of the Gastroesophageal Junction Non-small Cell Lung Cancer Carcinoma, Transitional Cell Biliary Tract Cancer 收起 << | Phase 1 | Active, not recruiting | August 31, 2019 | United States, Connecticut ... 展开 >> Yale University School of Medicine New Haven, Connecticut, United States, 06520-8020 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33916 Florida Cancer Specialists and Research Institute Saint Petersburg, Florida, United States, 33705 United States, Tennessee Tennessee Oncology PLLC Chattanooga, Tennessee, United States, 37404 Sarah Cannon Research Institute SCRI Nashville, Tennessee, United States, 37203 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dijon Cedex, France, 21034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille Cedex, France, 59020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon Cedex 08, France, 69373 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris CEDEX 05, France, 75248 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tübingen, Germany, 72076 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kochi-Shi, Japan, 780-0051 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamanashi, Japan, 400-0124 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, United Kingdom, W1G 6AD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M20 4BX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sutton, United Kingdom, SM2 5PT 收起 << |
NCT00785785 | Gastrointestinal Stromal Tumor... 展开 >> (GIST) 收起 << | Phase 3 | Completed | - | - |
NCT00240331 | - | Completed | - | - | |
NCT00913458 | Active Rheumatoid Arthritis ... 展开 >> Arthritis, Rheumatoid Rheumatoid Arthritis 收起 << | Phase 4 | Completed | - | - |
NCT00820222 | Metastases, Brain | Phase 3 | Completed | - | - |
NCT00913458 | - | Completed | - | - | |
NCT01074047 | Acute Myeloid Leukemia | Phase 3 | Completed | - | - |
NCT00785785 | - | Completed | - | - | |
NCT01074047 | - | Completed | - | - | |
NCT00123487 | Myeloid Leukemia, Chronic, Acc... 展开 >>elerated Phase Leukemia, Lymphoblastic, Acute, Philadelphia-Positive 收起 << | Phase 3 | Completed | - | - |
NCT02453282 | Non-Small-Cell Lung Carcinoma ... 展开 >>NSCLC 收起 << | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT00820222 | - | Completed | - | - | |
NCT02677922 | Leukemia, Myeloid, Acute | Phase 1 Phase 2 | Active, not recruiting | January 28, 2019 | - |
NCT02545504 | Gastric Adenocarcinoma | Phase 3 | Active, not recruiting | December 2023 | - |
NCT00123487 | - | Completed | - | - | |
NCT00174343 | Breast Neoplasms | Phase 2 | Completed | - | France ... 展开 >> Pfizer Investigational Site Bordeaux, France Pfizer Investigational Site Clermont Ferrand, France Pfizer Investigational Site Montpellier, France Pfizer Investigational Site Poitiers Cedex, France Pfizer Investigational Site St. Cloud, France 收起 << |
NCT01454934 | Non-Small Cell Lung Cancer (NS... 展开 >>CLC) 收起 << | Phase 3 | Completed | - | - |
NCT01536873 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Recruiting | August 2018 | - |
NCT01454934 | - | Completed | - | - | |
NCT00404924 | Non-Small-Cell Lung Carcinoma | Phase 3 | Completed | - | - |
NCT00291330 | Thromboembolism | Phase 3 | Completed | - | - |
NCT00404924 | - | Completed | - | - | |
NCT00903422 | Myelodysplastic Syndrome | Phase 1 | Completed | - | - |
NCT00633893 | Venous Thrombosis | Phase 3 | Completed | - | - |
NCT03420781 | Gastroparesis ... 展开 >> Diabetes Mellitus 收起 << | Phase 3 | Enrolling by invitation | December 6, 2020 | - |
NCT00633893 | - | Completed | - | - | |
NCT00932893 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
NCT02205489 | Relapsing-remitting Multiple S... 展开 >>clerosis 收起 << | Phase 4 | Completed | - | Belgium ... 展开 >> Investigational Site Number 056002 Brugge, Belgium, 8000 Investigational Site Number 056001 Brussels, Belgium, 1070 France Investigational Site Number 250009 Dijon, France, 21000 Investigational Site Number 250005 Lille Cedex, France, 59037 Investigational Site Number 250001 Lyon Bron, France, 69677 Investigational Site Number 250006 Nancy, France Investigational Site Number 250010 Nantes, France, 44093 Investigational Site Number 250007 Nimes, France, 30029 Investigational Site Number 250008 PARIS Cedex 20, France, 75970 Investigational Site Number 250004 RENNES Cedex 9, France, 35033 Investigational Site Number 250003 Strasbourg Cedex 2, France, 67098 Investigational Site Number 250002 Toulouse, France, 31200 Netherlands Investigational Site Number 528001 Breda, Netherlands, 4818CK Investigational Site Number 528002 Rotterdam, Netherlands, 3079DZ Spain Investigational Site Number 724001 Barcelona, Spain, 08035 Investigational Site Number 724005 Bilbao, Spain, 48013 Investigational Site Number 724002 Madrid, Spain, 28040 Investigational Site Number 724006 Málaga, Spain, 29010 Investigational Site Number 724003 Sevilla, Spain, 41071 Investigational Site Number 724004 Valencia, Spain, 46009 收起 << |
NCT00987337 | Hepatitis Hep... 展开 >>atitis C 收起 << | Phase 2 | Completed | - | - |
NCT01327053 | Basal Cell Carcinoma | Phase 2 | Completed | - | - |
NCT01327053 | - | Completed | - | - | |
NCT03525678 | Multiple Myeloma | Phase 2 | Recruiting | June 30, 2020 | - |
NCT00291330 | - | Completed | - | - | |
NCT00932893 | - | Completed | - | - | |
NCT01977573 | Anaemia | Phase 2 | Completed | - | - |
NCT01977573 | - | Completed | - | - | |
NCT00883909 | - | Completed | - | - | |
NCT00987337 | - | Completed | - | - | |
NCT03383146 | Gastroparesis ... 展开 >> Diabetes Mellitus 收起 << | Phase 3 | Recruiting | September 28, 2020 | - |
NCT01308580 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT01288911 | Prostatic Neoplasms | Phase 2 | Completed | - | - |
NCT00805194 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
NCT01308580 | - | Completed | - | - | |
NCT00805194 | - | Completed | - | - | |
NCT01077518 | Lymphoma, Follicular | Phase 3 | Active, not recruiting | June 1, 2024 | - |
NCT02388165 | Staphylococcal Vaccine | Phase 2 | Recruiting | August 16, 2019 | - |
NCT01288911 | - | Completed | - | - | |
NCT00329238 | Thromboembolism | Phase 3 | Completed | - | - |
NCT01188252 | Neoplasms | Phase 1 | Completed | - | United States, Missouri ... 展开 >> St. Louis, Missouri, United States, 63110 United States, New York Buffalo, New York, United States, 14263-0001 United States, Ohio Cleveland, Ohio, United States, 44195 France Caen Cedex, France, 14033 Lyon Cedex, France, 69008 Marseille Cedex 20, France, 13915 Villejuif Cedex, France, 94805 Germany Heidelberg, Baden-Württemberg, Germany, 69120 Herne, Nordrhein-Westfalen, Germany, 44625 收起 << |
NCT00297778 | Parkinson Disease ... 展开 >> Depression 收起 << | Phase 4 | Completed | - | - |
NCT01328041 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Completed | - | - |
NCT00297778 | - | Completed | - | - | |
NCT00167973 | - | Completed | - | - | |
NCT00329238 | - | Completed | - | - | |
NCT01328041 | - | Completed | - | - | |
NCT00975884 | Influenza | Phase 3 | Completed | - | France ... 展开 >> GSK Investigational Site Clermont-Ferrand, France, 63003 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Paris Cedex 18, France, 75877 GSK Investigational Site Paris, France, 75679 GSK Investigational Site Poitiers, France, 86000 收起 << |
NCT01012895 | Chronic Hepatitis C | Phase 2 | Completed | - | United States, California ... 展开 >> Advanced Clinical Research Institute Anaheim, California, United States, 92801 Southern California Liver Centers Coronado, California, United States, 92118 San Jose Gastroenterology San Jose, California, United States, 95128 United States, Colorado University Of Colorado Denver & Hospital Aurora, Colorado, United States, 80045 United States, Maryland Mercy Medical Center Baltimore, Maryland, United States, 21202 United States, Michigan University Of Michigan Health System Ann Arbor, Michigan, United States, 48109 United States, North Carolina Carolinas Center For Liver Disease Statesville, North Carolina, United States, 28677 United States, Texas Texas Clinical Research Institute, Llc Arlington, Texas, United States, 76012 Alamo Medical Research San Antonio, Texas, United States, 78215 United States, Virginia Metropolitan Research Fairfax, Virginia, United States, 22031 France Local Institution Clichy Cedex, France, 92118 Local Institution Creteil Cedex, France, 94010 Local Institution Marseille Cedex 08, France, 13285 Local Institution Paris Cedex 12, France, 75571 Local Institution Paris Cedex 13, France, 75651 Local Institution Paris Cedex 14, France, 75679 Local Institution Pessac, France, 33604 Puerto Rico Local Institution San Juan, Puerto Rico, 00927 收起 << |
NCT02615691 | Hemophilia A | Phase 3 | Recruiting | June 29, 2023 | - |
NCT02667587 | Brain Neoplasms | Phase 3 | Recruiting | August 1, 2023 | - |
NCT01226563 | Acute Myocardial Infarction ... 展开 >> Congestive Heart Failure ST-Elevation Myocardial Infarction 收起 << | Not Applicable | Completed | - | - |
NCT00790907 | Acute Coronary Syndrome | Phase 4 | Completed | - | - |
NCT00374322 | Neoplasms, Breast | Phase 3 | Completed | - | - |
NCT02729051 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT02743494 | Advanced Cancer | Phase 3 | Recruiting | October 11, 2024 | - |
NCT02998528 | Non Small Cell Lung Cancer | Phase 3 | Recruiting | November 8, 2028 | - |
NCT02833844 | Subjects With Hyperlipidemia, ... 展开 >>Dyslipidemia and HIV Infection 收起 << | Phase 3 | Recruiting | February 27, 2020 | - |
NCT00358215 | Heart Failure ... 展开 >> Anemia Cardiovascular Disease Ventricular Dysfunction Congestive Heart Failure 收起 << | Phase 3 | Completed | - | - |
NCT00457002 | - | Completed | - | - | |
NCT02481830 | Lung Cancer | Phase 3 | Active, not recruiting | November 30, 2019 | - |
NCT00374322 | - | Completed | - | - | |
NCT01214421 | Autosomal Dominant Polycystic ... 展开 >>Kidney Disease (ADPKD) 收起 << | Phase 3 | Completed | - | - |
NCT02105948 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00623103 | Parkinson's Disease Dementia | Phase 3 | Completed | - | - |
NCT00790907 | - | Completed | - | - | |
NCT02726386 | Parkinson's Disease | Phase 2 | Active, not recruiting | August 2021 | - |
NCT00439777 | Pulmonary Embolism | Phase 3 | Completed | - | - |
NCT00358215 | - | Completed | - | - | |
NCT03139604 | Graft-versus-host Disease (GVH... 展开 >>D) 收起 << | Phase 3 | Recruiting | March 2020 | - |
NCT02354508 | Acromegaly | Phase 3 | Completed | - | - |
NCT01562834 | Growth Hormone Disorder ... 展开 >> Adult Growth Hormone Deficiency 收起 << | Phase 4 | Completed | - | France ... 展开 >> Novo Nordisk Investigational Site ANGERS cedex 09, France, 49033 Novo Nordisk Investigational Site Boisguillaume, France, 76233 Novo Nordisk Investigational Site Brest, France, 29609 Novo Nordisk Investigational Site Caen, France, 14033 Novo Nordisk Investigational Site Grenoble, France, 38043 Novo Nordisk Investigational Site Le Kremlin-bicetre, France, 94275 Novo Nordisk Investigational Site Lille, France, 59037 Novo Nordisk Investigational Site Lorient, France, 56322 Novo Nordisk Investigational Site Lyon, France, 69394 Novo Nordisk Investigational Site Lyon, France, 69437 Novo Nordisk Investigational Site MARSEILLE Cédex 05, France, 13385 Novo Nordisk Investigational Site MONTPELLIER cedex 5, France, 34295 Novo Nordisk Investigational Site Nantes, France, 44000 Novo Nordisk Investigational Site Nantes, France, 44093 Novo Nordisk Investigational Site Nice, France, 06002 Novo Nordisk Investigational Site Paris, France, 75010 Novo Nordisk Investigational Site Paris, France, 75015 Novo Nordisk Investigational Site Paris, France, 75571 Novo Nordisk Investigational Site Reims, France, 51092 Novo Nordisk Investigational Site Rennes, France, 35056 Novo Nordisk Investigational Site Strasbourg, France, 67098 Novo Nordisk Investigational Site TOULOUSE cedex, France, 31054 Novo Nordisk Investigational Site Tours, France, 37044 Novo Nordisk Investigational Site Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT00623103 | - | Completed | - | - | |
NCT02105948 | - | Completed | - | - | |
NCT01572727 | - | Completed | - | - | |
NCT00174252 | Fetal Growth Retardation | Phase 3 | Completed | - | France ... 展开 >> Pfizer Investigational Site Amiens, France, 80030 Pfizer Investigational Site ANGERS Cedex 03, France, 49000 Pfizer Investigational Site Besançon, France, 25030 Pfizer Investigational Site Bordeaux, France, 33000 Pfizer Investigational Site Bron Cedex, France, 69677 Pfizer Investigational Site Caen Cedex 5, France, 14033 Pfizer Investigational Site Dunkerque Cedex 1, France, 59385 Pfizer Investigational Site Lille, France, 59019 Pfizer Investigational Site Limoges Cedex, France, 87042 Pfizer Investigational Site Lorient, France Pfizer Investigational Site Nice, France, 06202 Pfizer Investigational Site PARIS Cedex 19, France, 75935 Pfizer Investigational Site Paris, France, 75571 Pfizer Investigational Site Paris, France, 75743 Pfizer Investigational Site Rennes, France, 35203 Pfizer Investigational Site Rouen, France, 76000 Pfizer Investigational Site Strasbourg, France, 67098 Pfizer Investigational Site Tarbes, France, 65000 Pfizer Investigational Site Toulouse, France, 31000 Pfizer Investigational Site Toulouse, France, 31026 Pfizer Investigational Site Tours, France, 37044 Pfizer Investigational Site Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT00153036 | Cerebrovascular Accident | Phase 3 | Completed | - | - |
NCT00174252 | - | Completed | - | - | |
NCT01572727 | Breast Cancer | Phase 2 Phase 3 | Completed | - | - |
NCT00439777 | - | Completed | - | - | |
NCT01051063 | Leukaemia, Myelocytic, Acute | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, Massachusetts GSK Investigational Site Worcester, Massachusetts, United States, 01655 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 France GSK Investigational Site Angers cedex 09, France, 49933 GSK Investigational Site Grenoble cedex 9, France, 38043 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille cedex 9, France, 13273 GSK Investigational Site Nantes cedex 1, France, 44093 GSK Investigational Site Paris cedex 10, France, 75475 GSK Investigational Site Pessac cedex, France, 33604 GSK Investigational Site Pierre-Bénite cedex, France, 69495 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69120 GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Erlangen, Bayern, Germany, 91054 GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Rostock, Mecklenburg-Vorpommern, Germany, 18057 GSK Investigational Site Oldenburg, Niedersachsen, Germany, 26133 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Dresden, Sachsen, Germany, 01307 GSK Investigational Site Berlin, Germany, 12200 收起 << |
NCT00480025 | Lung Cancer, Non-Small Cell | Phase 3 | Terminated(The study was termi... 展开 >>nated following assessment of the lack of efficacy of the study product by the Independent Data monitoring Committee for the study.) 收起 << | - | - |
NCT02260557 | Raynaud's Phenomenon Secondary... 展开 >> to Systemic Sclerosis 收起 << | Phase 2 | Completed | - | France ... 展开 >> Investigator Site Grenoble cedex, France, 38043 Investigator Site Lille Cedex, France, 59037 Investigator Site Nantes Cedex 1, France, 44093 Investigator Site Paris, France, 75679 Investigator Site Strasbourg, France, 67200 Germany Investigator Site Bad Nauheim, Germany, 61231 Investigator Site Berlin, Germany, 10117 Investigator Site Erlangen, Germany, 91054 Investigator Site Koln, Germany, 50937 Investigator Site Magdeburg, Germany, 39120 Investigator Site Mainz, Germany, 55131 United Kingdom Investigator Site Bath, United Kingdom, BA11RL Investigator Site Leeds, United Kingdom, LS74SA Investigator Site Liverpool, United Kingdom, L97AL Investigator Site London, United Kingdom, NW32QG Investigator Site Salford, United Kingdom, M55AP 收起 << |
NCT01682720 | Hepatitis C | Phase 3 | Completed | - | - |
NCT01682720 | - | Completed | - | - | |
NCT01051063 | - | Completed | - | - | |
NCT00621855 | - | Completed | - | - | |
NCT01728324 | - | Completed | - | - | |
NCT00621855 | Coronary Disease | Phase 2 | Completed | - | - |
NCT00559585 | Rheumatoid Arthritis (RA) | Phase 3 | Completed | - | - |
NCT01335464 | Pulmonary Fibrosis | Phase 3 | Completed | - | - |
NCT01004445 | Pneumonia | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Birmingham, Alabama, United States, 35233 United States, Florida Melbourne, Florida, United States, 32901 United States, New York Albany, New York, United States, 12208 United States, North Carolina Winston-Salem, North Carolina, United States, 27157 United States, Ohio Columbus, Ohio, United States, 43210 United States, Texas Houston, Texas, United States, 77030 San Antonio, Texas, United States, 78229 France Angers Cedex 9, France, 49933 Limoges Cedex, France, 87046 Paris Cedex 13, France, 75651 Paris Cedex 14, France, 75674 Paris Cedex 15, France, 75908 Paris, France, 75018 Rouen cedex, France, 76031 Spain Barcelona, Spain, 08003 Barcelona, Spain, 08036 Madrid, Spain, 28034 Madrid, Spain, 28040 Madrid, Spain, 28805 Murcia, Spain, 30120 收起 << |
NCT01335464 | - | Completed | - | - | |
NCT00439725 | Venous Thromboembolism | Phase 3 | Completed | - | - |
NCT00559585 | - | Completed | - | - | |
NCT01728324 | Hepatitis C, Chronic | Phase 3 | Completed | - | - |
NCT00439725 | - | Completed | - | - | |
NCT02905266 | Melanoma | Phase 3 | Active, not recruiting | November 17, 2020 | Australia, New South Wales ... 展开 >> Local Institution North Sydney, New South Wales, Australia, 2060 Australia, Queensland Local Institution Greenslopes, Queensland, Australia, 4120 Australia, Victoria Cabrini Hospital Malvern, Victoria, Australia, 3144 France Local Institution Lyon Cedex 08, France, 69373 Local Institution Marseille Cedex 5, France, 13385 Local Institution Nantes Cedex 1, France, 44093 Local Institution Paris Cedex 14, France, 75679 Local Institution Paris, France, 75475 Local Institution Tours, France, 37044 Italy Istituto Nazionale Per La Ricerca Sul Cancro - Oncologia Med Genova, Italy, 16128 Istituto Scientifico Romagnolo Per Lo Studio E Cura Tumori Meldola (FC), Italy, 47014 Istituto Europeo Di Oncologia Milan, Italy, 20141 Azienda Ospedaliera Citta della Salute e della Scienza Torino, Italy, 10137 Spain Local Institution Barcelona, Spain, 08036 Local Institution Madrid, Spain, 28007 Local Institution Sevilla, Spain, 41071 收起 << |
NCT00600886 | - | Completed | - | - | |
NCT03052517 | Asthma | Phase 3 | Recruiting | November 18, 2022 | - |
NCT00411528 | Metastatic Hormone Refractory ... 展开 >>Prostate Cancer 收起 << | Phase 2 | Completed | - | - |
NCT00930553 | - | Completed | - | - | |
NCT02308020 | Breast Cancer ... 展开 >> Non-small Cell Lung Cancer Melanoma Brain Metastases 收起 << | Phase 2 | Active, not recruiting | November 8, 2019 | - |
NCT00056407 | Neoplasms, Prostate | Phase 3 | Completed | - | - |
NCT00056407 | - | Completed | - | - | |
NCT00600886 | Acromegaly | Phase 3 | Completed | - | - |
NCT02451930 | Stage IV Non-Small Cell Lung C... 展开 >>ancer 收起 << | Phase 1 | Active, not recruiting | June 20, 2019 | United States, Florida ... 展开 >> Florida Cancer Specialists Fort Myers, Florida, United States, 33916 Florida Cancer Specialists Saint Petersburg, Florida, United States, 33705 United States, Tennessee Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France, 59037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon Cedex 08, France, 69373 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75015 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Herblain Cedex, France, 44805 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Strasbourg Cedex, France, 67091 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Villejuif Cedex, France, 94805 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chuo-Ku, Japan, 104-0045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Sunto-Gun, Japan, 411-8777 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Badajoz, Spain, 06080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08907 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46026 收起 << |
NCT00146328 | HIV Infections | Phase 2 Phase 3 | Completed | - | - |
NCT00496769 | Atrial Fibrillation | Phase 3 | Completed | - | - |
NCT00396448 | Obesity | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT00146328 | - | Completed | - | - | |
NCT01204125 | Breast Cancer Female | Phase 2 | Completed | - | France ... 展开 >> Investigational Site Number 250001 Besancon Cedex, France, 25030 Investigational Site Number 250004 Bordeaux, France, 33076 Investigational Site Number 250006 Bron Cedex, France, 69677 Investigational Site Number 250003 Paris Cedex 10, France, 75475 Investigational Site Number 250002 Toulouse, France, 31052 Investigational Site Number 250005 Villejuif, France, 94805 Germany Investigational Site Number 276003 Erlangen, Germany, 91054 Investigational Site Number 276004 Hamburg, Germany, 20357 Investigational Site Number 276002 Köln, Germany, 50931 Investigational Site Number 276001 Mönchengladbach, Germany, 41061 Spain Investigational Site Number 724001 Barcelona, Spain, 08035 Investigational Site Number 724009 Cáceres, Spain, 10003 Investigational Site Number 724013 Córdoba, Spain, 14004 Investigational Site Number 724006 Islas Baleares, Spain, 07014 Investigational Site Number 724012 Jaén, Spain, 23007 Investigational Site Number 724002 Lérida, Spain, 25198 Investigational Site Number 724005 Madrid, Spain, 28033 Investigational Site Number 724016 Madrid, Spain, 28041 Investigational Site Number 724007 Reus, Spain, 43201 Investigational Site Number 724018 Santiago De Compostela, Spain, 15706 Investigational Site Number 724017 Sevilla, Spain, 41009 Investigational Site Number 724010 Sevilla, Spain, 41013 Investigational Site Number 724003 Torrevieja, Spain, 03186 Investigational Site Number 724011 Valencia, Spain, 46009 Investigational Site Number 724015 Valencia, Spain, 46010 收起 << |
NCT02065622 | Ulcerative Colitis (UC) | Phase 3 | Active, not recruiting | December 18, 2019 | - |
NCT01408576 | Systemic Lupus Erythematosus | Phase 3 | Completed | - | - |
NCT00496769 | - | Completed | - | - | |
NCT01408576 | - | Completed | - | - | |
NCT01712217 | Non-small Cell Lung Cancer(NSC... 展开 >>LC) 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT03668119 | Pan Tumor | Phase 2 | Recruiting | September 8, 2023 | - |
NCT00975000 | Chronic Allograft Nephropathy ... 展开 >> Chronic Kidney Disease Chronic Renal Failure Disordered Mineral Metabolism End Stage Renal Disease Hyperparathyroidism Hypophosphatemia Kidney Disease Kidney Transplantation Post Renal Transplantation 收起 << | Phase 3 | Completed | - | - |
NCT02572687 | Gastric Cancer ... 展开 >> Gastroesophageal Junction Adenocarcinoma Non-Small Cell Lung Cancer Hepatocellular Carcinoma 收起 << | Phase 1 | Active, not recruiting | September 27, 2019 | - |
NCT00975000 | - | Completed | - | - | |
NCT00061022 | Cerebral Stroke ... 展开 >> Stroke, Acute Cerebrovascular Stroke Ischemic Attack, Transient 收起 << | Phase 3 | Completed | - | - |
NCT02422797 | HIV Infections | Phase 3 | Active, not recruiting | August 12, 2021 | - |
NCT02547922 | Lupus Nephritis | Phase 2 | Recruiting | January 22, 2021 | - |
NCT00168805 | Arthroplasty, Replacement, Kne... 展开 >>e Thromboembolism 收起 << | Phase 3 | Completed | - | - |
NCT00876395 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00135356 | HIV-Associated Lipodystrophy S... 展开 >>yndrome 收起 << | Phase 4 | Completed | - | - |
NCT01763866 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT00244686 | - | - | - | - | |
NCT00135356 | - | Completed | - | - | |
NCT00363896 | - | Completed | - | - | |
NCT00833768 | Chronic Kidney Disease ... 展开 >> Hyperphosphatemia 收起 << | Phase 3 | Terminated(After an extensive ... 展开 >>review,the ASPIRE in CKD study was terminated because it was not possible to complete the study in an appropriate time frame.) 收起 << | - | - |
NCT00189839 | Kidney Transplantation | Phase 3 | Completed | - | - |
NCT00168805 | - | Completed | - | - | |
NCT00189735 | Kidney Transplantation ... 展开 >> Renal Transplantation Transplantation, Renal Transplantation, Kidney Grafting, Kidney 收起 << | Phase 2 | Completed | - | - |
NCT01807923 | Cystic Fibrosis, Homozygous fo... 展开 >>r the F508del CFTR Mutation 收起 << | Phase 3 | Completed | - | - |
NCT02422797 | - | Active, not recruiting | - | - | |
NCT00471146 | Carcinoma, Pancreatic Ductal | Phase 3 | Completed | - | - |
NCT01807923 | - | Completed | - | - | |
NCT00363896 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 3 | Completed | - | - |
NCT02531516 | Prostatic Neoplasms | Phase 3 | Active, not recruiting | October 6, 2026 | - |
NCT01199081 | Atrial Fibrillation | Phase 4 | Completed | - | - |
NCT00090103 | - | Completed | - | - | |
NCT00356096 | Restless Legs Syndrome ... 展开 >> Depression 收起 << | Phase 4 | Completed | - | - |
NCT00090103 | Prostatic Hyperplasia | Phase 3 | Completed | - | - |
NCT00471146 | - | Completed | - | - | |
NCT01763866 | - | Completed | - | - | |
NCT02055482 | Anemia Renal ... 展开 >>Insufficiency, Chronic 收起 << | Phase 2 | Completed | - | - |
NCT02219490 | Chronic Hepatitis C Virus (HCV... 展开 >>) Infection Genotype 1 收起 << | Phase 3 | Active, not recruiting | May 13, 2021 | - |
NCT02568267 | Breast Cancer ... 展开 >> Cholangiocarcinoma Colorectal Cancer Head and Neck Neoplasms Lymphoma, Large-Cell, Anaplastic Melanoma Neuroendocrine Tumors Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Papillary Thyroid Cancer Primary Brain Tumors Renal Cell Carcinoma Sarcomas Salivary Gland Cancers Adult Solid Tumor 收起 << | Phase 2 | Recruiting | October 31, 2020 | - |
NCT01085136 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
NCT01976104 | Thrombocytopenia Associated Wi... 展开 >>th Liver Disease 收起 << | Phase 3 | Completed | - | - |
NCT01085136 | - | Completed | - | - | |
NCT00056446 | Colorectal Neoplasms ... 展开 >> Colonic Neoplasms Rectal Neoplasms 收起 << | Phase 3 | Completed | - | - |
NCT02967211 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT01976104 | - | Completed | - | - | |
NCT01616524 | Hepatitis C Virus (HCV) | Phase 3 | Completed | - | - |
NCT01188187 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT01106014 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Completed | - | - |
NCT01973049 | Hepatitis C | Phase 3 | Completed | - | - |
NCT00370552 | Metastatic Breast Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> East Valley Hematology And Oncology Medical Group Burbank, California, United States, 91505 Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 Ucsf-Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Iowa University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States, 52242 United States, Missouri Ellis Fischel Cancer Center Columbia, Missouri, United States, 65203 United States, New York Weill Medical College Of Cornell University New York, New York, United States, 10021 France Local Institution Besancon Cedex, France, 25030 Local Institution Clermont-Ferrand, France, 63000 Local Institution Marseille Cedex 9, France, 13273 Local Institution Paris Cedex 10, France, 75475 Local Institution Saint Herblain, France, 44805 Local Institution Strasbourg Cedex, France, 67085 Local Institution Tours Cedex, France, 37044 Italy Local Institution Cuneo, Italy, 12100 Local Institution Meldola Fc, Italy, 47014 Local Institution Milano, Italy, 20132 Local Institution Modena, Italy, 41100 Local Institution Napoli, Italy, 80131 Local Institution Roma, Italy, 00161 Spain Local Institution Hospitalet De Llobregat, Spain, 08907 Local Institution Jaen, Spain, 23007 United Kingdom Local Institution Chelmsford, Essex, United Kingdom, CM1 7ET Local Institution Manchester, Greater Manchester, United Kingdom, M20 4BX Local Institution Nottingham, Nottinghamshire, United Kingdom, NG5 1PB Local Institution Merseyside, United Kingdom, CH63 4JY 收起 << |
NCT01106014 | - | Completed | - | - | |
NCT02776072 | - | Completed | - | - | |
NCT01549834 | Alzheimer's Disease | Phase 2 | Completed | - | - |
NCT01030432 | Hepatitis C Virus | Phase 2 | Completed | - | - |
NCT01598090 | Hepatitis C Virus | Phase 3 | Completed | - | - |
NCT00300846 | Schizophrenia | Phase 4 | Completed | - | - |
NCT00313209 | - | Completed | - | - | |
NCT02417064 | Treatment-resistant Depression | Phase 3 | Completed | - | - |
NCT00370552 | - | Completed | - | - | |
NCT00313209 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 3 | Completed | - | - |
NCT00388674 | - | Completed | - | - | |
NCT00751803 | Migraine Disorders | Phase 2 | Completed | - | - |
NCT00738387 | Non-Small Cell Lung Cancer | Phase 3 | Terminated | - | - |
NCT00388674 | - | Completed | - | - | |
NCT00248170 | Breast Cancer | Phase 3 | Completed | - | - |
NCT01671007 | - | Active, not recruiting | January 14, 2020 | - | |
NCT00248170 | - | Completed | - | - | |
NCT01082549 | Squamous Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT01829711 | - | Active, not recruiting | - | - | |
NCT01515189 | Melanoma | Phase 3 | Completed | - | - |
NCT01829711 | Leukemia, Hairy Cell | Phase 3 | Active, not recruiting | December 31, 2018 | - |
NCT02546661 | Muscle Invasive Bladder Cancer | Phase 1 | Recruiting | March 27, 2020 | - |
NCT00804856 | Leukemia, Myeloid, Acute | Phase 2 | Active, not recruiting | August 2, 2019 | Austria ... 展开 >> LKH-Univ. Hospital Graz Graz, Austria, 8036 Belgium AZ Sint-Jan Brugge Brugge, Belgium, 8000 Brussels - UNIV Saint-Luc Bruxelles, Belgium, 1200 UZ Leuven Leuven, Belgium, 3000 Canada, Migration Data CHUS Fleurimont Sherbrooke, Migration Data, Canada, J1H 5N4 Canada, Ontario Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Montreal General Hospital - McGill University Health Centre Montreal, Quebec, Canada, H3G 1A4 France HOP Clémenceau, Hémato, Caen Caen, France, 14033 HOP, Centre Hospitalier René Dubos, Hémato, Paris Cergy Pontoise Cedex, France, 95303 HOP Dupuytren Limoges, France, 87042 HOP Herriot Lyon Cedex 03, France, 69437 CTR, fondation Paschetta, Hémato, Nice Nice Cedex 2, France, 06189 HOP Saint-Louis Paris cedex 10, France, 75475 CTR Henri Becquerel Rouen Cedex, France, 76088 Germany Campus Virchow-Klinikum, Berlin Berlin, Germany, 13353 Universitätsklinikum Frankfurt Frankfurt/Main, Germany, 60590 Universitätsklinikum Freiburg Freiburg, Germany, 79106 Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Universitätsklinikum Schleswig-Holstein, Campus Kiel Kiel, Germany, 24116 Universitätsklinikum Münster Münster, Germany, 48149 Universitätsklinikum Ulm Ulm, Germany, 89081 Italy A.O. Spedali Civili di Brescia Brescia, Italy, 25123 ASST Grande Ospedale Metropolitano Niguarda Milano, Italy, 20162 Azienda Ospedaliera Policlinico di Modena Modena, Italy, 41100 Norway Haukeland Universitetssykehus Bergen, Norway, N-5021 Oslo Universitetssykehus HF, Ullevål sykehus Oslo, Norway, N-0450 收起 << |
NCT01421524 | Multiple Myeloma ... 展开 >> Lymphoma, Large B-Cell, Diffuse Pleiotropic Pathway Modifier Glioblastoma Lymphoma Primary Central Nervous System Lymphoma 收起 << | Phase 1 | Active, not recruiting | August 1, 2019 | - |
NCT01515189 | - | Completed | - | - | |
NCT01007942 | HER2/Neu Over-expressing Local... 展开 >>ly Advanced Breast Cancer Metastatic Breast Cancer 收起 << | Phase 3 | Completed | - | - |
NCT01007942 | - | Completed | - | - | |
NCT00163241 | Osteoarthritis | Phase 3 | Terminated(Please see detailed... 展开 >> description for termination reason.) 收起 << | - | - |
NCT00274014 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00412061 | Carcinoid Tumor ... 展开 >> Malignant Carcinoid Syndrome 收起 << | Phase 3 | Completed | - | - |
NCT00503698 | - | Terminated(See termination rea... 展开 >>son in detailed description) 收起 << | - | - | |
NCT01708174 | Medulloblastoma | Phase 2 | Completed | - | - |
NCT02627963 | Carcinoma, Renal Cell | Phase 3 | Active, not recruiting | December 2019 | - |
NCT00503698 | Chronic Kidney Disease ... 展开 >> End-Stage Renal Disease 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description) 收起 << | - | - |
NCT02158936 | Thrombocytopaenia | Phase 3 | Terminated | - | - |
NCT00153062 | Stroke | Phase 4 | Completed | - | - |
NCT02158936 | - | Terminated | - | - | |
NCT02394028 | Crohn Disease | Phase 3 | Recruiting | February 19, 2021 | - |
NCT02403323 | Crohn Disease | Phase 3 | Recruiting | April 19, 2024 | - |
NCT00237913 | Schizophrenia | Phase 3 | Completed | - | - |
NCT01708174 | - | Completed | - | - | |
NCT02043678 | Prostatic Neoplasms | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT01902290 | Asthma | Phase 2 | Terminated(The decision to sto... 展开 >>p the study was due to a lack of observed efficacy in a pre-specified interim analysis. The decision was not related to safety concerns.) 收起 << | - | - |
NCT00045760 | Sepsis | Phase 4 | Completed | - | - |
NCT00144170 | HIV Infections | Phase 3 | Completed | - | - |
NCT02352363 | Idiopathic Parkinson's Disease | Phase 3 | Completed | - | - |
NCT02352363 | - | Completed | - | - | |
NCT00144170 | - | Completed | - | - | |
NCT01785875 | Hyperparathyroidism, Secondary | Phase 3 | Completed | - | - |
NCT02654132 | Multiple Myeloma | Phase 2 | Active, not recruiting | April 22, 2019 | - |
NCT02370238 | Metastatic Breast Cancer | Phase 2 | Active, not recruiting | February 2019 | - |
NCT01785875 | - | Completed | - | - | |
NCT00428948 | Polycystic Kidney Disease, Aut... 展开 >>osomal Dominant 收起 << | Phase 3 | Completed | - | - |
NCT00428948 | - | Completed | - | - | |
NCT00153062 | - | Completed | - | - | |
NCT02657369 | Thyroid Cancer, Anaplastic | Phase 2 | Terminated | - | - |
NCT02927067 | Cytomegalovirus (CMV) | Phase 3 | Recruiting | August 13, 2021 | - |
NCT01690195 | Alzheimer's Disease | Phase 2 | Terminated(Data obtained from ... 展开 >>the M11-428 study is not critical to the continued evaluation of ABT-126.) 收起 << | - | - |
NCT00460512 | Schizophrenia | Phase 3 | Active, not recruiting | December 31, 2021 | - |
NCT00247481 | Breast Cancer | Phase 2 | Completed | - | France ... 展开 >> Research Site Dijon, France Research Site Paris, France Research Site Saint Cloud, France Research Site Saint Germain en Laye, France Research Site Villejuif Cedex, France 收起 << |
NCT01844518 | Active Polyarticular Juvenile ... 展开 >>Idiopathic Arthritis 收起 << | Phase 3 | Active, not recruiting | December 29, 2023 | - |
NCT01844518 | - | Active, not recruiting | - | - | |
NCT01661634 | Acute Decompensated Heart Fail... 展开 >>ure 收起 << | Phase 3 | Completed | - | - |
NCT01212991 | Prostate Cancer | Phase 3 | Active, not recruiting | December 28, 2018 | - |
NCT00412061 | - | Completed | - | - | |
NCT01212991 | - | Active, not recruiting | - | - | |
NCT00245960 | Psoriatic Arthritis | Phase 4 | Completed | - | - |
NCT01345669 | - | Terminated | - | - | |
NCT00110799 | Hepatitis C, Chronic ... 展开 >> Hepatitis C Thrombocytopenia 收起 << | Phase 2 | Completed | - | - |
NCT00245960 | - | Completed | - | - | |
NCT00050960 | Non-small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT00557921 | Acute Coronary Syndrome ... 展开 >> Myocardial Infarction Coronary Artery Disease Percutaneous Coronary Intervention 收起 << | Phase 3 | Terminated(Terminated by Spons... 展开 >>or) 收起 << | November 2009 | - |
NCT02365649 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT00286897 | Parkinson's Disease | Phase 3 | Completed | - | - |
NCT00050960 | - | Completed | - | - | |
NCT00450333 | Anemia Kidney... 展开 >> Failure 收起 << | Phase 3 | Terminated(The termination of ... 展开 >>the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA) 收起 << | - | - |
NCT00450333 | - | Terminated(The termination of ... 展开 >>the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA) 收起 << | - | - | |
NCT02549651 | Diffuse Large B-Cell Lymphoma | Phase 1 | Recruiting | November 7, 2023 | - |
NCT01345669 | Head and Neck Neoplasms | Phase 3 | Terminated | - | - |
NCT01767311 | Alzheimer's Disease | Phase 2 | Completed | - | - |
NCT02281357 | Asthma | Phase 3 | Completed | - | - |
NCT02281357 | - | Completed | - | - | |
NCT00154492 | Acquired Bleeding Disorder ... 展开 >> Cirrhosis 收起 << | Phase 2 | Completed | - | - |
NCT00062660 | - | - | - | - | |
NCT01729455 | - | Recruiting | January 31, 2025 | - | |
NCT02438007 | Prostate Cancer | Phase 3 | Terminated | - | - |
NCT02409667 | Plaque Psoriasis | Phase 3 | Completed | - | - |
NCT00228163 | Multiple Sclerosis | Phase 2 | Completed | - | Canada ... 展开 >> Investigational Site Number 16 Calgary, Canada, T2N 2T9 Investigational Site Number 10 Halifax, Canada, B3H 1V7 Investigational Site Number 15 London, Canada, N6A 5A5 Investigational Site Number 12 Montreal, Canada, H2L 4M1 Investigational Site Number 11 Montreal, Canada, H3A 2B4 Investigational Site Number 13 Ottawa, Canada, K1H 8L6 Investigational Site Number 18 Quebec, Canada, G1J 1Z4 Investigational Site Number 14 Toronto, Canada, M5B 1W8 Investigational Site Number 17 Vancouver, Canada, V6T 2B5 Investigational Site Number 19 Winnipeg, Canada, R3E 3N4 France Investigational Site Number 24 Clermont Ferrand Cedex 1, France, 63003 Investigational Site Number 21 Lyon Cedex 03, France, 69394 Investigational Site Number 30 Marseille Cedex 5, France, 13385 Investigational Site Number 23 Montpellier Cedex 5, France, 34000 Investigational Site Number 28 Nice Cedex, France, 06002 Investigational Site Number 27 Rennes Cedex, France, 35033 收起 << |
NCT00321854 | Parkinson Disease | Phase 4 | Completed | - | - |
NCT00731692 | - | Terminated(The extension study... 展开 >> was terminated early after the results of the core study showed the study did not meet primary endpoint; confirmed disability progression) 收起 << | - | - | |
NCT02472145 | Leukemia, Myeloid, Acute | Phase 3 | Completed | - | - |
NCT00254891 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Terminated(See Termination Rea... 展开 >>son in Detailed Description) 收起 << | - | - |
NCT00998543 | - | Completed | - | France ... 展开 >> Gières, France, 38610 Lagord, France, 17140 Montpellier Cedex 5, France, 34094 Paris, France, 75015 Poitiers, France, 86000 收起 << | |
NCT00731692 | Primary Progressive Multiple S... 展开 >>clerosis 收起 << | Phase 3 | Terminated(The extension study... 展开 >> was terminated early after the results of the core study showed the study did not meet primary endpoint; confirmed disability progression) 收起 << | - | - |
NCT00089856 | Prostate Cancer | Phase 3 | Terminated(Based on futility a... 展开 >>nalysis showing <30% chance of meeting primary endpoint.) 收起 << | - | - |
NCT01556490 | Unresectable Hepatocellular Ca... 展开 >>rcinoma 收起 << | Phase 3 | Active, not recruiting | April 2019 | - |
NCT00359021 | - | Completed | - | - | |
NCT00321854 | - | Completed | - | - | |
NCT00359021 | HIV-1 | Phase 3 | Completed | - | - |
NCT02538666 | Lung Cancer | Phase 3 | Active, not recruiting | November 20, 2019 | - |
NCT01660906 | - | Completed | - | - | |
NCT01431274 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00114777 | Renal Transplantation | Phase 3 | Completed | - | - |
NCT01204762 | Hepatitis B Virus | Phase 2 | Completed | - | - |
NCT01660906 | Chronic Phase Chronic Myeloid ... 展开 >>Leukemia 收起 << | Phase 4 | Completed | - | United States, California ... 展开 >> Pacific Cancer Medical Center Anaheim, California, United States, 92801 United States, Connecticut Cancer Center Of Central Connecticut Southington, Connecticut, United States, 06489 United States, Maryland St. Agnes Healthcare, Inc. Baltimore, Maryland, United States, 21229 United States, Ohio Promedica Hematology & Oncology Assoicates Sylvania, Ohio, United States, 43560 United States, Texas The University Of Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 France Local Institution Creteil Cedex, France, 94010 Local Institution Lille CEDEX, France, 59037 Local Institution Pierre Benite cedex, France, 69495 Local Institution Pringy Cedex, France, 74374 Local Institution Vandoeuvre les Nancy, France, 54511 Germany Local Institution Jena, Germany, 07747 Local Institution Koln, Germany, 50937 Local Institution Lubeck, Germany, 23562 Local Institution Mannheim, Germany, 68169 Local Institution Rostock, Germany, 18055 Italy Local Institution Catania, Italy, 95124 Local Institution Firenze, Italy, 50134 Local Institution Napoli, Italy, 80131 Local Institution Roma, Italy, 00144 Local Institution Roma, Italy, 00161 Local Institution Torino, Italy, 10126 Korea, Republic of Local Institution Seoul, Korea, Republic of, 137-701 收起 << |
NCT00787202 | Ulcerative Colitis | Phase 2 | Completed | - | - |
NCT00787202 | - | Completed | - | - | |
NCT01283139 | - | Completed | - | - | |
NCT00171314 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00134147 | Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01283139 | Systemic Lupus Erythematosus | Phase 2 | Completed | - | - |
NCT00171314 | - | Completed | - | - | |
NCT01150890 | Crohn's Disease | Phase 2 | Terminated(Per recommendation ... 展开 >>from DRT) 收起 << | - | - |
NCT00663260 | Diabetes Mellitus, Type 2 | Phase 2 Phase 3 | Completed | - | - |
NCT01431274 | - | Completed | - | - | |
NCT01774409 | Neoplasms | Not Applicable | Recruiting | July 2023 | France ... 展开 >> Groupement Hospitalier Mutualiste Recruiting Grenoble, France, 38028 Principal Investigator: Cécile LEYRONNAS, MD Hôpital Edouard Herriot Not yet recruiting Lyon, France, 69003 Principal Investigator: Julien FORESTIER, MD Sub-Investigator: Catherine LOMBARD BOHAS, MD Sub-Investigator: Thomas WALTER, MD Centre Léon Bérard Recruiting Lyon, France, 69008 Sub-Investigator: Thomas BACHELOT, MD Sub-Investigator: Amine BELHABRI, MD Sub-Investigator: Christophe BERGERON, MD Sub-Investigator: Pierre BIRON, MD Sub-Investigator: Helen BOYLE, MD Sub-Investigator: Philippe CASSIER, MD Sub-Investigator: Patrick COMBEMALE, MD Sub-Investigator: Françoise DESSEIGNE, MD Sub-Investigator: Cécile FAURE-CONTER, MD Sub-Investigator: Jérome FAYETTE, MD Sub-Investigator: Aude FLECHON, MD Sub-Investigator: Christelle DE LA FOUCHARDIERE, MD Sub-Investigator: Didier FRAPPAZ, MD Sub-Investigator: Hervé GHESQUIERES, MD Sub-Investigator: Jean-Paul GUASTALLA, MD Sub-Investigator: Pierre GUIBERT, MD Sub-Investigator: Pierre-Etienne HEUDEL, MD Sub-Investigator: Aurélien MARABELLE, MD Sub-Investigator: Sylvie NEGRIER, MD Sub-Investigator: Eve-Marie NEIDHARDT, MD Sub-Investigator: Emmanuelle NICOLAS-VIRELIZIER, MD Sub-Investigator: Maurice PEROL, MD Sub-Investigator: Isabelle RAY-COQUARD, MD Sub-Investigator: Paul REBATTU, MD Sub-Investigator: Catherine SEBBAN, MD Sub-Investigator: Olivier TREDAN, MD Sub-Investigator: Alice LEVARD, MD Sub-Investigator: Virginie AVRILLON, MD Sub-Investigator: Louis TASSY, MD Centre Hospitalier Lyon Sud Recruiting Pierre-Bénite Cedex, France, 69495 Principal Investigator: Benoît YOU, MD Sub-Investigator: Cécile FOURNEL-FEDERICO, MD Sub-Investigator: Gilles FREYER, MD Sub-Investigator: Sophie TARTAS, MD Sub-Investigator: Véronique TRILLET-LENOIR, MD Institut de cancérologie LUCIEN NEUWIRTH Recruiting Saint-Priest-en-Jarez, France, 42270 Principal Investigator: Olivier COLLARD, MD 收起 << |
NCT00114777 | - | Completed | - | - | |
NCT00663260 | - | Completed | - | - | |
NCT00313300 | Acute Coronary Syndrome (ACS) | Phase 2 | Completed | - | - |
NCT00511459 | Locally Recurrent and Metastat... 展开 >>ic Breast Cancer 收起 << | Phase 2 | Completed | - | - |
NCT01740180 | - | Terminated(No recruitment) | - | France ... 展开 >> CHU de Bordeaux - Groupe Hospitalier Pellegrin Bordeaux, France, 33076 CH de Dax - Côte d'Argent Dax, France, 40100 CHU de Limoges - Hôpital Dupuytren Limoges, France, 87042 APHM - Hôpital La Timone Adultes Marseille, France, 13385 CHU de Montpellier - Hôpital Saint-Eloi Montpellier, France, 34295 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 9, France, 30029 CHU de Rouen - Hôpital Charles Nicolle Rouen, France, 76031 CHRU de Strasbourg - Hôpital Civil Strasbourg Cedex, France, 67091 CHRU de Toulouse - Hôpital de Rangueil Toulouse Cedex 9, France, 31059 CHRU de Toulouse - Hôpital Purpan Toulouse Cedex 9, France, 31059 CHRU de Tours - Hôpital Bretonneau Tours, France, 37044 收起 << | |
NCT00313300 | - | Completed | - | - | |
NCT01318941 | - | Completed | - | - | |
NCT00548405 | Multiple Sclerosis, Relapsing-... 展开 >>Remitting 收起 << | Phase 3 | Completed | - | - |
NCT01380860 | Parastomal Hernia | Not Applicable | Unknown | October 2018 | France ... 展开 >> CHRU de Besancon Besancon, France, 25030 CHU de Bordeaux Bordeaux, France, 33075 CHRU de Clermont Ferrand Clermont Ferrand, France, 63058 APHP - Hôpital Beaujon Clichy, France, 92110 Hôpital Albert Michallon, CHU de Grenoble Grenoble, France, 38043 APHP - Centre Hospitalier Universitaire de Bicêtre Le Kremlin Bicêtre Cedex, France, 94275 CHRU de Lille - Hôpital Claude Huriez Lille Cedex, France, 59037 Centre de Lutte Contre le Cancer - Centre Oscar Lambret Lille, France, 59020 CHU de Lyon Lyon, France, 69317 Centre Régional de Lutte Contre le Cancer - Institut Paoli-Calmettes Marseille, France, 13009 APHM - Hôpital La Timone Adultes Marseille, France, 13385 Centre Régional de Lutte Contre le Cancer Val d'Aurelle - Paul Lamarque Montpellier, France, 34298 CHU de Nantes Nantes, France, 44093 Centre Hospitalier Universitaire de Nîmes Nîmes, France, 30029 APHP - Hôpital Saint-Antoine Paris Cedex 12, France, 75571 APHP - Groupe Hospitalier Pitié-Salpetrière Paris Cedex 13, France, 75651 APHP - Hôpital Lariboisière Paris, France, 75010 Hôpital Pontchailou Rennes, France, 35033 CHU de Rouen Rouen, France, 76038 Centre Régional de Lutte contre le Cancer Centre Paul Strauss Strasbourg, France, 67065 CHU de Toulouse Toulouse, France CH de Vichy - Jacques Larin Vichy, France, 03207 收起 << |
NCT01199302 | Crohn's Disease | Phase 2 | Terminated(Per recommendation ... 展开 >>from DRT) 收起 << | - | - |
NCT00790283 | Lesion | Phase 2 Phase 3 | Unknown | September 2009 | France ... 展开 >> CHU Cote de Nacre Active, not recruiting Caen Cedex, France, 14033 CMC De Parly II Active, not recruiting Le Chesnay, France, 78150 Clinique Vert Coteau Active, not recruiting Marseille Cedex 12, France, 13375 Clinique Valmente Active, not recruiting Marseille, France, 13009 Centre Hospitalier Privé Beauregard Recruiting Marseille, France, 13012 Contact: Olivier Wittemberg 0033491121090 olwitt@aol.com Principal Investigator: Olivier Wittemberg Clinique Turin Not yet recruiting Paris, France, 75006 Principal Investigator: Thierry Corcos, MD, FACC Clinique Alleray-Labrouste Active, not recruiting Paris, France, 75018 Clinique Saint Gatien Active, not recruiting Tours Cedex, France, 37042 收起 << |
NCT00665223 | Huntington's Disease | Phase 3 | Completed | - | Austria ... 展开 >> LKH -Univ. Klinikum Graz, Universitaetsklinik fur Psychiatrie Graz Graz, Styria, Austria, 8036 Innsbruck Medical University, Anichstraße 35 Innsbruck, Tyrol, Austria, A-6020 Belgium University Hospital Gasthuisberg Leuven, Flemish Brabant, Belgium, 3000 France Hôpital Purpan, Place Docteur-Baylac, Bâtiment F Toulouse Cedex 9, Midi-Pyrénées region, France, 31059 CHU Roger Salengro Lille Cedex, Nord-Pas de Calais, France, 59037 Hôpital Nord, CHU d'Amiens, Service de Neurologie Amiens Cedex 1, Picardie, France, 80054 CHU La Timone, 264 Rue Saint Pierre Marseille Cedex 05, Provence-Alpes-Cote d'Azur, France, 13385 Germany Universitätsklinik Ulm, Neurologie/ Oberer Eselberg 45/1 Ulm, Baden-Württemberg, Germany, 89081 Klinikum rechts der Isar der Technischen Universität München, Neurologische Klinik und Poliklinik, Ismaninger Str. 22 München, Bavaria, Germany, 81675 Isar Amper Klinikum gemeinnützige GmbH, Klinik Taufkirchen (Vils), Bräuhausstr.5 Taufkirchen (Vils), Bavaria, Germany, 84416 St. Josef Hospital, Ruhr University Bochum, Gudrunstraße 56 Bochum, North Rhine-Westphalia, Germany, 44791 Westfaelische Wilhelms-Universitaet Muenster, Klinik fur Neurologie Muenster, North Rhine-Westphalia, Germany, 48149 Universitat Dresden, Klinikum Carl Gustav Carus, Fetscherstr. 74 Dresden, Saxony, Germany, 01307 Klinik für Psychiatrie und Psychotherapie, Charité - Universitätsmedizin Berlin, Schumannstrasse 20/21 Berlin, Germany, 10117 Italy Fondazione IRCCS Istituto Nazionale Neurologico "Carlos Besta", Department of Movement Disorders, 11 via Celoria Milano, Lombardy, Italy, 20133 IRCCS Neuromed, Localita Camarelle Pozzilli, Molise, Italy, 86077 Portugal University Hospital of Coimbra, Av. Rissaya Barreto Coimbra, Baixo Mondego, Portugal, 3000-075 Centro de Estudos Egas Moniz, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz Lisboa, Portugal, 1649-028 Spain Hospital Mútua de Terrassa, C/ Castell Terrassa, Catalonia, Spain, 08225 Hospital Clinic of Barcelona, Calle Villarroel, 170 Barcelona, Spain, 08036 Hospital Ramon y Cajal, Carretera Colemenar km 9.100 Madrid, Spain, 28034 Hospital Universitario La Fe, Avda. Campanar 21, Valencia, Spain, 46009 United Kingdom R&D Headquarters, Barberry Centre, 25 Vincent Drive Birmingham, England/West Midlands, United Kingdom, B15 2SG Department of Clinical Genetics, St Mary's Hospital, Hathersage Road Manchester, North West England, United Kingdom, M13 9WL First Floor Argyll House, Fosterhill, Cornhill Road Aberdeen, Scotland, United Kingdom, AB25 2ZR SE Scotland Genetic Service, Western General Hospital, Crewe Road Edinburgh, Scotland, United Kingdom, EH4 2XU Churchill Hospital, Old Road, Headington Oxford, South East England, United Kingdom, OX3 7LJ Academic Neurology Unit, E Floor Medical School Beech Hill Road Sheffield, South Yorkshire, United Kingdom, S10 2RX Institute of Human Genetics, Centre for Life, Central Parkway Newcastle on Tyne, Tyne and Wear, United Kingdom, NE1 3BZ Cardiff University School of Medicine, Department of Neurology & Medical Genetics, Heath Park Cardiff, Wales, United Kingdom, CF14 4XN Cambridge Centre for Brain repair, Cambridge University Cambridge, United Kingdom, CB2 2PY 收起 << |
NCT01517178 | Leakage Skin ... 展开 >>Condition 收起 << | Phase 3 | Terminated | - | Denmark ... 展开 >> Sygehus Sønderjylland i Aabenraa Aabenraa, Denmark, 6200 Bispebjerg Hospital Copenhagen, Denmark, 2400 Hvidovre Hospital Hvidovre, Denmark, 2650 Odense Universitetshospital Odense, Denmark, 5000 France Hôpital Nord Marseille, France, 13015 Hôpital Hôtel Dieu de Nantes Nantes cedex 1, France, 44093 Hôpital Lariboisière Paris cedex 10, France, 75475 CHRU La Milétrie Poitiers cedex, France, 86021 Hôpital de Pontchaillou, CHRU de Rennes Rennes cedex 9, France, 35033 Germany Sanitätshaus Fürst GmbH Passau, Germany, 94032 Iceland Landspitali University Hospital Reykjavik, Iceland, 108 收起 << |
NCT01257204 | Hepatitis C Virus | Phase 2 | Completed | - | - |
NCT01362296 | Lung Cancer, Non-Small Cell | Phase 2 | Completed | - | - |
NCT01231347 | Adenocarcinoma of the Pancreas... 展开 >> Advanced Solid Tumors Cancer Cancer of Pancreas Cancer of the Pancreas Metastases Metastatic Cancer Metastatic Pancreatic Cancer Pancreas Cancer Pancreatic Cancer Bone Metastases Endocrine Cancer Oncology Oncology Patients Solid Tumors Advanced Malignancy 收起 << | Phase 3 | Terminated(Planned independent... 展开 >> DMC Interim review ended for futility w/no safety concerns) 收起 << | - | - |
NCT00548405 | - | Completed | - | - | |
NCT01362296 | - | Completed | - | - | |
NCT01471574 | - | Completed | - | - | |
NCT01471574 | Hepatitis C, Genotype 1 | Phase 3 | Completed | - | - |
NCT01584648 | Melanoma | Phase 3 | Active, not recruiting | October 15, 2018 | - |
NCT01257204 | - | Completed | - | - | |
NCT02927262 | Acute Myeloid Leukemia (AML) ... 展开 >> Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation 收起 << | Phase 3 | Recruiting | March 2024 | - |
NCT01343888 | Hepatitis C | Phase 3 | Completed | - | - |
NCT01517178 | - | Terminated | - | - | |
NCT01343888 | - | Completed | - | - | |
NCT00256711 | Non-Small-Cell Lung Carcinoma | Phase 2 | Completed | - | - |
NCT00958971 | Metastatic Breast Cancer | Phase 2 | Completed | - | - |
NCT00327470 | Age Related Macular Degenerati... 展开 >>on (AMD) Macular Degeneration Choroidal Neovascularization (CNV) 收起 << | Phase 4 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01584648 | - | Active, not recruiting | - | - | |
NCT00327470 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00085943 | HIV Infection ... 展开 >> Infection, Human Immunodeficiency Virus 收起 << | Phase 3 | Completed | - | - |
NCT00683865 | Pelvic Inflammatory Disease | Phase 3 | Completed | - | - |
NCT00136565 | Peripheral T-cell Lymphoma | Phase 2 | Completed | - | Belgium ... 展开 >> Groupe d'Etude des Lymphomes de l'Adulte Yvoir, Belgium France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France 收起 << |
NCT01244750 | - | Active, not recruiting | August 30, 2020 | - | |
NCT01628692 | Hepatitis C Virus | Phase 2 | Completed | - | United States, California ... 展开 >> San Francisco General Hospital San Francisco, California, United States, 94110 Kaiser Permanente Med Ctr San Francisco, California, United States, 94118 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins University Lutherville, Maryland, United States, 21093 United States, Tennessee Nashville Medical Research Institute Nashville, Tennessee, United States, 37205 United States, Texas Texas Clinical Research Institute, Llc Arlington, Texas, United States, 76012 United States, Virginia Metropolitan Research Fairfax, Virginia, United States, 22031 Argentina Local Institution Buenos Aires, Argentina, 1119 Local Institution Buenos Aires, Argentina, C1181ACH France Local Institution Creteil Cedex, France, 94010 Local Institution Limoges, France, 87042 Local Institution Marseille Cedex 08, France, 13285 Local Institution Paris Cedex 13, France, 75651 Local Institution Paris Cedex 14, France, 75679 Local Institution Pessac, France, 33600 Local Institution Vandoeuvre Les Nancy, France, 54511 Germany Local Institution Berlin, Germany, 10969 Local Institution Frankfurt, Germany, 60590 Local Institution Hamburg, Germany, 20099 Local Institution Koeln, Germany, 50937 Hungary Local Institution Budapest, Hungary, 1097 Local Institution Budapest, Hungary, 1126 Local Institution Gyula, Hungary, 5700 Spain Local Institution Barcelona, Spain, 08035 Local Institution Madrid, Spain, 28046 Local Institution Valencia, Spain, 46010 收起 << |
NCT00261976 | - | Completed | - | - | |
NCT01087229 | Adhesive Capsulitis | Phase 4 | Completed | - | France ... 展开 >> Unité Rééducation Réadaptation Locomotrice Le Grau du Roi, Gard, France, 30240 Centre Hospitalier Universitaire de Nîmes Nîmes, Gard, France, 30029 CHU de Clermont Ferrand Cébézat, France, 63118 CHU Lapeyronie Montpellier Cedex 05, France, 34295 Centre Hélio Marin Vallauris, France, 06223 收起 << |
NCT00751881 | - | Completed | - | - | |
NCT00751881 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT00102778 | Infection, Human Immunodeficie... 展开 >>ncy Virus I HIV Infection 收起 << | Phase 2 | Terminated | - | - |
NCT03151551 | Psoriatic Arthritis | Phase 4 | Active, not recruiting | August 15, 2019 | - |
NCT01659099 | Diffuse Large B Cell Lymphoma ... 展开 >>CD20 Positive 收起 << | Phase 3 | Terminated(experimental treatm... 展开 >>ent not Superior to standard - no need to continue the follow-up) 收起 << | - | - |
NCT01762852 | Glomerulonephritis, Membranous | Phase 2 | Withdrawn(Withdrawn due to dif... 展开 >>ficulties in to recruiting due to competing studies, changing treatment practices, unavailability of eligible study population) 收起 << | January 2014 | - |
NCT01289041 | Advanced Endometrial Cancer | Phase 2 | Completed | - | - |
NCT01628692 | - | Completed | - | - | |
NCT00932451 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | - | - |
NCT03299049 | HIV Infections | Phase 3 | Active, not recruiting | March 11, 2022 | - |
NCT01011868 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT00757237 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT00932451 | - | Completed | - | - | |
NCT01470612 | Ulcerative Colitis | Phase 3 | Active, not recruiting | July 27, 2020 | - |
NCT01011868 | - | Completed | - | - | |
NCT01567956 | Ulcerative Colitis | Phase 3 | Terminated(Evidence of very lo... 展开 >>w probability to success. No safety issues) 收起 << | - | - |
NCT00757237 | - | Completed | - | - | |
NCT00105144 | Candidiasis C... 展开 >>andidemia 收起 << | Phase 3 | Completed | - | - |
NCT01289041 | - | Completed | - | - | |
NCT00320190 | Leukemia, Myeloid, Chronic | Phase 2 | Terminated(Terminated due to s... 展开 >>low participant accrual) 收起 << | - | Belgium ... 展开 >> Local Institution Antwerpen, Belgium, 2060 Local Institution Charleroi, Belgium, 6000 Finland Local Institution Helsinki, Finland, 00029 Local Institution Tampere, Finland, 33380 France Local Institution Lyon Cedex 03, France, 69437 Local Institution Marseille Cedex 9, France, 13273 Local Institution Montpellier Cedex 5, France, 34295 Local Institution Paris Cedex 10, France, 75475 Local Institution Rennes, France, 35033 Local Institution Strasbourg Cedex, France, 67091 Local Institution Toulouse Cedex 09, France, 31059 Germany Local Institution Leipzig, Germany, 04103 Italy Local Institution Orbassano (To), Italy, 10043 Norway Local Institution Oslo, Norway, 0027 Local Institution Trondheim, Norway, 7006 Portugal Local Institution Lisboa, Portugal, 1649-035 Russian Federation Local Institution Moscow, Russian Federation, 125167 Local Institution Saint-Petersburg, Russian Federation, 191024 Local Institution St.Petersburg, Russian Federation, 197022 Spain Local Institution Murcia, Spain, 30008 Sweden Local Institution Lund, Sweden, 221 85 Local Institution Orebro, Sweden, 70185 Local Institution Uppsala, Sweden, 751 85 United Kingdom Local Institution Glasgow, Central, United Kingdom, G31 2ER Local Institution London, Greater London, United Kingdom, SE5 9RS Local Institution London, Greater London, United Kingdom, W12 ONN Local Institution Leeds, North Yorkshire, United Kingdom, LS9 7FT 收起 << |
NCT02098395 | - | Completed | - | - | |
NCT00206310 | Heart Failure | Phase 3 | Completed | - | - |
NCT00320190 | - | Terminated(Terminated due to s... 展开 >>low participant accrual) 收起 << | - | - | |
NCT00143403 | Colorectal Neoplasms ... 展开 >> Liver Neoplasms 收起 << | Phase 3 | Completed | - | - |
NCT02098395 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00884390 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01581203 | Hepatitis C Virus | Phase 3 | Completed | - | - |
NCT00091650 | Borderline Personality Disorde... 展开 >>r 收起 << | Phase 3 | Completed | - | - |
NCT00375674 | Kidney Neoplasms | Phase 3 | Completed | - | - |
NCT00884390 | Hemophilia A | Phase 4 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT00059735 | Kidney Neoplasms ... 展开 >> Carcinoma, Renal Cell Adenocarcinoma, Renal Cell 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Sacramento, California, United States, 95817 United States, New York Bronx, New York, United States, 10466 New York, New York, United States, 10021 New York, New York, United States, 10032 France Villejuif Cedex, France, 94805 收起 << |
NCT01081145 | Attention-deficit/Hyperactivit... 展开 >>y Disorder 收起 << | Phase 3 | Completed | - | - |
NCT00143403 | - | Completed | - | - | |
NCT00418886 | Non Small Cell Lung Cancer ... 展开 >> Lung Cancer 收起 << | Phase 3 | Active, not recruiting | December 2019 | - |
NCT00418886 | - | Active, not recruiting | - | - | |
NCT02025907 | - | Completed | - | - | |
NCT00101660 | Chronic Myeloid Leukemia ... 展开 >> Philadelphia-Positive Myeloid Leukemia 收起 << | Phase 2 | Completed | - | - |
NCT01147250 | - | Completed | - | - | |
NCT00375674 | - | Completed | - | - | |
NCT01155986 | Pain Chronic ... 展开 >>Pain Neuropathic Pain Postoperative Pain 收起 << | Phase 2 | Terminated(Trial was stopped d... 展开 >>ue to difficult enrolment) 收起 << | - | France ... 展开 >> Site 31 Abbeville, France Site 26 Bayonne, France Site 34 Bobigny, France Site 35 Bordeaux, France Site 12 Boulogne-Billancourt, France Site 24 Brest, France Site 15 Chateauroux, France Site 30 Corbeil Essonnes, France Site 39 La Roche Sur Yon, France Site 23 Lille cedex, France Site 17 Limoges, France Site 21 Marseille, France Site 33 Montauban, France Site 14 Nice Cedex 1, France Site 18 Orleans, France Site 27 Paris, France Site 36 Paris, France Site 22 Rennes Cedex, France Site 19 Saint Genis Laval, France Site 20 Saint-Etienne cedex 2, France Site 38 Tours, France Site 28 Voiron, France 收起 << |
NCT01081145 | - | Completed | - | - | |
NCT02025907 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT00232687 | Schizophrenia | Phase 4 | Completed | - | - |
NCT01147250 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT00101660 | - | Completed | - | - | |
NCT01200589 | - | Terminated(The study stopped d... 展开 >>ue to futility.) 收起 << | - | - | |
NCT00992394 | Psoriasis | Phase 4 | Completed | - | - |
NCT01200589 | Non-Hodgkin's Lymphoma | Phase 3 | Terminated(The study stopped d... 展开 >>ue to futility.) 收起 << | - | - |
NCT00975195 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 4 | Completed | - | - |
NCT01843062 | Differentiated Thyroid Cancer | Phase 3 | Active, not recruiting | April 29, 2019 | - |
NCT00992394 | - | Completed | - | - | |
NCT01792518 | - | Completed | - | - | |
NCT00975195 | - | Completed | - | - | |
NCT01358864 | Hepatitis C, Chronic | Phase 3 | Completed | - | - |
NCT03446573 | HIV Infections | Phase 2 Phase 3 | Recruiting | July 22, 2022 | - |
NCT00279448 | Breast Neoplasms | Phase 3 | Completed | - | - |
NCT01850524 | Multiple Myeloma | Phase 3 | Active, not recruiting | February 22, 2021 | - |
NCT01792518 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01694485 | Ulcerative Colitis | Phase 2 | Completed | - | - |
NCT02599402 | Melanoma | Phase 3 | Active, not recruiting | October 8, 2019 | - |
NCT01358864 | - | Completed | - | - | |
NCT01227824 | Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 << | Phase 3 | Completed | - | - |
NCT01103323 | Metastatic Colorectal Cancer | Phase 3 | Completed | - | - |
NCT01227824 | - | Completed | - | - | |
NCT00409188 | Non-small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT00450580 | - | Completed | - | - | |
NCT00450580 | Infection, Human Immunodeficie... 展开 >>ncy Virus I HIV-1 Infection 收起 << | Phase 3 | Completed | - | - |
NCT00409188 | - | Completed | - | - | |
NCT01358578 | - | Completed | - | - | |
NCT01358578 | Chronic Plaque Psoriasis | Phase 3 | Completed | - | - |
NCT01103323 | - | Completed | - | - | |
NCT00124982 | - | Completed | - | - | |
NCT00403104 | Amyotrophic Lateral Sclerosis ... 展开 >>(ALS) 收起 << | Phase 2 | Completed | - | Austria ... 展开 >> L. Boltzmann Forschungsinstitut, Neurologische Abteilung, Kaiser Franz Josef Hospital, Wien Wien, Austria, 1100 Belgium UCL Saint-Luc Brussels, Belgium UZ Leuven Leuven, Belgium, 3000 France Hopital Roger Salengro - Clinique Neurologique, Neurologie A Lille Cedex, France, 59037 Hopital Duruytren Limoges Cedex, France, 87042 Hopital de la Timone Marseille, France, 13005 Hopital de Chauliac Montpellier cedex 5, France, 34295 Hopital l-Archet 1 Nice cedex 3, France, 06202 Hopital LaPitie Salpetriere Paris, France, 75013 Germany Charite Campus Virchow, ALS Ambulanz Berlin, Germany, 13353 Neurologische Universitatsklinik Bergmannsheil Bochum, Germany, 44789 Poliklinik der Universitat Erlangen-Nurnberg, Neurologische Klinik Erlangen, Germany, 91054 Martin-Luther-Universitat Halle-Wittenberg, Klinikum der Medizinischen Fakultat, Universitatsklinik und Poliklinik fur Neurologie Halle, Germany, 06120 Medizinische Hochschule Hannover, Neurologische Klinik Hannover, Germany, 30623 Interdisziplinares Zentrum fur Palliativmedizin Munchen, Germany Klinik und Poliklinik fur Neurologie der Universitat Ulm-Universitatsklinikum Ulm Ulm, Germany, 89081 Deutsche Klinik fur Diagnostik, Fachbereich Neurologie Wiesbaden, Germany, 65191 Italy Dipartimento di Neurologia e Laboratorio di Neuroscienze - Universita di Milano - IRCCS - Istituto Auxologico Italiano Milano, Italy, 20149 Divisione di Neuroriabilitazione II - Fondazione Salvatore Maugeri - IRCCS Pavia, Italy, 27100 Dipartimento di Neuroscienze - Divisione di Neurologia II - Azienda Ospedaliera S. Giovanni Battista - Molinette Torino, Italy, 10126 Netherlands Academic Medical Centre (AMC) Amsterdam - Dept of Neurology Amsterdam, Netherlands University Medial Center Utrecht Utrecht, Netherlands Switzerland Kantonsspital St. Gallen, Muskelzentrum/ALS Clinic St. Gallen, Switzerland, 9007 United Kingdom Academic Neuroscience Centre London, United Kingdom Royal Preston Hospital Preston, United Kingdom, PR29HT University of Sheffield - Academic Neurology Unit Sheffield, United Kingdom 收起 << |
NCT00662649 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT00124982 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT02696642 | Neoplasms | Phase 1 | Active, not recruiting | June 28, 2019 | France ... 展开 >> Caen, France, 14073 Dijon, France, 21000 Lille Cedex, France, 59020 Lyon Cedex, France, 69008 Marseille, France, 13915 Saint Herblain, France, 44805 Toulouse Cedex 9, France, 31059 Moldova, Republic of Chisinau, Moldova, Republic of, 2025 收起 << |
NCT00662649 | - | Completed | - | - | |
NCT01170065 | Pulmonary Fibrosis | Phase 2 | Completed | - | - |
NCT00257972 | Bipolar Disorder | Phase 3 | Completed | - | - |
NCT01107639 | Adenocarcinoma of the Gastroes... 展开 >>ophageal Junction Esophageal Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00958841 | Pancreatic Neoplasm ... 展开 >> Pituitary Neoplasm Nelson Syndrome Ectopic ACTH Syndrome 收起 << | Phase 2 | Terminated(Slow recruitment ra... 展开 >>te into this study with rare tumors of neuroendocrine origin (enrollment issues)) 收起 << | - | - |
NCT00034268 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
NCT00958841 | - | Terminated(Slow recruitment ra... 展开 >>te into this study with rare tumors of neuroendocrine origin (enrollment issues)) 收起 << | - | - | |
NCT01023308 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT01023308 | - | Completed | - | - | |
NCT01281527 | Schizophrenia | Phase 3 | Completed | - | - |
NCT00988208 | - | Completed | - | - | |
NCT00988208 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT01395888 | - | Completed | - | - | |
NCT01455090 | Chronic Hepatitis C | Phase 2 | Completed | - | - |
NCT01143038 | - | Completed | - | - | |
NCT01143038 | Idiopathic Thrombocytopenic Pu... 展开 >>rpura 收起 << | Phase 2 | Completed | - | - |
NCT00073528 | Neoplasms, Breast | Phase 3 | Completed | - | - |
NCT01395888 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00423605 | Fibromyalgia | Phase 3 | Completed | - | - |
NCT00073528 | - | Completed | - | - | |
NCT00423605 | - | Completed | - | - | |
NCT01263015 | Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 << | Phase 3 | Completed | - | - |
NCT00310843 | - | Completed | - | - | |
NCT02484547 | Alzheimer's Disease | Phase 3 | Active, not recruiting | April 30, 2022 | - |
NCT00676650 | Prostatic Neoplasms | Phase 3 | Terminated(Study A6181120 was ... 展开 >>prematurely discontinued due to futility on 27 September 2010. No new or unexpected safety issues were identified.) 收起 << | - | - |
NCT01263015 | - | Completed | - | - | |
NCT01740427 | - | Active, not recruiting | - | - | |
NCT03218488 | - | Recruiting | September 15, 2026 | Belgium ... 展开 >> UCL Hopital Saint-Luc Recruiting Bruxelles, Belgium, 1200 UZ Leuven Recruiting Leuven, Belgium, 3000 CHU de Liège - Domaine Universitaire du Sart Tilman Recruiting Liege, Belgium, 4000 Grand Hôpital de Charleroi Recruiting Loverval, Belgium, 6280 Denmark Bispebjerg Hospital Recruiting Copenhagen, Denmark, NV 2400 Gentofte Herlev Hospital Recruiting Hellerup, Denmark, 2800 Odense Universitetshospital Withdrawn Odense C, Denmark, 5000 France CH Victor Dupouy Argenteuil Recruiting Argenteuil, France, 95107 CHRU Besançon -Hôpital Jean Minjoz Recruiting Besançon Cedex, France, 25030 Groupe Hospitalier Pellegrin CHU de Bordeaux Recruiting Bordeaux, France, 33076 ICH Hopital A. Morvan Recruiting Brest Cedex 2, France, 29609 Le Bateau Blanc Recruiting Martigues, France, 13500 Hôpital Necker Enfants Malades Recruiting Paris Cedex 15, France, 75743 CHU Saint-Etienne - Hôpital Nord Recruiting Saint-Etienne Cedex 2, France, 42055 Germany Klinikum der Johann Wolfgang Goethe -Universitaet Not yet recruiting Frankfurt, Germany, 60590 Universitatsklinikum Schleswig-Holstein - Kiel Withdrawn Kiel, Germany, 24105 Praxis Dr. med. Beate Schwarz - Germany Recruiting Langenau, Germany, 89129 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Recruiting Mainz, Germany, 55131 Netherlands Radboudumc Recruiting Nijmegen, Netherlands, 6525 EX Norway Oslo universitetssykehus HF, Rikshospitalet Recruiting Oslo, Norway, 0027 United Kingdom Whipps Cross University Hospital Recruiting London, United Kingdom, E11 1NR Great Ormond Street Hospital Recruiting London, United Kingdom, WC1N 3JH Salford Royal Hospital Recruiting Salford, United Kingdom, M6 8HD 收起 << | |
NCT02709486 | Osteoarthritis, Hip ... 展开 >> Osteoarthritis, Knee 收起 << | Phase 3 | Active, not recruiting | December 2018 | - |
NCT01740427 | Breast Neoplasms | Phase 3 | Active, not recruiting | June 30, 2020 | - |
NCT00297973 | Hypertension | Phase 4 | Completed | - | - |
NCT00709865 | Renal Insufficiency ... 展开 >> Congestive Heart Failure 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT00676650 | - | Terminated(Study A6181120 was ... 展开 >>prematurely discontinued due to futility on 27 September 2010. No new or unexpected safety issues were identified.) 收起 << | - | - | |
NCT02491684 | Asthma | Phase 2 | Completed | - | Argentina ... 展开 >> Research Site Buenos Aires, Argentina Research Site C.a.b.a., Argentina Research Site Ciudad Autonomade Buenos Aires, Argentina Research Site Quilmes, Argentina Australia Research Site Bedford Park, Australia Research Site New Lambton, Australia Research Site Westmead, Australia Research Site Woolloongabba, Australia Colombia Research Site Bogota, Colombia Research Site Bogotá, Colombia Research Site Floridablanca, Colombia France Research Site Brest Cedex, France Research Site Dijon, France Research Site Lyon Cedex 04, France Research Site Marseille, France Research Site Montpellier Cedex 5, France Research Site Paris Cedex 18, France Research Site Pessac, France Korea, Republic of Research Site Bucheon-si, Korea, Republic of Research Site Jeonju-si, Korea, Republic of Research Site Seoul, Korea, Republic of Spain Research Site Barcelona, Spain Research Site Marbella (Málaga), Spain Research Site Málaga, Spain Research Site Sevilla, Spain Research Site Valencia, Spain United Kingdom Research Site Blackpool, United Kingdom Research Site Bradford, United Kingdom Research Site Lancaster, United Kingdom Research Site Leeds, United Kingdom Research Site Manchester, United Kingdom Research Site Nottingham, United Kingdom Research Site Southampton, United Kingdom 收起 << |
NCT00034593 | Urologic Neoplasms | Phase 2 | Completed | - | Finland ... 展开 >> "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Helsinki, Finland "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Pikonlinna, Finland "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Turku, Finland France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Bordeaux Cedex, France For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Lille Cedex, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Marseille Cedex 09, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Montpellier, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Paris Cedex 14, France Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Homburg/Saar, Germany 收起 << |
NCT01077154 | - | Terminated(Terminated Amgen de... 展开 >>cision following Primary Analysis. Not due to safety reason) 收起 << | - | - | |
NCT01077154 | Breast Cancer | Phase 3 | Terminated(Terminated Amgen de... 展开 >>cision following Primary Analysis. Not due to safety reason) 收起 << | - | - |
NCT01573338 | Small Cell Lung Carcinoma | Phase 1 Phase 2 | Terminated | - | United States, Missouri ... 展开 >> Saint Louis, Missouri, United States, 63110 United States, New York Buffalo, New York, United States, 14263-0001 United States, Ohio Cleveland, Ohio, United States, 44195 France Caen Cedex, France, 14033 Lyon Cedex, France, 69008 Marseille, France, 13005 Villejuif Cedex, France, 94805 Korea, Republic of Seoul, Korea, Republic of, 03080 Seoul, Korea, Republic of, 120-752 收起 << |
NCT02214771 | - | Completed | - | France ... 展开 >> Site Bethune, France Site Bordeaux, France Site Boulogne Billancourt, France Site Caen Cedex 9, France Site Chambéry, France Site Clermond-Ferrand, France Site Clichy, France Site Dijon, France Site Garches, France Site La Tronche, France Site Lille, France Site Lyon, France Site Marseille, France Site Morlaix, France Site Mulhouse, France Site Nantes, France Site Nimes, France Site Orléans Cedex 2, France Site Paris, France Site Poitiers, France Site Reims, France Site Rennes Cedex, France Site Roubaix Cedex 1, France Site Soissons, France 收起 << | |
NCT00514683 | Pulmonary Fibrosis | Phase 2 | Completed | - | - |
NCT03066804 | Heart Failure With Preserved E... 展开 >>jection Fraction 收起 << | Phase 3 | Recruiting | December 4, 2019 | - |
NCT00073307 | - | Completed | - | - | |
NCT03306043 | Hypereosinophilic Syndrome | Phase 3 | Recruiting | March 5, 2020 | United States, Minnesota ... 展开 >> GSK Investigational Site Recruiting Rochester, Minnesota, United States, 55905 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Utah GSK Investigational Site Recruiting Murray, Utah, United States, 84107 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Belgium GSK Investigational Site Recruiting Bruxelles, Belgium, 1070 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Leuven, Belgium, 3000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com France GSK Investigational Site Recruiting Lille Cedex, France, 59037 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Nantes Cedex 1, France, 44093 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Suresnes, France, 92151 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Toulouse Cedex 9, France, 31059 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Germany GSK Investigational Site Recruiting Mannheim, Baden-Wuerttemberg, Germany, 68167 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Fulda, Hessen, Germany, 36043 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Kirchheim unter Teck, Germany, 73230 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Italy GSK Investigational Site Not yet recruiting Napoli, Campania, Italy, 80131 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Mexico GSK Investigational Site Recruiting Guadalajara, Jalisco, Mexico, 44100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Villahermosa, Tabasco, Mexico, 86035 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Poland GSK Investigational Site Not yet recruiting Krakow, Poland, 31-066 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Romania GSK Investigational Site Recruiting Bucharest, Romania, 010306 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Russian Federation GSK Investigational Site Not yet recruiting Moscow, Russian Federation, 125167 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Saint-Petersburg, Russian Federation, 197341 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Spain GSK Investigational Site Not yet recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Valencia, Spain, 46026 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United Kingdom GSK Investigational Site Recruiting Leicester, United Kingdom, LE3 9QP Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT01968109 | Neoplasms by Site | Phase 1 Phase 2 | Recruiting | December 18, 2020 | - |
NCT00262600 | Atrial Fibrillation ... 展开 >> Stroke 收起 << | Phase 3 | Completed | - | - |
NCT00262600 | - | Completed | - | - | |
NCT00514683 | - | Completed | - | - | |
NCT03227224 | Depressive Disorder, Major | Phase 2 | Recruiting | January 9, 2019 | - |
NCT00246571 | Breast Neoplasms | Phase 2 | Completed | - | - |
NCT00073307 | Carcinoma, Renal Cell | Phase 3 | Completed | - | - |
NCT00451932 | Liver Transplantation | Phase 2 | Completed | - | - |
NCT01573351 | Hepatitis C Virus | Phase 3 | Completed | - | - |
NCT00169169 | CD20-Positive Large B-Cell Lym... 展开 >>phoma 收起 << | Phase 3 | Terminated | - | France ... 展开 >> Hôpital Henri Mondor Créteil, France Hôpital Saint Louis Paris, France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France Centre Henri Becquerel Rouen, France CHRU de Nancy Brabois Vandoeuvre-les-Nancy, France 收起 << |
NCT03541174 | Resistant Hypertension | Phase 3 | Recruiting | February 8, 2021 | - |
NCT03017014 | - | Recruiting | March 20, 2028 | France ... 展开 >> Centre Hospitalier Lyon Sud /ID# 152667 Recruiting Pierre Benite CEDEX, Auvergne-Rhone-Alpes, France, 69495 Centre Hospitalier Lyon Sud /ID# 152668 Not yet recruiting Pierre Benite CEDEX, Auvergne-Rhone-Alpes, France, 69495 Hopital Clocheville /ID# 152831 Not yet recruiting Tours, Centre-Val De Loire, France, 37044 CHU de Besancon - Jean Minjoz /ID# 154197 Recruiting Besancon, Doubs, France, 25000 Hopitaux de Brabois Adultes /ID# 152729 Recruiting Vandoeuvre les Nancy, Lorraine, France, 54500 CHU Toulouse /ID# 153251 Not yet recruiting Toulouse CEDEX 3, Occitanie, France, 31025 CHU Batiment Robert Debre /ID# 152665 Not yet recruiting Angers, France, 49933 CHU Bordeaux-Hopital Pellegrin /ID# 154620 Not yet recruiting Bordeaux, France, 33076 Chu de Bordeaux Hopital /Id# 157926 Not yet recruiting Bordeaux, France, 33076 Centre Hospitalier Universitai /ID# 155465 Recruiting Caen, France, 14033 CHU Hopital d'Estaing /ID# 152664 Recruiting Clermont Ferrand, France, 63100 Hopital Jeanne de Flandre /Id# 155464 Not yet recruiting Lille, France, 59037 Hopital de la Timone /ID# 160133 Not yet recruiting Marseille, France, 13385 Hopital Jacques Monod /ID# 152663 Not yet recruiting Montivillier, France, 76290 Hopital de la Source /ID# 159947 Not yet recruiting Orleans, France, 45067 Hopital de la Source /ID# 165534 Not yet recruiting Orleans, France, 45067 Robert Debre Hopital, FR /ID# 152666 Recruiting Paris, France, 75019 Hopital Armand Trousseau /Id# 152669 Not yet recruiting Paris, France, 75571 Hopital Armand Trousseau /Id# 157092 Not yet recruiting Paris, France, 75571 Necker Hopital, FR /ID# 152830 Recruiting Paris, France, 75743 Chu Lyon Sud /Id# 152838 Not yet recruiting Pierre Benite, France, 69495 CHU de Rennes - Hospital Sud /ID# 152730 Recruiting Rennes, France, 35203 Charles Nicolle Hosp chu rouen /ID# 152670 Not yet recruiting Rouen, France, 76031 Charles Nicolle Hosp chu rouen /ID# 158688 Not yet recruiting Rouen, France, 76031 收起 << | |
NCT03106779 | Chronic Myelogenous Leukemia | Phase 3 | Recruiting | March 19, 2025 | - |
NCT00275444 | HIV Infections | Phase 2 | Completed | - | - |
NCT00246571 | - | Completed | - | - | |
NCT00670592 | Non-Hodgkin's Lymphoma ... 展开 >> Hodgkin's Lymphoma 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT00184795 | Menopause Men... 展开 >>opausal Vasomotor Symptoms 收起 << | Phase 3 | Completed | - | - |
NCT00488631 | Colitis, Ulcerative | Phase 3 | Completed | - | - |
NCT00152984 | Pulmonary Disease, Chronic Obs... 展开 >>tructive Asthma 收起 << | Phase 4 | Completed | - | - |
NCT02032173 | Macular Edema ... 展开 >> Macular Degeneration Diabetes 收起 << | Phase 3 | Terminated | January 2018 | France ... 展开 >> Novartis Investigative Site Bobigny, France, 93009 Novartis Investigative Site Bordeaux Cedex, France, F-33076 Novartis Investigative Site Bordeaux, France, 33000 Novartis Investigative Site Créteil, France, 94000 Novartis Investigative Site Le Kremlin Bicetre Cedex, France, 94275 Novartis Investigative Site Lyon, France, 69003 Novartis Investigative Site Nice, France, 6 000 Novartis Investigative Site Paris Cedex 19, France, 75940 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Poitiers, France, 86021 收起 << |
NCT00496470 | Chronic Obstructive Pulmonary ... 展开 >>Disease, COPD 收起 << | Phase 4 | Completed | - | - |
NCT00076388 | Non-Small-Cell Lung Carcinoma | Phase 3 | Completed | - | - |
NCT02028884 | Neuromyelitis Optica (NMO) ... 展开 >> NMO Spectrum Disorder (NMOSD) 收起 << | Phase 3 | Active, not recruiting | June 2020 | - |
NCT00488631 | - | Completed | - | - | |
NCT00056641 | HIV Infections | Phase 2 | Completed | - | - |
NCT00771667 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT00496470 | - | Completed | - | - | |
NCT00771667 | - | Completed | - | - | |
NCT03662659 | Gastric Cancer ... 展开 >> Cancer of the Stomach Esophagogastric Junction 收起 << | Phase 2 | Recruiting | July 1, 2023 | - |
NCT00430677 | Systemic Lupus Erythematosus | Phase 2 Phase 3 | Terminated(Terminated due to f... 展开 >>ailure to meet the primary efficacy endpoint in the Short-term Period) 收起 << | - | - |
NCT01741545 | Hepatitis C Virus | Phase 3 | Completed | - | - |
NCT00430677 | - | Terminated(Terminated due to f... 展开 >>ailure to meet the primary efficacy endpoint in the Short-term Period) 收起 << | - | - | |
NCT00163319 | Asthma | Phase 3 | Completed | - | - |
NCT00088205 | Mantle-Cell Lymphoma | Phase 2 | Completed | - | Australia, Queensland ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Woolloongabba, Queensland, Australia Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Parkville, Victoria, Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Prahran, Victoria, Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Wodonga, Victoria, Australia Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician East Melbourne, Australia France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Creteil Cedex, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Lille, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Nantes Cedex 1, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Rouen Cedex, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tours Cedex, France Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Berlin, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Homburg Saar, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kassel, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Koln, Germany Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Groningen, Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Nijmegen, Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Rotterdam, Netherlands 收起 << |
NCT00753688 | - | Completed | - | - | |
NCT00529568 | Hepatitis C, Chronic | Phase 3 | Completed | - | - |
NCT00753688 | Sarcoma, Soft Tissue | Phase 3 | Completed | - | - |
NCT02128932 | - | Completed | - | - | |
NCT02128932 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00303771 | Colorectal Cancer | Phase 3 | Completed | - | - |
NCT02928393 | Stroke | Phase 2 | Terminated(Low participant enr... 展开 >>olment) 收起 << | - | France ... 展开 >> CHU de Besancon Hopital Jean Minjoz; Service de Neurologie Besançon, France, 25030 Hôpital Pellegrin Tripode - CHU de Bordeaux Bordeaux, France, 33076 Hopital la Cavale Blanche brest Cedex 2, France, 29609 Hopital Gabriel Montpied CHU de Clermont-Ferrand; Service de Neurologie B Clermont-Ferrand, France, 63003 Hôpital General; Hôpital du Bocage - Service de neurologie Dijon Cedex, France, 21079 Hopital Purpan Toulouse Cedex 9, France, 31059 Spain Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, 28222 Hospital de la Santa Creu i Sant Pau; Servicio de Neurologia Barcelona, Spain, 08025 Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 La Paz University Hospital Madrid, Spain Hospital Universitario Virgen Macarena Sevilla, Spain, 41009 Hospital Virgen del Rocio Sevilla, Spain, 41013 Hospital Clnico Universitario de Zaragoza Zaragoza, Spain, 50009 收起 << |
NCT00529568 | - | Completed | - | - | |
NCT00628745 | - | Recruiting | June 16, 2021 | - | |
NCT00689104 | Urinary Bladder, Overactive | Phase 3 | Completed | - | - |
NCT00812916 | - | Completed | - | France ... 展开 >> Hôpital Henri Mondor Créteil CEDEX, France Hôpital Saint Joseph Marseille, France, 13001 Hôpital Privé Jacques Cartier Service de Rhytmologie Massy, France CHU Arnaud de Villeneuve Montpellier, France, 34295 Clinique Ambroise Paré Neuilly sur Seine, France, 92200 Hôpital Les Franciscaines Service Rhythmologie Nîmes, France Hôpital Lariboisière Service de Rhytmologie Paris CEDEX 10, France, 75010 Hôpital Laënnec - CHU de Nantes St Herblain, France, 44814 Clinique Pasteur - Unité de Cardiologie interventionnelle Toulouse Cedex, France, 31076 CHU de Nancy Vandoeuvre Les Nancy, France, 54500 Germany Asklepios Klinik St. Georg Hamburg, Germany Städtisches Klinikum Karlsruhe Karlsruhe, Germany Hungary Gottsegen György Országos Kardiológiai Intézet Budapest, Hungary 收起 << | |
NCT02069834 | HIV Infection ... 展开 >> HAART-treated Virologically Controlled 收起 << | Phase 2 Phase 3 | Withdrawn(One of the both Fund... 展开 >>er partners decided to stop the study before the initiation thus no product provided and no funding to realize the study) 收起 << | October 2017 | France ... 展开 >> CHU Guadeloupe Point-a-pitre, Guadeloupe, France, 97159 CHU de Fort de France Fort de France, Martinique, France, 87261 Chu Jean Minjoz Besançon, France, 25030 Hôpital Avicenne Bobigny, France, 93000 Hôpital Jean Verdier Bondy, France, 93140 CHU de Bordeaux Bordeaux, France, 33076 CHU de DIJON Dijon, France, 21079 CHD La Roche sur Yon La Roche sur Yon, France, 85925 CHU Kremlin Bicêtre Le Kremlin Bicetre, France, 94275 Hôpital Perpetuel Secours Levallois-perret, France, 92300 CHU de Nantes Nantes, France, 44093 Hôpital Saint Louis Paris Cedex 10, France, 75475 CHU BICHAT - Claude Bernard Paris cedex 18, France, 75877 CHU Hôtel Dieu Paris Paris, France, 75004 Hôpital La Pitié Salpêtrière Paris, France, 75013 Hôpital Necker - enfants Malades Paris, France, 75015 Hôpital Européen Georges Pompidou Paris, France, 75908 CHU de Rennes - Hôpital Pontchaillou Rennes, France, 35000 CH Delafontaine Saint Denis, France, 93200 CHU Saint Etienne Saint Etienne, France, 42055 CHU de Strasbourg Strasbourg, France, 67091 Hôpital FOCH Suresnes, France, 92150 CHU Toulouse Toulouse, France, 31059 CHRU de Tours Tours Cedex 09, France, 37044 CHU de Nancy VANDOEUVRE LES NANCY cedex, France, 54511 收起 << |
NCT00689104 | - | Completed | - | - | |
NCT00107731 | Bipolar I Disorder | Phase 3 | Completed | - | - |
NCT00812916 | - | Completed | - | - | |
NCT00331604 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description) 收起 << | - | - |
NCT00496067 | Menorrhagia U... 展开 >>terine Fibroids 收起 << | Not Applicable | Terminated(Data required furth... 展开 >>er pilot work to be undertaken.) 收起 << | - | Denmark ... 展开 >> Viborg County Hospital Viborg, Denmark, DK-8800 France University Hospital Angers cedex, France, 49033 Service de Gynecologie Obsterique, Hopital Antoine Beclere Clamart Cedex, France, 92414 Maternite les Bazennes Dunkerque, France, 59430 CHRU de Lille, Hopital Jeanne de Flandre Lille Cedex, France, 59037 Germany Universitaeklinikum Erlangen Erlangen, Germany, 91054 Universitats-Frauenklinik Tubingen Tubingen, Germany, 72076 Netherlands VU Medical Center Amsterdam, Netherlands, 1081 HV Norway Ullevaal University Oslo, Norway, N-0407 Switzerland Universitats-Frauenklinik Bern, Switzerland, 3012 United Kingdom M1 Maternity, Bradford Royal Infirmary Bradford, United Kingdom, BD9 6RJ Hull and East Yorkshire Women & Children Hospital Hull, United Kingdom, HU3 2JZ Elizabeth Garret Anderson Hospital London, United Kingdom, WC1E 6DH Queen Elizabeth the Queen Mother Hospital Margate, United Kingdom, CT9 4AN 收起 << |
NCT00402428 | Chronic Hepatitis C | Phase 3 | Completed | - | - |
NCT00737789 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT00083304 | Breast Cancer ... 展开 >> Metastases 收起 << | Phase 3 | Completed | - | - |
NCT00411385 | Chronic Hepatitis C | Phase 3 | Completed | - | - |
NCT02334306 | Primary Sjögren's Syndrome | Phase 2 | Completed | - | United States, California ... 展开 >> Research Site San Francisco, California, United States, 94143 United States, Maryland Research Site Bethesda, Maryland, United States, 20892-1190 United States, Pennsylvania Research Site Pittsburgh, Pennsylvania, United States, 15213 France Research Site Brest Cedex, France, 29609 Research Site Le Kremlin-bicêtre, France, 94275 Research Site Lille Cedex, France, 59037 Research Site Paris Cedex 13, France, 75651 Research Site Paris, France, 75014 Research Site Strasbourg, France, 67098 Sweden Research Site Stockholm, Sweden United Kingdom Research Site London, United Kingdom, EC1M 6BQ Research Site Newcastle-upon-Tyne, United Kingdom, NE2 4HH Research Site Swindon, United Kingdom, SN3 6BB 收起 << |
NCT00131352 | - | Completed | - | - | |
NCT00783510 | - | Active, not recruiting | June 30, 2021 | - | |
NCT00880269 | - | Completed | - | - | |
NCT00171821 | Transfusion-dependent Iron Ove... 展开 >>rload 收起 << | Phase 3 | Completed | - | - |
NCT00131352 | Osteoarthritis, Knee ... 展开 >> Musculoskeletal Diseases 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> Hopital Erasme Bruxelles, Belgium, 1070 Universitair Ziekenhuis Gent Gent, Belgium, 9000 Universitair Ziekenhuis Gastuisberg Leuven Leuven, Belgium, 3000 CHU Liege Liege, Belgium, 4000 Czech Republic Faculty Hospital Bohunice Brno, Czech Republic, 62500 Institute of Rheumatology Prague 2, Czech Republic, 12850 Faculty Thomayer Hospital Prague 4, Czech Republic, 14059 Faculty Hospital Motol Prague, Czech Republic, 15006 France Hopital Henri Mondor Creteil Cedex, France, 94010 CHU Dupuytren Limoges Cedex, France, 87042 Hopital de la Conception Marseille, France, 13005 Hopital Rangueil Toulouse Cedex 9, France, 31059 CHU Hopital Trousseau Tours Cedex, France, 37044 Germany Johanna-Etienne Krankenhaus Neuss, Germany, 41462 Netherlands AMC/UVA Amsterdam, Netherlands, 1100 Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ United Kingdom University Hospital of Wales Cardiff, United Kingdom, CF14 4XW Kings College Hospital London, United Kingdom, SE5 9RJ Trafford General Hospital Manchester, United Kingdom, M41 5SL Freeman Hospital Newcastle-upon-Tyne, United Kingdom, NE7 7DN Nuffield Orthopaedic Centre Oxford, United Kingdom, OX3 7LD 收起 << |
NCT00863655 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00211068 | - | Completed | - | Brazil ... 展开 >> Sao Paulo, Brazil Sorocaba, Brazil France Bois Guillaume Cedex, France Grenoble Cedex 1, France Nantes Cedex 2, France Orleans Cedex 2, France Paris Cedex 20, France Norway Tvnsberg, Norway South Africa Bloemfontein, South Africa Sweden Karlshamn, Sweden Stockholm N/A, Sweden Trollhättan, Sweden Thailand Vlissingen, Thailand United Kingdom Birmingham, United Kingdom Brighton, United Kingdom Bristol, United Kingdom Chelmsford, United Kingdom Edinburgh, United Kingdom London, United Kingdom Manchester, United Kingdom Omagh N/A, United Kingdom Westcliff-On-Sea, United Kingdom 收起 << | |
NCT00880269 | Refractory Leukemia ... 展开 >> Acute Myelogenous Leukemia 收起 << | Phase 2 | Completed | - | - |
NCT00626106 | Breast Cancer ... 展开 >> Breast Tumors Metastatic Cancer 收起 << | Phase 2 | Completed | - | - |
NCT00261352 | Type 2 Diabetes | Phase 3 | Terminated(The development pro... 展开 >>gram has been terminated) 收起 << | - | - |
NCT00080301 | Breast Cancer ... 展开 >> Metastases 收起 << | Phase 3 | Completed | - | - |
NCT00080301 | - | Completed | - | - | |
NCT00863655 | - | Completed | - | - | |
NCT00333411 | Psoriasis | Phase 2 | Completed | - | - |
NCT00625898 | Breast Cancer | Phase 3 | Terminated | - | - |
NCT02120352 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 2 | Active, not recruiting | December 31, 2020 | - |
NCT00395772 | Venous Thromboembolism | Phase 2 | Completed | - | - |
NCT00296504 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Fountain Valley, California, United States, 92708 GSK Investigational Site San Francisco, California, United States, 94115-1931 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80262 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33145 GSK Investigational Site Orlando, Florida, United States, 32804 GSK Investigational Site Orlando, Florida, United States, 32806 GSK Investigational Site Sarasota, Florida, United States, 34239 GSK Investigational Site Tampa, Florida, United States, 33614 United States, New York GSK Investigational Site Manhasset, New York, United States, 11030 United States, Texas GSK Investigational Site Galveston, Texas, United States, 77555-1188 Brazil GSK Investigational Site Campinas, São Paulo, Brazil, 13083970 Chile GSK Investigational Site Santiago, Región Metro De Santiago, Chile France GSK Investigational Site Le Kremlin Bicêtre Cedex, France, 94275 GSK Investigational Site Marseille, France, 13005 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Paris Cedex 20, France, 75970 GSK Investigational Site Vandoeuvre Les Nancy Cedex, France, 54511 GSK Investigational Site Villejuif Cedex, France, 94805 Italy GSK Investigational Site Genova, Liguria, Italy, 16128 Portugal GSK Investigational Site Coimbra, Portugal, 3000-075 Spain GSK Investigational Site Badajoz, Spain, 6080 GSK Investigational Site Barcelona, Spain, 08036 United Kingdom GSK Investigational Site London, United Kingdom, NW3 2QG GSK Investigational Site London, United Kingdom, SE1 7EH 收起 << |
NCT00272779 | HIV Infections | Phase 3 | Completed | - | - |
NCT00272779 | - | Completed | - | - | |
NCT02585778 | Hypercholesterolaemia | Phase 3 | Completed | - | - |
NCT00406653 | Crohn's Disease | Phase 3 | Terminated(Sponsor Decision) | - | - |
NCT00296504 | - | Completed | - | - | |
NCT01225822 | Venous Thromboembolism | Phase 2 | Completed | - | - |
NCT02664701 | Suicidal Ideation ... 展开 >> Suicide, Attempt 收起 << | Not Applicable | Recruiting | January 2021 | France ... 展开 >> CHU de Clermont Ferrand - Hôpital Gabriel-Montpied Not yet recruiting Clermont Ferrand, France, 63003 Principal Investigator: Pierre-Michel Llorca, MD, PhD CHU de Lyon - Groupement Hospitalier Edouard Herriot Not yet recruiting Lyon Cedex 3, France, 69437 Principal Investigator: Emmanuel Poulet, MD, PhD CHRU de Montpellier - Hôpital Lapeyronie Not yet recruiting Montpellier, France, 34295 Principal Investigator: Philippe Courtet, MD, PhD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Sub-Investigator: Mocrane Abbar, MD Principal Investigator: Jorge Lopez Castroman, MD Sub-Investigator: Laurent Chaïb, PhD, pschologist Clinique Les Sophoras Not yet recruiting Nîmes, France, 30000 Principal Investigator: Stephane Torrès, MD CH Henri Laborit Not yet recruiting Poitiers, France, 86021 Principal Investigator: Nematollah Jaafari, MD CHRU de Tours - Clinique Psychiatrique Universitaire Not yet recruiting Saint Cyr sur Loire, France, 37540 Principal Investigator: Wissam El-Hage, MD CHRU de Strasbourg - Hôpital Civil Not yet recruiting Strasbourg Cedex, France, 67091 Principal Investigator: Pierre Vidailhet, MD, PhD 收起 << |
NCT02585778 | - | Completed | - | - | |
NCT01225822 | - | Completed | - | - | |
NCT00424268 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT00103740 | - | Completed | - | - | |
NCT00424268 | - | Completed | - | - | |
NCT00148512 | Parkinson Disease | Phase 2 | Completed | - | - |
NCT00103740 | Paget's Disease of Bone | Phase 3 | Completed | - | - |
NCT00406653 | - | Terminated(Sponsor Decision) | - | - | |
NCT00850577 | Non-small Cell Lung Cancer (NS... 展开 >>CLC) 收起 << | Phase 2 | Terminated | - | - |
NCT00819052 | - | Completed | - | - | |
NCT00988052 | Relapsing Multiple Sclerosis | Phase 3 | Terminated(Sponsor terminated ... 展开 >>RRMS studies as sufficient long term clinical data was collected for the study drug in the relevant dose.) 收起 << | - | - |
NCT00845728 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT00415246 | Prostate Cancer | Phase 3 | Terminated(The preliminary dat... 展开 >>a do not support the expected sustainable blood levels of triptorelin for a duration of 4 months in all patients.) 收起 << | - | Belgium ... 展开 >> ULB Erasme Bruxelles, Belgium, B-1070 Academisch Ziekenhuis Vrije Universiteit Brussel Bruxelles, Belgium, B-1090 UCL St Luc Bruxelles, Belgium, B-1200 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 UZ Gasthuisberg Leuven, Belgium, B-3000 France CHU Hôpital Gabriel Montpied Clermont Ferrand, France, 63003 Hôpital Claude Huriez Lille, France, 59037 Hôpital Edouard Herriot Lyon, France, 69437 CHU Hôpital Salvator Marseille, France, 13274 Hôtel Dieu Nantes Cedex 1, France, 44093 Hôpital du Val de Grace Paris Cedex 05, France, 75230 Centre Hospitalier Saint Louis Paris Cedex 10, France, 75475 Hôpital Cochin Paris cedex 14, France, 75679 Hôpital Bichat Paris Cedex 18, France, 75788 CHU Hôpital de la Miletrie Poitiers, France, 86000 Hôpital Pontchaillou Rennes Cedex 9, France, 35033 CHU Rangueil Toulouse Cedex 9, France, 31059 Latvia Olega Hublarova arsta prakse urologija Daugavpils, Latvia Latvijas Onkologijas centre Riga, Latvia Paula Stradina Kliniska Universitates slimnica Riga, Latvia Lithuania Kauno Medicinos Universitteto Klinikos Kaunas, Lithuania UAB 'Vilniaus onkourologijos-ginekologijos klinika Vilnius, Lithuania Vilniaus universiteto Vilnius, Lithuania Poland Swietokrzyskie Centrum Onkologii Kielce, Poland NZOZ Specjalista Sp, z.o.o. Kutno, Poland Centrum Onkologii Instytut im. M. Sklodowskiej-Curie Warszawa, Poland Akademicki Szpital Kliniczny Wroclaw, Poland Spain Hospital Gregorio Maranon Madrid, Spain Ukraine Ivano Frankovsk State Medical University Ivano-Frankivsk, Ukraine Scientific Research Institute of Urology Kiev, Ukraine United Kingdom Aberdeen Royal Infirmary Aberdeen, United Kingdom 收起 << |
NCT00819052 | HIV Infections | Phase 3 | Completed | - | - |
NCT00845728 | - | Completed | - | - | |
NCT00116298 | HIV Infections ... 展开 >> AIDS 收起 << | Phase 3 | Completed | - | - |
NCT00887198 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT00326248 | Nausea and Vomiting, Postopera... 展开 >>tive 收起 << | Phase 3 | Completed | - | - |
NCT00887198 | - | Completed | - | - | |
NCT00996177 | Pain Analgesi... 展开 >>a, Patient-Controlled Pain, Postoperative 收起 << | Phase 4 | Completed | - | - |
NCT01478373 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 2 | Completed | - | Finland ... 展开 >> Novartis Investigative Site HUS, Finland, FIN-00029 France Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Lille Cedex, France, 59020 Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Essen, Germany, 45147 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Roma, RM, Italy, 00168 Novartis Investigative Site Candiolo, TO, Italy, 10060 Novartis Investigative Site Torino, TO, Italy, 10153 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Palma De Mallorca, Islas Baleares, Spain, 07120 Novartis Investigative Site Barcelona, Spain, 08041 收起 << |
NCT01478373 | - | Completed | - | - | |
NCT01192165 | Cancer | Phase 1 | Completed | - | United States, Arizona ... 展开 >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, California GSK Investigational Site Duarte, California, United States, 91010 GSK Investigational Site Sacramento, California, United States, 95817 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80218 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89169 United States, New York GSK Investigational Site Albany, New York, United States, 12206 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77030 GSK Investigational Site Tyler, Texas, United States, 75702 United States, Virginia GSK Investigational Site Norfolk, Virginia, United States, 23502 United States, Washington GSK Investigational Site Vancouver, Washington, United States, 98684 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 France GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Marseille cedex 5, France, 13385 GSK Investigational Site Saint-Herblain cedex, France, 44805 GSK Investigational Site Toulouse cedex, France, 31052 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 收起 << |
NCT00247676 | Liver Neoplasms ... 展开 >> Unresectable Hepatocellular Carcinoma 收起 << | Phase 2 | Completed | - | France ... 展开 >> Pfizer Investigational Site Clichy Cedex, France, 92118 Pfizer Investigational Site Rennes Cedex, France, 4422935062 Pfizer Investigational Site Saint Herrblain Cedex, France, 44805 Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 135-710 Pfizer Investigational Site Seoul, Korea, Republic of, 138-736 Pfizer Investigational Site Seoul, Korea, Republic of, 152-703 Taiwan Pfizer Investigational Site Taipei, Taiwan, 110 收起 << |
NCT01402986 | Asthma | Phase 2 | Completed | - | - |
NCT01092611 | AIDS | Phase 1 | Completed | - | - |
NCT00633464 | Triple Negative Locally Advanc... 展开 >>ed Non-resectable Breast Cancer Metastatic Breast Cancer 收起 << | Phase 2 | Completed | - | Austria ... 展开 >> Local Institution Graz, Austria, 8036 Local Institution Wien, Austria, 1090 Czech Republic Local Institution Brno, Czech Republic, 656 53 Local Institution Prague 5, Czech Republic, 150 06 Local Institution Praha 2, Czech Republic, 128 08 France Local Institution Bayonne, France, 64100 Local Institution Dijon Cedex, France, 21079 Local Institution Lyon, France, 69008 Local Institution Paris Cedex 13, France, 75651 Local Institution Saint Brieuc, France, 22015 Local Institution Saint Herblain Cedex, France, 44805 Local Institution Toulouse Cedex, France, 31052 Greece Local Institution Thessaloniki, Greece, 54642 Italy Local Institution Napoli, Italy, 80131 Poland Local Institution Gdansk, Poland, 80952 Local Institution Olsztyn, Poland, 10-513 Spain Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08208 Local Institution Barcelona, Spain, 08221 收起 << |
NCT02234310 | Hemophilia B | Phase 3 | Active, not recruiting | April 2019 | - |
NCT00314860 | Restless Legs Syndrome ... 展开 >> Restless Legs Syndrome (RLS) 收起 << | Phase 3 | Completed | - | - |
NCT01402986 | - | Completed | - | - | |
NCT00247676 | - | Completed | - | - | |
NCT02412878 | Multiple Myeloma | Phase 3 | Active, not recruiting | January 4, 2019 | - |
NCT01059773 | Psoriasis | Phase 4 | Completed | - | - |
NCT01454089 | Urologic Neoplasms ... 展开 >> Metastatic Bladder Cancer Urinary Tract Neoplasms 收起 << | Phase 2 | Completed | - | - |
NCT00447902 | HIV Infections | Phase 3 | Terminated | - | United States, California ... 展开 >> 1182.99.32 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States United States, Florida 1182.99.31 Boehringer Ingelheim Investigational Site Fort Lauderdale, Florida, United States United States, Rhode Island 1182.99.12 Boehringer Ingelheim Investigational Site Providence, Rhode Island, United States United States, Texas 1182.99.1 Boehringer Ingelheim Investigational Site Austin, Texas, United States 1182.99.4 Boehringer Ingelheim Investigational Site Houston, Texas, United States Argentina 1182.99.54001 Capital Federal, Argentina Brazil 1182.99.55002 Hospital DIA Sacomã - São Paulo, Brazil 1182.99.55004 Unidade de Referência em doenças Infecciosas Preveníveis Santo André, Brazil 1182.99.55001 Universidade Federal de Sao Paulo Sao Paulo, Brazil 1182.99.55003 Centro de Referência e Treinamento - DST/AIDS Vila Mariana - Sao Paulo, Brazil France 1182.99.3301A Boehringer Ingelheim Investigational Site Garches, France 1182.99.3306G Boehringer Ingelheim Investigational Site Nantes, France 1182.99.3306K Boehringer Ingelheim Investigational Site Nantes, France 1182.99.3310C Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310D Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310E Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310F Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310G Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3310H Boehringer Ingelheim Investigational Site Nice cedex 3, France 1182.99.3304A Boehringer Ingelheim Investigational Site Paris, France 1182.99.3304C Boehringer Ingelheim Investigational Site Paris, France 1182.99.3302A Boehringer Ingelheim Investigational Site Perpignan, France Germany 1182.99.4909 Boehringer Ingelheim Investigational Site Düsseldorf, Germany Italy 1182.99.3912 Boehringer Ingelheim Investigational Site Ancona, Italy 1182.99.3901 Boehringer Ingelheim Investigational Site Milano, Italy 1182.99.3911 Boehringer Ingelheim Investigational Site Milano, Italy 1182.99.3916 Boehringer Ingelheim Investigational Site Milano, Italy 1182.99.3906 Boehringer Ingelheim Investigational Site Pavia, Italy Spain 1182.99.3402 Barcelona, Spain 1182.99.3407 Madrid, Spain 收起 << |
NCT00633464 | - | Completed | - | - | |
NCT00447902 | - | Terminated | - | - | |
NCT00896454 | Breast Cancer ... 展开 >> Hypercalcemia of Malignancy Colon Cancer Endocrine Cancer Head and Neck Cancer Kidney Cancer Lung Cancer Lymphoma Metastatic Cancer Multiple Myeloma Parathyroid Neoplasms Renal Cancer Thyroid Cancer Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Non-Small Cell Lung Cancer 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Research Site Encinitas, California, United States, 92024 United States, Connecticut Research Site New Haven, Connecticut, United States, 06520 United States, Maryland Research Site Salisbury, Maryland, United States, 21801 United States, Michigan Research Site Dearborn, Michigan, United States, 48124 Research Site Detroit, Michigan, United States, 48236 United States, Nebraska Research Site Omaha, Nebraska, United States, 68114 United States, New York Research Site Bronx, New York, United States, 10467 Research Site New York, New York, United States, 10065 Research Site Syracuse, New York, United States, 13210 United States, North Carolina Research Site Durham, North Carolina, United States, 27710 Research Site Goldsboro, North Carolina, United States, 27534 United States, Texas Research Site Houston, Texas, United States, 77030 Canada, Quebec Research Site Québec, Quebec, Canada, G1S 4L8 Research Site Québec, Quebec, Canada, G1S 4L8 France Research Site Limoges Cedex, France, 87042 Research Site Montpellier Cedex 5, France, 34298 Research Site Nantes Cedex 1, France, 44035 Research Site Villejuif cedex, France, 94805 Italy Research Site Bologna, Italy, 40138 Research Site Firenze, Italy, 50139 Research Site Milano, Italy, 20162 Research Site Padova, Italy, 35128 Research Site Roma, Italy, 00128 Poland Research Site Warszawa, Poland, 01-809 收起 << |
NCT02412878 | - | Active, not recruiting | - | - | |
NCT00561210 | Infections on ... 展开 >> Severe Burn Patients 收起 << | Phase 4 | Completed | - | France ... 展开 >> CHU Pellegrin-Unites des brules Bordeaux, France, 33076 Hôpital Saint Luc - Service des brûlés Lyon, France, 69009 Hôpital Edouard Herriot Lyon, France, 69437 Hopital Hotel Dieu-Service des brules Nantes, France, 44093 Hopital Saint Antoine- Service des Brules Paris Cedex 12, France, 75571 收起 << |
NCT01059773 | - | Completed | - | - | |
NCT00408252 | Recurrent Disease ... 展开 >> Squamous Cell Head and Neck Carcinoma Palliative Treatment 收起 << | Phase 2 | Terminated(Too frequent grade ... 展开 >>3-4 toxicities) 收起 << | - | Belgium ... 展开 >> Cliniques Universiatires St LUC UCL Bruxelles, Belgium, 1200 clinique Sainte Elisabeth Namur, Belgium, 5000 Clinique universiataire de Mont Godinnes UCL Yvoir, Belgium, 5004 France Centre Jean Perrin Clermont Ferrand, France, 263011 Centre G-f Leclerc DIJON Cedex, France, 8021079 Centre Alexis Vautrin Nancy, France, 4511 René Gauducheau Saint Herblain Cedex, France, 44805 CHU Bretonneau Tours cedex 1, France, 37044 Institut Gustave Roussy Villejuif Cedex, France, 94805 收起 << |
NCT00967018 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT01593254 | Chronic Phase Chronic Myeloid ... 展开 >>Leukemia 收起 << | Phase 2 | Active, not recruiting | February 17, 2022 | - |
NCT00896454 | - | Completed | - | - | |
NCT00322218 | Lymphoma, Large Cell, Diffuse | Phase 3 | Unknown | December 2009 | - |
NCT02831673 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Active, not recruiting | March 3, 2020 | - |
NCT01311687 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT02573324 | Glioblastoma Multiforme ... 展开 >> Gliosarcoma 收起 << | Phase 3 | Recruiting | February 13, 2021 | - |
NCT01252355 | Multiple Sclerosis Relapse | Phase 3 | Terminated(Sponsor decision to... 展开 >> prematurely stop the study, not linked to any safety concern.) 收起 << | - | - |
NCT00967018 | - | Completed | - | - | |
NCT01311687 | - | Completed | - | - | |
NCT01252355 | - | Terminated(Sponsor decision to... 展开 >> prematurely stop the study, not linked to any safety concern.) 收起 << | - | - | |
NCT01218113 | AIDS | Phase 2 | Completed | - | - |
NCT00388726 | Breast Cancer | Phase 3 | Completed | - | - |
NCT01854918 | Hyperlipidemia and Mixed Dysli... 展开 >>pidemia 收起 << | Phase 3 | Completed | - | - |
NCT00129766 | Respiratory Syncytial Virus In... 展开 >>fections 收起 << | Phase 3 | Completed | - | - |
NCT00388726 | - | Completed | - | - | |
NCT00930553 | Multiple Sclerosis, Relapsing-... 展开 >>Remitting 收起 << | Phase 3 | Completed | - | - |
NCT00148928 | Neoplasms, Prostate | Phase 1 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Bruxelles, Belgium, 1070 GSK Investigational Site Bruxelles, Belgium, 1200 GSK Investigational Site Turnhout, Belgium, 2300 France GSK Investigational Site Auxerre Cedex, France, 89011 GSK Investigational Site Besançon Cedex, France, 25030 GSK Investigational Site Paris Cedex 05, France, 75248 GSK Investigational Site Toulouse Cedex 4, France, 31403 GSK Investigational Site Villejuif Cedex, France, 94805 收起 << |
NCT03352557 | Alzheimer's Disease | Phase 2 | Recruiting | July 9, 2021 | - |
NCT01254019 | Muscular Dystrophies | Phase 3 | Completed | - | - |
NCT00046228 | Myocardial Infarction | Phase 3 | Completed | - | - |
NCT03194867 | Plasma Cell Myeloma | Phase 1 Phase 2 | Recruiting | August 2022 | - |
NCT02151981 | Anticancer Treatment | Phase 3 | Active, not recruiting | December 30, 2020 | - |
NCT00129766 | - | Completed | - | - | |
NCT00046228 | - | Completed | - | - | |
NCT01218113 | - | Completed | - | - | |
NCT03021187 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02327169 | Advanced Nonhematologic Malign... 展开 >>ancies 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 2114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 2115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 2115 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 France Institut Bergonie Bordeaux cedex, Gironde, France, 33076 Institut Claudius Regaud-Oncopole Toulouse cedex 09, Haute Garonne, France, 31059 Institut Gustave Roussy Villejuif cedex, Val De Marne, France, 94805 Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 8035 START Madrid. Fundacion Jimenez Diaz Madrid, Spain, 28040 Hospital Clinico Universitario Virgen de la Victoria Malaga, Spain, 29010 United Kingdom Sarah Cannon Research Institure UK London, Greater London, United Kingdom, W1G 6AD The Chrisie Manchester, Greater Manchester, United Kingdom, M20 4BX Churchill Hospital Oxford, Oxfordshire, United Kingdom, OX3 7LJ 收起 << |
NCT01712789 | Multiple Myeloma | Phase 3 | Active, not recruiting | December 11, 2019 | - |
NCT02151981 | - | Active, not recruiting | - | - | |
NCT02696902 | Pseudomonas Aeruginosa | Phase 2 | Recruiting | February 25, 2020 | - |
NCT03340766 | Relapsed or Refractory Diffuse... 展开 >> Large B Cell Lymphoma (DLBCL) 收起 << | Phase 1 | Recruiting | October 5, 2024 | United States, South Carolina ... 展开 >> Research Site Recruiting Charleston, South Carolina, United States, 29424 Australia, New South Wales Research Site Recruiting Darlinghurst, New South Wales, Australia, 2010 Research Site Recruiting St Leonards, New South Wales, Australia, 2065 Australia, South Australia Research Site Recruiting Adelaide, South Australia, Australia, 5000 Australia, Victoria Research Site Recruiting East Melbourne, Victoria, Australia, 3002 Research Site Recruiting Geelong, Victoria, Australia, 3220 Research Site Recruiting Melbourne, Victoria, Australia, 3004 Australia, Western Australia Research Site Recruiting Murdoch, Western Australia, Australia, 6150 France Research Site Recruiting Créteil Cedex, France, 94010 Research Site Recruiting Nantes Cedex 1, France, 44035 Research Site Recruiting Pierre Benite Cedex, France, 69495 收起 << |
NCT01580293 | Hemophilia A | Phase 2 Phase 3 | Active, not recruiting | January 10, 2020 | - |
NCT00497991 | Myeloid Leukemia | Phase 1 | Completed | - | United States, New York ... 展开 >> Research Site New York, New York, United States United States, Texas Research Site Houston, Texas, United States France Research Site Angers Cedex, France Research Site Grenoble Cedex, France Research Site Le Chesnay Cedex, France Italy Research Site Bologna, Italy Research Site Roma, Italy Netherlands Research Site Amsterdam, Netherlands Research Site Nijmegen, Netherlands Research Site Rotterdam, Netherlands 收起 << |
NCT03619213 | Heart Failure With Preserved E... 展开 >>jection Fraction 收起 << | Phase 3 | Recruiting | June 22, 2021 | - |
NCT02606461 | Dedifferentiated Liposarcoma | Phase 2 Phase 3 | Recruiting | March 2020 | - |
NCT02102204 | Hyperparathyroidism, Secondary | Phase 3 | Completed | - | - |
NCT01580293 | - | Active, not recruiting | - | - | |
NCT02304484 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02102204 | - | Completed | - | - | |
NCT02262273 | - | Completed | - | - | |
NCT00950859 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 2 | Completed | - | - |
NCT01557244 | Urinary Bladder, Neurogenic | Phase 3 | Recruiting | November 13, 2019 | - |
NCT02556086 | Hepatitis C | Phase 2 | Withdrawn | July 2017 | Canada, Alberta ... 展开 >> Local Institution Edmonton, Alberta, Canada, T6G 2B7 Canada, British Columbia Local Institution Vancouver, British Columbia, Canada, V6Z 2C7 Local Institution Victoria, British Columbia, Canada, V8V 3P9 Canada, Ontario Local Institution Ottawa, Ontario, Canada, K1H 8L6 Local Institution Toronto, Ontario, Canada, M5G 2N2 Canada, Quebec Local Institution Montreal, Quebec, Canada, H4A 3J1 Canada, Saskatchewan Local Institution Regina, Saskatchewan, Canada, S4P 0W5 Canada Local Institution Quebec, Canada, G1V 4G2 France Local Institution Marseille, France, 13009 Local Institution Nantes, France, 44093 Local Institution Nice Cedex, France, 06202 Local Institution Paris Cedex 14, France, 75679 Local Institution Paris Cedex 18, France, 75877 Local Institution Paris, France, 75010 Local Institution Paris, France, 75015 Local Institution Paris, France, 75020 Local Institution Pessac, France, 33604 收起 << |
NCT00136552 | Lymphoma | Phase 3 | Completed | - | Belgium ... 展开 >> Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Hôpital Saint Louis Paris, France, 75010 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Henri Becquerel Rouen, France, 76038 收起 << |
NCT00950859 | - | Completed | - | - | |
NCT00739739 | Interstitial Cystitis ... 展开 >> Painful Bladder Syndrome 收起 << | Phase 2 | Completed | - | - |
NCT02782104 | Depressive Disorder, Treatment... 展开 >>-Resistant 收起 << | Phase 3 | Recruiting | October 31, 2022 | - |
NCT02945813 | Prostate Cancer | Phase 2 | Recruiting | December 2030 | France ... 展开 >> Centre Hospitalier Régional Universitaire (CHRU) Jean Minjoz Recruiting Besançon, France, 25030 Contact: Bernardino De Bari, MD +33 381 23 24 28 bdebari@chu-besancon.fr Principal Investigator: Bernardino De Bari Clinique Pasteur - Centre finistérien de radiothérapie et d'oncologie Recruiting Brest, France, 29220 Contact: Ali Hasbini, MD +33 298 31 32 00 alihasbini@oncologie-brest.fr Principal Investigator: Ali Hasbini, MD Centre de lutte contre le cancer Léon Bérard Recruiting Lyon, France, 69008 Contact: Pascal Pommer, MD +33 478 78 51 66 pascal.pommier@lyon.unicancer.fr Principal Investigator: Pascal Pommer, MD Hôpital Saint-Louis Recruiting Paris, France, 75010 Contact: Christophe Hennequin, Prof +33 142 49 90 24 christophe.hennequin2@aphp.fr Principal Investigator: Christophe Hennequin, Prof CHU de Poitiers - La Miletrie Recruiting Poitiers Cedex, France, 86021 Contact: Stéphane Guerif, MD +33 549 44 29 61 stephane.guerif@chu-poitiers.fr Principal Investigator: Stéphane Guerif, MD Institut de Cancérologie de L'Ouest René Gauducheau Recruiting Saint Herblain cedex, France, 44800 Contact: Stéphane Supiot, MD +33 240 679 913 stephane.supiot@ico.unicancer.fr Principal Investigator: Stéphane Supiot, MD Institut de Cancérologie de la Loire Lucien Neuwirth Recruiting Saint Priest en Jarez, France, 42270 Contact: Nicolas Magne, Prof +33 477 91 71 04 nicolas.magne@icloire.fr Principal Investigator: Nicolas Magne, Prof Clinique Pasteur - Oncorad Recruiting Toulouse Cedex 3, France, 31076 Contact: Igor Latorzeff, MD +33 567 20 44 00 ilatorzeff@clinique-pasteur.com Principal Investigator: Igor Latorzeff, MD Germany Universitätsmedizin Berlin Recruiting Berlin, Germany, 13353 Contact: Pirus Ghadjar, MD +49 450 657055 pirus.ghadjar@charite.de Principal Investigator: Pirus Ghadjar, MD Klinikum der Universität München Not yet recruiting München, Germany, 81377 Contact: Claus Belka, Prof +49 89 4400 74520 claus.belka@med.uni-muenchen.de Principal Investigator: Claus Belka, Prof Universitätsklinikum Rostock Recruiting Rostock, Germany, 18059 Contact: Guido Hildebrandt, Prof +49 381 494 90 00 guido.hildebrandt@uni-rostock.de Principal Investigator: Guido Hildebrandt, Prof Universitätsklinikum Würzburg Recruiting Würzburg, Germany, 97080 Contact: Michael Flentje, Prof +49 931 201 288 91 flentje_m@ukw.de Principal Investigator: Michael Flentje, Prof Switzerland Universitätsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Alexandros Papachristofilou, MD +41 61 265 49 46 alexandros.papachristofilou@usb.ch Principal Investigator: Alexandros Papachristofilou, MD Istituto Oncologico della Svizzera Italiana IOSI - Ospedale San Giovanni Recruiting Bellinzona, Switzerland, 6500 Contact: Che Ngwa Azinwi, MD +41 091 811 89 32 ngwache.azinwi@eoc.ch Principal Investigator: Che Ngwa Azinwi, MD Inselspital Bern Recruiting Bern, Switzerland, 3010 Contact: Daniel Aebersold, Prof +41 31 632 26 32 daniel.aebersold@insel.ch Principal Investigator: Daniel Aebersold, Prof Kantonsspital Graubuenden Recruiting Chur, Switzerland, 7000 Contact: Daniel R. Zwahlen, MD +41 81 256 64 95 daniel.zwahlen@ksgr.ch Principal Investigator: Daniel R. Zwahlen, MD HFR - Hôpital cantonal Recruiting Fribourg, Switzerland, 1708 Contact: David Lauffer, MD +41 26 306 00 00 David.Lauffer@h-fr.ch Principal Investigator: David Lauffer, MD Hôpitaux Universitaires Genève HUG Recruiting Geneva, Switzerland, 1211 Contact: Thomas Zilli, MD +41 22 372 70 90 thomas.zilli@hcuge.ch Principal Investigator: Thomas Zilli, MD Clinique de Genolier Recruiting Genolier, Switzerland, 1272 Contact: Cristina Picardi, MD +41 22 366 94 59 cpicardi@genolier.net Principal Investigator: Cristina Picardi, MD Spital Thurgau Recruiting Münsterlingen, Switzerland, CH-8596 Contact: Christiane Reuter, MD +41 71 686 23 33 christiane.reuter@stgag.ch Principal Investigator: Christiane Reuter, MD Hopital de Sion Recruiting Sion, Switzerland, 1951 Contact: Kaouthar Khanfir, MD +41 27 603 87 72 kaouthar.khanfir@hopitalvs.ch Principal Investigator: Kaouthar Khanfir, MD Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Paul Martin Putora, MD +41 71 494 22 68 paulmartin.putora@kssg.ch Principal Investigator: Paul Martin Putora, MD Kantonsspital Winterthur KSW Recruiting Winterthur, Switzerland, 8401 Contact: Binaya Kumar Shrestha, MD +41 52 266 55 05 binayakumar.shrestha@ksw.ch Principal Investigator: Binaya Kumar Shrestha, MD Klinik Hirslanden Recruiting Zurich, Switzerland, 8032 Contact: Marcin Sumila, MD +41 44 387 25 51 marcin.sumila@hirslanden.ch Principal Investigator: Marcin Sumila, MD Stadtspital Triemli Recruiting Zurich, Switzerland, 8063 Contact: Helmut Kranzbühler, MD +41 44 466 13 67 helmut.kranzbuehler@triemli.zuerich.ch Principal Investigator: Helmut Kranzbühler, MD UniversitätsSpital Zürich Recruiting Zurich, Switzerland, 8091 Contact: Matthias Guckenberger, Prof +41 44 255 29 30 Matthias.Guckenberger@usz.ch Principal Investigator: Matthias Guckenberger, Prof 收起 << |
NCT02836496 | Hypereosinophilic Syndrome | Phase 3 | Recruiting | October 17, 2019 | - |
NCT02661217 | Heart Failure With Reduced Eje... 展开 >>ction Fraction 收起 << | Phase 4 | Completed | - | - |
NCT01765283 | Urea Cycle Disorders, ... 展开 >> Crigler Najjar Syndrome 收起 << | Phase 1 Phase 2 | Completed | - | Belgium ... 展开 >> Saint Luc University Hospital Brussels, Belgium Universitair Ziekenhuis (UZ) Antwerpen Edegem, Belgium, 2650 France CHU Bicêtre Le Kremlin Bicêtre Cedex, France, 94275 Hôpital Jeanne de Flandre, CHRU Lille Lille Cedex, France, 59037 Hôpital des Enfants, CHU de Toulouse Toulouse cedex 9, France, 31059 Israel Rambam Medical Center, Meyer Children's Hospital Haifa, Israel, 31096 Hadassah Ein-Kerem Medical Center Jerusalem, Israel, 91240 Schneider Children's Medical Center of israel Petach Tikva, Israel, 49202 Italy Ospedale Pediatrico Bambino Gesu di Roma Roma, Italy, 00165 United Kingdom Birmingham Children's Hospital Birmingham, United Kingdom, B4 6NH Great Ormond Street Hospital London London, United Kingdom, WC1N 3JH 收起 << |
NCT01691859 | - | Completed | - | - | |
NCT02078427 | - | Recruiting | December 1, 2019 | - | |
NCT01698918 | Hormone Receptor Positive Brea... 展开 >>st Cancer 收起 << | Phase 2 | Active, not recruiting | June 4, 2020 | - |
NCT02723955 | Cancer | Phase 1 | Recruiting | May 18, 2020 | United States, California ... 展开 >> GSK Investigational Site Recruiting Duarte, California, United States, 91010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10016 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Pennsylvania GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Tennessee GSK Investigational Site Recruiting Nashville, Tennessee, United States, 37203 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Nashville, Tennessee, United States, 37232-6307 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Australia, Victoria GSK Investigational Site Recruiting Heidelberg, Victoria, Australia, 3084 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Australia, Western Australia GSK Investigational Site Recruiting Nedlands, Western Australia, Australia, 6009 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Canada, Ontario GSK Investigational Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com France GSK Investigational Site Not yet recruiting Bordeaux Cedex, France, 33076 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Lyon cedex 08, France, 69373 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Paris, France, 75005 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Villejuif cedex, France, 94805 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Italy GSK Investigational Site Recruiting Siena, Toscana, Italy, 53100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Spain GSK Investigational Site Recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Madrid, Spain, 28040 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Málaga, Spain, 29010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Sevilla, Spain, 41009 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT03061812 | Small Cell Lung Cancer | Phase 3 | Recruiting | September 30, 2021 | - |
NCT01691859 | Asthma | Phase 3 | Completed | - | - |
NCT02265744 | Lupus | Phase 2 | Terminated(Inability to meet p... 展开 >>rotocol objectives) 收起 << | - | - |
NCT01951625 | Heart Failure | Phase 2 | Completed | - | - |
NCT02914561 | Crohn's Disease | Phase 3 | Recruiting | December 2019 | - |
NCT00952588 | Acute Myeloid Leukemia | Phase 2 Phase 3 | Completed | - | - |
NCT03033511 | Small Cell Lung Cancer | Phase 3 | Recruiting | August 31, 2021 | - |
NCT00952588 | - | Completed | - | - | |
NCT02180217 | Cushing's Disease | Phase 3 | Active, not recruiting | December 9, 2019 | - |
NCT02630966 | Crohn Disease | Phase 4 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37212-1375 United States, Texas Texas Digestive Disease Consultants Southlake, Texas, United States, 76092 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Canada, Alberta University of Calgary Calgary, Alberta, Canada, T2N 4Z6 Canada, British Columbia GIRI (GI Research Institute) Vancouver, British Columbia, Canada, V6Z 2K5 France CHRU de Lille - Hopital Claude Huriez Lille cedex, France, 59037 Hopital l'Archet II Nice Cedex 3, France, 06202 CHU de Rennes - Hopital de Pontchaillou Rennes cedex 9, France, 35033 Hopital de Brabois Vandoeuvre les Nancy, France, 54511 Italy Azienda Ospedaliera S. Orsola-Malpighi Bologna, Italy, 40138 Istituto Clinico Humanitas IRCCS Milan, Italy, 20089 Netherlands Academic Medical Center Amsterdam, Netherlands, 1105 AZ Leids Universitair Medisch Centrum Leiden, Netherlands, 2333 ZA Erasmus MC Rotterdam, Netherlands, 3015 CE Spain Hospital Clinic Barcelona Barcelona, Spain, 08036 Hospital Universitario y Politecnico La Fe Valencia, Spain, 46026 United Kingdom Nottingham University Hospitals NHS Trust Nottingham, United Kingdom, NG7 2UH John Radcliffe Hospital Oxford, United Kingdom, OX3 9DU 收起 << |
NCT02483585 | - | Completed | - | - | |
NCT03036098 | Urothelial Cancer | Phase 3 | Recruiting | December 23, 2022 | - |
NCT01509989 | - | Completed | - | France ... 展开 >> Hopital Cochin Paris, France, 75679 收起 << | |
NCT03285308 | Gastroparesis ... 展开 >> Diabetes Mellitus 收起 << | Phase 3 | Recruiting | November 23, 2019 | - |
NCT02483585 | Migraine | Phase 3 | Completed | - | - |
NCT02514668 | Plasma Cell Myeloma | Phase 1 | Recruiting | October 3, 2018 | United States, Arizona ... 展开 >> Investigational Site Number 840003 Active, not recruiting Scottsdale, Arizona, United States, 85054 United States, California Investigational Site Number 840004 Completed San Francisco, California, United States, 94117 United States, Michigan Investigational Site Number 840011 Completed Detroit, Michigan, United States, 48201 United States, Missouri Investigational Site Number 840015 Completed Saint Louis, Missouri, United States, 63110 United States, New Jersey Investigational Site Number 840005 Active, not recruiting Hackensack, New Jersey, United States, 07601 United States, North Carolina Investigational Site Number 840010 Recruiting Durham, North Carolina, United States, 27707 United States, Ohio Investigational Site Number 840013 Completed Canton, Ohio, United States, 44718 United States, Tennessee Investigational Site Number 840001 Completed Nashville, Tennessee, United States, 37232 United States, Utah Investigational Site Number 840002 Active, not recruiting Salt Lake City, Utah, United States, 84112-5550 United States, Wisconsin Investigational Site Number 840006 Completed Milwaukee, Wisconsin, United States, 53226 Czechia Investigational Site Number 203002 Active, not recruiting Brno, Czechia, 62500 Investigational Site Number 203001 Active, not recruiting Praha 2, Czechia, 12808 France Investigational Site Number 250008 Active, not recruiting Creteil Cedex, France, 94010 Investigational Site Number 250005 Active, not recruiting Montpellier, France, 34295 Investigational Site Number 250002 Active, not recruiting Nantes Cedex 01, France, 44093 Investigational Site Number 250007 Recruiting Paris, France, 75010 Investigational Site Number 250004 Completed Pessac Cedex, France, 33604 Investigational Site Number 250003 Recruiting Pierre Benite, France, 69310 Investigational Site Number 250001 Active, not recruiting Poitiers, France, 86021 Investigational Site Number 250006 Completed Vandoeuvre-Les-Nancy, France, 54511 收起 << |
NCT02134028 | Asthma | Phase 2 Phase 3 | Active, not recruiting | November 1, 2019 | - |
NCT03580408 | Hodgkin Lymphoma ... 展开 >> Coexisting Medical Conditions 收起 << | Phase 2 | Recruiting | July 2023 | - |
NCT03775486 | Non-small Cell Lung Cancer NSC... 展开 >>LC 收起 << | Phase 2 | Not yet recruiting | May 23, 2022 | - |
NCT00951015 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 2 | Completed | - | - |
NCT00908232 | Multiple Myeloma | Phase 2 | Completed | - | - |
NCT00908232 | - | Completed | - | - | |
NCT01316900 | - | Completed | - | - | |
NCT02993783 | Allogeneic Hematopoietic Stem ... 展开 >>Cell Transplantation 收起 << | Phase 2 | Terminated(Lack of efficacy of... 展开 >> the drug; no safety concern) 收起 << | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, New York Mount Sinai - PRIME Lake Success, New York, United States, 11041 United States, Ohio OSU - James Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75204 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Belgium ZNA Stuivenberg Antwerpen, Belgium, 2060 AZ Sint-Jan Brugge Brugge, Belgium, 8000 UZ Leuven Leuven, Belgium, 3000 France CHU Nantes - Hotel Dieu Nantes cedex 1, Loire Atlantique, France, 44093 Hopital Claude Huriez - CHU Lille Lille cedex, Nord, France, 59037 Hopital Saint-Antoine Paris cedex 12, Paris, France, 75571 Norway Oslo Universitetssykehus - Rikshospitalet Oslo, Norway, 3072 Sweden Skanes Universitetssjukhus, Lund Lund, Sweden, 22185 Akademiska Sjukhuset Uppsala, Sweden, 75185 收起 << |
NCT00076999 | HIV Infections | Phase 1 | Completed | - | - |
NCT02664740 | Diabetic Foot ... 展开 >> Staphylococcal Infections 收起 << | Phase 1 Phase 2 | Not yet recruiting | August 2019 | France ... 展开 >> CHU de Bordeaux - Hôpital Pellegrin Not yet recruiting Bordeaux, France, 33000 Principal Investigator: Michel Dupon, MD, PhD CHRU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi Not yet recruiting Le Grau du Roi, France, 30240 Principal Investigator: Sophie Schuldiner, MD CHU de Nantes - Hôtel Dieu Not yet recruiting Nantes Cedex 1, France, 44093 Principal Investigator: David Boutoille, MD, PhD APHP - Groupe Hospitalier Pitié-Salpetrière Not yet recruiting Paris Cedex 13, France, 75651 Principal Investigator: Agnès Hartemann, MD, PhD APHP - Hôpital Lariboisière Not yet recruiting Paris, France, 75010 Principal Investigator: Jean-François Gautier, MD,PhD CHRU de Toulouse - Hôpital de Rangueil Not yet recruiting Toulouse Cedex 9, France, 31059 Principal Investigator: Jacques Martini, MD CH de Tourcoing Not yet recruiting Tourcoing, France, 59200 Principal Investigator: Eric Senneville, MD, PhD Institut Robert Merle d'Aubigné Not yet recruiting Valenton, France, 94460 Principal Investigator: Gérard Chiesa, MD CH Intercommunal de Villeneuve-Saint-Georges Not yet recruiting Villeneuve-Saint-Georges, France, 94195 Principal Investigator: Olivier Patey, MD 收起 << |
NCT00076999 | - | Completed | - | - | |
NCT00951015 | - | Completed | - | - | |
NCT01316900 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT03131453 | Alzheimer's Disease | Phase 2 Phase 3 | Recruiting | March 31, 2025 | - |
NCT00688753 | - | Completed | - | - | |
NCT01125189 | - | Completed | - | - | |
NCT01125189 | Hepatitis C Virus | Phase 2 | Completed | - | - |
NCT02783300 | Cancer | Phase 1 | Recruiting | September 12, 2019 | United States, Florida ... 展开 >> GSK Investigational Site Recruiting Miami, Florida, United States, 33136 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10065 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Texas GSK Investigational Site Not yet recruiting Dallas, Texas, United States, 75230 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting San Antonio, Texas, United States, 78229 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Canada, Ontario GSK Investigational Site Recruiting Toronto, Ontario, Canada, M5G 1X6 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com France GSK Investigational Site Recruiting Bordeaux Cedex, France, 33076 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Lyon Cedex 08, France, 69373 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Villejuif cedex, France, 94805 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT03298061 | Churg-Strauss Syndrome | Phase 3 | Active, not recruiting | January 2, 2020 | - |
NCT00688753 | Carcinoma Ren... 展开 >>al Cell Non Clear Cell Renal Carcinoma Papillary Cell Renal Carcinoma Adenocarcinoma 收起 << | Phase 2 | Completed | - | Belgium ... 展开 >> Novartis Investigative Site Brussels, Belgium, BE-B-1200 Novartis Investigative Site Gent, Belgium, 9000 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Marseille, France, 13273 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 10098 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Muenster, Germany, 48149 Italy Novartis Investigative Site Arezzo, AR, Italy, 52100 Novartis Investigative Site Cremona, CR, Italy, 26100 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Napoli, Italy, 80132 Poland Novartis Investigative Site Otwock, Poland, 05-400 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Barcelona, Cataluña, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46009 Novartis Investigative Site Barcelona, Spain, 08041 收起 << |
NCT00140738 | Neoplasms, Breast | Phase 1 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Charleroi, Belgium, 6000 GSK Investigational Site Edegem, Belgium, 2650 GSK Investigational Site Hasselt, Belgium, 3500 GSK Investigational Site Ottignies, Belgium, 1340 Colombia GSK Investigational Site Bogotá, Colombia, 11001000 France GSK Investigational Site Lyon Cedex 08, France, 69373 GSK Investigational Site Montpellier Cedex 5, France, 34298 GSK Investigational Site Paris Cedex 05, France, 75248 GSK Investigational Site Saint-Cloud, France, 92210 GSK Investigational Site Saint-Herblain, France, 44805 GSK Investigational Site Toulouse cedex, France, 31052 GSK Investigational Site Vandoeuvre-Les-Nancy, France, 54511 Italy GSK Investigational Site Roma, Lazio, Italy, 00133 GSK Investigational Site Milano, Lombardia, Italy, 20141 Peru GSK Investigational Site Lima, Peru, Lima 34 收起 << |
NCT03569293 | Atopic Dermatitis | Phase 3 | Recruiting | May 6, 2022 | - |
NCT03439293 | Multiple Myeloma | Phase 2 | Recruiting | December 31, 2023 | United States, California ... 展开 >> Pacific Cancer Medical Center Recruiting Anaheim, California, United States, 92801 United States, Colorado Colorado Blood Cancer Institute Not yet recruiting Denver, Colorado, United States, 80218-1230 United States, Florida SCRI - Florida Cancer Specialists - Panhandle Not yet recruiting Tallahassee, Florida, United States, 32308 United States, Missouri Research Medical Center - Kansas City Not yet recruiting Kansas City, Missouri, United States, 64132 United States, Tennessee SCRI - Tennessee Oncology - Nashville - Centennial Not yet recruiting Nashville, Tennessee, United States, 58014 United States, Texas The University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030-4017 Czechia Fakultni Nemocnice Olomouc Not yet recruiting Olomouc, Olomoucky, Czechia, 77900 Fakultni Nemocnice Kralovske Vinohrady Not yet recruiting Praha 10, Praha, Czechia, 100 34 Fakultni Nemocnice Ostrava Not yet recruiting Ostrava - Poruba, Severomoravsky KRAJ, Czechia, 708 52 Fakultni Nemocnice Brno Not yet recruiting Brno, Czechia, 625 00 Onkologicka klinika Vseobecna fakultni nemocnice v Praze a 1 Not yet recruiting Praha, Czechia, 128 08 France Hopital Saint-Antoine Not yet recruiting Paris, Ile-de-france, France, 75012 Hopital Claude Huriez Not yet recruiting Lille Cedex, NORD Pas-de-calais, France, 59037 Hopital Hotel Dieu Not yet recruiting Nantes Cedex 1, PAYS DE LA Loire, France, 44093 Centre Hospitalier Lyon Sud Not yet recruiting Pierre Benite Cedex, Rhone-alpes, France, 69495 Greece Evaggelismos General Hospital Not yet recruiting Athens, Attica, Greece, 10676 Alexandra General Hospital of Athens Not yet recruiting Athens, Attica, Greece, 11528 University General Hospital of Patras Panagia I Voithia Not yet recruiting Patras, Peloponnese, Greece, 26504 Netherlands Medisch Centrum Leeuwarden Not yet recruiting Leeuwarden, Friesland, Netherlands, 8934 AD Vrije Universiteit Medisch Centrum Not yet recruiting Amsterdam, Noord-holland, Netherlands, 1081 HV Albert Schweitzer Ziekenhuis Dordwijk Not yet recruiting Dordrecht, South Holland, Netherlands, 3300 AK Erasmus Medisch Centrum Not yet recruiting Rotterdam, Zuid-holland, Netherlands, 3015 CE Universitair Medisch Centrum Utrecht Not yet recruiting Utrecht, Netherlands, 3584 CX Poland Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi Not yet recruiting Lodz, Lodzkie, Poland, 93-510 Szpital Uniwersytecki w Krakowie Not yet recruiting Krakow, Malopolskie, Poland, 31-501 Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza Not yet recruiting Brzozow, Podkarpackie, Poland, 36-200 Szpitale Pomorskie Spolka z ograniczona odpowiedzialnoscia Not yet recruiting Gdynia, Pomorskie, Poland, 81-519 Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich Not yet recruiting Chorzow, Slaskie, Poland, 41-500 收起 << |
NCT02779751 | Non Small Cell Lung Cancer ... 展开 >> Breast Cancer 收起 << | Phase 1 | Recruiting | June 30, 2021 | - |
NCT00622284 | - | Completed | - | - | |
NCT02610140 | Mesothelioma | Phase 2 | Active, not recruiting | July 29, 2019 | - |
NCT00790036 | Diffuse Large B-cell Lymphoma | Phase 3 | Completed | - | - |
NCT00095082 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT03412565 | Multiple Myeloma | Phase 2 | Active, not recruiting | February 1, 2021 | - |
NCT03398135 | Ulcerative Colitis (UC) | Phase 3 | Recruiting | June 20, 2023 | - |
NCT03398148 | Ulcerative Colitis (UC) | Phase 2 Phase 3 | Recruiting | August 29, 2022 | - |
NCT00391027 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT00790036 | - | Completed | - | - | |
NCT00391027 | - | Completed | - | - | |
NCT02585934 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT02586909 | Alzheimer's Disease | Phase 3 | Terminated(Intepirdine did not... 展开 >> meet its primary efficacy endpoints in lead-in study RVT-101-3001.) 收起 << | - | - |
NCT02585934 | - | Completed | - | - | |
NCT00622284 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00101816 | Chronic Myeloid Leukemia ... 展开 >> Blast Crisis 收起 << | Phase 2 | Completed | - | - |
NCT00069745 | Prostate Cancer ... 展开 >> Hormone Refractory Prostate Cancer 收起 << | Phase 3 | Completed | - | - |
NCT03682536 | Myelodysplastic Syndromes | Phase 3 | Recruiting | May 7, 2026 | - |
NCT01064401 | Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 3 | Completed | - | - |
NCT00101816 | - | Completed | - | - | |
NCT01064401 | - | Completed | - | - | |
NCT00242879 | Infection, Human Immunodeficie... 展开 >>ncy Virus I HIV-1 Infection 收起 << | Phase 2 | Terminated | - | - |
NCT01449929 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Completed | - | - |
NCT03521934 | Heart Failure-Type 2 Diabetes ... 展开 >>Mellitus 收起 << | Phase 3 | Recruiting | January 2021 | - |
NCT03525444 | Cystic Fibrosis | Phase 3 | Active, not recruiting | August 2019 | - |
NCT03131648 | Atopic Dermatitis | Phase 3 | Active, not recruiting | October 2019 | - |
NCT02931539 | Cytomegalovirus (CMV) | Phase 3 | Recruiting | May 6, 2019 | - |
NCT00189826 | Liver Transplantation | Phase 3 | Completed | - | - |
NCT03718117 | - | Recruiting | December 6, 2019 | France ... 展开 >> Centre Hospitalier Intercommunal du Pays d'Aix-Pertuis,Service de Pneumologie Recruiting Aix en Provence, France, 13616 Clinique de l Europe Recruiting Amiens, France, 80000 Centre Hospitalier d Avignon Recruiting Avignon, France, 84902 Centre Hospitalier de Beauvais Recruiting Beauvais, France, 60021 Centre Hospitalier General Beziers, Service De Pneumologie Recruiting Beziers, France, 34525 Centre Hospitalier de Cannes Recruiting Cannes, France, 06414 Centre Hospitalier Chalon sur Saone William Morey Recruiting Chalon sur Saone, France, 71321 Centre Hospitalier Metropole de Savoie-Site de Chambery Recruiting Chambery, France, 73000 Hopitaux Civils de Colmar - Hopital Louis Pasteur Recruiting Colmar Cedex, France, 68024 Centre Hospitalier Alpes Leman Recruiting Contamine sur Arve, France, 74130 Centre Hospitalier Intercommunal Frejus Recruiting Frejus, France, 83600 Centre Hospitalier Départemental Les Oudairies Recruiting La Roche Sur Yon Cedex 9, France, 85925 CHD Vendee Recruiting La Roche Sur Yon, France, 85925 Le Mans Hospital Center Recruiting Le Mans, France, 72037 Centre Hospitalier De Libourne - Hopital Robert Boulin Recruiting Libourne, France, 33505 Centre Hospitalier des Deux Vallees - Longjumeau BP 125 Recruiting Longjumeau, France, 91161 Centre Hospitalier de Macon Recruiting Macon cedex, France, 71018 Hopital Europeen - Service de Pneumologie Recruiting Marseille, France, 13003 GHR Mulhouse Sud Alsace Recruiting Mulhouse, France, 68051 Centre Hospitalier Regional d Orleans Recruiting Orleans, France, 45000 Centre Hospitalier Annecy Genevois Recruiting Pringy, France, 74374 Groupe Hospitalier Sud Reunion Recruiting Saint Pierre La Réunion, France, 97448 Hopitaux du Leman Recruiting Thonon les Bains, France Centre Hospitalier de Troyes, Service de Pneumologie - Oncologie Thoracique Recruiting Troyes, France, 10003 Centre Hospitalier de Villefranche sur Saone - BP80436 Recruiting Villefranche sur Saone, France, 69655 收起 << | |
NCT01449929 | - | Completed | - | - | |
NCT01285609 | Lung Cancer - Non Small Cell S... 展开 >>quamous 收起 << | Phase 3 | Completed | - | - |
NCT00049998 | Non-Small-Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT01285609 | - | Completed | - | - | |
NCT03191396 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00833248 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT02747043 | Lymphoma, Non-Hodgkin | Phase 3 | Recruiting | June 16, 2019 | - |
NCT00412984 | Atrial Fibrillation ... 展开 >> Atrial Flutter 收起 << | Phase 3 | Completed | - | - |
NCT00412984 | - | Completed | - | - | |
NCT02900664 | Colorectal Cancer, Triple Nega... 展开 >>tive Breast Cancer, NSCLC - Adenocarcinoma 收起 << | Phase 1 | Recruiting | February 17, 2020 | United States, Maryland ... 展开 >> Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21287-0013 United States, Massachusetts Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02215 United States, Tennessee Novartis Investigative Site Recruiting Nashville, Tennessee, United States, 37203 Contact: Michael Cain 615-329-7417 Michael.Cain@sarahcannon.com Principal Investigator: Melissa Johnson United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Munir Yi Chowdury 713-563-9033 MChowdhury@mdanderson.org Principal Investigator: Siqing Fu Belgium Novartis Investigative Site Recruiting Brussels, Belgium, BE-B-1200 Novartis Investigative Site Recruiting Wilrijk, Belgium, 2610 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Recruiting Lyon Cedex, France, 69373 Novartis Investigative Site Recruiting Paris, France, 75231 Novartis Investigative Site Recruiting Toulouse Cedex 9, France, 31059 Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Israel Novartis Investigative Site Recruiting Tel Aviv, Israel, 64239 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20132 Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 119228 Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Recruiting Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Novartis Investigative Site Recruiting Madrid, Spain, 28050 Taiwan Novartis Investigative Site Recruiting Tainan, Taiwan, 70421 Novartis Investigative Site Recruiting Taoyuan, Taiwan, 33305 收起 << |
NCT01687387 | Acute Myeloid Leukemia | Phase 2 | Completed | - | France ... 展开 >> CHU d'Amiens Amiens, France, 80054 CHU Angers Angers, France, 49933 Centre hospitalier Victor Dupouy Argenteuil, France, 95107 Centre hospitalier de la côte Basque Bayonne, France, 64100 CHU de Besançon Besançon, France, 25030 CH de Blois Blois, France, 41000 Hôpital Avicenne Bobigny, France, 93000 Hôpital Morvan CHU Brest Brest, France, 29609 CHG de Béziers Béziers, France, 34500 CH René Dubos Cergy Pontoise, France, 95303 Hôpital Militaire Percy Clamart, France, 92141 CHU Estaing Clermont-Ferrand, France, 63003 Centre hospitalier sud francilien Corbeil Essonnes, France, 91100 Hôpital Henri Mondor Créteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 Centre Hospitalier de Versailles Le Chesnay Cedex, France, 78157 Hôpital Claude Huriez Lille, France, 59037 CHU de Limoges Limoges, France, 87042 Institut Paoli - Calmettes Marseille Cedex 09, France, 13273 CH de Meaux Meaux, France, 77104 CHU Saint Eloi Montpellier Cedex 5, France, 34295 Centre Hospitalier de Mulhouse Mulhouse, France, 68100 CHU de Nantes Nantes, France, 44000 Centre Antoine Lacassagne Nice, France, 06189 CHU Caremeau Nîmes, France, 30029 CHR d'Orléans Orléans, France, 45067 Hôpital Necker Paris Cedex 15, France, 75743 Hôpital Saint-Louis Paris, France, 75010 Hôpital Saint-Antoine Paris, France, 75012 CH Saint-Jean Perpignan, France, 66000 CHU de Bordeaux - Hôpital Haut-Lévêque Pessac, France, 33604 Centre hospitalier Lyon Sud Pierre Bénite, France, 69495 CHU de Poitiers Poitiers, France, 86021 CHR d'Annecy Pringy, France, 74374 CHU de Reims Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Centre René Huguenin Saint-Cloud, France, 92210 CH Saint-Quentin Saint-Quentin, France, 02321 Hôpital Haute Pierre et Hôpital Civil Strasbourg, France, 67098 CHU Purpan Toulouse, France, 31059 CH Valenciennes Valenciennes, France, 59322 CHU de Nancy Hôpitaux de Brabois Vandoeuvre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT02391116 | Diffuse, Large B-Cell, Lymphom... 展开 >>a 收起 << | Phase 2 | Completed | - | - |
NCT02391116 | - | Completed | - | - | |
NCT02795429 | Advanced Hepatocellular Carcin... 展开 >>oma 收起 << | Phase 1 Phase 2 | Recruiting | December 24, 2019 | United States, Illinois ... 展开 >> Novartis Investigative Site Recruiting Chicago, Illinois, United States, 60637 Contact: Tamika Harris 773-834-7188 tharris@medicine.bsd.uchicago.edu Principal Investigator: Manish Sharma Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Recruiting Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Recruiting Montpellier cedex 5, Herault, France, 34059 Novartis Investigative Site Recruiting Lille Cedex, France, 59037 Novartis Investigative Site Recruiting Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Novartis Investigative Site Recruiting Wurzburg, Germany, 97080 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20132 Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Novartis Investigative Site Recruiting Modena, MO, Italy, 41124 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03080 Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03722 Taiwan Novartis Investigative Site Recruiting Tainan, Taiwan, 70421 Novartis Investigative Site Recruiting Taipei, Taiwan, 10002 收起 << |
NCT01642004 | Squamous Cell Non-small Cell L... 展开 >>ung Cancer 收起 << | Phase 3 | Active, not recruiting | December 29, 2018 | - |
NCT00833248 | - | Completed | - | - | |
NCT01642004 | - | Active, not recruiting | - | - | |
NCT00706797 | Rheumatoid Arthritis | Phase 4 | Terminated | - | - |
NCT00706797 | - | Terminated | - | - | |
NCT00634049 | Aspergillosis ... 展开 >> Invasive Fungal Infections 收起 << | Phase 3 | Completed | - | - |
NCT01321541 | Diffuse Large B-cell Lymphoma ... 展开 >> de Novo DLBCL DLBCL Transformed From Indolent Lymphoma Follicular Grade 3 Lymphoma 收起 << | Phase 3 | Completed | - | - |
NCT00617604 | De Novo Kidney Transplantation | Phase 2 | Completed | - | - |
NCT00347919 | Neoplasms, Breast | Phase 2 | Completed | - | - |
NCT02956486 | Alzheimer's Disease | Phase 3 | Recruiting | March 29, 2021 | - |
NCT03222973 | Multiple Sclerosis | Phase 2 | Recruiting | December 8, 2020 | - |
NCT00347919 | - | Completed | - | - | |
NCT01309932 | Hepatitis C | Phase 2 | Completed | - | - |
NCT00617604 | - | Completed | - | - | |
NCT00643929 | - | Completed | - | - | |
NCT01210495 | Hepatocellular Carcinoma | Phase 2 | Completed | - | - |
NCT00920140 | Cancer | Phase 2 | Completed | - | - |
NCT01210495 | - | Completed | - | - | |
NCT02516410 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT01991041 | - | Completed | - | - | |
NCT01677741 | Neoplasms, Brain | Phase 1 | Recruiting | September 2, 2019 | - |
NCT00634049 | - | Completed | - | - | |
NCT02516410 | - | Completed | - | - | |
NCT00656136 | - | Completed | - | - | |
NCT00920140 | - | Completed | - | - | |
NCT00766779 | Acute Myeloid Leukemia | Phase 3 | Terminated(Recommendation of D... 展开 >>MC) 收起 << | December 2020 | - |
NCT00656136 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
NCT00268216 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT02332577 | Pneumonia | Phase 4 | Recruiting | May 31, 2021 | - |
NCT00936676 | - | Completed | - | - | |
NCT02658890 | Advanced Cancer ... 展开 >> Melanoma Non-Small Cell Lung Cancer 收起 << | Phase 1 Phase 2 | Recruiting | February 28, 2020 | - |
NCT01208090 | Psoriasis | Phase 2 | Completed | - | - |
NCT00340080 | HIV Infection | Phase 4 | Completed | - | - |
NCT02677896 | Metastatic Hormone Sensitive P... 展开 >>rostate Cancer 收起 << | Phase 3 | Active, not recruiting | December 2023 | - |
NCT02257385 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00089986 | Sepsis | Phase 2 | Completed | - | - |
NCT00089986 | - | Completed | - | - | |
NCT00883337 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT02936635 | Amyotrophic Lateral Sclerosis ... 展开 >>(ALS) 收起 << | Phase 3 | Active, not recruiting | October 2019 | - |
NCT02373813 | Rheumatoid Arthritis | Phase 3 | Active, not recruiting | November 12, 2019 | - |
NCT02257385 | - | Completed | - | - | |
NCT00883337 | - | Completed | - | - | |
NCT00549757 | Type 2 Diabetes Mellitus ... 展开 >> Cardiovascular Disease 收起 << | Phase 3 | Terminated(Lack of benefit and... 展开 >> safety concern) 收起 << | - | - |
NCT00549757 | - | Terminated(Lack of benefit and... 展开 >> safety concern) 收起 << | - | - | |
NCT00423813 | Fibromyalgia | Phase 3 | Completed | - | - |
NCT01178073 | - | Completed | - | - | |
NCT01178073 | Hypertension, Pulmonary | Phase 3 | Completed | - | - |
NCT00175929 | Epilepsy, Focal | Phase 2 | Completed | - | - |
NCT00423813 | - | Completed | - | - | |
NCT02496689 | - | - | - | United States, Colorado ... 展开 >> Colorado Center for Bone Research Lakewood, Colorado, United States, 80227 United States, Pennsylvania Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 France Hôpital Bicêtre Le Kremlin-Bicêtre, France, 94275 Hôpital Necker - Enfants Malades Paris, France, 75015 Hôpital des Enfants Toulouse Cedex 9, France, 31259 收起 << | |
NCT02924402 | B-cell Non-Hodgkins Lymphoma ... 展开 >> Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma 收起 << | Phase 1 | Recruiting | September 2020 | United States, California ... 展开 >> Moores UC San Diego Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Mark Buss 858-822-7916 mabuss@ucsd.edu United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States, 32224 Contact: Torsak Vimoktayon 904-953-3238 vimoktayon.torsak@mayo.edu Contact: Lula Downey 904-953-3087 downey.lula@mayo.edu United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Reem Karmali, MD 312-695-0990 United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Tycel Phillips, MD 734-647-8901 tycelp@umich.edu United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: William Wierda, MD wwierda@mdanderson.org Contact: Jeanne Lichty, RN 713-794-4683 jmlichty@mdanderson.org MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Sheeba Thomas, MD 713-792-2860 SThomas@mdanderson.org Contact: Ashley Morphey 713-792-8785 Alandry1@mdanderson.org United States, Virginia UVA Health System, Division of Hematology & Oncology Recruiting Charlottesville, Virginia, United States, 22908 Contact: Craig Portell, MD 434-982-4982 CP4YS@virginia.edu United States, Washington Swedish Cancer Institute Recruiting Seattle, Washington, United States, 98104 Contact: Krish Patel, MD 206-215-2338 krish.patel@swedish.org Contact: Tenzin Tsomo 206-386-2831 Tenzin.Tsomo@swedish.org France Hopital Henri Mondor Recruiting Creteil, France, 94010 Contact: Dr. Corinne Haioun 33 1 49 81 20 51 corinne.haioun@aphp.fr Institut Paoli Calmette Dpt of Oncology/Hematology Recruiting Marseille Cedex 9, France, 13273 Contact: Reda Bouabdallah, MD 33 6 70 27 68 77 bouabdallahr@ipc.unicancer.fr Chu Montpellier, Hematologie Clinique St. Eloi Recruiting Montpellier Cedex 5, France, 34295 Contact: Dr. Guillaume Cartron 33 4 67 33 26 45 g-cartron@chu-montpellier.fr Centre Antoine Lacassagne Recruiting Nice Cedex, France, 06189 Contact: Pr. Frederic Peyrade 33 4 92 03 10 47 frederic.peyrade@nice.unicancer.fr CHU Haut-Leveque, Service d'Hematologie Clinique et Therapie Cellulaire Recruiting Pessac, France, 33604 Contact: Kamal Krimo Bouabdallah, MD 33 5 57 65 65 11 krimo.bouabdallah@chu-bordeaux.fr Centre Hospitalier Lyon-Sud, Service d'Hematologie Recruiting Pierre-Benite Cedex, France, 69495 Contact: Pr Gilles Salles 33 4 78 86 43 07 gilles.salles@chu-lyon.fr Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Dr. Hervé Tilly 33 2 32 08 22 20 herve.tilly@chb.unicancer.fr CLCC Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Dr. Vincent Ribrag 33 1 42 11 58 20 mathilde.miyalou@gustaveroussy.fr 收起 << |
NCT01300013 | Heart Failure | Phase 2 | Completed | - | - |
NCT02075255 | Asthma | Phase 3 | Completed | - | - |
NCT01648140 | Hepatitis C, Chronic | Phase 2 | Completed | - | - |
NCT02075255 | - | Completed | - | - | |
NCT01266525 | Dementia Alzheimer's Type | Phase 2 | Completed | - | - |
NCT01648140 | - | Completed | - | - | |
NCT01776424 | Prevention & Control | Phase 3 | Active, not recruiting | June 30, 2021 | - |
NCT01376323 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Miramar, Florida, United States, 33025 France GSK Investigational Site Nantes cedex 01, France, 44093 GSK Investigational Site Pierre-Bénite Cedex, France, 69495 GSK Investigational Site Rennes Cedex, France, 35046 GSK Investigational Site Rueil-Malmaison, France, 92502 Spain GSK Investigational Site Alicante, Spain, 03114 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Granada, Spain, 18004 GSK Investigational Site Madrid, Spain, 28046 United Kingdom GSK Investigational Site Edinburgh, Midlothian, United Kingdom, EH4 2XU GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site Coventry, United Kingdom, CV2 2DX GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP 收起 << |
NCT00411645 | Cytomegalovirus Infections | Phase 3 | Completed | - | - |
NCT01084330 | Advanced Gastric Cancer ... 展开 >> Gastro-esophageal Junction Cancer 收起 << | Phase 2 | Completed | - | - |
NCT01376323 | - | Completed | - | - | |
NCT00781391 | Stroke Atrial... 展开 >> Fibrillation Embolism 收起 << | Phase 3 | Completed | - | - |
NCT01776424 | - | Active, not recruiting | - | - | |
NCT02041533 | - | Active, not recruiting | - | - | |
NCT00411645 | - | Completed | - | - | |
NCT02065570 | Crohn's Disease | Phase 3 | Active, not recruiting | December 11, 2020 | - |
NCT01029262 | Anemia | Phase 3 | Completed | - | - |
NCT02041533 | Stage IV or Recurrent Non-Smal... 展开 >>l Cell Lung Cancer 收起 << | Phase 3 | Active, not recruiting | October 1, 2018 | - |
NCT02279862 | Prostate Cancer | Phase 2 | Terminated(This study was term... 展开 >>inated after a separate trial (CA184-095) failed to reach its primary endpoint.) 收起 << | - | - |
NCT00781391 | - | Completed | - | - | |
NCT02279862 | - | Terminated(This study was term... 展开 >>inated after a separate trial (CA184-095) failed to reach its primary endpoint.) 收起 << | - | - | |
NCT01029262 | - | Completed | - | - | |
NCT01903733 | Chronic Myeloid Leukemia | Not Applicable | Active, not recruiting | April 3, 2020 | - |
NCT01403636 | Lymphoma | Phase 2 | Completed | - | - |
NCT01502631 | Acute Spinal Cord Injury | Phase 2 | Completed | - | - |
NCT02926898 | Dravet Syndrome | Phase 3 | Active, not recruiting | December 2018 | United States, California ... 展开 >> University of California San Francisco San Francisco, California, United States, 94143 United States, Colorado The Children'S Hospital Colorado Aurora, Colorado, United States, 80045 United States, Illinois Ann & Robert Lurie Children'S Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Canada, British Columbia British Columbia Children'S Hospital Vancouver, British Columbia, Canada, V6H3V4 Canada, Quebec Centre Hospitalier Universitaire Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 France Chu Amiens Picardie Service de Neurologie Pediatrique Amiens, France, 80054 CHU DE BORDEAUX Service De Pédiatrie Médicale Bordeaux, France, 33000 CHRU LILLE Centre Hospitalier Régional Universitaire De Lille 2 Lille, France, 59037 HÔPITAL FEMME-MÈRE-ENFANT Hôpital Femme-mère-enfant Service De Neurologie Pédiatrique Lyon, France, 69500 Hôpital La Timone, Service de Neurologie Pédiatrique Marseille, France, 13385 Hôpital Necker Paris, France, 75743 Hôpital Robert Debré Paris, France, 75743 CENTRE REFERENT DES EPILEPSIES Hopital De Hautpierre Strasbourg Cedex, France, F-67098 HÔPITAL DES ENFANTS Pédiatrie Toulouse Cedex 9, France, 31059 Hopital Denfants Chru de Nancy Vandoeuvre Les Nancy Cedex, France, 54511 Germany Krankenhaus Mara Ggmbh, Epilepsiezentrum Bethel Bielefeld, Germany, 33617 Universitätsklinikum Schleswig-Holstein, Klinik Für Neuropädiatrie Kiel, Germany, 24105 Kleinwachau Sächsisches Epilepsiezentrum Radeberg Gemeinnützige Gmbh Radeberg, Germany, 1454 Netherlands Kempenhaeghe Heeze, Netherlands, 5590 Ab Stichting Epilepsie Instellingen Nederland Zwolle, Netherlands, 8025 BV Spain Hospital Sant Joan de Déu Barcelona, Spain, 08950 Hospital Ruber Internacional Primera Planta Servicio de Neurologia Madrid, Spain, 28034 Clinica Universitaria de Navarra Pamplona, Spain, 31008 United Kingdom Institute of Neurosciences Queens Elizabeth University Glasgow, United Kingdom, G51 4TF Alder Hey Children'S Nhs Foundation Trust Liverpool, United Kingdom, L12 2AP Evelina Hospital London, United Kingdom, SE1 7EH Great Ormonnd Street Hospital For Children Nhs Foundation Trust London, United Kingdom, WC1N 3JH 收起 << |
NCT03481660 | Diabetic Macular Edema | Phase 3 | Recruiting | July 22, 2021 | - |
NCT02234141 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 2 | Completed | - | - |
NCT02269917 | - | Active, not recruiting | - | - | |
NCT02269917 | Human Immunodeficiency Virus T... 展开 >>ype 1 收起 << | Phase 3 | Active, not recruiting | March 31, 2020 | - |
NCT01437735 | Asthma | Phase 2 | Completed | - | - |
NCT01844505 | - | Active, not recruiting | - | - | |
NCT00105950 | Neoplasms, Breast | Phase 2 | Completed | - | - |
NCT01964430 | Pancreatic Neoplasms ... 展开 >> Digestive System Neoplasms Neoplasms by Site Neoplasms Endocrine Gland Neoplasms Pancreatic Diseases Digestive System Diseases Endocrine System Diseases Gemcitabine Antimetabolites, Antineoplastic 收起 << | Phase 3 | Active, not recruiting | February 15, 2019 | - |
NCT01254513 | Prostate Cancer | Phase 2 | Recruiting | October 2018 | France ... 展开 >> Clinique Claude Bernard Recruiting Albi, France, 81000 Contact: Philippe HOUYAU, Dr philippe.houyau@claude-bernard-albi.com Principal Investigator: Philippe HOUYAU CHI Annemasse-Bonneville Not yet recruiting Ambilly, France, 74100 Contact: Carol ALLIOT 04 50 87 40 37 calliot@chi-annemasse-bonneville.fr Principal Investigator: Carol ALLIOT Centre Paul Papin Recruiting Angers, France, 49933 Contact: Sophie ABADIE sophie.abadie-lacourtoisie@ico.unicancer.fr Principal Investigator: Sophie ABADIE CH de Blois Not yet recruiting Blois, France, 41016 Contact: Charles-Emmanuel GEFFROY 02 54 55 63 95 cegeffroy@ch-blois.fr Principal Investigator: Charles-Emmanuel GEFFROY Institut Bergonie Recruiting Bordeaux Cedex, France, 33076 Contact: Nadine HOUEDE, Dr houede@bergonie.org Principal Investigator: Nadine HOUEDE Centre Francois Baclesse Recruiting Caen, France, 14076 Contact: Emmanuel SEVIN, Dr e.sevin@baclesse.fr Principal Investigator: Emmanuel SEVIN CH Intercommunal Recruiting Castres, France, 81108 Contact: Corinne SARDA c-sarda@chic-cm.fr Principal Investigator: Corinne SARDA Centre Hospitalier de Chambery Not yet recruiting Chambery, France, 73011 Contact: Armelle DUFRESNES, Dr a.dufresne@hotmail.com Principal Investigator: Armelle DUFRESNES Centre Jean Perrin Recruiting Clermont-ferrand, France, 63011 Contact: Hakim MAHAMMEDI 04 73 27 80 80 hakim.mahammedi@cjp.fr Principal Investigator: Hakim MAHAMMEDI Clinique Sainte Marguerite Recruiting Hyeres, France, 83400 Contact: Jean-François BERDAH Principal Investigator: Jean-françois BERDAH Chd Vendee Recruiting La Roche Sur Yon, France, 85925 Contact: Frank PRIOU, Dr frank.priou@chd-vendee.fr Principal Investigator: Frank Priou Clinique Hartmann Recruiting Levallois-perret, France, 92300 Contact: Jean-Michel VANNETZEL, Dr jmvannetzel@i-o-h.org Principal Investigator: Jean-Michel VANNETZEL Centre Oscar Lambret Not yet recruiting Lille, France, 59020 Contact: Armelle CATY Principal Investigator: Armelle Caty Hôpital Saint Vincent de Paul Not yet recruiting Lille, France, 59020 Contact: Christophe DESAUW desauw.christophe@ghicl.net Principal Investigator: Christophe DESAUW Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Aude FLECHON Principal Investigator: Aude FLECHON Institut Paoli Calmettes Recruiting Marseille, France, 13273 Contact: Gwenaëlle GRAVIS-MESCAM, Dr gravisg@marseille.fnclcc.fr Principal Investigator: Gwenaëlle GRAVIS-MESCAM CHU Nimes Recruiting Nimes, France, 30000 Contact: Mounira EL DEMERY 04 66 68 43 77 mounia.eldemery@chu-nimes.fr Principal Investigator: Mounira EL DEMERY Chr Orleans Recruiting Orleans, France, 45100 Contact: Jérôme MEUNIER, Dr jerome.meunier@chr-orleans.fr Principal Investigator: Jérôme Meunier Institut Curie/Claudius Regaud Not yet recruiting Paris, France, 75005 Contact: Philippe BEUZEBOC Principal Investigator: Philippe BEUZEBOC Centre Hospitalier Lyon Sud Recruiting Pierre-benite, France Principal Investigator: Claire FALANDRY Centre Hospitalier de La Region D'Annecy Recruiting Pringy Cedex, France, 74374 Contact: Laetitia STEFANI, Dr lstefani@ch-annecy.fr Principal Investigator: Laetitia STEFANI Polyclinique Francheville Recruiting Périgueux, France, 24000 Contact: Laurent CANY 05 53 02 13 32 l.cany@oncoradio24.com Principal Investigator: Laurent CANY Institut Curie - Centre Rene Huguenin Not yet recruiting Saint-cloud, France, 92210 Contact: Alain GOUPIL, Dr alain.goupil@curie.net Principal Investigator: Alain GOUPIL Ico - Centre Rene Gauducheau Recruiting Saint-herblain Cedex, France, 44885 Contact: Emmanuelle BOMPAS, Dr e-bompas@nantes.fnclcc.fr Principal Investigator: Emmanuelle BOMPAS CH de Senlis Recruiting Senlis, France, 60300 Contact: Elisabeth CAROLA elisabeth.carola@ch-senlis.fr Principal Investigator: Elisabeth CAROLA Centre Paul Strauss Not yet recruiting Strasbourg, France, 67065 Contact: Christian BOREL, Dr cborel@strasbourg.fnclcc.fr Principal Investigator: Christian Borel Hôpitaux du Léman Recruiting Thonon-les-bains, France, 74200 Contact: Francesco DEL PIANO Principal Investigator: Francesco DEL PIANO Institut Claudius Regaud Recruiting Toulouse, France, 31052 Contact: Loïc MOUREY 05 61 42 41 74 loic.mourey@claudiusregaud.fr Principal Investigator: Loic Mourey Polyclinique Du Parc Recruiting Toulouse, France, 31078 Contact: Igor LATORZEFF, Dr i.latorzeff@clinique-pasteur.com Principal Investigator: Igor LATORZEFF Clinique Saint Jean du Languedoc Not yet recruiting Toulouse, France, 31400 Contact: Etienne SUC esucsjl@club-internet.fr Principal Investigator: Etienne SUC Clinique Pasteur Recruiting Toulouse, France Principal Investigator: Igor LATORZEFF 收起 << |
NCT02105636 | Squamous Cell Carcinoma of the... 展开 >> Head and Neck 收起 << | Phase 3 | Active, not recruiting | October 27, 2020 | - |
NCT01271712 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 3 | Active, not recruiting | May 31, 2019 | - |
NCT01271712 | - | Active, not recruiting | - | - | |
NCT02105636 | - | Active, not recruiting | - | - | |
NCT01484496 | Systemic Lupus Erythematosus | Phase 3 | Completed | - | - |
NCT01844505 | Unresectable or Metastatic Mel... 展开 >>anoma 收起 << | Phase 3 | Active, not recruiting | March 31, 2019 | - |
NCT01297491 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT01484496 | - | Completed | - | - | |
NCT01896102 | Cerebral Adrenoleukodystrophy ... 展开 >>(CALD) 收起 << | Phase 2 Phase 3 | Active, not recruiting | December 2021 | United States, California ... 展开 >> Mattel Children's Hospital UCLA/Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Boston Children's Hospital/Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 France Hôpital Bicêtre Le Kremlin-Bicêtre Cedex, France, 94275 United Kingdom Great Ormond Street Hospital for Children NHS Foundation Trust London, United Kingdom, WC1N3JH 收起 << |
NCT01297491 | - | Completed | - | - | |
NCT01785849 | Hyperparathyroidism, Secondary | Phase 3 | Completed | - | - |
NCT01261273 | - | Unknown | April 2017 | - | |
NCT02364999 | Non-Small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT01275222 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 1 Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York College of Physicians & Surgeons of Columbia University New York, New York, United States, 10032 United States, Pennsylvania Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Belgium Novarts Investigative Site Edegem, Belgium, 2650 Novarts Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux Cedex, France, 33076 Novartis Investigative Site Lille Cedex, France, 59020 Novartis Investigative Site Lyon Cedex 08, France, 69373 Novartis Investigative Site Marseille, France, 13005 Novartis Investigative Site Villejuif, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Koln, Germany, 50973 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Tubingen, Germany, 72076 收起 << |
NCT00143455 | Small Cell Lung Carcinoma | Phase 3 | Completed | - | - |
NCT01788046 | Hyperparathyroidism, Secondary | Phase 3 | Completed | - | - |
NCT01785849 | - | Completed | - | - | |
NCT01788046 | - | Completed | - | - | |
NCT00251979 | Gastrointestinal Hemorrhage | Phase 3 | Completed | - | - |
NCT00143455 | - | Completed | - | - | |
NCT02638948 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT02364999 | - | Completed | - | - | |
NCT01197508 | Major Depressive Disorder | Phase 3 | Completed | - | - |
NCT00251979 | - | Completed | - | - | |
NCT02600364 | - | Recruiting | December 2019 | - | |
NCT01500720 | Small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT00250640 | - | Completed | - | - | |
NCT01197508 | - | Completed | - | - | |
NCT00185315 | Hypertension, Pulmonary | Phase 3 | Completed | - | Belgium ... 展开 >> Bruxelles, Belgium, 1070 Leuven, Belgium, 3000 France Clamart Cedex, France, 92141 Grenoble Cedex 9, France, 38043 Lille, France, 59037 Reims, France, 51092 Tours Cedex, France, 37044 Italy Bologna, BO, Italy, 40138 Montescano, Pavia, Italy, 27040 Pisa, PI, Italy, 56100 Netherlands Amsterdam, Netherlands, 1081 HV Poland Warszawa, Poland, 01138 Portugal Coimbra, Portugal, 3000-076 Vila Nova de Gaia, Portugal, 4434-506 Spain Barcelona, Spain, 08035 Madrid, Spain, 28041 收起 << |
NCT00329628 | Venous Thromboembolism | Phase 3 | Completed | - | - |
NCT01227902 | - | Completed | - | - | |
NCT02366195 | Unresected Stage IIIb to IVM1c... 展开 >> Melanoma 收起 << | Phase 2 | Active, not recruiting | March 29, 2019 | - |
NCT01964443 | - | Completed | - | - | |
NCT02366195 | - | Active, not recruiting | - | - | |
NCT02352753 | Osteogenesis Imperfecta | Phase 3 | Recruiting | January 31, 2022 | - |
NCT01500720 | - | Completed | - | - | |
NCT02738151 | - | Completed | - | - | |
NCT02020889 | Churg-Strauss Syndrome | Phase 3 | Completed | - | - |
NCT02006641 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT02738151 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT02020889 | - | Completed | - | - | |
NCT02686346 | Hodgkin Disease | Phase 1 Phase 2 | Active, not recruiting | July 2021 | Belgium ... 展开 >> Clinique Universitaire Saint-Luc Bruxelles, Belgium, 1200 CHU Dinant Godinne Yvoir, Belgium, 5530 France Institut d'Hématologie de Basse Normandie - CHU Côte de Nacre Caen, France, 14033 APHP-Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon - Hôpital le Bocage Dijon, France, 21000 CHRU Lille - Hôpital Claude Huriez Lille, France, 59037 Centre Léon Bérard Lyon, France, 69373 CHU Saint Eloi Montpellier, France, 34295 CHU De Nantes Nantes, France, 44093 APHP - Hôpital Saint Louis PARIS Cedex 10, France, 75475 Hôpital Necker Paris, France, 75015 CHU Lyon Sud Pierre Bénite Cedex, France, 69495 CHU de Poitiers - Hôpital de La Milétrie Poitiers, France, 86021 CHU De Rennes Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76000 CHU De Strasbourg Strasbourg, France, 67098 IUCT Toulouse Toulouse, France, 31100 CHU De Nancy - Hôpital Brabois Vandœuvre-lès-Nancy, France, 54511 Institut Gustave Roussy VILLEJUIF Cedex, France, 94085 收起 << |
NCT00410072 | Hepatitis B, Chronic | Phase 3 | Completed | - | - |
NCT01227902 | Epilepsy | Phase 3 | Completed | - | - |
NCT00361894 | Prevention Ve... 展开 >>nous Thromboembolism 收起 << | Phase 3 | Completed | - | - |
NCT02034916 | Breast Neoplasms ... 展开 >> BRCA 1 Gene Mutation BRCA 2 Gene Mutation 收起 << | Phase 2 | Completed | - | - |
NCT02006641 | - | Completed | - | - | |
NCT02108262 | Acute Myocardial Infarction | Phase 2 | Completed | - | - |
NCT02319031 | - | Completed | - | - | |
NCT01718158 | Hepatitis C | Phase 3 | Completed | - | - |
NCT00410072 | - | Completed | - | - | |
NCT02319031 | Hepatitis C | Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Local Institution Darlinghurst, New South Wales, Australia, 2010 Australia, Queensland Local Institution Greenslopes, Queensland, Australia, 4120 Australia, South Australia Local Institution Adelaide, South Australia, Australia, 5000 Australia, Victoria Local Institution Clayton, Victoria, Australia, 3168 Local Institution Fitzroy, Victoria, Australia, 3065 Local Institution Heidelberg, Victoria, Australia, 3084 France Local Institution Creteil Cedex, France, 94010 Local Institution Grenoble Cedex 09, France, 38043 Local Institution Paris Cedex 14, France, 75679 Local Institution Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT02034916 | - | Completed | - | - | |
NCT02990338 | Plasma Cell Myeloma | Phase 3 | Active, not recruiting | November 23, 2020 | - |
NCT02825251 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT02754141 | Malignant Solid Tumor | Phase 1 Phase 2 | Recruiting | May 21, 2020 | United States, Maryland ... 展开 >> Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Dung Le, Site 0001 443-287-0002 United States, Massachusetts Local Institution Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Site 0022 United States, New York Roswell Park Cancer Institute Active, not recruiting Buffalo, New York, United States, 14263 Columbia University Medical Center (Cumc) Recruiting New York, New York, United States, 10032 Contact: Richard Carvajal, Site 0005 United States, Pennsylvania Local Institution Not yet recruiting Pittsburgh, Pennsylvania, United States, 15232-1305 Contact: Site 0020 United States, Tennessee Tennessee Oncology, PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact: Howard Burris, Site 0004 615-329-7274 United States, Texas Mary Crowley Medical Research Center Recruiting Dallas, Texas, United States, 75230 Contact: James Strauss, Site 0009 214-658-1965 Australia, New South Wales The Kinghorn Cancer Centre Recruiting Darlinghurst, New South Wales, Australia, 2010 Contact: Anthony Joshua, Site 0017 Scientia Clinical Research Limited Recruiting Randwick, New South Wales, Australia, 2031 Contact: Charlotte Lemech, Site 0019 +61293825800 Australia, Victoria Local Institution Recruiting Melbourne, Victoria, Australia, 3004 Contact: Site 0018 Canada, Ontario Local Institution Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Site 0003 Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 1Z5 Contact: Lillian Siu, Site 0002 4169462911 Canada, Quebec Local Institution Not yet recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Site 0014 France Local Institution Recruiting Marseille Cedex 5, France, 13385 Contact: Site 0021 Local Institution Recruiting Toulouse Cedex 9, France, 31059 Contact: Site 0008 Local Institution Recruiting Villejuif Cedex, France, 94805 Contact: Site 0007 Germany Local Institution Withdrawn Freiburg, Germany Klinikum rechts der Isar der Technischen Universitat Muenchen Klinik und Poliklinik fur Innere Mediz Recruiting Munich, Germany, 81675 Contact: Sylvie Lorenzen, Site 0015 +498941405145 Italy Local Institution Recruiting Napoli, Italy, 80131 Contact: Site 0012 Local Institution Recruiting Padova, Italy, Padova Contact: Site 0013 Netherlands Local Institution Recruiting Amsterdam, Netherlands, 1066 CX Contact: Site 0006 收起 << |
NCT02201108 | Multiple Sclerosis | Phase 3 | Active, not recruiting | September 2021 | - |
NCT01659021 | Chronic Lymphocytic Leukemia | Phase 3 | Completed | - | - |
NCT02825251 | - | Completed | - | - | |
NCT01344447 | Carotid Stenosis | Phase 3 | Completed | - | - |
NCT01698905 | Chronic Myeloid Leukemia | Phase 2 | Active, not recruiting | February 6, 2025 | - |
NCT01659021 | - | Completed | - | - | |
NCT01987960 | - | Terminated(The study was termi... 展开 >>nated due to challenges with patient eligibility; the decision to terminate was not based on any safety concerns) 收起 << | - | - | |
NCT02016534 | Stomach Neoplasms | Phase 2 | Terminated(Amgen decision foll... 展开 >>owing interim review of efficacy and safety data from the AMG 337 program.) 收起 << | - | - |
NCT02600819 | HIV-1 Infection | Phase 3 | Active, not recruiting | July 2019 | United States, California ... 展开 >> Peter J Ruane MD Inc Los Angeles, California, United States University of California Davis Sacramento, California, United States United States, Florida Midway Immunology & Research Center, LLC Fort Pierce, Florida, United States Infectious Disease Consultants, M.D., P.A. d/b/a Orlando Immunology Center Orlando, Florida, United States Triple O Research Institute PA West Palm Beach, Florida, United States United States, Georgia Medical College of Georgia Augusta, Georgia, United States Infectious Disease Specialists of Atlanta Decatur, Georgia, United States Mercer University School of Medicine Macon, Georgia, United States United States, Massachusetts The Research Institute Springfield, Massachusetts, United States United States, Michigan Henry Ford Health System Detroit, Michigan, United States United States, New Jersey Prime Health Care Services - St Michael's LLC d/b/a Saint Michael's Medical Center Newark, New Jersey, United States United States, North Carolina University of North Carolina at Chapel Hill / UNC School of Medicine Chapel Hill, North Carolina, United States Duke University Durham, North Carolina, United States Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States United States, Ohio University of Cincinnati Med Center Cincinnati, Ohio, United States MetroHealth Medical Center IRB Cleveland, Ohio, United States United States, Texas North Texas Infectious Diseases Consultants Dallas, Texas, United States Trinity Health and Wellness Center Fort Worth, Texas, United States Gordon E. Crofoot MD PA Houston, Texas, United States Austria Otto Wagner Spital Wien, Austria France Hopital Henri Mondor Creteil, France CHU de Nice-l Archet NICE Cedex 03, France Hopital Saint Louis Paris Cedex 10, France Hopital Bichat-Claude Bernard Paris, France Centre Hospitalier de Tourcoing Tourcoing Cedex, France Germany Klinikum rechts der Isar, TUM Munchen, Germany 收起 << |
NCT01813422 | - | Completed | - | - | |
NCT01344447 | - | Completed | - | - | |
NCT01987960 | Post-traumatic Stress Disorder... 展开 >> PTSD 收起 << | Phase 3 | Terminated(The study was termi... 展开 >>nated due to challenges with patient eligibility; the decision to terminate was not based on any safety concerns) 收起 << | - | - |
NCT02600819 | - | Active, not recruiting | - | - | |
NCT01416181 | Secondary Progressive Multiple... 展开 >> Sclerosis 收起 << | Phase 3 | Terminated(The ASCEND Study di... 展开 >>d not achieve statistical significance on the primary or secondary endpoints.) 收起 << | - | - |
NCT01813422 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00558103 | Neoplasms, Breast | Phase 2 | Completed | - | - |
NCT00558103 | - | Completed | - | - | |
NCT02017717 | Recurrent Glioblastoma | Phase 3 | Active, not recruiting | October 26, 2018 | - |
NCT01973504 | Trauma Hemorr... 展开 >>hagic Shock Lactic Acidosis 收起 << | Phase 2 | Withdrawn(Sangart ceased opera... 展开 >>tions) 收起 << | March 2016 | - |
NCT01964235 | Advanced Hepatocellular Carcin... 展开 >>oma 收起 << | Phase 2 | Withdrawn(Study was cancelled ... 展开 >>by Sponsor.) 收起 << | July 2019 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Mass General Hospital Boston, Massachusetts, United States, 02115 United States, Missouri Research Medical Center Onc Dept Kansas City, Missouri, United States, 64132 Australia, New South Wales Novartis Investigative Site Kogarah, New South Wales, Australia, 2217 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 France Novartis Investigative Site Clichy, France, 92110 Novartis Investigative Site LILLE Cedex, France, 59037 Novartis Investigative Site Montpellier Cedex 5, France, 34298 Novartis Investigative Site Nice Cedex 3, France, 06202 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Würzburg, Germany, 97080 Hong Kong Novartis Investigative Site Hong Kong SAR, Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Spain Novartis Investigative Site Cordoba, Andalucia, Spain, 14004 Switzerland Novartis Investigative Site Bern, Switzerland, 3010 Novartis Investigative Site Genève, Switzerland, 1211 收起 << |
NCT01536418 | Crohn's Disease | Phase 3 | Terminated | - | - |
NCT01416181 | - | Terminated(The ASCEND Study di... 展开 >>d not achieve statistical significance on the primary or secondary endpoints.) 收起 << | - | - | |
NCT02551861 | Hepatitis C | Phase 2 | Withdrawn | June 2017 | Canada, Alberta ... 展开 >> Local Institution Calgary, Alberta, Canada, T2N 4Z6 Local Institution Edmonton, Alberta, Canada, T6G 2S2 Canada, British Columbia Local Institution Vancouver, British Columbia, Canada, V5Z 1H2 Local Institution Vancouver, British Columbia, Canada, V6Z 2K5 Local Institution Victoria, British Columbia, Canada, V8V 3P9 Canada, Ontario Local Institution Toronto, Ontario, Canada, M5G 2C4 France Local Institution Creteil Cedex, France, 94010 Local Institution Limoges, France, 87042 Local Institution Montpellier Cedex 5, France, 34295 Local Institution Paris Cedex 14, France, 75679 Local Institution Pessac, France, 33604 Local Institution Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT01674647 | - | Completed | - | - | |
NCT00387088 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT01674647 | Atrial Fibrillation | Phase 3 | Completed | - | - |
NCT01536418 | - | Terminated | - | - | |
NCT01750281 | Locally Advanced or Metastatic... 展开 >> Non Small Cell Lung Cancer Stage IIIb - IV 收起 << | Phase 2 | Active, not recruiting | December 31, 2018 | - |
NCT02428686 | Myelodysplastic Syndromes | Phase 2 | Completed | - | France ... 展开 >> CHU de Bicêtre Le Kremlin-Bicêtre, Ile de France, France, 94275 CHU d'AMIENS Amiens, France, 80054 CH Angers Angers, France, 49 000 CH d'Avignon-305 rue Follereau- Avignon, France, 84000 Hopital de la Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93 000 Hôpital Boulogne Sur Mer Boulogne Sur Mer, France, 62321 CHU de Brest Brest, France, 29609 CHU Clémenceau Caen, France, 14033 CH René Dubos Cergy-pontoise, France, 95303 Centre Hospitalier du Mans Le Mans cedex, France, 72037 CHRU Huriez Lille, France, 59037 Hopital Saint-Vincent de Paul- Lille, France, 59160 CHRU de Limoges Limoges, France, 87046 centre hospitalier de Mantes-la-jolie Mantes-la-jolie, France, 78201 Institut Paoli Calmette Marseille, France, 13273 CHU Brabois Nancy, France, 54511 Hematology Dpt, Hopital de l'Hotel Dieu Nantes, France, 44093 Hôpital Américain de Paris Neuilly Sur Seine, France, 92200 CHU Archet Nice, France, 06202 Hôpital La Source Orléans, France, 45067 Hôpital Saint-Antoine. Paris-Cedex 12, France, 75571 Hôpital Saint Louis Paris, France, 75475 Hopital Cochin Paris, France, 75679 Hôpital Jean Bernard Poitiers, France, 86021 Centre Hospitalier de la région d'Annecy Pringy cedex, France, 74374 CHU de Reims Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Centre Hospitalier Universitaire de STRASBOURG Strasbourg, France, 67098 Chu Purpan Toulouse, France, 31059 Hopital Bretonneau Tours, France, 37044 收起 << |
NCT02782663 | Crohn's Disease (CD) | Phase 2 | Active, not recruiting | August 23, 2025 | - |
NCT00807859 | Breast Cancer ... 展开 >> Breast Neoplasms Breast Tumors Cancer Locally Recurrent and Metastatic Breast Cancer Metastases Metastatic Cancer Oncology Solid Tumors Tumors 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Research Site Tucson, Arizona, United States, 85724 United States, Florida Research Site Boca Raton, Florida, United States, 33428 United States, Iowa Research Site Iowa City, Iowa, United States, 52242 United States, Massachusetts Research Site Boston, Massachusetts, United States, 02111 United States, Minnesota Research Site Minneapolis, Minnesota, United States, 55407 United States, New Hampshire Research Site Lebanon, New Hampshire, United States, 03756-0001 Research Site Lebanon, New Hampshire, United States, 03756 United States, New Mexico Research Site Albuquerque, New Mexico, United States, 87131 United States, New York Research Site Great Neck, New York, United States, 11021 Research Site New City, New York, United States, 10956 Research Site New York, New York, United States, 10032 Research Site Nyack, New York, United States, 10960 United States, Ohio Research Site Middletown, Ohio, United States, 45042 Belgium Research Site Leuven, Belgium, 3000 Research Site Liege, Belgium, 4000 Research Site Wilrijk, Belgium, 2610 France Research Site Bordeaux, France, 33075 Research Site Caen Cedex 05, France, 14076 Research Site La Roche Sur Yon Cedex 9, France, 85925 Research Site Marseille, France, 13009 Research Site Nantes Cedex 2, France, 44202 Research Site Pierre Bénite Cedex, France, 69495 Research Site Toulouse, France, 31052 收起 << |
NCT01507831 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00387088 | - | Completed | - | - | |
NCT01920477 | Pemphigus | Phase 3 | Completed | - | - |
NCT01744561 | Cystic Fibrosis | Not Applicable | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-1212 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 Austria Mukoviszidose-Ambulanz, Universitätsklinik für Kinder- und Jugendheilkunde, Graz, Austria, 8036 Cystische Fibrose Zentrum für Kinder, Jugendliche und Erwachsene Innsbruck, Austria, 6020 Canada, Quebec Montreal Children's Hospital, McGill University Health Centre - Glen Site Monrtreal, Quebec, Canada, H4A 3J1 France Hôpital Renée Sabran, Service : Maladies respiratoires Hyeres, France, 83406 Hôpital Calmette, Service Pneumologie-immuno-allergologie boulevard du Pr Leclercq Lille cedex, France, 59037 Hôpital Jeanne de Flandre, Service: Pneumologie et allergologie pédiatriques Lille cedex, France, 59037 Hôpital Arnaud de Villeneuve, Service: Maladies respiratoires Montpellier cedex 5, France, 34295 Hôpital Necker, Service : Pneumologie et allergologie pédiatriques Paris, France, 75015 Hôpital Maison Blanche, Service : Maladies respiratoires Reims, France, 51092 Germany Olgahospital, Klinikum Stuttgart Stuttgart, Baden-Württemberg, Germany, 70174 Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen Tübingen, Baden-Württemberg, Germany, 72076 Children´s Hospital of the University Würzburg, Bavaria, Germany, 97080 Pediatric Pulmonology and CF centre, Children´s Hospital, Ruhr University Bochum, Germany, 44791 Klinik und Poliklinik für Kinderheilkunde - Universitäts-Mukoviszidose-Centrum Dresden, Germany, 01307 Christiane Herzog CF-Zentrum, Goethe Universität Frankfurt, Germany, 60323 CF Zentrum Hamburg-Altona, Kinderarztpraxis Runge, Sextro,Held Hamburg, Germany, 22763 CF- Ambulanz, Kinderklinik, Pädiatrische Pneumologie, Allergologie und Neonatologie Hannover, Germany, 30625 Zentrum für Kinder- und Jugendmedizin, Pädiatrische Pneumologie, Allergologie und Mukoviszidose Mainz, Germany, 55101 Praxis für Lungen- und Bronchialheilkunde Munich, Germany, 81241 Klinik für Kinder- und Jugendmedizin / Universitätsklinikum Münster, Germany, 48149 Netherlands University Medical Center, Child Development & Exercise Center, Wilhelmina Children's Hospital Utrecht, Netherlands Switzerland QuartierBleu, Praxis für Pneumologie am Lindenhofspital Bern, Switzerland, 3001 Inselspital, Universitätsklinik für Kinderheilkunde, Pneumologie Bern, Switzerland Kinderspital, Pneumologie Zurich, Switzerland, 8032 UniversitätsSpital, Klinik für Pneumologie Zurich, Switzerland, 8091 United Kingdom Royal Hospital for Sick Children Edinburgh, Scottland, United Kingdom, EH9 1LF 收起 << |
NCT02138838 | Chronic Kidney Disease, Second... 展开 >>ary Hyperparathyroidism 收起 << | Phase 3 | Terminated(Sponsor decision) | - | - |
NCT02138838 | - | Terminated(Sponsor decision) | - | - | |
NCT03098550 | Advanced Cancer | Phase 1 Phase 2 | Active, not recruiting | August 30, 2020 | United States, California ... 展开 >> Pacific Shores Medical Group Huntington Beach, California, United States, 92648 United States, Colorado University Of Colorado Aurora, Colorado, United States, 80045 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Michigan University Of Michigan Ann Arbor, Michigan, United States, 48109-5247 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 Australia, New South Wales Local Institution St Leonards, New South Wales, Australia, 2065 Canada Local Institution Edmonton, Canada, T6G 1Z2 France Local Institution Lyon Cedex 08, France, 69373 Local Institution Marseille Cedex 9, France, 13273 Local Institution Strasbourg Cedex, France, 67085 Germany Universitaetsklinikum Carl Gustav Carus Dresden, Germany, 01307 Medizinische Universitaetsklinik Freiburg Freiburg, Germany, 79106 Universitaetsklinik Heidelberg Heidelberg, Germany, 69120 Italy Local Institution Milano, Italy, 20132 Local Institution Napoli, Italy, 80131 Puerto Rico Fundacion De Investigacion San Juan, Puerto Rico, 00927 Spain Hospital Gral. Univ. Gregorio Maranon Madrid, Spain, 28007 Local Institution Majadahonda - Madrid, Spain, 28222 Switzerland Klinik Fur Onkologie Basel, Switzerland, 4031 University Hospital of Lausanne Lausanne, Switzerland, 1011 收起 << |
NCT00050141 | Breast Cancer | Phase 2 | Completed | - | United States, Florida ... 展开 >> Miami, Florida, United States United States, Illinois Chicago, Illinois, United States United States, North Carolina Durham, North Carolina, United States United States, Ohio Cleveland, Ohio, United States United States, Texas Fort Worth, Texas, United States Tyler, Texas, United States Belgium Brussel, Belgium Leuven, Belgium France Bordeaux Cedex, France Clermont Ferrand Cedex 1, France Montpellier Cedex 5 N/A, France Rennes Cedex, France Saint Herblain, France Vandoeuvre Les Nancy, France Netherlands Den Haag, Netherlands Russian Federation Moscow N/A, Russian Federation Moscow, Russian Federation St Petersburg N/A, Russian Federation St Petersburg, Russian Federation United Kingdom Huddersfield, United Kingdom Leeds, United Kingdom London, United Kingdom Manchester, United Kingdom Newcastle Upon Tyne, United Kingdom Sutton, United Kingdom 收起 << |
NCT02854436 | Prostatic Neoplasms | Phase 2 | Recruiting | June 2021 | - |
NCT02261220 | Advanced Solid Tumors | Phase 1 | Active, not recruiting | September 9, 2019 | - |
NCT01750281 | - | Active, not recruiting | - | - | |
NCT02714218 | Melanoma | Phase 3 | Active, not recruiting | April 15, 2022 | - |
NCT01619085 | Idiopathic Pulmonary Fibrosis | Phase 3 | Active, not recruiting | March 4, 2019 | - |
NCT01910987 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00678587 | Non-alcoholic Steatohepatitis ... 展开 >> Chronic Liver Disease HCV NASH - Nonalcoholic Steatohepatitis HIV Infection Thrombocytopenia Hepatitis C Virus HBV Human Immunodeficiency Virus Liver Diseases Hepatitis B Virus 收起 << | Phase 3 | Terminated(GSK decision) | - | - |
NCT00668070 | Non-Alcoholic Steatohepatitis | Phase 2 | Completed | - | Belgium ... 展开 >> Antwerp, Belgium, 2650 Brussels, Belgium, 1200 Gent, Belgium, 9000 La Louviere, Belgium, 7100 Leuven, Belgium, 3000 Czech Republic Brno-Bohunice, Czech Republic, 62500 Prague, Czech Republic, 18000 Praha, Czech Republic, 14021 France Amiens Cedex 1, France Angers cedex 9, France, 49933 Montpellier cedex 5, France, 34295 Paris Cedex 13, France, 75651 Paris, France, 75571 Pessac, France, 33604 Germany Berlin, Germany, 13353 Essen, Germany, 45122 Frankfurt am Main, Germany, 60590 Mainz, Germany, 55101 Regensburg, Germany, 93042 Romania Bucharest, Romania, 021105 Bucharest, Romania, 022328 Iasi, Romania, 700111 Timisoara, Romania, 300736 Switzerland Basel, Switzerland, 4031 Bern, Switzerland, 3010 Zurich, Switzerland, 8091 United Kingdom Birmingham, United Kingdom London, United Kingdom Newcastle upon Tyne, United Kingdom, NE77DN Nottingham, United Kingdom, NG77DN 收起 << |
NCT01507831 | - | Completed | - | - | |
NCT02000947 | NSCLC Non-sma... 展开 >>ll Cell Lung Cancer Lung Cancer 收起 << | Phase 1 Phase 2 | Active, not recruiting | April 24, 2019 | - |
NCT01619085 | - | Active, not recruiting | - | - | |
NCT02494778 | Huntington's Disease | Phase 2 | Terminated(This study served i... 展开 >>ts purpose in providing considerable safety data. The decision to terminate the studies was not based on any new or emerging safety concern.) 收起 << | - | - |
NCT01844986 | Newly Diagnosed ... 展开 >> Advanced Ovarian Cancer FIGO Stage III-IV BRCA Mutation Complete Response Partial Response First Line Platinum Chemotherapy 收起 << | Phase 3 | Active, not recruiting | June 6, 2023 | - |
NCT02101268 | Primary Myelofibrosis (PMF) ... 展开 >> Post-polycythemia Vera (Post-PV) Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) 收起 << | Phase 3 | Active, not recruiting | March 2019 | - |
NCT02106546 | Squamous Non-Small Cell Lung C... 展开 >>ancer 收起 << | Phase 3 | Active, not recruiting | July 15, 2019 | - |
NCT01951638 | Heart Failure | Phase 2 | Completed | - | - |
NCT00678587 | - | Terminated(GSK decision) | - | - | |
NCT01578655 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT00796445 | Melanoma | Phase 3 | Terminated(The study was termi... 展开 >>nated early following assessment of the two co-primary endpoints showing the lack of efficacy of the study product.) 收起 << | - | - |
NCT00215592 | Epilepsy | Phase 4 | Completed | - | Austria ... 展开 >> Universitatsklinikum fur Neurologie Innsbruck, Austria, 6020 Denmark Danish Epilepsy Center Dianalund, Denmark, 4293 The Epilepsy Clinic Glostrup, Denmark, 2600 France Centre Hospitalier d'Annecy Annecy cedex, France, 74011 CH Germon et Gauthier Bethune, France, 62408 Hopital Pellegrin Tripode Bordeaux cedex, France, 33076 Hopital Gabriel Montpied Clermont-Ferrand Cedex 1, France, 63003 Hopital General Dijon, France, 21033 Hopital Victor Jousselin Dreux, France, 28102 Cabinet de neurologie Gap, France, 05000 Hopital de la Timone Adultes Marseille, France, 13385 Groupe hospitalier Pitie Salpetriere Paris, France, 75651 Hopital de Font Pre Toulon cedex, France, 83056 CHU Bretonneau Tours Cedex, France, 37044 Germany Universitatsklinikum Campus Virchow-Klinikum Wedding Berlin, Germany, 13353 Epilepsieklinik Tabor Bernau b. Berlin, Germany, 16321 Universitat Freiburg Freiburg, Germany, 79106 Epilepsiezentrum Kork Kehl-Kork, Germany, 77694 Arzneimittelforschung Leipzig GmbH Leipzig, Germany, 04107 Klinik die Weissenau Revensburg, Germany, 88214 Italy Ospedale Riuniti di Bergamo Bergamo, Italy, 24128 Azienda Ospedaliero- Universitaria Policlinico di Catania Catania, Italy, 95125 Istituto Nazionale Neurologico Carlo Besta di Milano Milano, Italy, 20133 Azienda Ospedaliera San Paolo Milano, Italy, 20142 Universita di Parma Parma, Italy, 43100 Azienda Ospedaliera Bianchi-Melancrino-Morelli Reggio Calabria, Italy, 89100 Universita degli studi La Sapienza Roma, Italy, 00161 Universita degli Studi La Sapienza Roma, Italy, 00185 Norway Nevrologisk avdelning, 10 etasje Lillehammer, Norway, 2609 Sandvika Neurologpraksis Sandvika, Norway, 1338 Avd. for nevrologi og klinisk nevrofysiologi Trondheim, Norway, 7006 United Kingdom University Hospital of Wales Cardiff, United Kingdom, CF14 4XW University Hospital of North Staffordshire Royal Infirmary Stoke On Trent, United Kingdom, ST4 7LN 收起 << |
NCT03068455 | Melanoma | Phase 3 | Active, not recruiting | February 17, 2023 | - |
NCT01381809 | Myelodysplastic Syndromes | Phase 3 | Completed | - | Bulgaria ... 展开 >> Plovdiv, Bulgaria Sofia, Bulgaria Varna, Bulgaria France Amiens, France Angers Cedex 9, France Bobigny, France Colmar, France Paris Cedex 10, France Pessac Cedex, France Pierre Benite Cedex, France Saint Priest En Jarez, France Tours Cedex 9, France Vandoeuvre Les Nancy, France Germany Berlin, Germany Dresden, Germany Duisburg, Germany Düsseldorf, Germany Dÿsseldorf, Germany München, Germany Oldenburg, Germany Würzburg, Germany Greece Athens, Greece Goudi-Athens, Greece Larisa, Greece Patra, Greece Thessalonikis, Greece Russian Federation Ekaterinburg, Russian Federation St. Petersburg, Russian Federation 收起 << |
NCT03141177 | Renal Cell Carcinoma | Phase 3 | Recruiting | April 22, 2023 | - |
NCT00774345 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia 收起 << | Phase 3 | Active, not recruiting | October 27, 2020 | - |
NCT01474421 | Dyskinesias D... 展开 >>rug-induced 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Sacramento, California, United States, 95817 United States, New York Novartis Investigative Site Manhasset, New York, United States, 11030 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45219 Novartis Investigative Site Cleveland, Ohio, United States, 44195 France Novartis Investigative Site Bron, France, 69677 Novartis Investigative Site Clermont Fd, France, 63003 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Marseille cedex 05, France, 13385 Novartis Investigative Site Montpellier cedex 5, France, 34295 Novartis Investigative Site Nantes Cedex 1, France, 44093 Novartis Investigative Site Paris, France, 75013 Novartis Investigative Site Pessac, France, 33604 Novartis Investigative Site Poitiers, France, 86021 Novartis Investigative Site Strasbourg, France, 67098 Novartis Investigative Site Toulouse cedex 9, France, 31059 Germany Novartis Investigative Site Berlin, Germany, 10178 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Gera, Germany, 07551 Novartis Investigative Site Haag, Germany, 83527 Novartis Investigative Site Kassel, Germany, 34128 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muenchen, Germany, 80804 Novartis Investigative Site Tübingen, Germany, 72076 Italy Novartis Investigative Site Roma, RM, Italy, 00163 收起 << |
NCT02938520 | HIV Infections | Phase 2 Phase 3 | Active, not recruiting | July 7, 2022 | - |
NCT01526928 | Locally Advanced or Metastatic... 展开 >> Non Small Cell Lung Cancer 收起 << | Phase 1 Phase 2 | Active, not recruiting | August 31, 2019 | - |
NCT00596830 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00596830 | Carcinoma, Squamous Cell ... 展开 >> Carcinoma, Adenosquamous Carcinoma, Large Cell Carcinoma, Non-Small-Cell Lung 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01124786 | Metastatic Pancreatic Adenocar... 展开 >>cinoma 收起 << | Phase 2 | Completed | - | - |
NCT01587703 | Carcinoma, Midline | Phase 1 | Active, not recruiting | December 14, 2018 | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02215 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Australia, Victoria GSK Investigational Site Clayton, Victoria, Australia, 3168 Canada, Alberta GSK Investigational Site Edmonton, Alberta, Canada, T6G 1Z2 France GSK Investigational Site Bordeaux Cedex, France, 33076 GSK Investigational Site Lyon Cedex 08, France, 69373 GSK Investigational Site Paris Cedex 5, France, 75248 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 03080 GSK Investigational Site Seoul, Korea, Republic of, 03722 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1066 CX Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Málaga, Spain, 29010 United Kingdom GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 << |
NCT01124786 | - | Completed | - | - | |
NCT01752985 | Diabetic Kidney Disease | Phase 2 | Completed | - | - |
NCT00404768 | Obstetric Labour, Premature | Phase 2 | Completed | - | - |
NCT00404768 | - | Completed | - | - | |
NCT02349295 | - | Active, not recruiting | - | - | |
NCT02349295 | Psoriatic Arthritis | Phase 3 | Active, not recruiting | June 2019 | - |
NCT02525523 | Pouchitis | Phase 3 | Completed | - | - |
NCT01313676 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00409617 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT00409617 | - | Completed | - | - | |
NCT00613951 | - | Completed | - | - | |
NCT01313676 | - | Completed | - | - | |
NCT00613951 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 2 | Completed | - | Finland ... 展开 >> Novo Nordisk Investigational Site Helsinki, Finland, 00260 Novo Nordisk Investigational Site Kuopio, Finland, 70210 Novo Nordisk Investigational Site Lahti, Finland, 15110 Novo Nordisk Investigational Site Pori, Finland, FI-28100 France Novo Nordisk Investigational Site Bar-Le-Duc, France, 55000 Novo Nordisk Investigational Site GRENOBLE cedex, France, 38043 Novo Nordisk Investigational Site Hayange, France, 57700 Novo Nordisk Investigational Site LA ROCHELLE cedex, France, 17019 Novo Nordisk Investigational Site Nanterre, France, 92014 Novo Nordisk Investigational Site NEVERS cedex, France, 58033 Novo Nordisk Investigational Site Pointe à Pitre, France, 97159 Germany Novo Nordisk Investigational Site Berlin, Germany, 12163 Novo Nordisk Investigational Site Pirna, Germany, 01796 Novo Nordisk Investigational Site Riesa, Germany, 01587 Novo Nordisk Investigational Site Saarbrücken, Germany, 66121 Novo Nordisk Investigational Site St. Ingbert, Germany, 66386 Novo Nordisk Investigational Site Völklingen, Germany, 66333 Novo Nordisk Investigational Site Wangen, Germany, 88239 Poland Novo Nordisk Investigational Site Bydgoszcz, Poland, 85-822 Novo Nordisk Investigational Site Gniewkowo, Poland, 88-140 Novo Nordisk Investigational Site Nysa, Poland, 48-300 Novo Nordisk Investigational Site Plock, Poland, 09-400 Novo Nordisk Investigational Site Szczecin, Poland, 70-483 Novo Nordisk Investigational Site Tychy, Poland, 43-100 Novo Nordisk Investigational Site Warszawa, Poland, 02-507 Novo Nordisk Investigational Site Wroclaw, Poland, 50-127 Spain Novo Nordisk Investigational Site Almería, Spain, 04001 Novo Nordisk Investigational Site Barcelona, Spain, 08035 Novo Nordisk Investigational Site Granada, Spain, 18012 Novo Nordisk Investigational Site Madrid, Spain, 28034 Novo Nordisk Investigational Site San Juan, Spain, 03550 收起 << |
NCT01263886 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT01290406 | Endometrial Cancer | Phase 2 | Withdrawn | December 2017 | - |
NCT01360554 | - | Completed | - | - | |
NCT01437787 | Hematopoietic Neoplasm | Phase 3 | Completed | - | - |
NCT00861614 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT01360554 | Non-Small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT02312206 | Primary Systemic (AL) Amyloido... 展开 >>sis 收起 << | Phase 3 | Terminated(The NEOD001 program... 展开 >> was terminated due to lack of clinical benefit) 收起 << | - | - |
NCT01240421 | - | - | November 2014 | Belgium ... 展开 >> Brussels, Belgium Canada Edmonton, Canada London, Canada Moncton, Canada Montreal, Canada Ottawa, Canada Quebec, Canada Toronto, Canada Vancouver, Canada France Besancon, France Marseille Cedex 09, France Paris Cedex 05, France Saint-cloud, France Toulouse cedex, France 收起 << | |
NCT00861614 | - | Completed | - | - | |
NCT01021332 | Lower Urinary Tract Symptoms ... 展开 >> Benign Prostatic Hyperplasia 收起 << | Phase 3 | Completed | - | - |
NCT01029886 | - | Completed | - | - | |
NCT01021332 | - | Completed | - | - | |
NCT01261793 | Systemic Lupus Erythematosus | Phase 3 | Completed | - | - |
NCT00996216 | - | Completed | - | - | |
NCT00508157 | Metabolic Syndrome ... 展开 >> Schizophrenia 收起 << | Phase 4 | Terminated(Slow Accrual) | - | Belgium ... 展开 >> Local Institution Brussels, Belgium, 1160 Czech Republic Local Institution Brno, Czech Republic, 602 00 Local Institution Brno, Czech Republic, 625 00 Local Institution Havirov, Czech Republic, 736 01 Local Institution Hradec Kralove, Czech Republic, 500 05 Local Institution Prague, Czech Republic, 190 00 Local Institution Praha 10, Czech Republic, 100 00 Local Institution Praha 6, Czech Republic, 160 00 Local Institution Prerov, Czech Republic, 750 02 Local Institution Roudnice Nad Labem, Czech Republic, 41301 France Local Institution Fains Veel, France, 55000 Local Institution Lille Cedex, France, 59037 Local Institution Limoges Cedex, France, 87025 Local Institution Montpellier, France, 34295 Local Institution Paris Cedex 14, France, 75674 Local Institution Paris, France, 75013 Local Institution Poitiers, France, 86000 Local Institution Strasbourg, France, 67000 Germany Local Institution Ellwangen, Germany, 73479 Local Institution Werneck, Germany, 97440 Greece Local Institution Chania-Crete, Greece, 73300 Local Institution Corfu, Greece, 49100 Hungary Local Institution Budapest, Hungary, 1125 Local Institution Gyula, Hungary, 5700 Spain Local Institution Oviedo, Asturias, Spain, 33011 Local Institution Barcelona, Spain, 08025 Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08907 Switzerland Local Institution Wetzikon, Switzerland, 8620 Turkey Local Institution Izmir, Turkey, 35370 收起 << |
NCT01029886 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00508157 | - | Terminated(Slow Accrual) | - | - | |
NCT00996216 | Hepatitis C | Phase 3 | Completed | - | - |
NCT00890825 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT00890825 | - | Completed | - | - | |
NCT01261793 | - | Completed | - | - | |
NCT00986154 | Venous Thromboembolism ... 展开 >> Deep Vein Thrombosis (DVT) Pulmonary Embolism (PE) Thromboembolism Venous Thrombosis 收起 << | Phase 3 | Completed | - | - |
NCT00955409 | Alzheimer Disease | Phase 2 | Completed | - | France ... 展开 >> Pfizer Investigational Site Bordeaux, France, 33076 Pfizer Investigational Site Lille, France, 59037 Pfizer Investigational Site Marseille cedex 5, France, 13385 Pfizer Investigational Site Paris Cedex 13, France, 75651 Pfizer Investigational Site Paris, France, 75013 Pfizer Investigational Site Toulouse cedex 9, France, 31059 Germany Pfizer Investigational Site Berlin, Germany, 14050 Pfizer Investigational Site Bonn, Germany, 48129 Pfizer Investigational Site Bonn, Germany, 53127 Pfizer Investigational Site Freiburg, Germany, 79106 Pfizer Investigational Site Goettingen, Germany, 37075 Pfizer Investigational Site Mannheim, Germany, 68159 Pfizer Investigational Site Munich, Germany, 81675 Spain Pfizer Investigational Site Barcelona, Spain, 08003 Pfizer Investigational Site Barcelona, Spain, 08025 Pfizer Investigational Site Barcelona, Spain, 08036 收起 << |
NCT00516321 | Hepatitis C, Chronic | Phase 3 | Completed | - | - |
NCT00496938 | Coronary Artery Stenosis ... 展开 >> Coronary Arteriosclerosis Coronary Artery Disease Coronary Artery Restenosis Total Coronary Occlusion Stent Thrombosis Vascular Disease Myocardial Ischemia 收起 << | Phase 4 | Completed | - | - |
NCT01376310 | Cancer | Phase 2 | Completed | - | - |
NCT00986154 | - | Completed | - | - | |
NCT01383148 | Non-Small-Cell Lung Carcinoma | Phase 2 Phase 3 | Terminated | - | - |
NCT00516321 | - | Completed | - | - | |
NCT00430781 | - | Completed | - | - | |
NCT00430781 | Neoplasms, Uterine Cervix ... 展开 >> Metastatic Cervical Cancer 收起 << | Phase 2 | Completed | - | - |
NCT02391545 | CD20+ Follicular Lymphoma | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Los Angeles, California, United States, 90095 Palo Alto, California, United States, 94304 United States, New Jersey Hackensack, New Jersey, United States, 07601 United States, New York Rochester, New York, United States, 14642 United States, Texas Dallas, Texas, United States, 75246 Belgium Kortrijk, Belgium, 8000 Leuven, Belgium, 3000 Wilrijk, Belgium, 2610 France Clermont-Ferrand, France, 63003 Marseille Cedex 05, France, 13385 Pessac, France, 33600 Rouen Cedex 1, France, 76038 Tours Cedex 01, France, 37044 Italy Bologna, Italy, 40138 Varese, Italy, 21100 Spain Badalona, Barcelona, Spain, 8916 Barcelona, Spain, 8097 Madrid, Spain, 28222 Salamanca, Spain, 37007 United Kingdom Leeds, United Kingdom, LS9 7TF London, United Kingdom, NW1 1BU 收起 << |
NCT00998764 | Alzheimer Disease | Phase 3 | Terminated(The study was termi... 展开 >>nated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns.) 收起 << | - | - |
NCT00382031 | Head and Neck Cancer ... 展开 >> Squamous Cell Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00382031 | - | Completed | - | - | |
NCT01171976 | Diabetic Macular Edema | Phase 3 | Completed | - | - |
NCT01171976 | - | Completed | - | - | |
NCT00791778 | Ovarian Neoplasms | Phase 2 | Completed | - | - |
NCT00791778 | - | Completed | - | - | |
NCT02616783 | HIV-1 Infection | Phase 3 | Completed | - | Belgium ... 展开 >> CHU Saint-Pierre University Hospital Brussels, Belgium University Hospital Gent Ghent, Belgium France CHU - Groupe Saint-Andre Bordeaux, France CHU de Dijon Dijon, France Hopital Europeen Marseille Marseille, France C.H.U. de Nantes Nantes, France C.H.U. de NICE Nice, France Hopital Saint Louis Paris cedex 10, France Hopital Saint Antoine Paris cedex 12, France CHU Hotel Dieu Paris, France Hopital Necker les Enfants Malades Paris, France Hopital Haut-Leveque Pessac, Cedex, France Service des Maladies Infectieuses et du Voyageur Tourcoing, France Italy Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy Busto Arsizio Hospital Busto Arsizio, Italy IRCCS A.O.U. San Martino Genova, Italy Azienda Ospedaliera Luigi Sacco Milano, Italy Azienda Ospedaliero Universitaria Policlinico di Modena Modena, Italy U.O. Malattie Infettive Pescara, Italy Istituto Nazionale Malattie Infettive Lazzaro Spallanzani I.R.C.C.S. Roma, Italy Azienda Ospedaliero Universitaria di Sassari Sassari, Italy Dipartimento di Malattie Infettive e Tropicali Torino, Italy Spain Hospital Clinic de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital Universitari Germans Trias i Pujol Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital 12 de Octubre Madrid, Spain Hospital General Universitario Gregorio Maranon Madrid, Spain Hospital Universitario La Paz Madrid, Spain Ramon Y Cajal University Hospital Madrid, Spain Hospital Costa Del Sol Marbella, Spain Hospital General Universitario de Valencia Valencia, Spain United Kingdom Royal Victoria Hospital Belfast, United Kingdom Mortimer Market Centre London, United Kingdom Newcastle Royal Victoria Infirmary Newcastle Upon Tyne, United Kingdom 收起 << |
NCT00998764 | - | Terminated(The study was termi... 展开 >>nated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns.) 收起 << | - | - | |
NCT02504268 | Rheumatoid Arthritis | Phase 3 | Active, not recruiting | March 20, 2020 | - |
NCT00529529 | Asthma | Phase 3 | Completed | - | - |
NCT02636686 | - | - | - | - | |
NCT00529529 | - | Completed | - | - | |
NCT02429791 | HIV Infections | Phase 3 | Active, not recruiting | August 13, 2021 | - |
NCT00578097 | Overactive Bladder | Phase 2 | Terminated(The study was termi... 展开 >>nated early due to poor recruitment.) 收起 << | - | Belgium ... 展开 >> ULB Hôpital Erasme Brussels, Belgium, B-1070 CH Régional Huy - Polyclinique A Rue Trois Ponts Huy, Belgium, 2 4500 UZ Gasthuisberg Leuven, Belgium, 3000 CHU Liege Sart Tilman Liege, Belgium Czech Republic Urologická klinika Olomouc, Czech Republic, 775 20 Urologické oddělení Praha 4, Czech Republic, 140 00 France Hôpital Michallon - CHU de Grenoble Grenoble Cedex, France, 38043 Groupe Hospitalier Pitié-Salpétrière Paris Cedex 16, France, 75661 Hôpital Charles Nicolle - CHU de Rouen Rouen Cedex, France, 76031 Hôpital Henri Gabrielle - Hôpitaux Civils de Lyon Saint Genis Laval, France, 69230 Hôpital Rangueil - CHU de Toulouse Toulouse, France, 31059 Germany Medizinische Einrichtungen der RWTH Aachen, Germany, 52074 Praxis für Urologie Bad Kreuznach, Germany, 55543 Praxis für Urologie Emmendingen, Germany, 79312 Praxis für Urologie Günzburg, Germany, 89312 Praxis für Urologie Lahr, Germany, 77933 Beckenboden Zentrum München München, Germany, 81679 Städtisches Klinikum Neunkirchen gGmbH Neunkirchen, Germany, 66538 Krankenhaus St. Trudpert Pforzheim, Germany, 75177 Italy Unità Spinale, Azienda Ospedaliera Careggi Firenze, Italy, 50139 Unità Spinale, Ospedale Niguarda Milano, Italy, 20100 Struttura Complessa di Neuro-Urologia Torino, Italy, 1053 Netherlands General Urology Academisch Ziekenhuis Maastricht Maastricht, P.Debyelaan 25, Netherlands, 6229 HX VU Medisch Centrum Amsterdam Amsterdam, Netherlands, 1081 HV UMC St. Radboud Nijmegen, Netherlands, 6525 GA Erasmus MC, Universitair Medisch Centrum Rotterdam Rotterdam, Netherlands, 3000 CA Spain Hospital Clínico Universitario Canarias La Laguna, Spain, 38330 Hospital San Rafael Madrid, Spain, 28016 Hospital Universitario La Fe Valencia, Spain, 46009 United Kingdom Southmead Hospital Bristol, United Kingdom, BS10 5NB Western General Hospital Edinburgh, United Kingdom, EH4 2XU St George's Hospital London, United Kingdom, SW17 OQT Churchill Hospital Oxford, United Kingdom, OX3 7LJ Royal Berkshire Hospital Reading, United Kingdom, RG1 5AN 收起 << |
NCT00363051 | Islet Cell Carcinoma ... 展开 >> Neuroendocrine Carcinoma Neuroendocrine Tumor Pancreatic Neoplasms 收起 << | Phase 2 | Completed | - | - |
NCT00363051 | - | Completed | - | - | |
NCT00517192 | - | Terminated | - | - | |
NCT02605954 | HIV-1 Infection | Phase 3 | Completed | - | - |
NCT02674386 | Osteoarthritis | Phase 3 | Recruiting | August 12, 2019 | - |
NCT01406938 | Moderate to Severe Plaque-type... 展开 >> Psoriasis 收起 << | Phase 3 | Completed | - | - |
NCT02429791 | - | Active, not recruiting | - | - | |
NCT02629692 | Chronic Myeloid Leukemia (for ... 展开 >>Part B and C) Healthy (For Part A) 收起 << | Phase 1 Phase 2 | Recruiting | January 2022 | - |
NCT02616029 | HIV-1 Infection | Phase 3 | Active, not recruiting | June 2019 | United States, California ... 展开 >> Southern California Men's Medical Group Los Angeles, California, United States, 90069 United States, Florida Midway Immunology & Research Center, LLC Fort Pierce, Florida, United States, 34982 Orlando Immunology Center Orlando, Florida, United States, 32803 Triple O Research Institute PA West Palm Beach, Florida, United States, 33401 France Hopital Sainte Marguerite - Hospital Marseille, France, 13009 CHU de Nantes Nantes, France, 44093 CHU de Nice-l Archet Nice, France CHR Orleans la Source Orleans, France Hopital Saint Louis Paris Cedex 10, France CHU Hotel Dieu Paris Cedex 14, France Hopital Necker les Enfants Malades Paris Cedex 15, France CHU Tours Service de Médecine Internes et Maladies Infectieuses Tours, France Germany Universitatsklinikum Essen Essen, Germany Infektiologikum Frankfurt Frankfurt, Germany, 60596 ICH Study Center- Dedicated Research Hamburg, Germany, 22083 Universitat Mainz Mainz, Germany Italy IRCCS A.O.U. San Martino Genova, Italy Dipartimento di Malattie Infettive e Tropicali dell'Università di Milano Milano, Italy Fondazione IRCCS San Raffaele del Monte Tabor Milano, Italy Dipartimento di Malattie Infettive e Tropicali Torino, Italy Spain Hospital Universitari Germans Trias i Pujol Badalona, Spain Hospital Clinic de Barcelona - Hospital Barcelona, Spain, 08035 Hospital Universitario 12 de Octubre - Hospital Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 收起 << |
NCT00517192 | HIV Infections | Phase 3 | Terminated | - | - |
NCT01406938 | - | Completed | - | - | |
NCT01024036 | Multicentric Castleman's Disea... 展开 >>se 收起 << | Phase 2 | Completed | - | - |
NCT00848549 | - | Completed | - | - | |
NCT02605954 | - | Completed | - | - | |
NCT02794285 | Active Systemic Lupus Erythema... 展开 >>tosus 收起 << | Phase 3 | Active, not recruiting | December 30, 2021 | - |
NCT03473743 | Urothelial Carcinoma | Phase 1 Phase 2 | Recruiting | November 30, 2022 | - |
NCT01486940 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00848549 | Epilepsy | Phase 3 | Completed | - | - |
NCT01609582 | - | Terminated(Due to potential co... 展开 >>ncerns about liver safety (See Detailed Description)) 收起 << | - | - | |
NCT02935634 | Advanced Gastric Cancer | Phase 2 | Recruiting | November 18, 2021 | - |
NCT02607930 | - | Active, not recruiting | - | - | |
NCT01024036 | - | Completed | - | - | |
NCT01609582 | Type 2 Diabetes ... 展开 >> Cardiovascular Disease 收起 << | Phase 3 | Terminated(Due to potential co... 展开 >>ncerns about liver safety (See Detailed Description)) 收起 << | - | - |
NCT01377090 | - | Completed | - | - | |
NCT00631371 | - | Completed | - | - | |
NCT01114529 | Kidney Transplantation | Phase 3 | Completed | - | - |
NCT00631371 | Renal Cell Carcinoma | Phase 3 | Completed | - | - |
NCT01114529 | - | Completed | - | - | |
NCT02607930 | HIV-1 Infection | Phase 3 | Active, not recruiting | April 2020 | - |
NCT00911170 | Cancer Colon ... 展开 >>Cancer Colorectal Cancer Fever Locally Advanced Metastatic Colorectal Cancer Neutropenia Rectal Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00911170 | - | Completed | - | - | |
NCT01332331 | Hypertension, Pulmonary | Phase 2 | Suspended(Ongoing juvenile rat... 展开 >> toxicology studies.) 收起 << | February 1, 2019 | - |
NCT00810693 | - | Completed | - | - | |
NCT02737501 | Non-small Cell Lung Cancer ... 展开 >> Lung Cancer Advanced Malignancies Carcinoma 收起 << | Phase 3 | Active, not recruiting | July 31, 2020 | - |
NCT01696045 | Malignant Melanoma | Phase 2 | Terminated(Slow accrual) | - | - |
NCT00810693 | Pulmonary Hypertension | Phase 3 | Completed | - | - |
NCT00662597 | Non-Small Cell Lung Cancer | Phase 3 | Terminated | - | - |
NCT01342952 | Hypertension, Pulmonary | Phase 2 | Recruiting | October 24, 2024 | - |
NCT00533793 | Trauma | Phase 2 | Completed | - | - |
NCT01340027 | Urologic Diseases ... 展开 >> Urinary Bladder Diseases Urological Manifestations Signs and Symptoms Urinary Bladder, Overactive 收起 << | Phase 2 | Completed | - | - |
NCT00855465 | Pulmonary Hypertension | Phase 3 | Completed | - | - |
NCT01640951 | Moderate to Severe Chronic Pla... 展开 >>que-Type Psoriasis 收起 << | Phase 3 | Completed | - | - |
NCT03315143 | Type 2 Diabetes Mellitus ... 展开 >> Chronic Kidney Diseases 收起 << | Phase 3 | Recruiting | March 2022 | - |
NCT01696045 | - | Terminated(Slow accrual) | - | - | |
NCT03089944 | Hepatitis C Virus (HCV) | Phase 3 | Recruiting | November 2, 2019 | - |
NCT01209689 | Spondylitis, Ankylosing | Phase 3 | Terminated(Clinical developmen... 展开 >>t program terminated due to failure to achieve efficacy) 收起 << | - | - |
NCT01340027 | - | Completed | - | - | |
NCT01209689 | - | Terminated(Clinical developmen... 展开 >>t program terminated due to failure to achieve efficacy) 收起 << | - | - | |
NCT01729871 | Atrial Fibrillation | Phase 3 | Completed | - | - |
NCT02955251 | Advanced Solid Tumors Cancer | Phase 1 | Recruiting | January 7, 2021 | United States, Arizona ... 展开 >> HonorHealth Research Institute - Pima /ID# 155461 Recruiting Scottsdale, Arizona, United States, 85258-2345 United States, California UC Davis Comp Cancer Ctr /ID# 154439 Recruiting Sacramento, California, United States, 95817 United States, Illinois University of Chicago /ID# 154440 Recruiting Chicago, Illinois, United States, 60637-1443 United States, Pennsylvania Fox Chase Cancer Center /ID# 170665 Not yet recruiting Philadelphia, Pennsylvania, United States, 19111 United States, South Carolina Greenville Hospital System /ID# 154437 Recruiting Greenville, South Carolina, United States, 29605 United States, Texas MD Anderson Cancer Center /ID# 154441 Recruiting Houston, Texas, United States, 77030 South Texas Accelerated Research Therapeutics /ID# 154442 Recruiting San Antonio, Texas, United States, 78229 Australia, New South Wales Chris O'Brien Lifehouse /ID# 163131 Recruiting Camperdown, New South Wales, Australia, 2050 Northern Cancer Institute /ID# 163132 Recruiting St Leonards, New South Wales, Australia, 2065 France Institut Bergonie /ID# 202391 Not yet recruiting Bordeaux, Gironde, France, 33000 Institut Curie /ID# 162258 Recruiting Paris CEDEX 05, Ile-de-France, France, 75248 Institut Gustave Roussy /ID# 162257 Recruiting Villejuif, Ile-de-France, France, 94805 Hopital de la Timone /ID# 162256 Recruiting Marseille CEDEX 05, Provence-Alpes-Cote-d Azur, France, 13385 Centre Leon Berard /ID# 168072 Recruiting Lyon CEDEX 08, Rhone, France, 69373 Taiwan National Cheng Kung University Hospital /ID# 169035 Not yet recruiting Tainan City, Tainan, Taiwan, 70403 National Taiwan Univ Hosp /ID# 169034 Not yet recruiting Taipei City, Taipei, Taiwan, 10002 收起 << |
NCT01640951 | - | Completed | - | - | |
NCT01729871 | - | Completed | - | - | |
NCT01402440 | Diffuse Large B-Cell Lymphoma | Phase 1 | Terminated(Study terminated du... 展开 >>e to enrolment challenges and availability of other options for DLBCL patients. The termination is not a consequence of any safety concern.) 收起 << | - | - |
NCT00855465 | - | Completed | - | - | |
NCT01159600 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01511172 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 2 | Completed | - | - |
NCT01159600 | - | Completed | - | - | |
NCT00623727 | - | Terminated | - | - | |
NCT01358357 | Bipolar I Disorder | Phase 3 | Completed | - | - |
NCT01462942 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 3 | Completed | - | - |
NCT00623727 | Hemophilia A | Phase 2 | Terminated | - | - |
NCT00174447 | Schizophrenia | Phase 3 | Completed | - | France ... 展开 >> Pfizer Investigational Site Avignon, France, 84000 Pfizer Investigational Site Dole Saint Ylie, France, 39108 Pfizer Investigational Site Lievin, France, 62800 Pfizer Investigational Site Lyon Cedex, France, 69373 Pfizer Investigational Site Montfavet, France, 84143 Pfizer Investigational Site Orvault, France, 44700 Pfizer Investigational Site Rennes, France, 35000 Pfizer Investigational Site Saint Egreve Cedex, France, 38521 Pfizer Investigational Site Saint Remy, France, 70160 Pfizer Investigational Site Strasbourg, France, 67100 Pfizer Investigational Site Toulon Cedex, France, 83056 Pfizer Investigational Site Toulouse, France, 31000 Pfizer Investigational Site Toulouse, France, 31200 Pfizer Investigational Site Versailles, France, 78000 收起 << |
NCT01807949 | Cystic Fibrosis, Homozygous fo... 展开 >>r the F508del CFTR Mutation 收起 << | Phase 3 | Completed | - | - |
NCT01358357 | - | Completed | - | - | |
NCT00174447 | - | Completed | - | - | |
NCT01462942 | - | Completed | - | - | |
NCT00894387 | Acute Decompensated Heart Fail... 展开 >>ure Congestive Heart Failure 收起 << | Phase 3 | Completed | - | - |
NCT00894387 | - | Completed | - | - | |
NCT01298492 | - | Completed | - | - | |
NCT03071757 | Advanced Solid Tumors Cancer | Phase 1 | Recruiting | March 25, 2020 | United States, California ... 展开 >> Ucsd /Id# 201334 Not yet recruiting La Jolla, California, United States, 92037 UC Davis Comp Cancer Ctr /ID# 201342 Not yet recruiting Sacramento, California, United States, 95817 United States, North Carolina Carolina BioOncology Institute /ID# 160786 Recruiting Huntersville, North Carolina, United States, 28078 United States, South Carolina Greenville Hospital System /ID# 160785 Recruiting Greenville, South Carolina, United States, 29605 United States, Texas UT Southwestern Medical Center /ID# 201934 Not yet recruiting Dallas, Texas, United States, 75390-7208 South Texas Accelerated Research Therapeutics /ID# 160788 Recruiting San Antonio, Texas, United States, 78229 United States, Virginia Virginia Cancer Specialists /ID# 160787 Recruiting Fairfax, Virginia, United States, 22031 France Institut Curie /ID# 165038 Not yet recruiting Paris CEDEX 05, Ile-de-France, France, 75248 Hopital de la Timone /ID# 165036 Not yet recruiting Marseille CEDEX 05, Provence-Alpes-Cote-d Azur, France, 13385 Centre Leon Berard /ID# 165037 Not yet recruiting Lyon CEDEX 08, Rhone, France, 69373 Institut Gustave Roussy /ID# 165035 Not yet recruiting Villejuif, Val-de-Marne, France, 94800 Taiwan National Cheng Kung University Hospital /ID# 164002 Not yet recruiting Tainan City, Tainan, Taiwan, 70403 National Taiwan Univ Hosp /ID# 164000 Not yet recruiting Taipei City, Taipei, Taiwan, 10002 Taipei Medical University Hosp /ID# 164001 Not yet recruiting Taipei City, Taiwan, 11031 收起 << |
NCT02744989 | Mental Disorders ... 展开 >> Schizophrenia 收起 << | Not Applicable | Recruiting | November 2019 | France ... 展开 >> Centre Hospitalier Le Vinatier - Service de Psychiatrie Adulte Recruiting Bron, France, 69678 Contact: Felipe GALVAO, MD Principal Investigator: Felipe GALVAO, MD Centre Esquirol - CHU de Caen - Service de Psychiatrie Adulte, Recruiting Caen, France, 14033 Contact: Sonia DOLLFUS, MD Principal Investigator: Sonia DOLLFUS, MD CHU de Clermont-Ferrand - Pôle de Psychiatrie B Recruiting Clermont-Ferrand, France, 63000 Contact: Pierre Michel LLORCA, MD Principal Investigator: Pierre Michel LLORCA, MD Hôpital Fontan - CHRU de Lille - Pôle de Psychiatrie Recruiting Lille, France, 59037 Contact: Renaud JARDRI, MD Principal Investigator: Renaud JARDRI, MD Hôpital Edouard Herriot - Service d'Urgences Psychiatriques Recruiting Lyon cedex 03, France, 69437 Contact: Emmanuel POULET, MD Principal Investigator: Emmanuel POULET, MD Hôpital de la Colombière - CHU Montpellier - Service de Psychiatrie Adulte Recruiting Montpellier, France, 34295 Contact: Jérôme ATTAL, MD Principal Investigator: Jérôme ATTAL, MD Centre Hospitalier Saint-Antoine - Service de Psychiatrie Recruiting Paris, France, 75012 Contact: Stéphane MOUCHALAC, MD Principal Investigator: Stéphane MOUCHALAC, MD Centre Hospitalier Saint-Anne - Service de Psychiatrie Adultes Recruiting Paris, France, 75014 Contact: Marion PLAZE, MD Principal Investigator: Marion PLAZE, MD CHU de St-Etienne - Service d'Urgences Psychiatriques Recruiting Saint-Etienne Cedex 2, France, 42055 Contact: Catherine MASSOUBRE, MD Principal Investigator: Catherine MASSOUBRE, MD Hôpital Civil - CHU Strasbourg - CEntre de neuro-Modulation Non-Invasive Recruiting Strasbourg, France, 67091 Contact: Jack FOUCHER, MD Principal Investigator: Jack FOUCHER, MD CHRU de Tours - Clinique Psychiatrique Universitaire Recruiting Tours Cedex 9, France, 37044 Contact: Wissam EL HAGE, MD Principal Investigator: Wissam EL HAGE, MD Monaco Centre Hospitalier Princesse Grace - Service de Psychiatrie Recruiting Monaco, Monaco, 98000 Contact: David SZEKELY, MD Principal Investigator: David SZEKELY, MD 收起 << |
NCT01807949 | - | Completed | - | - | |
NCT01596114 | Chronic Myeloid Leukemia | Phase 3 | Active, not recruiting | June 2018 | - |
NCT01637272 | Dumping Syndrome | Phase 2 | Completed | - | United States, California ... 展开 >> Ximed Center for Weight Management Ximed Research La Jolla, California, United States, 92037 Stanford University Medical Center SC - SOM230X2203 Stanford, California, United States, 94304 United States, Minnesota Mayo Clinic - Rochester Mayo MN Rochester, Minnesota, United States, 55905 United States, New York Montefiore Medical Center CLCZ696B2320 Bronx, New York, United States, 10467 United States, Texas Texas Tech University Health Science Center El Paso, Texas, United States, 79905 United States, Virginia Virginia Endocrinology Research SC Chesapeake, Virginia, United States, 23321 Belgium Novartis Investigative Site Brugge, Belgium, 8310 Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Gent, Belgium, 9000 Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Pessac Cedex, France, 33604 Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Würzburg, Germany, 97080 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Utrecht, Netherlands, 3584CX 收起 << |
NCT01374451 | Islet Cell Tumor | Phase 2 | Terminated(The study was stopp... 展开 >>ed for not meeting the primary endpoint for PFS.) 收起 << | - | - |
NCT01298492 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01714739 | CANCER,NOS | Phase 1 Phase 2 | Active, not recruiting | October 16, 2019 | - |
NCT01374451 | - | Terminated(The study was stopp... 展开 >>ed for not meeting the primary endpoint for PFS.) 收起 << | - | - | |
NCT01026285 | - | Completed | - | - | |
NCT01314222 | Diabetic Peripheral Neuropathi... 展开 >>c Pain 收起 << | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Achieve Clinical Research, Llc Birmingham, Alabama, United States, 35216 United States, Arizona Arizona Research Center Phoenix, Arizona, United States, 85023 United States, California Torrance Clinical Research Lomita, California, United States, 90717 Office Of Richard S. Cherlin, Md Los Gatos, California, United States, 95032 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Florida Brain Matters Research Delray Beach, Florida, United States, 33445 Renstar Medical Research Ocala, Florida, United States, 34471 Compass Research, Llc Orlando, Florida, United States, 32806 Comprehensive Clinical Development, Inc. St Petersburg, Florida, United States, 33716 United States, Illinois Northwest Neurology Ltd. Lake Barrington, Illinois, United States, 60010 United States, Kentucky Commonwealth Biomedical Research, Llc Madisonville, Kentucky, United States, 42431 United States, Missouri The Center For Pharmaceutical Research. Pc Kansas City, Missouri, United States, 64114 Mercy Health Research St. Louis, Missouri, United States, 63141 United States, New York Finger Lakes Clinical Research Rochester, New York, United States, 14618 United States, North Carolina Physicians East P.A. Greenville, North Carolina, United States, 27834 Pmg Research Of Winston-Salem Winston-Salem, North Carolina, United States, 27103 United States, Ohio Radiant Research, Inc. Akron, Ohio, United States, 44311 Neurology & Neuroscience Center Of Ohio Toledo, Ohio, United States, 43623 United States, Tennessee Clinical Research Associates, Inc. Nashville, Tennessee, United States, 37203 United States, Texas Dallas Diabetes & Endocrine Center Dallas, Texas, United States, 75230 R/D Clinical Research, Inc. Lake Jackson, Texas, United States, 77566 France Local Institution Dijon Cedex, France, 21079 Local Institution Nantes Cedex 1, France, 44093 Local Institution Nice Cedex 1, France, 06003 收起 << |
NCT00997061 | - | Completed | - | - | |
NCT01637272 | - | Completed | - | - | |
NCT01585987 | Locally Advanced (Unresectable... 展开 >>) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction 收起 << | Phase 2 | Completed | - | - |
NCT01853878 | Lung Cancer, Non-Small Cell | Phase 2 | Completed | - | - |
NCT00383708 | Acromegaly | Phase 3 | Completed | - | Czechia ... 展开 >> University Hospital, Charles University Hradec Kralove, Czechia, 500 05 Charles University Prague, Czechia, 120 00 PRAHA 2 Denmark Aarhus Kommunehospital Aarhus, Denmark France Groupe Hospitalier Henri Mondor- Albert Chenevier Créteil Cedex, France Hôpital Bicêtre Le Kremlin-Bicêtre, France, 94275 Clinique Marc Linquette Lille Cedex, France, 59037 Hôpital de la Timone Marseille Cedex, France, 13385 CHU de Rangueil Toulouse, France, 31054 Germany Charite Campus Mitte Berlin, Germany, 10117 Klinikum Johann Wolfgang Goethe-Universität Frankfurt, Germany, 605090 Medizinische Klinik Innenstadt Munchen, Germany, 80336 Greece Anticancer Hospital Metaxa Piraeus Piraeus, Greece, 18537 Italy Universitá degli Studi di Milano Milano, Italy, 20122 University Federico II Napoli, Italy, 80131 Universitá di Torino Torino, Italy, 10126 Netherlands Leiden University Medical Center Leiden, Netherlands, 2300 RC Dept. of Internal Medicine Erasmus MC Rotterdam, Netherlands, 3015 GD Spain Hospital General de Alicante Alicante, Spain, 03012 Clínica Puerta de Hierro Madrid, Spain, 28035 Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, Spain, 15706 Sweden Sahlgrenska University Hospital Göteborg, Sweden, 413 45 Uppsala University Hospital Uppsala, Sweden, 75185 United Kingdom Christie Hospital and Holt Radium Institute Manchester, United Kingdom, M20 4BX Royal Hallamshire Hospital Sheffield, United Kingdom 收起 << |
NCT01585987 | - | Completed | - | - | |
NCT00742027 | Classical Hodgkin's Lymphoma (... 展开 >>i.e. Nodular Sclerosing, Mixed-cellularity, Lymphocyte-rich, Lymphocyte-depleted) 收起 << | Phase 2 | Completed | - | - |
NCT00113308 | Arthritis, Rheumatoid | Phase 3 | Completed | - | - |
NCT01289990 | - | Completed | - | - | |
NCT01289990 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01798056 | Herpes Zoster | Phase 3 | Completed | - | Canada, British Columbia ... 展开 >> GSK Investigational Site Kelowna, British Columbia, Canada, V1Y 5L3 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M4C 3E7 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 Czechia GSK Investigational Site Praha 8, Czechia, 180 00 France GSK Investigational Site Besançon cedex, France, 25030 GSK Investigational Site Ferolles-Attilly, France, 77150 GSK Investigational Site Lyon Cedex 08, France, 69373 GSK Investigational Site Montpellier, France, 34070 GSK Investigational Site Nîmes cedex 9, France, 30029 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 02841 GSK Investigational Site Seoul, Korea, Republic of, 03080 GSK Investigational Site Seoul, Korea, Republic of, 05505 Spain GSK Investigational Site Badajoz, Spain, 6080 GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Madrid, Spain, 28007 GSK Investigational Site Madrid, Spain, 28034 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Madrid, Spain, 28041 GSK Investigational Site Madrid, Spain, 28050 GSK Investigational Site Majadahonda (Madrid), Spain, 28222 GSK Investigational Site Móstoles, Spain, 28935 GSK Investigational Site Pozuelo De Alarcón/Madrid, Spain, 28223 GSK Investigational Site San Sebastian de los Reyes, Spain, 28702 United Kingdom GSK Investigational Site Cheltenham, Gloucestershire, United Kingdom, GL53 7AN GSK Investigational Site Woolwich, London, United Kingdom, SE18 4QH GSK Investigational Site Swindon, Wiltshire, United Kingdom, SN3 6BB GSK Investigational Site Exeter, United Kingdom, EX2 5DW GSK Investigational Site Sheffield, United Kingdom, S10 2SJ GSK Investigational Site York, United Kingdom, YO31 8HE 收起 << |
NCT00175916 | Epilepsy | Phase 3 | Active, not recruiting | February 2019 | - |
NCT01945775 | - | Active, not recruiting | - | - | |
NCT01798056 | - | Completed | - | - | |
NCT00383708 | - | Completed | - | - | |
NCT00297102 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 3 | Completed | - | - |
NCT00799877 | - | Active, not recruiting | September 15, 2022 | - | |
NCT03652064 | Multiple Myeloma | Phase 3 | Not yet recruiting | April 30, 2025 | - |
NCT00297102 | - | Completed | - | - | |
NCT03416179 | Leukemia, Myeloid, Acute | Phase 3 | Recruiting | July 22, 2025 | - |
NCT01945775 | Breast Neoplasms ... 展开 >> BRCA 1 Gene Mutation BRCA 2 Gene Mutation 收起 << | Phase 3 | Active, not recruiting | September 22, 2019 | - |
NCT02857426 | Lymphoma | Phase 2 | Recruiting | December 6, 2019 | - |
NCT02149108 | - | Completed | - | - | |
NCT02551159 | Squamous Cell Carcinoma of the... 展开 >> Head and Neck 收起 << | Phase 3 | Active, not recruiting | December 31, 2018 | - |
NCT01306214 | Diabetes Mellitus, Type 2 ... 展开 >> Obesity 收起 << | Phase 3 | Completed | - | - |
NCT02149108 | Colorectal Neoplasms | Phase 3 | Completed | - | - |
NCT01306214 | - | Completed | - | - | |
NCT00905632 | Hepatitis C, Chronic | Phase 1 | Completed | - | France ... 展开 >> 1241.7.3307A CHU de Grenoble Grenoble cédex 9, France 1241.7.3303A Hôpital Claude Huriez Lille, France 1241.7.3302A Hopital de l'Hotel Dieu Lyon cedex 02, France 1241.7.3301A Hôpital Saint Eloi Montpellier, France 1241.7.3305A HOP Archet 2 Nice Cedex 3, France 1241.7.3306A Hôpital Haut-Lévêque Pessac Cedex, France 1241.7.3304A HOP de Brabois Vandoeuvre, France Germany 1241.7.49010 Boehringer Ingelheim Investigational Site Aachen, Germany 1241.7.49012 Boehringer Ingelheim Investigational Site Berlin, Germany 1241.7.49004 Boehringer Ingelheim Investigational Site Essen, Germany 1241.7.49011 Boehringer Ingelheim Investigational Site Freiburg, Germany 1241.7.49001 Boehringer Ingelheim Investigational Site Hamburg, Germany 1241.7.49013 Boehringer Ingelheim Investigational Site Mainz, Germany 1241.7.49009 Boehringer Ingelheim Investigational Site Regensburg, Germany 1241.7.49002 Boehringer Ingelheim Investigational Site Ulm, Germany Switzerland 1241.7.41003 Boehringer Ingelheim Investigational Site Basel, Switzerland 1241.7.41004 Boehringer Ingelheim Investigational Site Lugano, Switzerland 1241.7.41001 Boehringer Ingelheim Investigational Site St. Gallen, Switzerland 收起 << |
NCT01076764 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT01865110 | Mantle Cell Lymphoma | Phase 3 | Recruiting | March 2024 | - |
NCT00365170 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 4 | Completed | - | - |
NCT01000727 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT00071331 | Congestive Heart Failure | Phase 3 | Completed | - | - |
NCT01000727 | - | Completed | - | - | |
NCT00949650 | Carcinoma, Non-Small-Cell Lung... 展开 >> Adenocarcinoma 收起 << | Phase 3 | Completed | - | - |
NCT00905632 | - | Completed | - | - | |
NCT00909038 | - | Completed | - | - | |
NCT01399619 | Hepatitis C, Chronic | Phase 3 | Completed | - | - |
NCT00424255 | - | Completed | - | - | |
NCT00949650 | - | Completed | - | - | |
NCT01399619 | - | Completed | - | - | |
NCT01764997 | Rheumatoid Arthritis | Phase 3 | Terminated(Due to small number... 展开 >> of participants entering randomization. Not a safety issue.) 收起 << | - | - |
NCT00424255 | Neoplasms, Head and Neck | Phase 3 | Completed | - | - |
NCT00065325 | Locally Advanced Breast Cancer... 展开 >> Metastatic Breast Cancer 收起 << | Phase 3 | Completed | - | - |
NCT01764997 | - | Terminated(Due to small number... 展开 >> of participants entering randomization. Not a safety issue.) 收起 << | - | - | |
NCT01266902 | HIV-1 Infection | Phase 3 | Active, not recruiting | December 31, 2021 | - |
NCT00375219 | Chronic Myeloid Leukemia | Phase 2 | Completed | - | - |
NCT03498716 | Triple Negative Breast Cancer | Phase 3 | Recruiting | December 29, 2024 | - |
NCT00101595 | Chronic Myeloid Leukemia ... 展开 >> Leukemia, Lymphoblastic, Acute, Philadelphia-positive 收起 << | Phase 2 | Completed | - | - |
NCT00384176 | - | Completed | - | - | |
NCT00312013 | Thrombosis, Venous | Phase 3 | Completed | - | - |
NCT01375127 | - | Completed | - | - | |
NCT00384176 | Colorectal Cancer | Phase 2 Phase 3 | Completed | - | - |
NCT01375127 | - | Completed | - | - | |
NCT00375219 | - | Completed | - | - | |
NCT00101647 | Chronic Myelogenous Leukemia | Phase 2 | Completed | - | - |
NCT00144339 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00547651 | Small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT00101647 | - | Completed | - | - | |
NCT01369329 | - | Completed | - | - | |
NCT00462943 | Chronic Myeloid Leukemia | Phase 2 | Completed | - | - |
NCT00371345 | Breast Cancer ... 展开 >> Metastasis 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Ucsf-Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Florida Mayo Clinic Florida Jacksonville, Florida, United States, 32224 United States, Massachusetts Dana-Farber Cancer Inst Boston, Massachusetts, United States, 02115 United States, New York Montefiore Medical Center Bronx, New York, United States, 10461 United States, North Carolina University Of North Carolina At Chapel Hill Chapel Hill, North Carolina, United States, 275997305 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas University Of Texas Md Anderson Cancer Ctr Houston, Texas, United States, 77030 Argentina Local Institution Haedo, Buenos Aires, Argentina, 1684 Local Institution Buenos Aires, Argentina, 1019 Local Institution Buenos Aires, Argentina, 1185 Belgium Local Institution Bruxelles, Belgium, 1000 Local Institution Bruxelles, Belgium, 1200 France Local Institution Dijon Cedex, France, 21079 Local Institution Paris, France, 75231 Local Institution Saint Herblain Cedex, France, 44805 Local Institution Toulouse Cedex 3, France, 31052 Italy Local Institution Modena, Italy, 41100 Peru Local Institution Arequipa, Peru Local Institution Lima, Peru, 34 Local Institution Lima, Peru, LIMA 11 Spain Local Institution Barcelona, Spain, 08035 Local Institution Lleida, Spain, 25198 Local Institution Madrid, Spain, 28041 收起 << |
NCT00144339 | - | Completed | - | - | |
NCT01369329 | Crohn's Disease ... 展开 >> IBD Colitis Inflammatory Bowel Disease 收起 << | Phase 3 | Completed | - | - |
NCT00080262 | Breast Cancer ... 展开 >> Metastases 收起 << | Phase 2 | Completed | - | - |
NCT00256750 | Kidney Transplantation ... 展开 >> Chronic Kidney Failure 收起 << | Phase 3 | Completed | - | - |
NCT00462943 | - | Completed | - | - | |
NCT00082433 | - | Completed | - | - | |
NCT01506609 | Metastatic Breast Cancer | Phase 2 | Active, not recruiting | May 30, 2019 | - |
NCT00540449 | - | Completed | - | - | |
NCT00371345 | - | Completed | - | - | |
NCT00256750 | - | Completed | - | - | |
NCT02021292 | Chronic Thromboembolic Pulmona... 展开 >>ry Hypertension 收起 << | Phase 2 | Completed | - | - |
NCT00540449 | HIV Infections ... 展开 >> HIV-1 Human Immunodeficiency Virus Type 1 收起 << | Phase 3 | Completed | - | - |
NCT02021292 | - | Completed | - | - | |
NCT01543477 | - | Active, not recruiting | April 2022 | - | |
NCT00699517 | Sarcoma | Phase 3 | Completed | - | - |
NCT00082433 | Cancer Breast... 展开 >> Cancer 收起 << | Phase 3 | Completed | - | - |
NCT02719171 | Arthritis, Psoriatic | Phase 2 | Completed | - | - |
NCT00364351 | Non Small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT01775982 | - | Completed | - | France ... 展开 >> CH d'Alès Alès, France, 30103 CHU de Rouen - Hôpital de Bois-Guillaume Bois Guillaume, France, 76230 APHP - Hôpital Charles Foix Ivry Sur Seine Cedex, France, 94205 APHM - Hôpital Sainte-Marguerite Marseille, France, 13274 CHU de Montpellier - Centre Antonin Balmes Montpellier cedex 5, France, 34295 CHU de Nice - Hôpital de Cimiez Nice, France, 06003 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, France, 30029 CHU de Reims - Hôpital Maison Blanche Reims, France, 51092 收起 << | |
NCT00184574 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00364351 | - | Completed | - | - | |
NCT01369342 | Crohn's Disease ... 展开 >> Inflammatory Bowel Disease IBD Colitis 收起 << | Phase 3 | Completed | - | - |
NCT01972529 | - | Completed | - | - | |
NCT01934361 | Recurrent Glioblastoma Multifo... 展开 >>rme 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Barrow Neurological Insitute St. Joseph's Hospital Phoenix, Arizona, United States, 85013 United States, Arkansas Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Texas MD Anderson Cancer Center/University of Texas Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 Novartis Investigative Site Parkville, Victoria, Australia, 3050 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1Z6 France Novartis Investigative Site Marseille Cedex 05, France, 13885 Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Saint Herblain cedex, France, 44805 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 收起 << |
NCT01369342 | - | Completed | - | - | |
NCT02322710 | Surgical Acute Wounds | Phase 4 | Completed | - | France ... 展开 >> Research facility ID ORG-001264 Ajaccio, France, 20303 Research facility ID ORG-001263 Angoulême, France, 16959 Research facility ORG-001090 Athis-Mons, France, 91200 Research facility ORG-001101 Aubervilliers, France, 93300 Research facility ID ORG-001099 Carpentras, France, 84200 Research facility ORG-001099 Carpentras, France, 84200 Research facility ORG-001107 Cornebarrieu, France, 31700 Research facility ID ORG-001223 La Rochelle, France, 17000 Research facility ORG-001096 Levallois Perret, France, 92300 Research facility ORG-001096 Levallois-perret, France, 92300 Research facility ID ORG-001276 Lille, France, 59037 Research facility ORG-001102 Lille, France, 59037 Research facility ORG-001360 Lyon, France, 69003 Research facility ORG-001132 Mantes La Jolie, France, 78200 Research facility ORG-001133 Montpellier cedex 5, France, 34295 Research facility ID ORG-001133 Montpellier, France, 34295 Research facility ID ORG-001220 Montreuil-sous-Bois Cedex, France, 93105 Research facility ID ORG-001189 Nice, France, 6002 Research facility ID ORG-001190 Ollioules, France, 89190 Research facility ID ORG-001221 Paris Cedex 18, France, 75877 Research facility ID ORG-001088 Paris, France, 75008 Research facility ID ORG-001105 Paris, France, 75008 Research facility ORG-001105 Paris, France, 75008 Research facility ID ORG-001134 Paris, France, 75014 Research facility ID ORG-001265 Paris, France, 75014 Research facility ORG-001088 Paris, France, 75018 Research facility ORG-001166 Pierre Benite, France, 69495 Research facility ID ORG-001278 Reims, France, 51090 Research facility ORG-001137 Roubaix, France, 59100 Research facility ORG-001136 Rouen, France, 76000 Research facility ORG-001089 Saint Nazaire, France, 44600 Research facility ID ORG-001222 Sarreguemines, France, 57200 Research facility ORG-001097 Sarreguemines, France, 57200 Research facility ORG-001093 Toulon, France, 83100 收起 << |
NCT01972529 | Thrombocytopenia Associated Wi... 展开 >>th Liver Disease 收起 << | Phase 3 | Completed | - | - |
NCT01523171 | Hematopoietic Neoplasm | Phase 2 | Completed | - | - |
NCT01691508 | - | Completed | - | - | |
NCT02211131 | Completely Resectable Stage II... 展开 >>IB, IIIC, or IVM1a Melanoma 收起 << | Phase 2 | Active, not recruiting | April 30, 2022 | - |
NCT02060721 | Chronic Thromboembolic Pulmona... 展开 >>ry Hypertension 收起 << | Phase 2 | Active, not recruiting | December 22, 2020 | - |
NCT01691508 | Asthma | Phase 3 | Completed | - | - |
NCT00680992 | Cancer Giant ... 展开 >>Cell Tumors Giant Cell Tumor of Bone Benign Giant Cell Tumors 收起 << | Phase 2 | Completed | - | - |
NCT00171340 | - | Completed | - | - | |
NCT00353873 | Asthma | Phase 4 | Completed | - | - |
NCT00171340 | Bone Loss Bre... 展开 >>ast Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00353873 | - | Completed | - | - | |
NCT01739400 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Terminated(The parent study AC... 展开 >>-055-305/MAESTRO (NCTNCT01743001) did not meet its primary endpoint, the sponsor decided to prematurely terminate this open-label study.) 收起 << | - | - |
NCT00743938 | Non Small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT02509026 | Spondylitis, Ankylosing | Phase 4 | Active, not recruiting | November 4, 2019 | - |
NCT00680992 | - | Completed | - | - | |
NCT01721876 | Leukemia, Myeloid, Acute | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT01824290 | Hypertension, Pulmonary | Phase 3 | Recruiting | January 16, 2023 | - |
NCT01743001 | - | Completed | - | - | |
NCT00414440 | Autosomal Dominant Polycystic ... 展开 >>Kidney Disease 收起 << | Phase 4 | Completed | - | Austria ... 展开 >> Novartis Investigative Site Innsbruck, Austria, INNSBRUCK Novartis Investigative Site Linz, Austria, A-4010 Novartis Investigative Site Wien, Austria, 1090 France Novartis Investigative Site Brest, France, 29200 Novartis Investigative Site Grenoble, France, 38043 Novartis Investigative Site Nantes Cedex, France, 44035 Novartis Investigative Site Paris cedex 15, France, 75015 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Germany Novartis Investigative Site Berlin, Germany, 10117 Novartis Investigative Site Berlin, Germany, 13353 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt am Main, Germany, 60596 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Homburg, Germany, 66421 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Koeln, Germany, 51109 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Lübeck, Germany, 23538 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Würzburg, Germany, 97080 收起 << |
NCT00822094 | - | Completed | - | - | |
NCT01743001 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Completed | - | - |
NCT00414440 | - | Completed | - | - | |
NCT00822094 | Acute Myeloid Leukemia | Phase 2 | Completed | - | - |
NCT01997892 | - | Completed | - | - | |
NCT00487539 | Colitis, Ulcerative | Phase 2 Phase 3 | Completed | - | - |
NCT00487539 | - | Completed | - | - | |
NCT01997892 | - | Completed | - | Belgium ... 展开 >> Research Site Edegem, Belgium, 2650 France Research Site Antony, France, 92160 Research Site Aurillac, France, 15000 Research Site Blois, France, 41000 Research Site Boulogne sur Mer, France, 62200 Research Site Béziers, France, 34500 Research Site Cahors, France, 46000 Research Site Essey lès Nancy, France, 54270 Research Site Grabels, France, 34790 Research Site La Roche sur Yon Cedex 9, France, 85925 Research Site La Réunion, France, 97420 Research Site Libourne, France, 33505 Research Site Lille Cedex, France, 59800 Research Site Metz, France, 57000 Research Site Paris, France, 75015 Research Site Paris, France, 75016 Research Site Poitiers, France, 86021 Research Site Saint Nazaire, France, 44606 Research Site Saint Pierre, France, 97410 Research Site Saint Priest en Jarez, France, 42270 Research Site Saint-Denis de la Réunion, France, 97400 Research Site Strasbourg, France, 67000 Research Site Vandoeuvre Les Nancy Cedex, France, 54504 Germany Research Site Kiel, Germany, 24106 Research Site Nordhorn, Germany, 48527 Greece Research Site Athens, Greece, 11528 Research Site Athens, Greece, 15562 Netherlands Research Site Arnhem, Netherlands, 6815 AD Spain Research Site Ribeira, Galicia, Spain, 15993 Research Site Santiago de Compostela, Galicia, Spain, 15701 Research Site Santiago de Compostela, Galicia, Spain, 15706 Switzerland Research Site Sion, Switzerland, 1950 收起 << | |
NCT01001494 | - | Completed | - | - | |
NCT00090025 | Biliary Tract Cancer | Phase 3 | Terminated(Futility reasons af... 展开 >>ter Independent Data Monitoring Committee interim analysis) 收起 << | - | - |
NCT00330369 | Hypertension | Phase 3 | Completed | - | - |
NCT01777269 | Prostatic Hyperplasia | Phase 4 | Completed | - | - |
NCT00356421 | Diabetes Mellitus, Type 1 | Phase 4 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | United States, New Jersey ... 展开 >> Pfizer Investigational Site Hamilton, New Jersey, United States, 08610 Pfizer Investigational Site New Brunswick, New Jersey, United States, 08903 Austria Pfizer Investigational Site Vienna, Austria, A-1030 Pfizer Investigational Site Vienna, Austria, A-1130 Belgium Pfizer Investigational Site Edegem, Belgium, 2650 Pfizer Investigational Site Genk, Belgium, 3600 Pfizer Investigational Site Leuven, Belgium, 3000 Denmark Pfizer Investigational Site Aarhus, Denmark, 8000 Finland Pfizer Investigational Site Kuopio, Finland, 70211 France Pfizer Investigational Site Brest CEDEX, France, 29609 Pfizer Investigational Site Corbeil Essonnes Cedex, France, 91106 Pfizer Investigational Site Strasbourg Cedex, France, 67091 Ireland Pfizer Investigational Site Waterford, Ireland Netherlands Pfizer Investigational Site Amsterdam, Netherlands, NL-1105 AZ Norway Pfizer Investigational Site Stavanger, Norway, 4095 Portugal Pfizer Investigational Site Lisboa, Portugal, 1349-019 Spain Pfizer Investigational Site Las Palmas, Las Palmas de Gran Canaria, Spain, 35016 Pfizer Investigational Site Valencia, Spain, 46010 Sweden Pfizer Investigational Site Stockholm, Sweden, 171 76 Pfizer Investigational Site Stockholm, Sweden, 182 88 United Kingdom Pfizer Investigational Site Bournemouth, Dorset, United Kingdom, BH7 7DW Pfizer Investigational Site Dundee, Tayside, United Kingdom, DD1 9SY Pfizer Investigational Site Birmingham, West Midlands, United Kingdom, B9 5SS 收起 << |
NCT01777269 | - | Completed | - | - | |
NCT00356421 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT02161770 | Solid Tumours | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site San Diego, California, United States, 92123 United States, Georgia Research Site Atlanta, Georgia, United States, 30322 United States, Michigan Research Site Detroit, Michigan, United States, 48202 United States, Ohio Research Site Cleveland, Ohio, United States, 44106-4948 United States, Texas Research Site San Antonio, Texas, United States, 78229-3900 Belgium Research Site Brussels, Belgium, 1200 Research Site Gent, Belgium, 9000 France Research Site Angers Cedex 9, France, Angers Cedex 9 Research Site Marseille Cedex 20, France, 13915 Research Site Pierre Benite Cedex, France, 69495 Research Site Rennes, France, 35000 Research Site Saint Herblain, France, 44805 Research Site Toulouse, France, 31059 Korea, Republic of Research Site Seoul, Korea, Republic of, 05505 Spain Research Site Madrid, Spain, 28034 Research Site Madrid, Spain, 28040 Research Site Madrid, Spain, 28046 Research Site Madrid, Spain, 28050 United Kingdom Research Site Newcastle Upon Tyne, United Kingdom, NE7 7DN 收起 << |
NCT01110057 | Pain, Neuropathic | Phase 2 | Completed | - | Denmark ... 展开 >> GSK Investigational Site Hoersholm, Denmark, 2970 GSK Investigational Site Odense C, Denmark, 5000 France GSK Investigational Site Bois-Guillaume, France, 76230 GSK Investigational Site Boulogne-Billancourt, France, 92100 GSK Investigational Site Lyon cedex 03, France, 69394 GSK Investigational Site Nice cedex 1, France, 06002 GSK Investigational Site Paris Cedex 4, France, 75181 Germany GSK Investigational Site Schoenau, Baden-Wuerttemberg, Germany, 69250 GSK Investigational Site Muenchen, Bayern, Germany, 80333 GSK Investigational Site Leipzg, Sachsen, Germany, 04109 GSK Investigational Site Hamburg, Germany, 20255 GSK Investigational Site Hamburg, Germany, 22767 Norway GSK Investigational Site Hamar, Norway, 2317 GSK Investigational Site Oslo, Norway, 0027 GSK Investigational Site Trondheim, Norway, 7030 Sweden GSK Investigational Site Stockholm, Sweden, SE-115 22 GSK Investigational Site Örebro, Sweden, SE-703 62 收起 << |
NCT00255463 | Breast Cancer | Phase 2 | Completed | - | Czech Republic ... 展开 >> Research Site Brno, Czech Republic Research Site Chomutov, Czech Republic Research Site Ostrava - Poruba, Czech Republic Research Site Ostrava, Czech Republic Research Site Praha 2, Czech Republic France Research Site Clermont Ferrand, France Research Site Montpellier Cedex 5, France Research Site Tours Cedex, France Research Site Villejuif Cedex, France Hungary Research Site Budapest, Hungary Research Site Debrecen, Hungary Research Site Kecskemet, Hungary Portugal Research Site Coimbra, Portugal Research Site Funchal, Portugal Research Site Lisboa, Portugal Spain Research Site Santiago de Compostela, A Coruña, Spain Research Site Jaen, Jaén, Spain Research Site A Coruna, Spain Research Site Sevilla, Spain Research Site Valencia, Spain Research Site Zaragoza, Spain Sweden Research Site Göteborg, Sweden Research Site Molndal, Sweden Research Site Stockholm, Sweden United Kingdom Research Site Chelmsford, Essex, United Kingdom Research Site Bournemouth, United Kingdom Research Site Croydon, United Kingdom Research Site Dundee, United Kingdom Research Site Leeds, United Kingdom Research Site Liverpool, United Kingdom Research Site London, United Kingdom Research Site Manchester, United Kingdom Research Site Newcastle Upon Tyne, United Kingdom Research Site Poole, United Kingdom 收起 << |
NCT00163436 | Asthma | Phase 3 | Completed | - | - |
NCT00753545 | Ovarian Cancer | Phase 2 | Active, not recruiting | December 28, 2018 | - |
NCT01001494 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 3 | Completed | - | - |
NCT00216619 | Migraine | Phase 3 | Completed | - | - |
NCT00753545 | - | Active, not recruiting | - | - | |
NCT00505414 | Pain Neoplasm... 展开 >> Cancer 收起 << | Phase 3 | Terminated(Recall of rescue me... 展开 >>dication, alternative rescue medication availability issues.) 收起 << | - | - |
NCT00505414 | - | Terminated(Recall of rescue me... 展开 >>dication, alternative rescue medication availability issues.) 收起 << | - | - | |
NCT00144105 | HIV Infections | Phase 2 | Terminated | - | - |
NCT00528528 | Chronic Hepatitis C | Phase 2 | Completed | - | Austria ... 展开 >> Wien, Austria Belgium Brussels, Belgium Bruxelles, Belgium Gent, Belgium Leuven, Belgium Liège, Belgium France Angers Cedex 9, France Clichy, France Grenoble, France Lille Cedex, France Nice, France Paris Cedex 12, France Paris, France Vandoeuvre Les Nancy, France Germany Düsseldorf, Germany Frankfurt N/A, Germany Freiburg, Germany Hamburg, Germany Hannover, Germany Koln, Germany Tübingen, Germany Netherlands Leiden, Netherlands Nijmegen, Netherlands Spain Barcelona, Spain Madrid, Spain Valencia, Spain 收起 << |
NCT03170882 | Relapsed and/or Refractory Mul... 展开 >>tiple Myeloma 收起 << | Phase 2 Phase 3 | Recruiting | March 31, 2023 | - |
NCT00528528 | - | Completed | - | - | |
NCT00263588 | Neoplasms, Breast | Phase 2 | Completed | - | - |
NCT00665561 | - | Active, not recruiting | February 26, 2019 | - | |
NCT00099216 | Vascular Dementia | Phase 3 | Completed | - | - |
NCT00667251 | Breast Cancer | Phase 3 | Active, not recruiting | December 31, 2020 | - |
NCT00667251 | - | Active, not recruiting | - | - | |
NCT00312377 | Non-small Cell Lung Cancer ... 展开 >> Lung Cancer 收起 << | Phase 3 | Completed | - | - |
NCT02000427 | - | Completed | - | - | |
NCT02447302 | Ulcerative Colitis | Phase 2 | Completed | - | - |
NCT00418574 | Ovarian Cancer | Phase 2 Phase 3 | Terminated(No benefit on prima... 展开 >>ry end point (RFS); no rationale to collect survival data) 收起 << | - | - |
NCT00331851 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02000427 | Relapsed/Refractory Philadelph... 展开 >>ia Positive B-precursor ALL 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Research Site Duarte, California, United States, 91010 Research Site La Jolla, California, United States, 92093-0960 United States, Georgia Research Site Atlanta, Georgia, United States, 30322 United States, Minnesota Research Site Rochester, Minnesota, United States, 55905 United States, Missouri Research Site Saint Louis, Missouri, United States, 63110 United States, New York Research Site New York, New York, United States, 10065 United States, North Carolina Research Site Durham, North Carolina, United States, 27710 United States, Texas Research Site Houston, Texas, United States, 77030 France Research Site Nantes Cedex 1, France, 44093 Research Site Paris Cedex 10, France, 75475 Research Site Toulouse cedex 9, France, 31059 Germany Research Site Berlin, Germany, 12200 Research Site Essen, Germany, 45122 Research Site Frankfurt am Main, Germany, 60590 Research Site Würzburg, Germany, 97080 Italy Research Site Bergamo, Italy, 24127 Research Site Bologna, Italy, 40138 Research Site Roma, Italy, 00161 Research Site Venezia, Italy, 30174 Research Site Verona, Italy, 37134 United Kingdom Research Site London, United Kingdom, NW3 2PF Research Site Sutton, United Kingdom, SM2 5PT 收起 << |
NCT02205359 | Heart Failure With Left Bundle... 展开 >> Branch Block 收起 << | Not Applicable | Recruiting | March 2023 | - |
NCT00908037 | Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 << | Phase 2 | Completed | - | - |
NCT00690430 | Symptomatic Refractory Resista... 展开 >>nt Carcinoid Disease 收起 << | Phase 3 | Completed | - | - |
NCT00312377 | - | Completed | - | - | |
NCT02706847 | Rheumatoid Arthritis | Phase 3 | Active, not recruiting | August 6, 2020 | - |
NCT00940095 | Aneurysmal Subarachnoid Hemorr... 展开 >>hage 收起 << | Phase 3 | Terminated(Lack of efficacy da... 展开 >>ta from the Phase 3 clinical study (AC-054-301; CONSCIOUS-2)) 收起 << | - | - |
NCT00690430 | - | Completed | - | - | |
NCT00117637 | Carcinoma, Renal Cell | Phase 2 | Completed | - | - |
NCT00269048 | Atherosclerosis | Phase 2 | Completed | - | - |
NCT00117637 | - | Completed | - | - | |
NCT01112306 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Active, not recruiting | February 1, 2021 | - |
NCT02915159 | Sjogrens Disease | Phase 3 | Active, not recruiting | January 14, 2023 | - |
NCT01078688 | - | Completed | - | - | |
NCT00908037 | - | Completed | - | - | |
NCT02536404 | Ulcerative Colitis | Phase 2 | Active, not recruiting | October 26, 2018 | - |
NCT00280059 | Epilepsy, Partial | Phase 3 | Completed | - | - |
NCT00280059 | - | Completed | - | - | |
NCT01555099 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 2 | Completed | - | - |
NCT00768053 | Rheumatoid Arthritis | Phase 4 | Completed | - | France ... 展开 >> Pfizer Investigational Site Amiens, France, 80054 Pfizer Investigational Site Amiens, France, 80090 Pfizer Investigational Site Belfort, France, 90000 Pfizer Investigational Site Berck sur Mer, France, 62608 Pfizer Investigational Site Bonneville Cedex, France, 74136 Pfizer Investigational Site Cahors, France, 49000 Pfizer Investigational Site Corbeil-Essonnes, France, 91100 Pfizer Investigational Site Créteil, France, 94010 Pfizer Investigational Site Dijon, France, 21076 Pfizer Investigational Site Lomme, France, 59160 Pfizer Investigational Site Montpellier, France, 34000 Pfizer Investigational Site Mulhouse, France, 68100 Pfizer Investigational Site PARIS Cedex 14, France, 75674 Pfizer Investigational Site Paris, France, 75674 Pfizer Investigational Site Rodez Cedex 9, France, 12027 Pfizer Investigational Site Saint-priest En Jarez, France, 42270 Pfizer Investigational Site Valenciennes, France, 59322 Monaco Pfizer Investigational Site Monaco, Monaco, 98000 收起 << |
NCT00418574 | - | Terminated(No benefit on prima... 展开 >>ry end point (RFS); no rationale to collect survival data) 收起 << | - | - | |
NCT02076009 | Multiple Myeloma | Phase 3 | Active, not recruiting | September 29, 2020 | - |
NCT00768053 | - | Completed | - | - | |
NCT00175890 | Epilepsy, Partial | Phase 3 | Completed | - | - |
NCT02076009 | - | Active, not recruiting | - | - | |
NCT00381472 | Parkinson Disease | Phase 3 | Completed | - | - |
NCT02388906 | Melanoma | Phase 3 | Active, not recruiting | November 26, 2019 | - |
NCT00145457 | Growth Hormone Deficiency | Phase 4 | Completed | - | France ... 展开 >> Pfizer Investigational Site Besançon, France, 25030 Pfizer Investigational Site Bordeaux, France, 33000 Pfizer Investigational Site Dunkerque, France, 59385 Pfizer Investigational Site Limoges Cedex, France, 87042 Pfizer Investigational Site Nice, France, 06202 Pfizer Investigational Site Paris Cedex 14, France, 75674 Pfizer Investigational Site Tarbes, France, 65013 Pfizer Investigational Site Toulouse Cedex 9, France, 31059 收起 << |
NCT01977482 | Anaemia | Phase 2 | Completed | - | - |
NCT02164864 | - | Completed | - | - | |
NCT02164864 | Atrial Fibrillation ... 展开 >> Percutaneous Coronary Intervention 收起 << | Phase 3 | Completed | - | - |
NCT02923947 | Solid Tumours | Phase 1 | Active, not recruiting | December 31, 2019 | France ... 展开 >> Research Site Angers Cedex 2, France, 49055 Research Site Bordeaux Cedex, France, 33075 Research Site Dijon, France, 21079 Research Site Lille Cedex, France, 59020 Research Site Saint Herblain, France, 44805 Korea, Republic of Research Site Seoul, Korea, Republic of, 03080 Research Site Seoul, Korea, Republic of, 05505 Spain Research Site Madrid, Spain, 28040 Research Site Madrid, Spain, 28046 Research Site Madrid, Spain, 28050 Research Site Sevilla, Spain, 41013 收起 << |
NCT00909038 | - | Completed | - | - | |
NCT01977482 | - | Completed | - | - | |
NCT00376337 | Invasive Aspergillosis | Phase 2 | Terminated(Study was stopped d... 展开 >>ue to difficulties in recruitment and changes in standard care for invasive aspergillosis) 收起 << | - | - |
NCT00680186 | Thromboembolism | Phase 3 | Completed | - | - |
NCT01064037 | Heart Failure ... 展开 >> Heart Decompensation 收起 << | Phase 2 | Terminated | - | - |
NCT00680186 | - | Completed | - | - | |
NCT02413489 | Lymphoma, Mantle-Cell ... 展开 >> Lymphoma, Large B-Cell, Diffuse Lymphoma, Follicular 收起 << | Phase 2 | Terminated(DLBCL and FL cohort... 展开 >>s met the pre-specified futility criteria and will not proceed. The MCL cohort was terminated due to slow recruitment and aggressive disease.) 收起 << | - | - |
NCT02413489 | - | Terminated(DLBCL and FL cohort... 展开 >>s met the pre-specified futility criteria and will not proceed. The MCL cohort was terminated due to slow recruitment and aggressive disease.) 收起 << | - | - | |
NCT03624127 | Psoriasis | Phase 3 | Recruiting | July 19, 2020 | - |
NCT02555683 | Asthma | Phase 3 | Recruiting | December 20, 2019 | - |
NCT02878330 | Respiratory Syncytial Virus In... 展开 >>fections 收起 << | Phase 2 | Active, not recruiting | December 5, 2018 | - |
NCT01297465 | Assisted Reproductive Techniqu... 展开 >>es Reproductive Technology, Assisted 收起 << | Phase 3 | Completed | - | Denmark ... 展开 >> Merck Serono Research Site Dronninglund, Denmark Merck Serono Research Site Fredericia, Denmark Finland Merck Serono Research Site Helsinki, Finland France Merck Serono Research Site Bondy CEDEX, France Merck Serono Research Site Bruges, France Merck Serono Research Site Clamart CEDEX, France Merck Serono Research Site Tenon, France Merck Serono Research Site Villeurbanne, France Germany Merck Serono Research Site Berlin, Germany Merck Serono Research Site Halle, Germany Greece Merck Serono Research Site Heraklion, Crete, Greece Merck Serono Research Site Pylaia, Thessaloniki, Greece Merck Serono Research Site Athen, Greece Italy Merck Serono Research Site Bologna, Italy Merck Serono Research Site Firenze, Italy Merck Serono Research Site Torino, Italy Netherlands Merck Serono Research Site Zwolle, Netherlands Poland Merck Serono Research Site Warszawa, Poland Russian Federation Merck Serono Research Site Moscow, Russian Federation Merck Serono Research Site Samara, Russian Federation Slovakia Merck Serono Research Site Bratislava, Slovakia United Kingdom Merck Serono Research Site London, United Kingdom Merck Serono Research Site Swansea, United Kingdom 收起 << |
NCT03523858 | Progressive Multiple Sclerosis... 展开 >> (PMS) 收起 << | Phase 3 | Recruiting | January 31, 2024 | - |
NCT03345342 | Schizophrenia | Phase 3 | Recruiting | August 31, 2020 | - |
NCT03277105 | Multiple Myeloma | Phase 3 | Recruiting | October 8, 2020 | - |
NCT02477800 | Alzheimer's Disease | Phase 3 | Active, not recruiting | April 30, 2022 | - |
NCT02759419 | Hypertension, Pulmonary | Phase 4 | Recruiting | December 28, 2019 | France ... 展开 >> Recruiting Besancon, France, 25030 Recruiting Brest, France, F-29609 Recruiting Le Kremlin Bicetre Cedex, France, 94275 Recruiting Lille Cedex, France, 59037 Recruiting Rouen, France, 76031 Italy Withdrawn Roma, Lazio, Italy, 00161 Withdrawn Pavia, Lombardia, Italy, 27100 Korea, Republic of Recruiting Seoul, Korea, Republic of, 03080 Recruiting Seoul, Korea, Republic of, 03722 Recruiting Seoul, Korea, Republic of, 05505 Recruiting Seoul, Korea, Republic of, 06351 Thailand Withdrawn Bangkok, Thailand, 10330 收起 << |
NCT03367819 | Prostate Cancer ... 展开 >> Non-small Cell Lung Cancer 收起 << | Phase 1 Phase 2 | Recruiting | August 31, 2022 | United States, Alabama ... 展开 >> Investigational Site Number 8400003 Recruiting Birmingham, Alabama, United States, 35249 United States, California Investigational Site Number 8400009 Recruiting Santa Monica, California, United States, 90403 United States, Georgia Investigational Site Number 8400007 Recruiting Atlanta, Georgia, United States, 30322 United States, New Jersey Investigational Site Number 8400002 Recruiting Hackensack, New Jersey, United States, 07601 United States, Tennessee Investigational Site Number 8400005 Recruiting Nashville, Tennessee, United States, 37203 United States, Texas Investigational Site Number 8400006 Recruiting Dallas, Texas, United States, 75230 Investigational Site Number 8400004 Recruiting Houston, Texas, United States, 77030 France Investigational Site Number 2500002 Recruiting Bordeaux Cedex, France, 33076 Investigational Site Number 2500001 Recruiting Villejuif Cedex, France, 94805 Italy Investigational Site Number 3800006 Recruiting Napoli, Italy, 80131 Investigational Site Number 3800001 Recruiting Orbassano, Italy, 10043 Investigational Site Number 3800004 Recruiting Padova, Italy, 35128 Investigational Site Number 3800003 Recruiting Rozzano, Italy, 20089 Investigational Site Number 3800005 Recruiting Verona, Italy, 37134 Taiwan Investigational Site Number 1580002 Recruiting Tainan, Taiwan, 704 Investigational Site Number 1580001 Recruiting Taipei 100, Taiwan United Kingdom Investigational Site Number 8260002 Recruiting Newcastle Upon Tyne, United Kingdom, NE7 7DN Investigational Site Number 8260001 Recruiting Sutton, United Kingdom, SM2 5PT 收起 << |
NCT01297465 | - | Completed | - | - | |
NCT03668470 | Adult Subjects With Type1Diabe... 展开 >>tes and Insulin Microsecretion 收起 << | Phase 2 | Not yet recruiting | June 2020 | France ... 展开 >> Service d'Endocrinologie, Maladies Métaboliques et Nutrition, CHU Grenoble, Hopital de la Tronche Not yet recruiting La Tronche, France, 38700 Contact: Pierre-Yves BENHAMOU +33 4 76 76 55 09 PYBenhamou@chu-grenoble.fr Principal Investigator: Pierre-Yves BENHAMOU Sub-Investigator: Sandrine LABLANCHE Département d''Endocrinologie, Diabétologie, Nutrition ; CHU Montpellier ; Hôpital Lapeyronie, Avenue du Doyen Giraud Not yet recruiting Montpellier 5, France, 34295 Contact: Eric RENARD +33 4 67 33 83 82 e-renard@chu-montpellier.fr Principal Investigator: Eric RENARD Sub-Investigator: Anne WOJTUSCISZYN Service d'Endocrinologie, Maladies Métaboliques et Nutrition,CHU Nantes,Hôpital Nord Laennec,Bd Jacques-Monod,Saint-Herblain Not yet recruiting NANTES cedex 1, France, 44093 Contact: Bertrand CARIOU +33 2 53 48 27 01 bertrand.cariou@univ-nantes.fr Principal Investigator: Bertrand CARIOU Sub-Investigator: Lucy CHAILLOUS Service de Diabétologie et Maladies Métaboliques, Assistance Publique des Hôpitaux de Paris ;Hôpital Cochin, 27 rue du Faubourg Saint-Jacques Not yet recruiting Paris, France, 75014 Contact: Etienne LARGER +33 1 58 41 19 19 etienne.larger@cch.aphp.fr Principal Investigator: Etienne LARGER Service d'Endocrinologie, Diabétologie, Maladies de la Nutrition, Hospices Civils de Lyon, Centre hospitalier Lyon-Sud Not yet recruiting Pierre-Bénite, France, 69495 Contact: Charles THIVOLET +33 4 78 86 14 87 charles.thivolet@chu-lyon.fr Principal Investigator: Charles THIVOLET Sub-Investigator: Lucien MARCHAND Service de Diabétologie Maladies Métaboliques et Nutrition ; CHU Toulouse, Pôle cardiovasculaire et métabolique, Hôpital Rangueil ; 1, avenue du Professeur Jean Poulhès - TSA 50032 Not yet recruiting TOULOUSE cedex 9, France, 31059 Contact: Hélène HANAIRE : +33 5 61 32 30 18 hanaire.h@chu-toulouse.fr Principal Investigator: Hélène HANAIRE Service de Diabétologie, Maladies Métaboliques, Nutrition ; CHU Nancy ; Technopôle Nancy-Brabois ; Rue du Morvan, Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Bruno GUERCI +33 3 83 65 65 28 b.guerci@chu-nancy.fr Principal Investigator: Bruno GUERCI 收起 << |
NCT03575351 | Lymphoma, Non-Hodgkin | Phase 3 | Recruiting | January 13, 2023 | - |
NCT03023423 | Carcinoma, Non-Small-Cell Lung | Phase 1 Phase 2 | Active, not recruiting | April 24, 2019 | - |
NCT02659020 | Soft Tissue Sarcoma | Phase 1 Phase 2 | Recruiting | December 2020 | - |
NCT02808390 | Ulcerative Colitis | Phase 2 | Terminated(Sponsor decision) | - | - |
NCT01387594 | - | Completed | - | - | |
NCT03568929 | - | Recruiting | November 2020 | Austria ... 展开 >> Landeskrankenhaus Steyr Not yet recruiting Steyr, Austria France Centre Hospitalier Universitaire d'Amiens (CHU d'Amiens) - Hopital Nord Not yet recruiting Amiens Cedex 1, France, 80054 Centre Hospitalier Bourg-en-Bresse Fleyriat Recruiting Bourg-en-Bresse, France CHU de Dijon Not yet recruiting Bourgogne, France, 2100 Centre Hospitalier de Cannes Not yet recruiting Cannes, France, 06400 Hôpital Privé Sévigné Not yet recruiting Cesson-Sévigné, France Centre Hospitalier Chalon sur Saône William Morey Recruiting Chalon-Sur-Saone, France, 71100 Centre Hospitalier Universitaire Estaing Not yet recruiting Clermont-Ferrand, France, 63003 Groupe Hospitalier Mutualiste de Grenoble - Institut Daniel Hollard Recruiting Grenoble, France Clinique Victor Hugo Not yet recruiting Le Mans Cedex 2, France Centre Hospitalier Le Mans Not yet recruiting Le Mans, France, 72037 Centre Hospitalier de Lens Not yet recruiting Lens, France, 62300 Centre Hospitalier Régional d'Orléans Recruiting Orléans, France, 45650 Centre hospitalier de Perigueux Not yet recruiting Pessac, France, 33604 Germany Klinikum Frankfurt Hochst Not yet recruiting Frankfurt, Germany, 65929 Klinikum Südstadt Rostock Not yet recruiting Rostock, Germany Gemeinschaftspraxis für Hämatologie und Onkologie Westerstede Recruiting Westerstede, Germany, 26655 Ireland Midland Regional Hospital - Mullingar Not yet recruiting Mullingar, Ireland Italy Ospedali Riuniti di Ancona, Clinica Ematologica Not yet recruiting Ancona, Italy, 60126 Ospedale Mazzoni Recruiting Ascoli Piceno, Italy Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Not yet recruiting Brescia, Italy Azienda Ospedaliera Universitaria Maggiore Della Carita di Novara Recruiting Novara, Italy, 28100 Ospedale Casa Sollievo della Sofferenza Not yet recruiting San Giovanni Rotondo, Italy, 71013 Spain Hospital Universitario Son Dureta Not yet recruiting Palma de Mallorca, Spain Clínica Universidad de Navarra Not yet recruiting Pamplona, Spain 收起 << | |
NCT01387594 | Crohn's Disease ... 展开 >> Ileitis Ileo-colonic and Colonic Crohn's Disease Granulomatous Colitis Regional Enteritis Ulcerative Colitis 收起 << | Phase 1 | Completed | - | Austria ... 展开 >> AKH Wien Universitaetsklinik fuer Innere Medizin III Klinische Abteilung fuer Gastroenterologie und Wien, Austria, 1090 Belgium Hopital Erasme Brussels, Belgium, B-1000 UZ Gasthuisberg Leuven, Belgium, B-3000 France Hopital Cardiologique Lille Cedex, France, 59037 Hopital Huriez, CHRU de Lille Lille Cedex, France, 59037 Hopital Saint-Louis - CIC Paris, France, 75010 Hopital Saint-Louis Paris, France, 75010 Germany Charité, Universitaetsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany, 13353 Netherlands Academic Medical Center - University of Amsterdam, Dept. of Gastroenterology Amsterdam, Netherlands, 1105 AZ 收起 << |
NCT01218672 | Benign Prostatic Hyperplasia | Phase 4 | Unknown | January 2015 | Austria ... 展开 >> Krankenhaus der Barmherzigen Schwestern Linz Linz, Austria Belgium AZ Maria Middelares Gent Gent, Belgium France Nouvel Hopital Civil de Strasbourg Strasbourg Cedex, France CHU Bretonneau Tours Cedex, France Germany Helmut Knispel Berlin, Germany Kurt Miller Berlin, Germany Krankenhaus Nordwest Frankfurt, Germany University Hospital of Heidelberg Heidelberg, Germany, 69120 Hospital University of Jena Jena, Germany Universitatsklinikum Schleswig-Holstein, Campus Kiel Kiel, Germany Universitatsklinikum Leipzig Leipzig, Germany Prof. Martin Schostak Magdeburg, Germany Diakoniekrankenhaus Rotenburg (W.) gGmbH Rotenburg (Wumme), Germany Italy Unita di chirurgia Urologica mininvasiva,Azienda Ospedatiera Sant'Andrea Hospital Rome, Italy Netherlands ZGT Almelo Almelo, Netherlands RadBound University Njmegen Medical Centre Njmegen, Netherlands, 6500 HB Nijmegen Spain Carlos Capitan Madrid, Spain Hospital de Manacor Manacor, Spain Switzerland University of Basel Basel, Switzerland United Kingdom Frimley Park Hospital Frimley, Camberley Surrey, United Kingdom, GU16 7UJ- UK Brighton and Sussex University Hospitals NHS Trust Brighton, East Sussex, United Kingdom, BN2 1EX UK Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, Hampshire, United Kingdom, RG24 9NA, UK Princess of Wales Hospital Mid Glamorgan, Wales UK, United Kingdom, CF31 1RQ Nirjan Gogoi Dewsbury, United Kingdom Western General Hospital Edinburgh, United Kingdom, EH4 2XU Nitin Shrotri Kent, United Kingdom Kings's College Hospital London,, United Kingdom, SE5 9RS Mr Stuart Graham London, United Kingdom Mr Andrew Thorpe Newcastle, United Kingdom 收起 << |
NCT02808390 | - | Terminated(Sponsor decision) | - | - | |
NCT03444870 | Alzheimer Disease | Phase 3 | Recruiting | May 2, 2023 | - |
NCT03611751 | Psoriasis | Phase 3 | Recruiting | July 8, 2020 | - |
NCT02965846 | Dry Eye Syndromes | Phase 3 | Terminated | - | - |
NCT03528551 | Congenital Bleeding Disorder ... 展开 >> Haemophilia A 收起 << | Phase 3 | Enrolling by invitation | December 3, 2020 | - |
NCT03451422 | Systemic Lupus Erythematosus | Phase 1 Phase 2 | Recruiting | February 27, 2022 | United States, New York ... 展开 >> Research Site Recruiting Great Neck, New York, United States, 11021 United States, Pennsylvania Research Site Recruiting Duncansville, Pennsylvania, United States, 16635 France Research Site Recruiting Lille cedex 01, France, 59037 Research Site Recruiting Paris Cedex 13, France, 75651 Research Site Recruiting Strasbourg, France, 67091 Germany Research Site Recruiting Berlin, Germany, 10117 Poland Research Site Recruiting Poznan, Poland, 60-848 Research Site Recruiting Swidnik, Poland, 21-040 Research Site Recruiting Warszawa, Poland, 00-874 Research Site Recruiting Wroclaw, Poland, 51-124 收起 << |
NCT03419897 | Hepatocellular Carcinoma (HCC) | Phase 2 | Recruiting | September 2021 | United States, Ohio ... 展开 >> Dayton Oncology & Hematology, P.A. Recruiting Kettering, Ohio, United States, 45409 China, Guangdong Nanfang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 China, Heilongjiang Harbin Medical University Cancer Hospital Recruiting Harbin, Heilongjiang, China, 150081 China, Hubei Union Hospital Tongji Medical College Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430022 Hubei Cancer Hospital Recruiting Wuhan, Hubei, China, 430079 China, Jiangsu Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China, 221009 China, Shandong Weifang People's Hospital Recruiting Weifang, Shandong, China, 261041 China, Shanghai Zhongshan Hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 China, Zhejiang The First Affiliated Hospital, Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 Principal Investigator: Weijia Fang, The First Affiliated Hospital, Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 Principal Investigator: Sheng Yan Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 The First Affiliated Hospital of Wenzhou Medical University Recruiting Wenzhou, Zhejiang, China, 00000 China Chinese PLA General Hospital Medical School of Chinese PLA Recruiting Beijing, China, 100853 France Groupe Hospitalier Sud - Hôpital Haut Lévêque Recruiting Pessac Cedex, Gironde, France, 33604 Hopital Saint Eloi Recruiting Montpellier, Herault, France, 34090 CRLCC Eugene Marquis Recruiting Rennes cedex, Ille Et Vilaine, France, 35042 Centre Hospitalier de la Croix Rousse Recruiting Lyon, Rhone, France, 69004 Italy Istituto Clinico Humanitas Recruiting Rozzano, Milano, Italy, 20089 收起 << |
NCT03473756 | Urothelial Carcinoma | Phase 1 Phase 2 | Recruiting | July 25, 2022 | - |
NCT03032380 | Healthcare-associated Pneumoni... 展开 >>a (HCAP) Hospital Acquired Pneumonia (HAP) Ventilator Associated Pneumonia (VAP) 收起 << | Phase 3 | Recruiting | February 1, 2019 | - |
NCT02965846 | - | Terminated | - | - | |
NCT03194542 | Primary Myelofibrosis ... 展开 >> Anemia 收起 << | Phase 2 | Recruiting | November 21, 2023 | United States, Arizona ... 展开 >> Mayo Clinic - Arizona Recruiting Phoenix, Arizona, United States, 85054 United States, California Stanford Cancer Center Recruiting Stanford, California, United States, 94305 United States, Florida Mayo Clinic - Jacksonville Recruiting Jacksonville, Florida, United States, 32224 Mid Florida Hematology and Oncology Centers, PA Recruiting Orange City, Florida, United States, 32763 H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 United States, New York Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 United States, South Dakota Avera Research Institute Recruiting Sioux Falls, South Dakota, United States, 57105 United States, Texas MD Anderson Cancer Center The University of Texas Recruiting Houston, Texas, United States, 77030 University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 France CHRU de Brest - Hopital Morvan Recruiting Brest Cedex, France, 29609 Centre Hospitalier de Lens Recruiting Lens Cedex, France, 62307 Hopital Saint Louis Recruiting Paris, France, 75010 Institut Gustave Roussy Recruiting Villejuif, France, 94805 Italy Azienda Ospedaliera Papa Giovanni XXIII Recruiting Bergamo, Italy, 24127 Azienda Ospedaliera Universitaria Careggi Recruiting Firenze, Italy, 50134 Fondazione IRCCS Policlinico San Matteo Recruiting Pavia, Italy, 27100 Istituto Clinico Humanitas Recruiting Rozzano (MI), Italy, 20089 Ospedale di Circolo di Varese Recruiting Varese, Italy, 21100 United Kingdom Belfast Health and Social Care Trust Not yet recruiting Belfast Northern Ireland, United Kingdom, BT9 7AB University Hospital of Wales Recruiting Cardiff, United Kingdom, CF14 4XW University of Oxford Recruiting Headington, Oxford, United Kingdom, OX3 7LE Guys Hospital Recruiting London, United Kingdom, SE1 9RT Imperial College London Recruiting London, United Kingdom, W12 0HS 收起 << |
NCT00979407 | - | Completed | - | - | |
NCT00979407 | Influenza | Phase 3 | Completed | - | France ... 展开 >> GSK Investigational Site Caen cedex 9, France, 14033 GSK Investigational Site Paris Cedex 18, France, 75877 GSK Investigational Site Paris, France, 75679 GSK Investigational Site Poitiers, France, 86000 Germany GSK Investigational Site Regensburg, Bayern, Germany, 93053 GSK Investigational Site Wuerzburg, Bayern, Germany, 97070 GSK Investigational Site Schmiedeberg, Sachsen, Germany, 01762 收起 << |
NCT03519256 | Bladder Cancer ... 展开 >> Bladder Tumors Neoplasms, Bladder 收起 << | Phase 2 | Recruiting | April 16, 2023 | - |
NCT01459016 | Alzheimer's Disease | Phase 1 | Completed | - | France ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cahors, France, 46005 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Castres, France, 81108 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Foix Cedex, France, 09017 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lavaur, France, BP85 81502 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France, 59037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Limoges, France, 87042 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Léon, France, 33076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marseille, France, 13385 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montauban Cedex, France, 82013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nancy, France, 54511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75651 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rennes, France, 35000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Strasbourg, France, 67091 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31059 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tours, France, 37044 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vic-En-Bigorre, France, 65500 收起 << |
NCT02955355 | Chronic Inflammatory Demyelina... 展开 >>ting Polyradiculoneuropathy 收起 << | Phase 3 | Recruiting | September 30, 2024 | Canada, Ontario ... 展开 >> Toronto General Hospital, University Health Network Recruiting Toronto, Ontario, Canada, M5G 2C4 Czechia Fakultni nemocnice Ostrava Recruiting Ostrava, Poruba, Czechia, 708 52 Fakultni nemocnice v Motole, Dept of Neurologicka klinika 2. LF UK a FN Motol Recruiting Prague 5, Czechia, 150 06 Denmark Århus Universitetshospital, Neurologisk Terminated Aarhus C, Denmark, 8000 France Groupe Hospitalier Pellegrin - Hôpital Pellegrin Recruiting Bordeaux Cedex, Gironde, France, 33076 Hopital Neurologique Pierre Wertheimer, Pathologies neuro-musculaires. Electromyographie Recruiting Bron Cedex, Rhone, France, 69677 Greece University of Patras Medical School Recruiting Patras, Greece, 26504 Italy Azienda Ospedaliera Universitaria Policlinico G. Martino, UOC Neuropatologia Recruiting Messina, Italy, 98122 Fondazione Istituto Neurologico Casimiro Mondino, Unità Complessa Malattie Cerebrovascolari/Stroke U Recruiting Pavia, Italy, 27100 Azienda Ospedaliero Universitaria Pisana, Dipartimento di Neuroscienze Recruiting Pisa, Italy, 56126 Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, U.O. di Neurologia Recruiting Udine, Italy, 33100 Serbia Clinical Center of Serbia, Clinic of Neurology Recruiting Belgrade, Serbia, 11000 Military Medical Academy Recruiting Belgrade, Serbia, 11000 Clinical Center Nis Recruiting Nis, Serbia, 18000 Slovakia Fakultna nemocnica Nitra, Ambulancia pre nervosvalové ochorenia Recruiting Nitra, Slovakia, 95001 Spain Hospital Universitari Vall d'Hebron, Neurology Dept. Recruiting Barcelona, Spain, 08035 Turkey Pamukkale Uni. Med. Fac., Emergency Medicine Recruiting Denizli, Turkey, 20070 Dokuz Eylul University Faculty of Medicine, Neurology Department Recruiting Izmir, Turkey, 35340 Selcuk Universitesi Selcuklu Tip Fakultesi Hastanesi, Brain and Nerve Surgery Recruiting Konya, Turkey, 42075 United Kingdom The Walton Centre, Dept of Neurology Recruiting Liverpool, Merseyside, United Kingdom, L9 7LJ 收起 << |
NCT02197234 | Non Small Cell Lung Cancer | Phase 1 | Active, not recruiting | December 31, 2018 | United States, Georgia ... 展开 >> Research Site Atlanta, Georgia, United States, 30322 Belgium Research Site Leuven, Belgium, 3000 France Research Site Angers Cedex 9, France, Angers Cedex 9 Research Site Dijon cedex, France, 21079 Research Site Marseille, France, 13385 Research Site Rennes, France, 35033 Research Site Saint Herblain, France, 44805 Korea, Republic of Research Site Seongnam-si, Korea, Republic of, 463-707 Research Site Seoul, Korea, Republic of, 03080 Research Site Seoul, Korea, Republic of, 03722 Research Site Seoul, Korea, Republic of, 05505 Research Site Seoul, Korea, Republic of, 06351 Spain Research Site Badalona, Spain, 08916 Research Site Barcelona, Spain, 08041 Research Site Madrid, Spain, 28046 Research Site Sevilla, Spain, 41013 收起 << |
NCT01271920 | Advanced HER2-positive Breast ... 展开 >>Cancer 收起 << | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 France Novartis Investigative Site Dijon Cedex, France, 21034 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Tuebingen, Germany, 72076 Italy Novartis Investigative Site Prato, PO, Italy, 59100 Novartis Investigative Site Candiolo, TO, Italy, 10060 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 Novartis Investigative Site Madrid, Spain, 28009 Sweden Novartis Investigative Site Stockholm, Sweden, SE-171 76 United Kingdom Novartis Investigative Site Birmingham, United Kingdom, B15 2TT Novartis Investigative Site Leicester, United Kingdom, LE1 5WW Novartis Investigative Site Manchester, United Kingdom, M20 2BX Novartis Investigative Site Oxford, United Kingdom, OX2 6HE 收起 << |
NCT03517956 | Advanced or Metastatic Solid T... 展开 >>umor 收起 << | Phase 1 | Recruiting | March 10, 2021 | - |
NCT01459016 | - | Completed | - | - | |
NCT02720731 | - | Unknown | November 2017 | France ... 展开 >> Centre Creac'h Ar Roual Recruiting Dirinon, France, 29460 Contact: Françoise ROGE IME section polyhandicapes Kerlaouen Recruiting Guipavas, France, 29490 Contact: Françoise ROGE SEAPH-IME Kerveguen Not yet recruiting Plabennec, France, 29860 Contact: Sylvain Brochard IEM Plerin Not yet recruiting Plerin cedex, France, 22193 Contact: Bruno Fagnet IEM Ar Men Not yet recruiting Ploemeur, France, 56270 Contact: Mathilde Creusat Centre de Rééducation fonctionnelle de Kerpape Recruiting Ploemeur, France, 56275 Contact: Hélène Le Tallec CHRU de Rennes Not yet recruiting Rennes, France, 35000 Contact: Hélène Rauscent Fondation Ildys site de Perhardy Recruiting Roscoff Cedex, France, 29684 Contact: Sylvaine Rumeur Centre Rééducation Trestel Not yet recruiting Trevou Treguignec, France, 22660 Contact: Laurent Jesequel EEAP Maison de L'estran Not yet recruiting Trevou Treguignec, France, 22660 Contact: Dr Darnois 收起 << | |
NCT02197234 | - | Active, not recruiting | - | - | |
NCT02568683 | Non-Hodgkin Lymphoma | Phase 1 Phase 2 | Completed | - | United States, Mississippi ... 展开 >> Forrest General Hospital Hattiesburg, Mississippi, United States United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States France Groupe Hospitalier du Haut Leveque Pessac, Aquitaine, France Centre Hospitalier Régional Universitaire de Lille (CHRU de Lille) Lille cedex, Nord Pas-de-calais, France Institut Paoli Calmettes Marseille, Provence Alpes Cote D'azur, France Centre Hospitalier Universitaire de Dijon Hôpital du Bocage Dijon Cedex, France Centre Hospital Lyon Sud Pierre Benite, France 收起 << |
NCT02465528 | Tumors With Aberrations in ALK | Phase 2 | Completed | - | Czechia ... 展开 >> Novartis Investigative Site Brno, Czech Republic, Czechia, 656 53 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Novartis Investigative Site Strasbourg, France, F-67085 Germany Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Mainz, Germany, 55131 Israel Novartis Investigative Site Tel Aviv, Israel, 64239 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Milano, MI, Italy, 20133 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28034 Novartis Investigative Site Madrid, Spain, 28040 Thailand Novartis Investigative Site Bangkok, Thailand, 10330 Novartis Investigative Site Bangkok, Thailand, 10700 收起 << |
NCT02077933 | Neoplasms Bre... 展开 >>ast Neoplasms Kidney Neoplasms Pancreatic Neuroendocine Neoplasms 收起 << | Phase 1 | Active, not recruiting | November 30, 2018 | United States, Arkansas ... 展开 >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, New York Memorial Sloan Kettering Cancer Center SC - BYL719Z2102 New York, New York, United States, 10065 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 12203 Novartis Investigative Site Essen, Germany, 45136 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Hannover, Germany, 30625 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Hungary Novartis Investigative Site Budapest, Hungary, H-1077 Italy Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Milano, MI, Italy, 20141 Novartis Investigative Site Modena, MO, Italy, 41124 Novartis Investigative Site Verona, VR, Italy, 37126 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Utrecht, Netherlands, 3584CX Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28007 Novartis Investigative Site Madrid, Spain, 28034 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT02278718 | Thermal Burns | Phase 3 | Recruiting | July 2019 | Belgium ... 展开 >> University Hospital, Department of Plastic Surgery Recruiting Gent, Belgium, B 9000 Contact: Prof. Dr. Stan J. Monstrey 0032-(0) 9-332 2220 stan.monstrey@UGENT.be Bulgaria UMHATEM N.I.Pirogov Recruiting Sofia, Bulgaria, 1606 Contact: Dr. Prof. Ognyan Hadzhiyski 00359 2 9526690 burns_hadj@hotmail.com France Hôpital Pellegrin - Tripode Recruiting Bordeaux cedex, France, 33076 Contact: Pr. Vincent Casoli 00 33 (0)5 56 79 56 79 vincent.casoli@chu-bordeaux.fr Hôpital Nord Recruiting Marseille, France, 13015 Contact: Dr. Renaud Vialet 0033(0)4 91 96 86 68 renaud.vialet@ap-hm.fr Service de Chirurgie Plastique, Centre des Brûlés Recruiting Nantes cedex, France, 44093 Contact: Pr. Franck Duteille 02 40 08 37 12 pierre.perrot@chu-nantes.fr Germany Unfallkrankenhaus Berlin Zentrum für Schwerbrandverletzte mit Plastischer Chirurgie Recruiting Berlin, Germany, 12683 Contact: Dr. Bernd Hartmann 030 5681 3501 bernd.hartmann@ukb.de AKK Altonaer Kinderkrankenhaus Recruiting Hamburg, Germany, D- 22763 Contact: Dr. med. Ingo Königs +49 40 88908- 230 ingo.koenigs@kinderkrankenhaus.de Klinikum Nürnberg Kinderchirurgie Recruiting Nürnberg, Germany, 90471 Contact: Dr. Karl Bodenschatz Contact 0911 398-5455 karl.bodenschatz@klinikum-nuernberg.de Klinikum Stuttgart - Olgahospital Recruiting Stuttgart, Germany, D-70176 Contact: Dr. Torsten Hannmann +49 711 2787 3625 t.hanmann@klinikum-stuttgart.de Israel Rambam Healthcare Campus Recruiting Haifa, Israel, 3525408 Contact: Dr. Prof.Yehuda Ullmann +972-4-8542794 y_ullmann@rambam.health.gov.il Italy Ospedale Sant'Eugenio Not yet recruiting Roma, Italy Contact: Dr Giancarlo Delli Santi +393203678544 gdsanti@yahoo.com Netherlands Acute Burn Care &Trauma Surgery, Dept Surgery/Burn Center, Rode Kruis Ziekenhuis, LUMC University Leiden Recruiting Beverwijk, Netherlands, 1942 Contact: Prof. Dr. Rolf Breederveld 0031 251 265555 rbreederveld@rkz.nl Romania Spitalul Clinic de Urgenta pentru Copii, "Grigore Alexandrescu" Recruiting Bucharest, Romania, 011743 Contact: DR. Prof. Dan Mircea Enescu +40744355511 enescudr@hotmail.com Spitalul Clinic de Urgență pentru Copii Recruiting Cluj, Romania, 400001 Contact: Dr. Horatiu Gocan +4 0744500525 horatiugocan@yahoo.com Spitalul Clinic de Urgenta pentru Copii "Sfanta Maria" Recruiting Iasi, Romania, 700309 Contact: Dr. Elena Hanganu +4 0744709689 dr.elenahanganu@gmail.com Spitalul Clinic de Urgenta Tg- Mures Recruiting Tg-Mures, Romania, 54000 Contact: Dr. Gheorghe Horea Gozar +4 0740070534 horea_gozar@yahoo.com Spitalul Clinic de Urgenta pentru Copii "Louis Turcanu" Recruiting Timisoara, Romania, 300011 Contact: DR. Sorin Eugen Boia +4 0732890553 boiaeugen@yahoo.com Slovakia Univerzitná nemocnica Bratislava, Klinika popálenin a rekonštrukčnej chirurgie Recruiting Bratislava, Slovakia, 826 06 Contact: Dr. Ján Koller +421(2)48234527 koller@ru.unb.sk Klinika popálenin a rekonštrukčnej chirurgie, Nemocnica Košice-Šaca a.s. Recruiting Košice-Šaca, Slovakia, 040 15 Contact: Dr. Prof. Peter Lengyel 00421911500551 plengyel@nemocnicasaca.sk Spain Vall d'Hebron Institut de Recerca (VHIR) Recruiting Barcelona, Spain, 08035 Contact: Dr. Ricardo Palao +34 629 33 01 02 rpalao@vhebron.net La Paz University Hospital Recruiting Madrid, Spain, 28046 Contact: Dr. Juan Carlos López Gutierrez +34 639 20 38 67 queminfantil.hulp@salud.madrid.org Boulevar Sur s/n Recruiting Valencia, Spain, 46026 Contact: Dr. Patricia Gutierrez Ontalvilla +34 669 88 49 28 patricia@dragutierrez.com Aragonese Institute of Health Sciences Not yet recruiting Zaragoza, Spain, 50009 Contact: Dr. Enrique Monclús Fuertes +34 607 476 794 doctorenriquemonclus@gmail.com Sweden Brännskadecentrum, VO Plastikkirurgi och Käkkirurgi, Akademiska sjukhuset Recruiting Uppsala, Sweden, 751 85 Contact: Prof. Dr. Fredrik Huss +46 70 7941 574 fredrik.huss@akademiska.se United Kingdom Queen Victoria Hospital Recruiting East Grinstead, West Sussex, United Kingdom, RH19 3DZ Contact: Dr. Baljit Dheansa 0044 1342 4140 24 Baljit.Dheansa@QVH.nhs.uk Birmingham Children´s Hospital NHS Foundation Trust Not yet recruiting Birmingham, United Kingdom Contact: Dr. Yvonne Wilson +44 121 333 8964 收起 << |
NCT02213731 | Atrial Fibrillation | Not Applicable | Completed | - | France ... 展开 >> Hôpital Henri Mondor Créteil, France CHU de Grenoble Grenoble, France CHU de la Timone Marseille Cedex, France CHU - Hôpitaux de Rouen Rouen Cedex, France Clinique Pasteur Toulouse, France Germany Herz- und Diabeteszentrum NRW Bad Oeynhausen, Germany Charite - Universitaetsmedizin Berlin, Germany, 10117 Cardioangiologisches Centrum Bethanien Frankfurt, Germany Asklepios Klinik St. Georg Hamburg, Germany Krankenhaus Porz am Rhein Köln, Germany St. Vinzenz-Hospital Köln, Germany Klinikum Nürnberg Süd Nürnberg, Germany Uniklinik Ulm Ulm, Germany Greece Henry Dunant Hospital Center Athens, Greece, 11526 收起 << |
NCT02513186 | Plasma Cell Myeloma | Phase 1 | Recruiting | August 2022 | France ... 展开 >> Investigational Site Number 250002 Active, not recruiting Nantes Cedex 01, France, 44093 Investigational Site Number 250003 Completed Pierre Benite, France, 69310 Investigational Site Number 250001 Active, not recruiting Toulouse Cedex 9, France, 31059 Germany Investigational Site Number 276003 Active, not recruiting Berlin, Germany, 12200 Investigational Site Number 276002 Active, not recruiting Leipzig, Germany, 04103 Italy Investigational Site Number 380003 Active, not recruiting Milano, Italy, 20132 Investigational Site Number 380002 Completed Roma, Italy, 00161 Investigational Site Number 380001 Active, not recruiting Torino, Italy, 10126 Spain Investigational Site Number 724003 Recruiting Madrid, Spain, 28041 Investigational Site Number 724001 Recruiting Pamplona, Spain, 31008 Investigational Site Number 724002 Recruiting Salamanca, Spain, 37007 收起 << |
NCT00500292 | Colorectal Ca... 展开 >>ncer 收起 << | Phase 2 | Completed | - | France ... 展开 >> Research Site Lille Cedex, France Research Site Toulouse Cedex 9, France Hungary Research Site Budapest, Hungary Research Site Debrecen, Hungary Research Site Szeged, Hungary Korea, Republic of Research Site Seoul, Korea, Republic of Slovakia Research Site Bratislava, Slovakia Research Site Poprad, Slovakia Research Site Trnava, Slovakia Research Site Zilina, Slovakia Spain Research Site Hospitalet deLlobregat, Spain Research Site Oviedo, Spain Research Site Santander, Spain Taiwan Research Site Taipei, Taiwan Research Site Tao-Yuan, Taiwan 收起 << |
NCT00555009 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00500292 | - | Completed | - | - | |
NCT00308581 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT02875223 | Lymphoma, Non-Hodgkin ... 展开 >> Neoplasms 收起 << | Phase 1 | Recruiting | June 18, 2021 | France ... 展开 >> Centre Georges Francois Leclerc Recruiting Dijon, France, 21079 Institut Paoli Calmettes Recruiting Marseille Cedex 9, France, 13273 Institut Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Italy Bologna University Recruiting Bologna, Italy, 40123 Istituto Nazionale Dei Tumori Recruiting Milano, Italy, 20133 Istituto Europeo di Oncologia Recruiting Milano, Italy, 20141 Spain Hospital Universitario Vall D hebron Recruiting Barcelona, Spain, 08035 Fundacion Jimenez Daaz Recruiting Madrid, Spain, 28040 Hospital Universitario Marques de Valdecilla Recruiting Santander, Spain, 39008 United Kingdom Royal Marsden Hospital Recruiting London, United Kingdom, SW3 6JJ Freeman Hospital Recruiting Newcastle Upon Tyne, United Kingdom, NE7 7DN 收起 << |
NCT00122330 | Hemoglobinuria, Paroxysmal | Phase 3 | Completed | - | - |
NCT01389427 | Mantle Cell Lymphoma Refractor... 展开 >>y 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> CHU de Grenoble MICHALLON Grenoble Cedex 9, Hôpital Nord 217, France, 38043 Hôtel Dieu - Université de Nantes Nantes cedex, Place Alexis Ricordeau, France, 44093 Hôpital Henri Mondor Creteil, France, 94010 CHU de Dijon Dijon, France, 21000 Hôpital Saint-Eloi Montpellier, France, 34295 Hôpital Saint Louis Paris, France, 75475 Hôpital Necker Paris, France, 75743 Groupe hospitalier Sud Hôpital Haut-Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69310 CHU Pontchaillou Rennes, France, 35003 CHU de Tours - Hôpital Bretonneau Tours, France, 37000 收起 << |
NCT00555009 | Brain Injuries ... 展开 >> Growth Hormone Deficiency 收起 << | Phase 4 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | France ... 展开 >> Pfizer Investigational Site Creteil Cedex, France, 94010 Pfizer Investigational Site Paris Cedex 13, France, 75651 Italy Pfizer Investigational Site Ferrara, Italy, 44100 Pfizer Investigational Site Roma, Italy, 00168 Netherlands Pfizer Investigational Site Rotterdam, Netherlands, 3015 GD Spain Pfizer Investigational Site Sevilla, Spain, 41013 Sweden Pfizer Investigational Site Göteborg, Sweden, 413 45 Pfizer Investigational Site Stockholm, Sweden, 171 76 United Kingdom Pfizer Investigational Site Salford, Manchester, United Kingdom, M6 8HD 收起 << |
NCT01614665 | Heart Transplantation ... 展开 >> Kidney Transplantation Liver Transplantation 收起 << | Phase 2 | Active, not recruiting | May 2026 | Czechia ... 展开 >> Site CZ61 Prague 5, Czechia, 150 06 France Site FR33 Bron Cedex, France, 69677 Site FR32 Paris Cedex 15, France Italy Site IT52 Rome, Italy, 00165 Poland Site PL71 Warsaw, Poland, 04-730 United Kingdom Site GB43 Birmingham, United Kingdom, B4 6NH Site GB46 Liverpool, United Kingdom, L12 2AP Site GB44 London, United Kingdom, SE5 9RS Site GB45 London, United Kingdom, WC1 3JH Site GB42 Manchester, United Kingdom, M13 9WL 收起 << |
NCT01086254 | Non-small Cell Lung Cancer Sta... 展开 >>ge IV 收起 << | Phase 2 | Completed | - | France ... 展开 >> Sanofi-Aventis Investigational Site Number 250002 Caen Cedex, France, 14033 Sanofi-Aventis Investigational Site Number 250003 Marseille Cedex 09, France, 13009 Sanofi-Aventis Investigational Site Number 250004 Toulouse, France, 31059 Sanofi-Aventis Investigational Site Number 250001 Villejuif, France, 94805 Germany Sanofi-Aventis Investigational Site Number 276003 Essen, Germany, 45122 Sanofi-Aventis Investigational Site Number 276002 Gauting, Germany, 82131 Sanofi-Aventis Investigational Site Number 276001 Großhansdorf, Germany, 22927 Italy Sanofi-Aventis Investigational Site Number 380003 Livorno, Italy, 57123 Sanofi-Aventis Investigational Site Number 380001 Orbassano, Italy, 10043 Sanofi-Aventis Investigational Site Number 380002 Rozzano, Italy, 20089 Spain Sanofi-Aventis Investigational Site Number 724001 Badalona, Spain, 08916 Sanofi-Aventis Investigational Site Number 724002 Barcelona, Spain, 08035 United Kingdom Sanofi-Aventis Investigational Site Number 826001 Newcastle Upon Tyne, United Kingdom, NE7 7DN Sanofi-Aventis Investigational Site Number 826002 Wolverhampton, United Kingdom, WV10 0QP 收起 << |
NCT02317016 | Non Small Cell Lung Cancer | Phase 1 | Completed | - | United States, Virginia ... 展开 >> Research Site Fairfax, Virginia, United States, 22031 France Research Site Bordeaux Cedex, France, 33075 Research Site Bordeaux Cedex, France, 33076 Research Site Montpellier, France, 34298 Research Site Rennes, France, 35033 Spain Research Site Barcelona, Spain, 08036 Research Site Madrid, Spain, 28007 Research Site Málaga, Spain, 29010 Research Site Sevilla, Spain, 41013 Research Site Sevilla, Spain, 41071 United Kingdom Research Site London, United Kingdom, EC1A 7BE Research Site London, United Kingdom, W1G 6AD Research Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT02276053 | - | Completed | - | France ... 展开 >> 337 Lille, France 334 Lyon Cedex, France 335 Paris Cedex 13, France Germany 491 Bonn, Germany 493 Freiburg, Germany 492 Regensburg, Germany 494 Tübingen, Germany Italy 398 Ancona, Italy 397 Lecco, Italy 394 Milano, Italy 391 Perugia, Italy 392 Roma, Italy 396 Roma, Italy 395 San Fermo Della Battaglia, Italy 393 Torino, Italy 399 Venezia, Italy Netherlands 311 Amsterdam, Netherlands 312 Leidschendam, Netherlands 314 Tilburg, Netherlands Spain 341 Badalona, Spain 344 Barcelona, Spain United Kingdom 443 Edgbaston, United Kingdom 441 Edinburgh, United Kingdom 442 London, United Kingdom 收起 << | |
NCT00308581 | - | Completed | - | - | |
NCT01611142 | Peripheral T-Cell Lymphoma | Phase 2 | Completed | - | Denmark ... 展开 >> Aarhus University Hospital Aarhus, Denmark, 8000 France CHU Henri Mondor Créteil Cedex, France, 94010 CHRU Lille Lille Cedex, France, 59037 Hopital Saint-Louis Paris, France, 75010 Centre Hospitaliser de Lyon Sud Pierre Benite, France, 69310 Centre Henri Becquerel Rouen, France, 76038 Italy Università di Bologna Bologna, Italy Netherlands Vrije Universiteit Medisch Centrum (VUMC) Amsterdam, Netherlands, 1081 HV Universitair Medisch Centrum Groningen (UMCG) Groningen, Netherlands, 9713 GZ Spain Institut Catalá D`Oncologia, Hospital Duran y Reynals Barcelona, Spain, 08908 Hospital Univesitario 12 de Octubre Madrid, Spain, 28041 Hospital Clínico Universitario de Salamanca Salamanca, Spain, 37191 United Kingdom Guy's Hospital London, United Kingdom, SE1 9RT Christie Hospital Manchester, United Kingdom, M20 4BX Cancer Research UK Centre/Southhampton General Hospital SouthHampton, United Kingdom, SO16 6YD 收起 << |
NCT02460458 | - | Unknown | April 2018 | Finland ... 展开 >> Helsinki University Central Hospital, Department Internal Medicine, Coagulation Disorders, at Haematology and Laboratory Services Helsinki, Finland, FIN-00029 HUS France Institut d'Hématologie - Hôpital Cardiologique - University of Lille - Haematology Department Lille Cedex, France, 59037 Centre Régional de Traitement de l'Hémophilie - Laboratoire d'Hématologie Nantes Cedex 1, France, 44093 Germany University Clinic Bonn - Institute of Experimental Haematology & Transfusion Medicine Bonn, Germany, 53127 University Children's Hospital - Department of Pediatric Hematology and Oncology Hamburg, Germany, 20246 Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation - Hannover Medical School - Haemophilia Care Centre Hannover, Germany, 30625 Hungary St. Istvan & St. Laszlo Hospital of Budapest - Hematology and Stem Cell Transplantation Budapest, Hungary, 1097 Iran, Islamic Republic of Ahvaz Jundishpur University of Medical Sciences - Research Center for Thalassemia & Hemoglobinopathy - Division of Hematology & Oncology Ahwaz, Iran, Islamic Republic of Seid-ol-Shohada Hospital - Hemophilia Center - Esfahan University of Medical Science Esfahan, Iran, Islamic Republic of Hemophilia- Thalassaemia Center of Mashhad (Sarvar Clinic) - Mashad University of Medical Science Mashad, Iran, Islamic Republic of Nemazee Hospital Hemophilia Center - Shiraz University of Medical Science Shiraz, Iran, Islamic Republic of Iranian Hemophilia Comprehensive Treatment Centre - Iranian Hemophilia Society Tehran, Iran, Islamic Republic of Mofid Comprehensive Care Centre for Children with Hemophilia - Shahid Beheshti University of Medical Science Tehran, Iran, Islamic Republic of Thrombosis Hemostasis Research Center - Vali-Asr Hospital - Emam Khmeini Complex Hospital - Tehran University of Medical Science Tehran, Iran, Islamic Republic of Italy Azienda Ospedaliera Policlinico Consorziale di Bari - Unità Operativa Semplice di Emostasi e Trombosi Bari, Italy, 70124 Azienda Ospedaliera Universitaria Careggi - Agenzia per l'Emofilia - Centro di Riferimento Coagulopatie Congenite Firenze, Italy, 50141 Centro Emofilia e Trombosi - Fondazione Angelo Bianchi Bonomi - IRCCS Ospedale Ca' Granda - Dip. di Medicina Interna - Università degli Studi di Milano Milano, Italy, 20122 Dipartimento di Biotecnologie Cellulari ed Ematologia - Università "Sapienza" di Roma - Policlinico Umberto I Roma, Italy, 00161 Dipartimento di Terapie Cellulari ed Ematologia - Centro Malattie Emorragiche e Trombotiche - Ospedale San Bortolo Vicenza, Italy, 36100 Netherlands Leiden University Medical Center - Department of Hematology - Hemostasis and Thrombosis Center Leiden, Netherlands, 2333 Erasmus Medical Center - Department of Hematology Rotterdam, Netherlands, 3015 Spain Complejo Hospitalario Universitario de A Coruña - Servicio de Hematología y Hemoterapia A Coruña, Spain, 15006 Hospital Universitari General Vall d'Hebron - Unidad de Hemofilia Barcelona, Spain, 08035 Hospital Universitario La Paz - Unidad de Hemofilia - Servicio de Hematología Madrid, Spain, 28046 Sweden Lund University - Centre for Thrombosis and Haemostasis - Skane University Hospital Malmö, Sweden, 205 02 United Kingdom Katherine Dormandy Haemophilia Centre and Thrombosis Unit - Royal Free Campus - University College London Medical School London, United Kingdom, NW3 2PF Central Manchester University Hospital NHS Foundation Trust - Manchester Royal Infirmary - Manchester Royal Eye Hospital Manchester, United Kingdom, M13 9WL 收起 << | |
NCT02317016 | - | Completed | - | - | |
NCT00920582 | Type 1 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02460458 | - | Unknown | - | - | |
NCT00044577 | Human Immunodeficiency Virus I... 展开 >> Infection HIV Infection 收起 << | Phase 3 | Completed | - | - |
NCT02085148 | Pediatric Oncology | Phase 1 | Recruiting | October 24, 2019 | France ... 展开 >> Recruiting Lyon Cedex, France, 69008 Recruiting Marseille, France, 13005 Recruiting Paris, France, 75005 Not yet recruiting Paris, France, 75012 Recruiting Villejuif Cedex, France, 94805 Italy Not yet recruiting Roma, Lazio, Italy, 00168 Recruiting Genova, Liguria, Italy, 16147 Recruiting Milano, Lombardia, Italy, 20133 Spain Not yet recruiting Barcelona, Spain, 08035 Recruiting Madrid, Spain, 28009 Not yet recruiting Madrid, Spain, 28046 Recruiting Valencia, Spain, 46026 United Kingdom Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Recruiting Newcastle Upon Tyne, Tyne And Wear, United Kingdom, NE1 4LP Active, not recruiting Birmingham, West Midlands, United Kingdom, B4 6NH Not yet recruiting Leeds, West Yorkshire, United Kingdom, LS1 3EX Not yet recruiting Glasgow, United Kingdom, G51 4TF Recruiting Manchester, United Kingdom, M13 9WL 收起 << |
NCT01278342 | - | Completed | - | - | |
NCT01278342 | Acromegaly | Phase 4 | Completed | - | France ... 展开 >> Novartis Investigative Site Brest Cedex, France, 29609 Novartis Investigative Site Bron Cedex, France, 69677 Novartis Investigative Site Kremlin-Bicetre, France, 94275 Novartis Investigative Site Nice, France, 06202 Novartis Investigative Site Nimes, France, 30029 Novartis Investigative Site Pessac, France, 33604 Novartis Investigative Site Toulouse, France, 31059 Italy Novartis Investigative Site Genova, Italy, 16132 Novarts Investigative Site Naples, Italy Novartis Investigative Site Napoli, Italy, 80131 Novartis Investigative Site Padova, Italy Novartis Investigative Site Perugia, Italy, 06126 Novartis Investigative Site Pisa, Italy, 56124 Novartis Investigative Site Torino, Italy, 10126 Poland Novartis Investigative Site Lodz, Poland, 91-425 Novartis Investigative Site Warszawa, Poland Novartis Investigative Site Wroclaw, Poland Novartis Investigative Site Zabrze, Poland, 41-800 Portugal Novartis Investigative Site Porto, Portugal, 4200-319 Switzerland Novartis Investigative Site Lausanne, Switzerland, CH-1011 收起 << |
NCT00153023 | Diabetic Nephropathies ... 展开 >> Hypertension 收起 << | Phase 4 | Completed | - | - |
NCT02163733 | Advanced Non Small Cell Lung C... 展开 >>ancer Advanced (Inoperable) Non Small Cell Lung Cancer 收起 << | Phase 1 | Active, not recruiting | December 31, 2019 | France ... 展开 >> Research Site Dijon cedex, France, 21079 Research Site Lyon Cedex 08, France, 69373 Research Site Saint Herblain, France, 44805 Korea, Republic of Research Site Seoul, Korea, Republic of, 03722 Research Site Seoul, Korea, Republic of, 05505 Spain Research Site Madrid, Spain, 28040 Research Site Madrid, Spain, 28041 Research Site Madrid, Spain, 28050 Research Site Sevilla, Spain, 41013 United Kingdom Research Site Manchester, United Kingdom, M20 4BX Research Site Newcastle upon Tyne, United Kingdom, NE7 7DN Research Site Sutton, United Kingdom, SM2 5PT 收起 << |
NCT02163733 | - | Active, not recruiting | - | - | |
NCT00372775 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | United States, Connecticut ... 展开 >> Pfizer Investigational Site Norwalk, Connecticut, United States, 06856 United States, Florida Pfizer Investigational Site Cocoa Beach, Florida, United States, 32931 Pfizer Investigational Site Merritt Island, Florida, United States, 32952 Pfizer Investigational Site Titusville, Florida, United States, 32796 United States, Missouri Pfizer Investigational Site Creve Coeur, Missouri, United States, 63141 Pfizer Investigational Site St. Louis, Missouri, United States, 63110-1094 Pfizer Investigational Site St. Louis, Missouri, United States, 63110 Pfizer Investigational Site St. Peters, Missouri, United States, 63376 United States, New Jersey Pfizer Investigational Site Basking Ridge, New Jersey, United States, 07920 United States, New York Pfizer Investigational Site Commack, New York, United States, 11725 Pfizer Investigational Site New York, New York, United States, 10022 United States, Pennsylvania Pfizer Investigational Site Sayre, Pennsylvania, United States, 18840 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78705 Pfizer Investigational Site Austin, Texas, United States, 78745 Pfizer Investigational Site Austin, Texas, United States, 78758 Pfizer Investigational Site Austin, Texas, United States, 78759 Pfizer Investigational Site Round Rock, Texas, United States, 78664 France Pfizer Investigational Site Pessac, Be1 04495, France, 33604 Pfizer Investigational Site Marseille Cedex 09, France, 13009 Pfizer Investigational Site Saint-Priest en Jarez Cedex, France, 42271 Pfizer Investigational Site Toulouse cedex 9, France, 31059 Italy Pfizer Investigational Site Bologna, Italy, 40139 Pfizer Investigational Site Genova, Italy, 16132 Pfizer Investigational Site Orbassano (TO), Italy, 10043 Pfizer Investigational Site Roma, Italy, 00151 Spain Pfizer Investigational Site Madrid, Spain, 28046 Pfizer Investigational Site Valencia, Spain, 46014 收起 << |
NCT00372775 | - | Completed | - | - | |
NCT00212121 | Breast Cancer | Phase 3 | Unknown | December 2018 | France ... 展开 >> Hôpital J-Minjoz Besancon, France, 25030 Institut Bergonié Bordeaux, France, 33076 CHU Henri Mondor Creteil, France, 94000 Centre Oscar Lambret Lille, France, 59000 Institut Paoli Calmettes Marseille, France, 13009 Centre Val d'Aurelle Montpellier cedex 5, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Institut Curie Paris, France, 75005 Hôpital Saint Louis Paris, France, 75010 Centre Hospitalier Lyon Sud Pierre Benite Cedex, France, 69495 Centre Eugène Marquis Rennes, France, 35000 Centre Henri Becquerel Rouen, France, 76000 Centre René Huguenin Saint Cloud, France, 92210 Centre René Gauducheau Saint Herblain Cedex, France, 44805 Centre Paul Strauss Strasbourg, France, 67085 CHU de Tours Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94800 Netherlands The Netherlands Cancer Institute Amsterdam, Netherlands, 1066 CX 收起 << |
NCT03393806 | Asthma | Phase 2 | Recruiting | October 10, 2019 | France ... 展开 >> GSK Investigational Site Not yet recruiting Brest Cedex, France, 29609 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Marseille, France, 13015 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Montpellier cedex 5, France, 34295 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1105 AZ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United Kingdom GSK Investigational Site Recruiting Wythenshawe, Greater Manchester, United Kingdom, M23 9LT Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Leicester, Leicestershire, United Kingdom, LE3 9QP Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Liverpool, Merseyside, United Kingdom, L7 8XP Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Birmingham, United Kingdom, B9 5SS Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Bradford, United Kingdom, BD9 6RJ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Edgbaston, United Kingdom, B15 2GW Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00195663 | Early Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00051051 | Breast Neoplasms | Phase 2 | Completed | - | - |
NCT00867087 | Lymphoma, B-Cell | Phase 2 | Completed | - | - |
NCT00867087 | - | Completed | - | - | |
NCT00127881 | Mycosis Fungoides ... 展开 >> Sezary Syndrome 收起 << | Phase 3 | Terminated(New sponsor, other ... 展开 >>treatments available) 收起 << | - | - |
NCT00234884 | - | Completed | - | - | |
NCT00195663 | - | Completed | - | - | |
NCT00234884 | - | Completed | - | - | |
NCT00185393 | Lymphoma, Non-Hodgkin | Phase 3 | Completed | - | - |
NCT00242775 | Asthma | Phase 3 | Completed | - | - |
NCT00589693 | Ventilator-Associated Pneumoni... 展开 >>a 收起 << | Phase 3 | Terminated(Observed lower cure... 展开 >> rates and higher mortality rates in one of the treatment groups.) 收起 << | - | - |
NCT00449033 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
NCT00405756 | - | Completed | - | - | |
NCT00405756 | Newly Diagnosed Multiple Myelo... 展开 >>ma 收起 << | Phase 3 | Completed | - | - |
NCT00449033 | - | Completed | - | - | |
NCT00589693 | - | Terminated(Observed lower cure... 展开 >> rates and higher mortality rates in one of the treatment groups.) 收起 << | - | - | |
NCT00385827 | Cancer, Prostate | Phase 2 | Terminated(Prematurely stopped... 展开 >> after Independent Data Monitoring Committee (IDMC) evaluation for lack of efficacy.) 收起 << | - | - |
NCT00358943 | - | Recruiting | January 31, 2030 | - | |
NCT00563381 | - | Completed | - | - | |
NCT00563381 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 4 | Completed | - | - |
NCT00665847 | HIV-1 | Phase 2 | Completed | - | - |
NCT00385827 | - | Terminated(Prematurely stopped... 展开 >> after Independent Data Monitoring Committee (IDMC) evaluation for lack of efficacy.) 收起 << | - | - | |
NCT00665847 | - | Completed | - | - | |
NCT01117350 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT00524368 | - | Completed | - | - | |
NCT00524368 | Human Immunodeficiency Virus -... 展开 >> Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00421109 | Urticaria | Phase 3 | Completed | - | - |
NCT01117350 | - | Completed | - | - | |
NCT00038467 | Breast Neoplasms | Phase 3 | Completed | - | - |
NCT00081588 | HIV Infection | Phase 2 | Completed | - | - |
NCT00038467 | - | Completed | - | - | |
NCT00768989 | - | Terminated(Efficacy endpoint m... 展开 >>et, but overall experimental dosing regimen not considered optimal to support further clinical development in this population.) 收起 << | - | - | |
NCT00393939 | Breast Neoplasms | Phase 3 | Completed | - | - |
NCT00393939 | - | Completed | - | - | |
NCT00768989 | HIV | Phase 2 | Terminated(Efficacy endpoint m... 展开 >>et, but overall experimental dosing regimen not considered optimal to support further clinical development in this population.) 收起 << | - | United States, Arizona ... 展开 >> Southwest Center For HIV/AIDS Phoenix, Arizona, United States, 85006 United States, Connecticut Yale University School Of Medicine New Haven, Connecticut, United States, 06510 United States, District of Columbia Dupont Circle Physicians Group Washington, District of Columbia, United States, 20009 United States, Florida Orlando Immunology Center Orlando, Florida, United States, 32803 United States, New York The Aaron Diamond AIDS Research Center New York, New York, United States, 10016 United States, Ohio University Of Cincinnati Cincinnati, Ohio, United States, 45267 United States, Texas Tarrant County Infectious Disease Associates Ft Worth, Texas, United States, 76104 Therapeutic Concepts, P.A. Houston, Texas, United States, 77004 Diversified Medical Practices, P.A. Houston, Texas, United States, 77057 Argentina Local Institution Buenos Aires, Bs As, Buenos Aires, Argentina, 1141 Local Institution Capital Federal, Buenos Aires, Argentina, 1264 Local Institution Mar Del Plata, Buenos Aires, Argentina, B7600CTO Local Institution Rosario, Santa Fe, Argentina, 2000 France Local Institution Nantes Cedex 01, France, 44035 Local Institution Paris Cedex 10, France, 75475 Local Institution Paris Cedex 20, France, 75970 收起 << |
NCT00122382 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00648596 | Erectile Dysfunction | Phase 4 | Completed | - | - |
NCT00122382 | - | Completed | - | - | |
NCT01197560 | Diffuse Large B-cell Lymphoma | Phase 2 Phase 3 | Completed | - | - |
NCT00110877 | HIV Infection | Phase 3 | Completed | - | - |
NCT01197560 | - | Completed | - | - | |
NCT03069352 | Acute Myeloid Leukemia (AML) | Phase 3 | Recruiting | October 7, 2019 | - |
NCT00160563 | Asthma | Phase 3 | Terminated(The predecessor stu... 展开 >>dy A00309 (NCT00152464) did not show statistical significance in time to onset of asthma between the levocetirizine and placebo groups.) 收起 << | - | - |
NCT00160563 | - | Terminated(The predecessor stu... 展开 >>dy A00309 (NCT00152464) did not show statistical significance in time to onset of asthma between the levocetirizine and placebo groups.) 收起 << | - | - | |
NCT01396148 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Czechia Fakultni nemocnice Brno Brno, Czechia, 613 00 FN Brno Brno, Czechia, 625 00 Masarykuv onkologicky ustav Brno, Czechia, 656 33 France CHU de La Timone, Hopital enfants Marseille cedex 5, France, 13385 Hopital d'Enfants de la Timone Marseille cedex 5, France, 13385 Hopital de la Timone Marseille cedex 5, France, 13385 收起 << |
NCT01396148 | - | Completed | - | - | |
NCT00826514 | Chronic Prostatitis With Chron... 展开 >>ic Pelvic Pain Syndrome 收起 << | Phase 2 | Completed | - | - |
NCT00589914 | - | Completed | - | - | |
NCT00119678 | - | Completed | - | - | |
NCT00091637 | Acute Myocardial Infarction | Phase 3 | Completed | - | - |
NCT00119678 | Systemic Lupus Erythematosus | Phase 2 | Completed | - | - |
NCT01213472 | Melanoma | Phase 1 | Completed | - | - |
NCT00589914 | Schizophrenia | Phase 3 | Completed | - | - |
NCT00283751 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00144794 | - | Recruiting | December 31, 2020 | - | |
NCT02147990 | Non-small Cell Lung Cancer | Phase 2 | Active, not recruiting | August 31, 2019 | - |
NCT00168831 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00426556 | Metastatic Breast Cancer | Phase 1 | Completed | - | United States, California ... 展开 >> Wilshire Oncology Medical Group La Verne *see Various Departments*, California, United States Compassionate Cancer Care Medical Group Dept.ofCCCMG Fountain Valley, California, United States, 92708 Loma Linda University Dept.ofLomaLindaCancerCent(3) Loma Linda, California, United States, 92354 University of California at Los Angeles Dept.of UCLA Dept.ofMed. Los Angeles, California, United States, 90095 United States, Florida Florida Cancer Research Institute Davie, Florida, United States, 33328 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2) Atlanta, Georgia, United States, 30322 United States, Illinois North Shore University Health System Evanston, Illinois, United States, 60201 United States, Maryland Peninsula Regional Medical Center Deptof Oncology and Hematology Salisbury, Maryland, United States, 21801 United States, Missouri Washington University School Of Medicine-Siteman Cancer Ctr StudyCoordinator:CRAD001J2101 St. Louis, Missouri, United States, 63110 United States, South Carolina Cancer Centers of the Carolinas CC of C -Eastside Greenville, South Carolina, United States, 29605 United States, Texas Sammons Cancer Center - Texas Oncology Dallas, Texas, United States, 78246 Belgium Novartis Investigative Site Charleroi, Belgium, 6000 Novartis Investigative Site Liege, Belgium, 4000 Novartis Investigative Site Turnhout, Belgium, 2300 France Novartis Investigative Site Paris, France, 75970 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Novartis Investigative Site Toulouse Cedex 9, France, 31059 Novartis Investigative Site Villejuif Cedex, France, 94805 Netherlands Novartis Investigative Site Maastricht, Netherlands, 6229 HX Spain Novartis Investigative Site Lleida, Cataluna, Spain, 25198 收起 << |
NCT00002399 | Candidiasis, Oral ... 展开 >> HIV Infections 收起 << | Phase 2 | Completed | - | - |
NCT00426556 | - | Completed | - | - | |
NCT00168831 | - | Completed | - | - | |
NCT01874431 | Diabetic Nephropathies | Phase 2 | Completed | - | - |
NCT00371566 | - | Completed | - | - | |
NCT01522170 | - | Terminated(Remaining patients ... 展开 >>were offered a similar observational study (Alexion M11-001) to allow for robust, high quality data collection in a larger, single database) 收起 << | - | - | |
NCT00371566 | Squamous Cell Carcinoma of Hea... 展开 >>d and Neck 收起 << | Phase 2 | Completed | - | France ... 展开 >> GSK Investigational Site Caen, France, 14076 GSK Investigational Site Montpellier Cedex 5, France, 34298 GSK Investigational Site Villejuif Cedex, France, 94805 Greece GSK Investigational Site Athens, Greece, 142 33 India GSK Investigational Site Bangalore, India, 560029 GSK Investigational Site Thiruvananthapuram, India, 695 011 Peru GSK Investigational Site Lima, Peru, Lima 34 Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Madrid, Spain, 28041 收起 << |
NCT01393626 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01370863 | - | Terminated(This study was term... 展开 >>inated early due to recruitment difficulties. There were no safety concerns.) 收起 << | - | - | |
NCT01393626 | - | Completed | - | - | |
NCT01949311 | Atopic Dermatitis | Phase 3 | Enrolling by invitation | December 2018 | - |
NCT01977651 | Metastatic Castration-resistan... 展开 >>t Prostate Cancer (mCRPC) 收起 << | Phase 4 | Active, not recruiting | November 2018 | - |
NCT01470599 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01370863 | Gastroesophageal Reflux Diseas... 展开 >>e 收起 << | Phase 2 | Terminated(This study was term... 展开 >>inated early due to recruitment difficulties. There were no safety concerns.) 收起 << | - | Belgium ... 展开 >> CUB Hôpital Erasme Brussels, Bruxelles, Belgium, 1070 Cliniques universitaires Saint Luc Bruxelles, Belgium, 1200 UZ Leuven, Belgium Leuven, Belgium, 3000 France CHU de Bordeaux - Hôpital Saint André Bordeaux Cedex, France, 33075 CHU de Lyon - Groupement Hospitalier Edouard Herriot Lyon, France, 69437 Hôtel Dieu - CHU de Nantes Nantes Cedex 1, France, 44093 Germany Klinikum Garmisch-Partenkirchen GmbH Garmisch-Partenkirchen, Germany, 82467 Otto-von-Guericke University Magdeburg, Germany, 39120 Netherlands Academisch Medisch Centrum (AMC) Amsterdam, Netherlands, 1105 AZ Switzerland Inselspital Bern (Bern University Hopsital) Bern, Switzerland, BHH D140 Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 University Hospital Zurich Zurich, Switzerland, CH-8091 United Kingdom Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Wingate Institute of Neurogastroenterology London, United Kingdom, E12AJ Queen's Medical Center (Nottingham University Hospital) Nottingham, United Kingdom, NG7 2UH 收起 << |
NCT02921971 | Systemic Sclerosis | Phase 2 | Active, not recruiting | April 2019 | - |
NCT01470599 | - | Completed | - | - | |
NCT02757768 | Benign Prostatic Hyperplasia ... 展开 >> Overactive Bladder 收起 << | Phase 4 | Completed | - | - |
NCT01459757 | - | Completed | - | - | |
NCT02264574 | Chronic Lymphocytic Leukemia ... 展开 >> Small-Cell Lymphoma 收起 << | Phase 3 | Active, not recruiting | January 2020 | - |
NCT01863732 | Spondylitis, Ankylosing | Phase 3 | Completed | - | - |
NCT02138825 | - | Terminated(Study terminated pe... 展开 >>r recommendation of iDMC. On iDMC request, protocol amended to include 4-month safety follow-up for patients after withdrawal of riociguat.) 收起 << | - | - | |
NCT03313557 | Solid Tumors | Phase 1 | Recruiting | August 11, 2020 | United States, Arizona ... 展开 >> Research Site Withdrawn Tucson, Arizona, United States, 85724 United States, California Research Site Withdrawn Los Angeles, California, United States, 90048 Research Site Withdrawn Pasadena, California, United States, 91105 United States, Maryland Research Site Withdrawn Silver Spring, Maryland, United States, 20910 United States, Michigan Research Site Recruiting Bingham Farms, Michigan, United States, 48025 Research Site Recruiting Detroit, Michigan, United States, 48202 United States, New Hampshire Research Site Recruiting Lebanon, New Hampshire, United States, 03756 United States, Ohio Research Site Recruiting Cincinnati, Ohio, United States, 45229 United States, Rhode Island Research Site Recruiting Providence, Rhode Island, United States, 02906 United States, South Carolina Research Site Recruiting Greenville, South Carolina, United States, 29605 United States, Texas Research Site Recruiting Dallas, Texas, United States, 75251 Research Site Withdrawn Houston, Texas, United States, 77030 France Research Site Completed Bordeaux Cedex, France, 33075 Research Site Completed Saint Herblain Cedex, France, 44805 Netherlands Research Site Active, not recruiting Amsterdam, Netherlands, 1066 CX Research Site Active, not recruiting Amsterdam, Netherlands, 1081 HV Research Site Active, not recruiting Maastricht, Netherlands, 6229 HX United Kingdom Research Site Active, not recruiting Glasgow, United Kingdom, G12 0YN Research Site Active, not recruiting Manchester, United Kingdom, M20 4BX 收起 << |
NCT02138825 | Idiopathic Interstitial Pneumo... 展开 >>nias / Hypertension,Pulmonary 收起 << | Phase 2 | Terminated(Study terminated pe... 展开 >>r recommendation of iDMC. On iDMC request, protocol amended to include 4-month safety follow-up for patients after withdrawal of riociguat.) 收起 << | - | - |
NCT01939366 | Chronic Pain ... 展开 >>Diabetic Neuropathies Diabetes Mellitus 收起 << | Phase 2 | Completed | - | - |
NCT02308111 | Liver Cirrhosis, Biliary | Phase 4 | Recruiting | April 2025 | - |
NCT02605967 | Nasopharyngeal Carcinoma | Phase 2 | Recruiting | May 23, 2019 | United States, Georgia ... 展开 >> Novartis Investigative Site Recruiting Marietta, Georgia, United States, 30060 Contact: Feseha Makonnen 770-333-2161 fmakonnen@gnoc.com Principal Investigator: Steve McCune United States, Michigan Novartis Investigative Site Recruiting Detroit, Michigan, United States, 48201 Contact: Masumeh Alipour 313-576-8994 manicab@karmanos.org Principal Investigator: Ammar Sukari United States, New York NYU Laura and Isaac Perlmutter Cancer Center Laura & Isaac Perlmutter Ctr Recruiting New York, New York, United States, 10016 Principal Investigator: Zujun Li United States, Virginia Novartis Investigative Site Recruiting Fairfax, Virginia, United States, 22031 Contact: Monica Cochrane 703-280-5390 monica.cochrane@usoncology.com Principal Investigator: Alexander Spira China Novartis Investigative Site Active, not recruiting Guangzhou, China, 510060 France Novartis Investigative Site Active, not recruiting Nice Cedex 2, Alpes Maritimes, France, 06189 Novartis Investigative Site Active, not recruiting Villejuif Cedex, France, 94805 Hong Kong Novartis Investigative Site Active, not recruiting Hong Kong, Hong Kong Novartis Investigative Site Active, not recruiting Kowloon, Hong Kong Novartis Investigative Site Active, not recruiting Tuen Mun, Hong Kong Singapore Novartis Investigative Site Active, not recruiting Singapore, Singapore, 169610 Taiwan Novartis Investigative Site Active, not recruiting Tainan, Taiwan ROC, Taiwan, 70421 Novartis Investigative Site Active, not recruiting Kaohsiung City, Taiwan, 83301 Novartis Investigative Site Completed Taipei, Taiwan, 10002 Novartis Investigative Site Active, not recruiting Taoyuan, Taiwan, 33305 Thailand Novartis Investigative Site Active, not recruiting Songkla, Hat Yai, Thailand, 90110 Novartis Investigative Site Active, not recruiting Bangkok, Thailand, 10330 Novartis Investigative Site Active, not recruiting Chiang Mai, Thailand, 50200 收起 << |
NCT02955069 | Well-differentiated Non-functi... 展开 >>onal NET of Thoracic Origin Well-differentiated Non-functional NET of Gastrointestinal Origin Well-differentiated Non-functional NET of Pancreatic Origin Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma 收起 << | Phase 2 | Active, not recruiting | April 3, 2020 | - |
NCT01915602 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | - |
NCT02049515 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma 收起 << | Phase 3 | Enrolling by invitation | June 2019 | - |
NCT02152761 | Muscle Wasting (Atrophy) After... 展开 >> Hip Fracture Surgery 收起 << | Phase 2 | Completed | - | - |
NCT02741570 | Head and Neck Cancer | Phase 3 | Recruiting | August 15, 2025 | - |
NCT02258451 | Breast Neoplasms | Phase 2 | Active, not recruiting | August 30, 2019 | - |
NCT00523380 | Cancer Ovaria... 展开 >>n Cancer 收起 << | Phase 2 | Completed | - | France ... 展开 >> Novo Nordisk Investigational Site Lyon Cedex 08, France, 69373 Novo Nordisk Investigational Site Marseille, France, 13273 Novo Nordisk Investigational Site Saint-Herblain Cedex, France, 44805 Novo Nordisk Investigational Site Villejuif, France, 94805 Germany Novo Nordisk Investigational Site Essen, Germany, 45122 Novo Nordisk Investigational Site Marburg, Germany, 35043 Novo Nordisk Investigational Site Wiesbaden, Germany, 65199 收起 << |
NCT02310672 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 4 | Active, not recruiting | September 1, 2019 | - |
NCT02137850 | Congenital Bleeding Disorder ... 展开 >> Haemophilia A 收起 << | Phase 3 | Enrolling by invitation | November 13, 2021 | - |
NCT02784795 | Solid Tumor B... 展开 >>reast Cancer Colon Cancer Cholangiocarcinoma Soft Tissue Sarcoma 收起 << | Phase 1 | Active, not recruiting | January 31, 2019 | United States, Florida ... 展开 >> Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Denmark Rigshospitalet Copenhagen, København Ø, Denmark, 2100 France Institut Bergonie Bordeaux, France, 33076 Centre Leon Berard Lyon Cedex 08, France, 69373 Gustave Roussy Villejuif Cedex, France, 94805 Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Fundacion Jimenez Diaz Madrid, Spain, 28040 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 收起 << |
NCT03148418 | Cancer | Phase 3 | Recruiting | August 5, 2027 | - |
NCT02500043 | Refractory Metastatic Gastric ... 展开 >>Cancer 收起 << | Phase 3 | Completed | - | - |
NCT01887938 | Metachromatic Leukodystrophy (... 展开 >>MLD) 收起 << | Phase 1 Phase 2 | Enrolling by invitation | April 27, 2023 | Australia ... 展开 >> The Children's Hospital at Westmead Westmead, Australia, 2145 Brazil Hospital de Clinicas de Porto Alegre Porto Alegre, Brazil, 90035-003 Czechia Detska Interni Klinika, Lf Mu A Fn Brno Brno, Czechia, 61300 Denmark Rigshospitalet Copenhagen, Denmark, 2100 France Hôpital de Bicêtre Le Kremlin Bicetre, Ile-de-France, France, 94275 Hopital Femme Mere Enfant Bron Cedex, France, 69 677 Hopital Gui de Chauliac - CHRU de Montpellier Montpellier, France, 34000 CHU de Nantes Nantes Cedex 1, France, 44093 CHR Orleans - Hopital La Source Orleans, France, 45067 Germany Center for Pediatric Clinical Studies (CPCS) Tubingen, Baden-Wuerttemberg, Germany, 72076 Klinikum Oldenburg Oldenburg, Germany, 26133 Marien-Hospital Wesel gGmbh Wesel, Germany, 46483 Japan Kitakyushu Municipal Yahata Hospital Fukuoka, Japan, 805-8534 Kurashiki Central Hospital Okayama Prefecture, Japan, 710-8602 Osaka University Hospital Osaka, Japan, 565-0871 收起 << |
NCT03337724 | Breast Cancer | Phase 2 Phase 3 | Recruiting | December 22, 2021 | - |
NCT01810393 | Breast Cancer | Phase 3 | Active, not recruiting | August 10, 2019 | - |
NCT03257631 | Central Nervous System Neoplas... 展开 >>ms Medulloblastoma 收起 << | Phase 2 | Recruiting | March 18, 2023 | United States, California ... 展开 >> Stanford University Cancer Center Recruiting Stanford, California, United States, 94305-5750 United States, Florida University of Florida Recruiting Gainesville, Florida, United States, 32611 United States, Illinois Ann and Robert H Lurie Childrens Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 United States, Maryland National Cancer Institute Recruiting Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 France Centre Oscar Lambret Recruiting Lille, France, 59020 Centre Leon Berard Recruiting Lyon, France, 69008 Hopital d'Enfants de la Timone Recruiting Marseille Cedex 01, France, 13005 Institut Curie Recruiting Paris, France, 75005 Hopital des Enfants Recruiting Toulouse, France, 31059 CHU Nancy Hematology Recruiting Vandoeuvre les Nancy, France, 54511 Institut Gustave Roussy Faculte de Medecine Paris Sud Service de pneumologie Recruiting Villejuif Cedex, France, 94805 Italy Istituto G. Gaslini Ospedale Pediatrico IRCCS Recruiting Genova, Italy Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Ospedale Bambin Gesu Recruiting Roma, Italy, 00165 Spain Hospital Universitario Vall D Hebron Recruiting Barcelona, Spain, 8035 Hospital Infantil Universitario Nino Jesus Recruiting Madrid, Spain, 28009 Hospital Universitario La Fe Recruiting Valencia, Spain, 46026 United Kingdom Leeds General Infirmary Recruiting Leeds, United Kingdom, LS7 4SA Great Ormond Street Hospital Recruiting London, United Kingdom, WC1N 3JH The Royal Marsden Hospital Recruiting Sutton-Surrey, United Kingdom, SM2 5PT 收起 << |
NCT02629159 | Rheumatoid Arthritis | Phase 3 | Active, not recruiting | August 10, 2020 | - |
NCT02389413 | Alzheimer's Disease | Phase 2 | Completed | - | Belgium ... 展开 >> Ziekenhuis Netwerk Antwerpen / Geheugenkliniek Hoboken, Belgium, 2660 Finland Kliininen tutkimuskeskus Kuopio, Finland, 70211 Oulu University Hospital Oulu, Finland, 90220 CRST Oy Turku, Finland, 20520 France CHU Bordeaux Pellegrin (CMRR) Bordeaux, France, 33076 CHU François Mitterand (Centre Mémoire Ressources Recherche (CMRR)) Dijon, France, 21079 CHRU de Lille / Hôpital Roger Salengro Lille Cedex, France, 59037 Hôpital La Grave / Centre de Recherche Clinique Toulouse Cedex 9, France, 31059 Germany Charité - Universitätsmedizin Berlin Berlin, Germany, 10450 Universitätsmedizin Göttingen / Klinik für Psychiatrie und Psychotherapie Göttingen, Germany, 37075 Universitätsklinikum Halle (Saale) Klinik und Poliklinik für Psychiatrie, Psychotherapie und Psychosomatik Halle (Saale), Germany, 06112 Arzneimittelforschung Leipzig GmbH Leipzig, Germany, 04107 Universitätsklinikum Magdeburg / Institut für Kognitive Neurologie und Demenzforschung Magdeburg, Germany, 39120 Klinikum rechts der Isar der TU München / Klinik für Psychiatrie und Psychotherapie München, Germany, 81675 Universitätsklinikum Münster / Klinik für Allgemeine Neurologie Münster, Germany, 48149 Universitätsmedizin Rostock / Zentrum für Nervenheilkunde/ Klinik für Psychosomatik und Psychotherapeutische Medizin Rostock, Germany, 18147 Neurologische Universitätsklinik Ulm Ulm, Germany, 89081 Netherlands Alzheimer Research Center Amsterdam, Netherlands, 1081 GM Spain Hospital de la Santa Creu i Sant Pau, Neurology Department, Memory Unit Barcelona, Spain, 08025 Fundació ACE. Institut Català de Neurociències Aplicades Barcelona, Spain, 08028 Complexo Hospitalario Universitario de Santiago (CHUS) Santiago de Compostela, Spain, 15706 Hospital Universitario Virgen Macarena Sevilla, Spain, 41009 Sweden Verksamheten för neuropsykiatri Sahlgrenska universitetssjukhuset Mölndal, Sweden, 43141 收起 << |
NCT02581891 | Macular Degeneration | Phase 4 | Active, not recruiting | May 15, 2019 | - |
NCT02010255 | Chronic HCV Infection | Phase 2 | Completed | - | - |
NCT02414854 | Asthma | Phase 3 | Completed | - | - |
NCT03452137 | Locally Advanced Squamous Cell... 展开 >> Carcinoma of the Head and Neck (SCCHN) 收起 << | Phase 3 | Recruiting | April 28, 2025 | - |
NCT02010255 | - | Completed | - | - | |
NCT02408523 | Epilepsy | Phase 3 | Recruiting | March 2019 | - |
NCT01743469 | Advanced or Metastatic Hepatoc... 展开 >>ellular Cancer Advanced or Metastatic Ovarian Cancer Metastatic Renal Cell Cancer Advanced or Metastatic Gastric Carcinoma 收起 << | Phase 2 | Completed | - | Belgium ... 展开 >> Antwerp University Hospital, Wilrijkstraat 10 Edegem, Belgium, 2650 Ghent University Hospital, 1K12 IE, De Pintelaan 185 Gent, Belgium, 9000 Leuven cancer institute (LKI), Herestraat Leuven, Belgium, 3000 Canada, Ontario Juravinski Cancer Centre, 699 Concession St Hamilton, Ontario, Canada, L8V 5C2 London Health Sciences Center, 790 Commissoners Road East London, Ontario, Canada, N6A 4L6 Sunnybrook, 2075 Bayview Avenue, Suite T2049 Toronto, Ontario, Canada, M4N 3M5 Princess Margaret, 610 University Avenue Toronto, Ontario, Canada, M5G 2M9 France Hospital Beaujon, 100 Blvd du Général Leclerc Clichy, France, 92110 Centre Oscar Lambret, 3 rue Frédéric Combemale Lille cedex, France, 59020 Bureau d'Etudes Cliniques du Centre Léon Bérard, 28, rue Laennec Lyon, France, 69008 Hospital Saint-Antoine, 184 rue du Faubourg St Antoine Paris, France, 75012 Hopital Europeen Georges-Pompidou, AP-HP, 20 Rue Leblanc Paris, France, 75015 Centre Eugene Marquis, Avenue bataille Flandres Dunkerque Rennes cedex, France, 35042 Centre René Gauducheau, Boulevard Jacques Monod Saint Herblain, France, 44805 Institute Gustave-Roussy, 114 rue Edouard Vaillant Villejuif, France, 94805 Spain Hospital del mar, Paseo Maritimo 25-29 Barcelona, Spain, 08003 Hospital Gregorio Marañon, Dr. Esquerdo, 44-46 Madrid, Spain, 28007 MD Anderson Cancer Centre, Ctra. Colmenar Viejo Km. 9 100, Madrid, Spain, 28034 United Kingdom Beatson West of Scotland Cancer Centre, 1053 Great Western Road Glasgow, United Kingdom, G12 0YN Leicester General Hospital, Gwndolen Road Leicester, United Kingdom, LE5 4PW The Royal Marsden Hospital, Downs Rd, Sutton London, United Kingdom, SM2 5PT The Christie Hospital, Wilmslow Road, Withington Manchester, United Kingdom, M20 4BX Freeman Hospital, Freeman Road, High Heaton Newcastle-upon-Tyne, United Kingdom, NE7 7DN Southampton General Hospital, Tremona Road, Shirley Southampton, United Kingdom, SO16 6YD 收起 << |
NCT01747876 | Malignant Rhabdoid Tumors (MRT... 展开 >>), Neuroblastoma 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> University of California San Francisco Dept of Pediatic Oncology San Francisco, California, United States, 94101 United States, Georgia Children's Healthcare of Atlanta Dept of Oncology Atlanta, Georgia, United States, 30342 United States, Massachusetts Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center Dept of Onc New York, New York, United States, 10065 United States, Ohio Cincinnati Children's Hospital Medical Center Dept of Oncology Cincinnati, Ohio, United States, 45229-3039 United States, Tennessee St. Jude's Children's Research Hospital Dept of Oncology Memphis, Tennessee, United States, 38105-2794 Australia, Western Australia Novartis Investigative Site Perth, Western Australia, Australia, 6840 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Paris, France, 75231 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Koeln, Nordrhein-Westfalen, Germany, 50937 Novartis Investigative Site Augsburg, Germany, 86156 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT 收起 << |
NCT03019406 | Glycogen Storage Disease Type ... 展开 >>II-Pompe's Disease 收起 << | Phase 2 | Recruiting | April 2022 | United States, New York ... 展开 >> Investigational Site Number 8400002 Recruiting Valhalla, New York, United States, 10595 United States, North Carolina Investigational Site Number 8400001 Recruiting Durham, North Carolina, United States, 27710 United States, Washington Investigational Site Number 8400005 Recruiting Seattle, Washington, United States, 98105 France Investigational Site Number 2500002 Recruiting Paris Cedex 19, France, 75935 Investigational Site Number 2500001 Recruiting Tours Cedex 1, France, 37044 Japan Investigational Site Number 3920001 Recruiting Fuchu-Shi, Japan Investigational Site Number 3920002 Recruiting Fuchu-Shi, Japan Taiwan Investigational Site Number 1580001 Recruiting Taipei, Taiwan, 10043 United Kingdom Investigational Site Number 8260001 Recruiting London, United Kingdom, WC1N 3JH Investigational Site Number 8260002 Recruiting Manchester, United Kingdom, M13 9WL 收起 << |
NCT02414854 | - | Completed | - | - | |
NCT02859324 | Carcinoma, Hepatocellular | Phase 1 Phase 2 | Active, not recruiting | March 1, 2020 | United States, California ... 展开 >> UCLA Division of Hematology Oncology Los Angeles, California, United States, 90095-1752 United States, Florida University of Florida Gainesville, Florida, United States, 32610 United States, New York NYU Langone Medical Center New York, New York, United States, 10016 United States, Texas Mary Crowley Cancer Research Dallas, Texas, United States, 75251 France Institut Paoli Calmettes Marseille Cedex 9, France, 13273 Centre Eugene Marquis Rennes, France, 35200 Institut Universitaire du Cancer IUCT - Oncopole Toulouse Cedex, France, 31059 Institut G. Roussy Villejuif, France, 94800 Italy IRCCS - Istituo Clinico Humanitas - Humanitas Cancer Center Milan, Italy, 20089 Fondazione IRCCS Policlinico San Matteo Pavia, Italy, 27100 Istituto Nazionale Tumori Regina Elena Roma, Italy, 144 Spain Hospital Universitario Vall D Hebron Barcelona, Spain, 8035 Hospital Ramon y Cajal Madrid, Spain, 28034 Hospital 12 de Octubre Madrid, Spain, 28041 收起 << |
NCT01063036 | Chronic Hepatitis B | Phase 3 | Completed | - | France ... 展开 >> Local Institution Clichy, France, 92110 Local Institution Lyons Cedex 04, France, 69317 Local Institution Orleans Cedex 2, France, 45067 Local Institution Strasbourg, France, 67000 Germany Local Institution Berlin, Germany, 10969 Local Institution Berlin, Germany, 13353 Local Institution Hamburg, Germany, 20099 Local Institution Hamburg, Germany, 20246 Local Institution Hannover, Germany, 30625 Local Institution Heindelberg, Germany, 69120 Local Institution Munchen, Germany, 81675 Local Institution Tubingen, Germany, 72076 Italy Local Institution Bagno A Ripoli (Fi), Italy, 50012 Local Institution Bari, Italy, 70124 Local Institution Foggia, Italy, 71100 Local Institution Milano, Italy, 20122 Netherlands Local Institution Amsterdam, Netherlands, 1105 AZ Local Institution Arnhem, Netherlands, 6815 AD Local Institution Rotterdam, Netherlands, 3015 CE Poland Local Institution Kielce, Poland, 25-317 Local Institution Krakow, Poland, 31-531 Local Institution Lodz, Poland, 91-347 Local Institution Wroclaw, Poland, 50-349 Romania Local Institution Bucuresti, Romania, 021105 Local Institution Burcuresti, Romania, 022328 Local Institution Timisoara, Romania, 300 002 Spain Local Institution Barcelona, Spain, 08025 Local Institution Valencia, Spain, 46014 收起 << |
NCT01063036 | - | Completed | - | - | |
NCT01237236 | Advanced Solid Tumor ... 展开 >> Lymphomas 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States, +1 48109 0944 United States, New York Memorial Sloan Kettering MSKCC (2) New York, New York, United States, 10017 United States, Tennessee Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2) Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Villejuif Cedex, France, 94805 Netherlands Novartis Investigative Site Utrecht, Netherlands, 3584CX 收起 << |
NCT02205398 | Squamous Cell Carcinoma of Hea... 展开 >>d and Neck (SCCHN) Metastatic Colorectal Cancer 收起 << | Phase 1 | Terminated | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Head & Neck Boston, Massachusetts, United States, 02114 United States, New York Memorial Sloan Kettering MSKCC NY New York, New York, United States, 10017 United States, Utah University of Utah / Huntsman Cancer Institute Onc Dept Salt Lake City, Utah, United States, 84103 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X6 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Wurzburg, Germany, 97080 Italy Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Milano, MI, Italy, 20162 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 收起 << |
NCT01743469 | - | Completed | - | - | |
NCT02296424 | Systemic Juvenile Idiopathic A... 展开 >>rthritis (SJIA) 收起 << | Phase 3 | Completed | - | - |
NCT02402712 | Breast Cancer | Phase 3 | Active, not recruiting | March 19, 2019 | - |
NCT03023878 | High-risk Diffuse Large B-Cell... 展开 >> Lymphoma 收起 << | Phase 2 | Active, not recruiting | November 15, 2019 | United States, Illinois ... 展开 >> Research Site Chicago, Illinois, United States, 60612 Research Site Maywood, Illinois, United States, 60153 United States, Louisiana Research Site New Orleans, Louisiana, United States, 70112 United States, Maryland Research Site Baltimore, Maryland, United States, 21201 United States, New Jersey Research Site New Brunswick, New Jersey, United States, 08903 United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States, 73104 United States, Oregon Research Site Portland, Oregon, United States, 97213 United States, South Carolina Research Site Greenville, South Carolina, United States, 29607 Canada, Alberta Research Site Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Research Site Sault Ste. Marie, Ontario, Canada, P6B 0A8 Research Site Toronto, Ontario, Canada, M5G 2M9 France Research Site Créteil Cedex, France, 94010 Research Site Paris Cedex 10, France, 75475 Germany Research Site Dresden, Germany, 01307 Research Site Ulm, Germany, 89081 Spain Research Site Sevilla, Andalucía, Spain, 41013 Research Site Salamanca, Castilla León, Spain, 37007 Research Site Barcelona, Cataluña, Spain, 08003 Research Site L Hospitalet De Llobregat, Cataluña, Spain, 08907 Research Site Valencia, Comunidad Valenciana, Spain, 46026 Research Site A coruña, Galicia, Spain, 15006 Research Site Madrid, Spain, 28007 United Kingdom Research Site Bristol, United Kingdom, BS2 8ED Research Site Sheffield, United Kingdom, S10 2JF 收起 << |
NCT01960348 | TTR-mediated Amyloidosis ... 展开 >> Amyloidosis, Hereditary Amyloid Neuropathies, Familial Familial Amyloid Polyneuropathies Amyloid Neuropathies Amyloidosis, Hereditary, Transthyretin-Related 收起 << | Phase 3 | Completed | - | - |
NCT00150449 | Anxiety Neuroses | Phase 3 | Completed | - | - |
NCT01832727 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | February 28, 2019 | United States, California ... 展开 >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States United States, Kansas University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States Massachusetts General Hospital Boston, Massachusetts, United States United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States United States, North Carolina Division of Hematology/ Oncology, UNC at Chapel Hill Chapel Hill, North Carolina, United States United States, Ohio Gabrail Cancer Center Research Canton, Ohio, United States United States, Wisconsin Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States France CHRU, Hopital Huriez - Department of Hematology Lille CEDEX, France CHU Hotel Dieu - Service d'Hematologie Clinique NANTES Cedex, France CHU de NANCY - Hopital de BRABOlS Vandoeuvre Les Nancy, France 收起 << |
NCT01803555 | Asthma | Phase 3 | Completed | - | - |
NCT02585960 | Hemophilia A | Phase 3 | Completed | - | - |
NCT01168817 | Erectile Dysfunction | Phase 2 | Completed | - | Finland ... 展开 >> Oulu, Finland, 90100 Tampere, Finland, FIN-33520 Turku, Finland, 20100 France Chambery Cedex, France, 73011 Garches, France, 92380 Lille, France, 59000 Lyon Cedex, France, 69437 Nice, France, 06200 Nimes, France, 30000 Germany Weiden, Bayern, Germany, 92637 Marburg, Hessen, Germany, 35039 Osnabrück, Niedersachsen, Germany, 49076 Mülheim, Nordrhein-Westfalen, Germany, 45468 Koblenz, Rheinland-Pfalz, Germany, 56068 Leipzig, Sachsen, Germany, 04105 Leipzig, Sachsen, Germany, 04109 Hamburg, Germany, 20246 Hamburg, Germany, 20354 Italy Firenze, Italy, 50141 Milano, Italy, 20132 Napoli, Italy, 80131 Roma, Italy, 00133 Netherlands Den Haag, Netherlands, 2545 CH Groningen, Netherlands, 9713 GZ Leiden, Netherlands, 2333 ZA Spain Aravaca, Madrid, Spain, 28023 Majadahonda, Madrid, Spain, 28222 Barcelona, Spain, 08003 Barcelona, Spain, 08036 Málaga, Spain, 29007 Sweden Eskilstuna, Sweden, 633 40 Göteborg, Sweden, 405 45 Halmstad, Sweden, 302 45 Jönköping, Sweden, 554 66 Linköping, Sweden, 581 85 Stockholm, Sweden, 141 86 收起 << |
NCT02104947 | Hemorrhage | Phase 3 | Completed | - | - |
NCT02519452 | Multiple Myeloma | Phase 1 | Recruiting | June 17, 2021 | United States, Georgia ... 展开 >> Winship Cancer Institute Emory University Completed Atlanta, Georgia, United States, 30322 United States, New York Mt. Sinai School of Medicine Active, not recruiting New York, New York, United States, 10029 United States, North Carolina Levine Cancer Institute Completed Charlotte, North Carolina, United States, 28204 United States, Pennsylvania University of Pennsylvania-Abramson Cancer Center Completed Philadelphia, Pennsylvania, United States, 19104 Denmark Vejle Sygehus Recruiting Vejle, Denmark, 7100 France Hôpital Huriez, CHRU Lille Withdrawn Lille, France, 59037 CHU de Nantes hôtel-Dieu Active, not recruiting Nantes Cedex 1, France, 44093 Centre hospitalier Lyon-Sud Withdrawn Pierre-Bénite, France, 69495 CHU Bretonneau Completed Tours Cedex, France, 37044 Netherlands VU Medisch Centrum Recruiting Amsterdam, Netherlands, 1061 HV Erasmus MC Withdrawn Rotterdam, Netherlands, 3015 CN Spain Hosp. Univ. Germans Trias I Pujol Recruiting Badalona, Spain, 08916 Clinica Univ. de Navarra Completed Pamplona, Spain, 31008 Hosp. Clinico Univ. de Salamanca Recruiting Salamanca, Spain, 37007 Sweden Haematology Centre, R 51 Completed Stockholm, Sweden, SE-141 86 收起 << |
NCT02501629 | Asthma Elevat... 展开 >>ed Blood Eosinophils Oral Corticosteroid Dependence 收起 << | Phase 3 | Completed | - | - |
NCT01821118 | Cerebral Amyloid Angiopathy | Phase 2 | Completed | - | United States, California ... 展开 >> UCLA Ronald Reagan Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts MGH Stroke Research Center Boston, Massachusetts, United States, 02114 Boston Medical Center - Menino Pavilion Boston, Massachusetts, United States, 02118 Boston Medical Center - Shapiro Center Boston, Massachusetts, United States, 02118 Anthinoula A. Martinos Center for Biomedical Imaging Charlestown, Massachusetts, United States, 02129 United States, Missouri Barnes Jewish Hospital St. Louis, Missouri, United States, 63110 United States, New York Columbia University New York, New York, United States, 10032 Canada, Alberta University of Calgary/Foothills Medical Centre Calgary, Alberta, Canada, T2N 2T9 Canada, Ontario Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 France CHRU de Lille - Hôpital Roger Salengro Lille Cedex, NAP, France, 59037 CHRU de Lille Lille Cedex, NAP, France, 59037 Netherlands University Medical Center Utrecht Utrecht, Netherlands, 3584 CX United Kingdom University College of London London, United Kingdom, WC1N 3BG 收起 << |
NCT02104947 | - | Completed | - | - | |
NCT02338154 | - | Completed | - | Austria ... 展开 >> Salzburger Universitätsklinikum Salzburg, Austria, 5020 Landesklinikum - St. Pölten St Pölten, Austria, 3100 Klinisshe Abteiluing Für Herz-thoraxchirurgie Vienna, Austria, 1090 Denmark Aarhus Universitetshospital Skejby Aarhus N, Denmark, 8200 France CHU Bocage Central Dijon Dijon, France, 21074 Hôpital Saint Joseph - Marseille Marseille Cedex, France, 13285 Centre Hospitalier de Mulhouse Mulhouse Cedex, France, 68051 Centre Cardiologique du Nord St Denis St Denis, France, 93200 Germany Herz- und Gefäß-Klinik GmbH Bad Neustadt Bad Neustadt, Germany, 97616 Westdeutsches Herzcentrum Uniklinik Essen Essen, Germany, 45147 Klinikum Nürnberg Süd Nürenberg, Germany, 90471 Italy Clinica Santa Maria Bari, Italy, 70124 S. Anna Hospital Catanzaro, Italy, 88100 G. Pasquinucci Heart Hospital - "G.Monasterio" Foundation Massa, Italy, 54100 Centro Cardiologico Monzino Milan, Italy, 20138 Ospedale Niguarda Ca' Granda Milan, Italy, 20162 Università Cattolica del Sacro Cuore Policlinico Roma, Italy, 00168 Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" Udine, Italy, 33100 Netherlands Catharina Hospital Eindhoven Eindhoven, Netherlands, 5623 Spain Hospital Universitario Cruces Barakaldo Barakaldo, Spain, 48903 Hospital Universitario Virgen de la Arrixaca El Palmar (Murcia), Spain, 30120 Hospital Clínico San Carlos Madrid, Spain, 28040 Switzerland Universitätsklinik Für Herz und Gefässchirurgie Bern, Switzerland, 3010 Cardiocentro Ticino Lugano, Switzerland, 6903 Universität Zurich Zurich, Switzerland, 8091 United Kingdom St Thomas' Hospital London, United Kingdom, SE1 7EH King's College Hospital London, United Kingdom, SE5 9RS 收起 << | |
NCT03375203 | Insomnia Disorders | Phase 2 | Recruiting | April 24, 2019 | - |
NCT02360579 | Metastatic Melanoma | Phase 2 | Active, not recruiting | September 2023 | - |
NCT01821118 | - | Completed | - | - | |
NCT02598661 | Myelodysplastic Syndromes | Phase 3 | Recruiting | February 28, 2022 | - |
NCT02501629 | - | Completed | - | - | |
NCT03661320 | Bladder Cancer ... 展开 >> Muscle-Invasive Bladder Cancer BMS-986205 收起 << | Phase 3 | Recruiting | December 30, 2026 | - |
NCT01938001 | Lymphoma, Non-Hodgkin | Phase 3 | Active, not recruiting | December 28, 2021 | - |
NCT02961881 | Non-Hodgkin's Lymphoma | Phase 1 | Recruiting | May 1, 2020 | United States, California ... 展开 >> Research Site Recruiting Duarte, California, United States, 91010 United States, New Jersey Research Site Completed Hackensack, New Jersey, United States, 07601 Australia, New South Wales Research Site Recruiting Concord, New South Wales, Australia, 2139 Australia, Victoria Research Site Recruiting Fitzroy, Victoria, Australia, 3065 Research Site Recruiting Richmond, Victoria, Australia, 3121 France Research Site Recruiting Créteil Cedex, France, 94010 Research Site Recruiting Paris Cedex 10, France, 75475 Germany Research Site Recruiting Dresden, Germany, 01307 Research Site Recruiting Frankfurt am Main, Germany, 60590 Research Site Recruiting Ulm, Germany, 89081 Italy Research Site Recruiting Bergamo, Italy, 24127 Research Site Recruiting Bologna, Italy, 40138 Research Site Recruiting Brescia, Italy, 25123 Research Site Recruiting Milano, Italy, 20132 Research Site Recruiting Rozzano MI, Italy, 20089 收起 << |
NCT02920008 | Acute Myeloid Leukemia | Phase 3 | Active, not recruiting | December 2019 | - |
NCT02490787 | Congenital Bleeding Disorder ... 展开 >> Haemophilia A 收起 << | Phase 1 | Completed | - | - |
NCT01960348 | - | Completed | - | - | |
NCT02462525 | Multiple Myeloma | Phase 1 | Terminated(No Go decision for ... 展开 >>ABBV-838) 收起 << | - | United States, Illinois ... 展开 >> The University of Chicago Medical Center /ID# 139403 Chicago, Illinois, United States, 60637 United States, Michigan University of Michigan Medical Center /ID# 139402 Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School of Medicine /ID# 135708 Saint Louis, Missouri, United States, 63110-1093 United States, New York Mount Sinai Medical Center /ID# 133569 New York, New York, United States, 10029 United States, Tennessee The Sarah Cannon Research Institute /ID# 135814 Nashville, Tennessee, United States, 37203 France CHRU de Lille, Hopital Claude Huriez /ID# 133634 Lille Cedex, France, 59037 CHU de Nantes, Hotel Dieu - HME /ID# 133633 Nantes Cedex 1, France, 44093 CHU de la miletrie, Centre d'investigation clinique /ID# 147542 Poitiers, France, 86021 Germany Universitaetsklinikum Koeln /ID# 141535 Cologne, Germany, 50937 Universitaetklinikum Dresden /ID# 141860 Dresden, Germany, 01307 Universitaetsklinikum Heidelberg /ID# 140046 Heidelberg, Germany, 69210 Universitaetsklinikum Schleswig-Holstein /ID# 141534 Kiel, Germany, 24105 Universitaetsklinikum Tuebingen /ID# 141074 Tuebingen, Germany, 72076 Universitaetsklinikum Wuerzburg /ID# 141533 Wuerzburg, Germany, 97080 Spain Hospital Clinic de Barcelona /ID# 141643 Barcelona, Spain, 08036 Hospital Universitario de la Princesa /ID# 140881 Madrid, Spain, 28006 Hospital Universitario 12 de Octubre /ID# 140878 Madrid, Spain, 28041 Clinica Universitaria de Navarra /ID# 141411 Pamplona-Navarra, Spain, 31008 Hospital Clinico Universitario Salamanca /ID# 140880 Salamanca, Spain, 37007 收起 << |
NCT03034915 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 4 | Completed | - | - |
NCT00806351 | Fungemia Neut... 展开 >>ropenia Candidiasis 收起 << | Phase 3 | Terminated(The study was prema... 展开 >>turely terminated on May 18, 2012 due to slow enrollment. The study was not terminate due to any safety issues or concerns.) 收起 << | - | Bosnia and Herzegovina ... 展开 >> Pfizer Investigational Site Sarajevo, Bosnia and Herzegovina, 71000 France Pfizer Investigational Site GRENOBLE Cedex 09, France, 38043 Pfizer Investigational Site Strasbourg Cedex, France, 67098 Italy Pfizer Investigational Site Bologna, Italy, 40138 Pfizer Investigational Site Roma, Italy, 00133 Poland Pfizer Investigational Site Gdansk, Poland, 80-952 Pfizer Investigational Site Warszawa, Poland, 02-776 Pfizer Investigational Site Wroclaw, Poland, 50-367 Russian Federation Pfizer Investigational Site Moscow, Russian Federation, 115478 Slovakia Pfizer Investigational Site Kosice, Slovakia, 04190 收起 << |
NCT03184870 | Colorectal Cancer ... 展开 >> Pancreatic Cancer 收起 << | Phase 1 Phase 2 | Recruiting | December 20, 2021 | - |
NCT03484923 | Melanoma | Phase 2 | Recruiting | March 28, 2022 | United States, California ... 展开 >> The Angeles Clinic and Research Institute Recruiting Los Angeles, California, United States, 90025 Contact: Jamie Perez 310-231-2122 jperez@theangelesclinic.org Principal Investigator: Omid Hamid University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Art Villanueva avillanueva@mednet.ucla.edu Principal Investigator: Antoni Ribas United States, New York NYU Laura and Isaac Perlmutter Cancer Center Perlmutter Cancer Center Recruiting New York, New York, United States, 10016 Contact 212-731-6160 Principal Investigator: Jeffrey S Weber United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact 412-623-4897 Principal Investigator: John M. Kirkwood Australia, New South Wales Novartis Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Marseille, France, 13009 Novartis Investigative Site Recruiting Paris Cedex 10, France, 75475 Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Recruiting Dresden, Germany, 01307 Novartis Investigative Site Recruiting Essen, Germany, 45122 Novartis Investigative Site Recruiting Muenchen, Germany, 80336 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Recruiting Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Switzerland Novartis Investigative Site Recruiting Zuerich, Switzerland, 8091 收起 << |
NCT02000622 | Breast Cancer Metastatic ... 展开 >> BRCA 1 Gene Mutation BRCA 2 Gene Mutation 收起 << | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT03334617 | Non-Small Cell Lung Cancer | Phase 2 | Recruiting | July 30, 2021 | - |
NCT02849626 | Partial-Onset or Primary Gener... 展开 >>alized Tonic-Clonic Seizures 收起 << | Phase 3 | Active, not recruiting | February 27, 2019 | - |
NCT00806351 | - | Terminated(The study was prema... 展开 >>turely terminated on May 18, 2012 due to slow enrollment. The study was not terminate due to any safety issues or concerns.) 收起 << | - | - | |
NCT03366272 | Lymphoma, Non-Hodgkin | Phase 2 Phase 3 | Recruiting | November 2024 | - |
NCT02891850 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 4 | Recruiting | February 28, 2020 | - |
NCT02616640 | Multiple Myeloma | Phase 1 | Active, not recruiting | August 6, 2019 | - |
NCT01468688 | 3rd Line GIST | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute SC (2) Boston, Massachusetts, United States, 02215 United States, Washington Seattle Cancer Care Alliance Onc Seattle, Washington, United States, 98105 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 4E6 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Villejuif Cedex, France, 94805 Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site London, United Kingdom, SW3 6JJ Novartis Investigative Site Manchester, United Kingdom, M20 9BX 收起 << |
NCT02000622 | - | Active, not recruiting | - | - | |
NCT00540228 | - | Completed | - | - | |
NCT00540228 | Influenza | Phase 2 | Completed | - | France ... 展开 >> GSK Investigational Site Caen cedex 4, France, 14052 GSK Investigational Site Lagord, France, 17140 GSK Investigational Site Lille, France, 59019 GSK Investigational Site Paris Cedex 18, France, 75877 GSK Investigational Site Paris, France, 75679 GSK Investigational Site Toulouse, France, 31300 Germany GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72074 GSK Investigational Site Wuerzburg, Bayern, Germany, 97070 GSK Investigational Site Dresden, Sachsen, Germany, 01307 GSK Investigational Site Freiberg, Sachsen, Germany, 09599 GSK Investigational Site Schmiedeberg, Sachsen, Germany, 01762 Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Barcelona, Spain, 08036 GSK Investigational Site Madrid, Spain, 28035 GSK Investigational Site Marid, Spain, 28040 收起 << |
NCT03096834 | Episodic Migraine | Phase 3 | Active, not recruiting | January 19, 2021 | - |
NCT03539744 | Multiple Myeloma | Phase 3 | Recruiting | January 25, 2022 | - |
NCT02301143 | Pancreatic Neoplasms | Phase 2 | Completed | - | - |
NCT02053792 | Hemophilia B | Phase 3 | Recruiting | April 30, 2020 | - |
NCT03252587 | Systemic Lupus Erythematosus | Phase 2 | Recruiting | July 21, 2020 | - |
NCT02751879 | - | Completed | - | - | |
NCT03332017 | Relapsed/Refractory Follicular... 展开 >> Non-Hodgkin Lymphoma 收起 << | Phase 2 | Recruiting | October 2021 | - |
NCT02860286 | Mesothelioma ... 展开 >>BAP1 Loss of Function 收起 << | Phase 2 | Active, not recruiting | December 2018 | United States, California ... 展开 >> University of California, Los Angeles Los Angeles, California, United States, 90025 City of Hope National Medical Center Los Angeles, California, United States, 90301 University of California San Francisco San Francisco, California, United States, 94143 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 France Institut Bergonie Bordeaux Cedex, France, 33076 CHRU de Lille Lille, France, 59037 Institut Gustave Roussy Villejuif cedex, France, 94805 United Kingdom University Hospital of South Manchester Greater Manchester, United Kingdom, M23 9LT University of Leicester & Leicester University Hospitals Leicester, United Kingdom, LE1 9HN St. Bartholomew's Hospital London, United Kingdom, EC1M 6BQ University College Hospital London, United Kingdom, NW1 2PG Royal Marsden Hospital - Chelsea London, United Kingdom, SW3 6JJ Royal Marsden Hospital - Surrey Surrey, United Kingdom, SM2 5PT 收起 << |
NCT03064854 | Non-small Cell Lung Cancer | Phase 1 | Recruiting | February 15, 2022 | - |
NCT00482170 | Psoriasis | Phase 3 | Completed | - | - |
NCT02107196 | - | Completed | - | - | |
NCT01976741 | Neoplasms | Phase 1 | Active, not recruiting | June 10, 2019 | United States, Illinois ... 展开 >> Chicago, Illinois, United States, 60611-2908 Chicago, Illinois, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232 France Besancon, France, 25030 Creteil, France, 94010 Dijon, France, 21000 Lille Cedex, France, 59020 Lyon Cedex, France, 69008 Germany Heidelberg, Baden-Württemberg, Germany, 69120 Tübingen, Baden-Württemberg, Germany, 72076 Weiden, Bayern, Germany, 92637 Würzburg, Bayern, Germany, 97080 Essen, Nordrhein-Westfalen, Germany, 45147 Köln, Nordrhein-Westfalen, Germany, 50937 Dresden, Sachsen, Germany, 01307 Hamburg, Germany, 20246 Magdeburg, Germany, 39120 Korea, Republic of Seoul, Korea, Republic of, 03080 Seoul, Korea, Republic of, 120-752 Seoul, Korea, Republic of, 135-710 Singapore Singapore, Singapore, 119228 Singapore, Singapore, 169610 Spain Barcelona, Spain, 08035 Madrid, Spain, 28034 Madrid, Spain, 28041 Valencia, Spain, 46014 Switzerland Chur, Graubünden, Switzerland, 7000 St. Gallen, Sankt Gallen, Switzerland, 9007 Genève, Switzerland, 1205 收起 << |
NCT02059291 | Hereditary Periodic Fevers | Phase 3 | Completed | - | - |
NCT02107196 | Irritable Bowel Syndrome With ... 展开 >>Diarrhea 收起 << | Phase 3 | Completed | - | - |
NCT02708095 | Systemic Lupus Erythematosus | Phase 2 | Completed | - | - |
NCT03090191 | Clostridium Difficile Infectio... 展开 >>n 收起 << | Phase 3 | Recruiting | September 28, 2020 | - |
NCT02920398 | Congenital Bleeding Disorder ... 展开 >> Haemophilia A 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Novo Nordisk Investigational Site Torrance, California, United States, 90502-2004 United States, Iowa Novo Nordisk Investigational Site Iowa City, Iowa, United States, 52242 United States, Maryland Novo Nordisk Investigational Site Baltimore, Maryland, United States, 21287 United States, Ohio Novo Nordisk Investigational Site Dayton, Ohio, United States, 45404 United States, Tennessee Novo Nordisk Investigational Site Nashville, Tennessee, United States, 37232 Denmark Novo Nordisk Investigational Site Århus N, Denmark, 8200 France Novo Nordisk Investigational Site Bron Cedex, France, 69677 Novo Nordisk Investigational Site Nantes Cedex 1, France, 44093 Germany Novo Nordisk Investigational Site Berlin, Germany, 10249 Novo Nordisk Investigational Site Frankfurt/M., Germany, 60590 Novo Nordisk Investigational Site Homburg, Germany, 66421 Netherlands Novo Nordisk Investigational Site Groningen, Netherlands, 9713 GZ Spain Novo Nordisk Investigational Site Madrid, Spain, 28046 Novo Nordisk Investigational Site Málaga, Spain, 29010 收起 << |
NCT02059291 | - | Completed | - | - | |
NCT03318523 | Parkinson's Disease | Phase 2 | Recruiting | April 6, 2022 | - |
NCT02708095 | - | Completed | - | - | |
NCT00482170 | - | Completed | - | - | |
NCT02879305 | Anaemia | Phase 3 | Active, not recruiting | April 14, 2020 | - |
NCT02292706 | - | Enrolling by invitation | August 2023 | - | |
NCT00936221 | Melanoma | Phase 2 | Completed | - | - |
NCT01625182 | Chronic Inflammatory Demyelina... 展开 >>ting Polyradiculoneuropathy 收起 << | Phase 3 | Completed | - | - |
NCT01646125 | Advanced Non Small Cell Lung C... 展开 >>ancer (NSCLC) 收起 << | Phase 2 | Terminated(An interim analysis... 展开 >> was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility.) 收起 << | - | - |
NCT00936221 | - | Completed | - | - | |
NCT00704483 | Hyperphosphatemia Patients Wit... 展开 >>h Chronic Kidney Disease on 3x/Week Replacement Therapy 收起 << | Phase 2 | Completed | - | - |
NCT01344460 | - | Completed | - | - | |
NCT01625182 | - | Completed | - | - | |
NCT01636687 | Plaque-type Psoriasis | Phase 3 | Completed | - | - |
NCT01646125 | - | Terminated(An interim analysis... 展开 >> was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility.) 收起 << | - | - | |
NCT01575873 | Steroid-induced Osteopor, Gluc... 展开 >>ocorticoid-induced Ostepor 收起 << | Phase 3 | Completed | - | - |
NCT01344460 | Renal Artery Obstruction | Phase 3 | Completed | - | - |
NCT00984282 | Thyroid Neoplasms | Phase 3 | Completed | - | - |
NCT01389856 | Persistent Pulmonary Hypertens... 展开 >>ion of the Newborn 收起 << | Phase 3 | Terminated(To be compliant wit... 展开 >>h the timelines as agreed with Paediatric Committee (PC) within the Paediatric Investigational Plan) 收起 << | - | - |
NCT01373151 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT00984282 | - | Completed | - | - | |
NCT01478048 | Multiple Myeloma | Phase 2 | Completed | - | - |
NCT03314181 | Multiple Myeloma | Phase 2 | Recruiting | March 22, 2023 | - |
NCT01478048 | - | Completed | - | - | |
NCT01578499 | Primary Cutaneous Anaplastic L... 展开 >>arge Cell Lymphoma Mycosis Fungoides Cutaneous T-Cell Lymphoma 收起 << | Phase 3 | Completed | - | - |
NCT01389856 | - | Terminated(To be compliant wit... 展开 >>h the timelines as agreed with Paediatric Committee (PC) within the Paediatric Investigational Plan) 收起 << | - | - | |
NCT03530345 | Complex Regional Pain Syndrome... 展开 >> (CRPS) 收起 << | Phase 3 | Recruiting | April 2021 | - |
NCT01817504 | Renal Transplantation | Not Applicable | Recruiting | November 2019 | France ... 展开 >> Service de Néphrologie, Médecine interne, Hémodialyse, Transplantation Rénale, Hôpital Sud Recruiting Amiens, France, 80054 Contact: Gabriel CHOUKROU, MD Principal Investigator: Gabriel CHOUKROU, MD Service de Néphrologie, Dialyse et Transplantation - Hôpital Jean Minjoz Recruiting Besançon, France, 25030 Contact: Didier DUCLOUX, MD Principal Investigator: Didier DUCLOUX, MD Service de Néphrologie - Hôpital de La Cavale blanche Recruiting Brest, France, 29609 Contact: Yannick LE MEUR, MD Principal Investigator: Yannick LE MEUR, MD Service de Néphrologie et Transplantation Rénale, CHU Gabriel Montpied Recruiting Clermont-Ferrand Cedex, France, 63000 Contact: Anne-Elisabeth HENG, MD Principal Investigator: Anne-Elisabeth HENG, MD Hôpitaux Civils de Colmar Recruiting Colmar, France, 68024 Contact: Alexandre KLEIN, MD Principal Investigator: Alexandre KLEIN, MD Service de Néphrologie -Dialyse-Transplantation, Hôpital Michallon Recruiting Grenoble Cedex, France, 38043 Contact: Paolo MALVEZZI, MD Principal Investigator: Paolo MALVEZZI, MD Centre Hospitalier de Haguenau Recruiting Haguenau, France, 67504 Contact: Marc KRIBS, MD Principal Investigator: Marc KRIBS, MD Centre Hospitalier départemental Vendée - Site de la Roche-sur-Yon Recruiting La Roche-sur-Yon, France, 85925 Contact: Grégoire COUVRAT-DESVERGNES, MD Principal Investigator: Grégoire COUVRAT-DESVERGNES, MD Service de Néphrologie - Hôpital Claude Huriez Recruiting Lille, France, 59000 Contact: Marc HAZZAN, MD Principal Investigator: Marc HAZZAN, MD Transplantation Department, Hôpital Edourad Herriot Recruiting Lyon, France, 69003 Contact: Emmanuel MORELON, MD 33 472 110 150 ext +33 emmanuel.morelon@chu-lyon.fr Principal Investigator: Emmanuel MORELON, MD Service de Néphrologie et Transplantation Rénale - Hôpital Lapeyronie Recruiting Montpellier, France, 34295 Contact: Valérie GARRIGUE, MD Principal Investigator: Valérie GARRIGUE, MD Institut de Transplantation, Urologie et Néphrologie - CHU Nantes Recruiting Nantes, France, 44093 Contact: Gilles BLANCHO, MD Principal Investigator: Gilles BLANCHO, MD Unité de Transplantation Rénale - Hôpital de l'Archet Recruiting Nice, France, 06202 Contact: Elisabeth CASSUTO, MD Principal Investigator: Elisabeth CASSUTO, MD Urgence Néphrologique et Transplantation Rénale - Hôpital Tenon Recruiting Paris, France, 75020 Contact: Alexandre HERTIG, MD Principal Investigator: Alexandre HERTIG, MD Service de Néphrologie, Centre Hospitalier Lyon Sud Recruiting Pierre Bénite, France, 69310 Contact: Solenne PELETTIER, MD Principal Investigator: Solenne PELETTIER, MD Service de Néphrologie-Dialyse, Centre Hospitalier d'Annecy Recruiting Pringy, France, 74374 Contact: Maizé DUCRET, MD Principal Investigator: Maizé DUCRET, MD Service de Néphrologie, Dialyse et Transplantation Rénale, Hôpital Nord Recruiting Saint-Etienne, France, 42055 Contact: Christophe MARIAT, MD Principal Investigator: Christophe MARIAT, MD Service de Néphrologie et Transplantation Rénale - Nouvel Hôpital Civil Recruiting Strasbourg, France, 67091 Contact: Bruno MOULIN, MD Principal Investigator: Bruno MOULIN, MD Département de Néphrologie et Transplantation d'Organes - Hôpîtal Rangueil Withdrawn Toulouse, France, 31059 Service de Néphrologie, Immunologie Clinique - CHU Bretonneau Recruiting Tours, France, 37044 Contact: Matthias BUCHLER, MD Principal Investigator: Matthias BUCHLER, MD 收起 << |
NCT01575873 | - | Completed | - | - | |
NCT00868296 | Gastroesophageal Reflux | Phase 3 | Completed | - | - |
NCT01636687 | - | Completed | - | - | |
NCT03462719 | Leukemia, Lymphocytic, Chronic... 展开 >>, B-Cell 收起 << | Phase 3 | Recruiting | April 30, 2024 | - |
NCT01578499 | - | Completed | - | - | |
NCT01442376 | Chemotherapy-Induced Nausea an... 展开 >>d Vomiting 收起 << | Phase 3 | Completed | - | - |
NCT01734486 | Genetic Disorder ... 展开 >> Turner Syndrome 收起 << | Phase 4 | Completed | - | France ... 展开 >> Novo Nordisk Investigational Site Besancon, France, 25030 Novo Nordisk Investigational Site Bordeaux, France, 33000 Novo Nordisk Investigational Site Dunkerque, France, 59385 Novo Nordisk Investigational Site Grenoble, France, 38043 Novo Nordisk Investigational Site Lille, France, 59037 Novo Nordisk Investigational Site Lorient, France Novo Nordisk Investigational Site NICE cedex 3, France, 06202 Novo Nordisk Investigational Site Paris, France Novo Nordisk Investigational Site Reims, France Novo Nordisk Investigational Site Rennes, France, 35056 Novo Nordisk Investigational Site Rouen, France, 76031 Novo Nordisk Investigational Site Tarbes, France Novo Nordisk Investigational Site TOULOUSE cedex, France, 31059 Novo Nordisk Investigational Site Tours, France, 37044 Novo Nordisk Investigational Site Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT00868296 | - | Completed | - | - | |
NCT01448707 | Human Immunodeficiency Virus (... 展开 >>HIV) Infections Acquired Immunodeficiency Syndrome (AIDS) Virus 收起 << | Phase 3 | Completed | - | - |
NCT01846299 | - | Completed | - | - | |
NCT01442376 | - | Completed | - | - | |
NCT01736683 | Anemia Myelod... 展开 >>ysplastic Syndromes Chronic Myelomonocytic Leukemia Low to Intermediate-1 MDS Myelodysplastic Syndromes (MDS) Chronic Myelomonocytic Leukemia (CMML) 收起 << | Phase 2 | Completed | - | United States, Colorado ... 展开 >> Rocky Mountain Cancer Center-Midtown Denver, Colorado, United States, 80218 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Dana-Farber / Harvard Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Monter Cancer Center, North Shore LIJ Health Systems Lake Success, New York, United States, 11042 Columbia University Medical Center/New York-Presbyterian Hospital New York, New York, United States, 10032 United States, Ohio The Cleveland Clinic Foundation Hematology and Medical Oncology Rm 35 Cleveland, Ohio, United States, 44195 United States, Tennessee Sarah Cannon Research Inst Nashville, Tennessee, United States, 37203 United States, Texas Texas Oncology Round Rock Cancer Center - Round Rock Round Rock, Texas, United States, 78681 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Texas Oncology, P.A. - Tyler Tyler, Texas, United States, 75702 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Yakima Valley Memorial Hospital/ North Star Lodge Yakima, Washington, United States, 98902 France Centre Hospitalier Universitaire d'Avicennes Bobigny Cedex, France, 93009 Institute Paoli-Calmettes Service Haematology Bp 156,, France, 13273 CHRU de Lille-Hopital Claude Huriez Service des Maladies du Sang Lille, France, 59037 CHRU Nantes Nantes, France, 44093 Hopital Cochin Hematologie Paris Cedex 14, France, 75679 Centre Henri Becquerel Rouen, France, 79038 CHU Purpan Toulouse, France, 31059 收起 << |
NCT01448707 | - | Completed | - | - | |
NCT03502616 | Ankylosing Spondylitis | Phase 3 | Recruiting | August 2, 2020 | - |
NCT01846299 | Macular Edema (ME) | Phase 3 | Completed | - | - |
NCT02299440 | Suicidal Ideation | Phase 3 | Recruiting | February 2019 | France ... 展开 >> CHU de Clermont Ferrand - Hôpital Gabriel-Montpied Not yet recruiting Clermont Ferrand, France, 63003 Principal Investigator: Pierre-Michel Llorca, MD, PhD CHRU de Lille - Hôpital Michel Fontan Not yet recruiting Lille, France, 59037 Principal Investigator: Guillaume Vaiva, MD, PhD CHRU de Montpellier - Hôpital Lapeyronie Not yet recruiting Montpellier, France, 34295 Sub-Investigator: Philippe Courtet, MD, PhD CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Sub-Investigator: Mocrane Abbar, MD Principal Investigator: Aurélie Chopin, MD Sub-Investigator: Fabrice Jollant, MD Clinique Les Sophoras Not yet recruiting Nîmes, France, 30000 Principal Investigator: Stéphane Torres, MD Centre Hospitalier Sainte-Anne Recruiting Paris cedex 14, France, 75674 Principal Investigator: Raphael Gaillard, MD, PhD APHP - Hôpital Lariboisière Not yet recruiting Paris, France, 75010 Sub-Investigator: Frank Bellivier, MD, PhD CMME Centre Hospitalier Sainte Anne Not yet recruiting Paris, France, 75674 Contact: Philip GORWOOD, MD PhD 0145658000 p.gorwood@ch-sainte-anne.fr CHRU de Tours - Clinique Psychiatrique Universitaire Recruiting Saint Cyr sur Loire, France, 37540 Sub-Investigator: Wissam El Hage, MD, PhD 收起 << |
NCT01607957 | Colorectal Cancer | Phase 3 | Completed | - | - |
NCT01708590 | Moderate to Severe Plaque Psor... 展开 >>iasis 收起 << | Phase 3 | Terminated(Sponsor decision) | August 2015 | - |
NCT01482156 | Advanced Solid Tumors ... 展开 >> Metastatic Breast Cancer Metastatic Renal Cell Carcinoma 收起 << | Phase 1 | Completed | - | United States, Arkansas ... 展开 >> Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 United States, Missouri Washington University School of Medicine Washington University (16) St. Louis, Missouri, United States, 63110 United States, South Carolina Medical University of South Carolina SC Charleston, South Carolina, United States, 29425 Belgium Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Montellier cedex 5, France, 34298 Italy Novartis Investigative Site Verona, VR, Italy, 37126 New Zealand Novartis Investigative Site Auckland, New Zealand Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site High Heaton, Newcastle Upon Tyne, United Kingdom, NE7 7DN 收起 << |
NCT00936403 | Growth Hormone Disorder ... 展开 >> Growth Hormone Deficiency in Children 收起 << | Phase 2 | Completed | - | Belgium ... 展开 >> Novo Nordisk Investigational Site Brussels, Belgium, 1090 Novo Nordisk Investigational Site Gent, Belgium, 9000 Czech Republic Novo Nordisk Investigational Site Prague 5, Czech Republic, 15018 Denmark Novo Nordisk Investigational Site Århus C, Denmark, 8000 France Novo Nordisk Investigational Site BRON cedex, France, 69677 Novo Nordisk Investigational Site Toulouse cedex 9, France, 31059 Israel Novo Nordisk Investigational Site Beer Sheva, Israel, 84101 Novo Nordisk Investigational Site Jerusalem, Israel, 91240 Novo Nordisk Investigational Site Kfar Saba, Israel, 44281 Novo Nordisk Investigational Site Petah Tikva, Israel, 49202 Macedonia, The Former Yugoslav Republic of Novo Nordisk Investigational Site Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Slovenia Novo Nordisk Investigational Site Ljubljana, Slovenia, 1525 Spain Novo Nordisk Investigational Site Barcelona, Spain, 08035 Novo Nordisk Investigational Site Esplugues Llobregat, Spain, 08950 Novo Nordisk Investigational Site Santiago de Compostela, Spain, 15706 Novo Nordisk Investigational Site Vitoria, Spain, 01009 Turkey Novo Nordisk Investigational Site Ankara, Turkey, 06100 Novo Nordisk Investigational Site Ankara, Turkey Novo Nordisk Investigational Site Istanbul, Turkey, 34093 United Kingdom Novo Nordisk Investigational Site Birmingham, United Kingdom, B4 6NH Novo Nordisk Investigational Site Cambridge, United Kingdom, CB2 2QQ 收起 << |
NCT01075048 | Metastatic Colorectal Cancer | Phase 1 Phase 2 | Completed | - | - |
NCT02999633 | T-cell Type Acute Leukemia-Pre... 展开 >>cursor T-lymphoblastic Lymphoma/Leukaemia 收起 << | Phase 2 | Terminated(Due to an unsatisfa... 展开 >>ctory benefit/risk ratio, as specified in & 14.8.1 of the protocol, Sanofi decided to stop enrollment and terminate ACT14596 prematurely) 收起 << | - | United States, Georgia ... 展开 >> Investigational Site Number 8400002 Atlanta, Georgia, United States, 30342 United States, New Jersey Investigational Site Number 8400003 Hackensack, New Jersey, United States, 07601 United States, Texas Investigational Site Number 8400001 Houston, Texas, United States, 77030 Finland Investigational Site Number 2460001 Helsinki, Finland, 00029 France Investigational Site Number 2500005 Nantes Cedex 01, France, 44093 Investigational Site Number 2500001 Paris Cedex 10, France, 75475 Investigational Site Number 2500004 Pessac, France, 33600 Investigational Site Number 2500002 Pierre Benite, France, 69310 Hungary Investigational Site Number 3480001 Budapest, Hungary, 1083 Investigational Site Number 3480003 Budapest, Hungary, 1097 Investigational Site Number 3480002 Debrecen, Hungary, 4032 Italy Investigational Site Number 3800001 Bergamo, Italy, 24127 Investigational Site Number 3800004 Brescia, Italy, 25123 Lithuania Investigational Site Number 4400001 Vilnius, Lithuania, 08661 Russian Federation Investigational Site Number 6430003 Moscow, Russian Federation, 117198 Investigational Site Number 6430004 Moscow, Russian Federation, 125167 Investigational Site Number 6430001 Moscow, Russian Federation, 129301 收起 << |
NCT01074658 | - | Completed | - | - | |
NCT00925587 | - | Completed | - | - | |
NCT03539536 | Non-small Cell Lung Cancer | Phase 2 | Recruiting | December 10, 2021 | - |
NCT01074658 | - | Completed | - | - | |
NCT00925587 | Anemia Chroni... 展开 >>c Kidney Disease 收起 << | Phase 3 | Completed | - | - |
NCT01106690 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01324479 | Solid Tumors | Phase 1 | Completed | - | - |
NCT01106690 | - | Completed | - | - | |
NCT03517722 | Lupus Erythematosus, Systemic | Phase 3 | Recruiting | August 31, 2028 | - |
NCT03329846 | Melanoma Skin... 展开 >> Cancer 收起 << | Phase 3 | Active, not recruiting | July 31, 2020 | - |
NCT01928459 | Advanced Solid Tumors ... 展开 >> Metastatic Solid Tumors 收起 << | Phase 1 | Completed | - | - |
NCT00734162 | Hepatitis B Virus (HBV) | Phase 3 | Completed | - | United States, California ... 展开 >> Children's Hospital & Research Center at Oakland Oakland, California, United States, 94609 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Washington Children's Hospital & Regional Medical Center, d/b/a Seattle Children's Research Institute Seattle, Washington, United States, 98105 Bulgaria Multiprofile Hospital for Active Treatment Sveti Georgi Plovdiv, Bulgaria, 4002 Clinic of Gastroenterology, Specialized Hospital for Active Treatment of Pediatric Diseases, Sofia Sofia, Bulgaria, 1606 France Hopital Femmes Meres Enfants Bron Cedex, France, 69677 Hôpital Claude Huriez Lille Cedex, France, 59037 Poland Samodzielny Publiczny Dzieciecy Szpital Kliniczny Akademii Medycznej w Bialymstoku Białystok, Poland, 15-274 Wojewodzki Specjalistyczny Szpital im Bieganskiego Bydgoszcz, Poland, 85-030 Wojewodzki Szpital Obserwacyjno-Zakazny im. T. Browicza Bydgoszcz, Poland, 85-030 Krakowski Szpital Specjalistyczny im. Jana Pawla II Kraków, Poland, 31-202 Samodzielny Publiczny Szpital Kliniczny im. Karola Johschera Poznan, Poland, 60-572 Specjalistyczny Zespol Opieki Zdrowotnej nad Matka i Dzieckiem Poznań, Poland, 61-734 Wojewodzki Szpital Zakazny Warszawa, Poland, 01-201 Samodzielny Publiczny Szpital Kliniczny Nr 1 Wrocław, Poland, 50-368 Romania Fundeni Clinical Institute Bucharest, Romania, 022328 Institute for Infectious Diseases Bucharest, Romania, 21105 Cluj Childrens Emergency Hospital Napaco, Romania, 400217 Spain Hosp Univ y Politecnico La Fe de Valencia Madrid, Spain, 28046 Hospital Universitario De Getafe Madrid, Spain, 46009 Turkey Ege Universitesi Tip Fakultesi Hastanesi Izmir, Turkey, 35100 收起 << |
NCT02124772 | Cancer | Phase 1 | Recruiting | October 15, 2020 | United States, Arizona ... 展开 >> Novartis Investigative Site Recruiting Phoenix, Arizona, United States, 85016-7710 United States, California Novartis Investigative Site Recruiting San Francisco, California, United States United States, Maryland Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21287 United States, Massachusetts Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02115 United States, Minnesota Novartis Investigative Site Recruiting Minneapolis, Minnesota, United States, 55455 United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10065 United States, Ohio Novartis Investigative Site Recruiting Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Novartis Investigative Site Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Recruiting Memphis, Tennessee, United States, 38105-3678 United States, Washington Novartis Investigative Site Recruiting DC, Washington, United States, DC 20010 Australia, New South Wales Novartis Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 1X8 France Novartis Investigative Site Recruiting Paris Cedex 05, France, 75248 Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 United Kingdom Novartis Investigative Site Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Novartis Investigative Site Recruiting London, United Kingdom, WC1N 3JH 收起 << |
NCT01939223 | - | Terminated | - | - | |
NCT01137812 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00734162 | - | Completed | - | - | |
NCT01492088 | Relapsed or Refractory Hodgkin... 展开 >> Lymphoma Relapsed or Refractory Anaplastic Large-cell Lymphoma 收起 << | Phase 1 Phase 2 | Completed | - | United States, Colorado ... 展开 >> Aurora, Colorado, United States United States, Missouri Kansas City, Missouri, United States United States, New York New York, New York, United States United States, Texas Houston, Texas, United States France Bordeaux Cedex, France Lyon, France Paris Cedex 12, France Germany Berlin, Germany Frankfurt, Germany Giessen, Germany Halle, Germany Munster, Germany Italy Padova, Italy Roma, Italy Mexico Mexico Df, Mexico Netherlands Rotterdam, Netherlands Spain Barcelona, Spain United Kingdom London, United Kingdom 收起 << |
NCT01137812 | - | Completed | - | - | |
NCT02411591 | Carcinoma, Non-Small-Cell Lung... 展开 >> Neoplasm Metastasis 收起 << | Phase 1 | Active, not recruiting | May 12, 2019 | Belgium ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Charleroi, Belgium, 6000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Leuven, Belgium, 3000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Roeselare, Belgium, 8800 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Brest, France, 29609 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Bron, France, 69677 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France, 59037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France, 69373 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Marseille Cedex 05, France, 13385 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Montpellier, France, 34295 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Pau, France, 64046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Strasbourg Cedex, France, 67091 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Villejuif, France, 94805 Spain Hospital Universitario Ramon y Cajal Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 46014 收起 << |
NCT01480180 | Congenital Bleeding Disorder ... 展开 >> Haemophilia A 收起 << | Phase 3 | Active, not recruiting | December 3, 2018 | - |
NCT01939223 | Colorectal Neoplasms | Phase 3 | Terminated | - | - |
NCT01164501 | Diabetes Mellitus, Type 2 ... 展开 >> Renal Insufficiency 收起 << | Phase 3 | Completed | - | - |
NCT01568229 | Schizophrenia | Phase 2 | Terminated(Toxic Epidermal Nec... 展开 >>rolysis) 收起 << | - | - |
NCT01492088 | - | Completed | - | - | |
NCT02015520 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT01489111 | Congenital Bleeding Disorder ... 展开 >> Haemophilia A 收起 << | Phase 3 | Recruiting | December 3, 2018 | - |
NCT03496779 | Refractory Peripheral T-Cell L... 展开 >>ymphoma Relapsed Peripheral T-Cell Lymphoma 收起 << | Phase 2 | Recruiting | October 2022 | Belgium ... 展开 >> ZNA Stuivenberg Recruiting Antwerpen, Belgium, 2060 Contact: Ka Lung WU, MD A. Z. Sint-Jan Recruiting Bruges, Belgium, 8000 Contact: Sylvia SNAUWAERT, MD Clinique Universitaire Saint LUC Recruiting Brussels, Belgium, 1200 Contact: Eric VAN DEN NESTE, Pr Institut Jules Bordet Recruiting Brussels, Belgium Contact: Marie MAEREVOET, MD ULB Hôpital Erasme Recruiting Brussels, Belgium Contact: Virginie DE WILDE, MD UZ Gent Recruiting Gent, Belgium, 9000 Contact: Fritz OFFNER, MD CHU de Liege Recruiting Liege, Belgium, 4000 Contact: Christophe BONNET, MD CHU UCL Namur Recruiting Yvoir, Belgium Contact: Marc ANDRE, MD France IHBN - CHU Cote de Nacre Recruiting Amiens, France, 80054 Contact: Ghandi DAMAJ, MD CHU d'Amiens Recruiting Amiens, France Contact: Caroline DELETTE, MD CHU Angers Recruiting Angers, France, 49033 Contact: Marie-Pierre MOLES-MOREAU, MD CH d'Avignon - Hôpital Henri Dufaut Recruiting Avignon, France, 84000 Contact: Hacene ZERAZHI, MD CH Côte Basque Recruiting Bayonne, France, 64100 Contact: Anne BANOS, MD CHU de Besançon - Hôpital Jean Minjoz Recruiting Besançon, France, 25030 Contact: Adrien CHAUCHET, MD CH Chambéry Recruiting Chambery, France, 73011 Contact: Maya Hacini, MD CHU d'Estaing Recruiting Clermont-Ferrand, France, 63000 Contact: Sebastien BAILLY, MD APHP - Hopital Henri Mondor Recruiting Creteil, France, 94010 Contact: Jehan DUPUIS, MD CHU de Dijon - Hôpital le Bocage Recruiting Dijon, France, 21000 Contact: Olivier CASASNOVAS, MD CHU Grenoble Recruiting Grenoble, France, 38043 Contact: Remy GRESSIN, MD CH de Versailles - Hopital André Mignot Recruiting Le Chesnay, France, 78157 Contact: Hassan Farhat, MD CH du Mans Recruiting Le Mans, France, 72000 Contact: Kamel LARIBI, Dr CHRU de Lille - Hôpital Claude Huriez Recruiting Lille, France Contact: Franck MORSCHHAUSER, Pr CHU de Limoges Recruiting Limoges, France Contact: Arnaud JACCARD, MD Centre Leon Berard Recruiting Lyon Cedex 8, France, 69373 Contact: Emmanuelle NICOLAS-VIRELIZIER, MD Institut Paoli Calmettes Withdrawn Marseille, France, 13000 Centre Hospitalier Annecy Genevois Recruiting Metz-Tessy, France, 74374 Contact: Nicolas DAGUINDAU, MD CH Saint-Eloi Recruiting Montpellier, France, 34295 Contact: Guillaume CARTRON, MD 04 67 33 83 62 Principal Investigator: Guillaume CARTRON, MD CH de Mulhouse Sud Alsace Recruiting Mulhouse, France, 68070 Contact: Bernard DRENOU, MD CHU Nancy - Brabois Recruiting Nancy, France, 54511 Contact: Pierre Feugier, MD CHU de Nantes - Hôtel Dieu Recruiting Nantes, France, 44093 Contact: Steven LE GOUILL, Pr APHP - Hôpital Saint Louis Recruiting Paris Cedex 10, France, 75475 Contact: Catherine Thieblemont, MD APHP - Hôpital Necker Recruiting Paris, France, 75015 Contact: Richard Delarue, MD Centre François Magendie - Hôpital du Haut Lévêque Recruiting Pessac, France, 33604 Contact: Kamal BOUABDALLAH, MD Centre Hospitalier Lyon Sud Recruiting Pierre Bénite, France, 69495 Contact: Emmanuel BACHY, MD CHU de Poitiers - Hôpital de la Milétrie Recruiting Poitiers, France, 86021 Contact: Vincent DELWAIL, MD CHU De Rennes Recruiting Rennes, France, 35033 Contact: Thierry LAMY DE LA CHAPELLE, MD Centre Henri BECQUEREL Recruiting Rouen, France, 76038 Contact: Hervé TILLY, Pr CHU de Toulouse Recruiting Toulouse, France, 31059 Contact: Loïc Ysebaert, MD CHRU de Tours Recruiting Tours, France, 37044 Contact: Emmanuel Gyan, MD CH de Valenciennes Recruiting Valenciennes, France, 59322 Contact: Sabine TRICOT, MD 收起 << |
NCT01164501 | - | Completed | - | - | |
NCT01860976 | Psoriatic Arthritis | Phase 3 | Active, not recruiting | July 6, 2020 | - |
NCT01860976 | - | Active, not recruiting | - | - | |
NCT01602315 | Recurrent Head and Neck Squamo... 展开 >>us Cell Carcinoma Metastatic Head and Neck Squamous Cell Carcinoma 收起 << | Phase 1 Phase 2 | Terminated(early termination d... 展开 >>ue to Sponsor decision (slow recruitment)) 收起 << | - | - |
NCT01402401 | Advanced Gastric Cancer | Phase 2 | Terminated | - | United States, California ... 展开 >> University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States, 90095 United States, New York Clinical Research Alliance Lake Success, New York, United States, 11042 United States, Texas University of Texas/MD Anderson Cancer Center UT SC Houston, Texas, United States, 77030-4009 Belgium Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Nice Cedex 2, France, 06189 Novartis Investigative Site Reims, France, 51092 Germany Novartis Investigative Site Mannheim, Baden-Württemberg, Germany, 68305 Novartis Investigative Site Heilbronn, Germany, 74078 Italy Novartis Investigative Site Modena, MO, Italy, 41100 Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 135-710 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 收起 << |
NCT02473965 | Myasthenia Gravis | Phase 2 | Active, not recruiting | March 2019 | - |
NCT00947193 | Hemophilia A ... 展开 >>Hemophilia B 收起 << | Phase 2 | Suspended | May 2012 | United States, Illinois ... 展开 >> The Bleeding and Clotting Disorders Institute Peoria, Illinois, United States, 61614 United States, Indiana St. Vincent Indianapolis Hospital Indianapolis, Indiana, United States, 46260 United States, Massachusetts New England Hemophilia Center Worcester, Massachusetts, United States, 01605 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt Hemostatis and Thrombosis Clinic Nashville, Tennessee, United States, 37232 United States, Washington Puget Sound Blood Center Seattle, Washington, United States, 98104 Canada, British Columbia St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 France Hôpital Cardiologique Lille Cedex, France Hôpital Edouard Herriot Lyon Cedex, France Hôpital Necker Enfants Malades Paris, France Italy Azienda Ospedaliero-Universitaria Careggi Viale G.B. Morgagni Firenze, Italy A.Bianchi Bonomi Hemophilia and Thrombosis Center Milano, Italy 收起 << |
NCT01544491 | Prevention of Acute Rejection ... 展开 >>in Paediatric Recipients of a Renal Transplant 收起 << | Phase 3 | Completed | - | - |
NCT02335944 | Non Small Cell Lung Cancer | Phase 1 Phase 2 | Recruiting | December 23, 2019 | United States, California ... 展开 >> City of Hope National Medical Center SC Completed Duarte, California, United States, 91010 United States, Florida H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt Completed Tampa, Florida, United States, 33612 United States, Massachusetts Massachusetts General Hospital Mass General Recruiting Boston, Massachusetts, United States, 02114 Contact: Lecia Sequist 617-724-4000 Contact: Beth Kennedy +1 617 724 1223 EAKENNEDY@mgh.harvard.edu Principal Investigator: Lecia Sequist Australia, Victoria Novartis Investigative Site Active, not recruiting Melbourne, Victoria, Australia, 3000 Canada, Alberta Novartis Investigative Site Active, not recruiting Edmonton, Alberta, Canada, T6G 1Z2 France Novartis Investigative Site Active, not recruiting Marseille cedex 05, France, 13385 Novartis Investigative Site Completed Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Active, not recruiting Heidelberg, Baden-Württemberg, Germany, 69126 Novartis Investigative Site Active, not recruiting Koeln, Nordrhein-Westfalen, Germany, 50937 Italy Novartis Investigative Site Active, not recruiting Bologna, BO, Italy, 40138 Novartis Investigative Site Completed Modena, MO, Italy, 41124 Novartis Investigative Site Active, not recruiting Perugia, PG, Italy, 06129 Korea, Republic of Novartis Investigative Site Active, not recruiting Seoul, Korea, Korea, Republic of, 05505 Norway Novartis Investigative Site Active, not recruiting Oslo, Norway, NO-0424 Singapore Novartis Investigative Site Active, not recruiting Singapore, Singapore, 119228 Novartis Investigative Site Active, not recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Active, not recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Active, not recruiting La Coruna, Galicia, Spain, 15006 Novartis Investigative Site Active, not recruiting Las Palmas De Gran Canarias, Las Palmas De Gran Canaria, Spain, 35016 Novartis Investigative Site Active, not recruiting Madrid, Spain, 28007 Novartis Investigative Site Active, not recruiting Madrid, Spain, 28041 Taiwan Novartis Investigative Site Active, not recruiting Taipei, Taiwan ROC, Taiwan, 10041 收起 << |
NCT01979939 | Hepatitis C | Phase 3 | Completed | - | - |
NCT01331681 | Diabetes Mellitus ... 展开 >> Macular Edema 收起 << | Phase 3 | Completed | - | - |
NCT02130362 | - | Active, not recruiting | February 27, 2028 | - | |
NCT01331681 | - | Completed | - | - | |
NCT01721746 | - | Active, not recruiting | - | - | |
NCT02404441 | Melanoma NSCL... 展开 >>C Triple Negative Breast Cancer Anaplastic Thyroid Cancer Other Solid Tumors 收起 << | Phase 1 Phase 2 | Active, not recruiting | May 20, 2020 | - |
NCT01721746 | Unresectable or Metastatic Mel... 展开 >>anoma 收起 << | Phase 3 | Active, not recruiting | March 6, 2019 | - |
NCT02971683 | Polymyositis ... 展开 >>Dermatomyositis Autoimmune Necrotizing Myopathy Overlap Myositis Juvenile Myositis Above the Age of 18 收起 << | Phase 3 | Recruiting | June 18, 2021 | - |
NCT01193257 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT01854047 | Asthma | Phase 2 | Completed | - | - |
NCT01602315 | - | Terminated(early termination d... 展开 >>ue to Sponsor decision (slow recruitment)) 收起 << | - | - | |
NCT01751022 | - | Completed | - | - | |
NCT01751022 | Heart Failure | Not Applicable | Completed | - | - |
NCT01239797 | Lymphoma Mult... 展开 >>iple Myeloma 收起 << | Phase 3 | Active, not recruiting | September 30, 2020 | - |
NCT03200717 | Advanced Renal Cell Carcinoma ... 展开 >> Metastatic Renal Cell Carcinoma 收起 << | Phase 2 | Recruiting | August 27, 2021 | - |
NCT02773030 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | January 14, 2023 | - |
NCT01239797 | - | Active, not recruiting | - | - | |
NCT01854047 | - | Completed | - | - | |
NCT03748641 | Metastatic Prostate Cancer | Phase 3 | Not yet recruiting | February 25, 2025 | - |
NCT01763905 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT02320721 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02342704 | - | Terminated(Business Decision) | - | - | |
NCT01763905 | - | Completed | - | - | |
NCT03094195 | Post-herpetic Neuralgia | Phase 2 | Recruiting | August 28, 2020 | - |
NCT02155582 | Non Hodgkin Lymphoma | Phase 1 | Completed | - | Belgium ... 展开 >> Bruxelles - Brussel, Belgium, 1000 Bruxelles - Brussel, Belgium, 1200 Gent, Belgium, 9000 France Caen Cedex 5, France, 14076 Lille, France, 59037 Nice Cedex 2, France, 06102 Pierre Benite, France, 69495 United Kingdom Sutton, Surrey, United Kingdom, SM2 5PT London, United Kingdom, W1G 6AD 收起 << |
NCT02320721 | - | Completed | - | - | |
NCT02342704 | Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 4 | Terminated(Business Decision) | - | - |
NCT02388295 | Multiple System Atrophy, MSA | Phase 2 | Completed | - | United States, California ... 展开 >> Research Site Stanford, California, United States, 94305 United States, Connecticut Research Site New Haven, Connecticut, United States, 06520-8048 United States, Florida Research Site Tampa, Florida, United States, 33613 United States, Massachusetts Research Site Boston, Massachusetts, United States, 02215 United States, Michigan Research Site Ann Arbor, Michigan, United States, 48105-2945 United States, Minnesota Research Site Rochester, Minnesota, United States, 55905 United States, New York Research Site New York, New York, United States, 10016 Research Site New York, New York, United States, 10032 Austria Research Site Innsbruck, Austria, 6020 Finland Research Site Turku, Finland, 20520 France Research Site Bordeaux Cedex, France, 33076 Research Site Toulouse Cedex 9, France, 31059 Italy Research Site Salerno, Italy, 84131 Sweden Research Site Stockholm, Sweden, 141 86 United Kingdom Research Site London, United Kingdom, SE5 9RJ Research Site London, United Kingdom, W12 0NN Research Site Oxford, United Kingdom, OX3 9DU 收起 << |
NCT01782326 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 3 | Completed | - | - |
NCT01015287 | Acute Coronary Syndromes | Phase 3 | Completed | - | - |
NCT01782326 | - | Completed | - | - | |
NCT01794520 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | May 29, 2021 | - |
NCT01015287 | - | Completed | - | - | |
NCT02775903 | Leukemia, Myeloid, Acute ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 2 | Active, not recruiting | April 16, 2019 | - |
NCT02388295 | - | Completed | - | - | |
NCT01500694 | Attention Deficit Hyperactivit... 展开 >>y Disorder (ADHD) 收起 << | Phase 3 | Completed | - | - |
NCT01968213 | Ovarian Cancer ... 展开 >> Fallopian Tube Cancer Peritoneal Cancer 收起 << | Phase 3 | Active, not recruiting | June 2020 | - |
NCT02964507 | Neoplasms | Phase 2 | Recruiting | June 1, 2020 | - |
NCT01399593 | Antibody Mediated Rejection | Phase 2 | Terminated(Did not achieve sta... 展开 >>tistical significance for primary endpoint) 收起 << | - | - |
NCT01968213 | - | Active, not recruiting | - | - | |
NCT01500694 | - | Completed | - | - | |
NCT00715182 | Advanced/ Metastatic Renal Cel... 展开 >>l Cancer 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site San Francisco, California, United States United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98109-1023 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site München, Germany, 81675 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Spain Novartis Investigative Site Madrid, Spain, 28041 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10002 收起 << |
NCT01399593 | - | Terminated(Did not achieve sta... 展开 >>tistical significance for primary endpoint) 收起 << | - | - | |
NCT01844765 | - | Active, not recruiting | - | - | |
NCT01844765 | Leukemia Leuk... 展开 >>emia,Pediatric Leukemia, Myleiod Leukemia, Mylegenous, Chronic Leukemia, Mylegenous, Accelerated BCR-ABL Positive Myeloproliferative Disorder Bone Marrow Disease Hematologic Diseases Neoplastic Processes Imatinib Dasatinib Enzyme Inhibitor Protein Kinase Inhibitor 收起 << | Phase 2 | Active, not recruiting | October 7, 2020 | - |
NCT01578239 | Carcinoid Tumor of the Small B... 展开 >>owel Neuroendocrine Tumour 收起 << | Phase 3 | Active, not recruiting | February 2021 | - |
NCT01998971 | Multiple Myeloma | Phase 1 | Active, not recruiting | June 12, 2020 | United States, California ... 展开 >> Duarte, California, United States United States, Georgia Atlanta, Georgia, United States United States, Illinois Chicago, Illinois, United States United States, Indiana Indianapolis, Indiana, United States United States, Massachusetts Boston, Massachusetts, United States United States, New York New York, New York, United States Rochester, New York, United States United States, North Carolina Charlotte, North Carolina, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas Dallas, Texas, United States France Lille Cedex, France Nantes, France Paris, France Pessac, France Toulouse Cedex 9, France Tours, France Spain Badalona, Spain Barcelona, Spain Madrid, Spain Pamplona, Spain Salamanca, Spain Valencia, Spain 收起 << |
NCT01578239 | - | Active, not recruiting | - | - | |
NCT01170624 | Heart Failure | Phase 4 | Terminated(Field Safety Notice... 展开 >> related to potential ventricular oversensing associated to the PhD feature on Paradym ICDs) 收起 << | - | Belgium ... 展开 >> Algemeen Ziekenhuis Middelheim Lindendref 1 2020 Antwerpen Antwerpen, Belgium, 2020 France Centre Hospitalier Général Albi Cedex 9, France, 81013 Centre Hospitalier Universitaire D'Amiens Amiens, France, 80090 Chu Annecy Annecy, France, 74011 CENTRE HOSP. HENRI DUFFAUT - Service de Cardiologie AVIGNON Avignon, France, 84000 Hopital D'Instruction Des Armees Clamart, France, 92141 Hôpital St Joseph Lyon, France, 69000 Centre Hospitalier Universitaire de La Timone Marseille, France, 13000 Hopital Le Raincy Montfermeil Montfermeil, France, 93370 HOPITAL ARNAUD DE VILLENEUVE - Service de Cardiologie Montpellier Cedex 5, France, 34295 Hopital de La Source Orleans, France, 45067 Centre Hospitalier PAU, France, 64000 CLINIQUE ST PIERRE Cardiologie Perpignan, France, 66000 Ccn: Centre Cardiologique Du Nord St Denis St Denis, France, 93000 Chru Hôpital Trousseau Tours, France, 37000 Germany Kerckhoff Klinik Cardiology Department Bad Nauheim, Germany, 61231 Lerckhoff Klinik Bad Neuheim, Germany, 61231 Praxis Westend Studien GbR, Medianzentrum Haus 9 Berlin, Germany, 14050 Klinik Frankische Schweiz Ebermannstadt, Germany, 91316 - 91320 Med. Univ. Klinik Lübeck Lübeck, Germany, 23501 − 23570 Italy Spedali Civili Divisione di Cardiologia Brescia, Italy, 25123 Azienda Ospedaliera S. Croce E Carle Cuneo, Italy, 12100 Portugal Hospital de Santa Cruz - Carnaxide (Adragão) Carnaxide, Lisbon, Portugal, 2795 Hospital Garcia de Orta Almada, Portugal, 2801-951 Hospital Central Faro Faro, Portugal, 8000 收起 << |
NCT01387555 | Hepatocellular Carcinoma ... 展开 >> Liver Cancer HCC 收起 << | Phase 2 | Completed | - | - |
NCT02161419 | Small Cell Lung Carcinoma | Phase 2 | Terminated | - | - |
NCT01866904 | - | Terminated(Study was terminate... 展开 >>d in order to secure the data quality of the study in terms of follow-up rates and data completeness.) 收起 << | - | - | |
NCT01387269 | Cachexia Non-... 展开 >>Small Cell Lung Cancer 收起 << | Phase 3 | Completed | - | - |
NCT01387269 | - | Completed | - | - | |
NCT02460224 | Advanced Solid Tumors | Phase 1 Phase 2 | Recruiting | July 24, 2019 | - |
NCT01395914 | - | Completed | - | - | |
NCT01393899 | - | Completed | - | - | |
NCT01892722 | Multiple Sclerosis | Phase 3 | Active, not recruiting | March 15, 2023 | - |
NCT01892722 | - | Active, not recruiting | - | - | |
NCT01395914 | Cachexia Non-... 展开 >>Small Cell Lung Cancer 收起 << | Phase 3 | Completed | - | - |
NCT01393899 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01760005 | Alzheimers Disease ... 展开 >> Dementia Alzheimers Disease, Familial 收起 << | Phase 2 Phase 3 | Active, not recruiting | December 2023 | - |
NCT02969356 | Spastic Hemiparesis | Phase 4 | Completed | - | United States, Kansas ... 展开 >> Kansas Institute of Research, Kansas City Bone & Joint Clinic, Division of Signature Medical Group of KC Kansas City, Kansas, United States, 66211 United States, Pennsylvania University of Pittsburgh Medical Center, Physical Medicine and Rehabilitation Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Department of Neurology, Division of Movement Disorders, Vanderbilt University Nashville, Tennessee, United States, 37240-7915 United States, Texas UT Southwestern Medical Center Dallas, Texas, United States, 75390 UT Health Physical Medicine & Rehabilitation Department, TIRR Memorial Hermann Houston, Texas, United States, 77030 Czechia Fakultní nemocnice Královské Vinohrady, Neurologická klinika Brno, Czechia, 100 34 Neurology and Physiotherapy Outpatient Clinic Brno, Czechia, 615 00 Fakultní nemocnice Brno Neurologická klinika Brno, Czechia, 625 00 Neurology Department - Regional Hospital Pardubice Pardubice, Czechia, 532 03 Department of Neurology and Center of Clinical Neuroscience, Charles University in Prague, 1st Faculty of Medicine and General University Hospital in Prague Praha, Czechia, 120 00 France Service de Médecine Physique et Réadaptation, Hôpital Albert-Chenevier Créteil, Cedex, France, 94010 Service de Médecine Physique et de Réadaptation, Bâtiment Tastet-Girard, Groupe Hospitalier Pellegrin Bordeaux, France, 33000 Service de Médecine Physique et Réadaptation, Hôpital Sébastopol - CHU de Reims Reims, France, 51100 Service de Médecine Physique et Réadaptation, CHU Saint Etienne - Hôpital Bellevue Saint-Étienne, France, 42055 Russian Federation Federal Siberian Scientific Clinical Center Krasnoyarsk, Russian Federation, 660049 Medical Rehabilitation Center Moscow, Russian Federation, 125367 Saint-Petersburg Bekhterev Psychoneurological Research Institute Saint-Petersburg, Russian Federation, 192019 Samara Regional Clinical Hospital n.a. V.D.Seredavin Samara, Russian Federation, 443035 收起 << |
NCT02094443 | Hepatitis C L... 展开 >>iver Disease 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Bakersfield, California, United States, 93301 Novartis Investigative Site Lancaster, California, United States, 93534 Novartis Investigative Site San Diego, California, United States, 92114 Novartis Investigative Site San Diego, California, United States, 92128 United States, Missouri Novartis Investigative Site St. Louis, Missouri, United States, 63110 United States, Texas Novartis Investigative Site Arlington, Texas, United States, 76012 Novartis Investigative Site Houston, Texas, United States, 77030 Novartis Investigative Site San Antonio, Texas, United States, 78215 United States, Virginia Novartis Investigative Site Newport News, Virginia, United States, 23602 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98101 Novartis Investigative Site Seattle, Washington, United States, 98104 France Novartis Investigative Site Clichy, France, 92110 Novartis Investigative Site Creteil, France, 94010 Novartis Investigative Site Lyon Cedex 04, France, 69317 Novartis Investigative Site Nice Cedex 3, France, 06202 Novartis Investigative Site Paris, France, 75014 收起 << |
NCT02094443 | - | Completed | - | - | |
NCT01081769 | Schizophrenia | Phase 3 | Completed | - | - |
NCT00863681 | Hypertension, Pulmonary | Phase 3 | Active, not recruiting | January 31, 2019 | - |
NCT00410384 | Systemic Lupus Erythematosus | Phase 3 | Completed | - | - |
NCT01081769 | - | Completed | - | - | |
NCT00136981 | Hypercholesterolemia, Familial... 展开 >> Hyperlipidemia 收起 << | Phase 3 | Completed | - | - |
NCT01385592 | Dyskinesias P... 展开 >>arkinson Disease Movement Disorders Parkinsonian Disorders 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Sunnyvale, California, United States, 94089 United States, Colorado Novartis Investigative Site Englewood, Colorado, United States, 80113 Canada, Ontario Novartis Investigative Site London, Ontario, Canada, N6A 4G5 Canada, Quebec Novartis Investigative Site Gatineau, Quebec, Canada, J9J 0A5 France Novartis Investigative Site Clermont-Ferrand Cedex 1, France, 63003 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Pessac, France, 33604 Novartis Investigative Site Poitiers, France, 86021 Germany Novartis Investigative Site Beelitz-Heilstaetten, Germany, 14547 Novartis Investigative Site Berlin, Germany, 12163 Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Duesseldorf, Germany, 40225 Novartis Investigative Site Kassel, Germany, 34128 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Muenchen, Germany, 80804 Novartis Investigative Site München, Germany, 81675 Novartis Investigative Site Stadtroda, Germany, 07646 Novartis Investigative Site Westerstede/Oldenburg, Germany, 26655 Hungary Novartis Investigative Site Budapest, Hungary, 1085 Novartis Investigative Site Kaposvár, Hungary, 7400 Novartis Investigative Site Szeged, Hungary, H-6725 Italy Novartis Investigative Site Bolzano, BZ, Italy, 39100 Novartis Investigative Site Pisa, PI, Italy, 56126 Novartis Investigative Site Roma, RM, Italy, 00163 Spain Novartis Investigative Site Sant Cugat, Barcelona, Spain, 08190 Novartis Investigative Site Barcelona, Cataluña, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28006 Novartis Investigative Site San Sebastian, Spain, 20014 收起 << |
NCT00410384 | - | Completed | - | - | |
NCT02445222 | Safety LTFU, Pts Receiving CD1... 展开 >>9 Directed CAR T-Cell Therapy 收起 << | Not Applicable | Recruiting | May 17, 2035 | - |
NCT00981058 | Non Small Cell Lung Cancer | Phase 3 | Active, not recruiting | December 31, 2018 | - |
NCT00981058 | - | Active, not recruiting | - | - | |
NCT01132664 | - | Terminated(Due to the rare pat... 展开 >>ient population and challenges to enroll patients.) 收起 << | - | - | |
NCT02346240 | Psoriasis Pla... 展开 >>que Psoriasis 收起 << | Phase 3 | Active, not recruiting | December 11, 2018 | - |
NCT02662569 | Diabetes, Hyperlipidemia, Mixe... 展开 >>d Dyslipidemia 收起 << | Phase 3 | Completed | - | - |
NCT03107988 | Neuroblastoma | Phase 1 | Recruiting | December 2020 | United States, California ... 展开 >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027-0700 Contact: Araz Marachelian, MD 323-361-5687 amarachelian@chla.usc.edu UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143 Contact: Katherine K. Matthay, MD 415-476-3831 matthayK@peds.ucsf.edu United States, Colorado Children Hospital of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Margaret Macy, MD 720-777-8856 Margaret.macy@childrenscolorado.org United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Kelly Goldsmith, MD 404-785-0853 kgoldsmith@emory.edu United States, Illinois University of Chicago, Comer Children's Hospital Recruiting Chicago, Illinois, United States, 60637 Contact: Ami Desai, MD 773-843-3943 adesai12@peds.bsd.uchicago.edu United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Recruiting Boston, Massachusetts, United States, 02115 Contact: Suzanne Shusterman, MD 617-632-3725 suzanne_shusterman@dfci.harvard.edu United States, Michigan C.S Mott Children's Hospital Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Rajen Mody, MD rmody@umich.edu United States, North Carolina University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Patrick Thompson, MD patom@email.unc.edu United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229-3039 Contact: Brian Weiss, MD 513-636-9866 brian.weiss@chmcc.org United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104-4318 Contact: Yael Mosse, MD 215-590-0965 mosse@chop.edu United States, Texas Cook Children's Healthcare System Recruiting Fort Worth, Texas, United States, 76104 Contact: Meaghan Granger, MD 682-885-4007 mgranger@cookchildrens.org United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Navin Pinto, MD 206-987-5783 navin.pinto@seattlechildrens.org Canada, Ontario Hospital for Sick Children Not yet recruiting Toronto, Ontario, Canada, M5G 1X8 Contact: Meredith Irwin, MD 416-813-7654 meredith.irwin@sickkids.ca France Institut Curie Not yet recruiting Paris, Cedex, France, 05 Contact: Gudrun Schleiermacher, MD 144324550 gudrun.schleiermacher@curie.fr United Kingdom Royal Marsden Hospital Not yet recruiting Sutton, Surrey, United Kingdom, SM25NG Contact: Louis Chelser, MD 2087224204 Louis.Chesler@icr.ac.uk 收起 << |
NCT02671435 | Advanced Solid Tumors | Phase 1 Phase 2 | Recruiting | October 15, 2021 | - |
NCT01132664 | Metastatic Breast Cancer ... 展开 >> HER2+ Breast Cancer 收起 << | Phase 1 Phase 2 | Terminated(Due to the rare pat... 展开 >>ient population and challenges to enroll patients.) 收起 << | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI Birmingham, Alabama, United States, 35294-0006 United States, Arkansas Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Michigan Karmanos Cancer Institute Dept.of KarmanosCancerInst (6) Detroit, Michigan, United States, 48201 United States, Missouri Washington University School Of Medicine-Siteman Cancer Ctr WA Siteman St. Louis, Missouri, United States, 63110 United States, New York Beth Israel Medical Center BIMC New York, New York, United States, 10003 United States, Tennessee Sarah Cannon Research Institute Sarah Cannon Cancer Center SC Nashville, Tennessee, United States, 37203 Belgium Novartis Investigative Site Liege, Belgium, 4000 Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Italy Novartis Investigative Site Cagliari, CA, Italy, 09134 Novartis Investigative Site Macerata, MC, Italy, 62100 Novartis Investigative Site Modena, MO, Italy, 41100 Novartis Investigative Site Terni, TR, Italy, 05100 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 United Kingdom Novartis Investigative Site Brighton, East Sussex, United Kingdom, BN2 5BE Novartis Investigative Site Nottingham, United Kingdom, NG5 1PB Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ 收起 << |
NCT01989754 | Diabetes Mellitus, Type 2 ... 展开 >> Albuminuria 收起 << | Phase 4 | Completed | - | - |
NCT02346240 | - | Active, not recruiting | - | - | |
NCT01551966 | Portal Hypertension ... 展开 >> Cirrhosis 收起 << | Not Applicable | Completed | - | France ... 展开 >> Service de Pédiatrie Médicale, Hôpital Pellegrin, CHU de Bordeaux Bordeaux, France, 33000 Service d'Hépatologie, gastroentérologie et nutrition pédiatrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon Bron, France, 69677 Clinique de Pédiatrie, Hôpital Jeanne de Flandre, CHU de Lille Lille, France, 59037 Service de Hépato Gastroentérologie et Nutrition, Hôpital Necker Enfants Malades, AP-HP Paris Cedex 15, France, 75743 Service de Gastroentérologie, Mucoviscidose et Nutrition, Hôpital Robert Debré, AP-HP Paris, France, 75019 Service de Pédiatrie, Hôpital Sud, CHU de Rennes Rennes, France, 35203 Service de Gastroentérologie, Hépatologie, Nutrition et Diabétologie, Hôpital des Enfants, CHU de Toulouse Toulouse Cedex 9, France, 31059 收起 << |
NCT01989754 | - | Completed | - | - | |
NCT02415595 | - | Terminated(The trial ended ear... 展开 >>ly due to GI intolerability and treatment-emergent resistance.) 收起 << | - | - | |
NCT00362609 | - | Completed | - | - | |
NCT01045304 | Breast Cancer, Metastatic | Phase 2 | Completed | - | Australia ... 展开 >> Sanofi-Aventis Investigational Site Number 036002 Parkville, Australia, 3052 Sanofi-Aventis Investigational Site Number 036001 Perth, Australia, 6000 Sanofi-Aventis Investigational Site Number 036003 Westmead, Australia, 2145 Belgium Sanofi-Aventis Investigational Site Number 056001 Bruxelles, Belgium, 1000 Sanofi-Aventis Investigational Site Number 056002 Leuven, Belgium, 3000 France Sanofi-Aventis Investigational Site Number 250005 Besancon Cedex, France, 25030 Sanofi-Aventis Investigational Site Number 250003 Bordeaux, France, 33076 Sanofi-Aventis Investigational Site Number 250002 Dijon, France, 21034 Sanofi-Aventis Investigational Site Number 250006 Paris Cedex 05, France, 75231 Sanofi-Aventis Investigational Site Number 250004 Paris, France, 75970 Sanofi-Aventis Investigational Site Number 250001 Toulouse, France, 31052 Italy Sanofi-Aventis Investigational Site Number 380004 Genova, Italy, 16132 Sanofi-Aventis Investigational Site Number 380001 Milano, Italy, 20133 Sanofi-Aventis Investigational Site Number 380002 Modena, Italy, 41100 Sanofi-Aventis Investigational Site Number 380003 Udine, Italy, 33100 Netherlands Sanofi-Aventis Investigational Site Number 528001 Rotterdam, Netherlands, 3075 EA Spain Sanofi-Aventis Investigational Site Number 724002 Barcelona, Spain, 08035 Sanofi-Aventis Investigational Site Number 724004 Madrid, Spain, 28050 Sanofi-Aventis Investigational Site Number 724001 Málaga, Spain, 29010 Sanofi-Aventis Investigational Site Number 724003 Valencia, Spain, 46010 收起 << |
NCT02415595 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 2 | Terminated(The trial ended ear... 展开 >>ly due to GI intolerability and treatment-emergent resistance.) 收起 << | - | - |
NCT03170960 | Urothelial Carcinoma ... 展开 >> Renal Cell Carcinoma Non-Small Cell Lung Cancer Castration-resistant Prostate Cancer Triple Negative Breast Cancer Ovarian Cancer Endometrial Cancer Hepatocellular Carcinoma Gastric Cancer Gastroesophageal Junction Adenocarcinoma Colorectal Cancer Head and Neck Cancer Differentiated Thyroid Cancer 收起 << | Phase 1 Phase 2 | Recruiting | December 2020 | - |
NCT02462928 | Macular Degeneration | Phase 3 | Active, not recruiting | May 31, 2019 | - |
NCT00362609 | Gastroesophageal Reflux | Phase 3 | Completed | - | - |
NCT00903175 | - | Completed | - | - | |
NCT00408629 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT02598960 | Solid Tumors | Phase 1 Phase 2 | Active, not recruiting | May 28, 2020 | - |
NCT02422186 | Depressive Disorder, Treatment... 展开 >>-Resistant 收起 << | Phase 3 | Completed | - | - |
NCT00903175 | Renal Cell Carcinoma | Phase 2 | Completed | - | - |
NCT03129100 | Axial Spondyloarthritis | Phase 3 | Recruiting | March 1, 2021 | - |
NCT01641393 | Exocrine Pancreatic Insufficie... 展开 >>ncy: Cystic Fibrosis 收起 << | Phase 3 | Completed | - | - |
NCT00420485 | Solid Tumors | Phase 1 | Completed | - | Canada, British Columbia ... 展开 >> Novartis Investigative Site Vancouver, British Columbia, Canada Canada, Ontario MD Anderson Cancer Center - Orlando Toronto, Ontario, Canada, M5G 2M9 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 France Novartis Investigative Site Dijon Cedex, France, 21034 Novartis Investigative Site Paris, France, 75005 Novartis Investigative Site Saint-Herblain Cedex, France, 44805 Novartis Investigative Site Toulouse, France, 31052 Germany Novartis Investigative Site Mainz, Germany, 55101 Novartis Investigative Site Tubingen, Germany, 72076 Netherlands Novartis Investigative Site Enschede, Netherlands Norway Novartis Investigative Site Oslo, Norway, 310 Spain Novartis Investigative Site Madrid, Spain, 28041 收起 << |
NCT02627768 | - | Recruiting | June 30, 2021 | - | |
NCT01265901 | Metastatic Renal Cell Carcinom... 展开 >>a 收起 << | Phase 3 | Completed | - | - |
NCT00408629 | - | Completed | - | - | |
NCT00528112 | - | Completed | - | - | |
NCT00528112 | Contraception | Phase 3 | Completed | - | - |
NCT01369511 | Muscular Atrophy | Phase 2 | Completed | - | - |
NCT01524978 | - | Completed | - | - | |
NCT01369511 | - | Completed | - | - | |
NCT02492711 | HER-2 Positive Breast Cancer ... 展开 >> Metastatic Neoplasm 收起 << | Phase 3 | Recruiting | March 2021 | - |
NCT01524978 | Multiple Myeloma, Neoplasms | Phase 2 | Completed | - | - |
NCT01361555 | Depression | Phase 2 | Terminated(Failure to meet pri... 展开 >>mary endpoint) 收起 << | - | - |
NCT01610336 | Non-small Cell Lung Cancer | Phase 2 | Active, not recruiting | February 7, 2019 | - |
NCT01309945 | Depression | Phase 2 | Completed | - | - |
NCT02367040 | Lymphoma,Non-Hodgkin | Phase 3 | Recruiting | August 28, 2020 | - |
NCT01001377 | - | Completed | - | - | |
NCT01525615 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT02603120 | - | Active, not recruiting | - | - | |
NCT01001377 | Metastatic Colorectal Cancer | Phase 3 | Completed | - | - |
NCT02465567 | COPD | Phase 3 | Active, not recruiting | June 19, 2019 | - |
NCT01537042 | - | Completed | - | - | |
NCT02603120 | HIV-1 Infection | Phase 3 | Active, not recruiting | June 2020 | - |
NCT02932410 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Recruiting | July 14, 2022 | - |
NCT01537042 | Restless Legs Syndrome ... 展开 >> End-Stage Renal Disease 收起 << | Phase 3 | Completed | - | United States, Florida ... 展开 >> 606 Brandon, Florida, United States United States, Massachusetts 604 Newton, Massachusetts, United States United States, New York 603 West Seneca, New York, United States United States, Ohio 607 Dublin, Ohio, United States United States, Pennsylvania 605 West Chester, Pennsylvania, United States United States, Texas 601 Austin, Texas, United States Austria 101 Innsbruck, Austria Finland 201 Helsinki, Finland 203 Tampere, Finland France 302 Bordeaux Cedex, France 301 Montpellier Cédex 5, France Germany 404 Berlin, Germany 401 Marburg, Germany 402 Schwerin, Germany Italy 502 Pisa, Italy 收起 << |
NCT00676143 | Alzheimer Disease | Phase 3 | Terminated(The study was termi... 展开 >>nated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns.) 收起 << | - | - |
NCT03399786 | Homozygous Familial Hyperchole... 展开 >>sterolemia 收起 << | Phase 3 | Recruiting | April 5, 2020 | - |
NCT00676143 | - | Terminated(The study was termi... 展开 >>nated on August 6, 2012, because 2 large Phase 3 studies showed no clinical benefit. This decision was not based on any new safety concerns.) 收起 << | - | - | |
NCT00321763 | Influenza | Phase 2 | Completed | - | - |
NCT00321763 | - | Completed | - | - | |
NCT02485691 | Prostate Cancer Metastatic | Phase 4 | Recruiting | August 2019 | - |
NCT01785888 | - | Completed | - | - | |
NCT03306394 | Metastatic Colorectal Cancer | Phase 3 | Recruiting | May 2019 | - |
NCT02988960 | Advanced Solid Tumors Cancer | Phase 1 | Recruiting | April 17, 2021 | United States, California ... 展开 >> The Angeles Clinic and Researc /ID# 156324 Recruiting Los Angeles, California, United States, 90025 United States, Illinois University of Chicago /ID# 155264 Recruiting Chicago, Illinois, United States, 60637-1443 United States, Massachusetts Massachusetts General Hospital /ID# 155267 Recruiting Boston, Massachusetts, United States, 02114 United States, North Carolina Carolina BioOncology Institute /ID# 155265 Recruiting Huntersville, North Carolina, United States, 28078 United States, Tennessee Tennessee Oncology-Sarah Cannon Research Institute /ID# 158654 Recruiting Nashville, Tennessee, United States, 37203 United States, Texas Univ TX, MD Anderson /ID# 155263 Recruiting Houston, Texas, United States, 77030 United States, Virginia Virginia Cancer Specialists /ID# 155266 Recruiting Fairfax, Virginia, United States, 22031 Australia, Victoria Peninsula & South Eastern Haem /ID# 164372 Recruiting Frankston, Victoria, Australia, 3199 Austin Health /ID# 171189 Recruiting Melbourne, Victoria, Australia, 3084 Canada, Ontario Princess Margaret Cancer Centr /ID# 200819 Not yet recruiting Toronto, Ontario, Canada, M5G 2M9 France Institut Bergonie /ID# 162665 Not yet recruiting Bordeaux, Gironde, France, 33000 Institut Regional du Cancer /ID# 163609 Not yet recruiting Montpellier CEDEX 5, Herault, France, 34298 Institut Gustave Roussy /ID# 162666 Not yet recruiting Villejuif, Ile-de-France, France, 94805 Centre Leon Berard /ID# 162663 Not yet recruiting Lyon CEDEX 08, Rhone, France, 69373 Korea, Republic of Yonsei University Health System, Severance Hospital /ID# 166292 Not yet recruiting Seodaemun-gu, Seoul Teugbyeolsi, Korea, Republic of, 03722 Seoul National University Hospital /ID# 166291 Not yet recruiting Seoul, Korea, Republic of, 03080 Spain Hospital Fundacion Jimenez Dia /ID# 200128 Not yet recruiting Madrid, Spain, 28040 Hosp Univ Madrid Sanchinarro /ID# 200127 Not yet recruiting Madrid, Spain, 28050 Hosp Univ Puerta de Hierro /ID# 200129 Not yet recruiting Majadahonda, Spain, 28222 Hospital Universitario La Fe /ID# 200975 Not yet recruiting Valencia, Spain, 46026 收起 << |
NCT02603445 | Follicular Lymphoma, Mantle Ce... 展开 >>ll Lymphoma 收起 << | Phase 1 | Completed | - | United States, New York ... 展开 >> Novartis Investigative Site New York, New York, United States, 10017 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030 Austria Novartis Investigative Site Salzburg, Austria, 5020 France Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Novartis Investigative Site Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Mainz, Germany, 55131 收起 << |
NCT02660580 | Psoriasis Pla... 展开 >>que Type Psoriasis Moderate to Severe Plaque Psoriasis 收起 << | Phase 3 | Completed | - | - |
NCT01525615 | - | Completed | - | - | |
NCT01305538 | Post-Herpetic Neuralgia (PHN) | Phase 2 | Completed | - | - |
NCT02834169 | - | Active, not recruiting | December 2018 | France ... 展开 >> Institut de Cancérologie de l'Ouest - Paul Papin Angers, France, 49100 CHU Jean Minjoz Besancon, France, 25030 Institut Bergonié Bordeaux, France, 33076 Centre François Baclesse Caen, France, 14076 CHU Estaing Clermont-ferrand, France, 63003 Centre Jean Perrin Clermont-ferrand, France, 63011 AP-HP Louis MOURIER Colombes, France, 92700 CHU Bocage Dijon, France, 21079 CHU A. Michallon La Tronche, France, 38700 Centre Oscar Lambret Lille, France, 59020 CHRU Claude Huriez Lille, France, 59037 Centre Léon Bérard Lyon, France, 69008 Institut Paoli Calmettes Marseille, France, 13273 Hôpital La Timône Marseille, France, 13385 Institut du Cancer Montpellier Montpellier, France, 34298 CHU Nantes Hôtel-Dieu Nantes, France, 44093 CHU L'Archet II Nice, France, 06200 AP-HP Lariboisière Paris Cedex 10, France, 75475 AP-HP Hôpîtal Europeen Georges Pompidou Paris Cedex 15, France, 75908 Institut Curie Paris, France, 75005 AP-HP St Antoine Paris, France, 75012 AP-HP La Pitié-Salpêtrière Paris, France, 75013 Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Service de Chirurgie Générale et Digestive - 165 chemin du grand Revoyet, Pierre-benite, France, 69495 CHU Poitiers Poitiers, France, 86021 Hôpital Robert Debré Reims, France, 51092 CHU Charles Nicolle Rouen, France, ROUEN Institut Cancérologie de l'Ouest - René Gauducheau Saint Herblain, France, 44805 CHU Nord St Etienne, France, 42055 CHRU Hautepierre Strasbourg, France, 67098 Institut Claudius Regaud Toulouse, France, 31052 Hôpital Purpan Toulouse, France, 31059 Institut de Cancérologie de Lorraine Vandoeuvre-les-nancy, France, 54519 Institut Gustave Roussy Villejuif, France, 94805 收起 << | |
NCT03000257 | Advanced Solid Tumors Cancer | Phase 1 | Recruiting | November 25, 2019 | - |
NCT00685373 | - | Completed | - | - | |
NCT01708629 | Moderate to Severe Plaque Psor... 展开 >>iasis 收起 << | Phase 3 | Terminated(Sponsor decision) | - | - |
NCT03085810 | Multiple Sclerosis, Relapsing-... 展开 >>Remitting 收起 << | Phase 3 | Recruiting | February 22, 2024 | - |
NCT00685373 | Cryopyrin-Associated Periodic ... 展开 >>Syndromes Familial Cold Autoinflammatory Syndrome Muckle Wells Syndrome Neonatal Onset Multisystem Inflammatory Disease 收起 << | Phase 3 | Completed | - | - |
NCT00737932 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT00903682 | HIV Infection ... 展开 >> HIV Acquired Immunodeficiency Syndrome 收起 << | Phase 2 | Completed | - | - |
NCT00903682 | - | Completed | - | - | |
NCT00426751 | - | Completed | - | - | |
NCT03039673 | Amyotrophic Lateral Sclerosis | Phase 2 | Recruiting | June 2021 | France ... 展开 >> CHRU de Lille - Hôpital Roger Salengro Recruiting Lille, France, 59037 Principal Investigator: Dr Véronique Danel, MD, PhD CHU de Limoges - Hôpital Dupuytren Recruiting Limoges, France, 87042 Principal Investigator: Philippe Couratier, MD, PhD HCL - Hôpital Neurologique P. Wertheimer Recruiting Lyon, France, 69677 Principal Investigator: Dr Emilien Bernard, MD, PhD APHM - Hôpital de la Timone Recruiting Marseille, France, 13385 Principal Investigator: P Shahram Attarian, MD, PHD CHRU de Montpellier - Hôpital Gui de Chauliac Recruiting Montpellier Cedex 5, France, 34295 Principal Investigator: William Camu, MD, PhD CHU de Nice - Hôpital Pasteur Recruiting Nice, France, 06002 Principal Investigator: Hélène Soriani, MD, PhD APHP - Groupe Hospitalier Pitié-Salpetrière Recruiting Paris Cedex 13, France, 75651 Principal Investigator: François Salachas, MD CENTRE HOSPITALIER DE SAINT BRIEUC - Hôpital Yves Le Foll Recruiting Saint Brieuc, France, 22027 Principal Investigator: Kolev Ivan, MD,PhD CHU de Strasbourg - Hôpital de Hautepierre Recruiting Strasbourg, France, 67098 Principal Investigator: Marie FLEURY-LESAUNIER, MD,PhD CHRU de Tours - Hôpital Bretonneau Recruiting Tours, France, 37044 Principal Investigator: Philippe Corcia, MD, PhD United Kingdom Trafford Centre for Biomedical Research Recruiting Brighton, United Kingdom, BN1 9RY Principal Investigator: P Nigel Leigh, MD, PhD Institute of Neurological Sciences, Queen Elizabeth University Hospital Recruiting Glasgow, United Kingdom, G514TF Principal Investigator: George Gorrie, MD,PhD North-East London and Essex MND Regional Care Centre Recruiting London, United Kingdom, E1 4NS Principal Investigator: Andrea Malaspina, MD, PhD King's MND Care and Research Centre Recruiting London, United Kingdom, SE5 8AF Principal Investigator: Ammar Al-Chalabi, MD, PhD Centre for Neuromuscular Diseases - National Hospital of Neurology Recruiting London, United Kingdom, WC1N 3BG Principal Investigator: Dr Nikhil SHARMA, MD, PhD Sheffield Care and Research Centre Recruiting Sheffield, United Kingdom, S10 2JF Principal Investigator: Pamela J Shaw, MD, PhD 收起 << |
NCT00426751 | Infarction, Myocardial | Phase 3 | Completed | - | France ... 展开 >> GSK Investigational Site Alençon, France, 61014 GSK Investigational Site Bordeaux, France, 33076 GSK Investigational Site Caen Cedex 5, France, 14033 GSK Investigational Site Créteil, France, 94010 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Melun, France, 77000 GSK Investigational Site Melun, France, 77007 GSK Investigational Site Nancy, France, 54000 GSK Investigational Site Ollioules, France, 83190 GSK Investigational Site Pau, France, 64046 GSK Investigational Site Perpignan, France, 66000 GSK Investigational Site Pessac Cedex, France, 33604 GSK Investigational Site Toulon, France, 83056 GSK Investigational Site Vandoeuvre Les Nancy, France, 54511 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69120 GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Offenbach, Hessen, Germany, 63069 GSK Investigational Site Aachen, Nordrhein-Westfalen, Germany, 52074 GSK Investigational Site Dortmund, Nordrhein-Westfalen, Germany, 44137 GSK Investigational Site Moenchengladbach, Nordrhein-Westfalen, Germany, 41063 GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41464 GSK Investigational Site Ludwigshafen, Rheinland-Pfalz, Germany, 67063 GSK Investigational Site Homburg, Saarland, Germany, 66421 收起 << |
NCT00468728 | Clostridium Infections ... 展开 >> Diarrhea 收起 << | Phase 3 | Completed | - | - |
NCT00722553 | - | Completed | - | - | |
NCT01369095 | Depression | Phase 2 | Completed | - | - |
NCT00615199 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT00615199 | - | Completed | - | - | |
NCT00722553 | Carcinoma, Transitional Cell ... 展开 >> Bladder Cancer Bladder Neoplasm 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> The University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 United States, Georgia Peachtree Hematology/Oncology Consultants Atlanta, Georgia, United States, 30318 United States, New York University of Rochester Cancer Center Rochester, New York, United States, 14642 United States, Utah University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Argentina Centro de Terapia Radiante Cumbres (CAICI) Rosario, Santa Fe, Argentina, 2000 IONC (Instituto Oncológuci de Cordoba) Cordoba, Argentina, X5004BAL Belgium Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Institut Jules Bordet Brussels, Belgium, 1000 Croatia CH Split Clinic of Oncology and Radiotherapy Split, Croatia, 21000 CHU Zagreb University Hospital Center Rebro in Zagreb Zagreb, Croatia, 10000 Clinic of Oncology and Nuclear Medicine, CH "Sestre Milosrdnice" Zagreb, Croatia, 10000 France Institut Sainte Catherine Avignon, France, 84082 Centre Oscar Lambret Lille Cedex, France, 59020 Centre Hospitalier Rene Dubos Pontoise, France, 95301 Hopital Foch Suresnes, France Institut Gustave Roussy Villejuif Cedex, France, 94 805 Spain Ciutat Sanitari de Vall d'Hebron Barcelona, Spain, 08035 Hospital Del Mar - Barcelona Barcelona, Spain, 8003 Hospital Virgen del Rocio Sevilla, Spain, 41013 收起 << |
NCT00873119 | - | Completed | - | - | |
NCT01461928 | Non-Hodgkin's Lymphoma | Phase 3 | Completed | - | - |
NCT00468728 | - | Completed | - | - | |
NCT02970942 | Hepatobiliary Disorders ... 展开 >> Non-alcoholic Steatohepatitis 收起 << | Phase 2 | Active, not recruiting | April 2, 2020 | - |
NCT00599196 | Early Stage Parkinson's Diseas... 展开 >>e 收起 << | Phase 3 | Completed | - | - |
NCT00873119 | Carcinoma of Unknown Primary | Phase 2 | Completed | - | United States, Florida ... 展开 >> Florida Cancer Specialists Fort Myers, Florida, United States, 33619 United States, Georgia Northwest Georgia Oncology Centers Marietta, Georgia, United States, 30060 United States, Louisiana Baton Rouge Medical Center Baton Rouge, Louisiana, United States, 70809 United States, Maryland Center for Cancers and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, Ohio Oncology Hematology Care Inc. Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology & Hematology Associates, PC Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Sarah Cannon Research Nashville, Tennessee, United States, 37203 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23230 Denmark H:S Rigshospital, The Finsen Centre Copenhagen, Denmark, DK-2100 France CRLCC Francois Baclesse, Oncologie medicale Caen, France, 14000 Centre Oscar Lambert Lille, France, 59020 Centre Léon Bérard, Oncologie Lyon, France, 69008 Centre Eugène Marquis Rennes cedex, France, 35042 Centre Henri Becquerel, Oncologie Médicale Rouen, France, 76038 Institut de Cancerologie de la Loire Saint Priest en Jarez, France, 42270 Institut Gustave Roussy IGR Villejuif cedex, France, 94805 Germany Carl-Gustav-Carus Medicinische Klinik und Poliklinik I Dresden, Germany, 01307 Kliniken Essen-Mitte Essen, Germany, 45136 ASKLEPIOS Klinik Altona Hamburg, Germany, 22763 Ostholstein-Onkologie Oldenburg in Holstein, Germany, 23758 收起 << |
NCT00599196 | - | Completed | - | - | |
NCT01281839 | Hepatitis C | Phase 3 | Completed | - | - |
NCT00627640 | Idiopathic Parkinson's Disease | Phase 3 | Completed | - | - |
NCT01587040 | Neoplasm Malignant | Phase 1 Phase 2 | Completed | - | - |
NCT00853827 | - | Completed | - | - | |
NCT01281839 | - | Completed | - | - | |
NCT00853827 | Coronary Artery Disease (CAD) ... 展开 >> Coronary Atherosclerosis 收起 << | Phase 3 | Completed | - | - |
NCT01605227 | Prostate Cancer ... 展开 >> Castration Resistant Prostate Cancer Pain Prostatic Neoplasms 收起 << | Phase 3 | Completed | - | - |
NCT02993731 | Carcinoma, Pancreatic Ductal | Phase 3 | Recruiting | - | - |
NCT01605227 | - | Completed | - | - | |
NCT03110107 | Advanced Cancer | Phase 1 Phase 2 | Recruiting | March 20, 2021 | United States, Colorado ... 展开 >> Local Institution Withdrawn Aurora, Colorado, United States, 80045 United States, Massachusetts Local Institution Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Site 0025 United States, Nevada Local Institution Withdrawn Las Vegas, Nevada, United States, 89128 United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Martin Gutierrez, Site 0002 551-996-5900 United States, New York Columbia University Medical Center (Cumc) Recruiting New York, New York, United States, 10032 Contact: Charles Drake, Site 0001 646-317-3141 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Claire Friedman, Site 0007 281-208-6570 United States, Pennsylvania University Of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Mark O'Hara, Site 0004 215-360-0919 UPMC Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Diwakar Davar, Site 0015 412-623-5396 Australia, New South Wales Local Institution Not yet recruiting North Sydney, New South Wales, Australia, 2060 Contact: Site 0006 Local Institution Not yet recruiting Westmead, New South Wales, Australia, 2145 Contact: Site 0026 Australia, Victoria Local Institution Withdrawn Heidelberg, Victoria, Australia, 3084 France Local Institution Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Site 0019 Local Institution Not yet recruiting Toulouse Cedex 9, France, 31059 Contact: Site 0020 Local Institution Not yet recruiting Villejuif, France, 94805 Contact: Site 0018 Israel Local Institution Recruiting Ramat Gan, Israel, 52621 Contact: Site 0008 Italy Local Institution Recruiting Napoli, Italy, 80131 Contact: Site 0011 Local Institution Not yet recruiting Siena, Italy, 53100 Contact: Site 0010 Spain Local Institution Not yet recruiting Barcelona, Spain, 08035 Contact: Site 0014 Local Institution Not yet recruiting Madrid, Spain, 28050 Contact: Site 0013 Local Institution Not yet recruiting Pamplona, Spain, 31008 Contact: Site 0012 收起 << |
NCT03299686 | Asthma | Phase 2 | Recruiting | September 26, 2019 | - |
NCT03275285 | Plasma Cell Myeloma | Phase 3 | Recruiting | October 2023 | - |
NCT01436656 | Melanoma and Metastatic Colore... 展开 >>ctal Cancer 收起 << | Phase 1 | Active, not recruiting | February 28, 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Moffitt SC Tampa, Florida, United States, 33612 United States, Massachusetts Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02114 Australia, New South Wales Array BioPharma Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Victoria Array BioPharma Investigative Site Parkville, Victoria, Australia, 3050 France Array BioPharma Investigative Site Toulouse Cedex 9, France, 31059 Array BioPharma Investigative Site Villejuif Cedex, France, 94805 Japan Array BioPharma Investigative Site Chuo-ku, Tokyo, Japan Norway Array BioPharma Investigative Site Oslo, Norway, NO-0424 Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08036 Array BioPharma Investigative Site Madrid, Spain, 28050 Switzerland Array BioPharma Investigative Site Chur, Switzerland, 7000 Array BioPharma Investigative Site Zuerich, Switzerland, 8091 收起 << |
NCT02254967 | Clostridium Difficile | Phase 4 | Completed | - | - |
NCT03422627 | Chronic Graft Versus Host Dise... 展开 >>ase cGVHD 收起 << | Phase 1 Phase 2 | Recruiting | January 14, 2022 | United States, California ... 展开 >> Research Site Recruiting Duarte, California, United States, 91010 United States, Florida Research Site Recruiting Tampa, Florida, United States, 33612 United States, Georgia Research Site Recruiting Atlanta, Georgia, United States, 30322 United States, Massachusetts Research Site Recruiting Boston, Massachusetts, United States, 02215 United States, Ohio Research Site Recruiting Columbus, Ohio, United States, 43210 United States, Washington Research Site Recruiting Seattle, Washington, United States, 98109-1024 Belgium Research Site Recruiting Leuven, Belgium, 3000 France Research Site Recruiting Grenoble Cedex 09, France, 38043 Research Site Recruiting Paris Cedex 10, France, 75475 Japan Research Site Recruiting Okayama-shi, Okayama, Japan, 700-8558 Research Site Recruiting Osaka-shi, Osaka, Japan, 545-8586 Research Site Recruiting Chuo-ku, Tokyo, Japan, 104-0045 收起 << |
NCT02753699 | Hepatitis C | Phase 3 | Completed | - | - |
NCT02753699 | - | Completed | - | - | |
NCT02294786 | Cancer | Phase 2 | Terminated(study was stopped d... 展开 >>ue to futility by the DMC in September 2016) 收起 << | - | - |
NCT01098487 | Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 << | Phase 4 | Completed | - | - |
NCT01098487 | - | Completed | - | - | |
NCT01419197 | - | Completed | - | - | |
NCT01693562 | Advanced Solid Tumors | Phase 1 Phase 2 | Active, not recruiting | November 29, 2019 | - |
NCT01147926 | - | Completed | - | - | |
NCT02268214 | Type 1 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01715285 | Prostate Neoplasms | Phase 3 | Active, not recruiting | August 3, 2021 | - |
NCT01147926 | Male Subjects With Chronic Con... 展开 >>stipation 收起 << | Phase 3 | Completed | - | - |
NCT02268214 | - | Completed | - | - | |
NCT00465985 | Muckle Wells Syndrome | Phase 3 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site San Francisco, California, United States, 94115 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60612 United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States, 53792 France Novartis Investigative Site Le Kremlin Bicetre, France Novartis Investigational Site Lille Cedex, France Novartis Investigative Site Montpellier Cedex, France Novartis Investigative Site Nantes, France Novartis Investigative Site Paris, France Germany Novartis Investigative Site Tubingen, Germany India Novartis Investigative Site New Delhi, India Spain Novartis Investigative Site Barcelona, Spain United Kingdom Novartis Investigative Site London, United Kingdom 收起 << |
NCT03276728 | Heart Failure | Phase 1 | Recruiting | July 30, 2019 | United States, California ... 展开 >> Research Site Recruiting Anaheim, California, United States, 92801 Research Site Recruiting Tustin, California, United States, 92780 United States, Florida Research Site Recruiting Jacksonville, Florida, United States, 32216 United States, Louisiana Research Site Recruiting Metairie, Louisiana, United States, 70006 United States, Maryland Research Site Recruiting Baltimore, Maryland, United States, 21201 United States, Minnesota Research Site Recruiting Minneapolis, Minnesota, United States, 55415 United States, Nevada Research Site Recruiting Las Vegas, Nevada, United States, 89148 Australia, South Australia Research Site Recruiting Leabrook, South Australia, Australia, 5068 Canada, Quebec Research Site Recruiting Sherbrooke, Quebec, Canada, J1G 2E8 France Research Site Recruiting Nantes Cedex 1, France, 44093 Research Site Recruiting Paris, France, 75015 Research Site Recruiting Rennes Cedex 9, France, 35033 Germany Research Site Recruiting Berlin, Germany, 13353 Netherlands Research Site Recruiting Groningen, Netherlands, 9713 GZ New Zealand Research Site Recruiting Christchurch, New Zealand, 8011 Poland Research Site Recruiting Otwock, Poland, 05-400 Research Site Recruiting Wroclaw, Poland, 51-162 Singapore Research Site Recruiting Singapore, Singapore, 169609 收起 << |
NCT01715285 | - | Active, not recruiting | - | - | |
NCT01366521 | Asthma | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> GSK Investigational Site Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 Estonia GSK Investigational Site Tallinn, Estonia, 13619 GSK Investigational Site Tartu, Estonia, 51014 France GSK Investigational Site Marseille cedex 20, France, 13915 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Pessac Cedex, France, 33604 Germany GSK Investigational Site Gauting, Bayern, Germany, 82131 GSK Investigational Site Frankfurt am Main, Hessen, Germany, 60596 GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Berlin, Germany, 14050 收起 << |
NCT01366521 | - | Completed | - | - | |
NCT00465985 | - | Completed | - | - | |
NCT03236857 | Malignancies ... 展开 >>Acute Lymphoblastic Leukemia (ALL) Acute Myeloid Leukemia (AML) Non-Hodgkin's Lymphoma Neuroblastoma 收起 << | Phase 1 | Recruiting | April 7, 2022 | - |
NCT01419197 | Breast Cancer | Phase 3 | Completed | - | - |
NCT03635983 | Melanoma | Phase 3 | Recruiting | March 15, 2025 | - |
NCT01555125 | Moderate to Severe Plaque-type... 展开 >> Psoriasis 收起 << | Phase 3 | Completed | - | - |
NCT01750918 | Cancer | Phase 2 | Active, not recruiting | April 30, 2019 | United States, Arizona ... 展开 >> Novartis Investigative Site Scottsdale, Arizona, United States, 85259 United States, California Novartis Investigative Site San Francisco, California, United States, 94115 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, New York Novartis Investigative Site New York, New York, United States, 10065 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Paris cedex 12, France, 75571 Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Milano, Lombardia, Italy, 20162 Novartis Investigative Site Candiolo (TO), Piemonte, Italy, 10060 Japan Novartis Investigative Site Aichi, Japan, 464-8681 Novartis Investigative Site Chiba, Japan, 277-8577 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Utrecht, Netherlands, 3584 CX Spain Novartis Investigative Site Barcelona, Spain, 08035 United Kingdom Novartis Investigative Site Birmingham, United Kingdom, B15 2TH 收起 << |
NCT00725985 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT01287897 | - | Completed | - | - | |
NCT01555125 | - | Completed | - | - | |
NCT01287897 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT00725985 | - | Completed | - | - | |
NCT01173731 | Parkinson Disease ... 展开 >> Dyskinesia, Drug-Induced Levodopa 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Sunnyvale, California, United States, 94089 United States, Colorado Novartis Investigative Site Englewood, Colorado, United States, 80113 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46202 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3081 Novartis Investigative Site Parkville, Victoria, Australia, 3050 Novartis Investigative Site Prahran, Victoria, Australia, 3181 Canada, Ontario Novartis Investigative Site Ottawa, Ontario, Canada, K1G 4G3 Canada, Quebec Novartis Investigative Site Gatineau, Quebec, Canada, J9J 0A5 Novartis Investigative Site Greenfield Park, Quebec, Canada, J4V 2J2 France Novartis Investigative Site Clermont-Ferrand Cedex 1, France, 63003 Novartis Investigative Site Lille Cedex, France, 59037 Novartis Investigative Site Pessac, France, 33604 Germany Novartis Investigative Site Bochum, Germany, 44791 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Kassel, Germany, 34128 Novartis Investigative Site Marburg, Germany, 35039 Novartis Investigative Site Muenchen, Germany, 80804 Novartis Investigative Site Stadtroda, Germany, 07646 Novartis Investigative Site Tuebingen, Germany, 72076 Italy Novartis Investigative Site Lido di Camaiore, LU, Italy, 55041 Novartis Investigative Site Roma, RM, Italy, 00163 Novartis Investigative Site Napoli, Italy, 80131 收起 << |
NCT03373383 | Drug-resistant Epilepsy ... 展开 >> Focal-Onset Seizures 收起 << | Phase 2 | Recruiting | April 28, 2020 | - |
NCT00395018 | Hepatitis B, Chronic | Phase 3 | Completed | - | - |
NCT00395018 | - | Completed | - | - | |
NCT00774397 | Hepatitis C, Chronic | Phase 2 | Completed | - | - |
NCT02298283 | Hodgkin Lymphoma | Phase 2 | Recruiting | February 2021 | France ... 展开 >> CH Victor Dupouy Recruiting Argenteuil, France, 95100 Contact: Driss CHAOUI, MD driss.chaoui@ch-argenteuil.fr Principal Investigator: Driss CHAOUI, MD Polyclinique Bordeaux Nord Recruiting Bordeaux, France, 33300 Contact: Olivier FITOUSSI, MD o.fitoussi@bordeauxnord.com Contact: Olivier Principal Investigator: FITOUSSI, MD Centre François Baclesse Recruiting Caen, France, 14076 Contact: Christophe FRUCHART, MD c.fruchart@baclesse.unicancer.fr Principal Investigator: Christophe FRUCHART, MD CH de Chambéry Recruiting Chambéry, France, 73011 Contact: Gian Mathéo PICA, MD gian-matteo.pica@ch-chambery.fr Principal Investigator: Gian Mathéo PICA, MD CH Sud Francilien Recruiting Corbeil-Essonnes, France, 91108 Contact: Bertrand JOLY, MD bertrand.joly@ch-sud-francilien.fr Principal Investigator: Bertrand JOLY, MD Hôpital Henri Mondor Recruiting Creteil, France, 94010 Contact: Corinne HAIOUN, Prof corinne.haioun@hmn.aphp.fr Principal Investigator: Corinne HAIOUN, Prof CHU de Dijon - Hôpital le Bocage Recruiting Dijon, France, 21034 Contact: Olivier CASASNOVAS, MD olivier.casasnovas@chu-dijon.fr Principal Investigator: Olivier CASASNOVAS, MD Hôpital André Mignot Recruiting Le Chesnay, France, 78157 Contact: Hassan FARHAT, MD hfarhat@ch-versailles.fr Principal Investigator: Hassan FARHAT, MD Clinique Victor Hugo Recruiting Le Mans, France, 72000 Contact: Katell LE DÛ, MD k.ledu@cjb72.org Principal Investigator: Katell LE DÛ, MD CHRU Lille - Hôpital Claude Huriez Recruiting Lille, France, 59037 Contact: Franck MORSCHHAUSER, Prof franck.morschhauser@chru-lille.fr Principal Investigator: Franck MORSCHHAUSER, Prof CHU de Limoges Recruiting Limoges, France, 87042 Contact: Mohamed TOUATI, MD mohamed.touati@chu-limoges.fr Principal Investigator: Mohamed TOUATI, MD Centre Léon Bérard Recruiting Lyon, France, 69008 Contact: Emmanuelle NICOLAS- VIRELIZIER, MD emmanuelle.nicolas@lyon.unicancer.fr Principal Investigator: Emmanuelle NICOLAS- VIRELIZIER, MD Institut Paoli Calmette Recruiting Marseille, France, 13273 Contact: Réda BOUABDALLAH, MD bouabdallahr@ipc.unicancer.fr Principal Investigator: Réda BOUABDALLAH, MD Hôpital de la Conception Recruiting Marseille, France, 13385 Contact: Régis COSTELLO, Prof regis.costello@free.fr Principal Investigator: Régis COSTELLO, Prof CHU Montpellier - Saint ELOI Recruiting Montpellier, France, 34295 Contact: Philippe QUITTET, MD p-quittet@chu-montpellier.fr Principal Investigator: Philippe QUITTET, MD CHU de Nantes Recruiting Nantes, France, 44093 Contact: Thomas GASTINNE, MD thomas.gastinne@chu-nantes.fr Principal Investigator: Thomas GASTINNE, MD Hôpital Saint Louis Recruiting Paris cedex 10, France, 75475 Contact: Pauline BRICE, MD pauline.brice@sls.aphp.fr Principal Investigator: Pauline BRICE, MD Hôpital Cochin Recruiting Paris, France, 75004 Contact: Bénédicte DEAU-FISCHER, MD benedicte.deau-fischer@cch.aphp.fr Principal Investigator: Bénédicte DEAU-FISCHER, MD Hôpital de la Pitié Salpétrière Recruiting Paris, France, 75651 Contact: Jean GABARRE, MD jean.gabarre@psl.aphp.fr Principal Investigator: Jean GABARRE, MD CH Perpignan Recruiting Perpignan, France, 66046 Contact: Laurence SANHES, MD laurence.sanhes@ch-perpignan.fr Principal Investigator: Laurence SANHES, MD Hôpital Haut Lévêque Recruiting Pessac, France, 33604 Contact: Krimo BOUABDALLAH, MD krimo.bouabdallah@chu-bordeaux.fr Principal Investigator: Krimo BOUABDALLAH, MD CHU Lyon Sud Recruiting Pierre Bénite Cedex, France, 69495 Contact: Gilles SALLES, Prof gilles.salles@chu-lyon.fr Principal Investigator: Gilles SALLES, Prof CHU Robert Debre Recruiting Reims, France, 51092 Contact: Alain DELMER, MD adelmer@chu-reims.fr Principal Investigator: Alain DELMER, MD CHU Pontchaillou Recruiting Rennes, France, 35033 Contact: Thierry LAMY de la CHAPELLE, Prof thierry.lamy.de.la.chapelle@chu-rennes.fr Principal Investigator: Thierry LAMY de la CHAPELLE, Prof Centre Henri Becquerel Recruiting Rouen, France, 76000 Contact: Aspasia STAMATOULLAS, MD aspasia.stamatoullas@chb.unicancer.fr Principal Investigator: Aspasia STAMATOULLAS, MD CHU de Strasbourg Recruiting Strasbourg, France, 67098 Contact: Luc-Matthieu FORNECKER, MD luc-matthieu.fornecker@chru-strasbourg.fr Principal Investigator: Luc-Matthieu FORNECKER, MD I.U.C.T Oncopole Recruiting Toulouse, France, 31059 Contact: Cécile BOREL, MD borel.c@chu-toulouse.fr Principal Investigator: Cécile BOREL, MD CHU Bretonneau Recruiting Tours, France, 37044 Contact: Marjan ERTAULT, MD m.ertault@chu-tours.fr Principal Investigator: Marjan ERTAULT, MD CHU de Brabois Recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Serge BOLOGNA, MD s.bologna@chu-nancy.fr Principal Investigator: Serge BOLOGNA, MD Gustave Roussy Cancer Campus Recruiting Villejuif, France, 94805 Contact: Vincent RIBRAG, MD vincent.ribrag@gustaveroussy.fr Principal Investigator: Vincent RIBRAG, MD 收起 << |
NCT02701634 | Chronic Graft Versus Host Dise... 展开 >>ase 收起 << | Phase 2 | Terminated | - | - |
NCT02163694 | Metastatic Breast Cancer | Phase 3 | Active, not recruiting | May 30, 2019 | - |
NCT00757588 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT00774397 | - | Completed | - | - | |
NCT00757588 | - | Completed | - | - | |
NCT00689338 | Invasive Candidiasis | Phase 3 | Completed | - | - |
NCT01763918 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT01763918 | - | Completed | - | - | |
NCT00331149 | Parkinson Disease | Phase 3 | Completed | - | - |
NCT00689338 | - | Completed | - | - | |
NCT00808067 | Atrial Fibrillation | Phase 3 | Completed | - | - |
NCT00247273 | Postmenopausal Osteoporosis | Phase 3 | Completed | - | - |
NCT00605735 | Rheumatoid Arthritis, NOS | Phase 2 | Completed | - | - |
NCT01807221 | Heart Failure | Phase 2 | Completed | - | - |
NCT02234583 | Pain Associated With Fibromyal... 展开 >>gia 收起 << | Phase 3 | Completed | - | - |
NCT00247273 | - | Completed | - | - | |
NCT02231749 | Advanced Renal Cell Carcinoma ... 展开 >> Metastatic Renal Cell Carcinoma 收起 << | Phase 3 | Active, not recruiting | September 30, 2019 | - |
NCT01666106 | - | Active, not recruiting | April 9, 2021 | - | |
NCT03493685 | Focal Segmental Glomeruloscler... 展开 >>osis 收起 << | Phase 3 | Recruiting | December 2022 | - |
NCT01915589 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | - |
NCT02006472 | Huntington's Disease | Phase 2 | Completed | - | - |
NCT00808067 | - | Completed | - | - | |
NCT02536118 | - | Recruiting | August 2026 | - | |
NCT02231749 | - | Active, not recruiting | - | - | |
NCT01636817 | Inflammation ... 展开 >>Rheumatoid Arthritis 收起 << | Phase 2 | Terminated | - | - |
NCT01761968 | Chronic Myeloproliferative Neo... 展开 >>plasms 收起 << | Phase 2 | Recruiting | December 2020 | France ... 展开 >> Hopital Saint Vincent de Paul - GHICL Lille Recruiting Lille, Lille Cedex, France, 59020 Contact: Laurent Pascal, MD +33320874532 pascal.laurent@ghicl.net Principal Investigator: Laurent Pascal, MD Germany Charite Research Organization GmbH Recruiting Berlin, Germany, 10117 Contact: Antonio Pezzutto, Prof. antonio.pezzutto@charite.de Principal Investigator: Antonio Pezzutto, Prof. Universitaetsklinikum Freiburg, Innere Medizin I - Haematologie und Onkologie Recruiting Freiburg, Germany, 79106 Contact: Nikolas von Bubnoff, MD nikolas.bubnoff@uniklinik-freiburg.de Principal Investigator: Nikolas von Bubnoff, MD Italy Azienda Ospedaliero-Universitaria Policlinico Consorziale, Bari Recruiting Bari, BA, Italy, 70124 Contact: Giorgina Specchia, MD Principal Investigator: Giorgina Specchia, MD Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico di Bari Recruiting Bari, BA, Italy, 70125 Contact: Attilio Guarini, MD attilioguarini@oncologico.bari.it Azienda Ospedaliera Papa Giovanni XXIII Recruiting Bergamo, BG, Italy, 24127 Contact: Alessandro Rambaldi, MD arambaldi@hpg23.it Principal Investigator: Alessandro Rambaldi, MD Azienda Ospedaliero-Universitaria Careggi, Florence Recruiting Florence, FI, Italy, 50134 Contact: Alessandro M Vannucchi, MD Principal Investigator: Alessandro M Vannucchi, MD Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico UOS Oncoematologia anziano Recruiting Milan, MI, Italy, 20122 Contact: Alessandra Iurlo, Prof aiurlo@policlinico.mi.it Azienda Unità Sanitaria Locale - Presidio Ospedaliero "Spirito Santo", Pescara Recruiting Pescara, PE, Italy, 65124 Contact: Paolo Di Bartolomeo, MD Principal Investigator: Paolo Di Bartolomeo, MD Fondazione I.R.C.C.S.-Policlinico San Matteo, Pavia Recruiting Pavia, PV, Italy, 27100 Contact: Vittorio Rosti, MD Principal Investigator: Vittorio Rosti, MD Azienda Ospedaliera "Bianchi-Melacrino-Morelli" Recruiting Reggio Calabria, RC, Italy, 89125 Contact: Bruno Martino, MD Principal Investigator: Bruno Martino, MD Ospedale San Bortolo, Vicenza Recruiting Vicenza, VI, Italy, 36100 Contact: Marco Ruggeri, MD Principal Investigator: Marco Ruggeri, MD Azienda Ospedaliera Universitaria Università degli Studi "Federico II", Naple Recruiting Naples, Italy, 80131 Contact: Vincenzo Martinelli, MD Principal Investigator: Vincenzo Martinelli, MD Università "Campus Bio-Medico", Rome Recruiting Rome, Italy, 00128 Contact: Giuseppe Avvisati, MD Principal Investigator: Giuseppe Avvisati, MD United Kingdom Belfast City Hospital Recruiting Belfast, United Kingdom, BT9 7BL Contact: Mary Frances McMullin, MD m.mcmullin@qub.ac.uk Principal Investigator: Mary Frances McMullin, MD Royal Cornwall Hospital Recruiting Truro, United Kingdom, TR1 3LJ Contact: Richard Noble, MD richard.noble@rcht.cornwall.nhs.uk Principal Investigator: Richard Noble, MD 收起 << |
NCT01885078 | Rheumatoid Arthritis | Phase 3 | Active, not recruiting | March 22, 2024 | - |
NCT03059446 | Nonalcoholic Steatohepatitis ... 展开 >> Liver Cirrhosis Non-alcoholic Fatty Liver Disease 收起 << | Phase 2 | Enrolling by invitation | October 31, 2019 | - |
NCT00353574 | Hypertension | Phase 3 | Terminated(Study DAR-312 did n... 展开 >>ot meet primary co-endpoints) 收起 << | - | - |
NCT00410410 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT00154102 | Epidermal Growth Factor Recept... 展开 >>or (EGFR) Expressing Metastatic Colorectal Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00410410 | - | Completed | - | - | |
NCT00555321 | Immunosuppression in Solid Org... 展开 >>an Transplant 收起 << | Phase 2 | Terminated | - | - |
NCT02367794 | Squamous Non-Small Cell Lung C... 展开 >>ancer 收起 << | Phase 3 | Active, not recruiting | February 15, 2023 | - |
NCT00196742 | - | Recruiting | July 30, 2021 | - | |
NCT01251588 | - | Completed | - | Czechia ... 展开 >> Urazova nemocnice v Brne Brno, Czechia, 662 50 University Hospital Na Bulovce- Department of Orthopaedic Surgery Postgraduate Medical Institute Praha 8, Czechia, 180 81 France Polyclinique Saint-Roch Montpellier Cedex 2, France, 34967 Clinique Maussins-Nollet Paris, France, 75019 Hôpital d'instruction des Armées Robert Picqué VILLENAVE d'ORNON cedex, France, 33882 Netherlands Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ St. Elisabeth Ziekenhuis Tilburg, Netherlands, 5022 GC University Medical Centre of Utrecht, Department of Orthopaedics Utrecht, Netherlands, 3508 GA Norway St Olavs Hospital Trondheim, Norway, 7006 Poland Orthopaedic & Traumatology of Motor Organs, Independent Public Clinic Hospital Bydgoszcz, Poland, 85-094 Regional Centre of Knee Surgery & Arthroscopy, Regional Hospital of Traumatologic Surgery Piekary Slaskie, Poland, 41-940 Lekmed Medical Center Warsow, Poland, 01-480 Sweden Kungsbacka Närsjukhus Kungsbacka, Sweden, 434 80 United Kingdom University of Oxford, Nuffield Dept. of Orthopaedic Surgery Oxford, United Kingdom, OX3 7LD 收起 << | |
NCT01251588 | - | Completed | - | - | |
NCT00260832 | Acute Myeloid Leukemia | Phase 3 | Completed | - | - |
NCT00902291 | Carcinoma, Pancreatic Ductal ... 展开 >> Pancreatic Cancer Pancreatic Disease 收起 << | Phase 2 | Completed | - | - |
NCT03104478 | - | Recruiting | December 2020 | France ... 展开 >> CHU Caen Recruiting Caen, France, 14000 Contact: Gandhi Laurent DAMAJ damaj-gl@chu-caen.fr Principal Investigator: Gandhi Laurent DAMAJ, Doctor Hopital Henri Mondor Recruiting Creteil, France, 94010 Contact: Corinne HAIOUN corinne.haioun@hmn.aphp.fr Principal Investigator: Corinne HAIOUN, Professor CHU Le Bocage Recruiting Dijon, France, 21034 Contact: Olivier CASASNOVAS olivier.casasnovas@chu-dijon.fr Principal Investigator: Olivier CASASNOVAS, Doctor CH Départemental Recruiting La Roche sur Yon, France, 85925 Contact: Hervé MAISONNEUVE herve.maisonneuve@chd-vendee.fr Principal Investigator: Hervé MAISONNEUVE, Doctor CHU Claude Hurriez Recruiting Lille, France, 59037 Contact: Franck MORSCHHAUSER franck.morschhauser@chru-lille.fr Principal Investigator: Franck MORSCHHAUSER, Doctor CHU Montpellier Recruiting MONTPELLIER Cedex 5, France, 34295 Contact: Guillaume CARTRON g-cartron@chu-montpellier.fr Principal Investigator: Guillaume CARTRON, Professor CHU de Nantes Recruiting Nantes, France, 44093 Contact: Steven LE GOUILL steven.legouill@chu-nantes.fr Principal Investigator: Steven LE GOUILL, Porfessor Centre Francois Magendie Recruiting Pessac, France, 33604 Contact: Krimo BOUABDALLAH krimo.bouabdallah@chu-bordeaux.fr Principal Investigator: Krimo BOUABDALLAH, Doctor CHU Lyon Sud Recruiting Pierre Bénite cedex, France, 69495 Contact: Gilles SALLES gilles.salles@chu-lyon.fr Principal Investigator: Gilles SALLES, Professor CHU de Poitiers - Hôpital de la Miletrie Recruiting Poitiers, France, 86021 Contact: Vincent DELWAIL vincent.delwail@chu-poitiers.fr Principal Investigator: Vincent DELWAIL, Doctor Ch Annecy Genevois Recruiting Pringy, France, 74370 Contact: Nicolas DAGUINDAU ndaguindau@ch-annecygenevois.fr Principal Investigator: Nicolas DAGUINDAU, Doctor Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Fabrice JARDIN fabrice.jardin@chb.unicancer.fr Principal Investigator: Fabrice JARDIN, Professor IUCT Oncopôle - CHU de Toulouse Recruiting Toulouse, France, 31059 Contact: Lucie OBERIC oberic.l@chu-toulouse.fr Principal Investigator: Lucie OBERIC, Doctor CHU Nancy Brabois Recruiting Vandoeuvre Les Nancy, France, 54511 Contact: PIERRE FEUGIER p.feugier@chu-nancy.fr Principal Investigator: Pierre FEUGIER, Professor Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Vincent RIBRAG vincent.ribrag@gustaveroussy.fr Principal Investigator: Vincent RIBRAG, doctor 收起 << | |
NCT00942162 | - | Completed | - | - | |
NCT02609828 | Neoplasm Metastasis ... 展开 >> Musculoskeletal Pain 收起 << | Phase 3 | Recruiting | January 12, 2021 | - |
NCT00297258 | Sarcoma, Soft Tissue | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Bruxelles, Belgium, 1000 GSK Investigational Site Leuven, Belgium, 3000 France GSK Investigational Site Lyon cedex 03, France, 69437 GSK Investigational Site Marseille, France, 13385 GSK Investigational Site Paris Cedex 05, France, 75248 GSK Investigational Site Villejuif, France, 94805 Hungary GSK Investigational Site Budapest, Hungary, 01135 Netherlands GSK Investigational Site Groningen, Netherlands, 9713 GZ GSK Investigational Site Leiden, Netherlands, 2300 RC GSK Investigational Site Rotterdam, Netherlands, 3075 EA United Kingdom GSK Investigational Site Manchester, Lancashire, United Kingdom, M20 4BX GSK Investigational Site Glasgow, United Kingdom, G11 6NT GSK Investigational Site Leeds, United Kingdom, LS9 7TF GSK Investigational Site London, United Kingdom, SW3 6JJ GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN GSK Investigational Site Sheffield, United Kingdom, S10 2SJ 收起 << |
NCT00154102 | - | Completed | - | - | |
NCT00297258 | - | Completed | - | - | |
NCT01571583 | Chronic Hepatitis C Virus (HCV... 展开 >>) Infection 收起 << | Phase 3 | Completed | - | Austria ... 展开 >> Linz, Austria Wien, Austria Belgium Brussels, Belgium Gent, Belgium Leuven, Belgium Liege, Belgium France Clichy, France Marseille, France Montpellier, France Rennes Cedex N/A, France Villejuif Cedex, France Germany Essen, Germany Frankfurt A. M., Germany Hannover, Germany Leipzig, Germany Münster, Germany Spain Barcelona, Spain Madrid, Spain Valencia, Spain United Kingdom Birmingham, United Kingdom London, United Kingdom 收起 << |
NCT00555321 | - | Terminated | - | - | |
NCT00942162 | Melanoma | Phase 2 | Completed | - | - |
NCT02426086 | Primary Myelofibrosis | Phase 2 | Active, not recruiting | April 26, 2019 | - |
NCT01984424 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT01435928 | Schizophrenia | Phase 3 | Completed | - | - |
NCT00260832 | - | Completed | - | - | |
NCT01984424 | - | Completed | - | - | |
NCT00152516 | Epilepsy, Partial | Phase 3 | Completed | - | - |
NCT01435928 | - | Completed | - | - | |
NCT00437073 | - | Terminated(Lapatinib-topotecan... 展开 >> arm enrollment closed early per protocol amendment 2. Then enrollment into remaining arm terminated due to operational issues.) 收起 << | - | - | |
NCT00207688 | - | Completed | - | - | |
NCT00152516 | - | Completed | - | - | |
NCT02503423 | Solid Tumors ... 展开 >>Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | December 2019 | - |
NCT02130557 | Leukemia, Myelogenous, Chronic... 展开 >>, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive 收起 << | Phase 3 | Active, not recruiting | April 4, 2020 | - |
NCT00111007 | Melanoma | Phase 3 | Completed | - | - |
NCT00437073 | Neoplasms, Breast | Phase 2 | Terminated(Lapatinib-topotecan... 展开 >> arm enrollment closed early per protocol amendment 2. Then enrollment into remaining arm terminated due to operational issues.) 收起 << | - | - |
NCT00319098 | Influenza | Phase 3 | Completed | - | - |
NCT02488759 | Various Advanced Cancer | Phase 1 Phase 2 | Recruiting | December 31, 2019 | - |
NCT00319098 | - | Completed | - | - | |
NCT00765830 | Diabetes Mellitus, Type 2 ... 展开 >> Renal Insufficiency 收起 << | Phase 3 | Completed | - | - |
NCT02130557 | - | Active, not recruiting | - | - | |
NCT00811018 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Terminated(This trial was prem... 展开 >>aturely terminated on Dec 9 2010 due to safety concerns, specifically emerging evidence of hepatic injury.) 收起 << | - | - |
NCT02755597 | Relapsed/Refractory Multiple M... 展开 >>yeloma 收起 << | Phase 3 | Active, not recruiting | September 3, 2019 | - |
NCT00772980 | Subjective Tinnitus | Phase 3 | Completed | - | - |
NCT01004575 | Coronary Artery Disease ... 展开 >> Angioplasty, Transluminal, Percutaneous Coronary 收起 << | Phase 2 Phase 3 | Unknown | August 2016 | France ... 展开 >> Hopital Cardiovasculaire et Pneumologie Louis Pradel Lyon, France, 69677 CHU NORD Nantes, France, 44035 Clinique les Franciscaines Nimes, France, 30000 Hopital d'Instructions des Armées du Val de Grace Paris CEDEX 05, France, 75230 CHU Rangeuil Toulouse CEDEX 9, France, 31059 Germany Klinikum Fulda gAG Fulda, Germany, 36043 Klinikum Ludwigshafen Ludwigshafen, Germany, 67063 Klinikum des Johannes Gutenberg Universität Mainz, Germany, 55131 Italy Ospedale Careggi Florence, Italy, 50141 Policlinico Milano Milan, Italy, 20122 Ospedale Civico Palermo Palermo, Italy, 90100 Serbia Clinical Centre of serbia Belgrade, Serbia, 11000 Clinical Hospital Center Zemun Belgrade, Serbia, 11000 Institute for Cardiovascular Disease Dedinje Belgrade, Serbia, 11040 Spain Hospital Clinico San Carlos Madrid, Spain, 28040 Hospital La Paz Madrid, Spain, 28046 Hospital Meixoeiro Vigo, Spain, 36214 收起 << |
NCT00811018 | - | Terminated(This trial was prem... 展开 >>aturely terminated on Dec 9 2010 due to safety concerns, specifically emerging evidence of hepatic injury.) 收起 << | - | - | |
NCT01132313 | Hepatitis C, Chronic | Phase 2 | Completed | - | - |
NCT02632786 | AL Amyloidosis | Phase 2 | Completed | - | - |
NCT00111007 | - | Completed | - | - | |
NCT02554812 | Advanced Cancer | Phase 2 | Recruiting | July 23, 2020 | - |
NCT01132313 | - | Completed | - | - | |
NCT00105443 | Carcinoma, Hepatocellular | Phase 3 | Completed | - | - |
NCT00105443 | - | Completed | - | - | |
NCT00306202 | Leukemia | Phase 1 | Active, not recruiting | October 4, 2022 | Austria ... 展开 >> Local Institution Vienna, Austria, 1090 France Local Institution Nantes, France, 44093 Local Institution Paris Cedex 10, France, 75475 Local Institution Paris Cedex 12, France, 75571 Germany Local Institution Berlin, Germany, 13353 Local Institution Frankfurt, Germany, 60590 Local Institution Hannover, Germany, 30625 Italy Local Institution Monza (mi), Italy, 20052 Netherlands Local Institution Rotterdam, Netherlands, 3015 GJ United Kingdom Local Institution Manchester, Greater Manchester, United Kingdom, M27 4HA Local Institution Bristol, Somerset, United Kingdom, BS2 8BJ Local Institution Sutton, Surrey, United Kingdom, SM2 5PT Local Institution Birmingham, West Midlands, United Kingdom, B4 6NH 收起 << |
NCT01057810 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT00185354 | Contraception | Phase 3 | Completed | - | Austria ... 展开 >> Wörgl, Tirol, Austria, 6300 Bregenz, Austria, 6900 Graz, Austria, 8010 Wien, Austria, 1030 Wien, Austria, 1090 Zeltweg, Austria, 8740 Finland Helsinki, Finland, 00100 Helsinki, Finland, 00180 Turku, Finland, 20100 Turku, Finland, 20541 France Biarritz, France, 64200 Bordeaux, France, 33000 COMPIEGNE cedex, France, 60204 Compiegne, France, 60200 Maisons lafitte, France, 78600 Montargis, France, 45200 Nancy Cedex, France, 54042 Pantin, France, 93500 Paris, France, 75018 Roanne, France, 42300 Saint Germain En Laye, France, 78100 Toulouse, France, 31500 Spain San Fernando, Cádiz, Spain, 11100 Pontevedra, Galicia, Spain, 36002 Salt, Girona, Spain, 17190 Barcelona, Spain, 08006 Guadalajara, Spain, 19002 Santiago de Compostela, Spain, 15701 收起 << |
NCT00767325 | - | Completed | - | - | |
NCT01045850 | - | Completed | - | - | |
NCT01779791 | Lymphoma | Phase 2 | Completed | - | - |
NCT01057810 | - | Completed | - | - | |
NCT00813605 | Metastatic Colorectal Cancer | Phase 2 | Completed | - | - |
NCT00306202 | - | Active, not recruiting | - | - | |
NCT00986414 | Parkinson Disease ... 展开 >> Dyskinesias 收起 << | Phase 2 | Completed | - | - |
NCT00393458 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT00393458 | - | Completed | - | - | |
NCT00767325 | Rheumatoid Arthritis | Phase 3 | Completed | - | Denmark ... 展开 >> Local Institution Glostrup, Denmark, DK-2600 France Local Institution Bois Guillaume Cedex, France, 76230 Local Institution Boulogne, France, 92104 Local Institution Echirolles, France, 38434 Local Institution Nice Cedex 03, France, 06202 Germany Local Institution Munchen, Germany, 80639 Hungary Local Institution Budapest, Hungary, 1036 Italy Local Institution Jesi (Ancona), Italy, 60035 Local Institution Pisa, Italy, 56126 Local Institution Roma, Italy, 00161 Local Institution Roma, Italy, 00168 Local Institution Siena, Italy, 53100 Local Institution Verona, Italy, 37126 Norway Local Institution Oslo, Norway, N0319 Local Institution Trondheim, Norway, 7006 Spain Local Institution Barcelona, Spain, 08006 Local Institution Madrid, Spain, 28006 Local Institution Madrid, Spain, 28040 Local Institution Madrid, Spain, 28911 Local Institution Madrid, Spain, 28935 United Kingdom Local Institution Leeds, North Yorkshire, United Kingdom, LS7 4SA 收起 << |
NCT01124864 | Non-small-cell Lung Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> University of California at Los Angeles UCLA - Santa Monica Los Angeles, California, United States, 90095 United States, Maryland Maryland Oncology Hematology, P.A. Dept. of Assoc. Onc/Hem Rockville, Maryland, United States, 20850 United States, Massachusetts Dana Farber Cancer Institute DFCI Boston, Massachusetts, United States, 02215 United States, Pennsylvania St. Luke's Hospital and Health Network St Luke's Bethlehem, Pennsylvania, United States Canada, Alberta Novartis Investigative Site Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Creteil, France, 94000 Novartis Investigative Site Marseille cedex 20, France, 13915 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Oldenburg, Germany, 26121 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 137-701 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Groningen, Netherlands, 9713 GZ Norway Novartis Investigative Site Oslo, Norway, NO-0379 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Badalona, Catalunya, Spain, 08916 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Turkey Novartis Investigative Site Izmir, Turkey, 35040 收起 << |
NCT00488774 | Colitis, Ulcerative | Phase 2 Phase 3 | Terminated(Protocol was cancel... 展开 >>led by company based on overall efficacy, no safety concern) 收起 << | - | - |
NCT02032277 | Triple Negative Breast Cancer | Phase 3 | Active, not recruiting | November 2, 2020 | - |
NCT01124864 | - | Completed | - | - | |
NCT00853658 | Chronic Heart Failure | Phase 3 | Completed | - | - |
NCT00488774 | - | Terminated(Protocol was cancel... 展开 >>led by company based on overall efficacy, no safety concern) 收起 << | - | - | |
NCT01491529 | Dyskinesias P... 展开 >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents 收起 << | Phase 2 | Completed | - | - |
NCT01491932 | Dyskinesias P... 展开 >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents 收起 << | Phase 2 | Completed | - | - |
NCT02745080 | Psoriatic Arthritis | Phase 3 | Recruiting | March 4, 2020 | - |
NCT00296374 | Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00349310 | - | Completed | - | Austria ... 展开 >> Boehringer Ingelheim Investigational Site Innsbruck, Austria, 6020 Boehringer Ingelheim Investigational Site Wien, Austria, 1090 Boehringer Ingelheim Investigational Site Wien, Austria, 1130 France Hopital Rangueil Toulouse cedex 9, France, 31059 Hopital Purpan Toulouse cedex, France, 31073 Germany Neurologisches Fachkrankenhaus fur Beelitz-Heilstatten, Germany, 14547 Universitatsklinikum Carl Gustav Carus Dresden Dresden, Germany, 01307 Boehringer Ingelheim Investigational Site Gera, Germany, 07551 Gertrudis-Kliniken Biskirchen Leun, Germany, 35638 Boehringer Ingelheim Investigational Site Unterhaching, Germany, 82008 Parkinson Klinik Wolfach Wolfach, Germany, 77709 Italy Policlinico di Catania Catania, Italy, 95125 Azienda Ospedaliera S. Martino Genova, Italy, 16100 Universita Federico II Napoli, Italy, 80131 Universita La Sapienza di Roma Roma, Italy, 00161 Netherlands Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6229 HX Spain Hospital de Cruces. Neurology Baracaldo / Bilbao, Spain, 48903 Hospital Clinic i Provincial. Neurology Barcelona, Spain, 08036 Hospital Puerta del Mar. Neurology Cadiz, Spain, 11519 Switzerland Clinica Hildebrand Brissago, Switzerland, 6614 Hopital Cantonal (HUG) Geneve, Switzerland, 1211 Kantonsspital St. Gallen St.Gallen, Switzerland, 9007 United Kingdom Boehringer Ingelheim Investigational Site London, United Kingdom, NW3 2QG Boehringer Ingelheim Investigational Site Newark, United Kingdom, NG24 4DE 收起 << | |
NCT00853658 | - | Completed | - | - | |
NCT00296374 | - | Completed | - | - | |
NCT01987492 | Asthma | Phase 2 | Completed | - | - |
NCT02625623 | - | Active, not recruiting | - | - | |
NCT02625623 | Unresectable, Recurrent, Local... 展开 >>ly Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Gastric Cancer Third Line 收起 << | Phase 3 | Active, not recruiting | September 30, 2022 | - |
NCT02866175 | Atrial Fibrillation | Phase 3 | Active, not recruiting | June 2019 | - |
NCT02279654 | - | Recruiting | December 31, 2022 | - | |
NCT02279173 | Immune Thrombocytopenia | Phase 3 | Active, not recruiting | September 23, 2019 | - |
NCT00630747 | Hunter Syndrome ... 展开 >> Mucopolysaccharidosis II (MPS II) 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT00820911 | Kidney Transplantation | Phase 2 | Completed | - | - |
NCT02104076 | Carcinomas/Neoplasms | Not Applicable | Completed | - | United States, Colorado ... 展开 >> University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Florida Borland-Groover Clinic Jacksonville, Florida, United States, 32256 Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Indiana Indiana University Hospital Indianapolis, Indiana, United States, 46202 United States, North Carolina Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, Virginia University of Virginia Health System Charlottesville, Virginia, United States, 22908-0908 Canada, Ontario St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 Canada, Quebec Centre Hospitalier de 1'Université Montréal, Quebec, Canada, H2W 1T8 France Hôpital Edouard Herriot Lyon Cedex 03, France, 69437 Hôpital L'Archet 2 Nice Cedex 03, France, 23079 Netherlands Erasmus Medish Centrum Rotterdam, Netherlands, 3015 收起 << |
NCT00630747 | - | Completed | - | - | |
NCT02825420 | - | Recruiting | December 2019 | - | |
NCT00262990 | Ovarian Cancer ... 展开 >> Fallopian Tube Cancer Peritoneal Neoplasms 收起 << | Phase 3 | Completed | - | - |
NCT01440088 | Soft Tissue Sarcoma | Phase 3 | Completed | - | - |
NCT01974752 | Metastatic Uv... 展开 >>eal Melanoma 收起 << | Phase 3 | Completed | - | - |
NCT00982488 | Leukemia | Phase 2 | Completed | - | - |
NCT02839850 | Osteoarthritis | Not Applicable | Recruiting | June 1, 2024 | United States, Florida ... 展开 >> Recruiting DeLand, Florida, United States United States, New Hampshire Recruiting New London, New Hampshire, United States United States, Texas Recruiting Lubbock, Texas, United States United States, Virginia Recruiting Newport News, Virginia, United States Austria Krankenhaus der Barmherzigen Schwestern Ried im Innkreis Recruiting Ried im Innkreis, Upper Austria, Austria, 4910 Contact: Norbert Freund +437752602 ortho.ried@bhs.at Principal Investigator: Norbert Freund Canada, Alberta Foothills Medical Centre, University of Calgary Recruiting Calgary, Alberta, Canada Contact: Shannon Puloski 403-944-8635 spuloski@ucalgary.ca Principal Investigator: Shannon Puloski France CHU de la Cavale Blanche Recruiting Brest, Cedex, France, 29285 Contact: Frederic Dubrana +33607597865 Frederic.dubrana@chu-brest.fr Principal Investigator: Frederic Dubrana Germany Active, not recruiting Garmisch-Partenkirchen, Germany Netherlands Recruiting Helmond, Netherlands New Zealand Active, not recruiting Christchurch, New Zealand United Kingdom Wrightington Hospital Recruiting Wigan, United Kingdom 收起 << |
NCT01974752 | - | Completed | - | - | |
NCT02296125 | Locally Advanced or Metastatic... 展开 >> EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 收起 << | Phase 3 | Active, not recruiting | June 28, 2019 | - |
NCT00982488 | - | Completed | - | - | |
NCT02616562 | Growth Hormone Disorder ... 展开 >> Growth Hormone Deficiency in Children 收起 << | Phase 2 | Active, not recruiting | August 31, 2020 | - |
NCT02296125 | - | Active, not recruiting | - | - | |
NCT00625664 | Urinary Bladder Neoplasms | Phase 3 | Completed | - | - |
NCT02928224 | BRAF V600E-mutant Metastatic C... 展开 >>olorectal Cancer 收起 << | Phase 3 | Recruiting | July 2019 | - |
NCT01545050 | Crohn's Disease | Phase 2 | Terminated(due to sponsor deci... 展开 >>sion) 收起 << | - | - |
NCT00703118 | Hepatitis C, Chronic | Phase 3 | Completed | - | - |
NCT00393198 | Contraception ... 展开 >> Menorrhagia 收起 << | Phase 4 | Completed | - | Finland ... 展开 >> Helsinki, Finland, 00100 Hyvinkää, Finland, 05800 Jyväskylä, Finland, 40100 Kuopio, Finland, 70110 Tampere, Finland, 33100 Turku, Finland, 20100 France Brignoles, France, 83170 Compiegne Cedex, France, 60204 Nancy Cedex, France, 54042 Quetigny, France, 21800 Reims, France, 51100 Roanne, France, 42300 Ireland Mallow, Cork, Ireland Drogheda, Ireland Sweden Stockholm, Sweden, 118 83 Stockholm, Sweden, 182 88 Stockholm, Sweden, S-171 76 收起 << |
NCT02997202 | Acute Myeloid Leukemia | Phase 3 | Recruiting | August 2024 | - |
NCT00703118 | - | Completed | - | - | |
NCT01226316 | Advanced Solid Malignancy ... 展开 >> Safety and Tolerability Pharmacokinetics Pharmacodynamics Tumour Response Advanced or Metastatic Breast Cancer Ovarian Cancer Cervical Cancer Endometrial Cancer PIK3CA AKT1 PTEN ER Positive HER2 Positive 收起 << | Phase 1 | Recruiting | November 15, 2019 | - |
NCT00938860 | Hepatitis C L... 展开 >>iver Transplantation 收起 << | Phase 4 | Completed | - | - |
NCT01103999 | - | Completed | - | France ... 展开 >> Centre Hospitalier d'Alès Alès, France, 30100 CH d'Avignon - Centre Hospitalier Henri Duffaut Avignon, France, 84902 Centre Hospitalier Général Louis Pasteur Bagnols sur Ceze, France, 30200 Centre Hospitalier Général Beziers, France, 34525 Centre Hospitalier Antoine Gayraud Carcassonne Cedex 9, France, 11890 APHM - Hôpital Nord Marseille Cedex 20, France, 13915 Centre Hospitalier de Mende Mende, France, 48001 Hôpital Saint Eloi Montpellier, France, 34295 Centre Hospitalier de Narbonne Narbonne, France, 11108 Centre Hospitalier Universitaire de Nîmes Nîmes, France, 30029 Centre Hospitalier Saint Jean Perpignan, France, 66000 Centre Hospitalier du bassin de Thau Sete, France, 34200 收起 << | |
NCT00938860 | - | Completed | - | - | |
NCT01160211 | Neoplasms, Breast | Phase 3 | Active, not recruiting | May 5, 2019 | - |
NCT02038933 | Lymphoma. Non-Hodgkin | Phase 2 | Active, not recruiting | April 1, 2019 | - |
NCT02038933 | - | Active, not recruiting | - | - | |
NCT02038946 | Lymphoma | Phase 2 | Active, not recruiting | April 8, 2019 | - |
NCT02038946 | - | Active, not recruiting | - | - | |
NCT00456833 | Non Small Cell Lung Cancer | Phase 1 | Completed | - | United States, Georgia ... 展开 >> Novartis Investigative Site Atlanta, Georgia, United States, 30322 United States, Illinois Novartis Investigative Site Chicago, Illinois, United States, 60637-1470 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02115 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030-4009 United States, Wisconsin Novartis Investigative Site Madison, Wisconsin, United States, 53792 Canada, British Columbia Novartis Investigative Site Richmond, British Columbia, Canada, V7C 5L9 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2L 4M1 Denmark Novartis Investigative Site Herlev, Denmark, DK-2730 France Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Novartis Investigative Site Villejuif Cedex, France, 94805 Russian Federation Novartis Investigative Site Moscow, Russian Federation, 115478 收起 << |
NCT01153763 | Melanoma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90025 GSK Investigational Site Los Angeles, California, United States, 90095 GSK Investigational Site San Francisco, California, United States, 94115 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030-4009 Australia, New South Wales GSK Investigational Site Newcastle, New South Wales, Australia, 2300 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 France GSK Investigational Site Bordeaux, France, 33075 GSK Investigational Site Boulogne-Billancourt, France, 92100 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Villejuif, France, 94805 Germany GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Luebeck, Schleswig-Holstein, Germany, 23538 GSK Investigational Site Berlin, Germany, 10117 Italy GSK Investigational Site Napoli, Campania, Italy, 80131 GSK Investigational Site Genova, Liguria, Italy, 16132 GSK Investigational Site Padova, Veneto, Italy, 35128 收起 << |
NCT00184678 | Growth Hormone Disorder ... 展开 >> Adult Growth Hormone Deficiency 收起 << | Phase 3 | Completed | - | - |
NCT01153763 | - | Completed | - | - | |
NCT02656329 | Heart Failure | Phase 3 | Suspended(Suspended - Recruitm... 展开 >>ent rate) 收起 << | August 2021 | - |
NCT00492635 | Erectile Dysfunction ... 展开 >> Sexual Dysfunction, Physiological 收起 << | Phase 3 | Completed | - | - |
NCT00010088 | Extrahepatic Bile Duct Cancer ... 展开 >> Pancreatic Cancer 收起 << | Phase 2 | Unknown | - | - |
NCT00925600 | - | Completed | - | - | |
NCT00925600 | Cancer Catara... 展开 >>ct Low Bone Mineral Density Osteopenia Osteoporosis Prostate Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00117598 | Lymphoma | Phase 3 | Completed | - | - |
NCT01500278 | Rheumatoid Arthritis | Phase 4 | Completed | - | - |
NCT00097084 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00863746 | Carcinoma Non... 展开 >>-Small-Cell Lung 收起 << | Phase 3 | Completed | - | - |
NCT01227889 | Cancer | Phase 3 | Completed | - | - |
NCT00117598 | - | Completed | - | - | |
NCT00207142 | HIV Infections | Phase 4 | Completed | - | Estonia ... 展开 >> Local Institution Tallinn, Estonia France Local Institution Le Kremlin Bicetre 94, France Local Institution Orleans, France Local Institution Paris Cedex 12, France Local Institution Paris Cedex 20, France Local Institution Paris, France Local Institution Suresnes, France Germany Local Institution Dusseldorf, Germany Local Institution Hannover, Germany Local Institution Stuttgart, Germany Local Institution Ulm, Germany Ireland Local Institution Dublin 3, Dublin, Ireland Local Institution Dublin 8, Dublin, Ireland Italy Local Institution Brescia, Italy Local Institution Milano, Italy Local Institution Napoli, Italy Local Institution Padova, Italy Latvia Local Institution Riga, Latvia Portugal Local Institution Cascais, Portugal Local Institution Porto, Portugal Russian Federation Local Institution Moscow, Russian Federation Local Institution Smolensk, Russian Federation Local Institution St. Petersburg, Russian Federation Spain Local Institution Elche, Alicante, Spain Local Institution Barcelona, Spain Local Institution Madrid, Spain Local Institution Valencia, Spain United Kingdom Local Institution Bristol, Avon, United Kingdom Local Institution Edinburgh, Central, United Kingdom Local Institution London, Greater London, United Kingdom 收起 << |
NCT00254046 | HIV | Phase 3 | Completed | - | - |
NCT01500278 | - | Completed | - | - | |
NCT00863746 | - | Completed | - | - | |
NCT01227889 | - | Completed | - | - | |
NCT00154401 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 2 | Completed | - | Denmark ... 展开 >> Novo Nordisk Investigational Site Aalborg, Denmark, 9000 Novo Nordisk Investigational Site Hellerup, Denmark, 2900 Novo Nordisk Investigational Site Hvidovre, Denmark, 2650 Novo Nordisk Investigational Site Kolding, Denmark, 6000 Novo Nordisk Investigational Site København S, Denmark, 2300 Novo Nordisk Investigational Site København, Denmark, 2400 Novo Nordisk Investigational Site Køge, Denmark, 4600 Novo Nordisk Investigational Site Århus C, Denmark, 8000 France Novo Nordisk Investigational Site Antibes, France, 06600 Novo Nordisk Investigational Site DAX, France, 40107 Novo Nordisk Investigational Site LA ROCHELLE cedex, France, 17019 Novo Nordisk Investigational Site Marseille, France, 13009 Novo Nordisk Investigational Site Montpellier, France, 34295 Novo Nordisk Investigational Site Mougins, France, 06250 Novo Nordisk Investigational Site Narbonne, France, 11108 Novo Nordisk Investigational Site NEVERS cedex, France, 58033 Novo Nordisk Investigational Site Nimes, France, 30006 Novo Nordisk Investigational Site Pessac, France, 33600 Novo Nordisk Investigational Site Rennes, France, 35056 Novo Nordisk Investigational Site Venissieux, France, 69200 Netherlands Novo Nordisk Investigational Site Amsterdam, Netherlands, 1105 AZ Novo Nordisk Investigational Site Apeldoorn, Netherlands, 7334 DZ Novo Nordisk Investigational Site Den Bosch, Netherlands, 5223 GV Novo Nordisk Investigational Site Den Haag, Netherlands, 2512 VA Novo Nordisk Investigational Site Groningen, Netherlands, 9713 GZ Novo Nordisk Investigational Site Hengelo, Netherlands, 7555 DL Novo Nordisk Investigational Site Sliedrecht, Netherlands, 3361 XV Slovakia Novo Nordisk Investigational Site Banska Bystrica, Slovakia, 95717 Novo Nordisk Investigational Site Bratislava, Slovakia, 811 08 Novo Nordisk Investigational Site Bratislava, Slovakia, 81526 Novo Nordisk Investigational Site Bratislava, Slovakia, 82102 Novo Nordisk Investigational Site Bratislava, Slovakia, 831 01 Novo Nordisk Investigational Site Kosice, Slovakia, 040 01 Novo Nordisk Investigational Site Kosice, Slovakia, 04011 Novo Nordisk Investigational Site Kosice, Slovakia, 04190 Novo Nordisk Investigational Site Lucenec, Slovakia, 98401 Novo Nordisk Investigational Site Presov, Slovakia, 080 01 Novo Nordisk Investigational Site Sahy, Slovakia, 93601 Novo Nordisk Investigational Site Zilina, Slovakia, 01001 收起 << |
NCT01197521 | - | Completed | - | - | |
NCT01197521 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00207142 | - | Completed | - | - | |
NCT01840410 | Choroidal Neovascularization (... 展开 >>CNV) 收起 << | Phase 3 | Completed | - | - |
NCT01193244 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT01840410 | - | Completed | - | - | |
NCT01422720 | Epilepsy | Phase 3 | Completed | - | - |
NCT01193244 | - | Completed | - | - | |
NCT00113815 | Partial Seizure Disorder ... 展开 >> Epilepsy Seizures 收起 << | Phase 3 | Completed | - | - |
NCT01063855 | Erectile Dysfunction ... 展开 >> Sexual Dysfunction 收起 << | Phase 3 | Completed | - | - |
NCT01063855 | - | Completed | - | - | |
NCT00159861 | Pulmonary Hypertension | Phase 3 | Completed | - | - |
NCT00190684 | Attention Deficit Hyperactivit... 展开 >>y Disorder 收起 << | Phase 3 | Completed | - | - |
NCT00159861 | - | Completed | - | - | |
NCT01284062 | Colitis, Ulcerative | Phase 2 | Completed | - | - |
NCT01422720 | - | Completed | - | - | |
NCT00190684 | - | Completed | - | - | |
NCT01147874 | Psoriasis Pso... 展开 >>riatic Arthritis 收起 << | Phase 4 | Completed | - | - |
NCT01307423 | Psoriatic Arthritis | Phase 3 | Completed | - | - |
NCT01307423 | - | Completed | - | - | |
NCT01284062 | - | Completed | - | - | |
NCT01147874 | - | Completed | - | - | |
NCT01628913 | Pancreatic Neuroendocrine Tumo... 展开 >>rs (pNET) 收起 << | Phase 2 | Terminated(This trial was term... 展开 >>inated based on an interim analysis as BEZ235 did not demonstrate a progression free survival advantage to everolimus treatment.) 收起 << | - | United States, California ... 展开 >> Cedars Sinai Medical Center SC-3 Los Angeles, California, United States, 90048 United States, Colorado University of Colorado Univ Colorado Aurora, Colorado, United States, 80045 United States, Kentucky University of Kentucky Univ Kebtucky Lexington, Kentucky, United States, 40536-0098 United States, New York Montefiore Medical Center SC Bronx, New York, United States, 10467 France Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Montpellier Cedex 5, France, 34298 Novartis Investigative Site Paris, France, 75015 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Toulouse Cedex 4, France, 31054 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Pisa, PI, Italy, 56126 Novartis Investigative Site Roma, RM, Italy, 00189 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1105 AZ Novartis Investigative Site Groningen, Netherlands, 9713 GZ Russian Federation Novartis Investigative Site Kazan, Russian Federation, 420029 Spain Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28034 Novartis Investigative Site Madrid, Spain, 28046 Switzerland Novartis Investigative Site Luzern, Switzerland, 6000 United Kingdom Novartis Investigative Site Glasgow, United Kingdom, G11 6NT Novartis Investigative Site London, United Kingdom, NW3 2QG Novartis Investigative Site London, United Kingdom, SE1 9RT Novartis Investigative Site Manchester, United Kingdom, M20 9BX Novartis Investigative Site Sheffield, United Kingdom, S10 2SJ 收起 << |
NCT01628913 | - | Terminated(This trial was term... 展开 >>inated based on an interim analysis as BEZ235 did not demonstrate a progression free survival advantage to everolimus treatment.) 收起 << | - | - | |
NCT00318422 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01958918 | Visual Impairment Due to Neova... 展开 >>scular AMD 收起 << | Phase 4 | Completed | - | - |
NCT00379769 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01719380 | Colorectal Cancer | Phase 1 Phase 2 | Active, not recruiting | July 31, 2019 | - |
NCT01310894 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT00338130 | Melanoma | Phase 2 | Completed | - | - |
NCT00337558 | Overactive Bladder ... 展开 >> Urinary Incontinence Urge Incontinence 收起 << | Phase 4 | Completed | - | - |
NCT00379769 | - | Completed | - | - | |
NCT00348712 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description) 收起 << | - | - |
NCT01625286 | Advanced or Metastatic Breast ... 展开 >>Cancer ER+ve Advanced or Metastatic Breast Cancer 收起 << | Phase 1 Phase 2 | Active, not recruiting | March 29, 2019 | - |
NCT00490035 | Epilepsy | Phase 3 | Completed | - | - |
NCT00490035 | - | Completed | - | - | |
NCT00168818 | Thromboembolism ... 展开 >> Arthroplasty, Replacement, Hip 收起 << | Phase 3 | Completed | - | - |
NCT01712490 | - | Active, not recruiting | - | - | |
NCT01703481 | Tumor or Lymphoma | Phase 1 | Completed | - | - |
NCT01318694 | Hepatitis C | Phase 3 | Completed | - | - |
NCT01318694 | - | Completed | - | - | |
NCT01362348 | Macular Degeneration | Phase 2 | Terminated(Lack of efficacy id... 展开 >>entified during a preliminary analysis) 收起 << | - | United States, Arizona ... 展开 >> GSK Investigational Site Phoenix, Arizona, United States, 85014 United States, Florida GSK Investigational Site Miami, Florida, United States, 33143 GSK Investigational Site Winter Haven, Florida, United States, 33880 United States, Georgia GSK Investigational Site Decatur, Georgia, United States, 30030 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Michigan GSK Investigational Site Grand Rapids, Michigan, United States, 49525 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 GSK Investigational Site Houston, Texas, United States, 77030 France GSK Investigational Site Paris cedex 10, France, 75475 GSK Investigational Site Paris cedex 12, France, 75571 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80336 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48145 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 收起 << |
NCT01712490 | Hodgkin Lymphoma | Phase 3 | Active, not recruiting | March 1, 2020 | - |
NCT00095238 | Congestive Heart Failure | Phase 3 | Completed | - | - |
NCT00168818 | - | Completed | - | - | |
NCT01450761 | - | Completed | - | - | |
NCT00358566 | Advanced Unresectable Pancreat... 展开 >>ic Cancer 收起 << | Phase 3 | Terminated(Preliminary data sh... 展开 >>owed no survival benefit in the GV1001 group compared to the gemcitabine group.) 收起 << | August 2008 | - |
NCT01450761 | Small Cell Lung Carcinoma | Phase 3 | Completed | - | - |
NCT00095238 | - | Completed | - | - | |
NCT01768559 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT01768559 | - | Completed | - | - | |
NCT02049957 | Breast Cancer | Phase 2 | Completed | - | - |
NCT02289690 | Small Cell Lung Cancer | Phase 1 Phase 2 | Active, not recruiting | March 27, 2019 | - |
NCT00712881 | Breast Cancer | Phase 2 | Completed | - | Austria ... 展开 >> Teva Investigational Site 16 Kufstein, Austria Teva Investigational Site 15 Wien, Austria Belgium Teva Investigational Site 9 Brussels, Belgium Teva Investigational Site 29 Yvoir, Belgium France Teva Investigational Site 4 Clichy Cedex, France Teva Investigational Site 5 Nancy, France Teva Investigational Site 33 Reims, France Teva Investigational Site 8 Vandoeuvre-Les-Nancy CEDEX, France Germany Teva Investigational Site 30 Aachen, Germany Teva Investigational Site 11 Dusseldorf, Germany Teva Investigational Site 25 Dusseldorf, Germany Teva Investigational Site 32 Essen, Germany Teva Investigational Site 34 Lorrach, Germany Teva Investigational Site 14 Munchen, Germany Teva Investigational Site 27 München, Germany Italy Teva Investigational Site 20 Napoli, Italy Teva Investigational Site 23 Roma, Italy Teva Investigational Site 21 Verona, Italy Spain Teva Investigational Site 26 Barcelona, Spain Teva Investigational Site 3 Barcelona, Spain Teva Investigational Site 1 Lleida, Spain Teva Investigational Site 2 Zaragoza, Spain 收起 << |
NCT00044512 | - | Completed | - | - | |
NCT01362348 | - | Terminated(Lack of efficacy id... 展开 >>entified during a preliminary analysis) 收起 << | - | - | |
NCT00114972 | Coronary Artery Disease | Phase 3 | Unknown | May 2012 | - |
NCT00114972 | - | Unknown | - | - | |
NCT01452347 | - | Terminated | - | - | |
NCT00044512 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | United States, California ... 展开 >> Los Angeles, California, United States, 90057 United States, New York New York, New York, United States, 10021-6007 Belgium Bruxelles - Brussel, Belgium, 1000 Bruxelles - Brussel, Belgium, 1070 Bruxelles - Brussel, Belgium, 1090 Gent, Belgium, 9000 Leuven, Belgium, 3000 France Lille Cedex, France, 59020 Marseille, France, 13005 Paris, France, 75020 Rennes Cedex, France, 35062 Saint Herblain, France, 44805 Israel Haifa, Israel, 31096 Jerusalem, Israel, 91120 Petach Tikva, Israel, 49100 Rehovot, Israel, 76100 Tel Aviv, Israel, 64239 Tel Hashomer, Israel, 52621 Italy Rozzano, Milano, Italy, 20089 Forlì, Italy, 47100 Milano, Italy, 20122 Pisa, Italy, 56126 Verona, Italy, 37126 收起 << |
NCT01281254 | Fallopian Tube Cancer ... 展开 >> Ovarian Cancer Primary Peritoneal Cancer 收起 << | Phase 3 | Terminated(Closure of long ter... 展开 >>m follow up (LTFU) and study earlier than previously outlined in the protocol as no beneficial information gained from continuing LTFU.) 收起 << | - | - |
NCT01302067 | - | Completed | - | - | |
NCT01452347 | Heart Valve Diseases | Phase 2 | Terminated | - | - |
NCT01882439 | Psoriatic Arthritis | Phase 3 | Completed | - | - |
NCT01882439 | - | Completed | - | - | |
NCT01302067 | Overactive Bladder | Phase 4 | Completed | - | - |
NCT00469092 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | - |
NCT03036488 | Triple Negative Breast Neoplas... 展开 >>ms 收起 << | Phase 3 | Active, not recruiting | March 14, 2025 | - |
NCT00101998 | Constipation ... 展开 >>Bowel Dysfunction 收起 << | Phase 2 | Completed | - | - |
NCT01868022 | Neoplasms | Phase 1 | Completed | - | - |
NCT02420262 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01332656 | Ovarian Cancer Recurrent | Phase 2 | Completed | - | - |
NCT01505881 | Thromboembolism ... 展开 >> Heart Valve Prosthesis 收起 << | Phase 2 | Terminated | - | Belgium ... 展开 >> 1160.138.32003 Boehringer Ingelheim Investigational Site Bruxelles, Belgium 1160.138.32002 Boehringer Ingelheim Investigational Site Genk, Belgium 1160.138.32001 Boehringer Ingelheim Investigational Site Leuven, Belgium Canada, New Brunswick 1160.138.11001 Boehringer Ingelheim Investigational Site Saint John, New Brunswick, Canada Canada, Ontario 1160.138.11009 Boehringer Ingelheim Investigational Site Hamilton, Ontario, Canada 1160.138.11011 Boehringer Ingelheim Investigational Site London, Ontario, Canada 1160.138.11012 Boehringer Ingelheim Investigational Site Newmarket, Ontario, Canada 1160.138.11007 Boehringer Ingelheim Investigational Site Toronto, Ontario, Canada Czech Republic 1160.138.42002 Boehringer Ingelheim Investigational Site Brno, Czech Republic 1160.138.42003 Boehringer Ingelheim Investigational Site Olomouc, Czech Republic 1160.138.42004 Boehringer Ingelheim Investigational Site Ostrava, Czech Republic 1160.138.42001 Boehringer Ingelheim Investigational Site Prague 5, Czech Republic Denmark 1160.138.45001 Boehringer Ingelheim Investigational Site Copenhagen, Denmark 1160.138.45002 Boehringer Ingelheim Investigational Site Odense C, Denmark France 1160.138.33004 Boehringer Ingelheim Investigational Site Bron, France 1160.138.33001 Boehringer Ingelheim Investigational Site Paris cedex 18, France 1160.138.33002 Boehringer Ingelheim Investigational Site Pessac, France 1160.138.33003 Boehringer Ingelheim Investigational Site Rennes Cedex 2, France Germany 1160.138.49001 Boehringer Ingelheim Investigational Site Dresden, Germany 1160.138.49002 Boehringer Ingelheim Investigational Site Essen, Germany 1160.138.49004 Boehringer Ingelheim Investigational Site Freiburg, Germany 1160.138.49003 Boehringer Ingelheim Investigational Site Heidelberg, Germany 1160.138.49010 Boehringer Ingelheim Investigational Site Witten, Germany Netherlands 1160.138.31002 Boehringer Ingelheim Investigational Site Amsterdam, Netherlands 1160.138.31004 Boehringer Ingelheim Investigational Site Breda, Netherlands Norway 1160.138.47002 Boehringer Ingelheim Investigational Site Bergen, Norway 1160.138.47001 Boehringer Ingelheim Investigational Site Oslo, Norway Poland 1160.138.48004 Boehringer Ingelheim Investigational Site Gdansk, Poland 1160.138.48003 Boehringer Ingelheim Investigational Site Warszawa, Poland 1160.138.48001 Boehringer Ingelheim Investigational Site Wroclaw, Poland 收起 << |
NCT00469092 | - | Completed | - | - | |
NCT02420262 | - | Completed | - | - | |
NCT00111787 | Neoplasms, Breast | Phase 2 | Completed | - | - |
NCT02286388 | Deep Caries | Phase 3 | Recruiting | August 2020 | France ... 展开 >> Hôpital Estaing Recruiting Clermont Ferrand, France, 63003 Contact: DOMEJEAN Sophie +33 6 63 04 71 43 sophie.domejean@udamail.fr Principal Investigator: DOMEJEAN Sophie Hôpital Albert Chenevier Recruiting Creteil, France, 94000 Contact: DURSUN Elisabeth +33 6 12 37 56 14 elisabeth.dursun@parisdescartes.fr Principal Investigator: DURSUN Elisabeth Sub-Investigator: LANDRU Marguerite-Marie Cabinet Libéral Recruiting Grenay, France, 62160 Contact: TRENTESAUX Thomas +33 676285205 thomas.trentesaux@univ-lille2.fr Principal Investigator: TRENTESAUX Thomas Hôpital Charles Foix Recruiting IVRY SUR SEINE Cedex, France, 94205 Contact: FRON-CHABOUIS Hélène +33 6 22 78 72 64 fronhelene@gmail.com Principal Investigator: FRON-CHABOUIS Hélène Sub-Investigator: DECUP Franck Sub-Investigator: ATTAL Jean-Pierre Sub-Investigator: CHATELAIN Claire CHU Lille Recruiting Lille, France Contact: LINEZ Marc +33 6 42 53 80 79 marc.linez@univ-lille2.fr Principal Investigator: LINEZ Marc Sub-Investigator: GAMBIEZ Alain Sub-Investigator: HILDELBERT Pierre Sub-Investigator: BECAVIN Thibault Sub-Investigator: ROBBERECHT Lieven Sub-Investigator: TRENTESAUX Thomas Sub-Investigator: CATTEAU Céline Service de consultations et traitements dentaires Recruiting Lyon, France, 69007 Contact: VILLAT Cyril +33 6 09 98 64 32 cyril.villat@univ-lyon1.fr Principal Investigator: VILLAT Cyril Sub-Investigator: LUCCHINI Marion Sub-Investigator: GASQUI Marie-Agnès Sub-Investigator: MORRIER Jean-Jacques Sub-Investigator: SELLI Thierry Sub-Investigator: THIVICHON-PRINCE Beatrice Principal Investigator: GROSGOGEAT Brigitte Hôpital de la Timone Recruiting Marseille, France, 13385 Contact: RASKIN Anne +33 4 91 38 59 55 anne.raskin@ap-hm.fr Sub-Investigator: TASSERY Hervé Sub-Investigator: JACQUOT Bruno Principal Investigator: RASKIN Anne CHRU de Nantes Recruiting Nantes, France, 44093 Contact: WEISS Pierre +33 6 87 74 10 55 pierre.weiss@univ-nantes.fr Principal Investigator: WEISS Pierre Sub-Investigator: LOPEZ-CAZAUX Serena Sub-Investigator: ENKEL Bénédicte Sub-Investigator: PRUD'HOMME Tony CHU Nice Recruiting Nice, France, 06003 Contact: BRULAT Nathalie +33 6 95 37 73 59 nathalie.brulat@unice.fr Principal Investigator: BRULAT Nathalie Sub-Investigator: MULLER BOLLA Michèle APAH Rothschild- Garancière Recruiting PARIS Cedex 12, France, 75571 Contact: PLASSE-PRADELLE Nelly +33 6 10 33 28 02 nx.pradelle@club-internet.fr Principal Investigator: PLASSE-PRADELLE Nelly Sub-Investigator: HARTMANN Aline Sub-Investigator: MESGOUEZ-MENEZ Catherine Groupe Hospitalier Pitié Salpétrière Recruiting Paris, France, 75013 Contact: BOSCO Julia +33 6 60 76 94 90 julia.bosco@univ-paris-diderot.fr Principal Investigator: BOSCO Julia Sub-Investigator: HOUARI Sophia Cabinet Libéral Recruiting Paris, France, 75017 Contact: DECUP Franck +33 607126524 franck.decup@orange.fr Principal Investigator: DECUP Franck Hopital Xavier Arnozan Recruiting Pessac, France, 33604 Contact: Dominique ORIEZ-PONS +33 679164583 dominique.oriez-pons@u-bordeaux.fr Sub-Investigator: BARSBY Terence Sub-Investigator: KEROUREDAN Olivia Sub-Investigator: AUSSEL Audrey Principal Investigator: ORIEZ-PONS Dominique CHRU Rennes Recruiting Rennes, France, 35033 Contact: TURPIN Yann-Loïg +33 6 74 69 53 96 yturpin@univ-rennes1.fr Principal Investigator: TURPIN Yann-Loïg Sub-Investigator: PERARD Matthieu CHRU Toulouse Recruiting Toulouse, France, 31059 Contact: JONIOT Sabine +33 6 77 38 99 20 s.joniot@free.fr Principal Investigator: JONIOT Sabine Sub-Investigator: GEORGELIN-GURGEL Marie Sub-Investigator: VAYSSE Fréderic Sub-Investigator: DIEMER Franck Sub-Investigator: BONIN Bertrand Sub-Investigator: MONSARRAT Paul 收起 << |
NCT01505881 | - | Terminated | - | - | |
NCT01688843 | Bradycardia S... 展开 >>inus Node Dysfunction 收起 << | Not Applicable | Active, not recruiting | January 2019 | - |
NCT00883116 | Endometrial Cancer | Phase 3 | Terminated(Interim analysis re... 展开 >>sults showed that ixabepilone did not improve survival compared with control chemotherapies.) 收起 << | - | - |
NCT00883116 | - | Terminated(Interim analysis re... 展开 >>sults showed that ixabepilone did not improve survival compared with control chemotherapies.) 收起 << | - | - | |
NCT01688843 | - | Active, not recruiting | - | - | |
NCT00300885 | - | Terminated(Based on the result... 展开 >>s of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early.) 收起 << | - | - | |
NCT03104413 | Crohn's Disease | Phase 3 | Recruiting | August 13, 2020 | - |
NCT01131676 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00300885 | Carcinoma, Non-Small Cell Lung | Phase 3 | Terminated(Based on the result... 展开 >>s of the interim analysis, it was determined that the study would not meet its primary efficacy endpoint and the study was terminated early.) 收起 << | - | - |
NCT00317044 | Asthma GERD | Phase 2 | Completed | - | - |
NCT00518882 | - | Completed | - | - | |
NCT00518882 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00317044 | - | Completed | - | - | |
NCT01327547 | - | Completed | - | - | |
NCT00068029 | Acromegaly | Phase 4 | Completed | - | - |
NCT00308464 | Growth Hormone Deficiency | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01599650 | - | Completed | - | - | |
NCT01455402 | - | Completed | - | - | |
NCT00410761 | Thyroid Cancer | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT01131676 | - | Completed | - | - | |
NCT01714726 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT01327547 | HIV Coinfection | Phase 4 | Completed | - | - |
NCT00567879 | Breast Cancer | Phase 1 Phase 2 | Terminated(The study was termi... 展开 >>nated early due to insufficient evidence of clinical benefit.) 收起 << | - | United States, California ... 展开 >> University of California at Los Angeles Los Angeles, California, United States, 90095 United States, Colorado University of Colorado Dept. of Univ. of Colorado Aurora, Colorado, United States, 80045 United States, Connecticut Norwalk Hospital Dept of Norwalk Hospital (2) Norwalk, Connecticut, United States, 06856 United States, Maryland VA Maryland Health Care Dept.of GreenbaumCancerCent(3) Baltimore, Maryland, United States, 21201 United States, Missouri The Center for Cancer Care and Research St. Louis, Missouri, United States, 63141 United States, Ohio Ohio State Comprehensive Cancer Center/James Cancer Hospital SC Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Cancer Institute Dept of Magee Women's Hospital Pittsburgh, Pennsylvania, United States, 15232 Canada, British Columbia Novartis Investigative Site Kelowna, British Columbia, Canada, V1Y 5L3 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Dijon Cedex, France, 21034 Novartis Investigative Site Paris, France, 75231 Novartis Investigative Site Saint-Herblain Cédex, France, 44805 Germany Novartis Investigative Site Heidelberg, Germany, 69115 Italy Novartis Investigative Site Meldola, FC, Italy, 47014 Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Modena, MO, Italy, 41100 United Kingdom Novartis Investigative Site Birmingham, United Kingdom, B15 2TH Novartis Investigative Site London, United Kingdom, W12 0HS Novartis Investigative Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT02314117 | Metastatic Gastric Adenocarcin... 展开 >>oma Gastroesophageal Junction Adenocarcinoma 收起 << | Phase 3 | Active, not recruiting | January 31, 2019 | - |
NCT01599650 | Branch Retinal Vein Occlusion | Phase 3 | Completed | - | - |
NCT00410761 | - | Active, not recruiting | - | - | |
NCT01740297 | Melanoma | Phase 1 Phase 2 | Active, not recruiting | February 25, 2021 | - |
NCT00567879 | - | Terminated(The study was termi... 展开 >>nated early due to insufficient evidence of clinical benefit.) 收起 << | - | - | |
NCT00979134 | Cancer Advanc... 展开 >>ed Solid Malignancies 收起 << | Phase 1 | Completed | - | - |
NCT01740297 | - | Active, not recruiting | - | - | |
NCT00439517 | Previously Untreated Metastati... 展开 >>c Colorectal Cancer 收起 << | Phase 2 | Completed | - | - |
NCT00135577 | Cancer Bowel ... 展开 >>Dysfunction 收起 << | Phase 2 | Completed | - | - |
NCT00647101 | Glaucoma, Open-Angle ... 展开 >> Ocular Hypertension 收起 << | Phase 4 | Completed | - | - |
NCT00601367 | Sexual Dysfunctions, Psycholog... 展开 >>ical 收起 << | Phase 3 | Completed | - | - |
NCT02960022 | Prostate Cancer | Phase 2 | Recruiting | July 2021 | - |
NCT02314117 | - | Active, not recruiting | - | - | |
NCT02119676 | CRC (Colorectal Cancer) | Phase 2 | Terminated(Substudy 1 was term... 展开 >>inated for futility at interim analysis and Substudy 2 was terminated per sponsor decision.) 收起 << | - | - |
NCT01620255 | Ulcerative Colitis | Phase 2 | Completed | - | - |
NCT03104374 | Psoriatic Arthritis | Phase 3 | Recruiting | February 26, 2022 | - |
NCT02119676 | - | Terminated(Substudy 1 was term... 展开 >>inated for futility at interim analysis and Substudy 2 was terminated per sponsor decision.) 收起 << | - | - | |
NCT00291655 | Epilepsy | Phase 3 | Completed | - | Belgium ... 展开 >> Brugge, Belgium Edegem, Belgium Gent, Belgium Haine St Paul, Belgium Jette, Belgium Kortrijk, Belgium Leuven, Belgium Oostende, Belgium Bulgaria Sofia, Bulgaria Varna, Bulgaria Finland Hus (helsinki), Finland Kuopio, Finland Tampere, Finland France Blaye, France Bordeaux, France Brest, France Carcassonne, France Cherbourg, France Lille, France Lyon Cedex, France Nancy, France Rennes, France Saint Brieuc, France Saint Quentin, France TOULOUSE Cedex 04, France Valenciennes, France Poland Czestochowa, Poland Krakow, Poland Olstyn, Poland Poznan, Poland Warszawa, Poland Switzerland Biel, Switzerland Lausanne, Switzerland St Gallen, Switzerland Zurich, Switzerland 收起 << |
NCT01620255 | - | Completed | - | - | |
NCT00291655 | - | Completed | - | - | |
NCT00109707 | Chronic Myelogenous Leukemia ... 展开 >> Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Hypereosinophilic Syndrome Systemic Mastocytosis 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT00412893 | Aspergillosis ... 展开 >> Invasive Fungal Infection 收起 << | Phase 3 | Completed | - | - |
NCT01482884 | - | Completed | - | - | |
NCT00601367 | - | Completed | - | - | |
NCT01482884 | Ulcerative Colitis | Phase 2 | Completed | - | Czech Republic ... 展开 >> Research Site Ceske Budejovice, Czech Republic Research Site Hradec Kralove, Czech Republic Research Site Olomouc, Czech Republic Research Site Praha 1, Czech Republic Research Site Praha 5, Czech Republic Research Site Praha 7, Czech Republic France Research Site Amiens Cedex 1, France Research Site Caen, France Research Site Clichy, France Research Site Nice Cedex 3, France Research Site Pessac, France Research Site Rouen, France Research Site Vandoeuvre Les Nancy, France Germany Research Site Ludwigshafen, Germany Research Site Oelde, Germany Research Site Potsdam, Germany Research Site Wangen, Germany Italy Research Site Firenze, Italy Research Site Padova, Italy Research Site Roma, Italy Research Site Rozzano, Italy Poland Research Site Bydgoszcz, Poland Research Site Częstochowa, Poland Research Site Sopot, Poland Research Site Warszawa, Poland Research Site Łódź, Poland United Kingdom Research Site Cambridge, United Kingdom Research Site Coventry, United Kingdom Research Site Oxford, United Kingdom Research Site Shrewsbury, United Kingdom 收起 << |
NCT00412893 | - | Completed | - | - | |
NCT00439517 | - | Completed | - | - | |
NCT01122368 | Mycoses | Phase 2 | Completed | - | - |
NCT00638690 | Prostatic Neoplasms | Phase 3 | Completed | - | - |
NCT02222207 | Macular Degeneration | Phase 2 | Terminated | - | - |
NCT01850004 | Chronic Phase Chronic Myeloid ... 展开 >>Leukemia 收起 << | Phase 2 | Active, not recruiting | October 10, 2021 | United States, California ... 展开 >> City of Hope National Medical Center Duarte, California, United States, 91010 David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 Ucsf-Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Illinois Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 United States, New Jersey John Theurer Cancer Center, Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Herbert Irving Comprehensive Cancer Center-Columbia University Medical Center New York, New York, United States, 10032 United States, Texas Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas, Texas, United States, 75246 MD Anderson Cancer Center Clinic Houston, Texas, United States, 77030-4000 Canada, Ontario Local Institution Toronto, Ontario, Canada, M5G 2M9 France Local Institution Paris, France, 75010 Local Institution Pessac, France, 33604 Local Institution Pierre Benite Cedex, France, 69495 Local Institution Vandoeuvre-les-Nancy Cedex, France, 54511 Germany Local Institution Aachen, Germany, D-52074 Local Institution Berlin, Germany, 13353 Local Institution Mannheim, Germany, 68167 Local Institution Rostock, Germany, 18057 Local Institution Ulm, Germany, 89081 Italy Local Institution Catania, Italy, 95123 Local Institution Firenze, Italy, 50134 Local Institution Napoli, Italy, 80131 Local Institution Orbassano, Italy, 10043 Local Institution Roma, Italy, 00144 Local Institution Roma, Italy, 00161 Spain Local Institution Las Palmas de Gran Canaria, Spain, 35010 Local Institution Madrid, Spain, 28034 Local Institution Malaga, Spain, 29010 Local Institution Oviedo, Spain, 33011 收起 << |
NCT00105300 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT01850004 | - | Active, not recruiting | - | - | |
NCT00219557 | Pancreatic Neoplasms | Phase 2 | Completed | - | - |
NCT00058526 | Neoplasms, Breast | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Boca Raton, Florida, United States, 33428 United States, New York GSK Investigational Site Buffalo, New York, United States, 14263 United States, North Carolina GSK Investigational Site Charlotte, North Carolina, United States, 28203 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98195 Australia, Victoria GSK Investigational Site East Melbourne, Victoria, Australia, 3002 GSK Investigational Site Footscray, Victoria, Australia, 3011 GSK Investigational Site Heidelberg, Victoria, Australia, 3084 Belgium GSK Investigational Site Bruxelles, Belgium, 1000 GSK Investigational Site Bruxelles, Belgium, 1200 GSK Investigational Site Charleroi, Belgium, 6000 GSK Investigational Site Leuven, Belgium, 3000 France GSK Investigational Site Lyon Cedex 08, France, 69373 GSK Investigational Site Paris Cedex 5, France, 75248 GSK Investigational Site Saint-Herblain, France, 44805 Italy GSK Investigational Site Roma, Lazio, Italy, 00161 GSK Investigational Site Milano, Lombardia, Italy, 20141 GSK Investigational Site Perugia, Umbria, Italy, 06156 收起 << |
NCT00219557 | - | Completed | - | - | |
NCT00122317 | Paroxysmal Hemoglobinuria, Noc... 展开 >>turnal 收起 << | Phase 3 | Completed | - | - |
NCT00127478 | Prostate Cancer ... 展开 >> Adenocarcinoma 收起 << | Phase 2 Phase 3 | Completed | - | United States, California ... 展开 >> Prostate Oncology Specialists Marina Del Rey, California, United States, 32589 Western Clinical Research, Inc. Torrance, California, United States, 90505 United States, Florida South Florida Medical Research Aventura, Florida, United States, 33180 United States, New York Beth Isreal Medical Center, Phillips Ambulatory Care Ceneter New York, New York, United States, 10003 ViaHealth Rochester General Hospital Center for Urology Rochester, New York, United States, 14609 United States, Oregon Oregon Urology Specialist, Division of Clinical Research Springfield, Oregon, United States, 97477 United States, Pennsylvania University of Pittsburgh Department of Urology Pittsburgh, Pennsylvania, United States, 15232 Canada, Alberta Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia CroMedia Prime/Prime Trials Vancouver Hospital Vancouver, British Columbia, Canada, V5Z 1M9 Canada, Ontario Ken Janz MD Burlington, Ontario, Canada, 3V2CAN McMaster Institute of Urology Hamilton, Ontario, Canada, L8N 4A6 Canada, Quebec McGill University Health Center Royal VIctoria Hosptial Montreal, Quebec, Canada, H3A1A1 France Hoptial de Ranguell Service d'Urologie Toulouse, Cedex, France, 31043 Netherlands University Hospital Rotterdam, Department of Urology Rotterdam, Netherlands United Kingdom Leighton Hospital Urology Research Dept., Michael Heal Outpatients Dept. Crewe, United Kingdom, CW1 4QT 收起 << |
NCT00122317 | - | Completed | - | - | |
NCT00638690 | - | Completed | - | - | |
NCT00122304 | Hemoglobinuria, Paroxysmal | Phase 3 | Completed | - | - |
NCT02222207 | - | Terminated | - | - | |
NCT00175903 | Epilepsy | Phase 3 | Completed | - | - |
NCT00696657 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 2 | Completed | - | - |
NCT01885208 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00993382 | Arrhythmia Prophylaxis ... 展开 >> Ventricular Arrhythmia 收起 << | Phase 2 | Completed | - | - |
NCT00696657 | - | Completed | - | - | |
NCT01885208 | - | Completed | - | - | |
NCT00359424 | Stroke | Phase 3 | Terminated(NINDS/NIH-DSMB reco... 展开 >>mmended halting trial due to futility, no safety concerns.) 收起 << | - | - |
NCT03235544 | Lymphoma | Phase 2 | Recruiting | May 2021 | - |
NCT00626002 | Moderate to Severe Plaque Psor... 展开 >>iasis 收起 << | Phase 3 | Completed | - | - |
NCT01252160 | Neuralgia, Postherpetic | Phase 4 | Completed | - | - |
NCT00359424 | - | Terminated(NINDS/NIH-DSMB reco... 展开 >>mmended halting trial due to futility, no safety concerns.) 收起 << | - | - | |
NCT00141193 | Colorectal Adenoma | Phase 3 | Completed | - | - |
NCT00160667 | Neuralgia, Postherpetic | Phase 2 | Completed | - | - |
NCT00285012 | Smoking Cessation | Phase 3 | Completed | - | - |
NCT00285012 | - | Completed | - | - | |
NCT03025763 | - | Recruiting | June 2029 | United States, California ... 展开 >> The International Craniosynostosis Consortium at University of California at Davis Recruiting Davis, California, United States, 95616 United States, Connecticut Yale University Recruiting Hartford, Connecticut, United States, 06520 United States, Iowa National Birth Defects Prevention Study at University of Iowa Recruiting Iowa City, Iowa, United States, 52242 United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21218 United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 United States, New York Birth Defect Registries of New York State Recruiting Albany, New York, United States, 12237 Principal Investigator: Paul Romitti New York University Recruiting New York, New York, United States, 10016 Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Principal Investigator: Ethylin Jabs, MD United States, Pennsylvania Pennsylvania State Milton S. Hershey Medical Center Recruiting Hershey, Pennsylvania, United States, 17033 Pennsylvania State University Active, not recruiting University Park, Pennsylvania, United States, 16802 United States, Texas Univ. of Texas at Southwestern Recruiting Dallas, Texas, United States, 75390 France University of Bordeaux Active, not recruiting Talence, Aquitaine, France, 33405 INSERM/ Hospital Necker-Enfants Malades Recruiting Paris, Cedex 14, France, 75993 Germany University Hospital Heidelberg Recruiting Heidelberg, Germany, 69120 Spain Hospital Sant Joan de Deu Recruiting Barcelona, Esplugues De Llobregat, Spain, 08950 United Kingdom Oxford University Recruiting Oxford, Oxfordshire, United Kingdom, OX1 2JD 收起 << | |
NCT00110305 | Human Immunodeficiency Virus T... 展开 >>ype 1 收起 << | Phase 2 | Completed | - | - |
NCT00110305 | - | Completed | - | - | |
NCT00464633 | Leukemia, Lymphocytic, Chronic | Phase 2 | Completed | - | - |
NCT00259922 | Bowel Dysfunction ... 展开 >> Constipation 收起 << | Phase 3 | Completed | - | - |
NCT00435019 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00474045 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00258557 | HIV | Phase 3 | Completed | - | - |
NCT01145859 | Venous Thrombosis ... 展开 >> Pediatrics 收起 << | Phase 1 | Completed | - | - |
NCT00251927 | Gastroesophageal Reflux | Phase 3 | Completed | - | - |
NCT00603525 | Arthritis, Rheumatoid | Phase 3 | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - |
NCT00251927 | - | Completed | - | - | |
NCT03302234 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Recruiting | February 22, 2024 | - |
NCT00205777 | Osteoporosis | Phase 3 | Completed | - | - |
NCT00141323 | Osteoporosis | Phase 3 | Completed | - | - |
NCT00265135 | Carcinoma, Renal Cell | Phase 1 Phase 2 | Completed | - | Czech Republic ... 展开 >> Brno, Czech Republic Hradec Nad Svitavou, Czech Republic France Caen, France Lyon Cedex 08, France Montpellier Cedex 5 N/A, France Montpellier, France Villejuif N/A, France Netherlands Groningen, Netherlands Nijmegen, Netherlands Rotterdam, Netherlands United Kingdom Birmingham, United Kingdom Leeds, United Kingdom Manchester, United Kingdom Plymouth, United Kingdom 收起 << |
NCT00474045 | - | Completed | - | - | |
NCT00467740 | Asthma | Phase 2 | Completed | - | - |
NCT00435019 | - | Completed | - | - | |
NCT02992132 | Agitation and Aggression in Al... 展开 >>zheimer's Disease 收起 << | Phase 2 | Completed | - | - |
NCT00467740 | - | Completed | - | - | |
NCT00249730 | Impotence | Phase 4 | Completed | - | - |
NCT00696332 | ALS | Phase 2 | Completed | - | - |
NCT00603525 | - | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - | |
NCT01000506 | Asthma | Phase 2 | Completed | - | - |
NCT01000506 | - | Completed | - | - | |
NCT01776840 | Mantle Cell Lymphoma | Phase 3 | Active, not recruiting | October 12, 2021 | - |
NCT03118947 | Agitation and Aggression in Al... 展开 >>zheimer's Disease 收起 << | Phase 2 | Active, not recruiting | August 2019 | - |
NCT01802632 | - | Active, not recruiting | - | - | |
NCT01171404 | - | Completed | - | - | |
NCT01258738 | Spondylitis, Ankylosing | Phase 3 | Completed | - | - |
NCT01034969 | - | Recruiting | May 24, 2023 | - | |
NCT01802632 | Advanced Non Small Cell Lung C... 展开 >>ancer Advanced (Inoperable) Non Small Cell Lung Cancer 收起 << | Phase 1 Phase 2 | Active, not recruiting | December 31, 2019 | - |
NCT00343486 | Overactive Bladder | Phase 2 | Completed | - | - |
NCT00396786 | Venous Thromboembolism | Phase 2 | Completed | - | - |
NCT00143325 | Smoking Cessation | Phase 3 | Completed | - | United States, California ... 展开 >> Pfizer Investigational Site Palo Alto, California, United States Pfizer Investigational Site Santa Ana, California, United States United States, Connecticut Pfizer Investigational Site Farmington, Connecticut, United States United States, Kentucky Pfizer Investigational Site Lexington, Kentucky, United States United States, Massachusetts Pfizer Investigational Site Worcester, Massachusetts, United States United States, Oregon Pfizer Investigational Site Portland, Oregon, United States Belgium Pfizer Investigational Site Bruxelles, Belgium Pfizer Investigational Site Edegem, Belgium Pfizer Investigational Site Gent, Belgium France Pfizer Investigational Site Caen, France Pfizer Investigational Site Clermont-Ferrand, France Pfizer Investigational Site Limeil Brevannes, France Pfizer Investigational Site Limeil-Brevannes, France Pfizer Investigational Site Metz CEDEX 01, France Pfizer Investigational Site Metz Cedex 1, France Pfizer Investigational Site Paris, France Pfizer Investigational Site Vandoeuvre les Nancy, France Netherlands Pfizer Investigational Site Amsterdam, Netherlands Pfizer Investigational Site Enschede, Netherlands Pfizer Investigational Site Maastricht, Netherlands Pfizer Investigational Site Zutphen, Netherlands United Kingdom Pfizer Investigational Site London, Surrey, United Kingdom Pfizer Investigational Site London, United Kingdom Pfizer Investigational Site Nottingham, United Kingdom 收起 << |
NCT00205777 | - | Completed | - | - | |
NCT00443534 | Neoplasms | Not Applicable | Completed | - | - |
NCT03260894 | Renal Cell Carcinoma (RCC) | Phase 3 | Active, not recruiting | June 2020 | - |
NCT00395070 | Metastatic Melanoma | Phase 3 | Completed | - | - |
NCT03277690 | Endogenous Cushing's Syndrome | Phase 3 | Recruiting | June 30, 2019 | - |
NCT00443534 | - | Completed | - | - | |
NCT00044564 | Carcinoma, Renal Cell | Phase 2 | Completed | - | - |
NCT00843193 | Asthma | Phase 2 | Completed | - | - |
NCT00483756 | Kidney Transplantation | Phase 2 | Completed | - | - |
NCT01323244 | Hepatitis C | Phase 3 | Completed | - | - |
NCT03334630 | Paroxysmal Atrial Fibrillation... 展开 >> Atrial Fibrillation 收起 << | Not Applicable | Active, not recruiting | April 2020 | United States, Alabama ... 展开 >> Grandview Medical Center Birmingham, Alabama, United States, 35242 University Of Alabama Birmingham, Alabama, United States, 35294 United States, California Keck School Of Medicine Los Angeles, California, United States, 90033 Sequoia Hospital Redwood City, California, United States, 94062 United States, Florida Florida Hospital Orlando Orlando, Florida, United States, 32803 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Mississippi Jackson Heart Clinic Jackson, Mississippi, United States, 39216 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Montefiore Medical Center New York, New York, United States, 10467 United States, South Carolina Trident Medical Center Charleston, South Carolina, United States, 29406 Medical University Of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Texas Cardiac Arrhythmia Research Foundation Austin, Texas, United States, 78705 Houston Methodist Research Institute Houston, Texas, United States, 77030 Canada, Newmarket/Ontario Southlake Regional Medical Centre Toronto, Newmarket/Ontario, Canada, L3Y 2P9 Czechia Na Homolce Praha, Prague, Czechia, 15000 St Ann's University Hospital Brno, Czechia, 65691 Institut Klinicke a Experimentalni Mediciny (IKEM) Praha, Czechia, 14021 France Clinique Pasteur Toulouse, Cedex 3, France, 31076 Clinique du Tonkin Villeurbanne, Lyon, France, 69100 CHRU Nancy Nancy, France, 54511 Italy Centro Cardiologico Monzino Milan, Milano, Italy, 20138 Ospedale dell'Angelo di Mestre Mestre, Venezia, Italy, 30174 收起 << |
NCT01258738 | - | Completed | - | - | |
NCT00483756 | - | Completed | - | - | |
NCT00527735 | - | Completed | - | - | |
NCT00843193 | - | Completed | - | - | |
NCT00527735 | Lung Cancer S... 展开 >>mall Cell Lung Cancer Carcinoma, Non-Small-Cell Lung 收起 << | Phase 2 | Completed | - | - |
NCT00597584 | - | Completed | - | - | |
NCT00357669 | Unverricht-Lundborg Disease | Phase 3 | Completed | - | Finland ... 展开 >> Kuopio, Finland Tampere, Finland France Marseille, France Montpellier Cedex 5, France Italy Bologna, Italy Messina, Italy Milano, Italy Napoli, Italy Netherlands Heemstede, Netherlands Heeze, Netherlands Réunion St Pierre Cedex, Réunion Sweden Goteborg, Sweden Tunisia Tunis, Tunisia 收起 << |
NCT00389155 | Bladder Cancer ... 展开 >> Transitional Cell Carcinoma Metastasis 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT00597584 | Chronic Renal Failure ... 展开 >> Chronic Kidney Disease Anemia 收起 << | Phase 3 | Completed | - | - |
NCT00767520 | Breast Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> Compassionate Cancer Care Medical Group, Inc Fountain Valley, California, United States, 92708 Compassionate Cancer Care Medical Group Inc Riverside, California, United States, 92501 United States, Pennsylvania Pennsylvania Oncology/Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Czech Republic Local Institution Hradec Kralove, Czech Republic, 500 05 Local Institution Prague 5, Czech Republic, 150 06 France Local Institution Lille, France, 59000 Local Institution Paris Cedex 13, France, 75651 Local Institution Saint-Cloud Cedex, France, 92211 Ireland Local Institution Dublin, Ireland, 24 Poland Local Institution Gdansk, Poland, 80-462 Local Institution Gdansk, Poland, 80-952 Local Institution Lodz, Poland, 93-509 Local Institution Opole, Poland, 45-060 Spain Local Institution Madrid, Spain, 28033 Local Institution Madrid, Spain, 28041 Local Institution Torrevieja, Spain, 03186 Sweden Local Institution Vasteras, Sweden, 72189 United Kingdom Local Institution Chelmsford, Essex, United Kingdom, CM1 7ET Local Institution London, Greater London, United Kingdom, NW1 2BU Local Institution Coventry, Warwickshire, United Kingdom, CV22DX 收起 << |
NCT00514943 | Head and Neck Neoplasms ... 展开 >> Carcinoma, Squamous Cell 收起 << | Phase 2 | Completed | - | - |
NCT00574873 | Chronic Myeloid Leukemia | Phase 3 | Completed | - | - |
NCT00767520 | - | Completed | - | - | |
NCT00514943 | - | Completed | - | - | |
NCT02007629 | Hypertension, Pulmonary | Phase 3 | Completed | - | - |
NCT00753272 | Influenza | Phase 3 | Completed | - | - |
NCT00574873 | - | Completed | - | - | |
NCT01963598 | Sarcopenia | Phase 2 | Completed | - | - |
NCT00101985 | Irritable Colon | Phase 2 | Completed | - | - |
NCT00251914 | Gastrointestinal Disease ... 展开 >> Signs and Symptoms, Digestive Dyspepsia 收起 << | Phase 3 | Completed | - | - |
NCT00975286 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00245596 | Impotence | Phase 4 | Completed | - | France ... 展开 >> Pfizer Investigational Site Amphion-Les-Bains, France Pfizer Investigational Site Bordeaux, France Pfizer Investigational Site La Rochelle, France Pfizer Investigational Site Lille, France Pfizer Investigational Site Lyon Cedex 03, France Pfizer Investigational Site Lyon, France Pfizer Investigational Site PARIS Cedex 13, France Pfizer Investigational Site Paris, France Pfizer Investigational Site Saint-Emilion, France Pfizer Investigational Site Thionville, France Pfizer Investigational Site Toulouse, France 收起 << |
NCT00753272 | - | Completed | - | - | |
NCT00711009 | - | Completed | - | - | |
NCT01055496 | Lymphoma, B-Cell | Phase 1 | Completed | - | - |
NCT00784654 | ADHD | Phase 3 | Completed | - | - |
NCT00975286 | - | Completed | - | - | |
NCT00479505 | Urinary Bladder, Overactive | Phase 2 | Completed | - | - |
NCT03075215 | - | Recruiting | August 1, 2022 | - | |
NCT00251992 | Gastrointestinal Disease ... 展开 >> Signs and Symptoms, Digestive Dyspepsia 收起 << | Phase 3 | Completed | - | - |
NCT00711009 | Human Immunodeficiency Virus I... 展开 >>nfection 收起 << | Phase 3 | Completed | - | - |
NCT00252005 | Deep-Vein Thrombosis | Phase 2 | Completed | - | - |
NCT00239421 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 4 | Completed | - | - |
NCT00784654 | - | Completed | - | - | |
NCT00608023 | Lipodystrophy ... 展开 >> HIV Infections 收起 << | Phase 3 | Completed | - | - |
NCT00847379 | Duchenne Muscular Dystrophy ... 展开 >> Becker Muscular Dystrophy 收起 << | Phase 2 Phase 3 | Terminated | - | - |
NCT00600821 | Non-Small-Cell Lung Carcinoma ... 展开 >> Adenocarcinoma 收起 << | Phase 2 | Completed | - | - |
NCT00849875 | Melanoma | Phase 2 | Terminated(Early end of trial ... 展开 >>notification after termination of long term follow up due to lack of scientific justification to continue collect information.) 收起 << | - | Belgium ... 展开 >> GSK Investigational Site Brussels, Belgium, 1200 GSK Investigational Site Brussel, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1180 GSK Investigational Site Liège, Belgium, 4000 GSK Investigational Site Roeselare, Belgium, 8800 GSK Investigational Site Yvoir, Belgium, 5530 France GSK Investigational Site Caen, France, 14033 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Nantes, France, 44093 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Paris, France, 75018 GSK Investigational Site Reims, France, 51092 GSK Investigational Site Villejuif, France, 94805 收起 << |
NCT00558363 | - | Completed | - | - | |
NCT00849875 | - | Terminated(Early end of trial ... 展开 >>notification after termination of long term follow up due to lack of scientific justification to continue collect information.) 收起 << | - | - | |
NCT01665053 | Coronary Artery Disease | Phase 3 | Active, not recruiting | January 2019 | - |
NCT00600821 | - | Completed | - | - | |
NCT00658528 | Gastroesophageal Reflux Diseas... 展开 >>e (GERD) 收起 << | Phase 3 | Completed | - | - |
NCT01665053 | - | Active, not recruiting | - | - | |
NCT00658528 | - | Completed | - | - | |
NCT00558363 | Neoplasms, Prostate ... 展开 >> Prostate Cancer After a Radical Treatment 收起 << | Phase 2 | Completed | - | - |
NCT00061594 | Macular Degeneration | Phase 3 | Completed | - | - |
NCT00849667 | Ovarian Cancer | Phase 3 | Completed | - | - |
NCT00608023 | - | Completed | - | - | |
NCT00049764 | Sepsis | Phase 3 | Completed | - | - |
NCT01245062 | - | Completed | - | - | |
NCT00907296 | Fracture Healing | Phase 2 | Completed | - | - |
NCT00033904 | Renal Cell Carcinoma | Phase 3 | Completed | - | - |
NCT01084252 | Hematological Malignancy | Phase 1 Phase 2 | Active, not recruiting | March 2019 | - |
NCT01203917 | Caucasian Patients With EGFR M... 展开 >>utation Positive Advanced NSCLC 收起 << | Phase 4 | Completed | - | - |
NCT01203917 | - | Completed | - | - | |
NCT01098084 | Chronic Myelomonocytic Leukemi... 展开 >>a 收起 << | Phase 2 | Completed | - | France ... 展开 >> CHU de Bicêtre Le Kremlin-Bicêtre, Ile de France, France, 94275 CHU d'Amiens Amiens, France, 80054 CH Angers Angers, France, 49 000 Hôpital Avignon Avignon, France, 84000 Hopital de la Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 CHU Haut-Lévèque Bordeaux, France, 33604 Hôpital Boulogne Sur Mer Boulogne Sur Mer, France, 62321 Hopital d'Instruction des Armées Percy Clamart, France, 92140 CHU de Clermont Ferrand, France, 63058 Centre Hospitalier Sud-Francilien Corbeil-Essonnes, France, 91106 Hopital Henri Mondor Creteil, France, 94000 CHU de Dijon Dijon, France, 21034 Hôpital Versailles Le Chesnay, France, 78157 Centre Hospitalier du Mans Le Mans cedex, France, 72037 Institut Paoli Calmettes Marseille, France, 13009 CHU de nantes Nantes, France, 44093 Hôpital Archet1 Nice, France, 06202 CHU Caremeau Nimes, France, 30029 CHR La Source orléans Orléans, France, 45067 Hôpital Saint-Antoine. Paris-Cedex 12, France, 75571 Hopital Cochin Paris, France, 75014 Hopital Necker Paris, France, 75015 Hopital Hotel Dieu Paris, France, 75181 Hoiptal St Louis Paris, France, 75475 Centre Hospitalier Joffre Perpignan, France, 66046 CHU de Reims Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Hematology Dpt, Hopital Purpan Toulouse, France, 40031 CHU Bretoneau Tours, France, 37044 Institut gustave Roussy Villejuif, France, 94805 收起 << |
NCT01245062 | Melanoma | Phase 3 | Completed | - | - |
NCT01034995 | Major Depression | Phase 2 | Completed | - | - |
NCT00116831 | - | Completed | - | - | |
NCT00103844 | Chronic Myeloid Leukemia ... 展开 >> Philadelphia-Positive Myeloid Leukemia 收起 << | Phase 2 | Completed | - | - |
NCT00103844 | - | Completed | - | - | |
NCT00116831 | Atherosclerosis | Phase 3 | Completed | - | - |
NCT00137345 | Kidney Transplant | Phase 3 | Terminated | - | - |
NCT03622593 | Diabetic Macular Edema | Phase 3 | Recruiting | July 1, 2022 | - |
NCT03715153 | Autism Spectrum Disorder (ASD) | Phase 3 | Recruiting | April 2021 | - |
NCT01245140 | Psoriasis | Phase 2 | Completed | - | France ... 展开 >> GSK Investigational Site Paris Cedex 10, France, 75475 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80337 GSK Investigational Site Witten, Nordrhein-Westfalen, Germany, 58453 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Berlin, Germany, 10827 GSK Investigational Site Hamburg, Germany, 20354 Netherlands GSK Investigational Site Nijmegen, Netherlands, 6525 GA United Kingdom GSK Investigational Site London, United Kingdom, SE1 7EH 收起 << |
NCT01245140 | - | Completed | - | - | |
NCT02974725 | Non-Small Cell Lung Cancer ... 展开 >> Melanoma 收起 << | Phase 1 | Recruiting | June 29, 2020 | United States, Massachusetts ... 展开 >> Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02114 Contact: Bakhan Barzangy 617-726-1849 bbarzangy@mgh.harvard.edu Principal Investigator: Rebecca Heist Australia, Victoria Novartis Investigative Site Recruiting Melbourne, Victoria, Australia, 3000 Belgium Novartis Investigative Site Recruiting Leuven, Belgium, 3000 France Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Recruiting Frankfurt, Germany, 60590 Novartis Investigative Site Recruiting Koeln, Germany, 50937 Italy Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 收起 << |
NCT02813408 | - | Completed | - | Denmark ... 展开 >> Regionshospitalet i Holstebro Holstebro N/A, Denmark, 7500 Næstved Hospital Naestved, Denmark, 4700 Odense Universitetshospital Odense, Denmark, 5000 France Hopital Jean MINJOZ Besancon Cedex, France, 25030 Centre de Radiotherapie de Beuvry Beuvry, France, 62660 Chu Bordeaux. Bordeaux, France, 33000 Medipole De Savoie Challes-Les-Eaux, France, 73190 Cabinet d'Oncologie Médicale Chalon Sur Saône, France, 71100 Centre d'oncologie et de radiothérapie du Parc Dijon, France, 21000 Hopital Prive Jean Mermoz Lyon, France, 69008 Clinique de la Sauvegarde Lyon, France, 69009 APHM Hopital Timone Marseille, France, 13005 Groupe Hospitalier Diaconesses Croix Saint Simon Paris, France, 75012 Centre Hopitalier Inter-Communal De Cornouaille Quimper, France, 29107 HIA Begin Saint Mande, France, 94163 Polyclinique Ste Anne Strasbourg, France, 67000 Clinique Saint Jean Languedoc Toulouse, France, 31400 United Kingdom Frimley Health NHS Foundation Trust Berkshire, United Kingdom, SL2 4HL Birmingham Heartlands Hospital Birmingham, United Kingdom, B9 5SS Royal Bolton NHS Foundation Trust Bolton, United Kingdom, BL4 OJR Derby City Hospital Derby, United Kingdom, DE22 3DT The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom Royal Lancaster Infirmary Lancaster, United Kingdom, LA1 4RP James Cook University Hospital Middlesbrough, United Kingdom, TS3 4BW The Royal Oldham Hospital Oldham, United Kingdom, OL1 2JH Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT New Cross Hospital Wolverhampton., United Kingdom, WV10 0QP 收起 << | |
NCT03420742 | Carcinoma, Advanced ALK+ or RO... 展开 >>S1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid Tumors 收起 << | Phase 1 | Not yet recruiting | August 18, 2020 | France ... 展开 >> Groupe Hospitalier Bichat-Claude Bernard - Hopital Bichat Not yet recruiting Paris, Ile-de-france, France, 75018 Hopital de la Timone Not yet recruiting Marseille Cedex 5, Provence Alpes COTE D'azur, France, 13385 Hopital de la Timone Not yet recruiting Marseille, Provence Alpes COTE D'azur, France, 13005 Italy Centro di Riferimento Oncologico di Aviano Not yet recruiting Aviano, Pordenone, Italy, 33081 Policlinico Sant'Orsola Malpighi Not yet recruiting Bologna, Italy, 40138 Ospedale San Raffaele Not yet recruiting Milano, Italy, 20132 Istituto Europeo di Oncologia Not yet recruiting Milano, Italy, 20141 Azienda Ospedaliero Universitaria di Parma Not yet recruiting Parma, Italy, 43126 Ospedale "degli Infermi" di Faenza Not yet recruiting Ravenna, Italy, 48121 Netherlands Netherlands Cancer Institute Not yet recruiting Amsterdam, Noord-holland, Netherlands, 1006 CX Spain Hospital Universitario Dexeus, Not yet recruiting Barakaldo, Vizcaya, Spain, 48903 Hospital Universitario Dexeus Not yet recruiting Barcelona, Spain, 08028 Hospital Universitari Vall d'Hebron Not yet recruiting Barcelona, Spain, 08035 Hospital Universitario Ramon Y Cajal Not yet recruiting Madrid, Spain, 28034 Hospital Universitario Fundacion Jimenez Diaz Not yet recruiting Madrid, Spain, 28040 HM Centro Integral Oncologico Clara Campal Not yet recruiting Madrid, Spain, 28050 收起 << |
NCT02370706 | Myelofibrosis | Phase 1 | Active, not recruiting | December 31, 2018 | Australia, Melbourne ... 展开 >> Novartis Investigative Site VIC, Melbourne, Australia, 3004 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Singapore Novartis Investigative Site Singapore, Singapore, 119228 United Kingdom Novartis Investigative Site London, United Kingdom, SE1 9RT 收起 << |
NCT00133224 | Prostate Cancer | Phase 3 | Terminated(Accrual and treatme... 展开 >>nt with CG1940/CG8711 stopped due to IDMC recommendation.) 收起 << | June 2009 | - |
NCT00639496 | Pulmonary Fibrosis | Phase 3 | Completed | - | Belgium ... 展开 >> U.Z. Ghent Gent, Belgium, B- 9000 France Hôpital A. Calmette Lille Cedex, France, F 59037 Germany Klinikum Grosshadern Munich, Germany, 81377 Italy U.O. di Pneumologia-Ospedale Arezzo, Italy, 52100 Netherlands Stichting St. Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Spain Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 United Kingdom The University of Edinburgh-Medical School Edinburgh, United Kingdom, EH8 9AG 收起 << |
NCT00235300 | Cadaveric Donor Renal Transpla... 展开 >>ntation Acute Renal Allograft Rejection Induction Therapy 收起 << | Phase 2 | Completed | - | - |
NCT00492297 | Melanoma | Phase 2 | Completed | - | France ... 展开 >> Bordeaux, France, 33000 Lyon Cedex, France, 39373 Toulouse, France, 31052 Villejuif, France, 94805 United Kingdom Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Southampton, Hampshire, United Kingdom, SO16 6YD Northwood, Middlesex, United Kingdom, HA6 2RN Sutton, Surrey, United Kingdom, SM2 5PT London, United Kingdom, NW3 2QG London, United Kingdom, SE1 7EH London, United Kingdom, SW3 6JJ Manchester, United Kingdom, M20 4BX 收起 << |
NCT01525290 | Stroke | Phase 3 | Completed | - | Belgium ... 展开 >> Katholieke Universitet Leuven Leuven, Belgium, 3000 Denmark Aarhus Universitetshospital, Aahrhus Sygehus Aarhus, Denmark, 8000 France Hospices Civils de Lyon Bron Cedex, France, 69677 Germany Charite - Universitätsmedizin Berlin Berlin, Germany, 10117 University Medical Center Hamburg-Eppendorf Hamburg, Germany, 20246 Spain Institut d'Investigacio Biomedica de Girona Doctor Josep Trueta Girona, Spain, 17007 United Kingdom University of Glasgow Glasgow, United Kingdom, G12 8QQ 收起 << |
NCT02088684 | Breast Cancer | Phase 1 Phase 2 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham/ Kirklin Clinic Dept Onc Birmingham, Alabama, United States, 35294-0006 United States, Massachusetts Dana Farber Cancer Institute Onc. Dept. Boston, Massachusetts, United States, 02215 United States, Tennessee Sarah Cannon Research Institute Onc Dept Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Lyon Cedex, France, 69373 Italy Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Modena, MO, Italy, 41124 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Madrid, Spain, 28050 Taiwan Novartis Investigative Site Taipei, Taiwan ROC, Taiwan, 10041 United Kingdom Novartis Investigative Site Leicester, United Kingdom, LE1 5WW 收起 << |
NCT02554708 | - | Recruiting | December 2018 | Argentina ... 展开 >> Clínica La Sagrada Familia Department of Neuroscience (P.L.), Equipo de Neurocirugía Endovascular y Radiología Intervencionista Recruiting Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina, 1642 Contact: Pedro Lylyk, Prof. Dr. Austria LKH-Univ. Klinikum Graz Universitätsklinik für Radiologie Recruiting Graz, Austria, 8036 Contact: Hannes Deutschmann, Prof. Dr. Christian Doppler Klinik Universitätsklinik für Neurologie der Paracelsus Medizinischen Privatuniversität Not yet recruiting Salzburg, Austria, 5020 Contact: Monika Killer-Oberpfalzer, Prof. Dr. France Hôpital Pierre Wertheimer (HCL Groupement Hospitalier Est) Recruiting Bron cedex, France, 69500 Contact: Francis Turjman, Prof. Dr. Hôpital Gui de Chauliac (CHRU de Montpellier) Recruiting Montpellier, France, 34295 Contact: Alain Bonafé, Prof. Dr. Germany KRH Klinikum Nordstadt Recruiting Hannover, Niedersachsen, Germany, 30167 Contact: Jörg Hattingen, Dr. Vivantes Klinikum Neukölln Recruiting Berlin, Germany, 12351 Contact: Annette Förschler, Dr. Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH Active, not recruiting Bochum, Germany, 44892 Universitätsklinikum Freiburg Active, not recruiting Freiburg, Germany, 79106 Universitätsklinikum Heidelberg Active, not recruiting Heidelberg, Germany, 69120 UKSH Universitätsklinikum Schleswig-Holstein Campus Kiel Not yet recruiting Kiel, Germany, 24105 Contact: Olav Jansen, Prof. Dr. Gemeinschaftsklinikum Mittelrhein gGmbH Recruiting Koblenz, Germany, 56068 Contact: Stephan Felber, Prof. Dr. UKSH Universitätsklinikum Schleswig-Holstein Campus Lübeck Not yet recruiting Lübeck, Germany, 23538 Contact: Peter Schramm, Prof. Dr. Klinikum Osnabrück Recruiting Osnabrück, Germany, 49076 Contact: Stephan Lowens, Dr. Knappschaftskrankenhaus Recklinghausen Recruiting Recklinghausen, Germany, 45657 Contact: Christian Loehr, Dr. Klinikum Stuttgart Katharinenhospital Recruiting Stuttgart, Germany, 70174 Contact: Marta Aguilar-Pérez, Dr. Italy A.O.U. Policlinico G. Martino Active, not recruiting Messina, Italy, 98125 A.S.L. Napoli 1 Centro - P.O. San Giovanni Bosco Active, not recruiting Napoli, Italy, 80145 ULSS9 Ca' Foncello Not yet recruiting Treviso, Italy, 31100 Contact: Francesco Di Paola, Dr. United Kingdom University Hospitals Birmingham NHS Foundation Trust Not yet recruiting Birmingham, United Kingdom, B15 2TH Contact: Lamin, Dr. Leeds Teaching Hospital NHS TRUST. Not yet recruiting Leeds, United Kingdom, LS1 3EX Contact: Anthony Goddard, Dr. James Cook University Hospital Not yet recruiting Middlesbrough, United Kingdom, TS4 3BW Contact: Rajeev Padmanabhan, Dr. 收起 << | |
NCT02375958 | Triple Negative Breast Cancer,... 展开 >> Head & Neck Cancer, Esophageal Cancer 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> Novartis Investigative Site Houston, Texas, United States, 77030 Novartis Investigative Site San Antonio, Texas, United States, 78229 France Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Japan Novartis Investigative Site Koto-ku, Tokyo, Japan, 135 8550 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Madrid, Spain, 28007 收起 << |
NCT00756509 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 4 | Active, not recruiting | December 31, 2019 | Finland ... 展开 >> Novartis Investigative Site HUS, Finland, FIN-00029 France Novartis Investigative Site Lyon Cedex, France, 69373 Germany Novartis Investigative Site Bad Saarow, Germany, 15526 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Muenchen, Germany, 81377 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Spain Novartis Investigative Site Hospitalet de LLobregat, Cataluña, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46009 Novartis Investigative Site Palma De Mallorca, Islas Baleares, Spain, 07120 收起 << |
NCT02090556 | - | Active, not recruiting | December 31, 2019 | Australia, Victoria ... 展开 >> Local Institution Geelong, Victoria, Australia, 3220 Austria Local Institution Wien, Austria, A-1130 France Local Institution Lille Cedex, France, 59037 Germany Local Institution Dresden, Germany, D-01067 Greece Local Institution Crete, Greece, 71110 Italy Local Institution Pavia, Italy, 27100 Monaco Local Institution Monaco, Monaco, 98012 Netherlands Local Institution Amsterdam, Netherlands, 1056 AB Spain Local Institution Barcelona, Spain, 08036 Switzerland Local Institution Diessenhofen, Switzerland, 8253 United Kingdom Local Institution Hull, Yorkshire, United Kingdom, HU3 2JZ Local Institution Cambridgeshire, United Kingdom, CB2 2QQ 收起 << | |
NCT00492297 | - | Completed | - | - | |
NCT01433445 | Idiopathic Myelofibrosis ... 展开 >> Post Essential Thrombocythemia Myelofibrosis Post Polycythemia-Vera Myelofibrosis 收起 << | Phase 1 | Active, not recruiting | December 31, 2018 | France ... 展开 >> Novartis Investigative Site Paris, France, 75010 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Magdeburg, Germany, 39120 Novartis Investigative Site Mainz, Germany, 55131 Ireland Novartis Investigative Site Dublin, Ireland, DUBLIN 8 Novartis Investigative Site Galway, Ireland Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Reggio Calabria, RC, Italy, 89124 Novartis Investigative Site Varese, VA, Italy, 21100 United Kingdom Novartis Investigative Site London, United Kingdom, SE1 9RT 收起 << |
NCT03101280 | Gynecologic Neoplasms | Phase 1 | Recruiting | January 30, 2019 | Australia, Victoria ... 展开 >> Peter Maccallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 3000 France Centre Leon Berard Recruiting Lyon, France, 69008 Gustave Roussy Recruiting Villejuif CEDEX, France, 94800 Spain Clínica Universidad de Navarra Recruiting Pamplona, Navarra, Spain, 31620 Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain, 08035 La Paz University Hospital Recruiting Madrid, Spain United Kingdom Royal Marsden Hospital - London Recruiting London, United Kingdom, SW3 6JJ University College London Hospitals NHS Foundation Trust - University College Hospital Recruiting London, United Kingdom, WC1E 6AU Lancashire Teaching Hospitals NHS Foundation Trust Not yet recruiting Preston, United Kingdom, PR2 9HT Royal Marsden NHS Foundation Trust Recruiting Sutton, United Kingdom, SM2 5PT 收起 << |
NCT02143635 | Advanced Solid and Hematologic... 展开 >>al TP53wt Tumors 收起 << | Phase 1 | Active, not recruiting | July 23, 2019 | United States, Massachusetts ... 展开 >> Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, New York Novartis Investigative Site New York, New York, United States, 10017 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Paris, France, 75010 Germany Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Wuerzburg, Germany, 97080 Japan Novartis Investigative Site Kobe-shi, Hyogo, Japan, 650-0017 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Novartis Investigative Site Utrecht, Netherlands, 3584CX Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Taiwan Novartis Investigative Site Taipei, Taiwan ROC, Taiwan, 10041 收起 << |
NCT01100034 | - | Completed | - | France ... 展开 >> Centre Hospitalier Victor Dupouy / Service de Dermatologie Argenteuil Cedex, France, 95107 Hopital Trousseau, Service de Dermatologie Chambray-lès-Tours, France, 37170 CHU de Nantes - Hôtel Dieu Nantes, France, 44093 Service de Dermatologie Quimper, France, 29107 Germany Klinik fuer Dermatologie, Allergologie und Venerologie Berlin, Germany, 10117 Universitatsklinikum der TU Dresden Carl Gustav CarusKlinik Dresden, Germany, 01307 Universitätsklinikum Hartmmannstrasse 14 Erlangen 91052 Erlangen, Germany, 91052 Universitätsklinikum Hufelandstr. 55 Essen 45147 Essen, Germany, 45122 J W Goethe Universitaet Frankfurt Frankfurt am Main, Germany, 60590 Kath. Kinderkrankenhaus Wilhelmstift Hamburg, Germany, 22149 Universitaetsklinik Koeln Köln, Germany, 50937 Kinderklinik der Johannes-Gutenberg Universitat Mainz Mainz, Germany, 55101 Asklepios Klinik Sankt Augustin GmbH Sankt Augustin, Germany, 53757 Greece University of Athens Andreas Syngros Hospital Athens, Greece Athens, Greece, 16121 Hospital for Skin and Venereal Diseases Thessaloniki, Greece, 54644 Hungary Heim Pal Children's Hospital Budapest, Hungary, 1089 Italy Universita degli Studi di Napoli Napoli, Italy, 80131 University of Padova Padova, Italy, 35128 U.O. di Dermatologia ARNAS Palermo, Italy, 90100 Cattedra Policlinico Gemelli Roma, Italy, 00168 Ospedale Alfredo Fiorini Terracina, Italy, 04019 Netherlands UMC St Radbound Nijmegen, Netherlands, 6500 HB Erasmus MC Rotterdam, Netherlands, 3000 CA Portugal Hospital Santa Maria Lisboa, Portugal, 1649-028 Spain Hospital de la Santa Cruz y San Pablo Barcelona, Spain, 08025 Hospital Parc Tauli Barcelona, Spain, 08208 Hospital La Paz Madrid, Spain, 28046 收起 << | |
NCT02535884 | Huntington Disease | Not Applicable | Recruiting | October 31, 2020 | Austria ... 展开 >> Medizinische Universität Innsbruck Recruiting Innsbruck, Austria, 6020 Contact: Klaus Seppi, Prof Dr + 43 (0)512 504-25810 klaus.seppi@tirol-kliniken.at Contact: Marina Peball, Dr. +43 512 504/82718 marina.peball@tirol-kliniken.at France CHU Amiens Hôpital nord, Department of neurosurgery and Department of neurology Recruiting Amiens, France, 80054 Contact: Pierre Krystkowiak, Prof +33322668240 krystkowiak.pierre@chu-amiens.fr Contact: Michel Lefranc, Dr Lefranc.Michel@chu-amiens.fr Hôpital Roger Salengro, Service de Neurologie et Pathologie du mouvement Recruiting Lille Cedex, France, 59037 Contact: Clemence Simonin, Dr. +33 3.20.44.67.52 clemence.simonin@chru-lille.fr Contact: Eric Decorte +33 03.20.44.59.62 eric.decorte@chru-lille.fr Germany Charité Campus Virchow Klinikum Recruiting Berlin, Germany, 13353 Contact: Andrea Kühn, Prof Dr 030 450 660203 andrea.kuehn@charite.de Contact: Mandy Schickor +49 (0)30 450 660 478 Mandy.Schickor@charite.de University hospital Heinrich Heine University Düsseldorf Recruiting Düsseldorf, Germany, 40225 Contact: Jan Vesper, Prof Dr +49 211 81 18408 jan.vesper@med.uni-duesseldorf.de Contact: Alfons Schnitzler, Prof Dr +49 211 81 17893 Schnitza@med.uni-duesseldorf.de Principal Investigator: Lars Wojtecki, Dr. University Hospital Freiburg Recruiting Freiburg, Germany, 79106 Contact: Volker Coenen, Prof Dr +4976127050630 volker.coenen@uniklinik-freiburg.de Contact: Eva Maria Wissner +49 761 270-50670 eva-maria.wissner@uniklinik-freiburg.de University Hospital Schleswig-Holstein Recruiting Kiel, Germany, 24105 Contact: Karsten Witt, Dr 0431 500 23810 Steffen.Paschen@uksh.de Contact: Birte Hackelberg 0431-597 8519 birte.hackelberg@uksh.de Universität zu Lübeck Recruiting Lubeck Hansestadt, Germany, 23562 Contact: Alexander Münchau, Prof Dr. 0451 31018215 alexander.muenchau@neuro.uni-luebeck.de Contact: Vera Tadic 0451 31018214 vera.tadic@neuro.uni-luebeck.de University hospital Munich LMU Recruiting Munich, Germany, 80336 Contact: Jan Mehrkens, Dr 08970952698 jan.mehrkens@med.uni-muenchen.de Contact: Kai Bötzel, PD Dr 089 7095 3673 Kai.Boetzel@med.uni-muenchen.de kbo-Isar-Amper-Clinic Taufkirchen Recruiting Taufkirchen, Germany, 84416 Contact: Ralf Marquard, Prof Dr 08084 934 495 Ralf.Marquard@kbo.de Contact: Erna Jobst 08084 934-307 erna.jobst@kbo.de Switzerland Center for Neurology Recruiting Bern, Gümlingen, Switzerland, 3073 Contact: Jean Marc Burgunder, Prof Dr +41 031 352 20 70 jean-marc.burgunder@dkf.unibe.ch Contact: Michael Schüpbach +41 316322168 wmms@bluewin.ch Inselspital, Department of Neurology Recruiting Bern, Switzerland, 3010 Contact: Michael Schüpbach, PD Dr +41 31 623 32 44 wmms@bluewin.ch Contact: Jean Marc Brugunder, Prof Dr. +41 031 352 20 70 jmburgunder@bluewin.ch 收起 << |
NCT01756456 | Neurotrophic Keratitis ... 展开 >> Keratitis Corneal Ulcer 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> CHU de Dijon - Service ophtalmologie Dijon, France, 21000 CHU Dupuytren - Service Ophtalmologie Limoges Cedex, France, 87042 Centre Hospitalier National d'Ophtalmologie - Service d'ophtalmologie Paris, France, 75 571 "Fondation Ophtalmologique Adolphe de Rothschild - "Unité de Recherche Clinique Paris, France, 75019 "CHU Toulouse-Purpan - Service Ophtalmologie Toulouse, France, 31059 Germany University Eye Clinic in Duesseldorf Duesseldorf, Germany, 50924 Universitätsklinikum Erlangen Erlangen, Germany, 91054 Universitäts-Augenklinik Freiburg Freiburg, Germany, 79106 Universität zu Köln - Zentrum für Augenheilkunde am Universitätsklinikum Köln Köln, Germany, 50924 Johannes-Gutenberg-Universität Augenklinik und Poliklinik - Department of Ophthalmology Mainz, Germany, 55131 Klinikum der Universität München - Augenklinik der Ludwig-Maximilians-Universtiät München Munchen, Germany, 80336 Italy OSPEDALE SAN RAFFAELE di Milano Milan, Lombardy, Italy, 20132 Università G. D' Annunzio - Clinica Oftalmologica - Centro regionale di Eccellenza in Oftalmologia Chieti, Italy, 66100 Azienda Ospedaliero Universitaria Careggi Florence, Italy, 50124 Dipartimento di Scienze Neurologiche Oftalmologia e Genetica - Universtità di Genova Genoa, Italy, 16132 Azienda Ospedaliero Universitaria di Messina - Dipartimento Specialità Chirurgiche Ambulatorio Studio delle Malattie dela Superficie Oculare Unità Operativa Complessa di Oftalmologia Messina, Italy, 98125 Azienda Ospedaliera San Paolo - U.O. Oculistica Milano, Italy, 20142 Azienda ospedaliera di Padova - Clinica Oculistica Policlinico 7° Piano Padova, Italy, 35128 Università Campus Bio-Medico di Roma Rome, Italy, 00128 Policlinico Umberto I Rome, Italy, 00161 Poland District Railway Hospital Katowice - Department of Ophthalmology Katowice, Poland, 40-760 "SPKSO Szpital Okulistyczny ul. - SPKSO Szpital Okulistyczny Warsawa, Poland, 03-709 Spain Vissum Corporación Oftalmológica de Alicante Alicante, Spain, 03016 Hospital de Cruces - Oftalmología Barakaldo, Spain, 48903 Barraquer Eye center Barcelona, Spain, 08021 Hospital Clinic de Barcelona - Oftalmología Barcelona, Spain, 08028 Hospital Clínico San Carlos - Oftalmología. Unidad de Superficie Ocular Madrid, Spain, 28040 Instituto Oftalmológico Fernández-Vega - Oftalmología Oviedo, Asturias, Spain, 33012 Cartuja Visión - Oftalmología Sevilla, Spain, 41092 United Kingdom University of Birmingham - Academic Unit of Ophthalmology, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham Birmingham, United Kingdom, "B15 2TT Moorfields Eye Hospital - Moorfields Eye Hospital London, United Kingdom, EC1V 2PD Manchester Royal Eye Hospital - Manchester Royal Eye Hospital Manchester, United Kingdom, M13 9WL Royal Victoria Infirmary - Dept. of Ophthalmology Newcastle upon Tyne, United Kingdom, NE1 4LP University of Southampton Southampton General Hospital - MP104, Eye Unit Southampton, United Kingdom, SO16 6YD 收起 << |
NCT01285583 | Amyotrophic Lateral Sclerosis | Phase 2 Phase 3 | Completed | - | Belgium ... 展开 >> University Hospital Gasthuisberg - Dept Neurology - Herestraat 49 Leuven, Belgium, 3000 France HCL Hôpital Neurologique et Neurochirurgical Pierre Wertheimer - Neurologie C et Laboratoire d'électromyographie - 59, boulevard Pinel Bron Cedex, France, 69677 CHRU de LILLE - Hôpital Roger Salengro - Centre SLA-MMN - Sce de Neurologie et Pathologie du Mouvement Lille, France, 59037 Centre SLA Limoges - Service de Neurologie Limoges, France, 87042 Hôpital La Timone - Service Neurologie et Maladies Neuromusculaires Marseille, France, 13005 Clinique du Motoneurone - Sce d'Explorations Neurologiques - Hôpital Gui de Chauliac Montpellier, France, 34295 CHU de Nice - Hôpital de l'Archet 1 - Centre de Référence pour les Maladies Neuromusculaires et la SLA Nice, France, 06202 Groupe Hospitalier PITIE-SALPETRIERE - Fédération des Maladies du Système Nerveux Paris, France, 75013 Germany Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Neurologische Poliklinik Ambulanz für ALS und andere Motoeneuronenerkrankungen Berlin, Germany, 13353 Universitätsklinik und Poliklinik für Neurologie - Martin-Luther-Universität Halle-Wittenberg Halle, Germany, 06097 Neurologische Klinik Medizinische Hochschule Hannover, Germany, D-30623 Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik Ulm, Germany, 89081 Spain Hospital Carlos III - Unidad de ELA - Sinesio Delgado, 10 Madrid, Spain, 28029 United Kingdom King's MND Care and Research Center - Academic Neurosciences Building PO Box 41 Institute of Psychiatry London, United Kingdom, SE58AF Academic Neurology Unit - University of Sheffield - Section of Neuroscience - Division of Genomic Medicine - School of Medicine and Biomedical Sciences Sheffield, United Kingdom, S10 2RX 收起 << |
NCT00868166 | Amyotrophic Lateral Sclerosis | Phase 2 Phase 3 | Completed | - | Belgium ... 展开 >> University Hospital Gasthuisberg - Dept Neurology - Herestraat 49 Leuven, Belgium, 3000 France HCL Hôpital Neurologique et Neurochirurgical Pierre Wertheimer - Neurologie C et Laboratoire d'électromyographie - 59, boulevard Pinel Bron Cedex, France, 69677 CHRU de LILLE - Hôpital Roger Salengro - Centre SLA-MMN - Sce de Neurologie et Pathologie du Mouvement Lille, France, 59037 Centre SLA Limoges - Service de Neurologie Limoges, France, 87042 Hôpital La Timone - Service Neurologie et Maladies Neuromusculaires Marseille, France, 13005 Clinique du Motoneurone - Sce d'Explorations Neurologiques - Hôpital Gui de Chauliac Montpellier, France, 34295 CHU de Nice - Hôpital de l'Archet 1 - Centre de Référence pour les Maladies Neuromusculaires et la SLA Nice, France, 06202 Groupe Hospitalier PITIE-SALPETRIERE - Fédération des Maladies du Système Nerveux Paris, France, 75013 Germany Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Neurologische Poliklinik Ambulanz für ALS und andere Motoeneuronenerkrankungen Berlin, Germany, 13353 Universitätsklinik und Poliklinik für Neurologie - Martin-Luther-Universität Halle-Wittenberg Halle, Germany, 06097 Neurologische Klinik Medizinische Hochschule Hannover, Germany, D-30623 Universitäts- und Rehabilitationskliniken Ulm (RKU) - Neurologische Universitätsklinik Ulm, Germany, 89081 Spain Hospital Carlos III - Unidad de ELA - Sinesio Delgado, 10 Madrid, Spain, 28029 United Kingdom King's MND Care and Research Center - Academic Neurosciences Building PO Box 41 Institute of Psychiatry London, United Kingdom, SE58AF Academic Neurology Unit - University of Sheffield - Section of Neuroscience - Division of Genomic Medicine - School of Medicine and Biomedical Sciences Sheffield, United Kingdom, S10 2RX 收起 << |
NCT01371331 | Kidney Transplantation ... 展开 >> Heart Transplantation Liver Transplantation 收起 << | Phase 4 | Completed | - | Belgium ... 展开 >> Site 40 Brussels, Belgium, 1200 France Site: 60 Bron Cedex, France, 69677 Germany Site 31 Hannover, Germany, 30625 Site 30 Heidelberg, Germany, 69120 Poland Site 50 Warsaw, Poland, 04-730 Spain Site 22 Madrid, Spain, 28007 Site 20 Madrid, Spain, 28046 Site 21 Madrid, Spain, 28046 United Kingdom Site 10 Birmingham, United Kingdom, B4 6NH Site 13 Manchester, United Kingdom, M13 9WL 收起 << |
NCT00983151 | Premature Ejaculation | Phase 3 | Terminated | - | - |
NCT02493946 | Glabellar Lines | Phase 3 | Completed | - | France ... 展开 >> Centre Médical Saint-Jean Arras, France, 62000 CHRU Hôpital Besançon cedex, France, 25000 Cabinet Médical Cannes, France, 06400 MEDITI/ Clinique Science et Beauté, Villa Sylvana Juan les Pins, France, 06160 Palais de Flore Lyon, France, 69006 Clinique Iéna Paris, France, 75116 Germany Dermatologisches Studienzentrum Berlin, Germany Privatpraxis für Dermatologie und ästhetische Medizin Berlin, Germany Klinik Darmstadt, Germany Rosenpark Research Darmstadt, Germany Medical Skin Center Düsseldorf, Germany Klinik für Dermatologie Frankfurt, Germany Abteilung Biochemie und Molekularbiologie Fachrichtung Kosmetikwissenschaft Kassel, Germany Rote Kreuz Krankenhaus Kassel, Germany Klinik Ludwigshafen, Germany Hautarztpraxis Mahlow Mahlow, Germany Universitäts-Hautklinik der Gutenberg Universität Mainz Mainz, Germany Privatpraxis für Dermatologie und Ästhetik München, Germany Praxisklinik Münster, Germany Klinische Forschung Osnabrück Osnabrück, Germany Hautzentrum am Starnberger See Starnberg, Germany Praxis für Dermatologie und Venerologie Wuppertal, Germany United Kingdom London Bridge Plastic Surgery London, United Kingdom PHI clinic London, United Kingdom 收起 << |
NCT02343172 | Liposarcoma | Phase 1 Phase 2 | Active, not recruiting | December 19, 2018 | Canada, Ontario ... 展开 >> Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Bordeaux, France, 33076 Novartis Investigative Site Lyon Cedex, France, 69373 Germany Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Ulm, Germany, 89081 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Madrid, Spain, 28222 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 收起 << |
NCT01910298 | Mastectomy and Breast Reconstr... 展开 >>uction 收起 << | Not Applicable | Terminated(The study is being ... 展开 >>terminated due to no enrollment in over one year in the control arm) 收起 << | September 2017 | France ... 展开 >> Institut Bergonie Bordeaux, France, 33076 Centre Oscar Lambret Lille Cedex, France, 59000 ICM Val d'Aurelle Montpellier, France, 34298 L'Institut du Sein- Paris Breast Center Paris, France, 75116 Hopital Tenon APHP Paris, France Germany Universitätsklinikum Erlangen Erlangen, Germany, 91054 Brustzentrum klinikum, Kliniken Essen-Mitte, Essen, Germany, 45131 Universitätsklinikum Freiburg Freiburg, Germany, 79106 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitäts-Frauenklinik Heidelberg Heidelberg, Germany, 69115 Klinik der Universität München, Campus Innenstadt Munich, Germany, 80337 Klinikum rechts der Isar Munich, Germany, 81675 Asklepios Paulinen Klinik Wiesbaden, Germany, 65197 United Kingdom St Luke's hospital / Bradford Royal Infirmary (BRI) Bradford, United Kingdom, BD5 0NA Dorset County Hospital Dorchester, United Kingdom, DT1 2JY Frimley Park Hospital Frimley, United Kingdom, GU16 7UJ City Hospital Nottingham, United Kingdom, NG5 1PB Wythenshawe Hospital UHSM NHS Foundation Trust Wythenshawe Manchester, United Kingdom, M23 9LT 收起 << |
NCT02908750 | Non Small Cell Lung Cancer | Phase 1 | Active, not recruiting | March 13, 2019 | France ... 展开 >> Research Site Rennes Cedex 9, France, 35033 Korea, Republic of Research Site Seongnam-si, Korea, Republic of, 13620 Research Site Seoul, Korea, Republic of, 05505 Spain Research Site Madrid, Spain, 28040 Research Site Madrid, Spain, 28046 Research Site Madrid, Spain, 28050 Research Site Sevilla, Spain, 41013 收起 << |
NCT01492101 | Locally Recurrent Breast Cance... 展开 >>r Metastatic Breast Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00655265 | Familial Hypercholesterolemia | Phase 4 | Completed | - | France ... 展开 >> Service d'Endocrinologie, Metabolisme Prevention des Maladies Cardio-Vasculaires Paris Cedex, France Germany Kardiologie Marburg, Germany Netherlands Academic Medical Centre Amsterdam, Netherlands University Medical Centre Nijmegen, Netherlands University Medical Centre Utrecht, Netherlands TweeSteden Ziekenhius Waalwijk, Netherlands Sweden Centre for Metabolism and Endocrinology Huddinge, Sweden United Kingdom Department of Medicine, University of Manchester Manchester, United Kingdom 收起 << |
NCT02299089 | Acromegaly Ne... 展开 >>uroendocrine Tumors 收起 << | Phase 2 | Completed | - | France ... 展开 >> Hospices Civils de Lyon Bron, France CHU Rouen, Hôpital Charles Nicolle Rouen cedex, France Germany Abteilung: Klinische Studien Bad Berka, Germany Charité Campus Virchow Klinikum Berlin, Germany Universitätsklinikum Essen Essen, Germany Italy RCCS Azienda Ospedaliera Universitaria San Martino IST Genova, Italy Fondazione Irccs Ca' Granda Milano, Italy Università degli Studi di Napoli Federico II Napoli, Italy Istituto Clinico Humanitas Rozzano, Italy Sweden Akademiska sjukhuset Uppsala, Sweden 收起 << |
NCT02299089 | - | Completed | - | - | |
NCT01449344 | Mantle Cell Lymphoma | Phase 3 | Active, not recruiting | December 2018 | - |
NCT01771107 | AIDS-Related Hodgkin Lymphoma ... 展开 >> Ann Arbor Stage II Hodgkin Lymphoma Ann Arbor Stage IIA Hodgkin Lymphoma Ann Arbor Stage IIB Hodgkin Lymphoma Ann Arbor Stage III Hodgkin Lymphoma Ann Arbor Stage IIIA Hodgkin Lymphoma Ann Arbor Stage IIIB Hodgkin Lymphoma Ann Arbor Stage IV Hodgkin Lymphoma Ann Arbor Stage IVA Hodgkin Lymphoma Ann Arbor Stage IVB Hodgkin Lymphoma Classic Hodgkin Lymphoma HIV Infection 收起 << | Phase 1 Phase 2 | Recruiting | December 12, 2019 | United States, California ... 展开 >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein UCLA Center for Clinical AIDS Research and Education Recruiting Los Angeles, California, United States, 90035 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Scott D. Christensen 916-734-3771 schristensen@ucdavis.edu Principal Investigator: Scott D. Christensen United States, Florida University of Miami Miller School of Medicine-Sylvester Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein United States, Illinois John H Stroger Jr Hospital of Cook County Recruiting Chicago, Illinois, United States, 60612 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein United States, Louisiana Louisiana State University Health Science Center Recruiting New Orleans, Louisiana, United States, 70112 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein United States, Massachusetts Boston Medical Center Recruiting Boston, Massachusetts, United States, 02118 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein Beth Israel Deaconess Medical Center Active, not recruiting Boston, Massachusetts, United States, 02215 United States, Missouri Siteman Cancer Center at Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein Washington University - Jewish Recruiting Saint Louis, Missouri, United States, 63110 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein United States, New York Montefiore Medical Center-Einstein Campus Recruiting Bronx, New York, United States, 10461 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein United States, Pennsylvania Pennsylvania Oncology Hematology Associates Recruiting Philadelphia, Pennsylvania, United States, 19106 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein United States, Washington Virginia Mason Medical Center Recruiting Seattle, Washington, United States, 98101 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein Harborview Medical Center Recruiting Seattle, Washington, United States, 98104 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Paul G. Rubinstein 312-864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein France Centre Hospitalier Universitaire (CHU) de Toulouse Recruiting Cedex, France, 31059 Contact: Pierre Delobel 33-5-6177-7508 delobel.p@chu-toulouse.fr Principal Investigator: Pierre Delobel Hopital Antoine Beclere Recruiting Clamart, France, 92140 Contact: Francois Boue 33-1-4537-4409 francois.boue@abc.aphp.fr Principal Investigator: Francois Boue Henri Mondor University-Hospital Center Recruiting Creteil, France, 94000 Contact: Corinne Haioun 33-1-49-81-20-51 corinne.haioun@hmn.aphp.fr Principal Investigator: Corinne Haioun Hopital l'Archet-CHU de Nice Recruiting Nice, France, 06202 Contact: Nicolas Mounier 334-9203-5841 mounier.n@chu-nice.fr Principal Investigator: Nicolas Mounier Hopital Saint Louis Recruiting Paris, France, 75010 Contact: Eric Oksenhendler 33-1-4249-9811 eric.oksenhendler@sls.aphp.fr Principal Investigator: Eric Oksenhendler Hospital Saint-Antoine Recruiting Paris, France, 75012 Contact: Paul Coppo 33-1-4928-2616 paul.coppo@sat.aphp.fr Principal Investigator: Paul Coppo Centre Hospitalier Lyon-Sud Recruiting Pierre Benite, France, 69310 Contact: Gilles Salles 33-(0)-4-78-86-43-02 gilles.salles@chu-lyon.fr Principal Investigator: Gilles Salles Chu Purpan Recruiting Toulouse, France, 31059 Contact: Paul G. Rubinstein (312) 864-7277 prubinstein@cookcountyhhs.org Principal Investigator: Paul G. Rubinstein 收起 << |
NCT02674568 | Small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT01174992 | Dura Defects | Phase 2 Phase 3 | Completed | - | Belgium ... 展开 >> Department of Neurosurgery, Ziekenhuis Oost Limburg Genk, Belgium, B-3600 Department of Neurosurgery, University Hospital of Liège Liège, Belgium, B-4000 Finland Department of Neurosciences and Rehabilitation, Tampere University Hospital Tampere, Finland, FI-33521 France Service de Neurochirurgie B, Hopital Neurologique de Lyon Cedex, France, 696 BRON Germany Klinik für Neurochirurgie, Universitätsklinikum Essen Essen, Germany, D-45122 Department of Neurosurgery, University Giessen-Marburg Giessen, Germany, 35385 Department of Neurosurgery, Klinikum Ingolstadt GmbH Ingolstadt, Germany, 85049 Department of Neurosurgery University Clinics of Schleswig-Holstein Campus Kiel Kiel, Germany, D-24105 Netherlands VU Medical Centre Amsterdam, Netherlands, 1081 HV United Kingdom Department of Neurosurgery, John Radcliffe Hospital Headington, Oxford, United Kingdom, OX3 9DU Department of Neurosurgery, Ninewells Hospital & Medical School Dundee, United Kingdom, DD1 9SY Edinburgh Centre for Neuro-Oncology, Western General Hospital Edinburgh, United Kingdom, EH4 2XU 收起 << |
NCT02913326 | Thromboembolism | Phase 3 | Completed | - | - |
NCT01448785 | Obesity Morbi... 展开 >>d Obesity 收起 << | Not Applicable | Unknown | January 2015 | France ... 展开 >> Polyclinique de Rillieux, Clinique Lyon-Nord Recruiting RILLIEUX Cedex, France, 69165 Contact: Jerome Dargent, MD Principal Investigator: Jerome Dargent, MD Germany MIC Ev. Krankenhaus Hubertus Recruiting Berlin, Germany, 14129 Contact: Martin Susewind, MD Principal Investigator: Martin Susewind, MD SRH Wald-Klinikum Gera Recruiting Gera, Germany, 07548 Contact: Christine Stroh, MD Principal Investigator: Christine Stroh, MD Wolfart Klinik Active, not recruiting Graefelfing, Germany, 92166 Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Oliver Mann, MD Principal Investigator: Oliver Mann, MD Stadtkrankenhaus Schwabach Recruiting Schwabach, Germany, 91126 Contact: Thomas Horbach, MD Principal Investigator: Thomas Horbach, MD Italy Azienda Ospedaliera- University Not yet recruiting Pisa, Italy Contact: Marco Anselmino, MD Principal Investigator: Marco Anselmino, MD Clinica San Luca Torino Not yet recruiting Turin, Italy Contact: Giuseppe M Rovera, MD Principal Investigator: Giuseppe M Rovera, MD Vicenza Regional Hospital Not yet recruiting Vicenza, Italy, 36100 Contact: Franco Favretti, MD Principal Investigator: Franco Favretti, MD Spain Complutense University of Madrid Hospital Clinico "San Carlos" Not yet recruiting Madrid, Spain, 28290 Contact: Antonio J Torres, MD Principal Investigator: Antonio J Torres, MD Hospital Virgen del Roció Recruiting Sevilla, Spain, 41013 Contact: Salvador Morales Conde, MD Principal Investigator: Salvador Morales Conde, MD Switzerland Klinik Lindberg Recruiting Winterthur, Switzerland, 8400 Contact: Fritz Horber, MD Principal Investigator: Fritz Horber, MD United Kingdom Spire Southampton Hospital Not yet recruiting Hampshire, Southampton, United Kingdom, SO16 6UY Contact: James Byrne, MD Principal Investigator: James Byrne, MD St. Anthony's Hospital Not yet recruiting North Cheam, Surrey, United Kingdom, SM3 9DW Contact: Alberic Fiennes, MD Principal Investigator: Alberic Fiennes, MD Mid Yorkshire NHS Trust Not yet recruiting Dewsbury, West Yorkshire, United Kingdom, WF13 4HS Contact: Chinnadorai Rajeswaran, MD Principal Investigator: Chinnadorai Rajeswaran, MD 收起 << |
NCT02112487 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Completed | - | France ... 展开 >> Hôpital Louis Pradel Bron Cedex, France, 69677 Hôpital Côte de Nacre Caen, France, 14033 Hôpital Albert Michallon Grenoble, France, 38700 CHU de Bicêtre Le Kremlin-Bicêtre, France, 94270 CHRU Lille - Hôpital Cardiologique Lille, France, 59037 Hôpital Arnaud de Villeneuve Montpellier, France, 34295 Hôpitaux de Brabois Nancy, France, 54511 Hôpital de Haut Levêque Pessac, France, 33604 Hôpital Pontchaillou Rennes, France, 35033 Hôpital Charles Nicolle Rouen, France, 76031 Hôpital Nord Saint-Etienne, France, 42227 Hôpital Civil Strasbourg, France, 67091 Hôpital Larrey Toulouse, France, 31059 Italy Ospedale Sant'Orsola Bologna, Italy, 40138 A.O.U.C. Careggi Firenze, Italy, 50124 UOC Immunologia Clinica B-PGRM Centro di Riferimento per la Sclerosi Sistemica Rome, Italy, 00161 Centro Per La Diagnosi E La Cura Dell'Ipertensione Polmonare Rome, Italy, 00186 Policlinico G.B. Rossi Verona, Italy, 37134 Spain Hospital General de Alicante Alicante, Spain, 03010 Hospital Val Hebron Barcelona, Spain, 08035 Hospital Clinic Barcelona, Spain, 08036 Hospital de Cruces Bilbao, Spain, 48903 Hospital Reina Sofia Córdoba, Spain, 14004 Hospital Dr Negrin Las Palmas de Gran Canaria, Spain, 35010 Hospital Universitario Insular Gran Canarias Las Palmas de Gran Canaria, Spain, 35016 Hospital 12 Octubre Madrid, Spain, 28041 Hospital La Paz Madrid, Spain, 28046 Hospital Carlos Haya Malaga, Spain, 29010 Hospital Son Espases Palma de Mallorca, Spain, 7010 Hospital de Valdecilla Santander, Spain, 39008 Hospital Virgen del Rocio Sevilla, Spain, 41013 Hospita General U. Valencia Valencia, Spain, 46014 收起 << |
NCT00679484 | Chronic Heart Failure ... 展开 >> High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level 收起 << | Phase 3 | Terminated(Lack of subject rec... 展开 >>ruitment) 收起 << | - | France ... 展开 >> Bron, France Cedex, France Cholet, France Langres, France Mannheim, France Pontoise, France Roubaix, France Germany Bad Nauheim, Germany Berlin, Germany Lambrecht, Germany Netherlands Ad Delft, Netherlands 收起 << |
NCT02110784 | Malaria, Vivax | Phase 2 | Terminated(Low recruitment) | - | France ... 展开 >> Hôpital St André-CHU, Médecine interne et Maladies tropicales Bordeaux Cedex, France Germany Medizinische Klinik mit Schwerpunkt Infektiologie, Charite/Campus Virchow-Klinikum Berlin, Germany Department of Infectious Diseases & Tropical Medicine, University of Munich Munich, Germany Israel 15. The Center for Geographic Medicine and Tropical Diseases, Department of Medicine C - The Chaim Sheba Medical Center Tel Hashomer, Israel Italy Clinica di Malattie Infettive e Tropicali, Universitá di Brescia Brescia, Italy Azienda ospedaliera Luigi Sacco Milano, Italy, 20157 Azienda Ospedaliera Arcispedale S. Maria Nuova IRCCS - Dip. Medicina Interna e Spec. Mediche Reggio Emilia, Italy, 42123 Centro di Malattie Tropicali - INMI Spallanzani Roma, Italy Netherlands Dep. Infectious Disease, Section Travel Medicine, Leiden University Medical Centre Leiden, Netherlands Spain CRESIB-Hospital Clinic, Barcelona Barcelona, Spain Hospital Vall d'Hebron, Barcelona Barcelona, Spain Switzerland Medical and Diagnostic Service Department, Swiss Tropical and Public Health Institute Basel, Switzerland Bern University Hospital Bern, Switzerland 收起 << |
NCT03083184 | Tunnelled Hemodialysis Cathete... 展开 >>r Infection 收起 << | Phase 3 | Not yet recruiting | March 2021 | France ... 展开 >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 0473751081 placarin@chu-clermontferrand.fr Principal Investigator: Julien ANIORT 收起 << |
NCT00407602 | Retinitis Pigmentosa | Phase 2 | Active, not recruiting | August 2019 | United States, California ... 展开 >> Doheny Eye Institute Los Angeles, California, United States, 90033 University of California San Francisco San Francisco, California, United States, 94143 United States, Maryland Johns Hopkins, Wilmer Eye Institute Baltimore, Maryland, United States, 21205 United States, New York Columbia University, Department of Ophthalmology, Edward S. Harkness Eye Institute New York, New York, United States, 10032 United States, Pennsylvania University of Pennsylvania, Scheie Eye Institute Philadelphia, Pennsylvania, United States, 19104 Wills Eye Hospital Philadelphia, Pennsylvania, United States, 19107 United States, Texas Retina Foundation of the Southwest Dallas, Texas, United States, 75231 France Centre d'Investigation Clinique, Service d'Ophtalmologie, Quinze-Vingts National Eye Hospital, 28 rue de Charenton, 75557 Cedex 12 Paris, France Mexico Puerta de Hierro, Centro Medico, Centro de Retina Zapopan, Jalisco, Mexico, 51116 Switzerland Clinique d'Ophthalmologie Hopitaux, Universitaires de Geneve 22 rue Alcide Jentzer 1205 Geneva, Switzerland United Kingdom Moorfields Eye Hospital, Vitreoretinal Research Unit London, United Kingdom, EC1V 2PD Manchester Royal Eye Hospital Manchester, United Kingdom 收起 << |
NCT00250250 | Turner's Syndrome | Phase 3 | Completed | - | Czech Republic ... 展开 >> Faculty Hospital Olomouc, Children's Clinic, Endocrinology Outpatient Department, I.P.Pavlova str. 6, Olomouc, Czech Republic, 775 20 Faculty Hospital Kralovske Vinohrady, Children's Clinic, Vinohradska str. 159 Prague 10, Czech Republic, 100 81 Masaryk Hospital Usti nad Labem, Children's Clinic, Building D2, Endocrinology Outpatient Department, Socialni pece 12a Usti nad Labem, Czech Republic, 401 13 France Centre d'Endocrinologie Pediatrique, 25 rue Boudet Bordeaux, France, 33000 Service de Pédiatrie, Groupe Hospitalier du Havre, 55 bis, rue Gustave Flaubert Le Havre cedex, France, 76083 Netherlands Vu medisch centrum, Paediatrics, De Boelelaan 1117, PO Box 7057 Amsterdam, Netherlands, 10007 MB 收起 << |
NCT03016325 | Heart Failure | Phase 2 | Recruiting | August 26, 2019 | - |
NCT00969046 | Colon Cancer | Phase 1 | Completed | - | Czech Republic ... 展开 >> Novartis Investigative Site Hradec Králové, Czech Republic Novartis Investigative Site Prague, Czech Republic France Novartis Investigative Site Saint-Herblain Cedex, France Novartis Investigative Site Toulouse, France Spain Novartis Investigative Site Barcelona, Spain United Kingdom Novartis Investigative Site London, United Kingdom 收起 << |
NCT03315091 | Solid Tumours | Phase 1 | Completed | - | France ... 展开 >> Research Site Bordeaux Cedex, France, 33075 Research Site Saint Herblain, France, 44805 Netherlands Research Site Amsterdam, Netherlands, 1066 CX Research Site Amsterdam, Netherlands, 1081 HV Research Site Maastricht, Netherlands, 6229 HX United Kingdom Research Site Glasgow, United Kingdom, G12 0YN Research Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT02143219 | Pancreatic Metastatic Cancer ... 展开 >> Toxicity 收起 << | Phase 2 | Recruiting | July 2021 | France ... 展开 >> ICO Paul Papin Recruiting Angers, France, 49000 Contact: Olivier CAPITAIN, MD +33 2 41 35 27 00 olivier.capitain@ico.unicancer.fr Principal Investigator: Olivier CAPITAIN, MD CH Vendée Not yet recruiting La Roche Sur Yon, France, 85925 Contact: Roger FAROUX, MD 02 51 44 61 68 Principal Investigator: Roger FAROUX, MD Sub-Investigator: Cécile GARCEAU, MD Sub-Investigator: Morgane AMIL, MD Sub-Investigator: François DEWAELE, MD Sub-Investigator: Jean-Pierre LAFARGUE, MD Sub-Investigator: Matthieu SCHNEE, MD Sub-Investigator: Vincent MACE, MD Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Antoine ADENIS, MD 03.20.29.55.00 Principal Investigator: Antoine ADENIS, MD Sub-Investigator: Farid EL HAJBI, MD Sub-Investigator: Eric AMELA, MD Sub-Investigator: Charlotte PEUGNIEZ, MD ICM (Val d'Aurelle) Not yet recruiting Montpellier Cedex 5, France, 34298 Contact: Emmanuelle SAMALIN, MD 04 67 67 25 92 Sub-Investigator: Emmanuel SAMALIN, MD Sub-Investigator: Blandine GALLET-SUCHET, MD Sub-Investigator: Laurence DALSTEIN, MD Sub-Investigator: Marc YCHOU, MD ICO René Gauducheau Recruiting Nantes - St Herblain, France, 44805 Contact: Sandrine HIRET, MD +33 2 40 67 99 00 ext 9357 sandrine.hiret@ico.unicancer.fr Principal Investigator: Sandrine HIRET, MD Sub-Investigator: Jean-Yves DOUILLARD, Pr Sub-Investigator: Jaafar BENNOUNA, Pr Sub-Investigator: Hélène SENELLART, MD Centre Eugène marquis Not yet recruiting Rennes, France, 35042 Contact: Bérengère LECONTE, MD 02 99 28 54 65 Principal Investigator: Bérengère LECONTE, MD Sub-Investigator: Evelyne BOUCHER, MD Sub-Investigator: Sylvain MANFREDI, MD Sub-Investigator: Julien EDELINE, MD 收起 << |
NCT00098345 | Thyroid Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> Research Site San Francisco, California, United States United States, Connecticut Research Site New Haven, Connecticut, United States United States, New York Research Site New York, New York, United States United States, North Carolina Research Site Durham, North Carolina, United States United States, Texas Research Site Houston, Texas, United States France Research Site Villejuif Cedex, France 收起 << |
NCT01046864 | Gastro-Intestinal Cancer | Phase 1 | Completed | - | United States, California ... 展开 >> Usc/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Texas Texas Oncology Dallas, Texas, United States, 75246 Scott & White Memorial Hospital And Clinic Temple, Texas, United States, 76508 Canada, Alberta Local Institution Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Local Institution Ottawa, Ontario, Canada, K1H 8L6 France Local Institution Villejuif Cedex, France, 94800 收起 << |
NCT00169143 | Untreated CD20-positive Large ... 展开 >>B-cell Lymphoma 收起 << | Phase 2 | Completed | - | France ... 展开 >> Hôpital Henri Mondor Créteil, France Service d'Hématologie Clinique - CHU Le Bocage Dijon, France Hôpital Saint Louis Paris, France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France Centre Henri Becquerel Rouen, France CHRU de Nancy Brabois Vandoeuvre-les-Nancy, France 收起 << |
NCT03180931 | - | Completed | - | Austria ... 展开 >> 5th Medical Department with Cardiology, Kaiser Franz Josef Hospital Vienna, Austria Belgium Department of Cardiology, University Hospital Leuven Leuven, Belgium France Cardiology Department, CHU Clermont-Ferrand Clermont-Ferrand, France Department of Cardiology, University Hospital Caremeau Nimes, France Department of Cardiology, CH F Mitterand, Pau Université Cedex, France. Pau, France Department of Cardiovascular Medicine, Hypertension and Heart Failure Unit, Health Innovation Lab (Hi-Lab) Clinique Pasteur Toulouse, France Germany Department of Cardiology, University of Giessen Giessen, Germany Department of Cardiology, Asklepios Klinik St. Georg Hamburg, Germany Heart Center, Segeberger Kliniken GmbH, Academic Teaching Hospital of the Universities of Kiel Kiel, Germany Deutsches Herzzentrum München, Technische Universität München, Munich, Germany Hong Kong Cardiology Division, Department of Medicine, Pamela Youde Nethersole Eastern Hospital Chai Wan, Hong Kong Cardiology Division, Department of Medicine, Queen Elizabeth Hospital Kowloon, Hong Kong Italy Cardiology Division, Bolognini Hospital Seriate, Italy Netherlands Academic Medical Center, University of Amsterdam Amsterdam, Netherlands Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands. Rotterdam, Netherlands Department of Cardiology, University Medical Centre Utrecht Utrecht, Netherlands Singapore Cardiac Department, National University Heart Centre Singapore, Singapore Spain Hospital Universitari de Bellvitge, Institut d' Investigació Biomèdica de Bellvitge, Universitat de Barcelona, L' Hospitalet de Llobregat, Spain. Barcelona, Spain Switzerland Department of Cardiology, Stadtspital Triemli Zurich, Switzerland 收起 << | |
NCT00340834 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT00948272 | Rabies | Phase 2 | Completed | - | France ... 展开 >> Gières, France, 38610 Montpellier Cedex 5, France, 34094 Pierre Bénite, France, 69130 Poitiers, France, 86000 Rennes, France, 35000 Rueil Malmaison, France, 92502 收起 << |
NCT00340834 | - | Completed | - | - | |
NCT00927875 | Small Cell Lung Carcinoma | Phase 1 | Completed | - | United States, Michigan ... 展开 >> Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Australia, Victoria Local Institution East Bentleigh, Victoria, Australia, 3165 Canada, Alberta Local Institution Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Local Institution Ottawa, Ontario, Canada, K1H 8L6 France Local Institution Villejuif Cedex, France, 94800 Ireland Local Institution Dublin, Ireland 收起 << |
NCT02218697 | - | Completed | - | - | |
NCT01681953 | Alpha-Mannosidosis | Phase 3 | Completed | - | Denmark ... 展开 >> Center for Metabolic Diseases, Department of Clinical Genetics, Juliane Marie Centre, Copenhagen University Hospital, Blegdamsvej 9 Copenhagen, Denmark, DK-2100 France Hôpital Femme Mère Enfant, Lyon, 59 boulevard Pinel Bron, France, 69677 Hôpital Trousseau, Service de neuropédiatrie, Centre Référence des Maladies Lysosomales, 26 avenue du Docteur Arnold Netter PARIS Cedex 12, France, 75 571 Germany Universitätsmedizin Mainz, Zentrum für Kinder- und Jugendmedizin, Langenbeckstrasse 1 Mainz, Germany, 55131 Poland The Children's Memorial Health Institute Warsaw, Department of Metabolic Diseases, Al Dzieci Polskich 20 Warszawa, Poland, 04 730 United Kingdom Genetic Medicine, 6th floor, St Mary's Hospital, Oxford Road, Manchester, United Kingdom, M13 9WL 收起 << |
NCT02218697 | Influenza | Phase 3 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Gent, Belgium, 9000 France GSK Investigational Site Angers, France, 49000 GSK Investigational Site Laval, France, 53000 GSK Investigational Site Nantes cedex 2, France, 44277 GSK Investigational Site Saint Cyr sur Loire, France, 37540 GSK Investigational Site Tours, France, 37100 收起 << |
NCT01112566 | - | Completed | - | Canada, Ontario ... 展开 >> London Health Sciences Centre, University Hospital London, Ontario, Canada, ON N6G 2V4 Czechia Nemocnice Ceske Budejovice A.S. Ceske Budejovice, Czechia, 37001 France Hôpital Haut - Leveque - CHU Pessac Cedex Bordeaux Bordeaux, France, 33604 CHU de Nantes - Hôpital Nord Laennec Nantes, France, 44800 Germany Deutsches Herzzentrum München München, Germany, 80636 SANA Herzchirurgie Stuttgart GmbH Stuttgart, Germany, 70174 Italy Azienda Ospedaliero Universitaria Careggi Firenze, Italy, 50134 收起 << | |
NCT00098345 | - | Completed | - | - | |
NCT00665730 | Abdominal Adhesions | Not Applicable | Terminated(Study terminated du... 展开 >>e to low enrollment.) 收起 << | - | Czech Republic ... 展开 >> Masarykova, Czech Republic Praha, Czech Republic Denmark Aarhus C, Denmark France Lille Cedex, France Germany Heidelberg, Germany United Kingdom Cottingham, East Yorkshire, United Kingdom 收起 << |
NCT01337765 | Unspecified Adult Solid Tumor,... 展开 >> Protocol Specific Solid Tumor 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02114 United States, Texas University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston, Texas, United States, 77030-4009 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3050 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Villejuif Cedex, France, 94805 Spain Novartis Investigative Site Barcelona, Cataluña, Spain, 08035 收起 << |
NCT02760797 | Neoplasms | Phase 1 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States United States, Pennsylvania University Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19104 Belgium Cliniques Universitaires St-Luc Bruxelles, Belgium, 1200 France Centre Leon Berard; Departement Oncologie Medicale Lyon, France, 69373 Institut Claudius Regaud; Departement Oncologie Medicale Toulouse, France, 31059 Institut Gustave Roussy; Sitep VILLEJUIF Cedex, France, 94805 收起 << |
NCT02298257 | HIV Infection ... 展开 >> HIV-associated Hodgkin Lymphoma Stage III Adult Hodgkin Lymphoma Stage IV Adult Hodgkin Lymphoma 收起 << | Phase 2 | Active, not recruiting | December 2019 | France ... 展开 >> APHP - Hôpital Antoine Béclère Clamart, France, 92140 CHU de Nice Nice, France, 06202 APHP - Hôpital Saint Antoine Paris Cedex 12, France, 75571 Hopital St Louis Paris, France, 75475 Centre Hospitalier Lyon Sud Pierre Bénite, France, 69495 CHU de Toulouse Toulouse, France 收起 << |
NCT00984230 | Infant Nutrition | Not Applicable | Completed | - | Austria ... 展开 >> Department of Pediatrics Vienna, Austria, 1090 France Service de Réanimation Néonatale et Néonatologie, Hôpital de la Croix Rousse Lyon CEDEX 04, France, 69317 Maternité Régionale, Service de Néonatologie Nancy, France, 54042 Service de Néonatologie Nantes, France, 44093 Hôpital Charles Nicolle, Département de Pédiatrie Rouen, France, 76031 Greece Alexandra Regional General Hospital, Department of Neonatology Palaio Faliro, Athens, Greece, 17562 收起 << |
NCT03126591 | Soft Tissue Sarcoma | Phase 1 | Recruiting | October 9, 2020 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact 617-632-5204 Principal Investigator: Andrew Wagner United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact 646-888-4545 Principal Investigator: William Tap United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact 412-623-7277 Principal Investigator: Melissa Burgess Belgium Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg Recruiting Leuven, Belgium, 3000 Contact 3216343821 Principal Investigator: Patrick Schöffski Denmark Herlev Hospital Recruiting Herlev, Denmark, 2730 Contact 4538682040 Principal Investigator: Niels Junker France Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Contact 33142114338 Principal Investigator: Christophe Massard 收起 << |
NCT02397395 | Renal Impairment ... 展开 >> End-stage Renal Disease 收起 << | Phase 2 | Withdrawn(Trial has been cance... 展开 >>lled due to availability of new therapeutic options for patient population) 收起 << | May 2016 | France ... 展开 >> Paris, France Toulouse Cedex 9, France Villejuif, France Spain Barcelona, Spain Madrid, Spain Santander, Spain 收起 << |
NCT01055483 | Acute Myeloid Leukemia | Phase 1 | Completed | - | France ... 展开 >> Novartis Investigative Site Paris Cedex 4, France, 75181 Novartis Investigative Site Paris, France, 75475 Germany Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Ulm, Germany, 89081 收起 << |
NCT00629616 | Breast Cancer | Phase 2 | Unknown | September 2016 | France ... 展开 >> Centre Jean Perrin Clermont-Ferrand, France, 63011 Hopital Dupuytren Limoges Cedex, France, 87042 Institut Curie Hopital Paris, France, 75248 Centre Eugene Marquis Rennes, France, 35042 Centre Rene Huguenin Saint-Cloud, France, 92210 Institut Gustave Roussy Villejuif, France, F-94805 收起 << |
NCT02369029 | Neoplasms | Phase 1 | Terminated | - | United States, Texas ... 展开 >> Houston, Texas, United States, 77030 Finland HUS, Finland, 00029 France Villejuif Cedex, France, 94805 Germany Heidelberg, Baden-Württemberg, Germany, 69120 Switzerland Bellinzona, Switzerland, 6500 United Kingdom Oxford, Oxfordshire, United Kingdom, OX3 7LJ 收起 << |
NCT02103062 | - | Completed | - | - | |
NCT01362933 | - | Completed | - | - | |
NCT01930890 | Lupus Nephritis | Phase 2 | Terminated(Results from pre-sp... 展开 >>ecified criteria in study NCT01499355 (211LE201) did not demonstrate sufficient efficacy to warrant continuation of the study) 收起 << | - | - |
NCT02103062 | Colorectal Neoplasms | Phase 2 | Completed | - | France ... 展开 >> Centre Oscar Lambret, Dept. de Cancerologie Digestive et Urologique Lille 59, France, 59020 Centre Regional de Lutte contre le Cancer Val d'Aurelle Montpellier cedex 5, France, 34298 CRLCC Centre René Gauducheau Saint Herblain 44, France, 44805 Institut Curie Saint-Cloud, France, 92210 Centre Alexis Vautrin Vandoeuvre-Les-Nancy, France, 54511 Institut Gustave RoussyHématologie Villejuif, France, 94805 收起 << |
NCT01551667 | - | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09, Gard, France, 30029 CHU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi Le Grau du Roi, France, 30240 CHU de Montpellier - Hôpital Saint-Eloi Montpellier, France, 34295 CHU de Nantes - Hôtel-Dieu Nantes, France, 44093 CHU de Nice - Hôpital Pasteur Nice, France, 06002 CHU de Nice - Hôpitaux L'Archet 1 et 2 Nice, France, 06202 收起 << | |
NCT01930890 | - | Terminated(Results from pre-sp... 展开 >>ecified criteria in study NCT01499355 (211LE201) did not demonstrate sufficient efficacy to warrant continuation of the study) 收起 << | - | - | |
NCT02638935 | Breast Neoplasms | Not Applicable | Recruiting | August 2018 | United States, Ohio ... 展开 >> Radiology Consultants, Inc. Recruiting Youngstown, Ohio, United States, 44512 Contact: Richard Barr, MD France Institut Gustave Roussy, Service de Radiologie, Villejuif Cedex Recruiting Villejuif, France Contact: Corinne Balleyguier, Dr. corinne.balleyguier@gustaveroussy.fr Germany Franziskus Hospital Recruiting Bielefeld, Germany, 33615 Contact: Sebastian Wojcinski, PD Dr. med. Universitätsmedizin Greifswald, Klinik für Frauenheilkunde und Geburtshilfe Recruiting Greifswald, Germany, 17475 Contact: Ralf Ohlinger, Prof.Dr.med. University of Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Michael Golatta, PD Dr. med. Universitätsklinikum Marburg, Klinik für Gynäkologie, gyn. Endokrinologie und Onkologie Senologische Diagnostik & Gynäkologischer Ultraschall Not yet recruiting Marburg, Germany, 35033 Contact: Volker Duda, Dr. duda@med.uni-marburg.de LMU Klinikum der Universität München Recruiting München, Germany, 81377 Contact: Dirk- André Clevert, Prof. Dr. med. Contact: Dorothea Rjosk- Dendorfer, Dr. med. Universitätsklinikum Tübingen Recruiting Tubingen, Germany, 72076 Contact: Markus Hahn, Prof.Dr.med. Contact: Ines Gruber, Dr. med. Japan Sagara Hospital Recruiting Kagoshima, Matsubaracho, Kagoshima-shi, Japan Contact: Tozaki Mitsuhiro, Dr. Netherlands Jeroen Bosch Hospital Recruiting 's-Hertogenbosch, Netherlands, GZ5223 Contact: Matthieu Rutten, Dr. Portugal Centro Hospitalar e Universitário de Coimbra, Departamento de Radiologia Recruiting Coimbra, Portugal, 3000-075 Contact: Manuela Goncalo, Dr. manuela_goncalo@hotmail.com Contact: Pedron Belo Oliveira, Dr. pedronboliveira@gmail.com Principal Investigator: Pedron Belo Oliveira, Dr. 收起 << |
NCT01760525 | Solid Tumor With p53 Wild Type... 展开 >> Status 收起 << | Phase 1 | Active, not recruiting | January 9, 2019 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute SC (2) Boston, Massachusetts, United States, 02215 France Novartis Investigative Site Lyon Cedex, France, 69373 Germany Novartis Investigative Site Koeln, Nordrhein-Westfalen, Germany, 50937 Novartis Investigative Site Essen, Germany, 45147 Singapore Novartis Investigative Site Singapore, Singapore, 169610 Switzerland Novartis Investigative Site Zürich, Switzerland, 8091 收起 << |
NCT03118570 | Osteogenesis Imperfecta, Type ... 展开 >>I Osteogenesis Imperfecta Type III Osteogenesis Imperfecta Type IV 收起 << | Phase 2 | Recruiting | October 31, 2020 | - |
NCT02004704 | Sphingomyelin Lipidosis | Phase 2 | Enrolling by invitation | September 2023 | United States, New York ... 展开 >> Investigational Site Number 840001 New York, New York, United States, 10029-6574 Brazil Investigational Site Number 076001 Porto Alegre, Brazil, 90035 003 France Investigational Site Number 250002 Bron Cedex, France, 69677 Italy Investigational Site Number 380001 Udine, Italy, 33100 United Kingdom Investigational Site Number 826001 London, United Kingdom, WC1N 3JZ Investigational Site Number 826002 Manchester, United Kingdom, M13 9WL 收起 << |
NCT00475852 | Heart Decompensation | Phase 3 | Completed | - | - |
NCT01201837 | Acute Coronary Syndrome | Phase 2 | Completed | - | - |
NCT00103506 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00850499 | - | Terminated | - | - | |
NCT01949545 | Solid Tumors ... 展开 >>Hematologic Malignancies Hepatic Impairment 收起 << | Phase 1 | Completed | - | United States, Michigan ... 展开 >> Karmanos Cancer Institute Detroit, Michigan, United States United States, North Carolina Duke Cancer Institute Durham, North Carolina, United States United States, Ohio Gabrail Cancer Center Canton, Ohio, United States United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States United States, Washington Evergreen Hematology and Oncology Spokane, Washington, United States France Institut Gustave Roussy Paris, Villejuif Cedex, France Netherlands University Medical Centre Utrecht Utrecht, Netherlands United Kingdom Northern Ireland Cancer Trials Centre - Queen's University Belfast TriaIs Centre Belfast, Northern Ireland, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom Velindre Hospital Cardlff, Wales, United Kingdom Sir Bobby Robson Cancer Trials Research Centre Newcastle, United Kingdom 收起 << |
NCT00103506 | - | Completed | - | - | |
NCT00402168 | Renal Transplant | Phase 2 | Completed | - | - |
NCT00850499 | Follicular Lymphoma | Phase 2 | Terminated | - | - |
NCT00425555 | Cutaneous T-Cell Lymphoma | Phase 2 Phase 3 | Completed | - | - |
NCT00402168 | - | Completed | - | - | |
NCT00314964 | Hot Flashes | Phase 2 | Completed | - | - |
NCT00700817 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00947856 | Disease, Hodgkin ... 展开 >> Lymphoma, Large-Cell, Anaplastic Lymphoma, Non-Hodgkin 收起 << | Phase 2 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-3300 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 Stanford Cancer Center Stanford, California, United States, 94305 United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Florida University of Miami Miller School of Medicine / Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Illinois Loyola University Medical Center - Cardinal Bernadin Cancer Center Maywood, Illinois, United States, 60153 United States, Indiana St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States, 46237 United States, Michigan Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States, 48201 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New Jersey The John Theurer Cancer Center, Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York NYU Clinical Cancer Center New York, New York, United States, 10016 Columbia University Medical Center New York, New York, United States, 10019 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Texas Charles A. Sammons Cancer Center Dallas, Texas, United States, 75246 MD Anderson Cancer Center /The University of Texas Houston, Texas, United States, 77030 United States, Washington Seattle Cancer Care Alliance / University of Washington Medical Center Seattle, Washington, United States, 98109-1023 France Hopital Saint-Louis/Service d'Hematologie Paris, Cedex 10, France, 75475 收起 << |
NCT00475852 | - | Completed | - | - | |
NCT00947856 | - | Completed | - | - | |
NCT01076647 | - | Completed | - | - | |
NCT00381901 | Breast Cancer | Phase 3 | Completed | - | - |
NCT00038519 | HIV Infections | Phase 2 Phase 3 | Completed | - | - |
NCT00046319 | Pulmonary Hypertension | Phase 2 | Completed | - | - |
NCT00056459 | Colorectal Neoplasms ... 展开 >> Colonic Neoplasms Rectal Neoplasms 收起 << | Phase 3 | Completed | - | - |
NCT01949545 | - | Completed | - | - | |
NCT01620489 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00700817 | - | Completed | - | - | |
NCT01498692 | Coronary Artery Disease | Not Applicable | Completed | - | - |
NCT01620489 | - | Completed | - | - | |
NCT01543698 | Solid Tumors Harboring a BRAF ... 展开 >>V600 Mutation 收起 << | Phase 1 Phase 2 | Active, not recruiting | July 31, 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Moffitt SC 2 Tampa, Florida, United States, 33612 United States, Maryland The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Johns Hopkins Baltimore, Maryland, United States, 21287-0013 United States, Massachusetts Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02115 United States, Texas University of Texas/MD Anderson Cancer Center MD Univ TX Houston, Texas, United States, 77030-4009 Australia, New South Wales Array BioPharma Investigative Site Camperdown, New South Wales, Australia, 2050 Array BioPharma Investigative Site North Sydney, New South Wales, Australia, 2060 Array BioPharma Investigative Site Westmead, New South Wales, Australia, 2145 Belgium Array BioPharma Investigative Site Leuven, Belgium, 3000 Canada, Quebec Array BioPharma Investigative Site Montreal, Quebec, Canada, H3T 1E2 France Array BioPharma Investigative Site Paris, Cedex 10, France, 75475 Italy Array BioPharma Investigative Site Milano, MI, Italy, 20162 Array BioPharma Investigative Site Napoli, Italy, 80131 Singapore Array BioPharma Investigative Site Singapore, Singapore, 169610 Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Array BioPharma Investigative Site Madrid, Spain, 28050 Switzerland Array BioPharma Investigative Site St. Gallen, Switzerland, 9007 Array BioPharma Investigative Site Zuerich, Switzerland, 8091 收起 << |
NCT01713530 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01713530 | - | Completed | - | - | |
NCT01076647 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00005918 | HIV Infections | Phase 3 | Completed | - | - |
NCT01993186 | Glucose Transporter Type 1 Def... 展开 >>iciency Syndrome (Glut1 DS) 收起 << | Phase 2 | Completed | - | United States, Colorado ... 展开 >> Children's Hospital Colorado - University of Colorado, Denver, School of Medicine Aurora, Colorado, United States, 80045 United States, Florida Miami Children's Hospital Miami, Florida, United States, 33155 Neurology & Epilepsy Research Center Orlando, Florida, United States, 32819 United States, New York Columbia University - Department of Neurology New York, New York, United States, 10032 Columbia University Medical Center New York, New York, United States, 10032 United States, Texas Cook Children's Hospital Fort Worth, Texas, United States, 76104 University of Texas Neurometabolic Clinic Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Australia, Victoria Melbourne Brain Centre Heidelberg, Victoria, Australia, 3084 France Service de Neurologie Pédiatrique et des Maladies Métaboliques - INSERM U1141 Hôpital Robert Debré - APHP Paris, Cedex 19, France, 75935 Israel Sheba University Medical Center Tel Aviv, Israel Italy Unita' Operativa Neurologia Pediatrica e Malattie Muscolari Istituto "Giannina Gaslini" Genova, Italy Spain Hospital Sant Joan de Deu Barcelona, Spain United Kingdom Newcastle University Newcastle Upon Tyne, United Kingdom 收起 << |
NCT00241514 | GERD | Phase 3 | Completed | - | - |
NCT01498692 | - | Completed | - | - | |
NCT03269175 | Multiple Sclerosis | Phase 4 | Completed | - | - |
NCT03108495 | Cervical Carcinoma | Phase 2 | Recruiting | June 2024 | - |
NCT01931839 | Cystic Fibrosis, Homozygous or... 展开 >> Heterozygous for the F508del-CFTR Mutation 收起 << | Phase 3 | Completed | - | - |
NCT03125902 | Triple-Negative Breast Cancer | Phase 3 | Recruiting | June 30, 2021 | - |
NCT03150056 | Solid Tumours | Phase 1 | Recruiting | July 29, 2019 | - |
NCT02907359 | Myelodysplastic Syndromes ... 展开 >> Leukemia, Myelomonocytic, Chronic 收起 << | Phase 3 | Recruiting | December 2019 | - |
NCT02197416 | Venous Thromboembolism ... 展开 >> Secondary Prevention 收起 << | Phase 3 | Recruiting | February 28, 2020 | - |
NCT02672852 | Psoriasis | Phase 3 | Completed | - | - |
NCT02405442 | Crohn's Disease | Phase 2 | Terminated | - | - |
NCT01969851 | Epilepsy | Phase 2 | Completed | - | United States, California ... 展开 >> 103 Los Angeles, California, United States United States, Florida 101 Orlando, Florida, United States United States, Nevada 104 Henderson, Nevada, United States United States, New Jersey 112 Hackensack, New Jersey, United States 108 New Brunswick, New Jersey, United States United States, Ohio 107 Akron, Ohio, United States France 309 Ile-De-France, France 303 Lyon Cedex, France Hungary 701 Budapest, Hungary 702 Budapest, Hungary 703 Budapest, Hungary 704 Budapest, Hungary 705 Debrecen, Hungary Mexico 154 Guadalajara, Mexico Poland 807 Katowice, Poland 801 Krakow, Poland 805 Lublin, Poland 802 Szczecin, Poland 收起 << |
NCT01931839 | - | Completed | - | - | |
NCT02847650 | Parkinson Disease | Phase 2 | Terminated(Study B7601011 was ... 展开 >>terminated on 29 Jan 2018 due to lack of efficacy in moderate/advanced Parkinson's disease.) 收起 << | - | - |
NCT02172950 | Hemophilia A ... 展开 >>Severe Hemophilia A 收起 << | Phase 3 | Recruiting | August 30, 2023 | - |
NCT02277769 | Dermatitis, Atopic | Phase 3 | Completed | - | - |
NCT02934568 | Continued Access to Study Trea... 展开 >>tment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies 收起 << | Phase 2 | Active, not recruiting | January 21, 2019 | United States, Alabama ... 展开 >> Novartis Investigative Site Birmingham, Alabama, United States, 35294-3300 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, Michigan Novartis Investigative Site Ann Arbor, Michigan, United States, 48109-5930 United States, New York Novartis Investigative Site Johnson City, New York, United States, 13790 United States, Tennessee Novartis Investigative Site Memphis, Tennessee, United States, 38105 France Novartis Investigative Site Villejuif Cedex, France, 94805 Singapore Novartis Investigative Site Singapore, Singapore, 119228 Spain Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Madrid, Spain, 28050 Taiwan Novartis Investigative Site Tainan, Taiwan, 70421 Novartis Investigative Site Taipei, Taiwan, 10002 收起 << |
NCT03215511 | Carcinoma, Non-Small-Cell Lung... 展开 >> Thyroid Neoplasms Sarcoma Colorectal Neoplasms Salivary Gland Neoplasms Biliary Tract Neoplasms Brain Neoplasm, Primary Melanoma Glioblastoma Bile Duct Neoplasms Astrocytoma Head and Neck Squamous Cell Carcinoma Pontine Glioma Pancreatic Neoplasms Ovarian Neoplasms Carcinoma, Renal Cell Cholangiocarcinoma Skin Carcinoma Carcinoma, Bronchogenic Bronchial Neoplasms Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms, Nerve Tissue Nevi and Melanomas Intestinal Neoplasms Thyroid Cancer GIST Malignant Peripheral Nerve Sheath Tumors Breast Secretory Carcinoma Uterine Neoplasms Fibrosarcoma Infantile Fibrosarcoma Congenital Mesoblastic Nephroma Central Nervous System Neoplasms 收起 << | Phase 1 Phase 2 | Recruiting | December 2019 | United States, California ... 展开 >> University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095 Stanford Cancer Center Recruiting Stanford, California, United States, 94304 United States, Colorado Sarah Cannon Research Institute at HealthONE Recruiting Denver, Colorado, United States, 80218 United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 United States, Texas University of Texas, Southwestern Medical Center Recruiting Dallas, Texas, United States, 75235 MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 United States, Virginia Virginia Oncology Associates Recruiting Norfolk, Virginia, United States, 23502 United States, Washington Seattle Children's Recruiting Seattle, Washington, United States, 98105 Australia, New South Wales Sydney Children's Hospital, Kids Cancer Centre Recruiting Randwick, New South Wales, Australia, 2031 Denmark Righospitalet Recruiting Copenhagen, Denmark, 2100 France Gustave Roussy Recruiting Villejuif cedex, France, 94805 Korea, Republic of Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Singapore National Cancer Centre Singapore Recruiting Singapore, Singapore, 169601 Spain Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain, 08035 Hospital Vall d'Hebron Recruiting Madrid, Spain, 28036 收起 << |
NCT02288377 | Metastatic/Locally Advanced, N... 展开 >>on-resectable, Duodeno-pancreatic Neuroendocrine Tumours 收起 << | Phase 2 Phase 3 | Recruiting | January 2024 | Belgium ... 展开 >> Clinique Universitaire saint-Luc Recruiting Bruxelles, Belgium Contact: Ivan BORBATH ivan.borbath@uclouvain.be Principal Investigator: Ivan BORBATH France CHU d'Angers - Hôtel Dieu Recruiting Angers, France Contact: François-Xavier CAROLI-BOSC FXCaroli-Bosc@chu-angers.fr Principal Investigator: François-Xavier CAROLI-BOSC CHU - Hôpital Avicenne Recruiting Bobigny, France Contact: Thomas APARICIO thomas.aparicio@aphp.fr Principal Investigator: Thomas APARICIO CHU Côte de Nacre Recruiting Caen, France Contact: Karine BOUHIER-LEPORRIER bouhierleporrier-k@chu-caen.fr Principal Investigator: Karine BOUHIER-LEPORRIER CHU Estaing Recruiting Clermont Ferrand, France Contact: Caroline PETORIN cpetorin@chu-clermontferrand.fr Principal Investigator: Caroline PETORIN Hôpital Beaujon Recruiting Clichy, France Contact: Olivia HENTIC DHOME olivia.hentic@bjn.aphp.fr Principal Investigator: Olivia HENTIC DHOME CHU Le Bocage Service d'HGE Recruiting Dijon Cedex, France, 21079 Contact: Côme LEPAGE, Pr + 33 3 80 29 37 50 come.lepage@u-bourgogne.fr Principal Investigator: Côme LEPAGE CH Les Oudairies Recruiting La Roche Sur Yon, France Contact: Roger FAROUX roger.faroux@chd-vendee.fr Principal Investigator: Roger FAROUX Hôpital Edouard Herriot Recruiting Lyon, France Contact: Thomas WALTER thomas.walter@chu-lyon.fr Principal Investigator: Thomas WALTER CHU La Timone Recruiting Marseille, France Contact: Laëticia DAHAN laetitia.dahan@ap-hm.fr Principal Investigator: Laëticia DAHAN Hôpital de la Source Recruiting Orléans, France Contact: Jean-Louis LEGOUX jean-louis.legoux@chr-orleans.fr Principal Investigator: Jean-Louis LEGOUX CHU Cochin Recruiting Paris, France Contact: Romain CORIAT romain.coriat@cch.aphp.fr Principal Investigator: Romain CORIAT Hôpital Haut Lévêque Bat Magellan, Service d'hépato-gastroentérologie Recruiting Pessac, France Contact: Denis SMITH denis.smith@chu-bordeaux.fr Principal Investigator: Denis SMITH Hôpital de la Milétrie Recruiting Poitiers, France Contact: David TOUGERON david.tougeron@chu-poitiers.fr Principal Investigator: David TOUGERON Hôpital Robert Debré Recruiting Reims, France Contact: Guillaume CADIOT gcadiot@chu-reims.fr Principal Investigator: Guillaume CADIOT CHU de Rennes - Hôpital Pontchaillou Recruiting Rennes, France Contact: Astrid LIEVRE astrid.lievre@chu-rennes.fr Principal Investigator: Astrid LIEVRE CHU Charles Nicolle Recruiting Rouen, France Contact: Frédéric DI FIORE Frederic.Di-Fiore@chu-rouen.fr Principal Investigator: Frédéric DI FIORE CHU de Saint Etienne Recruiting Saint Priest En Jarez, France Contact: Nadia BOUARIOUA nadiabouarioua@yahoo.fr ; nadia.bouarioua@chu-st-etienne.fr Principal Investigator: Nadia BOUARIOUA Hôpital Rangueil Recruiting Toulouse, France Contact: Rosine GUIMBAUD guimbaud.r@chu-toulouse.fr Principal Investigator: Rosine GUIMBAUD Institut Gustave Roussy Recruiting Villejuif, France Contact: Michel DUCREUX ducreux@igr.fr Principal Investigator: Michel DUCREUX Germany Charite Campus Virchow Kilikum Recruiting Berlin, Germany Contact: Cornelia EBERHARDT cornelia.eberhardt@charite.de Principal Investigator: Marianne PAVEL University Hospital Marburg Recruiting Marburg, Germany Contact: Dorothée STARK starkd@staff.uni-marburg.de Principal Investigator: Anja RINKE United Kingdom Royal Free Hospital Neuroendocrine Tumour Unit Recruiting London, United Kingdom Contact: Liz WOODFORD ewoodford@nhs.net Principal Investigator: Christos TOUMPANAKIS Manchester Academic Health Sciences Centre (MAHSC) Recruiting Manchester, United Kingdom Contact: Marie WOOLEY marie.wooley@christie.nhs.uk Principal Investigator: Juan W VALLE 收起 << |
NCT02300831 | - | Completed | - | - | |
NCT03285594 | Type 2 Diabetes Mellitus | Phase 3 | Active, not recruiting | August 24, 2019 | - |
NCT02818998 | Macular Edema | Phase 3 | Active, not recruiting | October 18, 2019 | - |
NCT03081494 | Metastatic Colorectal Cancer | Phase 1 | Recruiting | February 28, 2019 | Australia, New South Wales ... 展开 >> Novartis Investigative Site Active, not recruiting St Leonards, New South Wales, Australia, 2065 Australia, Western Australia Novartis Investigative Site Active, not recruiting Murdoch, Western Australia, Australia, 6150 Canada, Quebec Novartis Investigative Site Completed Montreal, Quebec, Canada, H3T 1E2 France Novartis Investigative Site Completed Toulouse Cedex 9, France, 31059 Israel Novartis Investigative Site Recruiting Tel Aviv, Israel, 64239 Italy Novartis Investigative Site Withdrawn Milano, MI, Italy, 20162 Novartis Investigative Site Withdrawn Rozzano, MI, Italy, 20089 Japan Novartis Investigative Site Completed Kashiwa, Chiba, Japan, 277-8577 Korea, Republic of Novartis Investigative Site Active, not recruiting Seoul, Korea, Korea, Republic of, 05505 Netherlands Novartis Investigative Site Recruiting Leiden, Netherlands, 2333 ZA Singapore Novartis Investigative Site Completed Singapore, Singapore, 169610 Spain Novartis Investigative Site Completed Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Terminated Madrid, Spain, 28040 Novartis Investigative Site Completed Madrid, Spain, 28041 收起 << |
NCT02277769 | - | Completed | - | - | |
NCT02574455 | Breast Cancer | Phase 3 | Recruiting | June 2020 | - |
NCT02269943 | - | Completed | - | - | |
NCT02269943 | Nasopharyngeal Neoplasms | Phase 2 | Completed | - | - |
NCT01689233 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT01231555 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 2 | Terminated | - | France ... 展开 >> GSK Investigational Site Levallois Perret, France, 92300 GSK Investigational Site Montpellier Cedex 5, France, 34295 GSK Investigational Site Nice, France, 06202 GSK Investigational Site Paris, France, 75018 Germany GSK Investigational Site Frankfurt, Hessen, Germany, 60311 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Berlin, Germany, 12157 GSK Investigational Site Hamburg, Germany, 20146 GSK Investigational Site Hamburg, Germany, 20246 Spain GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Barcelona, Spain, 08036 GSK Investigational Site Marid, Spain, 28040 收起 << |
NCT01231555 | - | Terminated | - | - | |
NCT01519661 | Pulmonary Infections ... 展开 >> Pseudomonas Aeruginosa in Cystic Fibrosis 收起 << | Phase 4 | Completed | - | - |
NCT01519661 | - | Completed | - | - | |
NCT01524276 | - | Recruiting | January 2030 | - | |
NCT01718379 | Myelodysplastic Syndromes | Phase 2 | Completed | - | - |
NCT02304393 | Solid Tumors | Phase 1 | Recruiting | October 3, 2019 | United States, Alabama ... 展开 >> University of Alabama Recruiting Birmingham, Alabama, United States, 35226 United States, Arizona Scottsdale Healthcare Hospitals DBA HonorHealth Recruiting Scottsdale, Arizona, United States, 85258 United States, California University of California San Diego Medical Center; Moores Cancer Center Recruiting La Jolla, California, United States, 92093 United States, Pennsylvania University of Pennsylvania Active, not recruiting Philadelphia, Pennsylvania, United States, 19104 Canada, Ontario University Health Network; Princess Margaret Hospital; Medical Oncology Dept Recruiting Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Jewish General Hospital / McGill University Suspended Montreal, Quebec, Canada, H3T 1E2 Denmark Rigshospitalet; Onkologisk Klinik Recruiting København Ø, Denmark, 2100 France Aphm; Cpcet Recruiting Marseille, France, 13385 Hopital Saint Louis, Service D Oncologie Medicale Active, not recruiting Paris, France, 75475 Institut Gustave Roussy; Sitep Recruiting VILLEJUIF Cedex, France, 94805 Netherlands Antoni van Leeuwenhoek Ziekenhuis Recruiting Amsterdam, Netherlands, 1066 CX Erasmus Medisch Centrum Rotterdam; Lokatie Daniel den Hoed Recruiting Rotterdam, Netherlands, 3015 GD Spain ICO L'Hospitalet; Servicio de oncologia medica Not yet recruiting L Hospitalet De Llobregat, Barcelona, Spain, 08908 Hospital Univ Vall d'Hebron; Servicio de Oncologia Recruiting Barcelona, Spain, 08035 START Madrid. Centro Integral Oncologico Clara Campal; CIOCC Recruiting Madrid, Spain, 28050 Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia Not yet recruiting Valencia, Spain, 46010 收起 << |
NCT00769405 | Colorectal Cancer ... 展开 >> Primary Peritoneal Cavity Cancer 收起 << | Phase 3 | Completed | - | France ... 展开 >> Centre Paul Papin Angers, France, 49036 Hôpital Antoine Béclère Clamart, France, 92141 CHU Estaing Clermont Ferrand, France, 63003 Louis Mourier Hospital Colombes Cedex, France, 92701 Hopital Du Bocage Dijon, France, 21034 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Centre Leon Berard Lyon, France, 69373 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Hopital de l'Archet CHU de Nice Nice, France, F-06202 Institut Curie Paris, France, 75005 Hopital Lariboisiere Paris, France, 75010 Hôpital Lariboisière Paris, France, 75010 Hopital Tenon Paris, France, 75970 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Institut Jean Godinot Reims, France, 51056 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Centre Hospitalier Regional de Purpan Toulouse, France, 31059 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 收起 << |
NCT01348087 | - | Terminated(Study treatment AFQ... 展开 >>056 failed to demonstrate efficacy in the adult patient with Fragile X Syndrome in 2 other clinical studies (CAFQ056B2214 and CAFQ056A2212)) 收起 << | - | - | |
NCT01745640 | Multiple Myeloma | Phase 2 | Completed | - | France ... 展开 >> CHRU-Hôpital Sud Amiens Amiens, France, 80054 Chru Caen Caen, France, 14033 CHU DIJON, Hôpital d'Enfants Dijon, France, 21000 CHRU, Hôpital A.Michallon Grenoble, France, 38043 Centre hospitalier départemental La Roche sur Yon La Roche sur Yon, France, 85025 Chru Lille Lille, France, 59037 Institut Paoli Calmette, Marseille, France, 13273 CHRU, Hôtel Dieu Nantes, France, 44035 Hôpital Saint-Louis Paris, France, 75475 CHU - Hôpital St Antoine, Paris, France, 75571 Hôpital Haut-Leveque PESSAC cedex, France, 33604 Centre Hospitalier Lyon Sud -1 Pierre Benite, France, 69495 Centre Hospitalier Lyon Sud -2 Pierre Benite, France, 69495 CHRU POITIERS-Hôpital Jean Bernard Poitiers, France, 86021 Hôpital Robert Debré, CHU Reims Reims, France, 51092 CHRU RENNES 2, Hôpital Pontchaillou Rennes, France, 35033 CHRU RENNES 1, Hôpital Sud Rennes, France, 35056 CHRU, Hôpital Purpan Toulouse, France, 31059 CHRU- Hôpital Bretonneau Tours, France, 37044 CHRU, Hôpitaux de Brabois Vandoeuvre, France, 54511 收起 << |
NCT01348087 | Fragile X Syndrome | Phase 2 | Terminated(Study treatment AFQ... 展开 >>056 failed to demonstrate efficacy in the adult patient with Fragile X Syndrome in 2 other clinical studies (CAFQ056B2214 and CAFQ056A2212)) 收起 << | - | - |
NCT02273739 | Solid Tumor G... 展开 >>lioma Angioimmunoblastic T-cell Lymphoma Intrahepatic Cholangiocarcinoma Chondrosarcoma 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Los Angeles, California, United States, 90095 Los Angeles, California, United States, 91010 United States, Florida Miami, Florida, United States, 33136 United States, Maryland Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston, Massachusetts, United States, 02114 United States, Nebraska Omaha, Nebraska, United States, 68198 United States, New York New York, New York, United States, 10065 United States, Ohio Cleveland, Ohio, United States, 44195 United States, Tennessee Nashville, Tennessee, United States, 37203 United States, Texas Dallas, Texas, United States, 75390 France Bordeaux, France, 61283 33076 Villejuif Cedex, France, 94805 收起 << |
NCT02149160 | Granulin Mutation | Phase 2 | Unknown | - | United States, California ... 展开 >> UCSF Memory and Aging Center San Francisco, California, United States United States, Florida Compass Research, LLC Orlando, Florida, United States United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, Minnesota Mayo Clinic Rochester, Minnesota, United States United States, Pennsylvania Perelman School of Medicine, University of Pennsylvania Philadelphia, Pennsylvania, United States Belgium University Hospitals Leuven Leuven, Belgium France CHU Bordeaux Hospital Pellegrin Bordeaux Cedex, France CHU Rouen, Charles Nicolle Hospital Rouen, France Italy IRCCS - Centro S. Giovanni di Dio FateBeneFratelli Brescia, Italy Neurological Clinic, University of Brescia, AO Civil Hospital of Brescia Brescia, Italy Fondazione Universita Gabriele D'Annunzio di Chieti Chieti Scalo, Italy Netherlands Erasmus Medical Center Rotterdam, Zuid-Holland, Netherlands United Kingdom The National Hospital for Neurology and Neuroscience London, United Kingdom 收起 << |
NCT01574053 | - | Recruiting | January 2062 | - | |
NCT01948180 | Lymphoma, Extranodal NK-T-Cell... 展开 >> EBV 收起 << | Phase 2 | Recruiting | September 2019 | United States, California ... 展开 >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Rosemarie Abary 626-218-8087 rabary@coh.org Principal Investigator: Elizabeth Budde, MD United States, District of Columbia Children's National Medical Center Recruiting Washington, D.C., District of Columbia, United States, 20010 Contact: Nana Ama K Afari-Dwamena 202-476-6768 nafaridwam@childrensnational.org Principal Investigator: Catherine Bollard, MD United States, Massachusetts Dana-Farber Cancer Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Kristin McHugh 617-582-7292 KMMCHUGH@PARTNERS.ORG Principal Investigator: Eric Jacobsen, MD United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Kristen Arends 507-284-5736 arends.kristen@mayo.edu Principal Investigator: Yi Lin, MD United States, New Jersey John Theurer Cancer Center at Hackensack UMC Withdrawn Hackensack, New Jersey, United States, 07601 United States, New York New York-Presbyterian/Weill Cornell Recruiting New York, New York, United States, 10065 Contact: Marissa Contento 212-746-1858 mac2363@med.cornell.edu Principal Investigator: Jia Ruan, MD United States, Ohio The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Raoof Giali 614-688-7313 Raoof.Giali@osumc.edu Principal Investigator: Jonathan Brammer, MD United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Vicky Torrano 832-824-7821 vxtorran@txch.org Principal Investigator: Helen Heslop, MD MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Linda Claret 713-792-1044 LCClaret@mdanderson.org Principal Investigator: Yasushiro Oki, MD France Centre Hospitalier Universitaire de Limoges Recruiting Limoges Cedex, France, 87042 Contact: Fabienne Auroy +33 (0)5 55 05 86 33 fabienne.auroy@chu-limoges.fr Principal Investigator: Arnaud Jaccard, Prof Universitaire Ouest Recruiting Paris, France, 75015 Contact: Thamila Berdous-Saheb +33 (0)1 44 49 56 83 thamila.berdous-saheb@nck.aphp.fr Principal Investigator: Felipe Suarez, Prof Centre Hospitalier de Lyon Recruiting Pierre Bénite, France, 69310 Contact: Cécile Francoise +33 (0)4 78 86 42 23 ext-cecile.francoise@chu-lyon.fr Principal Investigator: Gilles Salles, Prof. Germany Charite Withdrawn Berlin, Germany, 13353 Askelpios Klinik St Georg Withdrawn Hamburg, Germany, 20099 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Withdrawn Mainz, Germany, 55131 Korea, Republic of Korean Cancer Center Recruiting Seoul, Korea, Korea, Republic of, 139-709 Contact: Gyeong Ja Go +82-2-970-2530 bi-mil@hanmail.net Principal Investigator: Hye Jin Kang, Prof Severance Hospital, Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 120-752 Contact: Jong Eun Lee +02-2228-4242 515riz@yuhs.ac Principal Investigator: Jin Seok Kim Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Woo Rim Lee + 02-2148-9173 wr87.lee@samsung.com Principal Investigator: Won-Seog Kim Asan Cancer Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Hyunji Jun + 82-2-3010-3229 hyunjii@amc.seoul.kr Principal Investigator: CheolWon Suh United Kingdom University College London Hospital Recruiting London, UK, United Kingdom, NW1 2PG Contact: Thomas Taylor 020 3447 7834 Thomas.Taylor2@uclh.nhs.uk Principal Investigator: Kirit Ardeshna The Christie Clinic Recruiting Manchester, UK, United Kingdom, M20 4BX Contact: Joanna Dash 0161 9187964 Joanna.Dash@christie.nhs.uk Principal Investigator: John Radford 收起 << |
NCT02129699 | Lung Cancer Non-small Cell Sta... 展开 >>ge IV 收起 << | Phase 3 | Active, not recruiting | September 2020 | - |
NCT01395810 | Congenital Bleeding Disorder ... 展开 >> Haemophilia B 收起 << | Phase 3 | Completed | - | - |
NCT01395810 | - | Completed | - | - | |
NCT01569750 | CD20-positive B-cell Non-Hodgk... 展开 >>in Lymphoma 收起 << | Phase 1 | Completed | - | United States, New York ... 展开 >> New York, New York, United States Rochester, New York, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Houston, Texas, United States France Lille Cedex, France Paris, France Vandoeuvre Les Nancy, France 收起 << |
NCT02374099 | Breast Neoplasms | Phase 2 | Terminated | - | - |
NCT00491621 | Kidney Neoplasms | Not Applicable | Terminated(No enough inclusion... 展开 >>. The aim is no longer relevant. The sponsor decided to stop this study.) 收起 << | - | France ... 展开 >> CHU de Grenoble Grenoble, France, 38043 Hospices Civils de Lyon - Edouard Herriot LYON cedex 03, France, 69437 AP-HM Hôpital Nord Marseille, France, 13015 AP-HM Hôpital Salvator Marseille, France, 13274 CHU de Nancy Nancy, France, 54511 CHU de Saint-Etienne Saint-etienne, France, 42055 CHU de Toulouse Toulouse, France, 31403 收起 << |
NCT01575561 | Bipolar I Disorder | Phase 3 | Completed | - | - |
NCT02746952 | B-cell Acute Lymphoblastic Leu... 展开 >>kemia 收起 << | Phase 1 | Active, not recruiting | July 2020 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 France Hôpital Saint-Antoine PARIS Cedex 12, France, 75571 Hôpital Saint-Louis Paris, France, 75010 United Kingdom King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX 收起 << |
NCT01575561 | - | Completed | - | - | |
NCT01433354 | Fragile X Syndrome | Phase 2 Phase 3 | Terminated(The study treatment... 展开 >> failed to demonstrate efficacy in target population in two other clinical studies (CAFQ056B2214 and CAFQ056A2212).) 收起 << | - | - |
NCT02410512 | Neoplasms | Phase 1 | Active, not recruiting | August 12, 2018 | - |
NCT01433354 | - | Terminated(The study treatment... 展开 >> failed to demonstrate efficacy in target population in two other clinical studies (CAFQ056B2214 and CAFQ056A2212).) 收起 << | - | - | |
NCT02374099 | - | Terminated | - | - | |
NCT01439867 | - | Terminated(Sponsor decision) | - | - | |
NCT02004522 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma 收起 << | Phase 3 | Active, not recruiting | June 2021 | - |
NCT01439867 | Chronic Kidney Disease ... 展开 >> Hyperparathyroidism, Secondary 收起 << | Phase 2 | Terminated(Sponsor decision) | - | - |
NCT01659970 | - | Completed | - | - | |
NCT01826487 | Muscular Dystrophy, Duchenne ... 展开 >> Muscular Dystrophies Muscular Disorders, Atrophic Muscular Diseases Musculoskeletal Diseases Neuromuscular Diseases Nervous System Diseases Genetic Diseases, X-Linked Genetic Diseases, Inborn 收起 << | Phase 3 | Completed | - | - |
NCT01454739 | - | Completed | - | - | |
NCT01660451 | Lymphoma, Non-Hodgkin | Phase 2 | Active, not recruiting | March 8, 2019 | - |
NCT02252653 | - | Completed | - | - | |
NCT01454739 | Hemophilia A | Phase 3 | Completed | - | - |
NCT01663623 | Vasculitis | Phase 3 | Completed | - | - |
NCT01663623 | - | Completed | - | - | |
NCT01702571 | Breast Cancer | Phase 3 | Active, not recruiting | September 30, 2019 | - |
NCT01866930 | Chronic Hepatitis C Infection | Phase 3 | Completed | - | - |
NCT01502774 | ST Elevation Acute Myocardial ... 展开 >>Infarction 收起 << | Phase 3 | Completed | - | - |
NCT01660451 | - | Active, not recruiting | - | - | |
NCT02115750 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01513473 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT02510261 | Amyloidosis | Phase 3 | Enrolling by invitation | August 2022 | - |
NCT02770170 | Lupus Nephritis | Phase 2 | Recruiting | August 31, 2020 | - |
NCT02528357 | Cancer | Phase 1 | Recruiting | January 31, 2020 | United States, Massachusetts ... 展开 >> GSK Investigational Site Recruiting Boston, Massachusetts, United States, 02215 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Not yet recruiting New York, New York, United States, 10016 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting New York, New York, United States, 10065 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Tennessee GSK Investigational Site Recruiting Nashville, Tennessee, United States, 37203 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Texas GSK Investigational Site Not yet recruiting Houston, Texas, United States, 77030 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Canada, Ontario GSK Investigational Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com France GSK Investigational Site Recruiting Villejuif cedex, France, 94805 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT01940471 | HBV Chronic H... 展开 >>BV Infection 收起 << | Phase 3 | Active, not recruiting | November 2023 | - |
NCT01431716 | - | Completed | - | - | |
NCT02808780 | - | Recruiting | July 30, 2031 | - | |
NCT01513473 | - | Completed | - | - | |
NCT01773187 | Primary Myelofibrosis ... 展开 >> Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis 收起 << | Phase 3 | Terminated | - | - |
NCT02300987 | Teratoma | Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Los Angeles, California, United States, 90033 United States, Indiana Novartis Investigative Site Indianapolis, Indiana, United States, 46202 United States, Minnesota Mayo Clinic - Rochester Onc Department Rochester, Minnesota, United States, 55905 United States, New Mexico Novartis Investigative Site Albuquerque, New Mexico, United States, 87106 United States, New York Novartis Investigative Site New York, New York, United States, 10017 France Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Spain Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28041 收起 << |
NCT01940471 | - | Active, not recruiting | - | - | |
NCT01592747 | Autism Spectrum Disorder (ASD)... 展开 >> Autism Autistic Disorder Asperger's Disorder Asperger's Pediatric Autism Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Pervasive Child Development Disorder 收起 << | Phase 2 | Completed | - | - |
NCT02992483 | Multiple Myeloma (MM), Lymphom... 展开 >>a, Large B-Cell, Diffuse (DLBCL), Lymphoma 收起 << | Phase 1 | Recruiting | April 15, 2020 | United States, Ohio ... 展开 >> Novartis Investigative Site Recruiting Columbus, Ohio, United States, 43210 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Australia, Victoria Novartis Investigative Site Recruiting Heidelberg, Victoria, Australia, 3084 France Novartis Investigative Site Recruiting Nantes Cedex 1, France, 44093 Germany Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Novartis Investigative Site Recruiting Kiel, Germany, 24105 Italy Novartis Investigative Site Recruiting Rozzano, MI, Italy, 20089 Japan Novartis Investigative Site Recruiting Fukuoka-city, Fukuoka, Japan, 811-1395 Spain Novartis Investigative Site Recruiting Salamanca, Castilla Y Leon, Spain, 37007 收起 << |
NCT01592773 | Autism Spectrum Disorder (ASD)... 展开 >> Autism Autistic Disorder Asperger's Disorder Asperger's Pediatric Autism Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) 收起 << | Phase 2 | Terminated(Terminated because ... 展开 >>primary efficacy parameter failed to demonstrate statistically significant difference between memantine and placebo in controlled trials) 收起 << | - | - |
NCT01592773 | - | Terminated(Terminated because ... 展开 >>primary efficacy parameter failed to demonstrate statistically significant difference between memantine and placebo in controlled trials) 收起 << | - | - | |
NCT01431716 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> UZ Gasthuisberg Leuven, Belgium, 3000 Canada, Ontario University Health Network, Toronto TGH - 10 EN - 220 Toronto, Ontario, Canada, M5G 2N2 Canada, Quebec Sir Mortimer B Davis Jewish General Hospital Montreal, Quebec, Canada, H3T 1 E2 France Centre Hospitalier Universitaire Caen, France, 14033 Hôpital Antoine Béclère Clamart Cedex, France, 92141 Italy Orsola Malpighi Bologna, Italy, 40138 Netherlands VU Medisch Centrum (VUMC) Amsterdam, Netherlands, 1081 HV Spain Hospital Vall d'Hebron Barcelona, Spain, 8035 收起 << |
NCT01836523 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT01625390 | Hemophilia A, Hemophilia B | Phase 2 Phase 3 | Completed | - | - |
NCT02482298 | Sickle Cell Disease | Phase 2 | Completed | - | United States, Florida ... 展开 >> Research Site Miami, Florida, United States, 33136 United States, Maryland Research Site Bethesda, Maryland, United States, 20817 United States, South Carolina Research Site Charleston, South Carolina, United States, 29425 Egypt Research Site Alexandria, Egypt, 21131 Research Site Cairo, Egypt, 11566 Research Site Cairo, Egypt France Research Site Bordeaux Cedex, France, 33076 Research Site Strasbourg, France, 67091 Italy Research Site Verona, Italy, 37134 Kenya Research Site Kisian, Kenya, 40100 Research Site Kisumu, Kenya, 40100 Research Site Nairobi, Kenya, 00100 Lebanon Research Site Beirut, Lebanon, 1107 2020 Research Site Beirut, Lebanon, 113-6044 Turkey Research Site Adana, Turkey, 01130 Research Site Mersin, Turkey, 33079 Research Site Van, Turkey, 65080 United Kingdom Research Site Harrow, United Kingdom, HA1 3UJ Research Site London, United Kingdom, E1 1BB Research Site London, United Kingdom, E9 6SR 收起 << |
NCT01836523 | - | Completed | - | - | |
NCT02482298 | - | Completed | - | - | |
NCT00866281 | Acute Myeloid Leukemia ... 展开 >> Acute Lymphoblastic Leukemia 收起 << | Phase 1 Phase 2 | Terminated(Despite considerabl... 展开 >>e efforts to boost recruitment during the final year of the study, no new patients were enrolled.) 收起 << | - | United States, Washington ... 展开 >> Seattle Children's Hospital CPKC412A2114 Seattle, Washington, United States, 98105 France Novartis Investigative Site Paris Cedex 19, France, 75935 Italy Novartis Investigative Site Genova, GE, Italy, 16147 Novartis Investigative Site Monza, MB, Italy, 20900 Novartis Investigative Site Roma, RM, Italy, 00165 Novartis Investigative Site Torino, TO, Italy, 10126 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 GJ Sweden Novartis Investigative Site Stockholm, Sweden, SE-171 76 收起 << |
NCT02684357 | Psoriasis | Phase 3 | Completed | - | - |
NCT00866281 | - | Terminated(Despite considerabl... 展开 >>e efforts to boost recruitment during the final year of the study, no new patients were enrolled.) 收起 << | - | - | |
NCT02052778 | Cholangiocarcinoma ... 展开 >> Brain Tumor Urothelial Cancer Other Tumor Types With FGFR2 Gene Fusions Activating Mutations FGFR2 Amplification 收起 << | Phase 1 Phase 2 | Recruiting | September 2019 | - |
NCT02013271 | - | Completed | - | Austria ... 展开 >> LKH-Univ. Klinikum Graz Graz, Austria, 8036 Belgium ZNA-Campus Middelheim Antwerpen, Belgium, 2020 UZA Antwerp University Hospital Edegem, Belgium, 2650 Ziekenhuis Oost Limburg Genk, Belgium, 3600 AZ Groeninge Kortrijk, Belgium, 8500 France CHU Bordeaux Talence cedex, France, 33404 Germany Ev.Krankenhaus Königin Elisabeth Berlin, Germany, 10365 Asklepios Klinik St. Georg Hamburg, Germany, 20099 University Clinical Center Heidelberg Heidelberg, Germany, 69120 Westfälische Wilhelms-Universität Münster Münster, Germany, 48149 Krankenhaus Barmherzige Brüder Regensburg Regensburg, Germany, 93049 Medinos Kliniken Sonneberg Sonneberg, Germany, 96515 Universitätsklinikum Tübingen Tuebingen, Germany, 72076 Switzerland Luzerner Kantonsspital, Division of Angiology Lucerne, Switzerland, 6000 收起 << | |
NCT01866111 | Partial Epilepsy | Phase 2 | Active, not recruiting | December 2019 | - |
NCT02077868 | Metastatic Colorectal Cancer | Phase 3 | Active, not recruiting | May 2020 | - |
NCT02751918 | Ovarian Neoplasms | Phase 1 | Recruiting | September 25, 2020 | United States, California ... 展开 >> University of California, Los Angeles Not yet recruiting Los Angeles, California, United States, 90095 United States, Colorado Rocky Mountain Cancer Centers Recruiting Aurora, Colorado, United States, 80012 United States, Connecticut Yale University School of Medicine Recruiting New Haven, Connecticut, United States, 06520-8064 United States, Ohio University of Cincinnati Not yet recruiting Cincinnati, Ohio, United States, 45267 United States, Oklahoma Oklahoma University Health Science Center Recruiting Oklahoma City, Oklahoma, United States, 73104 United States, Oregon Oncology Associates of Oregon Not yet recruiting Eugene, Oregon, United States, 97401 Belgium UZ Leuven Gasthuisberg Recruiting Leuven, Belgium, 3000 France Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Japan Aichi Cancer Center Hospital Not yet recruiting Nagoya, Aichi, Japan, 464-8681 Nippon Medical School Musashikosugi Hospital Not yet recruiting Kawasaki, Kanagawa, Japan, 211-8533 Saitama Medical University International Medical Center Not yet recruiting Hidaka, Saitama, Japan, 350-1298 National Cancer Center Hospital Not yet recruiting Chuo-ku, Tokyo, Japan, 104-0045 Moldova, Republic of The Institute of Oncology Recruiting Chisinau, Moldova, Republic of, 2025 Spain Ciutat Sanitària i Universitaria de la Vall d'Hebron Recruiting Barcelona, Spain, 08035 Clinica Universidad de Navarra CUN en Madrid Recruiting Madrid, Spain, 28027 Clínica Universidad de Navarra CUN Recruiting Pamplona, Spain, 31008 Instituto Valenciano de Oncología Recruiting Valencia, Spain, 46009 收起 << |
NCT02090959 | Muscular Dystrophy, Duchenne ... 展开 >> Muscular Dystrophies Muscular Disorders, Atrophic Muscular Diseases Musculoskeletal Diseases Neuromuscular Diseases Nervous System Diseases Genetic Diseases, X-Linked Genetic Diseases, Inborn 收起 << | Phase 3 | Active, not recruiting | June 2018 | - |
NCT02750514 | Advanced Cancer | Phase 2 | Recruiting | April 29, 2021 | - |
NCT03001882 | Non-Small Cell Lung Cancer | Phase 2 | Recruiting | December 14, 2021 | - |
NCT01895777 | Venous Thromboembolism | Phase 3 | Recruiting | February 28, 2020 | - |
NCT00925002 | ATTR-PN | Phase 3 | Active, not recruiting | December 31, 2021 | United States, Maryland ... 展开 >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Argentina FLENI Ciudad Autonoma de Buenos aires, Argentina, C1428AQK Brazil Hospital Universitário Clementino Fraga Filho -HUCFF Universidade Federal do Rio de Janeiro Rio de Janeiro, RJ, Brazil, CEP 21941-913 France CHU Henri Mondor Creteil cedex, France, 94010 Germany Universitatsklinikum Muenster Muenster, Germany, 48149 Italy Centro per lo Studio e la Cura delle Amiloidosi Sistemiche IRCCS - Policlinico San Matteo Pavia, Italy, 27100 Dipartimento di Neurofisiopatologia Pavia, Italy, 27100 Fondazione IRCCS Policlinico San Matteo Pavia, Italy, 27100 IRCCS Pavia, Italy, 27100 Portugal Centro Hospitalar Lisboa Norte, EPE- Hospital de Santa Maria Lisboa, Portugal, 1649-028 Unidade Clinica de Paramiloidose, EPE - Centro Hospitalar do Porto, Hospital Geral de Santo Antonio Porto, Portugal, 4099-001 Sweden Norrlands University Hospital Umea, Sweden, 90185 Umea Universtiy Hospital Umea, Sweden, 90187 收起 << |
NCT01915576 | Neoplasms | Phase 1 | Completed | - | United States, California ... 展开 >> Santa Monica, California, United States, 90404 United States, Massachusetts Boston, Massachusetts, United States, 02215 United States, Missouri St. Louis, Missouri, United States, 63110 United States, Texas Houston, Texas, United States, 77030 France Villejuif Cedex, France, 94805 Germany Heidelberg, Baden-Württemberg, Germany, 69120 Switzerland St. Gallen, Sankt Gallen, Switzerland, 9007 收起 << |
NCT01896232 | - | Completed | - | - | |
NCT02791334 | Solid Tumor M... 展开 >>icrosatellite Instability-High (MSI-H) Solid Tumors Cutaneous Melanoma Pancreatic Cancer Breast Cancer (HR+HER2-) 收起 << | Phase 1 | Recruiting | July 31, 2020 | United States, Tennessee ... 展开 >> Sarah Cannon Research Institute SCRI Recruiting Nashville, Tennessee, United States, 37203 Contact 615-329-7274 Principal Investigator: SMO Sarah Cannon Research Inst. Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact 6153297274 Principal Investigator: Johanna Chock Bendell United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact 713-745-6754 Principal Investigator: Timothy Yap The START Center for Cancer Care Recruiting San Antonio, Texas, United States, 78229 Contact 210-593-5270 Principal Investigator: Amita Patnaik Belgium Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact 327645106 Principal Investigator: Jean-Pascal Machiels Universitair Ziekenhuis Antwerpen Recruiting Edegem, Belgium, 2650 Contact 3238213954 Principal Investigator: Marc Peeters Canada, Ontario Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5TY 2M9 Contact 4169464501 Principal Investigator: Marcus O Butler France Institut Bergonie Recruiting Bordeaux, France, 33076 Contact 33556333253 Principal Investigator: Antoine Italiano Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Contact 33142114385 Principal Investigator: Antoine Hollebecque Korea, Republic of Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact 82220722390 Principal Investigator: YUNG-JUE BANG Severance Hospital Yonsei University Health System Recruiting Seoul, Korea, Republic of, 03722 Contact 82222288132 Principal Investigator: Hyun Cheol Chung Spain Fundacion Jimenez Diaz Not yet recruiting Madrid, Spain, 28040 Contact 34915504800 Principal Investigator: Victor Moreno Hospital Madrid Norte Sanchinarro Recruiting Madrid, Spain, 28050 Contact 34917567825 Principal Investigator: Maria Jose Miguel Luken Taiwan National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact 88662353535 Principal Investigator: Wu-Chou Su National Taiwan University Hospital Recruiting Taipei, Taiwan, 10048 Contact +886223123456 ext. 67680 Principal Investigator: Chia-Chi Lin 收起 << |
NCT02576431 | Carcinoma, Non-Small-Cell Lung... 展开 >> Thyroid Neoplasms Sarcoma Colorectal Neoplasms Salivary Gland Neoplasms Biliary Tract Neoplasms Brain Neoplasm, Primary Carcinoma, Ductal, Breast Melanoma Solid Tumors Glioblastoma Bile Duct Neoplasms Astrocytoma Head and Neck Squamous Cell Carcinoma Pontine Glioma Pancreatic Neoplasms Ovarian Neoplasms Carcinoma, Renal Cell Cholangiocarcinoma Carcinoma Carcinoma, Bronchogenic Bronchial Neoplasms Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms, Nerve Tissue Nevi and Melanomas 收起 << | Phase 2 | Recruiting | December 2019 | - |
NCT01731600 | Congenital Bleeding Disorder ... 展开 >> Haemophilia A 收起 << | Phase 3 | Completed | - | - |
NCT00751205 | Prostate Cancer ... 展开 >> Ovarian Cancer 收起 << | Phase 2 | Completed | - | Belgium ... 展开 >> Bruxelles - Brussel, Belgium, 1200 France Caen, France, 14076 Montpellier Cedex, France, 34298 Nantes, France, 44805 Paris, France, 75012 Villejuif, France, 94805 Germany Tübingen, Baden-Württemberg, Germany, 72076 Rostock, Mecklenburg-Vorpommern, Germany, 18059 Bonn, Nordrhein-Westfalen, Germany, 53105 Essen, Nordrhein-Westfalen, Germany, 45122 Essen, Nordrhein-Westfalen, Germany, 45147 Magdeburg, Sachsen-Anhalt, Germany, 38108 Italy Meldola, Forlì, Italy, 47014 Bologna, Italy, 40138 Rimini, Italy, 47900 Roma, Italy, 00189 Netherlands Amsterdam, Netherlands, 1066 CX Amsterdam, Netherlands, 1081 HV Leiden, Netherlands, 2333 ZA Maastricht, Netherlands, 6229 HX United Kingdom Leicester, Leicestershire, United Kingdom, LE1 5WW Northwood, Middlesex, United Kingdom, HA6 2RN 收起 << |
NCT02571777 | Asthma | Phase 3 | Recruiting | June 3, 2019 | - |
NCT01954394 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02857270 | Advanced Cancer ... 展开 >> Metastatic Melanoma Metastatic Non-small Cell Lung Cancer Metastatic Pancreatic Ductal Adenocarcinoma Colorectal Cancer 收起 << | Phase 1 | Recruiting | July 13, 2020 | United States, District of Col... 展开 >>umbia Georgetown University Medical Center Not yet recruiting Washington, District of Columbia, United States, 20007 Contact 202-444-2223 Principal Investigator: Stephen V Liu United States, Florida Florida Cancer Specialists Recruiting Sarasota, Florida, United States, 34232 Contact 9413779993 Principal Investigator: Manish Rajni Patel United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact 617-643-3614 Principal Investigator: Ryan Sullivan United States, New Hampshire Dartmouth Hitchcock Medical Center Not yet recruiting Lebanon, New Hampshire, United States, 03756-0001 Contact 603-650-6344 Principal Investigator: Konstantin Dragnev United States, Pennsylvania UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232-1305 Contact 412-864-7859 Principal Investigator: Timothy F Burns United States, Tennessee Sarah Cannon Cancer Center Recruiting Nashville, Tennessee, United States, 37203 Contact 615-329-7274 Principal Investigator: SMO Sarah Cannon Research Inst. Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact 6153297274 Principal Investigator: Johanna Chock Bendell United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact 713-745-6601 Principal Investigator: Shubham Pant Australia, New South Wales St Vincent's Hospital Recruiting Sydney, New South Wales, Australia, 2010 Contact 61293555655 Principal Investigator: Anthony Joshua Australia, Western Australia Linear Clinical Research Ltd Recruiting Nedlands, Western Australia, Australia, 6009 Contact 61861510923 Principal Investigator: Michael J Millward France Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Contact 33142114385 Principal Investigator: Antoine Hollebecque 收起 << |
NCT01794507 | Relapsed/Refractory Multiple M... 展开 >>yeloma 收起 << | Phase 1 | Active, not recruiting | January 3, 2019 | United States, Arizona ... 展开 >> University Arizona Cancer Ctr /ID# 117876 Tucson, Arizona, United States, 85719-1478 United States, Florida Mayo Clinic /ID# 121495 Jacksonville, Florida, United States, 32224 United States, Illinois Northwestern University /ID# 117477 Chicago, Illinois, United States, 60611-2927 United States, Michigan University of Michigan Hospitals /ID# 80353 Ann Arbor, Michigan, United States, 48109-5008 United States, Minnesota Mayo Clinic - Rochester /ID# 77235 Rochester, Minnesota, United States, 55905-0001 Australia, Victoria Peter MacCallum Cancer Ctr /ID# 79553 Melbourne, Victoria, Australia, 3000 Royal Melbourne Hospital /ID# 79533 Parkville, Victoria, Australia, 3050 France CHRU Lille - Hôpital Claude Huriez /ID# 77234 Lille CEDEX, Hauts-de-France, France, 59045 CHU de Nantes, Hotel Dieu -HME /ID# 78773 Nantes, France, 44093 收起 << |
NCT01959282 | Colitis, Ulcerative | Phase 2 | Completed | - | - |
NCT02136901 | Meniscectomy ... 展开 >>Osteoarthritis 收起 << | Not Applicable | Active, not recruiting | June 2020 | Belgium ... 展开 >> AZ Monica Antwerp, Belgium, BE-2018 France Centre Hospitalier de Versailles Le Chesnay CEDEX, France, F 78158 Germany Universitätsklinikum Freiburg Freiburg, Germany, 79106 University Hospital of Munich Munich, Germany, 81377 Universitätklinikum Regensburg Regensburg, Germany, 93042 Israel Ichilov Hospital Tel Aviv, Israel, 64239 Meuhedet HCO Tel-Aviv, Israel, 62038 Assaf Harofeh Medical Center Zerifin, Israel, 70300 Italy Ospedale Sacro Cuore - Don Calabria Negrar, Verona, Italy, 37024 Netherlands Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 66202 Sweden Hallands Sjukhus Kungsbacka Kungsbacka, Halland, Sweden, SE-434 80 收起 << |
NCT02875548 | Diffuse Large B-cell Lymphoma ... 展开 >> Follicular Lymphoma Malignant Rhabdoid Tumors (MRT) Rhabdoid Tumors of the Kidney (RTK) Atypical Teratoid Rhabdoid Tumors (ATRT) Synovial Sarcoma Epitheliod Sarcoma Mesothelioma Advanced Solid Tumors 收起 << | Phase 2 | Recruiting | April 2024 | United States, Arizona ... 展开 >> Recruiting Tucson, Arizona, United States, 85719 United States, New York Recruiting New York, New York, United States, 10038 Australia Recruiting Clayton, Australia, 3168 Recruiting East Melbourne, Australia, 3002 France Recruiting Bordeaux, France Recruiting Lille, France Recruiting Montpellier, France Recruiting Pierre-Bénite, France Recruiting Rouen, France Recruiting Villejuif Cedex, France United Kingdom Recruiting Leicester, United Kingdom Recruiting London, United Kingdom 收起 << |
NCT01988961 | Colitis, Ulcerative | Phase 2 | Completed | - | - |
NCT02245568 | Alzheimer's Disease ... 展开 >> Behavioral Variant Frontotemporal Dementia 收起 << | Phase 3 | Terminated | - | - |
NCT02258464 | Breast Neoplasms | Phase 2 | Active, not recruiting | March 15, 2019 | - |
NCT01954394 | - | Completed | - | - | |
NCT01338493 | - | Completed | - | Canada ... 展开 >> Montreal General Hospital Quebec, Canada, H3G1A4 France CHU Pellegrin Tripode Bordeaux, France, 33076 CH Antoine Béclère - Service de Chirurgie Orthopédique Clamart, France, 92141 Service de Chirurgie Orthopédique, AP-HP, Hôpital Beaujon Clichy, France, 92110 Clinique de Neurochirurgie Hôpital Roger Salengro Lille Cedex, France, 59037 CH La Timone Marseille, France, 13385 CH de Meulan - Service de Chirurgie Orthopédique Meulan, France, 78250 Service de Neurochirurgie Hôpital Nice Nice, France, 06300 CH Lariboisière, Service de Neurochirurgie Paris, France, 75010 Clinique du Cours Dillon Toulouse, France, 31300 Germany Charité Berlin - Klinik für Orthopädie Berlin, Germany, 10117 Universitätsklinikum Magdeburg Magdeburg, Germany, 39120 Praxis für Orthopädie und Neurochirurgie Potsdam Potsdam, Germany, 14482 收起 << | |
NCT01338493 | - | Completed | - | - | |
NCT01896232 | Secondary Hyperparathyroidism ... 展开 >> Chronic Kidney Disease 收起 << | Phase 3 | Completed | - | - |
NCT00690612 | Hypertension | Phase 3 | Completed | - | Belgium ... 展开 >> Research Site Edegem, Belgium Research Site Gent, Belgium France Research Site Strasbourg Cedex, France Germany Research Site Erlangen, Germany Research Site Heidelberg, Germany Research Site Marburg, Germany Research Site Rostock, Germany Italy Research Site Genova, GE, Italy Research Site Padova, PD, Italy Poland Research Site Gda�sk, Poland Research Site Krakow, Poland Ukraine Research Site Crimea, Ukraine Research Site Kyiv, Ukraine 收起 << |
NCT02042183 | Constipation - Functional | Phase 3 | Completed | - | - |
NCT02735980 | Small Cell Lung Cancer | Phase 2 | Active, not recruiting | February 28, 2019 | - |
NCT01839526 | Fabry Disease | Not Applicable | Terminated(Enrollment period n... 展开 >>ot extended and screening stopped for slow recruitment and in accordance with provisions of the protocol. Not linked to any safety concern) 收起 << | - | - |
NCT02070991 | Pulmonary Hypertension | Phase 2 | Completed | - | - |
NCT02203773 | Acute Myelogenous Leukemia ... 展开 >> Myelogenous Leukemia Treatment Naive AML 收起 << | Phase 1 Phase 2 | Active, not recruiting | March 27, 2020 | - |
NCT02316106 | Multiple Myeloma | Phase 2 | Active, not recruiting | July 17, 2020 | - |
NCT02093897 | Congenital Hemophilia A | Phase 3 | Completed | - | - |
NCT00690612 | - | Completed | - | - | |
NCT02302495 | Multiple Myeloma | Phase 2 | Active, not recruiting | July 2021 | France ... 展开 >> Centre Hospitalier H. Duffaut Avignon, France, 84902 Centre Hospitalier de la côte basque Bayonne, France, 64109 Hôpital Jean Minjoz Besançon, France, 25030 Institut Bergonie Bordeaux, France, 33076 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33300 Centre Hospitalier William Morey Chalons-sur-Saone, France, 71100 Centre Hospitalier de Chambery Chambery, France, 73011 Hôpital St Antoine Béclére Clamart, France, 92140 CH Louis Pasteur Colmar, France, 68024 CH Francilien Corbeil - Essonnes, France, 91106 CHU Henri Mondor Creteil, France, 94010 Hématologie Clinique, CHU, Hôpital d'Enfants Dijon, France, 21000 Centre hospitalier départemental La Roche sur Yon La Roche sur Yon, France, 85025 Centre Jean Bernard Le Mans, France, 72000 Hôpital St Vincent de Paul - GH-ICL Lille, France, 59020 Chru Lille Lille, France, 59037 CHU de Limoges Limoges, France, 87000 Hématologie, Institut Paoli Calmette Marseille, France, 13273 CH Meaux Meaux, France, 77104 Hôpital Notre Dame de Bon Secours Metz, France, 57038 Hopital J Monod Montivilliers, France, 76290 Hôpital E Muller Mulhouse, France, 68100 CHRU, Hôtel Dieu Nantes, France, 44035 Centre de NICE 2/ Hôpital Archet Nice, France, 06202 CHU Nimes CAREMEAU Nimes, France, 30029 Hôpital St Antoine Paris, France, 75571 Groupe hospitalier Pitié Salpétrière Paris, France, 75651 Hôpital Haut-Leveque PESSAC cedex, France, 33604 Centre Hospitalier Lyon Sud -1 Pierre Benite, France, 69495 Unité de Recherche Clinique - CH Perigueux Périgueux, France, 24019 Hématologie Clinique, Hôpital Robert Debré, CHU Reims Reims, France, 51092 Hématologie, IUCT oncopole Toulouse, France, 31059 CHRU, Hôpitaux de Brabois Vandoeuvre, France, 54511 收起 << |
NCT01485159 | - | Completed | - | Belgium ... 展开 >> GSK Investigational Site Gent, Belgium, 9000 France GSK Investigational Site Toulouse cedex 09, France, 31059 Germany GSK Investigational Site Neu-Isenburg, Hessen, Germany, 63263 GSK Investigational Site Berlin, Germany, 13347 Greece GSK Investigational Site Thessaloniki, Greece, 570 10 Ireland GSK Investigational Site Dublin, Ireland, 4 GSK Investigational Site Dublin, Ireland, 9 Italy GSK Investigational Site Modena, Emilia-Romagna, Italy, 41124 GSK Investigational Site Tradate (VA), Lombardia, Italy, 21049 Netherlands GSK Investigational Site Amersfoort, Netherlands, 3818 ES GSK Investigational Site Sneek, Netherlands, 8601 ZK Spain GSK Investigational Site Madrid, Spain, 28046 GSK Investigational Site Palma de Mallorca, Spain, 07010 Sweden GSK Investigational Site Lund, Sweden, SE-222 21 GSK Investigational Site Malmö, Sweden, SE-205 02 收起 << | |
NCT01355445 | RHABDOMYOSARCOMA | Phase 2 | Active, not recruiting | September 2023 | France ... 展开 >> Centre Hospitalier Universitaire Nord Amiens, France, 80000 Hôpital des Enfants, Groupe Hospitalier Pellegrin Bordeaux, France, 33076 CHU Morvan Brest, France CHU Estaing Clermont ferrand, France, 63003 Centre Oscar Lambret Lille cedex, France, 59020 Centre Léon Bérard Lyon, France CHU, Hôpital d'Enfants de la Timone Marseille, France Hôpital Arnaud de Villeneuve - CHU Montpellier, France CHU, Hôpital Mère enfants Nantes, France Hôpital Armand Trousseau Paris, France Institut Curie Paris, France Hôpital Jean Bernard Poitiers, France CHU - Hôpital Américain Reims, France CHU Rennes - Hôpital Sud Rennes, France CHU St Etienne - Hôpital Nord Saint-Etienne, France Hôpital de Hautepierre Strasbourg, France Hôpital des enfants Toulouse, France CHRU Tours, France CHRU Hôpital d'Enfants Vandoeuvre les Nancy, France Institut Gustave Roussy Villejuif, France 收起 << |
NCT02323178 | CMML Thromboc... 展开 >>ytopenia 收起 << | Phase 1 Phase 2 | Active, not recruiting | December 2019 | France ... 展开 >> CHU d'Amiens Amiens, France, 80054 CHU d'Angers Angers, France, 49 033 CH Victor Dupouy Argenteuil, France, 95107 Hôpital Avicenne Bobigny, France, 93009 Hôpital privé Sévigné Cesson-Sévigné, France, 35510 CHU Henri Mondor Créteil, France, 94010 CHU de Grenoble Grenoble, France, 38043 CH Le Mans Le Mans, France, 72037 CHRU de Limoges Limoges, France, 87046 Centre Hospitalier Lyon Sud Lyon, France, 69495 Institut Paoli Calmettes Marseille, France, 13009 Centre Hospitalier de Meaux Meaux, France, 77100 CHU de Nantes Nantes, France, 44093 Centre Catherine de Sienne Nantes, France, 44277 Hôpital Archet 1 Nice, France, 06202 Hôpital Saint Louis - Service d'hématologie AJA Paris, France, 75010 Hôpital Saint Louis - Service d'hématologie séniors Paris, France, 75010 CHU de Haut-Lévèque Pessac, France, 33604 CHU de Poitiers Poitiers, France, 86021 Centre Hospitalier de la région d'Annecy Pringy cedex, France, 74374 Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Hôpital Purpan - Médecine interne Toulouse, France, 31059 Hôpital Purpan - Service d'Hématologie Clinique Toulouse, France, 31059 CHU Brabois Vandoeuvre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT03053596 | - | Active, not recruiting | December 2019 | Belgium ... 展开 >> Cliniques Universitaires Saint Luc Brussels, Belgium Hôpital Erasme Brussels, Belgium France Hôpital Beaujon Clinchamp, France CHRU Lille Lille, France Hôpital Universitaire Saint-Eloi Montpellier, France Hôpital L'Archet II Nice, France Institut Gustave Roussy Villejuif Cedex, France 收起 << | |
NCT02093897 | - | Completed | - | - | |
NCT02344004 | Mycobacterium Infections, Nont... 展开 >>uberculous 收起 << | Phase 3 | Active, not recruiting | April 9, 2019 | - |
NCT00062686 | Neoplasms, Breast | Phase 2 | Completed | - | Argentina ... 展开 >> GSK Investigational Site Buenos Aires, Argentina, C1455BWU France GSK Investigational Site Villejuif Cedex, France, 94805 Germany GSK Investigational Site Augsburg, Bayern, Germany, 86150 United Kingdom GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT GSK Investigational Site Bebington, Wirral, United Kingdom, CH63 4JY GSK Investigational Site London, United Kingdom, SW3 6JJ GSK Investigational Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT02119663 | Pancreatic Cancer | Phase 3 | Terminated(The safety committe... 展开 >>e found no safety issues but recommended halting the study based on a lack of efficacy in a similar trial. The sponsor terminated the trial.) 收起 << | - | - |
NCT02119663 | - | Terminated(The safety committe... 展开 >>e found no safety issues but recommended halting the study based on a lack of efficacy in a similar trial. The sponsor terminated the trial.) 收起 << | - | - | |
NCT01877915 | Heart Failure ... 展开 >> Coronary Artery Disease 收起 << | Phase 3 | Completed | - | - |
NCT02581995 | Macular Edema | Phase 4 | Completed | - | - |
NCT02581995 | - | Completed | - | - | |
NCT02344004 | - | Active, not recruiting | - | - | |
NCT02125877 | Chronic Iron Overload Due to T... 展开 >>ransfusion-dependant Anemias 收起 << | Phase 2 | Completed | - | - |
NCT02144610 | Critical Limb Ischemia | Phase 3 | Terminated | - | - |
NCT02338843 | Catecholamine-resistant Hypote... 展开 >>nsion (CRH) Distributive Shock High Output Shock Sepsis 收起 << | Phase 3 | Completed | - | - |
NCT02125877 | - | Completed | - | - | |
NCT02338843 | - | Completed | - | - | |
NCT03091192 | Carcinoma Car... 展开 >>cinoma, Renal Cell Kidney Neoplasms Urologic Neoplasms Kidney Diseases Neoplasms by Site Enzyme Inhibitors Protein Kinase Inhibitors 收起 << | Phase 3 | Active, not recruiting | June 24, 2020 | - |
NCT02809053 | Lymphoma, Follicular | Phase 3 | Recruiting | May 2019 | - |
NCT03130959 | Various Advanced Cancer | Phase 2 | Recruiting | June 15, 2021 | - |
NCT01617967 | TTR-mediated Amyloidosis | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Clinical Trial Site Boston, Massachusetts, United States Brazil Clinical Trial Site Rio de Janeiro, Brazil France Clinical Trial Site Le Kremlin-bicetre, France Clinical Trial Site Marseille Cedex, France Germany Clinical Trial Site Munster, Germany Portugal Clinical Trial Site Lisbon, Portugal Clinical Trial Site Porto, Portugal Spain Clinical Trial Site Barcelona, Spain Clinical Trial Site Palma De Mallorca, Spain Sweden Clinical Trial Site Umeå, Sweden 收起 << |
NCT02345070 | Idiopathic Pulmonary Fibrosis | Phase 2 | Completed | - | - |
NCT02382939 | Adult Growth Hormone Deficienc... 展开 >>y Growth Hormone Disorder 收起 << | Phase 3 | Completed | - | Denmark ... 展开 >> Novo Nordisk Investigational Site København Ø, Denmark, 2100 Novo Nordisk Investigational Site Odense, Denmark, 5000 Novo Nordisk Investigational Site Århus C, Denmark, 8000 France Novo Nordisk Investigational Site Angers, France, 49000 Novo Nordisk Investigational Site Brest, France, 29609 Novo Nordisk Investigational Site Bron, France, 69677 Novo Nordisk Investigational Site DIJON cedex, France, 21079 Novo Nordisk Investigational Site Saint Herblain, France, 44800 Germany Novo Nordisk Investigational Site Aachen, Germany, 52074 Novo Nordisk Investigational Site Berlin, Germany, 10117 Novo Nordisk Investigational Site Frankfurt, Germany, 60596 Japan Novo Nordisk Investigational Site Bunkyo-ku, Tokyo, Japan, 113-8603 Novo Nordisk Investigational Site Itabashi-ku, Tokyo, Japan, 173-8606 Novo Nordisk Investigational Site Izumo, Shimane, Japan, 691-8501 Novo Nordisk Investigational Site Kobe, Hyogo, Japan, 650-0017 Novo Nordisk Investigational Site Kobe-shi, Hyogo, Japan, 657-0846 Novo Nordisk Investigational Site Kyoto-shi Kyoto, Japan, 612-8555 Novo Nordisk Investigational Site Okayama, Okayama, Japan, 700-8558 Novo Nordisk Investigational Site Sagamihara-shi, Kanagawa, Japan, 252-0375 Sweden Novo Nordisk Investigational Site Göteborg, Sweden, 413 45 Novo Nordisk Investigational Site Lund, Sweden, 221 85 Novo Nordisk Investigational Site Stockholm, Sweden, 171 76 United Kingdom Novo Nordisk Investigational Site Birmingham, United Kingdom, B15 2TH Novo Nordisk Investigational Site Exeter, United Kingdom, EX2 5DW Novo Nordisk Investigational Site Leeds, United Kingdom, LS9 7TF Novo Nordisk Investigational Site London, United Kingdom, EC1A 7BE Novo Nordisk Investigational Site London, United Kingdom, SE5 9RS Novo Nordisk Investigational Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT01617967 | - | Completed | - | - | |
NCT03424005 | Triple Negative Breast Cancer | Phase 1 Phase 2 | Recruiting | August 1, 2021 | United States, California ... 展开 >> University of California San Diego Medical Center; Moores Cancer Center Recruiting La Jolla, California, United States, 92093 United States, Florida H. Lee Moffitt Cancer Center and Research Inst. Recruiting Tampa, Florida, United States, 33612 United States, New Jersey Hackensack Univ Medical Center; John Theurer Cancer Ctr Recruiting Hackensack, New Jersey, United States, 07601 Rutgers Cancer Institute of New Jersey Not yet recruiting New Brunswick, New Jersey, United States, 08901 United States, New York NYU Langone Medical Center; NYU Perlmutter Cancer Center Recruiting New York, New York, United States, 10016 United States, Pennsylvania Thomas Jefferson University Hospital Recruiting Philadelphia, Pennsylvania, United States, 19107 University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee The West Clinic; West Cancer Center Recruiting Germantown, Tennessee, United States, 38138 Australia, Victoria Peter MacCallum Cancer Centre-East Melbourne Recruiting Melbourne, Victoria, Australia, 3000 France Centre Léon Bérard Recruiting Lyon, France, 69008 Institut Universitaire du Cancer de Toulouse-Oncopole Recruiting Toulouse, France, 31059 Gustave Roussy Not yet recruiting Villejuif CEDEX, France, 94800 Germany Universitätsklinikum Erlangen; Frauenklinik Not yet recruiting Erlangen, Germany, 91054 Universitätsklinikum Essen Recruiting Essen, Germany, 45147 Korea, Republic of Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 University of Ulsan College of Medicine - Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Spain Vall d´Hebron Institute of Oncology (VHIO), Barcelona Recruiting Barcelona, Spain, 08035 Hospital Universitario Ramon y Cajal Recruiting Madrid, Spain, 28034 Centro Integral Oncológico Clara Campal Ensayos Clínicos START Recruiting Madrid, Spain, 28050 United Kingdom Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 0YN Barts Health NHS Trust - St Bartholomew's Hospital Recruiting London, United Kingdom, EC1A 7BE 收起 << |
NCT03368664 | Multiple Sclerosis | Phase 3 | Recruiting | March 2025 | - |
NCT02454270 | Leukemia, Lymphocytic, Chronic... 展开 >>, B-Cell Lymphoma, Large B-Cell, Diffuse Lymphoma, Follicular Lymphoma, Mantle-Cell Precursor Cell Lymphoblastic Leukemia-Lymphoma 收起 << | Phase 1 | Completed | - | United States, Michigan ... 展开 >> Detroit, Michigan, United States United States, New York New York, New York, United States United States, Ohio Columbus, Ohio, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Houston, Texas, United States Belgium Edegem, Belgium Leuven, Belgium Wilrijk, Belgium France Lille, France Pierre Benite, France Rennes, France Tours Cedex, France Israel Haifa, Israel Jerusalem, Israel Ramat Gan, Israel Tel Aviv, Israel Spain Barcelona, Spain Madrid, Spain Salamanca, Spain 收起 << |
NCT03022409 | Head and Neck Squamous Cell Ca... 展开 >>rcinoma 收起 << | Phase 1 | Recruiting | September 3, 2019 | United States, Pennsylvania ... 展开 >> Research Site Recruiting Pittsburgh, Pennsylvania, United States, 15240 Research Site Not yet recruiting Pittsburgh, Pennsylvania, United States, 15240 France Research Site Not yet recruiting Toulouse cedex 9, France, 31052 Research Site Not yet recruiting Villejuif, France, 94805 Taiwan Research Site Not yet recruiting Taipei, Taiwan, 100 United Kingdom Research Site Not yet recruiting Birmingham, United Kingdom, B15 2TT Research Site Not yet recruiting Manchester, United Kingdom, M20 4BX 收起 << |
NCT02247531 | Geographic Atrophy | Phase 3 | Terminated | - | - |
NCT02421510 | Type 1 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02247804 | Glaucoma, Open-Angle ... 展开 >> Ocular Hypertension 收起 << | Phase 3 | Active, not recruiting | July 31, 2019 | - |
NCT02294877 | - | Recruiting | September 2024 | - | |
NCT02323126 | Non Small Cell Lung Cancer | Phase 2 | Recruiting | April 11, 2022 | United States, Alabama ... 展开 >> Novartis Investigative Site Completed Birmingham, Alabama, United States, 35294 United States, Massachusetts Novartis Investigative Site Completed Boston, Massachusetts, United States, 02114 United States, North Carolina Novartis Investigative Site Completed Charlotte, North Carolina, United States, 28203 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Justina M. Price 713-794-5325 jusprice@mdanderson.org Principal Investigator: Vassiliki A Papadimitrakopoulou Australia, New South Wales Novartis Investigative Site Recruiting Camperdown, New South Wales, Australia, 2050 Australia, Queensland Novartis Investigative Site Recruiting Chermside, Queensland, Australia, 4032 Australia, South Australia Novartis Investigative Site Recruiting Adelaide, South Australia, Australia, 5000 France Novartis Investigative Site Recruiting Caen Cedex, France, 14021 Novartis Investigative Site Recruiting La Tronche, France, 38700 Germany Novartis Investigative Site Recruiting Koeln, Nordrhein-Westfalen, Germany, 50937 Novartis Investigative Site Recruiting Wurzburg, Germany, 97080 Italy Novartis Investigative Site Recruiting Perugia, PG, Italy, 06129 Novartis Investigative Site Recruiting Pisa, PI, Italy, 56124 Novartis Investigative Site Recruiting Aviano, PN, Italy, 33081 Netherlands NKI-AVL, Department of Thoracic-Oncology Recruiting Amsterdam, Netherlands, 1066 CX Contact: E.F. Smit, Prof. 0031-20-5122958 e.smit@nki.nl Principal Investigator: E.F. Smit, Prof. Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Alicante, Comunidad Valenciana, Spain, 03010 Novartis Investigative Site Recruiting Madrid, Spain, 28040 Switzerland Novartis Investigative Site Recruiting Chur, Switzerland, 7000 Novartis Investigative Site Recruiting Geneve, Switzerland, 1211 收起 << |
NCT02408549 | Epilepsy | Phase 3 | Enrolling by invitation | March 2024 | - |
NCT02807181 | Intrahepatic Cholangiocarcinom... 展开 >>a 收起 << | Phase 2 Phase 3 | Recruiting | June 2021 | - |
NCT01063231 | Colonic Diseases ... 展开 >> and Large Bowel Diseases 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> Hospital Erasme - Gastro-Enterologie Brussels, Belgium, 1070 France Chef de Service dHepato-Gastro-Enterologie et dAssistance Nutritionnelle CHU Nantes Nantes, France, 44093 CHU Nancy Vandoeuvre Cedex, France, 54511 Germany Evangelisches Krankenhaus Dusseldorf, Germany, 40217 Italy Ospedale Gemelli,ENDOSCOPIA DIGESTIVA Roma, Italy, 00168 Netherlands Academic Medical Center University of Amsterdam Amsterdam, Netherlands, 1100 Spain Clinica Universitaria de Navarra Pamplona, Spain, 31008 Sweden Malmo University Hospital Malmo, Sweden 收起 << |
NCT02399072 | Geographic Atrophy | Not Applicable | Terminated(There is no longer ... 展开 >>a plan to pursue an approval of lampalizumab.) 收起 << | - | - |
NCT02357147 | Mesothelioma, Malignant | Phase 2 | Active, not recruiting | November 30, 2018 | - |
NCT02717611 | Chronic Lymphocytic Leukemia | Phase 2 | Active, not recruiting | February 2020 | - |
NCT02993523 | Acute Myeloid Leukemia (AML) | Phase 3 | Recruiting | January 22, 2021 | - |
NCT02734160 | Metastatic Pancreatic Cancer | Phase 1 | Active, not recruiting | June 17, 2019 | United States, Arizona ... 展开 >> Honor Health Research Institute Scottsdale, Arizona, United States, 85258 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute SCRI Nashville, Tennessee, United States, 37203 Tennessee Oncology PLLC Nashville, Tennessee, United States, 37203 France Gustave Roussy Villejuif Cedex, France, 94805 Italy Ospedale Policlinico Giambattista Rossi, Borgo Roma Verona, Italy, 37134 Korea, Republic of Samsung Medical Center Seoul, Korea, Korea, Republic of, 06351 Seoul National University Hospital Seoul, Korea, Republic of, 03080 Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 收起 << |
NCT01486277 | Lymphoma, T-Cell, Cutaneous | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Pittsburgh, Pennsylvania, United States France Nantes Cedex 1, France Paris, France Pessac, France Germany Kiel, Germany Minden, Germany Portugal Lisboa, Portugal Porto, Portugal Spain Madrid N/A, Spain Málaga, Spain Valencia, Spain United Kingdom London, United Kingdom Manchester, United Kingdom 收起 << |
NCT03559062 | Cystic Fibrosis | Phase 3 | Recruiting | February 2019 | Australia ... 展开 >> Hunter Medical Research Institute (HMRI) Recruiting New Lambton Heights, Australia Princess Margaret Hospital for Children Recruiting Perth, Australia Lady Cilento Children's Hospital Recruiting South Brisbane, Australia The Children's Hospital at Westmead Recruiting Westmead, Australia Belgium Universitair Ziekenhuis Brussel - Campus Jette Recruiting Brussels, Belgium Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg Recruiting Leuven, Belgium Denmark University of Copenhagen Rigshospitalet Recruiting Copenhagen, Denmark France Groupe Hospitalier Pellegrin - Hôpital des Enfants Recruiting Bordeaux Cedex, France Hôpital Necker - Enfants Malades Recruiting Paris, France Germany Universitaetsklinikum Essen Recruiting Essen, Germany Klinikum der Johann Wolfgang Goethe-Universitaet Recruiting Frankfurt, Germany Universitaetsklinikum Giessen und Marburg GmbH Standort Giessen Recruiting Giessen, Germany Medizinische Hochschule Hannover Recruiting Hannover, Germany Universitaetsklinikum Heidelberg Recruiting Heidelberg, Germany Universitaetsklinikum Jena Recruiting Jena, Germany Universitaetsklinikum Koeln Not yet recruiting Koeln, Germany Universitaetsklinikum Tuebingen Recruiting Tuebingen, Germany Ireland Our Lady's Children's Hospital Recruiting Dublin, Ireland University Hospital Limerick Recruiting Limerick, Ireland Poland Klinika Mukowiscydozy, Oddział Chorób Płuc SZP ZOZ Recruiting Dziekanow Lesny, Poland Switzerland Inselspital - Universitaetsspital Bern Recruiting Bern, Switzerland Kinderspital Zuerich Recruiting Zuerich, Switzerland United Kingdom Royal Hospital for Sick Children Recruiting Edinburgh, United Kingdom Leeds General Infirmary Recruiting Leeds, United Kingdom Royal Brompton Hospital Recruiting London, United Kingdom Nottingham University Hospital City Campus Recruiting Nottingham, United Kingdom Southampton General Hospital Recruiting Southampton, United Kingdom 收起 << |
NCT02477618 | Super-Refractory Status Epilep... 展开 >>ticus 收起 << | Phase 3 | Completed | - | - |
NCT02966795 | Hepatitis C Virus (HCV) | Phase 3 | Completed | - | United States, California ... 展开 >> Cedars-Sinai Medical Ctr /ID# 157045 Los Angeles, California, United States, 90048 Research & Education, Inc. /ID# 157042 San Diego, California, United States, 92105 Kaiser Permanente /ID# 157044 San Diego, California, United States, 92154 Zuckerberg San Francisco Gener /ID# 157040 San Francisco, California, United States, 94110 United States, Washington University of Washington /ID# 157041 Seattle, Washington, United States, 98109 Australia, New South Wales Nepean Hospital Kingswood /ID# 157027 Kingswood, New South Wales, Australia, 2747 Australia, Queensland Royal Brisbane and Women's Hospital /ID# 157025 Herston, Queensland, Australia, 4029 Australia, Victoria Royal Melbourne Hospital /ID# 157024 Parkville, Victoria, Australia, 3050 Belgium AZ Groeninge /ID# 157029 Kortrijk, Belgium, 8500 UZ Leuven /ID# 157030 Leuven, Belgium, 3000 Canada, Alberta University of Calgary /ID# 157031 Calgary, Alberta, Canada, T2N 4Z6 Canada, Ontario Toronto General Hospital /ID# 157032 Toronto, Ontario, Canada, M5G 2C4 France Hopital Haut-Lévêque /ID# 157035 Pessac CEDEX, Gironde, France, 33604 Hopital Beaujon /ID# 157028 Clichy, Ile-de-France, France, 92110 CHU Estaing /ID# 157034 Clermont Ferrand, France, 63100 Hopital Saint Antoine /ID# 157036 Paris, France, 75012 New Zealand Auckland Clinical Studies Ltd /ID# 157033 Auckland, New Zealand, 1010 Singapore National University Hospital /ID# 156855 Singapore, Singapore, 119074 Singapore General Hospital /ID# 157037 Singapore, Singapore, 169608 South Africa Wits Clinical Research Site /ID# 157038 Johannesburg, Gauteng, South Africa, 2193 University of Cape Town /ID# 157039 Cape Town, Western Cape, South Africa, 7925 Vietnam National Tropical Diseases Hos /ID# 162282 Hanoi, Vietnam, 100000 Hoa Hao Medic Co. Ltd. /ID# 162283 Ho Chi Minh, Vietnam, 700000 Tropical Diseases Hospital /ID# 162281 Ho Chi Minh, Vietnam 收起 << |
NCT03622580 | Diabetic Macular Edema | Phase 3 | Recruiting | June 2, 2022 | - |
NCT02499900 | - | Completed | - | - | |
NCT01516528 | - | Completed | - | - | |
NCT00868699 | Bipolar Depression | Phase 3 | Completed | - | - |
NCT00868452 | - | Completed | - | - | |
NCT02499900 | Multiple Sclerosis | Phase 4 | Completed | - | - |
NCT00868959 | - | Completed | - | - | |
NCT00868959 | Bipolar Depression | Phase 3 | Completed | - | - |
NCT00868699 | - | Completed | - | - | |
NCT00868452 | Bipolar Depression | Phase 3 | Completed | - | - |
NCT01350804 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00761371 | Warts | Phase 4 | Completed | - | Belgium ... 展开 >> Départment de Gynécologie-Obstétrique CHU Saint-Pierre Brussels, Belgium, B-1000 Service de Dermatologie CHU Saint-Pierre Brussels, Belgium, B-1000 Service Dermatologie C.H. François Rabelais (César de Paepe) Brussels, Belgium, B-1000 Service de Dermatologie Hôpital Erasme Brussels, Belgium, B-1070 France Service de Dermatologie et Vénéréologie Hôpital Saint Jacques Besancon Cedex, France, F-25030 Cabinet Médical Bordeaux, France, F-33800 Service de Dermatologie, Hôpital Ambroise Paré Boulogne Billancourt, France, F-92100 Service de Maladies Infectieuses Hôpital de la Conception Marseille, France, F-13005 Service de Dermatologie Hôtel Dieu Nantes, France, F-44000 Service de Dermatologie Hôpital de l'Archet II Nice, France, F-06202 Service Dermatologie Hopital COCHIN - Pavillon Tarnier Paris, France, F-75006 Cabinet Médical Paris, France, F-75011 Institut Alfred Fournier Paris, France, F-75014 Cabinet Médical Paris, France, F-75015 Service de Dermatologie Groupe Hospitalier Bichat Claude Bernard Paris, France, F-75018 Service de Dermatologie Hopital Tenon Paris, France, F-75020 Service de Dermatologie Groupe Hospitalier La Grave Toulouse, France, F-31052 Service de Dermatologie Centre Hospitalier de Valence Valence, France, F-26000 收起 << |
NCT01036529 | - | Terminated(Closed due to conti... 展开 >>nued slow enrollment.) 收起 << | - | - | |
NCT01036529 | Failed Back Surgery Syndrome ... 展开 >> Pain Back Pain 收起 << | Phase 4 | Terminated(Closed due to conti... 展开 >>nued slow enrollment.) 收起 << | - | United States, California ... 展开 >> Scripps Clinic La Jolla, California, United States, 92037 University of California San Diego La Jolla, California, United States, 92037 United States, Georgia Orthopedic Research Foundation Savannah, Georgia, United States, 31405 United States, Illinois Millenium Pain Center Bloomington, Illinois, United States, 61701 Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 The University of Illinois Medical Center Chicago, Illinois, United States, 60612 United States, Maryland Sinai Hospital of Baltimore Baltimore, Maryland, United States, 21209 United States, Montana St. Patrick Hospital Missoula, Montana, United States, 59802 United States, North Carolina The Center for Clinical Research, LLC Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Washington Swedish Neuroscience Institute Seattle, Washington, United States, 98122 Pacific Medical Center Seattle, Washington, United States, 98144 Canada, Saskatchewan Regina General Hospital Regina, Saskatchewan, Canada, S4P 0W5 Canada Hopital de Enfant-Jesus Quebec, Canada, G1J 1Z4 France CHU de Nantes-Hopital Laennec Nantes Cedex, France, 44093 United Kingdom Frenchay Hospital Bristol, United Kingdom, BS16 1LE James Cook University Hospital Middlesbrough, United Kingdom, TS4 3BW 收起 << |
NCT01350804 | - | Completed | - | - | |
NCT00733343 | Heart Failure ... 展开 >> Sleep Disordered Breathing 收起 << | Phase 4 | Completed | - | - |
NCT00914693 | Contraception | Phase 3 | Completed | - | - |
NCT00777127 | Actinic Keratosis | Phase 4 | Completed | - | Austria ... 展开 >> Hospital Feldkirch, Department for Dermatology and Venereology Feldkirch, Austria, A-6807 Medical University Graz, University Clinic for Dermatology and Venereology Graz, Austria, A-8036 Medical University Innsbruck, University Clinic for Dermatology and Venereology Innsbruck, Austria, A-6020 Medical University Vienna, Department for General Dermatology Vienna, Austria, A-1090 France CHU St Jacques, Department for Dermatology Besancon Cedex, France, F-25030 Hospital Sainte Marguerite, Department for Dermatology and Venereology, Pavilion 3, First Floor Marseille, France, F-13009 CHU Nice - Hospital Archet 2, Department for Dermatology Nice, France, F-06202 Hospital Saint-Louis, Derpartment for Dermatology Paris, France, F-75010 Hospital Center Lyon South, Department for Dermatology and Immuno-Allergology Pierre Benite, France, F-69495 Germany Licca Clinical Research Institute Augsburg, Germany, D-86179 Charite - Medicine University Berlin, Dermatoma Center, Clinic for Dermatology, Allergology and Venereology Berlin, Germany, D-10117 Medical Practice Dominicus / Bockhorst Duelmen, Germany, D-48249 Medical practice Düsseldorf, Germany, D-40210 University Clinic Düsseldorf, Clinic for Dermatology Düsseldorf, Germany, D-40255 Clinic and Medical Faculty of Johann Wolfgang Goethe-University, Center for Dermatology and Venereology Frankfurt am Main, Germany, D-60590 SCiderm GmbH Hamburg, Germany, D-20354 Medical Practice Hannover, Germany, D-30159 University Clinic Schleswig-Holstein, Campus Kiel, Clinic for Dermatology, Venereology and Allergology Kiel, Germany, D-24105 Medical Department of Otto-von-Guericke-University Magdeburg, University Clinic for Dermatology and Venereology Magdeburg, Germany, D-39120 Department of Dermatology J. Gutenberg-University Mainz, Clinical Research Center Mainz, Germany, D-55131 Science, Onco & Beauty GbR, Practice for Dermatology and Medical Cosmetics Mönchengladbach, Germany, D-41061 University Clinic Münster, Clinic and Polyclinic for Skin Diseases Münster, Germany, D-48149 Clinic University Regensburg, Clinic and Polyclinic for Dermatology Regensburg, Germany, D-93053 Derma Center Vechta Vechta, Germany, D-49377 Centrovital Witten, Germany, D-58453 Medical practice for Dermatology and Venerology Wuppertal, Germany, D-42275 收起 << |
NCT01567735 | Hepatitis C | Phase 3 | Completed | - | Belgium ... 展开 >> Antwerpen, Belgium Brussel, Belgium Edegem, Belgium France Clichy, France Creteil, France Lyon, France Paris, France Villejuif Cedex, France 收起 << |
NCT01358175 | - | Completed | - | - | |
NCT01358175 | Ankylosing Spondylitis | Phase 3 | Completed | - | - |
NCT01412944 | - | Completed | - | - | |
NCT01412944 | Plaque-type Psoriasis | Phase 3 | Completed | - | - |
NCT01894204 | HTPPE Idiopat... 展开 >>hic Pulmonary Embolism 收起 << | Not Applicable | Terminated(The maximum of incl... 展开 >>usions was reached) 收起 << | - | France ... 展开 >> CHRU de Brest Brest, France, 29609 CHU Clermont-Ferrand Clermont-Ferrand, France, 63003 CH de Lannion Lannion, France, 22300 Hôpital Européen Georges Pompidou Paris cedex 15, France, 75908 CHU Pontchaillou - Hôpital Sud Rennes, France, 35056 Hôpital Yves Le Foll Saint-Brieuc, France, 22027 Hôpital de Bellevue - CHU de Saint-Etienne Saint-Etienne, France, 45055 Hôpital Rangueuil Toulouse, France, 31059 收起 << |
NCT03480802 | Pneumococcal Infections | Phase 3 | Recruiting | April 13, 2020 | United States, Florida ... 展开 >> Bliss Healthcare Services ( Site 0010) Recruiting Orlando, Florida, United States, 32806 Contact: Study Coordinator 407-203-5984 Triple O Research Institute, P.A. ( Site 0011) Recruiting West Palm Beach, Florida, United States, 33407 Contact: Study Coordinator 561-855-7871 United States, Texas Saint Hope Foundation, Inc. ( Site 0009) Recruiting Houston, Texas, United States, 77060 Contact: Study Coordinator 832-300-8040 The Crofoot Research Center, Inc. ( Site 0002) Recruiting Houston, Texas, United States, 77098 Contact: Study Coordinator 713-526-0005 France Hopital Gabriel Montpied ( Site 0084) Recruiting Clemont Ferrand, France, 63000 Contact: Study Coordinator +33473178417 Hopital Saint Louis ( Site 0094) Recruiting Paris Cedex 10, France, 75475 Contact: Study Coordinator +33142494683 Hopital Cochin du Paris ( Site 0089) Recruiting Paris, France, 75014 Contact: Study Coordinator +33158412858 Peru Via Libre ( Site 0043) Recruiting Lima, Peru, 15001 Contact: Study Coordinator +51944817657 Investigaciones Medicas en Salud - INMENSA ( Site 0041) Recruiting Lima, Peru, 15046 Contact: Study Coordinator +5116136168 Thailand Siriraj Hosp (Prev&Social Med). ( Site 0183) Recruiting Bangkok, Thailand, 10700 Contact: Study Coordinator +6624197388 Research Institute for Health. ( Site 0182) Recruiting Chiang Mai, Thailand, 50200 Contact: Study Coordinator +66815310775 收起 << |
NCT03273153 | Advanced BRAFV600 Wild-type Me... 展开 >>lanoma 收起 << | Phase 3 | Recruiting | September 17, 2024 | - |
NCT02757963 | Prostatic Hyperplasia | Phase 4 | Completed | - | - |
NCT00976911 | Ovarian Cancer | Phase 3 | Completed | - | - |
NCT01453205 | - | Completed | - | - | |
NCT01126437 | - | Completed | - | - | |
NCT00977483 | Diabetic Polyneuropathy | Phase 3 | Completed | - | - |
NCT00976911 | - | Completed | - | - | |
NCT01453205 | Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | - | - |
NCT00977665 | Multiple System Atrophy | Phase 2 | Completed | - | - |
NCT01126437 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00977665 | - | Completed | - | - | |
NCT01634061 | Castration-resistant Prostate ... 展开 >>Cancer 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Cedars Sinai Medical Center SC Los Angeles, California, United States, 90048 United States, New Jersey Hackensack University Medical Center Hackensack Univ Hackensack, New Jersey, United States, 07601 Belgium Novartis Investigative Site Brussels, Belgium, BE-B-1200 Novartis Investigative Site Wilrijk, Belgium, 2610 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 4E6 France Novartis Investigative Site Marseille, France, 13273 Novartis Investigative Site Villejuif Cedex, France, 94805 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Madrid, Spain, 28041 United Kingdom Novartis Investigative Site Sutton, United Kingdom, SM2 5PT 收起 << |
NCT01466153 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) 收起 << | Phase 2 | Completed | - | - |
NCT01466153 | - | Completed | - | - | |
NCT01476475 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00300157 | Coronary Arteriosclerosis | Phase 3 | Completed | - | France ... 展开 >> Polyclinique du Parc Rambot Aix-en-Provence, France, 13100 Clinique Rhône Durance Avignon, France, 84082 Clinique Saint Augustin Bordeaux, France, 33000 Chu Brest Brest, France, 29609 CHU CAEN CAEN Cedex, France, 14033 Hôpital Cardiologique Lille, France, 59037 Clinique du Tonkin Lyon, France, 69100 Unité Cardio-Vasculaire Marseille, France, 13009 CHU NORD Marseille, France, 13326 Institut Hospitalier Jacques Cartier-ICPS Massy, France, 91300 Hôpital Bon Secours Metz, France, 57000 Clinique du Millénaire Montpellier, France, 34960 Nouvelles Cliniques Nantaises Nantes, France, 44000 Hôpital privé Les Franciscaines Nimes, France, 30000 CHU Caremeau Nimes, France, 30029 Hôpital COCHIN Paris, France, 75014 Institut Mutualiste Montsouris Paris, France, 75014 Groupe Hospitalier La Pitié-Salpetrière Paris, France, 75651 CHU Pontchaillou Rennes, France, 35033 Clinique Saint Hilaire Rouen, France, 76000 Hôpital Charles Nicolle Rouen, France, 76031 Institut Arnaud Tzanck Saint Laurent du Var, France, 06700 Centre Cardiologique du Nord Saint-Denis, France, 93200 CHU Toulouse Rangueil Toulouse, France, 31059 Clinique Pasteur Toulouse, France, 31100 Clinique Saint Gatien Tours, France, 37042 收起 << |
NCT01318902 | Light-Chain Amyloidosis | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Boston Medical Center Boston, Massachusetts, United States, 02118 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Canada, Ontario University Health Network Toronto, Ontario, Canada, M5G 2M9 France CHU Limoges, Department of Hematology and Cell Therapy, Reference Center for AL amyloidosis Limoges Cedex, France, 87042 Germany Universitatsklinikum Heidelberg Innere Medizin V; Hamatologie, Onkologie und Rheumatologie Heidelberg, Germany, D-69120 Italy Amyloidosis Research & Treatment Center, Fondazione IRCCS Policlinico San Matteo Pavia, Italy, 27100 收起 << |
NCT01480076 | Multiple Sclerosis | Phase 4 | Completed | - | - |
NCT01476475 | - | Completed | - | - | |
NCT01667419 | Melanoma | Phase 3 | Active, not recruiting | October 14, 2020 | - |
NCT01658436 | Pancreatic Neuroendocrine Tumo... 展开 >>rs (pNET) 收起 << | Phase 2 | Completed | - | United States, Indiana ... 展开 >> Indiana University SC Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute GastrointestionalCancer Clinic Boston, Massachusetts, United States, 02215 United States, New York Montefiore Medical Center SC-2 Bronx, New York, United States, 10467 United States, Ohio Ohio State Comprehensive Cancer Center/James Cancer Hospital SC Columbus, Ohio, United States, 43210 Austria Novartis Investigative Site Wien, Austria, A-1090 Belgium Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Lyon, France, 69437 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Essen, Germany, 45147 Italy Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Milano, MI, Italy, 20141 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Novartis Investigative Site Madrid, Spain, 28041 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT01957176 | Thrombocytopaenia | Phase 4 | Active, not recruiting | January 1, 2024 | Argentina ... 展开 >> Novartis Investigative Site La Plata, Buenos Aires, Argentina, B1900AXI Belgium Novartis Investigative Site Leuven, Belgium, 3000 China Novartis Investigative Site Shanghai, China, 200025 France Novartis Investigative Site Paris Cedex 12, France, 75571 Greece Novartis Investigative Site Athens, Greece, 11527 Novartis Investigative Site Heraklion, Crete, Greece, 71201 Hong Kong Novartis Investigative Site Shatin, Hong Kong Hungary Novartis Investigative Site Debrecen, Hungary, 4012 Ireland Novartis Investigative Site Tullamore, Ireland Israel Novartis Investigative Site Tel Aviv, Israel, 64239 Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of, 136-705 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Peru Novartis Investigative Site San Isidro, Lima, Peru, Lima 27 Poland Novartis Investigative Site Chorzow, Poland, 41-500 Romania Novartis Investigative Site Bucharest, Romania, 022328 Tunisia Novartis Investigative Site Montfleury, Tunisia, 1008 Novartis Investigative Site Sousse, Tunisia, 4000 收起 << |
NCT01020500 | - | Completed | - | - | |
NCT03379675 | Respiratory Syncytial Virus In... 展开 >>fections 收起 << | Phase 2 | Recruiting | August 8, 2019 | - |
NCT01480076 | - | Completed | - | - | |
NCT01026142 | Breast Cancer | Phase 3 | Completed | - | - |
NCT01026142 | - | Completed | - | - | |
NCT01215643 | Hepatitis C C... 展开 >>hronic Pain 收起 << | Phase 2 | Completed | - | - |
NCT00855218 | - | Completed | - | - | |
NCT01667419 | - | Active, not recruiting | - | - | |
NCT01658436 | - | Completed | - | - | |
NCT01688206 | Neoplasms | Phase 1 | Completed | - | Belgium ... 展开 >> Cliniques Universitaires St-Luc Bruxelles, Belgium, 1200 UZ Leuven Gasthuisberg Leuven, Belgium, 3000 France Institut Bergonie; Oncologie Bordeaux, France, 33076 Centre Francois Baclesse; Oncologie Caen, France, 14076 Centre Leon Berard; Departement Oncologie Medicale Lyon, France, 69373 Institut Curie; Oncologie Medicale Paris, France, 75231 ICO - Site René Gauducheau Saint Herblain, France, 44805 Institut Gustave Roussy; Sitep VILLEJUIF Cedex, France, 94805 Spain Clinica Universitaria de Navarra; Servicio de Oncologia Pamplona, Navarra, Spain, 31008 Hospital del Mar; Servicio de Oncologia Barcelona, Spain, 08003 Hospital Univ Vall d'Hebron; Servicio de Oncologia Barcelona, Spain, 08035 Hospital Universitario 12 de Octubre; Servicio de Oncologia Madrid, Spain, 28041 Centro Integral Oncologico Clara Campal (CIOCC); Dirección Médica Madrid, Spain, 28050 Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia Valencia, Spain, 46010 收起 << |
NCT02003612 | - | Completed | - | United States, Massachusetts ... 展开 >> Research Site Boston, Massachusetts, United States, 02215 United States, Ohio Research Site Cleveland, Ohio, United States, 44195 Czech Republic Research Site Brno, Czech Republic, 625 00 France Research Site Paris Cedex 10, France, 75475 Germany Research Site Frankfurt am Main, Germany, 60590 Italy Research Site Bologna, Italy, 40138 Research Site Venezia, Italy, 30174 Poland Research Site Gliwice, Poland, 44-101 Spain Research Site Badalona, Cataluña, Spain, 08916 United Kingdom Research Site London, United Kingdom, NW3 2PF 收起 << | |
NCT03400033 | Anaemia | Phase 3 | Recruiting | July 7, 2020 | - |
NCT00855218 | Carcinoma, Hepatocellular | Phase 2 | Completed | - | - |
NCT01054573 | - | Completed | - | - | |
NCT01065454 | Hypertension, Pulmonary ... 展开 >> Ventricular Dysfunction, Left 收起 << | Phase 2 | Active, not recruiting | April 30, 2020 | - |
NCT01215643 | - | Completed | - | - | |
NCT01054573 | Hepatitis C, Chronic | Phase 3 | Completed | - | - |
NCT01896479 | Medullary Thyroid Cancer | Phase 4 | Recruiting | October 2020 | - |
NCT01742286 | Anaplastic Lymphoma Kinase | Phase 1 | Recruiting | February 13, 2019 | - |
NCT01244490 | - | Completed | - | - | |
NCT01065454 | - | Active, not recruiting | - | - | |
NCT01251536 | Colorectal Cancer | Phase 2 | Active, not recruiting | March 2019 | Austria ... 展开 >> Universitätsklinik für Innere medizin, Klinishe abteilung für hämatologie und Onkologie Innsbruck, Austria LKH Leoben, abteilung f. innere Medizin Leoben, Austria AKH Linz, Innere Medizin 3, Zentrum für Hämatologie und medizinishe Onkologie Linz, Austria Landeskrankenhaus Salzburg, Univ. Klinik für innere Medizin III, Universitätsklinikum der PMU Salzburg, Austria Krankenanstalt Rudolfstiftung, 1 medizinishe Abteilung Wien, Austria St Vincent Krankenhaus Betriebs GmbH Zams, Austria Belgium Imelda Ziekenhuis Bonheiden, Belgium Erasme Hospital Brussels, Belgium, 1070 Cliniques Universitaires St Luc Brussels, Belgium, 1200 AZ Middelares Gent Gent, Belgium UZ Gent Gent, Belgium Centre Hospitalier de Jolimont-Lobbes, Oncology Médicale Haine Saint Paul, Belgium AZ Groeninge Kortrijk, Belgium, 8500 UZ Gasthuisberg Leuven, Belgium, 3000 CHC Saint Joseph Liege, Belgium AZ Sint Maarten Mechelen/Duffel Mechelen, Belgium H. Hartziekenhuis Roeselare, Belgium, 8800 AZ Turnhout (Campus St Elisabeth) Turnhout, Belgium France Hôpital Avicennes Bobigny, France Hôpital Saint-André Bordeaux, France, 33000 Hopital Européen Georges Pompidou Paris, France, 75015 Centre Eugène Marquis Rennes Cedex, France, 35042 CHU Charles Nicolle Rouen, France, 76031 Hungary State Health Center Budapest, Hungary, 1062 Medical Center of the University of Pecs , National Institute Oncology Budapest, Hungary, 1122 Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 8035 Institut Català d'Oncologia Barcelona, Spain Hospital Universitario Marqués de Valdecilla Santander, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital Clinico Universitario De Valencia Valencia, Spain 收起 << |
NCT01274182 | Rheumatoid Arthritis | Phase 1 Phase 2 | Completed | - | - |
NCT01244490 | Attention Deficit Hyperactivit... 展开 >>y Disorder 收起 << | Phase 3 | Completed | - | - |
NCT01915303 | Cushing's Disease | Phase 2 | Active, not recruiting | December 31, 2019 | - |
NCT01609296 | Peripheral Arterial Disease | Not Applicable | Active, not recruiting | December 2020 | - |
NCT01274182 | - | Completed | - | - | |
NCT01110915 | Magnetic Resonance Imaging ... 展开 >> Cardiac Pacemaker, Artificial 收起 << | Not Applicable | Completed | - | - |
NCT01964560 | Epilepsy | Phase 3 | Enrolling by invitation | June 2022 | - |
NCT01110915 | - | Completed | - | - | |
NCT01485302 | Alzheimer's Disease | Phase 1 | Completed | - | Bulgaria ... 展开 >> Investigational Site Number 100001 Sofia, Bulgaria, 1612 France Investigational Site Number 250001 Pierre Bénite, France, 69310 Investigational Site Number 250002 Toulouse Cedex 3, France, 31059 Netherlands Investigational Site Number 528001 Leiden, Netherlands, 2333 CL South Africa Investigational Site Number 710001 Bloemfontein, South Africa, 9301 Sweden Investigational Site Number 752003 Malmö, Sweden, 21224 Investigational Site Number 752002 Mölndal, Sweden, 43141 Investigational Site Number 752001 Stockholm, Sweden, 14186 收起 << |
NCT01142778 | Breast Cancer | Phase 2 | Completed | - | France ... 展开 >> Centre Radiotherapie Marie Curie Arras, France, 62000 Centre Hospitalier; Hematologie-Oncologie Beauvais, France, 60021 Clinique Tivoli; Sce Radiotherapie Bordeaux, France, 33000 Hopital Augustin Morvan; Federation De Cancerologie Brest, France, 29200 Centre Jean Perrin; Hopital De Jour Clermont Ferrand, France, 63011 Pole Sante Republique;Oncologie Hematologie Clermont Ferrand, France, 63050 Centre Georges Francois Leclerc; Oncologie 3 Dijon, France, 21079 Institut Daniel Hollard Grenoble, France, 38000 Centre Hospitalier Departemental Les Oudairies La Roche Sur Yon, France, 85925 Hopital Dupuytren; Oncologie Medicale Limoges, France, 87042 Centre Leon Berard; Oncologie Genetique Lyon, France, 69373 Hopital Clinique Claude Bernard; Oncologie Medicale Metz, France, 57000 Ch De Montlucon; Sce Med Interne Hemato Onco Montlucon, France, 03100 Institut régional du Cancer Montpellier Montpellier, France, 34298 Centre D'Oncologie de Gentilly; Oncology Nancy, France, 54100 Centre Antoine Lacassagne; Hopital De Jour A2 Nice, France, 06189 Institut Curie; Oncologie Medicale Paris, France, 75231 GH Paris Saint Joseph; Hopital De Jour Oncologie Paris, France, 75674 HOPITAL TENON; Cancerologie Medicale Paris, France, 75970 Clinique Francheville; Radiotherapie Perigueux, France, 24000 Institut Jean Godinot; Oncologie Medicale Reims CEDEX, France, 51056 Centre Eugene Marquis; Unite Huguenin Rennes, France, 35042 Clinique de L'Union; Oncologie Saint Jean, France, 31240 Institut de Cancerologie de La Loire; Radiotherapie St Priest En Jarez, France, 42271 Centre Paul Strauss; Oncologie Medicale Strasbourg, France, 67065 Clinique Pasteur; Oncologie Medicale Toulouse, France, 31076 Centre Henry S Kaplan - CHU Bretonneau ; service oncologie Tours, France, 37044 Centre Alexis Vautrin; Oncologie Medicale Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT01838551 | Endogenous Cushing's Syndrome | Phase 3 | Completed | - | - |
NCT01466660 | - | Active, not recruiting | - | - | |
NCT01697358 | Failed Back Surgery Syndrome ... 展开 >> Back Pain Pain in Leg, Unspecified 收起 << | Phase 4 | Completed | - | - |
NCT01677052 | - | Completed | - | - | |
NCT01466660 | Lung Neoplasms | Phase 2 | Active, not recruiting | October 16, 2018 | - |
NCT02065700 | Rheumatoid Arthritis | Phase 2 | Active, not recruiting | May 2023 | - |
NCT01202591 | FGFR Inhibition, Pharmacokinet... 展开 >>ics, Biomarkers ER+ Breast Cancer 收起 << | Phase 1 Phase 2 | Completed | - | Belgium ... 展开 >> Research Site Leuven, Belgium Research Site Namur, Belgium Czech Republic Research Site Brno, Czech Republic Research Site Praha 4, Czech Republic France Research Site Villejuif Cedex, France Germany Research Site Erlangen, Germany Research Site München, Germany Research Site Rostock, Germany Hungary Research Site Budapest, Hungary Research Site Kaposvár, Hungary Research Site Nyíregyháza, Hungary Research Site Szeged, Hungary Italy Research Site Genova, Italy Research Site Lido di Camaiore, Italy Research Site Roma, Italy Romania Research Site Cluj Napoca, Romania United Kingdom Research Site Dundee, United Kingdom Research Site London, United Kingdom Research Site Manchester, United Kingdom Research Site Oxford, United Kingdom Research Site Sutton, United Kingdom 收起 << |
NCT01202591 | - | Completed | - | - | |
NCT01055067 | Non-CNS Germ Cell Tumors (Semi... 展开 >>nomas and Nonseminomas) 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Los Angeles, California, United States, 90033 United States, Florida Orlando, Florida, United States, 32806 United States, Indiana Indianapolis, Indiana, United States, 46202 United States, Missouri Saint Louis, Missouri, United States, 63110 United States, New York New York, New York, United States, 10065 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 France Lyon cedex, France, 69373 Villejuif, France, 94800 United Kingdom Leeds, United Kingdom, LS9 7TF London, United Kingdom, SM2 5PT 收起 << |
NCT00627094 | Leg Ulcers | Not Applicable | Completed | - | Denmark ... 展开 >> Aarhus Universitetshospital Aarhus, Denmark, 8000 Bispebjerg Hospital Copenhagen, Denmark, 2400 Odense Universitets Hospital Odense, Denmark, 5000 France CHU de Brest Arras, France, 62000 CHU de Nancy - Hôpital Fournier Nancy Cedex, France, 54035 Germany Department for Dermatology, University School of Medicine Essen, Germany, 45122 Georg-August-Universität Göttingen Göttingen, Germany, 37075 Klinik für Dermatologie und Venerologie Hannover, Germany, 30449 Universitätsklinikum des Saarlandes Homburg/Saar, Germany, 66421 Dr. Renzo Bause Praxis Luedenscheid, Germany, 58511 Fachartzpraxis für Dermatologie, Allergologie, Lasermedizin Mahlow, Germany, 15831 Spain C.S. SERGAS Rosalía de Castro - Enfermero Vigo, Pontevedra, Spain, 36201 Hospital de Fuenlabrada Fuenlabrada, Spain, 28942 收起 << |
NCT01897571 | B-cell Lymphomas (Phase 1) ... 展开 >> Advanced Solid Tumors (Phase 1) Diffuse Large B-cell Lymphoma (Phase 2) Follicular Lymphoma (Phase 2) Transformed Follicular Lymphoma Primary Mediastinal Large B-Cell Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | January 2020 | - |
NCT00627094 | - | Completed | - | - | |
NCT01697358 | - | Completed | - | - | |
NCT01239732 | - | Completed | - | - | |
NCT01250379 | Breast Cancer | Phase 3 | Completed | - | - |
NCT01980290 | - | Completed | - | Belgium ... 展开 >> Antwerpen, Belgium Brussels, Belgium Bruxelles, Belgium Genk, Belgium Haine-Saint-Paul, Belgium France Lomme, France Montpellier, France Perpignan Cedex, France Germany Berlin, Germany Biberach, Germany Kassel, Germany München, Germany Münster, Germany Netherlands Maastricht, Netherlands Switzerland Lausanne, Switzerland Zürich, Switzerland United Kingdom Dundee, United Kingdom London, United Kingdom Nottingham, United Kingdom 收起 << | |
NCT01239732 | Ovarian Cancer | Phase 3 | Completed | - | - |
NCT01854606 | CD79 Mutant or ABC-subtype Dif... 展开 >>fuse Large B-Cell Lymphoma 收起 << | Phase 1 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Dept of Oncology. Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center Onc. Dept. New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute Dept of Onc Nashville, Tennessee, United States, 37203 France Novartis Investigative Site Rouen Cedex 1, France, 76038 Germany Novartis Investigative Site Mainz, Germany, 55131 Novartis Investigative Site Muenchen, Germany, 81377 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Novartis Investigative Site New Territories, Hong Kong Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Milano, MI, Italy, 20141 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3015 CE Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 收起 << |
NCT00492986 | Carcinoma, Renal Cell | Phase 3 | Completed | - | - |
NCT01077544 | Chronic Myeloid Leukemia ... 展开 >> Acute Lymphoblastic Leukemia 收起 << | Phase 1 | Completed | - | United States, Illinois ... 展开 >> Ann & Robert H. Lurie Children's Hospital of Chicago Ann&Robert Lurie Chicago, Illinois, United States, 60611 Brazil Novartis Investigative Site Barretos, SP, Brazil, 14784-400 Novartis Investigative Site Sao Paulo, SP, Brazil Novartis Investigative Site São Paulo, SP, Brazil, 08270-070 France Novartis Investigative Site Bordeaux, Aquitaine, France, 33076 Novartis Investigative Site Lille cedex, France, 59037 Novartis Investigative Site Paris, France, 75571 Novartis Investigative Site Poitiers, France, 86021 Italy Novartis Investigative Site Monza, MB, Italy, 20900 Novartis Investigative Site Padova, PD, Italy, 35128 Novartis Investigative Site Roma, RM, Italy, 00161 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 110 744 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Novartis Investigative Site Rotterdam, Netherlands, 3015 GJ Russian Federation Novartis Investigative Site Moscow, Russian Federation, 117997 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Novartis Investigative Site Birmingham, United Kingdom, B4 6NH Novartis Investigative Site Bristol, United Kingdom, BS2 8BJ 收起 << |
NCT01813435 | Coronary Artery Disease (CAD) | Phase 3 | Completed | - | - |
NCT01302886 | Smoldering Multiple Myeloma | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States, 72703 United States, Florida H. Lee Moffitt Cancer Center & Research Institute SC - 3 Tampa, Florida, United States, 33612 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Hematology (2) Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Indiana Univ Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute DFCI (2) Boston, Massachusetts, United States, 02115 United States, Missouri Washington University School of Medicine Dept. of WUSTL St. Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Multiple Myeloma Division Hackensack, New Jersey, United States, 07601 United States, New York Mount Sinai School of Medicine Mt Sinai New York, New York, United States, 10029 United States, North Carolina Duke University Medical Center Duke SC Durham, North Carolina, United States, 27710 United States, Washington Fred Hutchinson Cancer Research Center Fred Hutchinson Seattle, Washington, United States, 98109 France Novartis Investigative Site LILLE Cedex, France, 59037 Germany Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Würzburg, Germany, 97080 收起 << |
NCT01077544 | - | Completed | - | - | |
NCT01294410 | Colitis, Ulcerative | Phase 2 | Completed | - | - |
NCT01839357 | Atrial Fibrillation | Phase 3 | Completed | - | Bulgaria ... 展开 >> Plovdiv, Bulgaria, 4000 Sofia, Bulgaria, 1309 Sofia, Bulgaria, 1750 Varna, Bulgaria, 9010 France Creteil, France, 94010 Marseille, France, 13005 Paris, France, 75571 TOULOUSE cedex, France, 31059 Germany Bonn, Nordrhein-Westfalen, Germany, 53105 Leipzig, Sachsen, Germany, 04289 Berlin, Germany, 13353 Hamburg, Germany, 20099 Poland Krakow, Poland, 31-121 Lodz, Poland, 91-347 Lublin, Poland, 20-954 Warszawa, Poland, 02-005 Warszawa, Poland, 02-507 Wroclaw, Poland, 50-420 Russian Federation Moscow, Russian Federation, 115093 Moscow, Russian Federation, 117997 Moscow, Russian Federation, 121552 Saratov, Russian Federation, 410039 St. Petersburg, Russian Federation, 194156 Turkey Istanbul, Turkey, 34662 Istanbul, Turkey, 34846 Istanbul, Turkey Samsun, Turkey, 55139 Ukraine Donetsk, Ukraine, 83045 Kiev, Ukraine, 03680 Odesa, Ukraine, 65025 Uzhhorod, Ukraine, 88000 收起 << |
NCT01371344 | Heart Transplantation ... 展开 >> Kidney Transplantation Liver Transplantation 收起 << | Phase 4 | Terminated(Trial will not comp... 展开 >>lete until at least 2025 and evolution of immunosuppressant therapy has made it unlikely that patients will convert from Modigraf to Prograf.) 收起 << | - | Belgium ... 展开 >> Site BE40 Clinique Univ. Saint Luc Brussels, Belgium, 1200 France Site FR60 Groupement Hospitalier EST Bron, France, 69677 Site FR61 Hopital Robert Debre Paris Cedex 19, France, 75945 Germany Site DE31 Kliniken der Medizinischen Hoc Hannover, Germany, 30625 Site DE30 Universitätsklin Heidelberg Heidelberg, Germany, 69120 Poland Site PL50 Centrum Zdrowia Dziecka Warsaw, Poland, 04-730 Spain Site ES22 H.U. Gregorio Maranon Madrid, Spain, 28007 Site ES20 Hospital Universitario La Paz Madrid, Spain, 28046 Site ES21 Hospital Universitario La Paz Madrid, Spain, 28046 Site ES23 Hospital Universitario La Paz Madrid, Spain, 28046 United Kingdom Site GB14 Alder Hey Children Hospital Liverpool, United Kingdom, L12 2AP Site GB13 Cent. Manchester Uni. Hospital Manchester, United Kingdom, M13 9WL 收起 << |
NCT01250379 | - | Completed | - | - | |
NCT02218372 | Clostridium Difficile-associat... 展开 >>ed Diarrhea (CDAD) 收起 << | Phase 3 | Completed | - | - |
NCT01995513 | Prostate Cancer | Phase 4 | Active, not recruiting | May 31, 2024 | - |
NCT02027961 | Melanoma | Phase 1 Phase 2 | Completed | - | United States, Arizona ... 展开 >> Research Site Scottsdale, Arizona, United States, 85258 United States, California Research Site Los Angeles, California, United States, 90095 Research Site San Francisco, California, United States, 94143 United States, Florida Research Site Miami Beach, Florida, United States, 33140 United States, Illinois Research Site Chicago, Illinois, United States, 60611 United States, Massachusetts Research Site Boston, Massachusetts, United States, 02114 United States, Missouri Research Site Saint Louis, Missouri, United States, 63110 Canada, Ontario Research Site Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Research Site Montreal, Quebec, Canada, H3A 1A1 France Research Site Villejuif cedex, France, 94805 Italy Research Site Napoli, Italy, 80131 收起 << |
NCT02031419 | Lymphoma, Large B-Cell, Diffus... 展开 >>e 收起 << | Phase 1 | Active, not recruiting | November 30, 2020 | United States, California ... 展开 >> Sansum Clinic Santa Barbara, California, United States, 93105 Stanford Cancer Center Stanford, California, United States, 94305 United States, Colorado Rocky Mountain Cancer Centers, LLP [Boulder-COBO] Boulder, Colorado, United States, 80303 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06510 United States, Florida H. Lee Moffitt Cancer Cencer and Research Institute Tampa, Florida, United States, 33612 United States, Illinois Northwestern University, Division of Hematology Oncology, Dept. of Medicine Chicago, Illinois, United States, 60611 Illinois Cancer Specialists Niles, Illinois, United States, 60714 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Oregon Willamette Valley Cancer Center Eugene, Oregon, United States, 97401-8122 United States, Tennessee West Cancer Center Germantown, Tennessee, United States, 38138 Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-400 United States, Wisconsin University of Wisconsin Osteoporosis Clinical Center and Research Program Madison, Wisconsin, United States, 53792 Canada, Alberta Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 France Institut Bergonie Centre Regional de Lutte Contre Le Cancer de Bordeaux Et Sud Ouest Bordeaux, France, 33076 Centre Leon Berard Lyon, France, 69373 Institut Gustave Roussy Villejuif Cedex, France, 94805 Italy Istituto Nazionale Dei Tumori Milano, Italy, 20133 Istituto Clinico Humanitas Rozzano (MI), Italy, 20089 Azienda Sanitaria Ospedaliera San Giovanni Battista Molinette Turin, Italy, 10126 收起 << |
NCT01995513 | - | Active, not recruiting | - | - | |
NCT01499355 | Lupus Nephritis | Phase 2 | Terminated(Results from pre-sp... 展开 >>ecified criteria did not demonstrate sufficient efficacy to warrant continuation of the study.) 收起 << | - | - |
NCT02218372 | - | Completed | - | - | |
NCT02023697 | Prostatic Neoplasms | Phase 2 | Completed | - | - |
NCT02053636 | Breast Cancer | Phase 2 | Completed | - | Australia ... 展开 >> Peter MacCallum Cancer Centre East Melbourne, Australia Westmead Hospital Westmead, Australia, 2145 Belgium Institut Jules Bordet Brussels, Belgium, 1000 Cliniques Universitaires St. Luc Oncology - Breast Clinic Bruxelles, Belgium, 1200 Grand Hôpital de Charleroi Oncologie-Hématologie Charleroi, Belgium, 6000 UZ Leuven Campus Gasthuisberg Dept. of General Medical Leuven, Belgium, 3000 Clinique Sainte-Elisabeth Médecine Interne - Oncologie Namur, Belgium, 5000 Canada McGill University Department of Oncologie - Clinical Reserach Program Montreal, Canada, H2W 1S6 Princess Margaret Cancer Centre Toronto, Canada, M5G 2M9 University Health Network - Princess Margaret Hospital Toronto, Canada, M5G 2M9 France Institut Claudius Regaud Dpt d'Oncologie Médicale Toulouse, France, 31059 Institut Gustave Roussy Villejuif Cedex, France, 94805 Institut Gustave Roussy Dépt d'oncologie - Cancer du sein Villejuif, France, 94805 Germany Kliniken Essen-Mitte Klinik für Senologie - Brustzentrum Essen, Germany, 45136 KLINIKUM OFFENBACH Klinik für Gynäkologie und Geburtshilfe Offenbach, Germany, 63069 Klinikum Offenbach Offenbach, Germany, 63069 Hungary Orszagos Onkologiai Intezet Kemoterapia B es Klin.Farm.Oszt. Budapest, Hungary, 1122 Debreceni Egyetem Orvos es Egeszsegtudomanyi Centrum Onkologiai Intezet Debrecen, Hungary, 4032 Italy Istituto Europeo di Oncologia Divisione Sviluppo Nuovi Farmaci per Terapie Innovative Milano, Italy, 20141 Istituto Europeo di Oncologia Milan, Italy, 20141 Spain H. Valle de Hebrón Servicio de Oncología Barcelona, Spain, 08035 Hospital Universitario Val d'Hebròn Madrid, Spain, 08035 MD Anderson Cancer Center Unidad de Investigación Clínica Madrid, Spain, 28033 H. Ramón y Cajal Servicio de Oncología Médica Madrid, Spain, 28034 H. Clínico de Valencia Servicio de Hematología y oncología Médica Valencia, Spain, 46010 United Kingdom Western General Hospital Edinburgh Cancer Centre Edinburgh, United Kingdom, EH4 2XU Royal Marsden Hospital London, United Kingdom, SW3 6JJ The Royal Marsden NHS Trust Dpt of Medicine-Oncology London, United Kingdom, SW3 6JJ Nottingham University Hospitals NHS Trust Department of Clinical Oncology Nottingham, United Kingdom, NG5 1PB 收起 << |
NCT01525550 | Well-differentiated Pancreatic... 展开 >> Neuroendocrine Tumor 收起 << | Phase 4 | Completed | - | - |
NCT01892319 | - | Active, not recruiting | December 31, 2019 | - | |
NCT02023697 | - | Completed | - | - | |
NCT01499355 | - | Terminated(Results from pre-sp... 展开 >>ecified criteria did not demonstrate sufficient efficacy to warrant continuation of the study.) 收起 << | - | - | |
NCT01217944 | Pathological Myopia | Phase 3 | Completed | - | - |
NCT01217944 | - | Completed | - | - | |
NCT01364597 | Epilepsy | Phase 3 | Enrolling by invitation | January 2024 | - |
NCT02260674 | Alzheimer's Disease | Phase 2 | Completed | - | Belgium ... 展开 >> Gent, Belgium Hoboken, Belgium France Montpellier Cedex 5, France Paris, France Toulouse, France Germany Essen, Germany Halle, Germany Hamburg N/A, Germany Homburg, Germany Luebeck, Germany Tübingen, Germany Ulm, Germany Netherlands Amsterdam, Netherlands Spain Barcelona, Spain Madrid, Spain Terrasa Barcelona N/A, Spain Valencia, Spain Sweden Mölndal, Sweden Stockholm, Sweden 收起 << |
NCT01138033 | Cancer | Phase 1 | Completed | - | Australia, Victoria ... 展开 >> GSK Investigational Site Heidelberg, Victoria, Australia, 3084 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 France GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Villejuif, France, 94805 United Kingdom GSK Investigational Site Glasgow, United Kingdom, G61 1BD GSK Investigational Site London, United Kingdom, NW1 2BU GSK Investigational Site London, United Kingdom, W12 0HS GSK Investigational Site London, United Kingdom, W1G 6AD GSK Investigational Site Manchester, United Kingdom, M20 4BX GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 << |
NCT01908829 | Urinary Bladder Diseases ... 展开 >> Urinary Bladder Overactive Urologic Diseases 收起 << | Phase 3 | Completed | - | - |
NCT01817738 | Prostate Cancer | Phase 1 Phase 2 | Terminated(Follow up period af... 展开 >>ter primary analysis was prematurely stopped because more mature data will not impact the study outcome) 收起 << | - | - |
NCT01908829 | - | Completed | - | - | |
NCT01525550 | - | Completed | - | - | |
NCT01950273 | Lymphoma, Follicular | Phase 1 | Completed | - | - |
NCT01936363 | Ovarian Cancer | Phase 2 | Completed | - | - |
NCT01950273 | - | Completed | - | - | |
NCT01936363 | - | Completed | - | - | |
NCT01412333 | Relapsing Multiple Sclerosis | Phase 3 | Active, not recruiting | January 16, 2020 | - |
NCT01607346 | Epilepsy | Phase 4 | Terminated | - | United States, Arkansas ... 展开 >> GSK Investigational Site Little Rock, Arkansas, United States, 72205 United States, California GSK Investigational Site Los Angeles, California, United States, 90073 United States, Indiana GSK Investigational Site Fort Wayne, Indiana, United States, 46804 United States, Maryland GSK Investigational Site Bethesda, Maryland, United States, 20817 GSK Investigational Site Ellicott City, Maryland, United States, 21042 United States, Michigan GSK Investigational Site Farmington Hills, Michigan, United States, 48334 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43210 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19107 United States, Texas GSK Investigational Site Arlington, Texas, United States, 76017 GSK Investigational Site Dallas, Texas, United States, 75251 GSK Investigational Site Temple, Texas, United States, 76508 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53715 France GSK Investigational Site Dijon, France, 21000 GSK Investigational Site Montlucon, France, 3100 GSK Investigational Site Rennes Cedex, France, 35033 GSK Investigational Site Strasbourg, France, 67091 Poland GSK Investigational Site Krakow, Poland, 31-209 GSK Investigational Site Warszawa, Poland, 02-957 收起 << |
NCT01412333 | - | Active, not recruiting | - | - | |
NCT01607346 | - | Terminated | - | - | |
NCT01331343 | Type 1 Diabetes Mellitus | Phase 4 | Completed | - | France ... 展开 >> Hospital Sud Francilien Corbeil-Essonnes Cedex, France CH Robert Debre Paris, France Germany Klinik fur Allgemeine Charite Berlin, Germany Israel Schneider Children Centre Petah Tikva, Israel Italy U.O. Medicina Generale Milano, Italy Slovenia University Children's Hospital Ljubljana, Slovenia Sweden Huddinge University Hospital Huddinge, Sweden United Kingdom Royal Bournemouth Hospital Dorset, United Kingdom 收起 << |
NCT01253629 | Fragile X Syndrome | Phase 2 | Completed | - | - |
NCT02406027 | Alzheimer Disease | Phase 2 | Terminated(Janssen concluded b... 展开 >>enefit risk no longer favorable to continue development atabecestat. Investigators instructed to stop dosing atabecestat immediately) 收起 << | - | Belgium ... 展开 >> Gent, Belgium Hoboken, Belgium France Montpellier Cedex 5, France Paris, France Toulouse, France Germany Essen, Germany Homburg, Germany Luebeck, Germany Tübingen, Germany Ulm, Germany Netherlands Amsterdam, Netherlands Spain Barcelona, Spain Madrid, Spain Terrasa Barcelona, Spain Valencia, Spain Sweden Mölndal, Sweden Stockholm, Sweden 收起 << |
NCT02151682 | Pain | Phase 2 Phase 3 | Active, not recruiting | November 2018 | - |
NCT01152346 | Myelodysplastic Syndrome | Phase 1 | Completed | - | United States, California ... 展开 >> Pacific Cancer Medical Center Inc. Anaheim, California, United States, 92801 Wilshire Oncology Medical Group Corona, California, United States, 92879 California Cancer Associates Fresno, California, United States, 93720 United States, Florida Holy Cross Hospital Fort Lauderdale, Florida, United States, 33308 France Service d'hématologie clinique Hôpital Avicenne Bobigny cedex, France, 93009 CHU de Brest- Hôpital Morvan Brest, France, 29609 Centre Hospitalier Lyon Sud Lyon, France, 69495 Hôpital Archet 1 Nice, France, 06200 Hôpital Haut-Lévêque Pessac, France, 33604 CH Annecy Pringy, France, 74374 CHU Purpan Toulouse, France, 31059 Centre régional de cancérologie Henry-Kaplan Service d'Hématologie et thérapie cellulaire Tours, France, 37000 Service d'hématologie et de médecine interne CHU de Nancy Hôpital de Brabois Vandoeuvre, France, 54511 收起 << |
NCT01846832 | Hepatitis C, Chronic ... 展开 >> Infection 收起 << | Phase 3 | Completed | - | Austria ... 展开 >> Linz, Austria Wien, Austria Belgium Brussels, Belgium Brussel, Belgium Edegem, Belgium France Clichy, France Limoges Cedex, France Orleans, France St Laurent Du Var, France Germany Berlin, Germany Düsseldorf, Germany Frankfurt, Germany Hamburg, Germany Würzburg, Germany Saudi Arabia Riyadh, Saudi Arabia Spain Barcelona, Spain Madrid, Spain Valencia, Spain Valme, Spain United Kingdom Glasgow, United Kingdom London, United Kingdom 收起 << |
NCT01281280 | - | Completed | - | Belgium ... 展开 >> ULB Hopital Erasme Brussels, Belgium UZ Gent Gent, Belgium Canada QE2 Health Sciences Centre Department of Neurology Halifax, Canada Hopital Notre Dame Montreal, Canada France CHU Grenoble Grenoble, France Hopital Roger Salengro Service de Neurologie Lille Cedex, France Hopital Neurologique Unite d' epileptologie Lyon, France Hopital Gui De Chauliac Montpellier, France Germany Universitatskliniken Bonn Bonn, Germany Universitatsklinl Erlangen Zentrum fur Epilepsie Erlangen, Germany Italy Azienda Ospedaliero Universitaria Ancona, Italy Universita di Bologna Bologna, Italy Universita di Pisa Pisa, Italy Azienda Ospedialiera "Bianchi Melacrino Morelli" Reggio Calabria, Italy Unisersita Cattolica Del Sacro Cuore Rome, Italy Centro Epilessia Torino, Italy Netherlands Hans Berger kliniek Neurology Oosterhout, Netherlands United Kingdom The National Hospital for Neurology and Neurosurgery London, United Kingdom 收起 << | |
NCT02049905 | Metastatic, Locally Advanced o... 展开 >>r Unresectable Soft Tissue Sarcoma 收起 << | Phase 3 | Completed | - | - |
NCT03325556 | Dementia-related Psychosis | Phase 3 | Recruiting | March 2020 | - |
NCT02242942 | Lymphocytic Leukemia, Chronic | Phase 3 | Active, not recruiting | September 1, 2021 | - |
NCT02788474 | Idiopathic Pulmonary Fibrosis | Phase 4 | Completed | - | - |
NCT00600626 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02783729 | Insomnia | Phase 3 | Completed | - | - |
NCT01961921 | - | Completed | - | - | |
NCT01961921 | TTR-mediated Amyloidosis | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Clinical Trial Site Boston, Massachusetts, United States Brazil Clinical Trial Site Rio de Janeiro, Brazil France Clinical Trial Site Le Kremlin-bicetre, France Clinical Trial Site Marseille Cedex, France Germany Clinical Trial Site Munster, Germany Portugal Clinical Trial Site Lisbon, Portugal Clinical Trial Site Porto, Portugal Spain Clinical Trial Site Palma De Mallorca, Spain Sweden Clinical Trial Site Umeå, Sweden 收起 << |
NCT02800642 | Central Retinal Vein Occlusion | Phase 4 | Active, not recruiting | August 29, 2019 | - |
NCT02558829 | - | Completed | - | - | |
NCT02558829 | Growth Hormone Deficiency With... 展开 >> Pituitary Anomalies 收起 << | Phase 3 | Completed | - | United States, California ... 展开 >> Harbor UCLA Medical Center Torrance, California, United States, 90509 United States, Texas Texas Diabetes and Endocrinology Austin, Texas, United States, 78731 Baylor College of Medicine-Endocrinology Houston, Texas, United States, 77030 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98108 Swedish Medical Center - Cherry Hill Seattle, Washington, United States, 98122 Austria Krankenanstalt Rudolfstiftung Vienna, Austria, 1030 Medical University & General Hospital of Vienna, AKH, Vienna, Austria, 1090 France CHU de Lyon HCL-GH Est Bron Cedex, France, 69677 GHU Paris-Sud - Hôpital de Bicêtre Le Kremlin-Bicêtre, France, 94270 Hôpital Haut-Lévêque Pessac, France, 33600 Germany Klinikum der LMU München Muenchen, Bayern, Germany, 80336 Max Planck Institut Muenchen, Bayern, Germany, 80804 University Hospital Marburg Marburg, Hessen, Germany, 35033 RWTH Aachen University Hospital Aachen, Nordrhein-Westfalen, Germany, 52074 Klinik für Endokrinologie, Diabetes und Ernährungsmedizin der Charité Berlin, Germany, 10117 Italy San Luca Hospital Milano, Italy, 20149 Poland Centrum Kliniczno-Badawcze Elblag, Poland, 82-300 Centrum Medyczne Angelius Provita Katowice, Poland, 40-611 Phase I - MTZ Clinical Research Sp. z o.o. Warszawa, Poland, 02-106 Wromedica Wrocław, Poland, 51-685 Serbia Clinical Centre of Serbia Belgrad, Serbia, 11000 Clinical Centre of Vojvodina Novi Sad, Serbia, 21000 Spain Hospital de Sant Pau Barcelona, Spain, 08026 Hospital Universitari Vall d' Hebron Barcelona, Spain, 08035 Hospital de Conxo Santiago de Compostela, Spain, 15706 United Kingdom St Bartholomew's Hospital London, United Kingdom, EC1A 7BE The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX 收起 << |
NCT02579603 | Idiopathic Pulmonary Fibrosis | Phase 4 | Completed | - | United States, Connecticut ... 展开 >> Western CT Medical Group, P.C. Danbury, Connecticut, United States, 06810 United States, Louisiana Tulane University Hospital and Clinic New Orleans, Louisiana, United States, 70112 United States, Minnesota Minnesota Lung Center Minneapolis, Minnesota, United States, 55407 United States, Missouri The Lung Research Center, LLC Chesterfield, Missouri, United States, 63017 United States, South Carolina Lowcountry Lung and Crit Care Charleston, South Carolina, United States, 29406 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-5735 Canada, British Columbia St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Manitoba Concordia Hospital Winnipeg, Manitoba, Canada, R2K 3S8 France HOP Avicenne Bobigny, France, 93009 HOP de la Cavale Blanche Brest, France, 29609 HOP Louis Pradel Bron cedex, France, 69677 HOP Calmette Lille, France, 59037 HOP Pasteur Nice, France, 06001 HOP Bichat Paris, France, 75018 HOP Pontchaillou Rennes, France, 35033 Germany Klinik Donaustauf Donaustauf, Germany, 93093 Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH Essen, Germany, 45239 Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg Heidelberg, Germany, 69126 Italy A.O.U. Policlinico Vittorio Emanuele Catania, Italy, 95124 Osp. S. Giuseppe Fatebenefratelli Milano, Italy, 20123 A.O.U. Senese Policlinico Santa Maria alle Scotte Siena, Italy, 53100 Netherlands Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Erasmus Medisch Centrum Rotterdam, Netherlands, 3015 CE 收起 << |
NCT03143153 | Various Advanced Cancer | Phase 3 | Recruiting | December 30, 2021 | - |
NCT02864953 | Brain Edema S... 展开 >>troke, Acute 收起 << | Phase 3 | Recruiting | December 30, 2021 | - |
NCT02579603 | - | Completed | - | - | |
NCT02292550 | Non-small Cell Lung Cancer | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Novartis Investigative Site Boston, Massachusetts, United States, 02114 France Novartis Investigative Site Marseille cedex 05, France, 13385 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Rozzano, MI, Italy, 20089 Korea, Republic of Novartis Investigative Site Seoul, Seocho-gu, Korea, Republic of, 06591 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Taiwan Novartis Investigative Site Tainan, Taiwan ROC, Taiwan, 70421 Novartis Investigative Site Taipei, Taiwan, 10002 收起 << |
NCT03732820 | Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 << | Phase 3 | Recruiting | August 17, 2022 | - |
NCT02949128 | Atypical Hemolytic Uremic Synd... 展开 >>rome (aHUS) 收起 << | Phase 3 | Active, not recruiting | November 2020 | - |
NCT02900651 | Diffuse Large B-cell Lymphoma | Phase 1 Phase 2 | Recruiting | August 5, 2019 | United States, California ... 展开 >> Novartis Investigative Site Recruiting San Francisco, California, United States, 94115 Novartis Investigative Site Recruiting Santa Monica, California, United States, 90404 Contact: Ruth M. Gonzalez Rngonzalez@mednet.ucla.edu Principal Investigator: Zev A. Wainberg United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Anna Lui 713-563-4667 alui@mdanderson.org Principal Investigator: Vivek Subbiah Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Recruiting Koeln, Germany, 50937 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Japan Novartis Investigative Site Recruiting Sunto-gun, Shizuoka, Japan, 411-8777 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Madrid, Spain, 28041 收起 << |
NCT02034123 | Carcinoma, Small Cell | Phase 1 | Terminated(The risk benefit in... 展开 >> relapsed refractory SCLC does not favor continuation of the study) 收起 << | - | United States, Missouri ... 展开 >> GSK Investigational Site Saint Louis, Missouri, United States, 63110 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43210 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 France GSK Investigational Site Villejuif cedex, France, 94805 Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Madrid, Spain, 28034 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Málaga, Spain, 29010 收起 << |
NCT03026166 | Small Cell Lung Cancer | Phase 1 | Active, not recruiting | July 3, 2019 | - |
NCT03038230 | Acute Myelogenous Leukemia ... 展开 >> Acute Myeloid Leukemia 收起 << | Phase 1 | Recruiting | December 2018 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel Deangelo Principal Investigator: Daniel Deangelo, MD United States, New York Icahn School of Medicine at Mount Sinai Not yet recruiting New York, New York, United States, 10029 Contact: John Mascarenhas, MD Principal Investigator: John Mascarenhas, MD United States, Texas The University of Texas, MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Jorge Cortes, MD Principal Investigator: Jorge Cortes, MD Belgium Ziekenhuis Netwerk Antwerpen Campus Stuivenberg Recruiting Antwerpen, Belgium, 2060 Principal Investigator: Dimitri A Breems, MD France Institut Gustave Roussy Recruiting Villejuif Cedex, Ile-de-France, France, 94805 Contact: Elodie Zedouard Principal Investigator: Stéphane De Botton, MD Italy Fondazione Policlinico Tor Vergata Recruiting Rome, Italy, 00133 Contact: Silvia Miccichè +390620903213 silvia.micciche@ptvonline.it Principal Investigator: Adriano Venditti, MD Netherlands Vrije Universiteit Medisch Centrum Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Gert Ossenkoppele, MD Principal Investigator: Gert Ossenkoppele, MD Erasmus MC Recruiting Rotterdam, Zuid-Holland, Netherlands Contact: Mojca Jongen-Lavrencic, MD Principal Investigator: Mojca Jongen-Lavrencic, MD Universitair Medisch Centrum Groningen Recruiting Groningen, Netherlands Contact: Gerwin Huls, MD Principal Investigator: Gerwin Huls, MD 收起 << |
NCT01045447 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02940626 | Pneumonia, Ventilator-associat... 展开 >>ed Pneumonia, Staphylococcal 收起 << | Phase 2 | Completed | - | - |
NCT00454220 | Multinodular Goiter | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Boston, Massachusetts, United States Brazil Curitiba, Brazil Rio de Janeiro, Brazil Canada, Ontario London, Ontario, Canada Canada Toronto, Canada Denmark Odense, Denmark France Lille Cedex, France Germany Wurzburg, Germany Italy Pisa, Italy Sienna, Italy Netherlands Netherlands, Netherlands 收起 << |
NCT03114657 | Alzheimer's Disease | Phase 3 | Recruiting | October 28, 2022 | - |
NCT02734615 | Advanced or Metastatic ER+ Bre... 展开 >>ast Cancer 收起 << | Phase 1 | Recruiting | October 30, 2020 | United States, Maryland ... 展开 >> Novartis Investigative Site Recruiting Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Dejan Juric, MD 617-726-6500 Juric.Dejan@mgh.harvard.edu Contact: Meghan Miles 617-726-6500 MEMILES@mgh.harvard.edu Principal Investigator: Dejan Juric, MD United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10021 Contact: Alexandra Burleigh 646-422-4394 burleiga@mskcc.org Principal Investigator: Komal Jhaveri United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Daniela Westerhold diwesterhold@mdanderson.org Principal Investigator: Rachel M Layman Belgium Novartis Investigative Site Recruiting Bruxelles, Belgium, 1200 Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Lyon Cedex, France, 69373 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Novartis Investigative Site Recruiting Milano, MI, Italy, 20141 Japan Novartis Investigative Site Recruiting Koto-ku, Tokyo, Japan, 135 8550 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 169610 Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08036 Novartis Investigative Site Recruiting Madrid, Spain, 28007 收起 << |
NCT03036280 | Alzheimer's Disease | Phase 3 | Recruiting | March 29, 2021 | - |
NCT00858754 | Opioid-Induced Constipation | Phase 4 | Withdrawn(Withdrawn [This stud... 展开 >>y was terminated early by Wyeth, prior to dosing any subjects, for business reasons not related to safety.) 收起 << | - | United States, California ... 展开 >> Pfizer Investigational Site Laguna Hills, California, United States, 92637 Pfizer Investigational Site Lancaster, California, United States, 93534 United States, North Carolina Pfizer Investigational Site Flat Rock, North Carolina, United States, 28731 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Canada, Alberta Pfizer Investigational Site Edmonton, Alberta, Canada, T6G 1Z2 France Pfizer Investigational Site Villejuif Cedex, France, 94804 Spain Pfizer Investigational Site El Palmar, Murcia/Spain, Spain, 30120 收起 << |
NCT01045447 | - | Completed | - | - | |
NCT00911859 | - | Completed | - | - | |
NCT00911859 | Multiple Myeloma | Phase 2 | Completed | - | - |
NCT00468559 | Gastroesophageal Reflux Diseas... 展开 >>e (GERD) 收起 << | Phase 3 | Completed | - | - |
NCT00604396 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01323959 | Acellular Pertussis ... 展开 >> Poliomyelitis Diphtheria Tetanus 收起 << | Phase 4 | Completed | - | France ... 展开 >> GSK Investigational Site Derval, France, 44590 GSK Investigational Site La Chapelle Basse Mer, France, 44450 GSK Investigational Site La Riche, France, 37250 GSK Investigational Site Nantes cedex 2, France, 44277 GSK Investigational Site Nantes, France, 44300 GSK Investigational Site Tours, France, 37000 GSK Investigational Site Tours, France, 37200 Germany GSK Investigational Site Deggendorf, Bayern, Germany, 94469 GSK Investigational Site Hoehenkirchen-Siegertsbrunn, Bayern, Germany, 85635 GSK Investigational Site Muenchen, Bayern, Germany, 80337 GSK Investigational Site Regensburg, Bayern, Germany, 93053 GSK Investigational Site Selbitz, Bayern, Germany, 95152 GSK Investigational Site Vilshofen, Bayern, Germany, 94474 GSK Investigational Site Weilheim, Bayern, Germany, 82362 GSK Investigational Site Wuerzburg, Bayern, Germany, 97070 收起 << |
NCT00556608 | Osteoarthritis, Knee | Phase 4 | Completed | - | Czech Republic ... 展开 >> Interni hemato-onkologická klinika, Fakultní nemocnice Brno - Bohunice, Czech Republic, 63900 ARTHROMED s.r.o. Pardubice, Czech Republic, 53002 Institute of Rheumatology Praha, Czech Republic, 12850 Centrum léčby pohybového aparátu spol. s.r.o. Praha, Czech Republic, 19061 France University Hospital Centre Bois-Guillaume Bois Guillaume, France, 76230 University Hospital Centre of Limoges - Rheumatology Service Limoges Cedex, France, 87042 Germany Orthopädische Universitätsklinik und Poliklinik der RWTH Aachen Aachen, Germany, 52074 Nova clinic Biberach an der Riss, Germany, 88400 Orthopädische Praxis Stockach, Germany, 78333 Italy Sezione Dipartimentale a valenza provinciale di Reumatologia - AzUSL 8 Arezzo, Italy, 52100 Ospedale Privato Accreditato Nigrisoli Bologna, Italy, 40138 Medicina e Traumatologia dello Sport - AzUSL 2 Lucca Lucca, Italy, 55100 Unità Operativa di Reumatologia - Istituto Ortopedico Gaetano Pini Milano, Italy, 20122 Rheumatology Unit Santa Chiara Hospital Pisa, Italy, 56126 Unità Operativa di Reumatologia - Az. Ospedaliera Universitaria Senese - Policlinico "Le Scotte" Siena, Italy, 53100 Slovakia F.D. Roosevelt's University Hospital Banská Bystrica, Slovakia, 975 17 Romjan s.r.o. Bratislava, Slovakia, 831 03 National Institute of Rheumatic Diseases Piest'any, Slovakia, 921 12 Rheumatology Clinic, Reumaglobal s.r.o Trnava, Slovakia, 917 01 Switzerland Department of Rheumatology and Institute of Physical Medicine - Zurich University Zürich, Switzerland, 8091 收起 << |
NCT00468559 | - | Completed | - | - | |
NCT01323959 | - | Completed | - | - | |
NCT00941031 | Chronic Plaque-type Psoriasis | Phase 2 | Completed | - | - |
NCT02942290 | Myelodysplastic Syndromes (MDS... 展开 >>) 收起 << | Phase 1 | Recruiting | December 12, 2020 | - |
NCT00941031 | - | Completed | - | - | |
NCT00622583 | - | Recruiting | December 1, 2021 | - | |
NCT01106352 | Bone Metastases ... 展开 >> Castration-Resistant Prostate Cancer 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> San Francisco, California, United States, 94115 United States, Illinois Evanston, Illinois, United States, 60201 United States, Maryland Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston, Massachusetts, United States, 02115-6013 United States, New York New York, New York, United States, 10065 United States, Washington Seattle, Washington, United States, 98109 France Villejuif Cedex, France, 94805 收起 << |
NCT00378690 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT00501969 | Advanced Stage Parkinson's Dis... 展开 >>ease 收起 << | Phase 3 | Completed | - | - |
NCT00501735 | Cutaneous T-cell Lymphoma (CTC... 展开 >>L), 收起 << | Phase 2 | Completed | - | - |
NCT00501969 | - | Completed | - | - | |
NCT00329303 | Psoriasis | Phase 2 | Completed | - | France ... 展开 >> Besançon, France Créteil, France Nice Cedex 3, France Paris, France Pierre Benite, France Germany Berlin, Germany Bonn, Germany Essen, Germany Frankfurt, Germany Hamburg, Germany Kiel, Germany Mahlow, Germany Mainz, Germany Munster, Germany 收起 << |
NCT00949442 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT00973882 | Prostate Cancer | Phase 2 | Completed | - | France ... 展开 >> Centre François Baclesse Caen, France, 14021 Hôpital Henri Mondor Créteil, France, 94000 Centre Georges François Leclerc Dijon, France, 21000 Centre Hospitalier Départemental Les Oudairies La Roche Sur Yon, France, 85925 Centre Leon Berard Lyon, France, 69008 Institut Paoli Calmette Marseille, France, 13273 Centre Val d'Aurelle Montpellier, France, 34298 Institut Curie Paris, France, 75005 Fondation Hôpital Saint-Joseph Paris, France, 75674 Hopital Européen Georges Pompidou Paris, France, 75908 Hopital Foch SURESNES Cedex, France, 92151 收起 << |
NCT02994407 | Congenital Bleeding Disorder ... 展开 >> Haemophilia A 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Novo Nordisk Investigational Site Orlando, Florida, United States, 32827 United States, Iowa Novo Nordisk Investigational Site Iowa City, Iowa, United States, 52242 United States, Michigan Novo Nordisk Investigational Site East Lansing, Michigan, United States, 48823 United States, Ohio Novo Nordisk Investigational Site Cleveland, Ohio, United States, 44106 Novo Nordisk Investigational Site Dayton, Ohio, United States, 45404 United States, South Carolina Novo Nordisk Investigational Site Charleston, South Carolina, United States, 29425-0001 United States, Virginia Novo Nordisk Investigational Site Norfolk, Virginia, United States, 23507 United States, Wisconsin Novo Nordisk Investigational Site Milwaukee, Wisconsin, United States, 53226 Austria Novo Nordisk Investigational Site Innsbruck, Austria, A 6020 Novo Nordisk Investigational Site Wien, Austria, 1090 France Novo Nordisk Investigational Site Nantes Cedex 1, France, 44093 Germany Novo Nordisk Investigational Site Berlin, Germany, 10249 Novo Nordisk Investigational Site Duisburg, Germany, 47051 Novo Nordisk Investigational Site Homburg, Germany, 66421 Japan Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160 0023 Novo Nordisk Investigational Site Suginami-ku, Tokyo, Japan, 167 0035 Serbia Novo Nordisk Investigational Site Belgrade, Serbia, 11000 Novo Nordisk Investigational Site Belgrade, Serbia, 11070 Novo Nordisk Investigational Site Novi Sad, Serbia, 21000 收起 << |
NCT01229436 | - | Completed | - | - | |
NCT01106352 | - | Completed | - | - | |
NCT01125800 | Medulloblastoma ... 展开 >> Rhabdomyosarcoma Neuroblastoma Hepatoblastoma Glioma Astrocytoma 收起 << | Phase 1 Phase 2 | Completed | - | United States, Georgia ... 展开 >> Children's Healthcare of Atlanta Childern Hosp - ATL Atlanta, Georgia, United States, 30342 United States, Maryland Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. John Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Dana Farber Cancer Institute DFCI (3) Boston, Massachusetts, United States, 02115 United States, Washington Seattle Children's Hospital CPKC412A2114 Seattle, Washington, United States, 98105 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3052 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 1X8 Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Paris, France, 75231 Novartis Investigative Site Villejuif Cedex, France, 94805 Italy Novartis Investigative Site Bologna, BO, Italy, 40139 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Roma, RM, Italy, 00168 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT Novartis Investigative Site Newcastle Upon Tyne, United Kingdom, NE1 4LP 收起 << |
NCT01229436 | Dupuytren's Contracture | Phase 3 | Completed | - | Denmark ... 展开 >> Pfizer Investigational Site Copenhagen, Denmark, 1402 K Pfizer Investigational Site Silkeborg, Denmark, 8600 France Pfizer Investigational Site Montpellier cedex 5, France, 34295 Pfizer Investigational Site Nice, France, 06000 Pfizer Investigational Site Paris, France, 75016 Pfizer Investigational Site Paris, France, Cedex 15 75908 Germany Pfizer Investigational Site Bad Neustadt, Germany, 97616 Pfizer Investigational Site Berlin, Germany, 10627 Pfizer Investigational Site Bonn, Germany, 53123 Pfizer Investigational Site Muenster, Germany, 48149 Pfizer Investigational Site Nurnberg, Germany, 90471 Pfizer Investigational Site Tubingen, Germany, 72076 Hungary Pfizer Investigational Site Miskolc, Hungary, 3526 Italy Pfizer Investigational Site Sesto San Giovanni, Milano, Italy, 20099 Pfizer Investigational Site Modena, Italy, 41124 Pfizer Investigational Site Savona, Italy, 17100 Spain Pfizer Investigational Site Elche, Alicante, Spain, 03203 Pfizer Investigational Site Hospitalet De Llobregat, Barcelona/ Spain, Spain, 08907 Pfizer Investigational Site Barcelona, Spain, 08022 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Málaga, Spain, 29010 Sweden Pfizer Investigational Site Malmö, Sweden, SE-205 02 Pfizer Investigational Site Stockholm, Sweden, SE 118 83 Pfizer Investigational Site Uppsala, Sweden, 751 85 United Kingdom Pfizer Investigational Site Derby, United Kingdom, DE22 3NE Pfizer Investigational Site Glasgow, United Kingdom, G4 0SF Pfizer Investigational Site Norwich, United Kingdom, NR4 7UY Pfizer Investigational Site Southampton, United Kingdom, SO16 6YD 收起 << |
NCT00679380 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT00504543 | Kidney Transplantation | Phase 2 | Completed | - | - |
NCT00679380 | - | Completed | - | - | |
NCT01125800 | - | Completed | - | - | |
NCT02748460 | - | Recruiting | December 2022 | - | |
NCT00994318 | - | Completed | - | - | |
NCT03039686 | Duchenne Muscular Dystrophy | Phase 2 Phase 3 | Recruiting | December 17, 2024 | - |
NCT02485379 | Prostate Cancer | Not Applicable | Completed | - | France ... 展开 >> Groupe Hospitalier Pellegrin - CHU de Bordeaux Bordeaux, France, 33076 Hôpital Michallon - CHU de Grenoble Grenoble, France, 38043 Hôpital Huriez - CHU de Lille Lille, France, 59037 Hôpital Privé La Louvière Lille, France, 59042 CLIMAL (Centre Libéral Imagerie Médicale Agglomération Lille) Lille, France, 59700 Hôpital Edouard Herriot Lyon Cedex 03, France, 69437 Centre Hospitalier St Joseph St Luc Lyon, France, 69365 Institut Paoli Calmettes Marseille, France, 13273 Clinique Jules Verne Nantes, France, 44300 Hopital Pitie Salpetriere Paris, France, 75013 Hôpital Cochin Paris, France, 75014 Hôpital Européen Georges Pompidou Paris, France, 75015 Hôpital Necker Paris, France, 75015 Centre Hospitalier Lyon Sud Pierre Bénite, France, 69495 CHU de Saint-Etienne Saint-Etienne, France, 42055 IRMAS Saint-Priest-en-Jarez, France, 42270 Clinique Urologique Nantes Atlantis St Herblain, France, 44815 Nouvel Hopital Civil - CHU de Strasbourg Strasbourg, France, 67091 Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole - CHU de Toulouse Toulouse, France, 31059 CHU Nancy Brabois Vandoeuvre-les-Nancy, France, 54511 收起 << |
NCT00994318 | Iron Deficiency Anaemia ... 展开 >> Chronic Kidney Disease 收起 << | Phase 3 | Completed | - | - |
NCT03535740 | ALK-positive Advanced NSCLC | Phase 2 | Not yet recruiting | April 22, 2022 | - |
NCT03073200 | Plaque Psoriasis | Phase 3 | Recruiting | June 11, 2021 | - |
NCT01007292 | Non-Hodgkin's Lymphoma | Phase 2 | Completed | - | United States, Georgia ... 展开 >> Site US2778 John B. Amos Cancer Center Columbus, Georgia, United States, 31904 United States, Illinois Site US55 Loyola University Hospital - Maywood Maywood, Illinois, United States, 60153 United States, New York Site US9 Mount Sinai School of Medicine New York, New York, United States, 10029 United States, North Carolina Site US2802 Mecklenburg Medical Group Charlotte, North Carolina, United States, 28204 United States, Ohio Site US2149 Gabrail Cancer Center Research Canton, Ohio, United States, 44718 United States, Texas Site US402 University of Texas Health Science Center - San Antonio San Antonio, Texas, United States, 78229 France Site FR1926 Institut Bergonie Bordeaux-cedex, France, 33076 Site FR2700 Centre Antoine Lacassagne Nice, France, 06189 Site FR476 Hopital Saint Louis Paris, France, 75475 Site FR1889 Centre de Lutte Contre le Cancer - Centre Henri Becquerel Rouen, France, 76038 Site FR1897 Hopital Bretonneau Tours, France, 37044 Spain Site ES1349 Hospital del Mar Barcelona, Spain, 08003 Site ES1339 Hospital Universitario Ramon y Cajal Madrid, Spain, 28034 Site ES2967 Hosptial Universitario Madrid Sanchinarro Madrid, Spain, 28050 Site ES1346 Hospital Universitario de Salamanca Salamanca, Spain, 37007 United Kingdom Site GB2702 Addenbrookes Hospital Cambridge, United Kingdom, CB2 0QQ Site GB1928 St. Georges Hospital London, United Kingdom, SW17 0QT Site GB2624 The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Site GB1903 Oxford Radcliffe Hospital Oxford, United Kingdom, OX3 7LJ 收起 << |
NCT02566993 | Small-cell Lung Cancer | Phase 3 | Active, not recruiting | - | - |
NCT02735083 | Advanced Lymphoid Malignancies | Phase 1 | Enrolling by invitation | March 2040 | United States, California ... 展开 >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Massachusetts Massachussetts General Hospital Boston, Massachusetts, United States, 02114 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Belgium Het Kinderziekenhuis Prinses Elisabeth - UZG Gent, Belgium, 9000 France Hôpital Saint-Antoine PARIS Cedex 12, France, 75571 Hôpital Saint-Louis Paris, France, 75010 Hôpital Robert-Debré Paris, France, 75019 United Kingdom King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS UCL Great Ormond Hospital London, United Kingdom The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX 收起 << |
NCT00180505 | Peripheral Vascular Diseases | Phase 4 | Completed | - | Austria ... 展开 >> Landeskrankenhaus Klagenfurt Klagenfurt, Austria, 9026 Allgemeines Krankenhaus der Stadt Wien (AKH Wien) Wien, Austria, 1090 Belgium CHR de Namur Namur, Belgium, 5000 France Polyclinique Louis Pasteur Essey les Nancy, France, 54270 Hôpital Pontchaillou- CHU Rennes Cedex, France, 35033 Germany Herzzentrum Bad Krozingen Bad Krozingen, Germany, 79189 Universitäres Herz & Gefässzentrum Hamburg Hamburg, Germany, 22527 Herzzentrum Leipzig Leipzig, Germany, 04289 Greece Papageorgiou Hospital Thessaloniki, Greece, 57001 Italy Nuovo Ospedale Civile Sant' Agostino Baggiovara (Modena), Italy, 41100 Casa di Cura Montevergine Mercogliano, Italy, 83013 Policlinico San Matteo Pavia, Italy, 27100 Spain Hospital de Donostia Donostia-San Sebastian, Spain, 20014 收起 << |
NCT03089411 | - | Active, not recruiting | July 15, 2017 | - | |
NCT00565448 | Nasopharyngeal Neoplasms ... 展开 >> Carcinoma 收起 << | Phase 2 | Completed | - | - |
NCT00565448 | - | Completed | - | - | |
NCT01320215 | Pelvic Organ Prolapse | Not Applicable | Active, not recruiting | September 2021 | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes, Gard, France, 30029 Groupe Urologie Saint Augustin Bordeaux, France, 33074 APHP - Centre Hospitalier Henri Mondor Créteil, France, 94000 CHU de Dijon Dijon, France, 21079 CHU de Montpellier - Hôpital Lapeyronie Montpellier, France, 34295 CHU de Nancy - Hôpitaux de Brabois Nancy, France CHU de Nantes Nantes, France, 44000 CHU de Nice - Hôpitaux L'Archet 1 et 2 Nice, France, 06202 Clinique Kennedy Nîmes, France, 30900 Groupe Hospitalier Diaconesses Croix Saint-Simon - Site Reuilly Paris, France, 75012 APHP - Groupe Hospitalier Pitié-Salpetrière Paris, France, 75651 CHU de Lyon - Centre Hospitalier Lyon Sud Pierre Benite, France, 69310 CHU de Rennes - Hôpital PontChaillou Rennes, France, 35033 Clinique Belledonne St Martin d'Héres, France, 38400 CHRU de Strasbourg - Hôpital Civil Strasbourg Cedex, France, 67091 Hôpital Foch Suresnes, France, 92151 CHRU de Toulouse - Hôpital de Rangueil Toulouse, France, 31059 CHRU de Tours - Hôpital Bretonneau Tours, France, 37044 收起 << |
NCT02608112 | - | Completed | - | - | |
NCT00724503 | Colorectal Cancer ... 展开 >> Colorectal Carcinoma Liver Metastases 收起 << | Not Applicable | Completed | - | - |
NCT03105102 | Crohn's Disease | Phase 3 | Recruiting | January 31, 2026 | - |
NCT00560235 | Ewing's Sarcoma Family of Tumo... 展开 >>rs 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT00902174 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Completed | - | - |
NCT00454779 | Metastatic or Recurrent Squamo... 展开 >>us Cell Carcinoma of Head and Neck 收起 << | Phase 2 | Completed | - | - |
NCT00560235 | - | Completed | - | - | |
NCT03196297 | Haemostasis H... 展开 >>aemophilia A 收起 << | Phase 2 | Active, not recruiting | March 31, 2020 | - |
NCT03192969 | Giant Cell Arteritis | Phase 3 | Withdrawn(Business objectives ... 展开 >>have changed) 收起 << | November 23, 2021 | - |
NCT00902174 | - | Completed | - | - | |
NCT00454779 | - | Completed | - | - | |
NCT01053715 | - | Completed | - | Austria ... 展开 >> CSLB Study Site 22 Graz, Austria CSLB Study Site 26 Grieskirchen, Austria CSLB Study Site 24 Innsbruck, Austria CSLB Study Site 29 Klagenfurt, Austria CSLB Study Site 23 Linz, Austria CSLB Study Site 25 St. Pölten, Austria CSLB Study Site 20 Vienna, Austria CSLB Study Site 21 Vienna, Austria CSLB Study Site 27 Vienna, Austria Belgium CSLB Study Site 52 Edegem, Belgium CSLB Study Site 51 Leuven, Belgium France CSLB Study Site 65 Amiens, France CSLB Study Site 68 Poitiers Cedex, France CSLB Study Site 60 Rouen, France CSLB Study Site 64 Strasbourg, France CSLB Study Site 66 Valence, France Germany CSLB Study Site 1 Berlin, Germany CSLB Study Site 3 Bonn, Germany CSLB Study Site 2 Bremen, Germany CSLB Study Site 6 Delmenhorst, Germany CSLB Study Site 7 Göttingen, Germany CSLB Study Site 4 München, Germany Italy CSLB Study Site 72 Genova, Italy CSLB Study Site 71 Milan, Italy CSLB Study Site 74 Napoli, Italy CSLB Study Site 73 Palermo, Italy Spain CSLB Study Site 98 Badajoz, Spain CSLB Study Site 95 Jaen, Spain CSLB Study Site 91 Valencia, Spain Switzerland CSLB Study Site 35 St. Gallen, Switzerland CSLB Study Site 36 Zürich, Switzerland 收起 << | |
NCT01241760 | Genotype 1 Chronic Hepatitis C... 展开 >> Treatment Naive 收起 << | Phase 3 | Completed | - | - |
NCT03150719 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT00946647 | Myelodysplastic Syndromes ... 展开 >> Chronic Myelomonocytic Leukemia Acute Myeloid Leukemia 收起 << | Phase 1 | Active, not recruiting | June 13, 2019 | - |
NCT01241760 | - | Completed | - | - | |
NCT00632736 | Parkinson Disease ... 展开 >> Parkinson's Disease 收起 << | Phase 3 | Completed | - | - |
NCT00632736 | - | Completed | - | - | |
NCT01113801 | Diabetic Kidney Disease ... 展开 >> Diabetic Nephropathy Diabetic Glomerulosclerosis 收起 << | Phase 2 | Terminated(Interim Assessment ... 展开 >>Lack of Efficacy) 收起 << | - | - |
NCT00813709 | Multiple Sclerosis ... 展开 >> Clinically Isolated Syndrome 收起 << | Phase 3 | Completed | - | - |
NCT01113801 | - | Terminated(Interim Assessment ... 展开 >>Lack of Efficacy) 收起 << | - | - | |
NCT01121237 | - | Completed | - | - | |
NCT00634725 | Pancreatic Cancer | Phase 3 | Completed | - | - |
NCT01128335 | Liver Transplantation | Phase 2 | Completed | - | - |
NCT01150097 | Liver Transplant Recipient | Phase 3 | Completed | - | - |
NCT01132612 | - | Completed | - | - | |
NCT01853228 | Acute Myeloid Leukemia | Phase 2 | Completed | - | Belgium ... 展开 >> Gent, Belgium Denmark Copenhagen Ø, Denmark France Paris, France Toulouse Cedex 9, France Vandoeuvre-Lès-Nancy, France Germany Essen, Germany Hamburg, Germany Hannover, Germany Stuttgart, Germany Netherlands Rotterdam, Netherlands Spain Barcelona, Spain Madrid, Spain Valencia, Spain United Kingdom Birmingham, United Kingdom Cambridge, United Kingdom Glasgow, United Kingdom Sutton, United Kingdom 收起 << |
NCT01150097 | - | Completed | - | - | |
NCT01172938 | - | Completed | - | - | |
NCT00700102 | Colorectal Cancer | Phase 3 | Completed | - | - |
NCT01177397 | Multiple Myeloma ... 展开 >> Diffuse Large B-Cell Lymphoma Glioblastoma Multiforme Hepatocellular Carcinoma Non-Small Cell Lung Cancer Neuroendocrine Tumors of Non-Pancreatic Origin Hormone Receptor-Positive Breast Cancer 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 UCLA Neuro-Oncology Program Los Angeles, California, United States, 90095 University of California, San Francisco Hellen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Minnesota Mayo Clinic Cancer Clinical Studies Unit Rochester, Minnesota, United States, 55905 United States, Montana Billings Clinic Billings, Montana, United States, 59102 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York NYU Cancer Institute - Bellevue Hospital New York, New York, United States, 10016 United States, Tennessee Sarah Cannon Research Institute Drug Development Unit Nashville, Tennessee, United States, 37203 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75201 France Institut Claudius Regaud Toulouse Cedex, France, 31052 Institut Gustave Roussy Faculte de Medecine Paris Sud Service de pneumologie Villejuif, France, 94800 Spain Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Virgen Del Rocio Sevilla, Spain, 41013 United Kingdom Sarah Cannon Research Institute UK London, United Kingdom, W1G 6AD UCL Cancer Institute London, United Kingdom, WC1E 6BT 收起 << |
NCT01172938 | Psoriatic Arthritis | Phase 3 | Completed | - | - |
NCT00813709 | - | Completed | - | - | |
NCT01132612 | Plaque-type Psoriasis | Phase 2 | Completed | - | - |
NCT00705016 | Squamous Cell Cancer | Phase 1 Phase 2 | Completed | - | - |
NCT03351478 | Type 2 Diabetes Mellitus | Phase 3 | Active, not recruiting | May 2019 | - |
NCT00700102 | - | Completed | - | - | |
NCT01040130 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | Australia, South Australia ... 展开 >> 1222.37.6171 Boehringer Ingelheim Investigational Site Daw Park, South Australia, Australia Australia, Victoria 1222.37.6174 Boehringer Ingelheim Investigational Site Clayton, Victoria, Australia 1222.37.6173 Boehringer Ingelheim Investigational Site Heidelberg, Victoria, Australia 1222.37.6172 Boehringer Ingelheim Investigational Site Melbourne, Victoria, Australia Austria 1222.37.4371 Boehringer Ingelheim Investigational Site Gänserndorf, Austria 1222.37.4372 Boehringer Ingelheim Investigational Site Neumarkt am Wallersee, Austria Canada, Ontario 1222.37.1072 Boehringer Ingelheim Investigational Site Hamilton, Ontario, Canada Canada, Quebec 1222.37.1074 Boehringer Ingelheim Investigational Site Montreal, Quebec, Canada 1222.37.1073 Boehringer Ingelheim Investigational Site Ste-Foy, Quebec, Canada France 1222.37.33005 Boehringer Ingelheim Investigational Site Bethune Cedex, France 1222.37.33002 Boehringer Ingelheim Investigational Site Montpellier, France 1222.37.33001 Boehringer Ingelheim Investigational Site Nîmes, France 1222.37.33006 Boehringer Ingelheim Investigational Site Paris, France 1222.37.33004 Boehringer Ingelheim Investigational Site Perpignan, France 1222.37.33003 Boehringer Ingelheim Investigational Site Strasbourg, France Germany 1222.37.4970 Boehringer Ingelheim Investigational Site Berlin, Germany 1222.37.4972 Boehringer Ingelheim Investigational Site Halle, Germany 1222.37.4973 Boehringer Ingelheim Investigational Site Magdeburg, Germany 1222.37.4971 Boehringer Ingelheim Investigational Site Rüdersdorf, Germany 收起 << |
NCT01040130 | - | Completed | - | - | |
NCT00705016 | - | Completed | - | - | |
NCT00711893 | - | Completed | - | Austria ... 展开 >> KH der Elisabethinen Linz Linz, Austria, 4010 KH der Barmherzigen Schwestern Ried/Innkreis Ried, Austria, 4910 Belgium Hartcentrum Hasselt - Dienst Cardiologie Hasselt, Belgium, 3500 China, Hong Kong Prince of Wales Hospital Hong Kong, Hong Kong, China France EHRU de Brest - Hospital de la Cavale Blanche Brest, France, 29200 CHU Dijon - Hospital du Bocage Dijon, France, 21000 CHR Orléans - Hospital la Source Orléans, France, 45067 CMC Parly II Parly, France, 78000 CHU de St. Etienne-Hospital Nord Saint Priest en Jarez, France, 42055 CHU de Tours Tours Cedex, France, 37044 Germany Kerckhoff-Klinik GmbH Bad Nauheim, Germany, 61231 Praxis Dres. Bischoff/Lang Erfurt, Germany, 99084 Klinikum Fulda Fulda, Germany, 36043 Marienhospital Herne Herne, Germany, 44625 Klinikum Kassel Kassel, Germany, 34125 Praxis Schnabel der Praxisgemeinschaft Kardiologie Meissen Meissen, Germany, 01662 Klinikum Nuernberg Nuernberg, Germany, 90471 Klinikum Dorothea Christiane Erxleben Quedlinburg GmbH Quedlinburg, Germany, 06484 Greece University Hospital of Heraklion Heraklion, Greece, 71409 Latvia Paul Stradina Clinical University Hospital Riga, Latvia, 1002 Netherlands Ziekenhius Rijnstate Arnhem Arnhem, Netherlands, 6815 Amphia Ziekenhius Breda Breda, Netherlands, 4818 Slovakia Narodny ustav srdcvych a cievnych chorob Bratislava, Slovakia, 83348 Spain Hospital Universitario Central de Asturias Oviedo, Spain, 33006 Hospital Son Llatzer Palma de Mallorca, Spain, 07004 Clinico Universitario de Valladolid Valladolid, Spain, 47005 Centro Miguel Servet Zaragoza, Spain, 50012 Switzerland University Hospital of Geneva Geneva, Switzerland, 1211 收起 << | |
NCT00717405 | - | Completed | - | - | |
NCT03395704 | Hereditary Hemochromatosis | Phase 2 | Recruiting | December 2018 | United States, Arkansas ... 展开 >> Investigative Site Recruiting North Little Rock, Arkansas, United States, 72117 United States, California Investigative Site Recruiting Palo Alto, California, United States, 94305 Investigative Site Recruiting Rialto, California, United States, 92377 Investigational Site Recruiting San Diego, California, United States, 91942 United States, Michigan Investigative Site Recruiting Wyoming, Michigan, United States, 49519 United States, Mississippi Investigative Site Recruiting Jackson, Mississippi, United States, 39216 United States, New York Investigative Site Recruiting East Setauket, New York, United States, 11733 Investigative Site Recruiting Manhasset, New York, United States, 11030 Investigative Site Recruiting New York, New York, United States, 10029 United States, Texas Investigative Site Recruiting Dallas, Texas, United States, 75246 Investigative Site Recruiting Fort Worth, Texas, United States, 76104 Investigative Site Recruiting Houston, Texas, United States, 77058 Investigative Site Recruiting San Antonio, Texas, United States, 78215 United States, Washington Investigative Site Recruiting Seattle, Washington, United States, 98104 Australia, New South Wales Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Australia, Queensland Investigative Site Recruiting Brisbane, Queensland, Australia, 4120 Investigative Site Recruiting Herston, Queensland, Australia, 4029 Australia, Victoria Investigative Site Recruiting Melbourne, Victoria, Australia, 3004 France Investigative Site Recruiting Bondy, France, 93140 Investigative Site Recruiting Orléans, France, 45000 Investigative Site Recruiting Pessac, France, 33604 Investigative Site Recruiting Rennes Cedex 9, France, 35033 United Kingdom Investigative Site Recruiting Bradford, England, United Kingdom, BD9 6RJ Investigative Site Recruiting Newcastle Upon Tyne, England, United Kingdom, NE7 7DN Investigative Site Recruiting Portsmouth, England, United Kingdom, PO6 3LY 收起 << |
NCT01280526 | Peripheral T Cell Lymphoma | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon Dijon, France, 21000 Hôpital Claude Huriez Lille, France, 59037 Centre Léon Bérard Lyon cedex 8, France, 69373 Hôpital St Louis Paris, France, 75475 Centre Hospitalier Lyon Sud Pierre-Bénite, France, 69495 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT01358721 | Renal Cell Carcinoma | Phase 1 | Active, not recruiting | November 16, 2018 | United States, California ... 展开 >> Ucsf Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Connecticut Yale University School Of Medicine New Haven, Connecticut, United States, 06520 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University Of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland The Bunting-Blaustein Cancer Research Building Baltimore, Maryland, United States, 21231 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Dana Farber Cancer Inst Boston, Massachusetts, United States, 02215 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Providence Portland Med Ctr Portland, Oregon, United States, 97213 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Upmc Cancer Pavilion Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin University Of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53705 France Local Institution Villejuif Cedex, France, 94805 Spain Local Institution Pamplona, Spain, 31192 收起 << |
NCT00717405 | Breast Cancer | Phase 2 | Completed | - | France ... 展开 >> Besancon, France, 25030 Bordeaux, France, 33000 Brest, France, 29609 Caen, France, 14076 Clermont Ferrand, France, 63011 Dijon, France, 21079 La Tronche, France, 38700 Lille, France, 59020 Lyon, France, 69373 Marseille, France, 13273 Montpellier, France, 34298 Nantes, France, 44202 Nice, France, 06189 Paris, France, 75231 Paris, France, 75475 Paris, France, 75970 Reims CEDEX, France, 51056 Rennes, France, 35042 Rouen, France, 76038 Saint Brieuc, France, 22015 Saint Herblain, France, 44805 St Cloud, France, 92210 St Priest En Jarez, France, 42271 Strasbourg, France, 67065 Strasbourg, France, 67098 Toulouse, France, 31059 Vandoeuvre Les Nancy, France, 54511 Villejuif, France, 94805 收起 << |
NCT01353625 | Glioblastoma Multiforme ... 展开 >> Squamous Cell Carcinoma of Head and Neck Prostate Cancer Ewing's Osteosarcoma Chronic Lymphocytic Leukemia Neoplasm Metastasis 收起 << | Phase 1 | Active, not recruiting | November 30, 2019 | United States, California ... 展开 >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 UCLA Los Angeles, California, United States, 90095 University of California, San Francisco Comprehensive Cancer Center and Cancer Research Institiute San Francisco, California, United States, 94115 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Henry Ford Health System Detroit, Michigan, United States, 48202 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Tennessee Sarah Cannon Research Institute Drug Development Unit Nashville, Tennessee, United States, 37203 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75201 The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77303 France Institut Gustave Roussy Villejuif Cedex, France, 94805 Germany Uniklinik Koln Koeln, Germany, 50937 Universitatsklinikum Wurzburg Würzburg, Germany, 97070 Spain Hospital Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario Madrid Sanchinarro Madrid, Spain, 28050 Hospital de Donosti San Sebastián (Guipuzcoa), Spain, 20014 Hospital Virgen del Rocio Sevilla, Spain, 41013 收起 << |
NCT00555919 | Metastatic Breast Cancer | Phase 2 | Completed | - | Austria ... 展开 >> Graz, Austria, 8036 Innsbruck, Austria, 6020 Salzburg, Austria, 5020 Wien, Austria, 1100 Finland Turku, Finland, FIN-20521 Vaasa, Finland, 65130 France Lille, France, 59020 Lyon Cedex, France, 69008 Montpellier, France, 34000 Nantes, France, 44805 Paris, France, 75020 Reims, France, 51056 Germany Tübingen, Baden-Württemberg, Germany, 72076 Erlangen, Bayern, Germany, 91054 Frankfurt, Hessen, Germany, 60590 Rostock, Mecklenburg-Vorpommern, Germany, 18059 Kiel, Schleswig-Holstein, Germany, 24105 Italy Rozzano, Milano, Italy, 20089 Poland Bialystok, Poland, 15-540 Gdansk, Poland, 80-219 Olsztyn, Poland, 10-226 Poznan, Poland, 60-569 Spain Madrid, Spain, 28040 Sweden Göteborg, Sweden, 413 45 Sundsvall, Sweden, 851 86 Växjö, Sweden, 351 85 Switzerland St. Gallen, Sankt Gallen, Switzerland, 9007 United Kingdom Nottingham, United Kingdom, NG5 1PB 收起 << |
NCT00737529 | Mantle Cell Lymphoma | Phase 2 | Completed | - | - |
NCT03405935 | HIV-1-infection | Phase 3 | Active, not recruiting | May 2020 | Belgium ... 展开 >> CHU Saint-Pierre Brussels, Belgium, 1000 UZ Gent Ghent, Belgium, 9000 France CHU Bordeaux - Groupe Hospitalier Sud Bordeaux, France, 33064 Hopital Saint-Andre Bordeaux, France, 33075 Hopital Europeen Marseille Marseille, France, 13006 C.H.U. de Nantes - Hotel Dieu Nantes, France, 44093 CHU de Nice Nice, France, 6203 Hopital Saint Louis PARIS cedex 10, France, 75475 Hopital Necker - Enfants Malades Paris, France, 75015 Hopital Saint Antoine Paris, France, 75571 CH de Tourcoing Tourcoing, France, 59208 Italy ASST Papa Giovanni XXIII Bergamo, Italy, 24127 ASST - Fatebenefratelli Sacco Milano, Italy, 20157 P.O. Spirito Santo - U.O. Malattie Infettive e Tropicali Pescara, Italy, 65124 IRCCS Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani Roma, Italy, 00149 Spain Hospital Universitari Germans Trias i Pujol Badalona, Spain, 8916 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08026 Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Clinic de Barcelona Barcelona, Spain, 08036 Hospital General Universitario Gregorio Maranon Madrid, Spain, 28007 Hospital Universitario Ramon y Cajal Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Costa Del Sol Marbella, Spain, 29603 United Kingdom Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle Upon Tyne, United Kingdom, NE1 4LP 收起 << |
NCT01061723 | Ankylosing Spondylitis | Phase 2 | Completed | - | - |
NCT01061723 | - | Completed | - | - | |
NCT03151408 | Acute Myeloid Leukemia | Phase 3 | Recruiting | May 2021 | - |
NCT02872116 | Gastric Cancer ... 展开 >> Gastroesophageal Junction Cancer 收起 << | Phase 3 | Recruiting | October 6, 2022 | - |
NCT01218477 | - | Completed | - | - | |
NCT00869856 | Anemia Chroni... 展开 >>c Renal Insufficiency 收起 << | Phase 3 | Withdrawn(investigation of adv... 展开 >>erse events in a related clinical study) 收起 << | - | Bulgaria ... 展开 >> MHAT "Dr. Tota Venkova" Gabrovo, Bulgaria, 5300 MHAT Pazardzhik Pazardzhik, Bulgaria, 4400 MHAT"Sveti Ivan Rilski" Sofia, Bulgaria, 1431 MHAT "Sveta Anna" Varna, Bulgaria, 9000 France Polyclinique de Bordeaux-Nord Bordeaux, France, 33077 Centre Hospitalier Universitaire Limoges, Hôpital Dupuytren Limoges Cedex, France, 87042 Germany KfH Nierenzentrum Bad König, Germany, 64732 KfH Nierenzentrum Berlin, Germany, 12045 Gemeinschaftspraxis Dr. Spitthöver, Dr. Knee, Dr. Gröschel Essen, Germany, 23538 Universitätsklinikum Schleswig-Holstein Lübeck, Germany, 68309 Gesundheitszentrum Alzey Internistische Gemeinschaftspraxis Slzrx, Germany, 55232 Nierenzentrum Weinheim Kreiskrankenhaus Weinheim Weinheim, Germany, 69469 Romania Spitalul Clinic de Nefrologie Dr. Carol Davila Bucuresti, Romania, 010731 Spitalul Universitar de Urgenta Bucuresti Bucuresti, Romania, 050098 Spitalul Judetean de Urgenta Deva Deva, Romania, 330084 Spitalul Clinic Municipal "Dr. Gavril Curteanu" Oradea, Romania, 410169 Spitalul Clinic Judetean Timisoara Timisoara, Romania, 300736 Spain Hospital Universitario Puerta de Hierro Majadahonda, Spain, 28222 Hospital de Navarra Pamplona, Spain, 31008 收起 << |
NCT02876835 | Anaemia | Phase 3 | Recruiting | August 17, 2020 | - |
NCT00737529 | - | Completed | - | - | |
NCT01387932 | Hepatocellular Carcinoma | Phase 3 | Active, not recruiting | December 2022 | - |
NCT00929110 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT03433482 | Meningitis, Meningococcal | Phase 2 | Recruiting | December 18, 2019 | Estonia ... 展开 >> GSK Investigational Site Recruiting Tallinn, Estonia, 10117 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Tallinn, Estonia Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Tartu, Estonia, 50106 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Finland GSK Investigational Site Recruiting Espoo, Finland, 02230 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Helsinki, Finland, 00100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Jarvenpaa, Finland, 04400 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Oulu, Finland, 90220 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Pori, Finland, 28100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Tampere, Finland, 33100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com France GSK Investigational Site Recruiting Angers, France, 49000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Nantes cedex 2, France, 44277 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Nice, France, 06300 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Tours, France, 37044 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Russian Federation GSK Investigational Site Recruiting Murmansk, Russian Federation, 183038 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Saint Petersburg, Russian Federation, 197022 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com South Africa GSK Investigational Site Recruiting Pretoria, Gauteng, South Africa, 0152 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Bellville, South Africa, 7530 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Spain GSK Investigational Site Recruiting Barcelona, Spain, 08025 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Centelles (Barcelona), Spain, 08540 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Hospitalet de Llobregat, Spain, 08907 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting La Roca Del Valles (Barcelona), Spain, 08430 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Madrid, Spain, 28050 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Quart De Poblet, Valencia, Spain, 46930 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Sevilla, Spain, 41014 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Valencia, Spain, 46011 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Valencia, Spain, 46022 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Valencia, Spain, 46200 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Vic/ Barcelona, Spain, 08500 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT01248195 | Schizophrenia ... 展开 >> Schizophreniform Disorder Schizoaffective Disorder 收起 << | Phase 4 | Completed | - | - |
NCT01336621 | Epilepsy | Phase 3 | Completed | - | - |
NCT00780455 | Multiple Sclerosis, Relapsing-... 展开 >>Remitting 收起 << | Phase 4 | Terminated | - | France ... 展开 >> Rennes, Bretagne, France, 35038 Avignon, France, 84025 Lille, France, 59037 Lomme, France, 59160 Montpellier, France, 34295 Mulhouse, France, 68051 Nimes, France, 30029 Quimper, France, 29000 Reims Cedex, France, 51091 Toulouse, France, 31059 收起 << |
NCT01218477 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> University Of California Medical Center San Francisco, California, United States, 94143 United States, Maryland Sidney Kimmel Cancer Center At Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Texas Ut M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8N 3Z5 Local Institution Toronto, Ontario, Canada, M5G 2M9 Finland Local Institution Helsinki, Finland, 00290 France Local Institution Bordeaux, France, 33076 Local Institution Poitiers Cedex, France, 86021 Germany Local Institution Frankfurt/main, Germany, 60590 Italy Local Institution Bologna, Italy, 40138 Local Institution Orbassano(To), Italy, 10043 United Kingdom Local Institution Glasgow, United Kingdom, G12 0YN 收起 << |
NCT00780455 | - | Terminated | - | - | |
NCT00929110 | - | Completed | - | - | |
NCT02936102 | Advanced Solid Tumors, Non-Sma... 展开 >>ll Cell Lung Carcinoma, Triple Negative Breast Cancer, Endometrial Cancer, Anaplastic Thyroid Cancer 收起 << | Phase 1 | Recruiting | February 28, 2020 | United States, California ... 展开 >> Novartis Investigative Site Recruiting Santa Monica, California, United States, 90404 United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10065 Contact: Afra Yehwalashet 646-888-5341 yehwalaa@mskcc.org Principal Investigator: Ayca Gucalp United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Anjali Raina 713-563-2632 ARaina@mdanderson.org Principal Investigator: Filip Janku Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Recruiting Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Recruiting Jena, Germany, 07740 Israel Novartis Investigative Site Recruiting Tel Aviv, Israel, 64239 Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Novartis Investigative Site Recruiting Modena, MO, Italy, 41124 Japan Novartis Investigative Site Recruiting Koto-ku, Tokyo, Japan, 135 8550 Singapore Novartis Investigative Site Recruiting Singapore, Singapore, 119228 Spain Novartis Investigative Site Recruiting Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 收起 << |
NCT01117987 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Terminated(Novartis discontinu... 展开 >>ed the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.) 收起 << | - | - |
NCT01117987 | - | Terminated(Novartis discontinu... 展开 >>ed the development of imatinib in PAH due to requirement of regulatory authorities for additional data to secure marketing approval in PAH.) 收起 << | - | - | |
NCT01120691 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT00631969 | Erectile Dysfunction | Phase 3 | Completed | - | - |
NCT01449058 | Advanced and Selected Solid Tu... 展开 >>mors AML High Risk and Very High Risk MDS 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> University of California San Diego - Moores Cancer Center Dept Onc La Jolla, California, United States, 92093-0658 United States, Florida H. Lee Moffitt Cancer Center & Research Institute H. Lee Moffitt SC Tampa, Florida, United States, 33612 United States, Illinois Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital CCPO Boston, Massachusetts, United States, 02114 United States, New York Memorial Sloan Kettering Cancer Center Onc. Dept New York, New York, United States, 90033 Montefiore Medical Center SC The Bronx, New York, United States, 10461 United States, Texas University of Texas/MD Anderson Cancer Center Dept. of Onc. Houston, Texas, United States, 77030-4009 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman (3) Salt Lake City, Utah, United States, 84103 Australia, Victoria Array BioPharma Investigative Site Parkville, Victoria, Australia, 3050 France Array BioPharma Investigative Site Villejuif Cedex, France, 94805 Italy Array BioPharma Investigative Site Milano, MI, Italy, 20133 Array BioPharma Investigative Site Roma, RM, Italy, 00168 Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08036 Switzerland Array BioPharma Investigative Site Bellinzona, Switzerland, 6500 United Kingdom Array BioPharma Investigative Site Sutton, United Kingdom, SM2 5PT 收起 << |
NCT03548207 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | September 14, 2021 | United States, California ... 展开 >> City of Hope Not yet recruiting Duarte, California, United States, 91010 University of California, San Francisco Not yet recruiting San Francisco, California, United States, 94143 United States, Illinois University of Chicago Not yet recruiting Chicago, Illinois, United States, 60637 United States, Michigan Barbara Ann Karmanos Cancer Institute Not yet recruiting Detroit, Michigan, United States, 48201 United States, Nebraska University of Nebraska Medical Center Not yet recruiting Omaha, Nebraska, United States, 68198 United States, New York Roswell Park Cancer Institute Not yet recruiting Buffalo, New York, United States, 14263 Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 United States, North Carolina Levine Cancer Institute Not yet recruiting Charlotte, North Carolina, United States, 28204 United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Belgium Universitair Ziekenhuis - Antwerpen Not yet recruiting Antwerp, Belgium, 2650 UZ Gent Not yet recruiting Gent, Belgium, 9000 UZ Leuven Not yet recruiting Leuven, Belgium, 3000 France CHRU de Lille - Hôpital Claude Huriez Not yet recruiting Lille, France, 59000 C.H.U. Hotel Dieu - France Not yet recruiting Nantes, France, 44093 Hopital Saint-Louis Not yet recruiting Paris Cedex 10, France, 75475 Netherlands VU Medisch Centrum Not yet recruiting Amsterdam, Netherlands, 1081 HV Erasmus MC Not yet recruiting Rotterdam, Netherlands, 3015 CN UMC Utrecht Not yet recruiting Utrecht, Netherlands, 3584 CX 收起 << |
NCT01336621 | - | Completed | - | - | |
NCT01120691 | - | Completed | - | - | |
NCT03548935 | Metabolism and Nutrition Disor... 展开 >>der Overweight or Obesity 收起 << | Phase 3 | Recruiting | April 20, 2020 | - |
NCT00828737 | Fibrosis Rena... 展开 >>l Impairment 收起 << | Phase 4 | Completed | - | - |
NCT03301857 | Giant Cell Tumor of Bone | Phase 4 | Active, not recruiting | July 19, 2023 | United States, California ... 展开 >> Research Site Santa Monica, California, United States, 90403 United States, District of Columbia Research Site Washington, District of Columbia, United States, 20010 United States, Minnesota Research Site Minneapolis, Minnesota, United States, 55455 United States, New York Research Site New York, New York, United States, 10003 United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States, 19106 Australia, New South Wales Research Site Camperdown, New South Wales, Australia, 2250 France Research Site Lyon CEDEX 08, France, 69373 Research Site Villejuif, France, 94805 Italy Research Site Bologna, Italy, 40136 Poland Research Site Warszawa, Poland, 01-211 Research Site Warszawa, Poland, 02-781 Spain Research Site Palma de Mallorca, Baleares, Spain, 07010 Sweden Research Site Lund, Sweden, 221 85 United Kingdom Research Site Birmingham, United Kingdom, B31 2AP 收起 << |
NCT00661219 | Erectile Dysfunction ... 展开 >> Depression 收起 << | Phase 3 | Completed | - | - |
NCT00631969 | - | Completed | - | - | |
NCT00833612 | Acute Myocardial Infarction (A... 展开 >>MI) 收起 << | Phase 4 | Completed | - | - |
NCT00839826 | Thromboembolism ... 展开 >> Prevention 收起 << | Phase 2 | Completed | - | - |
NCT00665496 | Erectile Dysfunction | Phase 3 | Completed | - | - |
NCT03349710 | Squamous Cell Carcinoma of the... 展开 >> Head and Neck 收起 << | Phase 3 | Active, not recruiting | November 10, 2022 | - |
NCT03047395 | Psoriasis | Phase 3 | Active, not recruiting | December 28, 2021 | - |
NCT03377491 | Pancreas Adenocarcinoma | Phase 3 | Recruiting | December 2022 | - |
NCT03100149 | Parkinson's Disease | Phase 2 | Recruiting | February 18, 2021 | - |
NCT02802345 | Idiopathic Pulmonary Fibrosis | Phase 3 | Completed | - | - |
NCT03118843 | Hepatitis C Virus Infection | Phase 3 | Completed | - | - |
NCT03072238 | Metastatic Prostate Cancer | Phase 3 | Recruiting | November 18, 2023 | - |
NCT03441113 | Post-polycythemia Vera Myelofi... 展开 >>brosis (Post-PV MF) Primary Myelofibrosis (PMF) Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) 收起 << | Phase 2 | Enrolling by invitation | June 2020 | - |
NCT00185250 | Cardiomyopathies ... 展开 >> Heart Diseases 收起 << | Phase 2 | Completed | - | France ... 展开 >> Nantes, France, 44805 Poitiers Cedex, France, 86021 Germany Bad Krozingen, Baden-Württemberg, Germany, 79189 Ulm, Baden-Württemberg, Germany, 89075 München, Bayern, Germany, 80636 Greifswald, Mecklenburg-Vorpommern, Germany, 17489 Rostock, Mecklenburg-Vorpommern, Germany, 18057 Göttingen, Niedersachsen, Germany, 37075 Bad Oeynhausen, Nordrhein-Westfalen, Germany, 32545 Dortmund, Nordrhein-Westfalen, Germany, 44137 Essen, Nordrhein-Westfalen, Germany, 45147 Köln, Nordrhein-Westfalen, Germany, 50931 Münster, Nordrhein-Westfalen, Germany, 48149 Wuppertal, Nordrhein-Westfalen, Germany, 42117 Ludwigshafen, Rheinland-Pfalz, Germany, 67063 Homburg, Saarland, Germany, 66421 Halle, Sachsen-Anhalt, Germany, 06097 Leipzig, Sachsen, Germany, 04103 Kiel, Schleswig-Holstein, Germany, 24105 Bad Berka, Thüringen, Germany, 99437 Berlin, Germany, 12200 Brandenburg, Germany, 14770 Hamburg, Germany, 20251 Italy Bergamo, BG, Italy, 24128 Milano, MI, Italy, 20132 Pavia, Italy, 27100 Poland Warszawa, Poland, 00-909 Warszawa, Poland, 04628 Spain Madrid, Spain, 28040 Sweden Göteborg, Sweden, 413 45 United Kingdom Glasgow, United Kingdom, G11 6NT 收起 << |
NCT03229200 | Lymphoma, B-Cell ... 展开 >> Lymphoma, Non-Hodgkin Leukemia, B-cell Graft Vs Host Disease Solid Tumor 收起 << | Phase 4 | Enrolling by invitation | July 2, 2027 | - |
NCT02890992 | Hypercholesterolaemia | Phase 2 | Active, not recruiting | February 22, 2019 | United States, Missouri ... 展开 >> Investigational Site Number 8400002 Saint Louis, Missouri, United States, 63110 United States, North Carolina Investigational Site Number 8400005 Charlotte, North Carolina, United States, 28204 United States, Ohio Investigational Site Number 8400001 Cincinnati, Ohio, United States, 45229 Canada Investigational Site Number 1240001 Quebec, Canada, G1V 4W2 Czechia Investigational Site Number 2030001 Brno, Czechia, 62500 Investigational Site Number 2030003 Praha 5 - Motol, Czechia, 15006 Investigational Site Number 2030002 Zlin, Czechia, 76275 France Investigational Site Number 2500001 Bron Cedex, France, 69677 Netherlands Investigational Site Number 5280001 Amsterdam, Netherlands, 1105 AZ Norway Investigational Site Number 5780001 Oslo, Norway, 0373 Russian Federation Investigational Site Number 6430001 Kemerovo, Russian Federation, 650002 Investigational Site Number 6430004 Saint-Petersburg, Russian Federation, 194100 South Africa Investigational Site Number 7100001 Parow, South Africa, 7500 Spain Investigational Site Number 7240004 A Coruna, Spain, 15001 Investigational Site Number 7240001 Madrid, Spain, 28009 Sweden Investigational Site Number 7520001 Stockholm, Sweden, 171 76 收起 << |
NCT03603847 | - | Recruiting | July 2023 | France ... 展开 >> CHU Amiens - Hôpital Sud Recruiting Amiens, France Contact: Ghandi DAMAJ, MD CHU d'Estaing Recruiting Clermont-Ferrand, France Contact: Sebastien BAILLY, MD APHP - Hopital Henri Mondor Recruiting Creteil, France Contact: Jehan DUPUIS, MD CHU Grenoble Recruiting Grenoble, France Contact: Remy GRESSIN, MD CHRU de Lille - Hôpital Claude Huriez Recruiting Lille, France Contact: Franck MORSCHHAUSER, Pr Institut Paoli Calmette Recruiting Marseille, France Contact: Reda BOUABDALLAH APHP - Hôpital Saint Louis Recruiting Paris Cedex 10, France Contact: Catherine Thieblemont, MD APHP - Hôpital Necker Recruiting Paris, France Contact: David Sibon, MD CHU Bordeaux - Centre François Magendie Recruiting Pessac, France Contact: Kamal BOUABDALLAH Centre Hospitalier Lyon Sud Recruiting Pierre Bénite, France Contact: Emmanuel BACHY, MD CHU de Rennes - Hôpital de Pontchaillou Recruiting Rennes, France Contact: Roch HOUOT, MD Centre Henri Becquerel Recruiting Rouen, France Contact: Hervé TILLY, MD CHRU de Strasbourg Recruiting Strasbourg, France Contact: Luc-Matthieu Fornecker, MD Institut Universitaire du Cancer de Toulouse - Oncopole Recruiting Toulouse, France Contact: Loïc YSEBAERT, MD CHU Brabois Recruiting Vandoeuvre les Nancy, France Contact: Pierre FEUGIER 收起 << | |
NCT03320642 | Hematologic Malignancies | Phase 1 | Recruiting | January 2021 | - |
NCT01403948 | Lymphoma, Non-Hodgkin | Phase 1 | Completed | - | France ... 展开 >> INS Paoli-Calmettes Marseille Cedex 09, France, 13273 HOP Lyon Sud Pierre Bénite, France, 69495 Germany Charité - Universitätsmedizin Berlin Berlin, Germany, 12200 Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany, 01307 Universitätsklinikum Frankfurt Frankfurt am Main, Germany, 60590 Universitätsmedizin Göttingen, Georg-August-Universität Göttingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, 20099 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Universitätsklinikum Jena Jena, Germany, 07740 Universitätsklinikum Ulm Ulm, Germany, 89081 Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Korea, Republic of, 135-710 收起 << |
NCT00004978 | HIV Infections | Phase 3 | Completed | - | - |
NCT01615029 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | December 8, 2022 | United States, Massachusetts ... 展开 >> Boston, Massachusetts, United States Denmark Copenhagen Ø, Denmark Vejle, Denmark France Lille Cedex, France Nantes N/A, France Vandoeuvre Les Nancy, France Netherlands Utrecht, Netherlands United Kingdom London, United Kingdom 收起 << |
NCT01615029 | - | Active, not recruiting | - | - | |
NCT02732951 | Macular Edema | Phase 2 | Completed | - | Belgium ... 展开 >> Brussels-UNIV Brugmann -Horta Brussel, Belgium, 1020 Leuven - UNIV UZ Leuven (Sint-Rafaël) Leuven, Belgium, 3000 France HOP Nord Marseille, France, 13915 HOP Hôtel-Dieu Nantes, France, 44093 HOP Lariboisière Paris, France, 75010 Hosp National 15-20, Ophtalmo, Paris Paris, France, 75012 HOP Pierre Paul Riquet Toulouse cedex 9, France, 31059 Germany RWTH Aachen Aachen, Germany, 52074 Augen Zentrum Nordwest, Ahaus Ahaus, Germany, 48683 Kamppeter Augenzentrum, Bayreuth Bayreuth, Germany, 95444 Universitätsmedizin Göttingen Göttingen, Germany, 37075 Universitätsmedizin Mainz Mainz, Germany, 55131 Augenarzt Dr. Dunker und Kollegen, Troisdorf Troisdorf-Sieglar, Germany, 53844 Universitätsklinikum Tübingen Tübingen, Germany, 72076 Universitätsklinikum Ulm Ulm, Germany, 89075 Greece Attikon, Panepistimiako Geniko Nosokomeio Athens, Greece, 12462 University General Hospital of Heraklion Herakleion,Crete, Greece, 71110 University Hospital of Patras Patras, Greece, 26504 Hungary Uzsoki Street Hospital, Ophtalmology Department, Budapest Budapest, Hungary, 1145 BAZ County Hospital, Ophtalmology Department, Miskolc Miskolc, Hungary, 3526 Univ.Szeged;Szent-Gyorgyi;Albert Heal.Cent.Ophtalmology Dep Szeged, Hungary, 6720 Portugal Hospital de Braga-Escala Braga Braga, Portugal, 4710-243 AIBILI - Association for Innovation and Biomedical Research on Light and Image Coimbra, Portugal, 3000-548 Centro Hospitalar São João,EPE Porto, Portugal, 4200-319 Hospital de Vila Franca de Xira Vila Franca de Xira, Portugal, 2600-009 Spain Centro de Oftalmología Barraquer Barcelona, Spain, 08021 Hospital Dos de Maig Barcelona, Spain, 08025 Hospital Vall d'Hebron Barcelona, Spain, 08035 Hospital La Paz Madrid, Spain, 28046 Instituto Oftalmológico Gómez-Ulla Santiago de Compostela, Spain, 15706 Hospital Clínico Universitario de Valladolid Valladolid, Spain, 47005 United Kingdom Frimley Park Hospital Frimley, United Kingdom, GU16 7UJ Moorfields Eye Hospital London, United Kingdom, EC1V 2PD Southampton General Hospital Southampton, United Kingdom, SO16 6YD 收起 << |
NCT00134238 | Mixed Hyperlipidemia | Phase 3 | Terminated | - | - |
NCT00004978 | - | Completed | - | - | |
NCT02985957 | Prostate Cancer | Phase 2 | Active, not recruiting | March 24, 2022 | United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 United States, Missouri Washington University School Of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Icahn School Of Medicine At Mount Sinai New York, New York, United States, 10029 United States, Pennsylvania University Of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 France Local Institution Clermont-ferrand, France, 63000 Local Institution Lyon, France, 69008 Local Institution Marseille Cedex 9, France, 13273 Local Institution Villejuif, France, 94805 收起 << |
NCT03283085 | Crohn's Disease ... 展开 >> Ulcerative Colitis 收起 << | Phase 3 | Recruiting | February 11, 2025 | - |
NCT00635492 | - | Completed | - | - | |
NCT00554229 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT02769273 | - | Recruiting | June 2021 | Austria ... 展开 >> Medical University Graz Recruiting Graz, Austria Contact: Marianne Brodmann Principal Investigator: Marianne Brodmann Krankenhaus Göttlicher Heiland GmbH Recruiting Vienna, Austria Contact: Hubert Trnka Principal Investigator: Hubert Trnka Belgium OLV Aalst Recruiting Aalst, Belgium Contact: Lieven Maene Principal Investigator: Lieven Maene Universitair Ziekenhuis Antwerpen Not yet recruiting Antwerpen, Belgium Contact: Karen Wurstenberghs Principal Investigator: Karen Wurstenberghs Imelda Not yet recruiting Bonheiden, Belgium Contact: Juergen Verbist Principal Investigator: Juergen Verbist AZ Sint Blasius Recruiting Dendermond, Belgium Contact: Koen Deloose Principal Investigator: Koen Deloose UZA Antwerpen Recruiting Edegem, Belgium, 2650 Contact: Jeroen Hendriks Principal Investigator: Jeroen Hendriks Universitair Ziekenhuis Gent Recruiting Gent, Belgium Contact: Frank Vermassen Principal Investigator: Frank Vermassen AZ Groeninge Recruiting Kortrijk, Belgium Contact: Philip Lerut Principal Investigator: Philip Lerut H.Hart Tienen Recruiting Tienen, Belgium Contact: Koen Keirse Principal Investigator: Koen Keirse France Clinique Générale Annecy Recruiting Annecy, France Contact: Laurence Destrieux Principal Investigator: Laurence Destrieux Clinique Rhone Durance Recruiting Avignon, France Contact: Jérôme Brunet Principal Investigator: Jérôme Brunet Clinique Médipole De Savoie Recruiting Challes Les Eaux, France Contact: Sébastien Pénillon Principal Investigator: Sébastien Pénillon Clinique Pasteur Recruiting Toulouse Cedex 3, France Contact: Antoine Sauguet Principal Investigator: Antoine Sauguet Clinique Sarrus teinturiers Rive Gauche Recruiting Toulouse, France Contact: Antoine Principal Investigator: Antoine Sauguet Germany Klinikum Arnsberg Recruiting Arnsberg, Germany Contact: Michael Lichtenberg Principal Investigator: Michael Lichtenberg Ev. Krankenhaus Königin Elisabeth Herzberge Recruiting Berlin, Germany Contact: Jens Stegemann Principal Investigator: Jens Stegemann Jüdisches Krankenhaus Berlin Recruiting Berlin, Germany Contact: Henrik Schröder Principal Investigator: Henrik Schröder MediClin Herzzentrum Coswig Recruiting Coswig / Sachsen Anhalt, Germany Contact: Uwe Winkler Principal Investigator: Uwe Winkler Cardioangiologisches Centrum Bethanien Recruiting Frankfurt, Germany Contact: Michael Piorkowski Principal Investigator: Michael Piorkowski Krankenhäuser Landkreis Freudenstadt GmbH Recruiting Freundenstadt, Germany Contact: Florian Bea Principal Investigator: Florian Bea Universitätsklinikum Halle Recruiting Halle a.d.Saale, Germany Contact: Jorg Ukkat Principal Investigator: Jorg Ukkat Universitätsklinikum Jena Recruiting Jena, Germany Contact: Ulf Teichgräber Principal Investigator: Ulf Teichgräber SRH Klinikum Karlsbad-Langensteinbach GmbH Recruiting Karlsbad, Germany Contact: Erwin Blessing Principal Investigator: Erwin Blessing Universitätsklinikum Leipzig Recruiting Leipzig, Germany Contact: Dierk Scheinert Principal Investigator: Dierk Scheinert Saint Vincenz Hospital Recruiting Limburg, Germany Contact: Patricia Schaub Principal Investigator: Patricia Schaub St. Franziskus-Hospital GmbH Recruiting Munster, Germany Contact: Giovanni Torsello Principal Investigator: Giovanni Torsello Italy Clinica Montevergine Recruiting Mercogliano AV, Italy Contact: Luigi Salemme Principal Investigator: Luigi Salemme Ospedale Civile Di Mirano Recruiting Mirano, Italy Contact: Salvatore Saccà Principal Investigator: Salvatore Saccà Multimedica Recruiting Sento San Giovanni (Milan), Italy Contact: Flavio Airoldi Principal Investigator: Flavio Airoldi United Kingdom The Royal Bournemouth Hospital Recruiting Bournemouth, United Kingdom Contact: Clare Bent Principal Investigator: Clare Bent Stoke Mandeville Hospital Recruiting Buckinghamshire, United Kingdom Contact: Dinuke Warakaulle Principal Investigator: Dinuke Warakaulle "Saint George's Vascular Institute Recruiting London, United Kingdom Contact: Pete Holt Principal Investigator: Pete Holt 收起 << | |
NCT00554229 | - | Completed | - | - | |
NCT00635492 | - | Completed | - | - | |
NCT00722267 | - | Completed | - | - | |
NCT03212521 | Hepatitis C Virus (HCV) | Phase 4 | Completed | - | - |
NCT02066220 | Brain Tumors | Phase 2 Phase 3 | Recruiting | April 2024 | - |
NCT02375971 | Retinopathy of Prematurity | Phase 3 | Completed | - | - |
NCT03040999 | Head and Neck Neoplasms | Phase 3 | Recruiting | June 29, 2023 | - |
NCT00355901 | - | Terminated | - | - | |
NCT02375971 | - | Completed | - | - | |
NCT01974440 | Lymphoma | Phase 3 | Active, not recruiting | August 3, 2021 | - |
NCT02412111 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT00242866 | Migraine Disorders | Phase 2 | Completed | - | - |
NCT00477295 | Epilepsy | Phase 3 | Completed | - | - |
NCT00477295 | - | Completed | - | - | |
NCT01006265 | Multiple Sclerosis | Phase 2 | Completed | - | - |
NCT02432846 | Renal Cell Carcinoma, Metastat... 展开 >>ic 收起 << | Phase 2 | Active, not recruiting | August 2019 | - |
NCT00615290 | - | Completed | - | France ... 展开 >> Boehringer Ingelheim Investigational Site Agen, France Boehringer Ingelheim Investigational Site Aix En Provence, France Boehringer Ingelheim Investigational Site Amiens, France Boehringer Ingelheim Investigational Site Argenteuil, France Boehringer Ingelheim Investigational Site Aulnay Sous Bois, France Boehringer Ingelheim Investigational Site Auxerre, France Boehringer Ingelheim Investigational Site Belfort, France Boehringer Ingelheim Investigational Site Besancon Cedex, France Boehringer Ingelheim Investigational Site Beziers, France Boehringer Ingelheim Investigational Site Bondy, France Boehringer Ingelheim Investigational Site Bordeaux, France Boehringer Ingelheim Investigational Site Briis Sous Forges, France Boehringer Ingelheim Investigational Site Cahors, France Boehringer Ingelheim Investigational Site Cannes, France Boehringer Ingelheim Investigational Site Chartres, France Boehringer Ingelheim Investigational Site Corbeil Essonnes, France Boehringer Ingelheim Investigational Site Creil, France Boehringer Ingelheim Investigational Site Creteil, France Boehringer Ingelheim Investigational Site DAX, France Boehringer Ingelheim Investigational Site Digne, France Boehringer Ingelheim Investigational Site Garches, France Boehringer Ingelheim Investigational Site La Roche Sur Yon, France Boehringer Ingelheim Investigational Site Le Mans, France Boehringer Ingelheim Investigational Site Le Petit Quevilly, France Boehringer Ingelheim Investigational Site Libourne, France Boehringer Ingelheim Investigational Site Lyon, France Boehringer Ingelheim Investigational Site Mantes La Jolie, France Boehringer Ingelheim Investigational Site Marseille, France Boehringer Ingelheim Investigational Site Metz, France Boehringer Ingelheim Investigational Site Mulhouse, France Boehringer Ingelheim Investigational Site Nancy, France Boehringer Ingelheim Investigational Site Nantes, France Boehringer Ingelheim Investigational Site Nevers, France Boehringer Ingelheim Investigational Site Nice, France Boehringer Ingelheim Investigational Site Orleans, France Boehringer Ingelheim Investigational Site Paris, France Boehringer Ingelheim Investigational Site Perigueux, France Boehringer Ingelheim Investigational Site Poitiers, France Boehringer Ingelheim Investigational Site Rouen, France Boehringer Ingelheim Investigational Site Saint Brieuc, France Boehringer Ingelheim Investigational Site Saint Nazaire, France Boehringer Ingelheim Investigational Site Saint-mande, France 1182.127.3301 Boehringer Ingelheim Investigational Site Strasbourg, France Boehringer Ingelheim Investigational Site Strasbourg, France Boehringer Ingelheim Investigational Site Suresnes, France Boehringer Ingelheim Investigational Site Toulouse, France Boehringer Ingelheim Investigational Site Valenciennes, France Boehringer Ingelheim Investigational Site Villeneuve St G, France 收起 << | |
NCT00615290 | - | Completed | - | - | |
NCT01927341 | Metastatic Colorectal Cancer | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> University of California at Los Angeles Dept of Onc Los Angeles, California, United States, 90095 United States, New York Memorial Sloan Kettering Cancer Center Oncology Dept NY, New York, United States, 90033 Belgium Array BioPharma Investigative Site Leuven, Belgium, 3000 Canada, Ontario Array BioPharma Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Array BioPharma Investigative Site Toulouse Cedex 9, France, 31059 Italy Array BioPharma Investigative Site Milano, MI, Italy, 20162 Netherlands Array BioPharma Investigative Site Amsterdam, Netherlands, 1066 CX Spain Array BioPharma Investigative Site Barcelona, Catalunya, Spain, 08035 收起 << |
NCT02001987 | Rheumatoid Arthritis | Phase 3 | Completed | - | France ... 展开 >> Amiens, France, 80054 Bordeaux, France, 33076 Brest, France, 29609 Caen, France, 14033 Cahors, France, 46005 Clermont-ferrand, France, 63003 Echirolles, France, 38434 La Source, France, 45100 Le Mans, France, 72037 Lille, France, 59037 Limoges, France, 87042 Lomme, France, 59462 Lyon cedex 3, France, 69437 Marseille, France, 13274 Marseille, France, 13285 Metz Tessy, France, 74370 Monaco, France, 98012 Montpellier, France, 34295 Mulhouse, France, 68070 Paris, France, 75475 Paris, France, 75571 Paris, France, 75651 Paris, France, 75679 Paris, France, 75877 Rennes, France, 35033 Rouen, France, 76031 St Mande, France, 94163 St Priest En Jarez, France, 42277 Strasbourg, France, 67098 Thonon Les Bains, France, 74203 Toulouse, France, 31059 Vandoeuvre-les-nancy, France, 54511 收起 << |
NCT00622869 | Liver Transplantation | Phase 3 | Completed | - | - |
NCT00268996 | - | Completed | - | - | |
NCT02001987 | - | Completed | - | - | |
NCT00373113 | Breast Neoplasms | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT02016105 | Plaque Type Psoriasis | Phase 3 | Completed | - | - |
NCT00622869 | - | Completed | - | - | |
NCT02016105 | - | Completed | - | - | |
NCT00784303 | Thyroid Cancer | Phase 2 | Completed | - | - |
NCT00373113 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00268996 | Atherosclerosis | Phase 2 | Completed | - | Austria ... 展开 >> GSK Investigational Site Vienna, Austria, A-1140 Belgium GSK Investigational Site Aalst, Belgium, 9300 GSK Investigational Site Antwerpen, Belgium, 2020 GSK Investigational Site Liège, Belgium, 4000 Czechia GSK Investigational Site Praha 2, Czechia, 128 08 Denmark GSK Investigational Site Aarhus N, Denmark, DK-8200 France GSK Investigational Site Besancon, France, 25000 GSK Investigational Site Brest Cedex, France, 29609 Germany GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69120 GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Muenchen, Bayern, Germany, 80336 GSK Investigational Site Bad Nauheim, Hessen, Germany, 61231 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Bad Segeberg, Schleswig-Holstein, Germany, 23795 GSK Investigational Site Hamburg, Germany, 22527 Netherlands GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Enschede, Netherlands, 7511JX GSK Investigational Site Leeuwarden, Netherlands, 8934 AD GSK Investigational Site Rotterdam, Netherlands, 3015 GD GSK Investigational Site Rotterdam, Netherlands, 3075 EA Norway GSK Investigational Site Bergen, Norway, 5053 Poland GSK Investigational Site Katowice, Poland, 40-635 GSK Investigational Site Krakow, Poland, 31-501 Spain GSK Investigational Site Marid, Spain, 28040 GSK Investigational Site Santander, Spain, 38008 Switzerland GSK Investigational Site Luzern 16, Switzerland, 6000 收起 << |
NCT02027701 | - | Completed | - | - | |
NCT02914665 | Heart Failure | Phase 2 | Completed | - | - |
NCT03371017 | Triple Negative Breast Neoplas... 展开 >>ms 收起 << | Phase 3 | Recruiting | January 31, 2021 | - |
NCT02471144 | Chronic Severe Plaque-type Pso... 展开 >>riasis 收起 << | Phase 3 | Recruiting | July 20, 2023 | - |
NCT02027701 | Chronic Inflammatory Demyelina... 展开 >>ting Polyneuropathy (CIDP) Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 收起 << | Phase 3 | Completed | - | - |
NCT00798161 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00395629 | - | Completed | - | - | |
NCT02479386 | Geographic Atrophy | Not Applicable | Terminated(There is no longer ... 展开 >>a plan to pursue an approval of lampalizumab.) 收起 << | - | - |
NCT00798889 | - | Completed | - | - | |
NCT00798889 | Solid Tumors | Not Applicable | Completed | - | - |
NCT00395629 | Iron Overload ... 展开 >> Hereditary Hemochromatosis 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> UC Irvine/Long Beach Long Beach, California, United States, 90822 United States, Connecticut University of Connecticut Health Center Farmington, Connecticut, United States, 06030 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri St. Louis University St. Louis, Missouri, United States, 63110 United States, New York Rochester General Hospital Rochester, New York, United States, 14625 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, South Carolina Three Medical Park Columbia, South Carolina, United States, 29203 Australia Novartis Investigative Site Brisbane, Australia Canada, Ontario Novartis Investigative Site London, Ontario, Canada France Novartis Investigative Site Rennes Cedex, France Germany Novartis Investigative Site Chemnitz, Germany Novartis Investigative Site Heidelberg, Germany Novartis Investigative Site Magdeburg, Germany Novartis Investigative Site Oberhausen, Germany Italy Novartis Investigative Site Modena, Italy Novartis Investigative Site Monza, Italy 收起 << |
NCT02607813 | NSCLC Ovarian... 展开 >> Cancer Melanoma Other Solid Tumors 收起 << | Phase 1 | Recruiting | December 16, 2019 | United States, Massachusetts ... 展开 >> Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02114 United States, New York Novartis Investigative Site Recruiting New York, New York, United States, 10021 Contact: Alida Beck becka@mskcc.org Principal Investigator: Gopakumar Iyer United States, Texas UT M.D Anderson Cancer Center SC - LXH254X2101 Recruiting Houston, Texas, United States, 77030 Contact: Zehra Maloo 713-563-4426 zmaloo@mdanderson.org Principal Investigator: Filip Janku Canada, Ontario Novartis Investigative Site Recruiting Toronto, Ontario, Canada, M6G 1Z5 France Novartis Investigative Site Recruiting Paris, France, 75010 Novartis Investigative Site Recruiting Toulouse Cedex 9, France, 31059 Germany Novartis Investigative Site Recruiting Essen, Germany, 45147 Novartis Investigative Site Recruiting Heidelberg, Germany, 69120 Japan Novartis Investigative Site Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Korea, Republic of, 03080 Netherlands Novartis Investigative Site Recruiting Groningen, Netherlands, 9713 GZ Contact: Department of Pulmonary Diseases University Medical Center Groningen +31 503611546 h.j.m.groen@umcg.nl Principal Investigator: H.J.M. Groen, M.D. Medical Oncology, Erasmus MC Recruiting Rotterdam, Netherlands, 3075 CE Contact m.dejonge@erasmusmc.nl Principal Investigator: M. de Jonge, M.D. Spain Novartis Investigative Site Recruiting Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Switzerland Novartis Investigative Site Recruiting Zuerich, Switzerland, 8091 收起 << |
NCT02277990 | CIED Related Infection | Phase 4 | Completed | - | - |
NCT00665626 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT00938912 | Epilepsy | Phase 2 | Enrolling by invitation | July 2022 | - |
NCT02074982 | Chronic Plaque Type Psoriasis | Phase 3 | Completed | - | - |
NCT00798161 | - | Completed | - | - | |
NCT00404352 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT00404352 | - | Completed | - | - | |
NCT01788020 | Waldenström's Macroglobulinemi... 展开 >>a 收起 << | Phase 3 | Recruiting | September 2023 | Germany ... 展开 >> University Hospital Ulm Recruiting Ulm, Germany, 89081 Contact: Christian Buske, MD +49 731 500 ext 65888 christian.buske@uni-ulm.de Principal Investigator: Christian Buske, MD 收起 << |
NCT02514473 | Cystic Fibrosis | Phase 3 | Completed | - | - |
NCT02528253 | Low Back Pain | Phase 3 | Active, not recruiting | December 2018 | - |
NCT02514473 | - | Completed | - | - | |
NCT00665626 | - | Completed | - | - | |
NCT00683969 | Myasthenia Gravis, Generalized | Phase 3 | Completed | - | - |
NCT02074982 | - | Completed | - | - | |
NCT02531633 | Giant Cell Arteritis | Phase 2 Phase 3 | Terminated(GSK decision to ret... 展开 >>urn rights to sirukumab to Janssen and discontinue sirukumab development in giant cell arteritis.) 收起 << | - | - |
NCT00974974 | Parkinson's Disease | Phase 3 | Completed | - | - |
NCT02756611 | Chronic Lymphocytic Leukemia | Phase 3 | Active, not recruiting | March 5, 2022 | - |
NCT02312960 | Neoplasm Metastasis / Bone and... 展开 >> Bones 收起 << | Phase 4 | Recruiting | December 2, 2024 | - |
NCT02545283 | Leukemia, Myeloid, Acute | Phase 3 | Recruiting | May 26, 2021 | - |
NCT00699998 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT00974974 | - | Completed | - | - | |
NCT00325442 | - | Completed | - | - | |
NCT00714493 | Rheumatoid Arthritis | Phase 4 | Completed | - | - |
NCT03046056 | Small Bowel Crohn's Disease | Phase 2 | Recruiting | March 2020 | - |
NCT00714493 | - | Completed | - | - | |
NCT02585895 | - | Completed | - | - | |
NCT02585895 | Hypercholesterolemia | Phase 3 | Completed | - | United States, Florida ... 展开 >> Research Site Boca Raton, Florida, United States, 33434 United States, Kansas Research Site Kansas City, Kansas, United States, 66160 United States, Michigan Research Site Grandville, Michigan, United States, 49418 United States, Oregon Research Site Portland, Oregon, United States, 97239 Australia, Victoria Research Site Heidelberg, Victoria, Australia, 3084 Czechia Research Site Hradec Kralove, Czechia, 500 05 France Research Site Bron, France, 69677 Research Site Nantes Cedex 1, France, 44093 Germany Research Site Berlin, Germany, 13353 Research Site Dresden, Germany, 01307 Research Site Düsseldorf, Germany, 40210 Research Site Flensburg, Germany, 24939 Italy Research Site Pisa, Italy, 56124 Research Site Roma, Italy, 00161 Spain Research Site Sevilla, Andalucía, Spain, 41013 United Kingdom Research Site Harefield, United Kingdom, UB9 6JH Research Site Penarth, United Kingdom, CF64 2XX 收起 << |
NCT00699998 | - | Completed | - | - | |
NCT02283918 | - | Completed | - | United States, Colorado ... 展开 >> Research Site Thornton, Colorado, United States, 80233 United States, Georgia Research site Decatur, Georgia, United States, 30033 United States, New York Research Site Latham, New York, United States, 12110 United States, Ohio Research Site Akron, Ohio, United States, 44320 France Research site Marseille Cedex 5, Bouches-du-Rhône, France, 13385 Research site Bordeaux, Gironde, France, 33076 Italy Research site Milano, Italy, 20162 Research site Roma, Italy, 179 收起 << | |
NCT02601950 | Malignant Rhabdoid Tumors (MRT... 展开 >>) Rhabdoid Tumors of the Kidney (RTK) Atypical Teratoid Rhabdoid Tumors (ATRT) Selected Tumors With Rhabdoid Features Synovial Sarcoma INI1-negative Tumors Malignant Rhabdoid Tumor of Ovary Renal Medullary Carcinoma Epithelioid Sarcoma Poorly Differentiated Chordoma (or Other Chordoma With Sponsor Approval) Any Solid Tumor With an EZH2 GOF Mutation 收起 << | Phase 2 | Recruiting | December 2018 | - |
NCT02387216 | Non-Small Cell Lung Cancer ... 展开 >> NSCLC Adenocarcinoma Heregulin 收起 << | Phase 2 | Recruiting | December 2018 | - |
NCT00348283 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT02376790 | Psoriatic Arthritis | Phase 3 | Completed | - | - |
NCT00348283 | - | Completed | - | - | |
NCT00325442 | Pulmonary Hypertension | Phase 3 | Completed | - | - |
NCT00744497 | Prostatic Neoplasms | Phase 3 | Completed | - | - |
NCT00214773 | - | Recruiting | December 2020 | - | |
NCT02611674 | - | Active, not recruiting | August 2, 2019 | - | |
NCT00355238 | Hepatocellular Carcinoma (HCC) | Phase 2 | Completed | - | - |
NCT00349284 | Hyperlipidemia Combined | Phase 3 | Completed | - | Belgium ... 展开 >> Site 113 Charleroi, Belgium Site 112 Couillet, Belgium Site 115 Dessel, Belgium Site 114 Dour, Belgium Site 106 Genk, Belgium Site 102 Genly, Belgium Site 111 Komen, Belgium Site 109 Kortessem, Belgium Site 104 Kortrijk, Belgium Site 108 Luik, Belgium Site 107 Menen, Belgium Site 105 Moen, Belgium Site 101 Oosteeklo, Belgium Site 110 Oostham, Belgium Site 116 Seraing, Belgium Site 103 Turnhout, Belgium France Site 213 Bondy, France Site 211 Le Beausset, France Site 209 Nantes, France Site 202 Orvault, France Site 212 Paris Cedex, France Site 206 Paris, France Site 208 Paris, France Site 203 Saint Cyr, France Site 210 Six Fours les Plages, France Site 201 St Sébastian sur Loire, France Site 205 St Sébastian sur Loire, France Site 207 St Sébastian sur Loire, France Site 204 Toulon, France Germany Site 313 Borna, Germany Site 307 Bretten, Germany Site 306 Dresden, Germany Site 305 Erbach, Germany Site 304 Frankfurt, Germany Site 308 Frankfurt, Germany Site 311 Frankfurt, Germany Site 301 Ilvesheim, Germany Site 302 Leipzig, Germany Site 303 Leipzig, Germany Site 314 Mannheim, Germany Site 309 Offenbach, Germany Site 312 Offenbach, Germany Site 310 Rodgau, Germany 收起 << |
NCT00900627 | Neoplasms Bre... 展开 >>ast Neoplasms Breast Cancer 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT02411253 | Type 1 Diabetes | Phase 2 | Unknown | December 2018 | Belgium ... 展开 >> Pediatric Department, Centre Hospitalier Régional de la Citadelle Not yet recruiting Liège, Province de Liège, Belgium, 4000 Contact: Ramona C NICOLESCU, Dr 0032 42 25 71 02 rcnicolescu@yahoo.com France Centre d'Investigations Cliniques, CHU-HOPITAL HAUTEPIERRE Active, not recruiting Strasbourg, Alsace, France, 67098 Centre d'Investigations Cliniques, HÔPITAL CIVIL Active, not recruiting Strasbourg, Alsace, France, 67098 Service de pédiatrie 1CHU de HAUTEPIERRE Recruiting Strasbourg, Alsace, France, 67098 Contact: Marie MANSILLA marie.mansilla@chru-strasbourg.fr Structure d'Endocrinologie-Diabète-Nutrition et Addictologie HOPITAUX UNIVERSITAIRES NHC Recruiting Strasbourg, Alsace, France, BP421 - 67091 Contact: Laurence KESSLER, Pr laurence.kessler@chru-strasbourg.fr Endocrinologie et diabétologie pédiatrique, Hôpital des Enfants - CHU-Bordeaux Withdrawn Bordeaux, Aquitaine, France, 33076 Bordeaux Cedex Service d'endocrinologie, diabétologie, maladies métaboliques, et nutrition, CHU de Bordeaux, Hôpital Haut Levêque Recruiting Pessac, Aquitaine, France, 33604 Contact: Vincent RIGALLEAU, Pr. 06 63 24 45 51 vincent.rigalleau@chu-bordeaux.fr Service d' Endocrinologie HOPITAL CAVALE BLANCHE Recruiting Brest, Brittany, France, 29609 Contact: Emmanuel SONNET, Pr 02 98 34 71 19 emmanuel.sonnet@chu-brest.fr Service de Pédiatrie, HOPITAL MORVAN Recruiting Brest, Brittany, France, 29609 Contact: Chantal METZ, MD 00 33 2 29 02 00 04 chantal.metz@chu-brest.fr Service de Pédiatrie CHRU DE NANTES Recruiting Nantes, Brittany, France, 44093 Contact: Sabine BARON, Pr sabine.baron@chu-nantes.fr Contact: celine ROBIN, CRC 02 40 08 78 04 celine.robin@chu-nantes.fr Service d' Endocrinologie Diabétologie CHRU DE RENNES Not yet recruiting Rennes, Brittany, France, 35033 Contact: Marc De Kerdanet, Pr 00 33 2 99 26 71 36 marc.de.kerdanet@chu-rennes.fr Médecine pédiatrique, CHU Jean Minjoz Recruiting Besançon, Franche-Compté, France, 59037 Contact: Anne-Marie Bertrand, Dr. 03 81 21 81 34 bertrand.anne-marie@wanadoo.fr Service Diabétologie -Endocrinologie, CHU Jean Minjoz Recruiting Besançon, Franche-Comté, France, 59037 Contact: Sophie Borot, Dr. 06 89 16 22 46 sophie.borot@gmail.com Service MME, ENDOCRINOLOGIE, GHU CAREMEAU Recruiting Nimes Cedex 9, Gard, France, 30029 Contact: Valeria COSMA, Pr valeria.COSMA@chu-nimes.fr CIC Paris-Est (Adultes), Hôpitaux Universitaires Pitié-Salpêtrière, Charles Foix Active, not recruiting Paris, Ile de france, France, 75013 CIC pédiatrique Hôpital Necker Enfants Malades Active, not recruiting Paris, Ile De france, France, 75015 Endocrinologie gynécologie diabétologie pédiatriques, Hôpital Universitaire Necker Enfants Malades. Recruiting Paris, Ile De France, France, 75015 Contact: Michel Polak, Pr +33 (0)1 44 49 48 02 michel.polak@nck.aphp.fr CIC Pédiatrique, Hôpital d'enfants Robert Debré Active, not recruiting Paris, Ile de France, France, 75019 Institut E3M, Hôpital Pitié-Salpêtrière Recruiting Paris, Ile-de France, France, 75013 Contact: Agnés Hartemann, Pr. 01 42 17 81 18 ext 80 70 agnes.hartemann@psl.aphp.fr Service d'Endocrinologie Pédiatrique, Hôpital d'enfants Robert Debré Recruiting Paris, Ile-de France, France, 75019 Contact: Jean-Claude CAREL, Pr 01 40 03 53 03 jean-claude.carel@inserm.fr Service de Diabétologie Endocrinologie Hôpital LARIBOISIERE Not yet recruiting Paris, Ile-de-France, France, 75010 Contact: Jean-François Gautier, Pr jean-francois.gautier@aphp.fr Service Pédiatrie - Pôle femmes enfants, CHU de Nîmes, Hôpital Universitaire Carémeau Recruiting Nïmes, Languedoc-Roussillon, France, 30029 Cédex 9 Contact: Tu Anh TRAN, Pr. 04 66 68 32 84 ext 32 85 tu.anh.tran@chu-nimes.fr Service Pédiatrie - Gastro-entérologie, Hépatologie, Nutrition, Diabétologie, Hôpital des Enfants Pôle Enfants Not yet recruiting Toulouse, Midi Pyrénnées, France, 31059 Toulouse cedex 9 Contact: Claire LE TALLEC, Dr 05 34 55 85 64 letallec.c@chu-toulouse.fr CHRU de Lille, Hôpital Claude Huriez Service d'endocrinologie Recruiting Lille, Nord-Pas-de-Calais, France, 59037 Contact: Pierre FONTAINE 03 20 44 45 13 pierre.fontaine@chru-lille.fr Service d'endocrinologie-diabétologie gynécologie pédiatriques, CHRU de Lille, Hôpital Jeanne de Flandre, Recruiting Lille, Nord-Pas-de-Calais, France, 59037 Contact: Jacques WEILL, Pr. 03 20 44 46 95 Jacques.WEILL@CHRU-LILLE.FR Service d' Endocrinologie, maladies métaboliques HOPITAL NORD Not yet recruiting Marseille, Paca, France, 13015 Contact: Anne DUTOUR, Pr AnneEveSophie.MEYER@ap-hm.fr Service de Nutrition - Maladies Métaboliques - Endocrinologie HOPITAL DE LA CONCEPTION Not yet recruiting Marseille, Paca, France, 13385 Contact: René VALERO, Pr rene.valero@ap-hm.fr Contact: Catherine ZEVACO, Pr Catherine.ZEVACO@ap-hm.fr Hopital G&R Laënnec , Endocrinologie, Maladies Métaboliques et Nutrition Recruiting Saint Herblain, Pays de la Loire, France, 44093 NANTES Cedex 1 Contact: Lucy Chaillous, Pr lucy.chaillous@chu-nantes.fr Unité d'Endocrinologie et Diabétologie Pédiatriques, CHU de Marseille, Hôpital La Timone Enfants Recruiting Marseille, Provence-Alpes-Côte-d'Azur, France, 13385 Marseille Cedex 5 Contact: Rachel Reynaud, Pr. 04 91 38 80 40 ext 67 30 Rachel.REYNAUD@ap-hm.fr Endocrinologie-Diabétologie-Maladies de la nutrition, Centre Hospitalier Lyon-Sud Recruiting Lyon, Rhones-Alpes, France, 69495 Contact: Charles THIVOLET, Pr. 04 78 86 14 87 charles.thivolet@chu-lyon.fr Service d'Endocrinologie pédiatrique - HFME Not yet recruiting Lyon-bron, France, 69677 Contact: Delphine Bernoux, Pr 00 33 4 72 35 79 99 delphine.bernoux@chu-lyon.fr Germany Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital of Freiburg Not yet recruiting Freiburg, Baden-Württemberg, Germany, 79106 Contact: Jochen SEUFERT, Pr Tel. +49 761 270 34200 jochen.seufert@uniklinik-freiburg.de Division of Endocrinology, Diabetology and Metabolic Diseases, University Hospital of Freiburg, Department for children and adolescents Not yet recruiting Freiburg, Baden-Württemberg, Germany, 79106 Contact: Karl O SCHWAB, Pr +49 761 270 44140 karl.otfried.schwab@uniklinik-freiburg.de Institute of Diabetes Research, Helmholtz Zentrum München Recruiting München, Bayern, Germany, D 80804 Contact: Annette G ZIEGLER, Pr 00 49 089 3187 2896 anette-g.ziegler@helmholtz-muenchen.de Institute of Diabetes Research, Helmholtz Zentrum München Not yet recruiting München, Bayern, Germany, D 80804 Contact: Katharina Warncke, Pr 00 49 089 3187 2896 Katharina.Warncke@lrz.tu-muenchen.de Netherlands Center for Pediatric and Adolescent Diabetes Care and Research Not yet recruiting Rotterdam, Randstad Holland, Netherlands, 3011 TG Rotterdam Contact: Henk-Jan AANSTOOT, Dr. +31-10-280-7277 ext 9872 h.j.aanstoot@diabeter.nl Sweden Dept. of Clinical Sciences Lund University, Skåne University Hospital. Not yet recruiting Malmö, Öresund Region, Sweden, 205 02 Malmö Contact: Corrado M. CILIO, Pr. +46-70 43 30338 ext +46-40-391127 corrado.cilio@med.lu.se Switzerland Endocrinology and Diabetes department, University Hospital of Basel Not yet recruiting Basel, Bâle-Ville, Switzerland, 4031 Basel Contact: Marc Donath, Pr. mdonath@uhbs.ch 收起 << |
NCT02625480 | Acute Lymphoblastic Leukemia | Phase 1 Phase 2 | Recruiting | October 2034 | - |
NCT00744497 | - | Completed | - | - | |
NCT00469586 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description) 收起 << | - | - |
NCT02419417 | Advanced Tumors | Phase 1 Phase 2 | Recruiting | December 3, 2021 | United States, California ... 展开 >> City Of Hope National Medical Center Recruiting Duarte, California, United States, 91010 Contact: Mihaela Cristea, Site 0004 626-359-8111 United States, Colorado University Of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Jennifer Diamond, Site 0020 720-848-0643 United States, Oregon Local Institution Not yet recruiting Portland, Oregon, United States, 97239 Contact: Site 0023 United States, South Carolina Institute for Translational Oncology Research-ITOR Recruiting Greenville, South Carolina, United States, 29605 Contact: William Edenfield, Site 0001 864-679-3926 Australia, Victoria Local Institution Recruiting Melbourne, Victoria, Australia, 3004 Contact: Site 0006 Belgium Local Institution Withdrawn Brussels, Belgium, 1000 Local Institution Not yet recruiting Bruxelles, Belgium, 1200 Contact: Site 0031 Local Institution Not yet recruiting Gent, Belgium, 9000 Contact: Site 0007 Canada, Ontario The Ottawa Hospital Cancer Centre Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: John Hilton, Site 0003 613737770073955 Local Institution Withdrawn Toronto, Ontario, Canada, M5G 1X6 France Local Institution Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Site 0025 Local Institution Recruiting Villejuif, France, 94800 Contact: Site 0024 Netherlands Local Institution Not yet recruiting Maastrict, Netherlands, 6229 HX Contact: Site 0011 Local Institution Not yet recruiting Rotterdam, Netherlands, 3015 CE Contact: Site 0010 Spain Local Institution Not yet recruiting Barcelona, Spain, 08035 Contact: Site 0030 Local Institution Not yet recruiting Madrid, Spain, 28050 Contact: Site 0019 Local Institution Not yet recruiting Pamplona, Spain, 31008 Contact: Site 0018 United Kingdom Local Institution Not yet recruiting London, Greater London, United Kingdom, EC1M 6BQ Contact: Site 0021 Local Institution Not yet recruiting London, Greater London, United Kingdom, NW1 2PG Contact: Site 0013 Local Institution Not yet recruiting Manchester, Greater Manchester, United Kingdom, M20 4BX Contact: Site 0014 Local Institution Withdrawn Newcastle Upon Tyne, United Kingdom, NE7 7DN Local Institution Not yet recruiting Whitchurch, United Kingdom, CF14 2TL Contact: Site 0032 收起 << |
NCT01153932 | Muscular Dystrophies | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site WEstmead, New South Wales, Australia, 2145 Australia, Victoria GSK Investigational Site Parkville, Victoria, Australia, 3052 Belgium GSK Investigational Site Gent, Belgium, 9000 France GSK Investigational Site Paris cedex 13, France, 75651 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 Israel GSK Investigational Site Jerusalem, Israel, 91240 Netherlands GSK Investigational Site Nijmegen, Netherlands, 6525 GA Spain GSK Investigational Site Esplugues (Barcelona), Spain, 08950 GSK Investigational Site Valencia, Spain, 46009 Turkey GSK Investigational Site Ankara, Turkey, 06100 United Kingdom GSK Investigational Site London, United Kingdom, WC1N 1EH GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 3BZ 收起 << |
NCT02628743 | Muscular Atrophy, Spinal | Phase 2 | Active, not recruiting | May 8, 2021 | Belgium ... 展开 >> UZ Gent Gent, Belgium, 9000 UZ Leuven Gasthuisberg Leuven, Belgium, 3000 France Hopital Femme Mere Enfant; Medecine Physique et Readaptation Pediatrique - L'ESCALE Bron, France, 69677 Hôpital Raymond Poincare; Serv. Neurologie et Réanimation pédiatriques - Centre réf. neuromusculaire Garches, France, 92380 Hopital Jeanne De Flandre; CIC pediatrique Lille, France, 59037 Hopital la Timone Enfants; Service de Pediatrie et Neurologie Pediatrique Marseille, France, 13005 CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie Montpellier, France, 34295 Hopital Armand Trousseau; centre reference Maladies Neuro-musculaires Est parisien Neuropediatrie Paris Cedex 12, France, 75571 Hopital des Enfants; Unite de Neurologie Pediatrique Toulouse, France, 31059 Germany Universitätsklinikum Essen; Neuropädiatrie Essen, Germany, 45147 Uniklinikum Freiburg Zentrum für Kinder- und Jugendmedizin; Neuropädiatrie und Muskelerkrankungen Freiburg, Germany, 79106 Dr. Von Haunersches Kinderspital München, Germany, 80337 Italy Ospedale Pediatrico Bambino Gesù; Dip. Neuroscienze e Salute Mentale Roma, Lazio, Italy, 00165 Policlinico Agostino Gemelli; Dipartimento di Neuropsichiatria Infantile Roma, Lazio, Italy, 00168 IRCCS Istituto G. Gaslini; UOC Neurologia Pediatrica e Malattie Muscolari Genova, Liguria, Italy, 16147 I.R.C.C.S. Cà Granda - Ospedale Maggiore Policlinico; Dip. di Salute Mentale Milano, Lombardia, Italy, 20100 ASST GRANDE OSPEDALE METROPOLITANO NIGUARDA;NEMO (NEuroMuscular Omnicentre);Centro clinico - Fonda Milano, Lombardia, Italy, 20162 Azienda Ospedaliera Universitaria Policlinico G.Martino; Dip. Neurologia e Malattie neuromuscolari Messina, Sicilia, Italy, 98125 Netherlands UMC Utrecht; Polkliniek Neuromusculaire ziekten Utrecht, Netherlands, 3584 CX Poland Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie; Klinika Neurologii Warszawa, Poland, 02-097 United Kingdom Heart of England NHS Trust Birmingham, United Kingdom, B9 5SS National Hospital for Neurology and Neurosurgery,; MRC Centre for Neuromuscular Diseases London, United Kingdom, WC1 3BG Great Ormond Street Hospital London, United Kingdom, WC1N 3JH Newcastle University & The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE1 4LP 收起 << |
NCT00915772 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT02640664 | Retinopathy of Prematurity | Phase 3 | Recruiting | October 31, 2022 | - |
NCT03155009 | Carcinoma, Non-Small-Cell Lung | Phase 2 | Recruiting | May 28, 2020 | France ... 展开 >> CHU Angers Active, not recruiting Angers, France, 49933 Hopital Jean Minjoz; Pneumologie Active, not recruiting Besancon, France, 25030 Hôpital Ambroise Paré - Boulogne-Billancourt Active, not recruiting Boulogne Billancourt, France, 92100 Hopital Augustin Morvan; Oncologie Thoracique Active, not recruiting Brest, France, 29609 Hopital Louis Pradel; Pneumologie Terminated Bron, France, 69677 Centre Francois Baclesse; Comite 3 Active, not recruiting Caen, France, 14076 Centre Hospitalier Intercommunal; Service de Pneumologie Active, not recruiting Creteil, France, 94010 Hôpital Nord Michallon; Pneumologie Active, not recruiting La Tronche, France, 38700 CHRU Lille Service de Pneumologie et Oncologie Thoracique Active, not recruiting Lille, France, 59000 Hôpital Universitaire Dupuytren Withdrawn Limoges, France, 87042 Hôpital Nord - AP-HM Marseille# Active, not recruiting Marseille, France, 13915 Hôpital Arnaud de Villeneuve Active, not recruiting Montpellier, France, 34295 Hopital Emile Muller;Pneumologie Active, not recruiting Mulhouse, France, 68070 Institut Curie Recruiting Paris, France, 75005 Hopital Tenon;Pneumologie Active, not recruiting Paris, France, 75970 CHU de Bordeaux Active, not recruiting Pessac, France, 33600 Hopital de Pontchaillou; Service de Pneumologie Active, not recruiting Rennes, France, 35033 CHU de Rouen - Hôpital Charles Nicolle Active, not recruiting Rouen, France, 76031 Hopital Civil; Pneumology Active, not recruiting Strasbourg, France, 67091 Hopital Sainte Musse; Pneumologie Active, not recruiting Toulon, France, 83056 CHU de Toulouse - Hôpital Larrey; Service de pneumologie et oncologie pneumologique Active, not recruiting Toulouse cedex 9, France, 31100 Hopital Robert Schuman; Pneumologie Active, not recruiting Vantoux, France, 57070 收起 << |
NCT03142334 | Renal Cell Carcinoma | Phase 3 | Recruiting | December 28, 2025 | - |
NCT03178552 | Non-Small Cell Lung Cancer | Phase 2 Phase 3 | Recruiting | January 2, 2022 | - |
NCT00492726 | - | Completed | - | - | |
NCT01065935 | Respiratory Syncytial Virus In... 展开 >>fections 收起 << | Phase 2 | Completed | - | - |
NCT00492726 | Infection | Phase 3 | Completed | - | - |
NCT00900627 | - | Completed | - | - | |
NCT00391443 | Idiopathic Pulmonary Fibrosis | Phase 3 | Completed | - | - |
NCT00915772 | - | Completed | - | - | |
NCT03194893 | Neoplasms | Phase 3 | Recruiting | June 12, 2024 | - |
NCT02696798 | Spondyloarthritis | Phase 3 | Active, not recruiting | January 31, 2019 | - |
NCT02493868 | Depressive Disorder, Treatment... 展开 >>-Resistant 收起 << | Phase 3 | Completed | - | - |
NCT00391443 | - | Completed | - | - | |
NCT02497287 | Treatment-resistant Depression | Phase 3 | Completed | - | - |
NCT03459222 | Advanced Cancer | Phase 1 Phase 2 | Recruiting | May 16, 2022 | United States, California ... 展开 >> City of Hope National Medical Center Recruiting Duarte, California, United States, 91010 Contact: Karen Reckamp, Site 0006 United States, Colorado University Of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Antonio Jimeno, Site 0003 United States, Maryland Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Evan Lipson, Site 0004 United States, Missouri Washington University School Of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: George Ansstas, Site 0005 United States, Tennessee The West Clinic, P.C. Recruiting Germantown, Tennessee, United States, 38138 Contact: Ari Vanderwalde, Site 0001 United States, Washington Local Institution Not yet recruiting Seattle, Washington, United States, 98109-1023 Contact: Site 0002 Australia, New South Wales Local Institution Not yet recruiting North Sydney, New South Wales, Australia, 2060 Contact: Site 0012 Australia, Western Australia Local Institution Not yet recruiting Nedlands, Western Australia, Australia, 6009 Contact: Site 0011 France Local Institution Not yet recruiting Marseille Cedex 5, France, 13385 Contact: Site 0017 Local Institution Not yet recruiting Toulouse, France, 31100 Contact: Site 0016 Local Institution Not yet recruiting Villejuif, France, 94800 Contact: Site 0015 Switzerland Local Institution Not yet recruiting Lausanne, Switzerland, 1011 Contact: Site 0008 Local Institution Not yet recruiting Zurich, Switzerland, 8091 Contact: Site 0007 United Kingdom Local Institution Not yet recruiting Newcastle Upon Tyne, United Kingdom, NE7 7DN Contact: Site 0014 Local Institution Not yet recruiting Oxford, United Kingdom, OX3 7LE Contact: Site 0013 收起 << |
NCT00827008 | Subjective Tinnitus | Phase 3 | Terminated | - | - |
NCT00400153 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT01199276 | Delirium | Phase 2 | Completed | - | Belgium ... 展开 >> UZ Leuven Leuven, Belgium, 3000 France Centre Hospitalier Universitaire de Grenoble La Tronche, France, 38700 Centre Hospitalier Régional Universitaire de Montpellier Montpellier, France, 34295 Groupe Hospitalier COCHIN Paris cedex 14, France, 75979 Groupe Hospitalier La Pitié-Salpêtriere Paris, France, 75651 CHU Pontchaillou - Université de Rennes 1 Rennes, France, 35033 Centre Hospitalier Universitaire de Toulouse Toulouse, France, 31059 Germany University Hospital Aachen Aachen, Germany, 52074 . Klinik für Anästhesiologie - Universitätsklinikum Düsseldorf Düsseldorf, Germany, 40225 Klinikum Mutterhaus Der Borromaerinnen Trier, Germany, 54290 Italy IRCCS Rizzoli Orthopaedic Institute Bologna, Italy, 40136 Spain Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 United Kingdom Imperial College NHS Trust London, United Kingdom, W2 1NY 收起 << |
NCT00398905 | Venous Thromboembolism | Phase 2 | Completed | - | - |
NCT00245765 | Chronic Plaque Psoriasis | Phase 2 | Completed | - | France ... 展开 >> Besancon, France Creteil, France Nice Cedex 3, France Paris, France Pierre Benite, France Saint-Etienne, France Germany Berlin, Germany Bonn, Germany Essen, Germany Frankfurt, Germany Göttingen, Germany Hamburg, Germany Kiel, Germany Mainz, Germany Munster, Germany 收起 << |
NCT02532283 | Influenza A Virus | Phase 2 | Completed | - | - |
NCT00152399 | Peptic Ulcer | Phase 2 | Completed | - | Belgium ... 展开 >> Bruxelles, Belgium Leuven, Belgium Liege, Belgium France Angers, France Bobigny Cedex, France Creteil, France Paris, France Villejuif, France Greece Athens, Greece Crete-Hellas, Greece Hungary Budapest, Hungary Debrecen, Hungary Gyor, Hungary Kaposvar, Hungary Vac, Hungary Poland Bydgoszcz, Poland Krakow, Poland Pruszkow, Poland Warsaw, Poland Spain Alicante, Spain Barcelona, Spain Madrid, Spain 收起 << |
NCT00550238 | Parkinson's Disease Psychosis | Phase 3 | Completed | - | - |
NCT00426764 | - | Active, not recruiting | - | - | |
NCT02340234 | Atopic Dermatitis | Phase 2 | Completed | - | - |
NCT00426764 | Peripheral T-cell Lymphoma | Phase 2 | Active, not recruiting | May 17, 2018 | - |
NCT00400153 | - | Completed | - | - | |
NCT00313222 | Chronic Thromboembolic Pulmona... 展开 >>ry Hypertension 收起 << | Phase 3 | Completed | - | - |
NCT02505542 | Axial Spondyloarthrithis ... 展开 >> Ankylosing Spondylitis 收起 << | Phase 3 | Active, not recruiting | April 2019 | - |
NCT01085838 | Myelodysplastic Syndrome | Phase 1 Phase 2 | Completed | - | France ... 展开 >> CHU d'Angers Angers, France, 49033 Hôpital Avicenne Bobigny, France, 93009 Centre Hospitalier du Mans Le Mans cedex, France, 72037 CHRU Huriez Lille, France, 59037 CHRU de Limoges Limoges, France, 87046 Centre Hospitalier Lyon Sud Lyon, France, 69495 Institut Paoli-Calmettes Marseille, France, 13273 CHU Nantes Nantes, France, 44093 CHU Caremeau Nimes, France, 30029 Hopital St Louis Paris, France, 75475 Hopital Cochin Paris, France, 75679 Hopital Purpan-Medecine interne Toulouse, France, 31059 Hopital Purpan Toulouse, France Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT00291382 | Asthma | Phase 4 | Completed | - | - |
NCT03071692 | Type2 Diabetes ... 展开 >> Dyslipidemia 收起 << | Phase 3 | Recruiting | May 2022 | - |
NCT00452569 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT01664949 | Dry Eye Disease | Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Randwick, New South Wales, Australia Belgium Leuven, Belgium France Marseille, France Tours Cedex, France Germany Freiburg, Germany Italy Padova, Italy Parma, Italy Russian Federation Moscow, Russian Federation Spain Huelva, Spain Valencia, Spain United Kingdom Southampton, Hampshire, United Kingdom Great Yarmouth, Norfolk, United Kingdom 收起 << |
NCT01664949 | - | Completed | - | - | |
NCT03588741 | Haemophilia A | Phase 3 | Recruiting | June 14, 2021 | Austria ... 展开 >> Novo Nordisk Investigational Site Not yet recruiting Wien, Austria, 1090 Bulgaria Novo Nordisk Investigational Site Not yet recruiting Sofia, Bulgaria, 1527 France Novo Nordisk Investigational Site Not yet recruiting Nantes Cedex 1, France, 44093 Germany Novo Nordisk Investigational Site Recruiting Berlin, Germany, 10249 Novo Nordisk Investigational Site Suspended Duisburg, Germany, 47051 Novo Nordisk Investigational Site Not yet recruiting Homburg, Germany, 66421 Serbia Novo Nordisk Investigational Site Not yet recruiting Belgrade, Serbia, 11000 Novo Nordisk Investigational Site Not yet recruiting Belgrade, Serbia, 11070 Novo Nordisk Investigational Site Not yet recruiting Nis, Serbia, 18000 Novo Nordisk Investigational Site Not yet recruiting Novi Sad, Serbia, 21000 Turkey Novo Nordisk Investigational Site Suspended Bornova-IZMIR, Turkey, 35100 United Kingdom Novo Nordisk Investigational Site Not yet recruiting London, United Kingdom, NW3 2QG Novo Nordisk Investigational Site Not yet recruiting Oxford, United Kingdom, OX3 7LJ Novo Nordisk Investigational Site Not yet recruiting Sheffield, United Kingdom, S10 2JF 收起 << |
NCT02842086 | Pre-Exposure Prophylaxis of HI... 展开 >>V-1 Infection 收起 << | Phase 3 | Active, not recruiting | July 2021 | - |
NCT02520752 | cMET-dysregulated Advanced Sol... 展开 >>id Tumors 收起 << | Phase 1 | Completed | - | United States, Georgia ... 展开 >> Emory University School of Medicine/Winship Cancer Institute SC-2 Atlanta, Georgia, United States, 30322 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1756 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 France Novartis Investigative Site Dijon Cedex, Cote D Or, France, 21034 Novartis Investigative Site Pierre Benite, France, 69310 Italy Novartis Investigative Site Rozzano, MI, Italy, 20089 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08003 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 United Kingdom Novartis Investigative Site London, United Kingdom, W12 0HS Novartis Investigative Site Manchester, United Kingdom, M20 9BX 收起 << |
NCT03502694 | Metapneumovirus | Phase 2 | Withdrawn(sponsor decision) | October 28, 2020 | - |
NCT02045017 | Multiple Myeloma | Phase 2 | Active, not recruiting | June 30, 2021 | Austria ... 展开 >> Krankenhaus der Elisabethinen Linz, I Interne Abteilung Linz, Austria, 4020 Medizinische Universitat Wien Wien, Austria, 1090 Wilhelminenspital der Stadt Wien Wien, Austria, 1160 France Hopital Dypuytren-CHU de Limoges Limoges cedex, France, 87042 Hopital Saint Louis Paris, France, 75475 CHU de Poitiers Poitiers, France, 86021 Germany Medizinische Klinik und Poliklinik V Hamatologie, Onkologie und Rheumatologie Neuenheimer Feld 410, Germany, 69120 University Hospital Tubingen Tubingen, Germany, 72076 Greece Alexandra Hospital, University of Athens Athens, Greece, 11528 Italy Azienda Ospedaliero Universitaria Ospedali Ancona, Italy, 60126 S.C. Oncologia Medica Lecco, Italy, 23900 Ospedale Maggiore Policlinico Mangiagalli Regina Elena Milano, Italy, 20122 Arcispedale Santa Maria Nuova Reggio Emilia, Italy, 42100 Netherlands VU University Medical Center VU Medisch Centrum Amsterdam, Netherlands, 1081 HV Daniel den Hoed Kliniek Medical Oncology, Erasmus MC Rotterdam, Netherlands, 3075 EA Spain Hospital de La Princesa Madrid, Spain, 28006 CEIC Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Doctor Peset Valencia, Spain, 46017 United Kingdom Queen Elizabeth Hospital UHB NHS Foundation Trust Birmingham, United Kingdom, B15 2TH Ninewells Hospital and Medical School Dundee, United Kingdom, DD1 9SY Oxford Radcliffe Hospital ICRF Medical Oncology Unit Headington, United Kingdom, OX37LJ St Thomas' HospitalGuy's Hospital Dept. of Haematology London, United Kingdom, SE1 9RT 收起 << |
NCT03308968 | Migraine Prophylaxis | Phase 3 | Active, not recruiting | June 6, 2019 | - |
NCT03478787 | Psoriasis | Phase 3 | Active, not recruiting | June 25, 2020 | - |
NCT02010931 | - | Completed | - | Czech Republic ... 展开 >> Research Site Brno, Czech Republic, 625 00 France Research Site Paris Cedex 10, France, 75475 Germany Research Site Frankfurt am Main, Germany, 60590 Italy Research Site Bologna, Italy, 40138 Research Site Roma, Italy, 00161 Research Site Venezia, Italy, 30174 Poland Research Site Gliwice, Poland, 44-101 Russian Federation Research Site Moscow, Russian Federation, 125167 Spain Research Site Badalona, Cataluña, Spain, 08916 United Kingdom Research Site London, United Kingdom, NW3 2PF 收起 << | |
NCT01834157 | - | Unknown | November 2017 | - | |
NCT02907463 | - | Completed | - | Austria ... 展开 >> Universitätsklinik für Herzchirurgie Medizinische Universität Innsbruck Innsbruck, Austria, 6020 Klinisshe Abteiluing Für Herz-thoraxchirurgie Vienna, Austria, 1090 Denmark Aarhus Universitets Hospital Skejby Aarhus N, Denmark, 8200 France CHU Bocage Central Dijon Dijon, France, 21074 Hôpital Cardiologique CHU Bordeaux Haut Leveque Pessac Cedex, France, 33 604 Germany Herz- und Gefäß-Klinik GmbH Bad Neustadt Bad Neustadt An Der Saale, Germany, 97616 Universitätsklinikum der Ruhr-Universität Bochum Klinik für Herz- und Thoraxchirurgie Bochum, Germany, 44789 Herzzentrum Uniklinik Köln Cologne, Germany, 50924 Medizinische Hochschule Hannover Hannover, Germany, 30625 Herzzentrum Leipzig Leipzig, Germany, 04289 University Hospital Würzburg Wurzburg, Germany, 97080 Italy G. Pasquinucci Heart Hospital - "G.Monasterio" Foundation Massa, Italy, 54100 CentroCardiologico Monzino Milan, Italy, 20138 Clinica San Gaudenzio Novara, Italy Università Cattolica del Sacro Cuore Policlinico Roma, Italy, 00168 Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" Udine, Italy, 33100 Luxembourg Institut National de Chirurgie Cardiaque et Cardiologie Interventionnelle (INCCI) Luxembourg, Luxembourg, 1210 Netherlands St Antonius Hospital Nieuwegein, Netherlands, 3430 EM / PO BOX 2500 Spain Hospital Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain, 30120 Complexo Hospitalario Universitario A Coruna La Coruna, Spain Hospital Clínico San Carlos Madrid, Spain, 28040 United Kingdom Royal Infirmary Hospital Edinburgh Edinburgh, United Kingdom, EH16 4SA St Thomas' Hospital London, United Kingdom, SE1 7EH 收起 << | |
NCT01208896 | Lymphoma, Follicular ... 展开 >> Stem Cell Transplantation 收起 << | Phase 2 | Completed | - | France ... 展开 >> University Hospital Angers Angers Cedex 01, Angers, France, 49033 Service Hématologie, Hôpital Minjoz Besançon, France, 25030 Service Hématologie, Hôpital Augustin Morvan Brest, France, 29609 University Hospital, Caen Caen, France Service Hématologie et Thérapie cellulaire, Pavillon Villemin Pasteur, CHU Clermont-Ferrand Clermont-Ferrand, France, 63000 CHU Grenoble Grenoble, France, 38043 CHRU Lille Lille, France, 59037 CHU Limoges Limoges, France, 87042 Hôpital Edouard Herriot Lyon, France, 69374 Service Hématologie Oncologie, Hôpital Lapeyronie, CHU de Montpellier Montpellier, France, 34295 CHU Nancy Nancy, France, 54511 Service Hématologie Clinique, CHU -Hôtel Dieu Nantes, France, 44093 Service Hématologie Clinique, Hôpital Archet 1 Nice, France, 06202 APHP Hôpital Necker-Enfants malades Paris, France, 75015 APHP Hôpital Saint Louis Paris, France, 75475 APHP Hôpital Pitié-Salpêtrière Paris, France, 75651 APHP Hôpital Henri-Mondor Paris, France, 94010 Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan Pessac, France, 33600 CHU Poitiers - La Milétrie Poitiers, France, 86000 Service Hématologie Clinique, Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France Institut de Cancérologie de la Loire Saint Etienne, France, 60008 Département d'Hématologie et d'Oncologie, Hôpital CHRU de Hautepierre Strasbourg, France, 67098 Service Hématologie, Hôpital Purpan Toulouse, France, 31059 CHRU Tours Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT03510715 | Hypercholesterolemia | Phase 3 | Recruiting | June 2020 | United States, California ... 展开 >> Investigational Site Number 8400004 Recruiting Los Angeles, California, United States, 90027 Austria Investigational Site Number 0400001 Recruiting Wien, Austria, 1090 Brazil Investigational Site Number 0760001 Recruiting Sao Paulo, Brazil, 05403-000 Canada Investigational Site Number 1240002 Recruiting Montreal, Canada, H3T 1C5 Investigational Site Number 1240001 Recruiting Quebec, Canada, G1V 4W2 Denmark Investigational Site Number 2080001 Recruiting Viborg, Denmark, 8800 France Investigational Site Number 2500001 Recruiting Bron Cedex, France, 69677 Italy Investigational Site Number 3800001 Recruiting Palermo, Italy, 90127 Mexico Investigational Site Number 4840006 Recruiting Oaxaca, Mexico, 68000 Netherlands Investigational Site Number 5280001 Recruiting Amsterdam, Netherlands, 1105 AZ Norway Investigational Site Number 5780001 Recruiting Oslo, Norway, 0373 Russian Federation Investigational Site Number 6430002 Recruiting Kemerovo, Russian Federation, 650002 Slovenia Investigational Site Number 7050001 Recruiting Ljubljana, Slovenia, 1000 Spain Investigational Site Number 7240001 Recruiting A Coruna, Spain, 15001 Taiwan Investigational Site Number 1580001 Recruiting Taipei, Taiwan, 112 Turkey Investigational Site Number 7920002 Recruiting Ankara, Turkey, 06500 Investigational Site Number 7920001 Recruiting Izmir, Turkey, 35040 收起 << |
NCT03434379 | Carcinoma, Hepatocellular | Phase 3 | Recruiting | June 29, 2022 | - |
NCT03510884 | Hypercholesterolaemia | Phase 3 | Recruiting | March 2022 | - |
NCT01882803 | Indolent Non-Hodgkin Lymphoma | Phase 2 | Active, not recruiting | October 20, 2021 | - |
NCT03219333 | Carcinoma, Transitional Cell ... 展开 >> Urinary Bladder Neoplasms Urologic Neoplasms Renal Pelvis Neoplasms Urothelial Cancer Ureteral Neoplasms Urethral Neoplasms 收起 << | Phase 2 | Recruiting | May 2025 | - |
NCT01882803 | - | Active, not recruiting | - | - | |
NCT01555710 | Extensive-Stage Small Cell Lun... 展开 >>g Cancer 收起 << | Phase 3 | Unknown | June 2015 | - |
NCT02264678 | Adv Solid Malig - H&N SCC, ATM... 展开 >> Pro / Def NSCLC, Gastric & Breast Cancer 收起 << | Phase 1 Phase 2 | Recruiting | April 30, 2020 | United States, California ... 展开 >> Research Site Recruiting Los Angeles, California, United States, 90033 Research Site Not yet recruiting Los Angeles, California, United States, 90048 Research Site Recruiting Newport Beach, California, United States, 92663 United States, Massachusetts Research Site Not yet recruiting Boston, Massachusetts, United States, 02215 United States, Minnesota Research Site Withdrawn Rochester, Minnesota, United States, 55905 United States, New York Research Site Recruiting New York, New York, United States, 10065 United States, Tennessee Research Site Not yet recruiting Nashville, Tennessee, United States, 37204 France Research Site Suspended Marseille CEDEX 5, France, 13005 Research Site Recruiting Saint Herblain, France, 44805 Research Site Recruiting Villejuif, France, 94805 Korea, Republic of Research Site Recruiting Seongnam-si, Korea, Republic of, 463-707 Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 135-710 United Kingdom Research Site Recruiting Cambridge, United Kingdom, CB2 0RE Research Site Recruiting London, United Kingdom, NW1 2PG Research Site Recruiting London, United Kingdom, SW3 6JB Research Site Recruiting London, United Kingdom, W1G 6AD Research Site Recruiting Manchester, United Kingdom, M20 4BX Research Site Recruiting Sutton, United Kingdom, SM2 5PT 收起 << |
NCT01392001 | - | Completed | - | - | |
NCT01564056 | Breast Cancer | Phase 3 | Active, not recruiting | March 2026 | - |
NCT02281084 | Myelodysplastic Syndromes | Phase 2 | Active, not recruiting | June 18, 2019 | - |
NCT01747915 | Generalized Tonic Clonic Seizu... 展开 >>res 收起 << | Phase 3 | Recruiting | February 24, 2019 | - |
NCT00149981 | Organ Transplantation | Phase 4 | Completed | - | - |
NCT01757184 | - | Active, not recruiting | - | - | |
NCT02447666 | Myelodysplastic Syndrome ... 展开 >> Leukemia, Myelomonocytic, Juvenile 收起 << | Phase 2 | Active, not recruiting | February 28, 2019 | - |
NCT01613326 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT01613326 | - | Completed | - | - | |
NCT01757184 | Cholesterol Ester Storage Dise... 展开 >>ase (CESD) Lysosomal Acid Lipase Deficiency 收起 << | Phase 3 | Active, not recruiting | January 2019 | - |
NCT01804686 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma Mantle Cell Lymphoma Follicular Lymphoma Diffuse Large B-cell Lymphoma 收起 << | Phase 3 | Enrolling by invitation | December 31, 2026 | - |
NCT00268398 | Colorectal Cancer ... 展开 >> Metastatic Cancer Chemotherapy 收起 << | Phase 3 | Completed | - | France ... 展开 >> Institut Sainte Catherine Avignon, France, 84000 Hopital Duffaut Avignon, France, 84902 C.H.G. Beauvais Beauvais, France, 60021 Hopital Saint Andre Bordeaux, France, 33075 Centre Hospitalier Docteur Duchenne Boulogne Sur Mer, France, 62200 Hopital Ambroise Pare Boulogne-Billancourt, France, F-92104 Centre Hospitalier de Briey Briey, France, 54151 Centre Regional Francois Baclesse Caen, France, 14076 Hopital Louis Pasteur Chartres, France, 28018 Hopital Beaujon Clichy, France, 92118 Louis Mourier Hospital Colombes Cedex, France, 92701 Clinique du Parc Croix, France, 59170 Hopital Drevon Dijon, France, 21000 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 Hopital Saint - Louis La Rochelle, France, 17000 Hopital Robert Boulin Libourne, France, 33500 Polyclinique Du Bois Lille, France, 59000 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 Polyclinique des Quatre Pavillons Lormont, France, 33310 Hopital Saint Joseph Marseille, France, 13008 Hopital Notre-Dame de Bon Secours Metz, France, 57038 Centre Hospitalier Intercommunal Le Raincy - Montfermeil Montfermeil, France, 93370 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Saint Antoine Paris, France, 75571 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Hopital Haut Leveque Pessac, France, 33604 Polyclinique De Courlancy Reims, France, F-51100 Clinique Specialise du Littoral-Cote d'Opale Saint Martin Boulogne, France, 62280 Clinique Charcot Sainte Foy Les Lyon, France, 69110 C.H. Senlis Senlis, France, 60309 Hopital Foch Suresnes, France, 92151 收起 << |
NCT02688764 | Hyperphosphatemia | Phase 3 | Recruiting | August 2019 | - |
NCT01820572 | Kidney Transplantation | Phase 3 | Active, not recruiting | January 10, 2020 | - |
NCT00274612 | Hypertension | Phase 4 | Completed | - | - |
NCT00282984 | Smoking Cessation | Phase 3 | Completed | - | - |
NCT01797965 | Relapsing-Remitting Multiple S... 展开 >>clerosis Multiple Sclerosis 收起 << | Phase 3 | Terminated(Study terminated be... 展开 >>cause of differences in the participant population under study compared with indicated Zinbryta use in most countries.) 收起 << | - | - |
NCT02580591 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | - |
NCT02580591 | - | Completed | - | - | |
NCT01589237 | - | Terminated(Interim analysis su... 展开 >>ggested that size of benefit anticipated from continued participation of patients in Part B no longer supported trial extension beyond Part A) 收起 << | - | - | |
NCT02027896 | Hip Fractures | Not Applicable | Recruiting | April 2020 | - |
NCT02234843 | Venous Thromboembolism | Phase 3 | Active, not recruiting | January 31, 2019 | - |
NCT00385580 | - | Completed | - | - | |
NCT00282984 | - | Completed | - | - | |
NCT00385580 | Prostate Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Illinois University Of Chicago Chicago, Illinois, United States, 60637 United States, Maryland The Bunting Blaustein Cancer Research Building Baltimore, Maryland, United States, 21231 United States, New York Memorial Sloan-Kettering Cancer Center-Sidney Kimmel Center New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 United States, Wisconsin University Of Wisconsin Paul P Carbone Comprehensive Ca Ctr Madison, Wisconsin, United States, 53792 France Local Institution Montpellier, France, 34298 Local Institution Paris, France, 75015 Local Institution Villejuif Cedex, France, 94800 Italy Local Institution Rome, Italy, 00152 收起 << |
NCT01589237 | Familial Chylomicronemia Syndr... 展开 >>ome (FCS) (HLP Type I) 收起 << | Phase 3 | Terminated(Interim analysis su... 展开 >>ggested that size of benefit anticipated from continued participation of patients in Part B no longer supported trial extension beyond Part A) 收起 << | - | United States, Washington ... 展开 >> Novartis Investigative Site Seatlle, Washington, United States, 98104 Canada, Quebec Novartis Investigative Site Chicoutimi, Quebec, Canada, G7H 7P2 Novartis Investigative Site Ste-Foy, Quebec, Canada, G1V4M6 Canada Novartis Investigative Site Ouest-Montreal, Canada, H2W1R7 France Novartis Investigative Site Nantes, France, 44093 Novartis Investigative Site Paris Cedex 13, France, 75651 Germany Novartis Investigative Site Hamburg, Germany, 20246 Netherlands Novartis Investigative Site Meibergdreef 9, Netherlands, 1105 AZ South Africa Novartis Investigative Site Cape Town, South Africa, 7925 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M13 9NT 收起 << |
NCT00303758 | Pancreatic Cancer | Phase 3 | Completed | - | France ... 展开 >> Centre Hospitalier d'Abbeville Abbeville, France, 80101 Hopital Duffaut Avignon, France, 84902 Centre Hospitalier de Blois Blois, France, 41016 Centre Hospitalier Docteur Duchenne Boulogne Sur Mer, France, 62200 Centre Hospitalier Universitaire Ambroise Pare - Boulogne Boulogne, France, F-92104 C.H. Bourg En Bresse Bourg En Bresse, France, 01012 Centre Hospitalier Pierre Oudot Bourgoin-Jallieu, France, 38300 Centre Hospitalier Universitaire d'Amiens Caen, France, 14076 Centre Hospitalier de Chalons-en-Champagne Chalons-en-Champagne, France, 51000 CHR Clermont Ferrand, Hotel dieu Clermont-Ferrand, France, 63003 Hopital Beaujon Clichy, France, 92118 Hopital Louis Pasteur Colmar, France, 68024 Hopital Du Bocage Dijon, France, 21034 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospitalier Draguignan Draguignan, France, 83300 Centre Hospitalier De Dunkerque - CHD Dunkerque, France, 59240 Centre Hospitalier Intercommunal St. Aubin les Elbeuf Elbeuf, France, 76503 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Clinique Pasteur Guilherand Granges, France, 07500 Hopital Robert Boulin Libourne, France, 33500 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 Centre Hospitalier Regional et Universitaire de Lille Lille, France, 59037 Hopital Edouard Herriot Lyon, France, 69437 Hopital Saint Joseph Marseille, France, 13008 CHU de la Timone Marseille, France, 13385 CHU Nord Marseille, France, 13915 Centre Hospitalier de Martigues Martigues, France, 13698 Centre Hospitalier General de Mont de Marsan Mont-de-Marsan, France, 40000 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 CHR Hotel Dieu Nantes, France, 44093 CHR D'Orleans - Hopital de la Source Orleans, France, 45100 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Bichat - Claude Bernard Paris, France, 75018 Hopital Haut Leveque Pessac, France, 33604 Clinique Ste - Marie Pontoise, France, 95301 CHU - Robert Debre Reims, France, 51092 Centre Eugene Marquis Rennes, France, 35064 Hopital Charles Nicolle Rouen, France, 76031 Clinique Armoricaine De Radiologie Saint Brieuc, France, F-22015 Centre Joliot Curie Des Docteurs Jean-Christophe Chardon Jacques Hernandez Et Laurent Gasnault Saint Martin Boulogne, France, 62280 Centre Hospitalier de Saint-Quentin Saint-Quentin, France, 02321 Centre Hospitalier de Semur en Auxois Semur en Auxois, France, 21140 Centre Hospitalier de Soissons Soissons cedex, France, 02209 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Centre Hospitalier de Tarbes Tarbes, France, 65013 Nouvelle Clinique Generale Valence, France, 26000 收起 << |
NCT02055820 | Lymphoma, Non-Hodgkin | Phase 1 Phase 2 | Active, not recruiting | February 27, 2020 | - |
NCT02831764 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Active, not recruiting | March 3, 2020 | - |
NCT00312156 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00313170 | - | Active, not recruiting | - | - | |
NCT01910402 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Active, not recruiting | December 31, 2020 | - |
NCT00313170 | Advanced Breast Cancer ... 展开 >> Metastatic Breast Cancer 收起 << | Phase 2 | Active, not recruiting | January 2, 2019 | - |
NCT02187354 | - | - | - | United States, Colorado ... 展开 >> Research Site Aurora, Colorado, United States, 80045 United States, Ohio Research Site Cincinnati, Ohio, United States, 45229 United States, Tennessee Research Site Memphis, Tennessee, United States, 38105 United States, Utah Research Site Salt Lake City, Utah, United States, 84113 Austria Research Site Wien, Austria, 1090 France Research Site Marseille cedex 5, France, 13385 Research Site Paris, France, 75019 Germany Research Site Berlin, Germany, 13353 Research Site Frankfurt am Main, Germany, 60590 Research Site Kiel, Germany, 24105 Research Site München, Germany, 80337 Research Site Münster, Germany, 48149 Research Site Tübingen, Germany, 72076 Research Site Würzburg, Germany, 97080 Italy Research Site Monza (MB), Italy, 20900 Research Site Padova, Italy, 35128 Research Site Roma, Italy, 00165 Switzerland Research Site Zuerich, Switzerland, 8032 United Kingdom Research Site Sheffield, United Kingdom, S10 2TH 收起 << | |
NCT01723020 | Advanced Malignancy ... 展开 >> Advanced Solid Tumors Cancer Oncology Oncology Patients Tumors Glioblastoma Multiple Myeloma 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Santa Monica, California, United States, 90403 United States, Connecticut Research Site Norwalk, Connecticut, United States, 06856 United States, Massachusetts Research Site Boston, Massachusetts, United States, 02115 Research Site Boston, Massachusetts, United States, 02215 United States, New Jersey Research Site Hackensack, New Jersey, United States, 07601 Research Site New Brunswick, New Jersey, United States, 08901 United States, New York Research Site New York, New York, United States, 10021 United States, South Carolina Greenville Hospital System Greenville, South Carolina, United States, 29605 Research Site Greenville, South Carolina, United States, 29605 France Research Site Lyon CEDEX 08, France, 69373 Research Site Villejuif, France, 94805 Netherlands Research Site Amsterdam, Netherlands, 1066 CX Research Site Rotterdam, Netherlands, 3015 CE Research Site Utrecht, Netherlands, 3584 CX 收起 << |
NCT01911429 | Schizophrenia | Phase 3 | Completed | - | - |
NCT02675426 | Rheumatoid Arthritis | Phase 3 | Active, not recruiting | August 6, 2020 | - |
NCT00159887 | Pulmonary Hypertension | Phase 3 | Completed | - | - |
NCT01914393 | Schizophrenia ... 展开 >> Autism Bipolar Depression 收起 << | Phase 3 | Completed | - | - |
NCT02694523 | Psoriasis | Phase 3 | Completed | - | - |
NCT00216476 | Schizophrenia ... 展开 >> Psychotic Disorders 收起 << | Phase 3 | Completed | - | - |
NCT01911429 | - | Completed | - | - | |
NCT01910402 | - | Active, not recruiting | - | - | |
NCT00537238 | Partial Seizures | Phase 3 | Completed | - | - |
NCT02699879 | - | Completed | - | - | |
NCT00537238 | - | Completed | - | - | |
NCT02707640 | Idiopathic Pulmonary Fibrosis | Phase 2 | Completed | - | - |
NCT00216476 | - | Completed | - | - | |
NCT00337103 | Metastatic Breast Cancer | Phase 3 | Completed | - | - |
NCT02707640 | - | Completed | - | - | |
NCT01771809 | Ulcerative Colitis | Phase 2 | Completed | - | - |
NCT00247390 | Chronic Insomnia | Phase 3 | Completed | - | - |
NCT01998828 | Polycythemia Vera ... 展开 >> Essential Thrombocythemia 收起 << | Phase 2 | Terminated | - | United States, Arizona ... 展开 >> Scottsdale, Arizona, United States United States, California Whittier, California, United States United States, Mississippi Tupelo, Mississippi, United States United States, Missouri Saint Louis, Missouri, United States United States, Texas Houston, Texas, United States Australia, Victoria Frankston, Victoria, Australia Parkville, Victoria, Australia Canada, Ontario Toronto, Ontario, Canada Canada, Quebec Montreal, Quebec, Canada Canada Vancouver, Canada France La Tronche, France Nantes Cedex 1, France Paris, France Germany Dresden, Germany Minden, Germany 收起 << |
NCT00580112 | Breast Neoplasms | Phase 2 | Completed | - | - |
NCT00337103 | - | Completed | - | - | |
NCT00381095 | Bone Neoplasms ... 展开 >> Pain, Intractable Cancer 收起 << | Phase 4 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT02604433 | Erythrocyte Transfusion ... 展开 >> Beta-Thalassemia 收起 << | Phase 3 | Active, not recruiting | June 7, 2025 | - |
NCT01971658 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00566631 | Schizophrenia | Phase 3 | Completed | - | Croatia ... 展开 >> Zagreb, Croatia France Dieppe N/A, France La Charite Sur Loire, France Metz Cedex 01, France Germany Augsburg, Germany Bonn, Germany Mainz, Germany Mannheim, Germany München, Germany Rostock, Germany Wasserburg, Germany Israel Be-Er Ya-Acov, Israel Beer Sheva, Israel Hod-Hasharon, Israel Pardesia, Israel Ramat Gan, Israel Lithuania Klaipeda, Lithuania Siauliai, Lithuania Vilnius, Lithuania Poland Gda Sk Poland, Poland Lubliniec, Poland Lublin, Poland Skape, Poland Swiecie, Poland Torun N/A, Poland Zabki, Poland Łódź, Poland Romania Bucharest, Romania Cluj-Napoca, Romania Craiova, Romania 收起 << |
NCT00381095 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT02044822 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia (CLL) With 17p Deletion 收起 << | Phase 2 | Terminated | - | - |
NCT02632409 | Various Advanced Cancer | Phase 3 | Recruiting | May 1, 2020 | - |
NCT02044822 | - | Terminated | - | - | |
NCT02046369 | Bipolar I Depression | Phase 3 | Completed | - | - |
NCT01956669 | Solid Tumours | Phase 2 | Recruiting | April 1, 2021 | - |
NCT00624338 | - | Completed | - | - | |
NCT02057705 | - | Completed | - | United States, Massachusetts ... 展开 >> Boston Children's Hospital, 300 Longwood Avenue Boston, Massachusetts, United States, 02115 Belgium Centre Hospitalier Regional de la Citadelle Liège, Belgium, 4000 Canada, Ontario Hospital for Sick Children, 555 University Avenue Toronto, Ontario, Canada, M5G 1X8 France Hôpital Femme Mère Enfant, CHU Lyon Escale Bron, France, 69500 Roger Salengro Hospital, CHU, Lille Lille, France, 59000 Croix Rousse Hospital Lyon, France, 69004 Institut de Myologie, GH Pitié Salpêtrière, Bâtiment Babinski Paris Cedex 13, France, 75651 Hôpital Armand Trousseau Paris, France, 75012 Institut I-Motion, Hôpital A. Trousseau Paris, France, 75012 Hôpital Sainte Musse Toulon, France, 83056 Germany University Hospital of Essen Essen, Germany, D-45147 Italy Bambino Gesù Children's Hospital Rome, Italy, 4-00165 Spain Hôpital Puertas de Mar Cadiz, Spain, 21-11009 收起 << | |
NCT00624338 | Lupus Erythematosus, Systemic | Phase 2 Phase 3 | Completed | - | - |
NCT02921919 | Cancer | Phase 2 | Recruiting | September 30, 2020 | - |
NCT02111577 | Metastatic Castrate Resistant ... 展开 >>Prostate Cancer 收起 << | Phase 3 | Active, not recruiting | June 2020 | - |
NCT02118337 | Select Advanced Malignancies ... 展开 >> Kidney Cancer Clear Cell Renal Cell Carcinoma 收起 << | Phase 1 Phase 2 | Active, not recruiting | March 18, 2021 | - |
NCT00566631 | - | Completed | - | - | |
NCT02120417 | Breast Cancer | Phase 2 | Terminated(The study was termi... 展开 >>nated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.) 收起 << | - | - |
NCT02117219 | Myelodysplastic Syndrome | Phase 1 | Recruiting | June 17, 2019 | - |
NCT03484702 | Lymphoma, Non-Hodgkin | Phase 2 | Recruiting | August 2, 2022 | Austria ... 展开 >> AKH - Medizinische Universität Wien Recruiting Vienna, Austria, 1090 Belgium Universitair Ziekenhuis Gent Recruiting Gent, Belgium, 9000 Finland Helsinki University Recruiting Helsinki, Finland, 00029 France CHRU-Hopital Claude Huriez Recruiting Lille, France, 59037 Centre Hospitalier Lyon Sud Recruiting Pierre Benite cedex, France, 69495 Germany Medizinische Kinik und Poliklinik I Not yet recruiting Dresden, Germany, 01307 Universitat zu Koln Not yet recruiting Köln, Germany, 50937 LMU Klinikum der Universität Not yet recruiting München, Germany, 81377 Universitatsklinikum Ulm Not yet recruiting Ulm, Germany, 89081 Italy Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Azienda Ospedaliera Citta della Salute e della Scienza di Torino Recruiting Torino, Italy, 10126 Japan National Cancer Center Hospital Recruiting Chuo-ku, Japan, 104-0045 Toranomon Hospital Recruiting Minato-ku, Japan, 105-8470 Netherlands Erasmus Medisch Centrum Recruiting Rotterdam, Netherlands, 3015 CE Spain Hospital Vall d'Hebron Recruiting Barcelona, Spain, 08035 Switzerland Universitatsspital Bern Not yet recruiting Bern, Switzerland, 3010 United Kingdom UCL Cancer Institute Recruiting London, United Kingdom, WC1E 6BT The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX 收起 << |
NCT00195715 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT00195715 | - | Completed | - | - | |
NCT02141074 | Congenital Bleeding Disorder ... 展开 >> Haemophilia B 收起 << | Phase 3 | Recruiting | October 30, 2022 | - |
NCT02120417 | - | Terminated(The study was termi... 展开 >>nated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.) 收起 << | - | - | |
NCT03178487 | Ankylosing Spondylitis (AS) | Phase 2 | Active, not recruiting | November 11, 2020 | - |
NCT00553358 | - | Active, not recruiting | - | - | |
NCT00235755 | Seizures | Phase 3 | Completed | - | - |
NCT02147938 | - | Completed | - | France ... 展开 >> Site Amiens, France Site Angers, France Site Besancon, France Site Brest, France Site Caen, France Site Clermond-Ferrand, France Site Creteil, France Site Dijon, France Site Le Krémlin-Bicêtre, France Site Lille, France Site Limoges, France Site Lyon 3, France Site Marseille, France Site Montpellier, France Site Nancy, France Site Nantes, France Site Nice, France Site Paris 10, France Site Paris Cedex 13, France Site Poitiers, France Site Rennes, France Site Rouen, France Site Saint Etienne, France Site Strasbourg, France Site Suresnes, France Site Toulouse, France Site Tours, France 收起 << | |
NCT00553358 | Neoplasms, Breast | Phase 3 | Active, not recruiting | December 23, 2019 | - |
NCT00235755 | - | Completed | - | - | |
NCT00239356 | Schizophrenia | Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Local Institution Ottawa, Ontario, Canada Canada, Quebec Local Institution Sherbrooke, Quebec, Canada Croatia Local Institution Rijeka, Croatia Local Institution Zagreb, Croatia Czech Republic Local Institution Hradec Kralove, Czech Republic Local Institution Prague 6, Czech Republic France Local Institution Nantes Orvault, France Local Institution Rennes Cedex, France Local Institution Uzes, France Hungary Local Institution Budapest, Hungary Local Institution Gyor, Hungary Netherlands Local Institution Vught, Netherlands Poland Local Institution Krakow, Poland Local Institution Poznan, Poland Romania Local Institution Bucharest, Romania Russian Federation Local Institution St. Petersburg, Russian Federation South Africa Local Institution Westdene, Free State, South Africa Local Institution Johannesburg, Gauteng, South Africa Local Institution Cape Town, Western Cape, South Africa United Kingdom Local Institution Antrim, United Kingdom 收起 << |
NCT00237939 | Schizophrenia | Phase 3 | Completed | - | Belgium ... 展开 >> Local Institution Antwerpen, Belgium Local Institution Bruxelles, Belgium Local Institution Diest, Belgium Local Institution Kortenberg, Belgium Local Institution Liege, Belgium Local Institution Sint-Michiels, Belgium Local Institution Sint-Niklaas, Belgium Local Institution Sint-Truiden, Belgium Local Institution Tournai, Belgium France Local Institution Rennes Cedex, France Netherlands Local Institution Amersfoort, Netherlands Local Institution Raalte, Netherlands Local Institution Rotterdam, Netherlands Portugal Local Institution Barcelos, Portugal Local Institution Ceira, Portugal Local Institution Coimbra, Portugal Local Institution Lisboa, Portugal Local Institution Lisbon, Portugal Spain Local Institution Barcelona, Spain Local Institution Salamanca, Spain Local Institution Sevilla, Spain 收起 << |
NCT02046369 | - | Completed | - | - | |
NCT00239356 | - | Completed | - | - | |
NCT02562235 | Hypertension, Pulmonary | Phase 3 | Recruiting | November 25, 2031 | - |
NCT02985879 | Progressive Supranuclear Palsy... 展开 >> (PSP) 收起 << | Phase 2 | Active, not recruiting | June 13, 2020 | - |
NCT02756845 | Advanced Non CNS Tumors | Phase 1 | Recruiting | December 31, 2021 | United States, Delaware ... 展开 >> Research Site Recruiting Wilmington, Delaware, United States, 19803 United States, Florida Research Site Recruiting Jacksonville, Florida, United States, 32207 United States, Illinois Research Site Recruiting Chicago, Illinois, United States, 60611 United States, Indiana Research Site Recruiting Indianapolis, Indiana, United States, 46202 United States, Michigan Research Site Recruiting Detroit, Michigan, United States, 48201 United States, New York Research Site Recruiting New York, New York, United States, 10032 United States, Ohio Research Site Recruiting Cincinnati, Ohio, United States, 45229 Research Site Recruiting Columbus, Ohio, United States, 43205 Canada, Quebec Research Site Recruiting Montreal, Quebec, Canada, H3T 1C5 France Research Site Recruiting Lyon, France, 69008 Research Site Recruiting Marseille cedex 5, France, 13385 Research Site Recruiting Paris, France, 75005 Spain Research Site Recruiting Barcelona, Cataluña, Spain, 08035 Research Site Recruiting Esplugues de Llobregat, Cataluña, Spain, 08950 Research Site Recruiting Valencia, Comunidad Valenciana, Spain, 46026 Research Site Recruiting Madrid, Spain, 28009 Switzerland Research Site Recruiting Basel, Switzerland, 4031 Research Site Recruiting Zurich, Switzerland, 8032 收起 << |
NCT02574637 | Crohn's Disease | Phase 2 | Terminated | - | - |
NCT01972217 | Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 << | Phase 2 | Active, not recruiting | December 31, 2018 | - |
NCT02979119 | - | Recruiting | December 2019 | - | |
NCT02198651 | Rheumatoid Arthritis ... 展开 >> Musculoskeletal and Connective Tissue Diseases 收起 << | Phase 4 | Completed | - | - |
NCT00496028 | Neoplasms | Phase 1 | Completed | - | France ... 展开 >> Research Site Paris, France Research Site Pierre Benite Cedex, France Netherlands Research Site Amsterdam, Netherlands Research Site Groningen, Netherlands Norway Research Site Oslo, Norway United Kingdom Research Site Glasgow, United Kingdom Research Site Sutton, United Kingdom 收起 << |
NCT02400242 | Multiple Myeloma | Phase 1 | Active, not recruiting | July 30, 2019 | United States, Arizona ... 展开 >> University of Arizona Tucson, Arizona, United States, 85719 United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Florida University of Miami Medical Center Miami, Florida, United States, 33136-2107 Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 United States, Ohio Gabrail Cancer Center Research Canton, Ohio, United States, 44718 United States, Texas CTRC at The UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 France CHRU de Lille-Hopital Claude Huriez Service des Maladies du Sang Lille, France, 59037 Hotel Dieu CHU Nantes Nantes Cedex 01, France, 44093 Germany Universitatsklinikum Heidelberg Medizinische Klinik Krehl-Klinik Haematologie, Onkologie, Rheumato Heidelberg, Germany, 69120 Greece Alexandra Hospital, University of Athens Athens, Greece, 11528 Spain Clinica Universitaria de Navarra Pamplona, Spain, 31008 Hospital Universitario de Salamanca Salamanca, Spain, 37007 收起 << |
NCT02207413 | Influenza | Phase 3 | Completed | - | - |
NCT01985334 | COPD | Phase 4 | Completed | - | - |
NCT02626000 | Carcinoma of the Head and Neck | Phase 1 | Active, not recruiting | August 28, 2020 | - |
NCT03223961 | Myelodysplastic Syndromes | Phase 3 | Recruiting | October 1, 2021 | France ... 展开 >> Chu Amiens Not yet recruiting Amiens, France Contact: Berengere gruson, MD +33322455985 gruson.berengere@chu-amiens.fr Principal Investigator: Berengere Gruson, MD CH Angers Not yet recruiting Angers, France, 49 000 Contact: Sylvain THEPOT +33 2 41 35 44 66 sylvain.thepot@chu-angers.fr Principal Investigator: Sylvain Tepot, MD CH Avignon Not yet recruiting Avignon, France, 84000 Contact: Bohrane Slama, MD 0432753132 bslama@ch-avignon.fr Principal Investigator: Bohrane Slama, MD Centre Hospitalier de La Cote Basque Not yet recruiting Bayonne, France, 64100 Contact: Anne Banos, MD 033559443832 abanos@ch-cotebasque.fr Principal Investigator: Anne Banos, MD Hopital Avicenne Not yet recruiting Bobigny, France, 9300 Contact: Thorsten Braun, MD +33148957057 thorsten.braun@aphp.fr Principal Investigator: Thorsten Braun, MD Hôpital Morvan Not yet recruiting Brest, France, 29609 Contact: Christian Berthou, Prof +33298223504 christianberthou@wanadoo.fr Principal Investigator: Christian Berthou, Prof CHU de Caen Not yet recruiting Caen, France, 14033 Contact: Stéphane Cheze, MD +33231272360 cheze-s@chu-caen.fr Principal Investigator: Stéphane Cheze, MD CHU Estaing Not yet recruiting Clermont-Ferrand, France, 63000 Contact: Benoit De RENZIS, MD +33 4 73 75 00 66 bderenzis@chu-clermontferrand.fr Principal Investigator: Benoit De RENZIS, MD CHSF Gilles de Corbeil Not yet recruiting Corbeil-Essonnes, France, 91100 Contact: Célia Salanoubat, MD +33160903178 celia.salanoubat@ch-sud-francilien.fr Principal Investigator: Célia Salanoubat, MD CHU de Grenoble Not yet recruiting Grenoble, France, 38043 Contact: Sophie Park, MD, PHD +33 4 76 76 62 77 spark@chu-grenoble.fr Principal Investigator: Sophie Park, MD, PHD Centre Hospitalier du Mans Not yet recruiting Le Mans cedex, France, 72000 Contact: Kamel Laribi, MD +33243434361 klaribi@ch-lemans.fr Principal Investigator: Kamel Laribi, MD Hopital Saint-Vincent de Paul Not yet recruiting Lille, France, 59160 Contact: Christian Rose, MD +33 20874532 rose.christian@ghicl.net Principal Investigator: Christian Rose, Prof CHRU Limoges Not yet recruiting Limoges, France, 87042 Contact: Marie-Pierre Gourin, MD +33555056642 marie-pierre.gourin@chu-limoges.fr Principal Investigator: Marie-Pierre Gourin, MD Centre Hospitalier Lyon Sud Not yet recruiting Lyon, France, 69495 Contact: Eric Wattel, MD, PHD +33 4 72 11 74 01 wattel@chu-lyon.fr Principal Investigator: Eric Wattel, MD, PHD IPC Not yet recruiting Marseille, France, 13273 Contact: Norbert Vey, prof 033 4 91 22 36 67 veyn@ipc.unicancer.fr Principal Investigator: Norbert Vey, prof CHU de Nantes Not yet recruiting Nantes, France, 44093 Contact: Pierre Peterlin, MD +33 2 40 08 32 77 pierre.peterlin@chu-nantes.fr Principal Investigator: Pierre Peterlin, MD CHU de Nice Not yet recruiting Nice, France Contact: Thomas Cluzeau, MD +33492035844 cluzeau.t@chu-nice.fr Principal Investigator: Thomas Cluzeau, MD Hopital St Louis T4 Not yet recruiting Paris, France, 75475 Contact: Pierre Fenaux, PHD +33 171207018 pierre.fenaux@aphp.fr Principal Investigator: Pierre Fenaux, prof Centre Hospitalier Joffre-Perpignan Not yet recruiting Perpignan, France, 66046 Contact: Laurence Sanhes, MD +33468616448 laurence.sanhes@ch-perpignan.fr Principal Investigator: Laurence Sanhes, MD Sophie Dimicoli-Salazar Not yet recruiting Pessac, France, 33604 Contact: Sophie Dimicoli-Salazar, MD +33557656511 sophie.dimicoli-salazar@chu-bordeaux.fr Principal Investigator: Sophie Dimicoli-Salazar, MD CHU de Poitiers Not yet recruiting Poitiers, France, 86021 Contact: Jose Miguel Torregrosa Diaz, MD +33 5 48 44 30 29 jose-miguel.torregrosa-diaz@chu-poitiers.fr Principal Investigator: Jose Miguel Torregrosa Diaz, MD CHR d'Annecy Recruiting Pringy, France, 74374 Contact: Pascale Cony-Makhoul, MD +33450636608 pconymakhoul@ch-annecy.fr Principal Investigator: Pascale Cony-Makhoul, MD CHRU de Reims Not yet recruiting Reims, France, 51092 Contact: Chantal HIMBERLIN, MD 003326783644 chimberlin@chu-reims.fr Principal Investigator: Chantal HIMBERLIN, MD CHU Pontchaillou Not yet recruiting Rennes, France, 35033 Contact: Stanislas Nimubona, MD 33299289521 stanislas.nimubona@chu-rennes.fr Principal Investigator: Stanislas Nimubona, MD Centre Henri Becquerel Not yet recruiting Rouen, France, 76038 Contact: Aspasia Stamatoulas, MD +33 232082288 aspasia.stamatoullas@chb.unicancer.fr Principal Investigator: Aspasia Stamatoullas, MD Centre Hospitalier Universitaire de STRASBOURG Not yet recruiting Strasbourg, France, 67098 Contact: Shanti NATAJARAN-AME, MD 00 33 3 88 12 76 70 shanti.ame@chru-strasbourg.fr Principal Investigator: Shanti NATAJARAN-AME, MD IUCT Oncopole Not yet recruiting Toulouse, France, 31059 Contact: Odile Beyne-Rauzy, Prof +33531156264 beynerauzy.odile@iuct-oncopole.fr Principal Investigator: Odile Beyne-Rauzy, Prof CHU Brabois Not yet recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Agnès Guerci-Bresler, MD +33383153281 a.guerci@chru-nancy.fr 收起 << |
NCT01972217 | - | Active, not recruiting | - | - | |
NCT02224157 | Asthma | Phase 3 | Completed | - | - |
NCT02207829 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT02848001 | Leukemia, Myeloid, Acute ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 1 | Recruiting | June 21, 2021 | United States, California ... 展开 >> City of Hope Not yet recruiting Duarte, California, United States, 91010-301 United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States, 06510 United States, Illinois Northwestern Memorial Recruiting Chicago, Illinois, United States, 60611 United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 United States, Missouri Washington University Siteman Cancer Center Recruiting Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 United States, New York Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 Canada, Ontario Princess Margaret Hospital University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 France Institut Paoli Calmettes Not yet recruiting Marseille Cedex 9, France, 13273 Institut Gustave Roussy Faculte de Medecine Paris Sud Service de pneumologie Not yet recruiting Villejuif, France, 94800 Italy Spedali Civili Di Brescia Not yet recruiting Brescia, Italy, 25123 A.O. Ospedale Ca Granda - Niguarda Not yet recruiting Milano, Italy, 20162 Norway Haukeland University Hospital Not yet recruiting Bergen, Norway, N-5053 Oslo University Hospital, Rikshospitalet HF Not yet recruiting Oslo, Norway, N-0027 Spain H Clinic I Provincial Not yet recruiting Barcelona, Spain, 08036 Hospital Clinico Universitario de Salamanca Not yet recruiting Salamanca, Spain, 37007 Hosptial La Fe Not yet recruiting Valencia, Spain, 46009 United Kingdom Beatson West of Scotland Cancer Centre Not yet recruiting Glasgow Scotland, United Kingdom, G12 OXL The Churchill Hospital Not yet recruiting Oxford, United Kingdom, 0X3 7LE 收起 << |
NCT01473472 | HIV Infection | Phase 3 | Completed | - | Canada ... 展开 >> CHUM - Hôpital Hôtel Dieu Montréal, Canada France Hôpital de La Croix Rousse Lyon, France CHU Hôtel Dieu Nantes, France, 44093 Hôpital de l'Archet Nice, France, 06202 Hôpital Saint-Louis Paris Cedex 10, France, 75475 Hôpital Tenon Paris, France, 75 Hôpital Gustave Dron Tourcoing, France, 59208 收起 << |
NCT02227251 | Diffuse Large B-cell Lymphoma | Phase 2 | Recruiting | August 2019 | - |
NCT02207413 | - | Completed | - | - | |
NCT02229227 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00297414 | - | Completed | - | - | |
NCT02229227 | - | Completed | - | - | |
NCT02207829 | - | Completed | - | - | |
NCT02253992 | Advanced Solid Tumors ... 展开 >> Advanced B-cell NHL 收起 << | Phase 1 Phase 2 | Active, not recruiting | September 27, 2019 | United States, California ... 展开 >> Stanford University School Of Medicine Palo Alto, California, United States, 94304 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University Of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Lutherville, Maryland, United States, 21093 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York NYU Langone Medical Center New York, New York, United States, 10016 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania UPMC Cancer Center Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Md Anderson Houston, Texas, United States, 77030 France Local Institution Besancon, France, 25000 Local Institution Marseille, France, 13005 Local Institution Rennes Cedex 9, France, 35033 Local Institution Villejuif, France, 94805 Germany Universitaetsklinikum Essen Essen, Germany, 45147 Spain Clinica Universitaria De Navarra Pamplona, Spain, 31008 收起 << |
NCT02268864 | - | Completed | - | - | |
NCT02278341 | Anemia End St... 展开 >>age Renal Disease (ESRD) 收起 << | Phase 3 | Completed | - | - |
NCT01809340 | Depressive Disorder | Phase 2 | Terminated(study team decision... 展开 >> because of IP supply issue and necessary amendment to protocol) 收起 << | - | Belgium ... 展开 >> Duffel, Belgium Lede, Belgium Leuven, Belgium France Besancon, France Clermont Ferrand, France Nimes Cedex 9, France Netherlands Leiden, Netherlands Spain Alicante, Spain Barcelona, Spain Coslada, Spain Madrid, Spain Zamora, Spain 收起 << |
NCT02268864 | Hepatitis C, Chronic | Phase 2 | Completed | - | Belgium ... 展开 >> Antwerpen, Belgium Brussel, Belgium Gent, Belgium France Creteil, France Lyon, France Montpellier, France Nice N/A, France Paris Cedex 12, France Paris, France Vandoeuvre Les Nancy, France Germany Frankfurt, Germany Hamburg, Germany Hannover, Germany Kiel, Germany Tübingen, Germany Würzburg, Germany Hungary Budapest, Hungary Debrecen, Hungary Spain Badalona, Spain Barcelona, Spain Santander, Spain Valencia, Spain United Kingdom Birmingham, United Kingdom London, United Kingdom 收起 << |
NCT02293395 | Acute Coronary Syndrome | Phase 2 | Completed | - | - |
NCT02293395 | - | Completed | - | - | |
NCT01883011 | Acute Ischaemic Middle Cerebra... 展开 >>l Artery Stroke 收起 << | Phase 4 | Terminated(This study was term... 展开 >>inated after a pre-specified interim analysis. Please see Detailed Study Description for further information.) 收起 << | - | - |
NCT00310388 | Epilepsy | Phase 3 | Terminated(No longer any benef... 展开 >>it in collecting data since retigabine has been withdrawn from market.) 收起 << | - | - |
NCT00812799 | Allergic Rhinoconjunctivitis | Phase 3 | Unknown | December 2011 | - |
NCT02306720 | - | Enrolling by invitation | December 2019 | - | |
NCT00306150 | Blood Loss, Surgical ... 展开 >> Postoperative Hemorrhage 收起 << | Phase 3 | Terminated | - | - |
NCT00310388 | - | Terminated(No longer any benef... 展开 >>it in collecting data since retigabine has been withdrawn from market.) 收起 << | - | - | |
NCT00980538 | HIV Infections ... 展开 >> HIV-1 收起 << | Phase 3 | Recruiting | January 31, 2024 | - |
NCT00798967 | - | Completed | - | - | |
NCT00798967 | Short Bowel Syndrome | Phase 3 | Completed | - | - |
NCT02421939 | Leukemia, Acute Myeloid (AML) | Phase 3 | Active, not recruiting | December 2020 | - |
NCT01142726 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01442038 | Coronary Artery Disease ... 展开 >> Angina Pectoris 收起 << | Phase 3 | Completed | - | - |
NCT01142726 | - | Completed | - | - | |
NCT01003990 | - | Completed | - | - | |
NCT01159964 | Lung Cancer, Non-Small Cell | Phase 1 | Terminated(Study termination d... 展开 >>ue to negative Phase III of another study product from same technology platform.) 收起 << | - | - |
NCT01283724 | Endometriosis | Phase 2 | Completed | - | Austria ... 展开 >> St. Pölten, Niederösterreich, Austria, 3100 Linz, Oberösterreich, Austria, 4020 Graz, Steiermark, Austria, 8044 Graz, Austria, 8010 Innsbruck, Austria, 6020 Wien, Austria, 1060 Wien, Austria, 1090 Czech Republic Brno, Czech Republic, 625 00 Ceske Budejovice, Czech Republic, 37001 Pisek, Czech Republic, 39701 Praha 2, Czech Republic Praha, Czech Republic, 13000 Finland Espoo, Finland, 02100 Helsinki, Finland, 00100 Turku, Finland, 20100 France Angers Cedex 01, France, 49033 Le Kremlin Bicetre, France, 94275 Paris, France, 75018 Rouen, France, 76031 Germany Erlangen, Bayern, Germany, 91054 Oldenburg, Niedersachsen, Germany, 26121 Westerstede, Niedersachsen, Germany, 26655 Münster, Nordrhein-Westfalen, Germany, 48149 Lübeck, Schleswig-Holstein, Germany, 23538 Berlin, Germany, 10117 Berlin, Germany, 12200 Berlin, Germany, 12587 Berlin, Germany, 13509 Berlin, Germany, 14129 Berlin, Germany, 14193 Hamburg, Germany, 20357 Spain Benidorm, Alicante, Spain, 03503 Vigo, Pontevedra, Spain, 36209 Sevilla, Spain, 41013 Sevilla, Spain, 41014 Valencia, Spain, 46017 收起 << |
NCT01003990 | HIV | Phase 3 | Completed | - | - |
NCT00075218 | Gastrointestinal Stromal Tumor | Phase 3 | Completed | - | - |
NCT00076336 | Hepatitis Hep... 展开 >>atitis B, Chronic Cirrhosis 收起 << | Phase 3 | Completed | - | - |
NCT01465763 | - | Completed | - | - | |
NCT00076336 | - | Completed | - | - | |
NCT00075218 | - | Completed | - | - | |
NCT01465763 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT01442038 | - | Completed | - | - | |
NCT01801111 | - | Completed | - | - | |
NCT01032629 | Diabetes Mellitus, Type 2 ... 展开 >> Cardiovascular Diseases Risk Factors 收起 << | Phase 3 | Completed | - | - |
NCT01032629 | - | Completed | - | - | |
NCT01208233 | Ischemic Stroke | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01727427 | - | Completed | - | - | |
NCT01801111 | Non-Small-Cell Lung Carcinoma | Phase 1 Phase 2 | Completed | - | - |
NCT00064207 | Pancreatic Cancer | Phase 2 Phase 3 | Completed | - | - |
NCT01205737 | DLBCL | Phase 1 | Completed | - | - |
NCT00067314 | Breast Neoplasms ... 展开 >> Neoplasm Metastasis 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Pfizer Investigational Site Manhasset, New York, United States, 11030 Pfizer Investigational Site New York, New York, United States, 10021 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44106 Pfizer Investigational Site Cleveland, Ohio, United States, 44121 Pfizer Investigational Site Orange Village, Ohio, United States, 44122 Pfizer Investigational Site Westlake, Ohio, United States, 44145 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37203 Australia, Victoria Pfizer Investigational Site East Bentleigh, Victoria, Australia, 3165 Pfizer Investigational Site Parkville, Victoria, Australia, 3050 Belgium Pfizer Investigational Site Brussel, Belgium, 1090 Pfizer Investigational Site Charleroi, Belgium, B-6000 Pfizer Investigational Site Haine St. Paul, Belgium, 7100 Pfizer Investigational Site Leuven, Belgium, 3000 Pfizer Investigational Site Wilrijk, Belgium, 2610 France Pfizer Investigational Site Dijon, France, 21034 Pfizer Investigational Site Montpellier, France, 34059 Pfizer Investigational Site Paris, France, 75015 Pfizer Investigational Site Toulouse Cedex, France, 31052 Pfizer Investigational Site Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT01974206 | Kidney Transplantation Cytomeg... 展开 >>alovirus (CMV) Negative Recipients 收起 << | Phase 2 | Active, not recruiting | November 2020 | - |
NCT00618982 | Carcinoma, Renal Cell | Phase 2 | Completed | - | France ... 展开 >> Bordeaux, France, 33000 La Roche Sur Yon, France, 85925 Marseille, France, 13385 Nantes, France, 44805 Paris Cedex 10, France, 75475 Tours, France, 37044 Germany Tübingen, Baden-Württemberg, Germany, 72076 Marburg, Hessen, Germany, 35043 Hannover, Niedersachsen, Germany, 30625 Mainz, Rheinland-Pfalz, Germany, 55131 Jena, Thüringen, Germany, 07740 Italy Aviano, Pordenone, Italy, 33081 Milano, Italy, 20133 Pavia, Italy, 27100 Poland Olsztyn, Poland, 10-226 Warszawa, Poland, 02-781 Warszawa, Poland, 04-141 Wroclaw, Poland, 50 - 556 United Kingdom Greater Manchester, Manchester, United Kingdom, M20 4BX Cardiff, South Glamorgan, United Kingdom, CF14 7TB Glasgow, United Kingdom, G12 0YN London, United Kingdom, SW3 6JJ 收起 << |
NCT01208233 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01241526 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 4 | Completed | - | France ... 展开 >> Centre Hospitalier d Antibes Juans-les-pins Antibes, France, 06606 Hôpitaux Civils de Colmar - Hôpital Pasteur Colmar, France, 68024 CHU de Grenoble Grenoble, France, 38043 Centre Hospitalier du Mans Le Mans, France, 72037 Hôpital de la Croix Rousse Lyon, France, 69317 Assistance Publique Hôpitaux de Marseille - Hôpital Nord Marseille, France, 13015 Hôpital MERCY Metz, France, 57085 Groupe Hospitalier Saint Joseph Paris Cedex 14, France, 75674 Hôpital Saint Louis Paris, France, 75010 Groupe Hospitalier Pitié-Salpétrière Paris, France, 75013 Hôpital Civil de Strasbourg Strasbourg, France, 67098 Hôpital Beauregard - CHR METZ Thionville, France, 57100 Hôpital Sainte Musse Toulon, France, 83100 Germany Marien Krankenhaus Kassel, Hesse, Germany, 34001 Universitatklinikum Aachen, Germany, 52074 Helios Hagen-Ambrock Hagen, Germany, 58091 Thoraxklinik Heidelberg gGmbh Heidelberg, Germany, 69126 Lungenklinik Hemer Hemer, Germany, 58675 Fachkrankenhaus Kloster Grafschaft Schmallenberg, Germany, 57392 Klinik für Pneumologie und Allergologie Solingen, Germany, 42699 Universitätsklinikum Ulm, - Klinik Innere Medizin II ULM, Germany, 89081 Italy Azienda ULSS 22 - Ospedale di Bussolengo Bussolengo, Italy, 37012 ASL Viterbo Civita Castellana, Italy, 01033 Ospedale di Macerata Macerata, Italy "Azienda Ospedaliera Niguarda Milano, Italy, 20162 Azienda Ospedaliera, "Ospedale San Carlo Borromeo" Milan, Italy, 20153 Azienda ospedialiera Di DESIO Vimercate Seregno, Italy, 20831 Spain Hospital Universitario de Burgos Burgos, Spain, 09006 Hospital San Pedro de Alcantara Caceres, Spain, 10001 Hospital La Princessa Madrid, Spain, 28006 Hospital Gregorio Maranon Madrid, Spain, 28007 Hospital Ramon Y Cajal Madrid, Spain, 28034 Hospital Universitario de Asturia Oviedo, Spain, 33006 Hospital Arnau de Vilanova Valencia, Spain, 46015 收起 << |
NCT00618982 | - | Completed | - | - | |
NCT01296932 | Leukemia, Lymphocytic, Chronic... 展开 >>, B-Cell 收起 << | Phase 1 | Completed | - | Belgium ... 展开 >> Brussels - UNIV St-Luc Bruxelles, Belgium, 1200 Edegem - UNIV UZ Antwerpen Edegem, Belgium, 2650 Gent - UNIV UZ Gent Gent, Belgium, 9000 France INS Paoli-Calmettes Marseille, France, 13273 CTR Investigation Clinique, onco, Montpellier Montpellier Cedex 5, France, 34295 INS Universitaire du Cancer Toulouse, France, 31059 Germany Universitätsklinikum Frankfurt Frankfurt am Main, Germany, 60590 Uniklinikum Heidelberg Heidelberg, Germany, 69120 Klinikum Köln, Klinik I für Innere Medizin Köln, Germany, 50937 Universitätsklinikum Ulm Ulm, Germany, 89081 收起 << |
NCT01583374 | Ankylosing Spondyloarthritis | Phase 3 | Active, not recruiting | October 2, 2018 | - |
NCT01272219 | - | Completed | - | - | |
NCT01606761 | Arthritis, Rheumatoid | Phase 3 | Completed | - | - |
NCT01583374 | - | Active, not recruiting | - | - | |
NCT01272219 | Metabolism and Nutrition Disor... 展开 >>der Obesity 收起 << | Phase 3 | Completed | - | - |
NCT01309243 | HIV-1 Infection | Phase 3 | Completed | - | - |
NCT01307267 | Lymphoma, Non-Hodgkin ... 展开 >> Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Squamous Cell of Head and Neck Malignant Melanoma 收起 << | Phase 1 | Active, not recruiting | March 2019 | - |
NCT01309243 | - | Completed | - | - | |
NCT00191932 | Major Depressive Disorder | Phase 4 | Completed | - | France ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Caen, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Cherbourg, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Palaiseau, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Paris Cedex 14, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Rennes, France Ireland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Belfast, Ireland Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Barcelona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Madrid, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ourense, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Salamanca, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Zamora, Spain United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Haywards Heath, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Horsham, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Wythenshawe, United Kingdom 收起 << |
NCT01632228 | Glioblastoma | Phase 2 | Completed | - | - |
NCT00043927 | Small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT01180400 | Major Depressive Disorder ... 展开 >> Depression 收起 << | Phase 3 | Completed | - | - |
NCT00978471 | Osteosarcoma | Phase 2 | Active, not recruiting | December 2018 | France ... 展开 >> CHU Besançon- Hôpital Jean Minjoz Besancon, France, 25000 Chu - Hopital Des Enfants Bordeaux Bordeaux, France, 33000 CHU Dijon Le Bocage, Hôpital d'Enfants Dijon, France, 21079 Chu Grenoble Grenoble, France, 38045 Centre Oscar Lambret Lille, France, 59000 Centre Léon Bérard - Institut d'Hémato-Oncologie Pediatrique LYON Cedex 08, France, 69373 Institut Paoli Calmettes Marseille, France, 13273 Hôpital des Enfants de la Timone Marseille, France, 13385 Chu Nantes - Hopital Meres Et Enfants Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 CHU Nice, Hôpital L'Archet 2 Nice, France, 06202 Institut Curie Paris, France, 75248 Hopital D'Enfants Armand Trousseau Paris, France, 75571 CHU Poitiers, site de la Milétrie Poitiers, France, 86021 CHU RENNES - Hôpital Sud Rennes, France, 35023 CHU de SAINT-ETIENNE, Hôpital Nord Saint Priest en Jarez, France, 42270 Chu La Reunion Saint-denis, France, 97405 Institut de Cancérologie de l'Ouest - René Gauducheau Saint-herblain, France, 44805 Institut Lucien Neurwith Saint-Priest-en -Jarez, France, 42270 Hopital de Hautepierre Strasbourg, France, 67098 Chu Toulouse - Hopital D'Enfants Toulouse, France, 31059 Chu Nancy - Hopital D'Enfants Vandoeuvre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 95805 收起 << |
NCT01180400 | - | Completed | - | - | |
NCT01381562 | Infections, Intestinal | Phase 2 | Terminated(Microbiological fin... 展开 >>dings of resistance on therapy in patients with complicated urinary tract infection) 收起 << | - | - |
NCT01370005 | - | Completed | - | - | |
NCT00124449 | Arthritis, Rheumatoid | Phase 2 | Completed | - | - |
NCT01370005 | Diabetes Mellitus, Type 2 ... 展开 >> Hypertension 收起 << | Phase 3 | Completed | - | - |
NCT01606761 | - | Completed | - | - | |
NCT00124449 | - | Completed | - | - | |
NCT01404234 | Cystic Fibrosis ... 展开 >> Pseudomonas Aeruginosa 收起 << | Phase 3 | Completed | - | - |
NCT01404234 | - | Completed | - | - | |
NCT02226120 | Chronic Heart Failure With Red... 展开 >>uced Ejection Fraction 收起 << | Phase 3 | Completed | - | - |
NCT00614055 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 2 | Completed | - | France ... 展开 >> Novo Nordisk Investigational Site Alès, France, 30100 Novo Nordisk Investigational Site Brest, France, 29609 Novo Nordisk Investigational Site LA ROCHELLE cedex, France, 17019 Novo Nordisk Investigational Site Le Creusot, France, 71200 Novo Nordisk Investigational Site Mont de Marsan, France, 40024 Novo Nordisk Investigational Site Venissieux, France, 69200 Germany Novo Nordisk Investigational Site Bad Kreuznach, Germany, 55545 Novo Nordisk Investigational Site Bad Mergentheim, Germany, 97980 Novo Nordisk Investigational Site Dormagen, Germany, 41539 Novo Nordisk Investigational Site Hohenmölsen, Germany, 06679 Novo Nordisk Investigational Site Neuss, Germany, 41460 Novo Nordisk Investigational Site Neuwied, Germany, 56564 Norway Novo Nordisk Investigational Site Elverum, Norway, 2408 Novo Nordisk Investigational Site Hamar, Norway, 2317 Novo Nordisk Investigational Site Kongsvinger, Norway, 2212 Novo Nordisk Investigational Site Oslo, Norway, 0586 Novo Nordisk Investigational Site Stavanger, Norway, 4011 Novo Nordisk Investigational Site Tromsø, Norway, 9038 Romania Novo Nordisk Investigational Site Bucharest, Romania, 011234 Novo Nordisk Investigational Site Bucharest, Romania, 020042 Novo Nordisk Investigational Site Bucharest, Romania, 020475 Novo Nordisk Investigational Site Bucharest, Romania, 020992 Novo Nordisk Investigational Site Bucharest, Romania Spain Novo Nordisk Investigational Site Almería, Spain, 04001 Novo Nordisk Investigational Site Partida de Bacarot, Spain, 03114 Novo Nordisk Investigational Site Sevilla, Spain, 41010 Novo Nordisk Investigational Site Valencia, Spain, 46014 Novo Nordisk Investigational Site Valladolid, Spain, 47011 收起 << |
NCT01381562 | - | Terminated(Microbiological fin... 展开 >>dings of resistance on therapy in patients with complicated urinary tract infection) 收起 << | - | - | |
NCT01420783 | Hematopoietic Neoplasm | Phase 2 | Completed | - | - |
NCT01440179 | Acute Lymphocytic Leukaemia | Phase 2 | Terminated(The study is stoppe... 展开 >>d due to very modest activity compared to competitors) 收起 << | - | United States, Colorado ... 展开 >> Investigational Site Number 840006 Denver, Colorado, United States, 80218 United States, Tennessee Investigational Site Number 840003 Nashville, Tennessee, United States, 37203 United States, Texas Investigational Site Number 840001 Houston, Texas, United States, 77030 Investigational Site Number 840002 San Antonio, Texas, United States, 78229 United States, Wisconsin Investigational Site Number 840004 Milwaukee, Wisconsin, United States, 53226 France Investigational Site Number 250006 Amiens, France, 80054 Investigational Site Number 250001 Paris Cedex 10, France, 75475 Investigational Site Number 250002 Pessac, France, 33600 Investigational Site Number 250008 Pierre Benite, France, 69310 Investigational Site Number 250004 Rennes, France, 35033 Investigational Site Number 250005 Strasbourg, France, 67200 收起 << |
NCT00001192 | - | Completed | - | United States, District of Col... 展开 >>umbia Childrens National Medical Center Washington, D.C., District of Columbia, United States United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Michigan Henry Ford Health Systems Detroit, Michigan, United States, 48202 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029-0574 Columbia University New York, New York, United States, 10032-3784 France Genethon Every Cedex, France Russian Federation Mosco Research Institute of Psychiatry Moscow, Russian Federation 收起 << | |
NCT00614055 | - | Completed | - | - | |
NCT01763827 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT01230801 | Pompe Disease | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Univ of California San Diego School of Medicine La Jolla, California, United States, 92103-8765 United States, Florida University of Florida College of Medicine Gainesville, Florida, United States, 32610 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Australia, Adelaide, SA Royal Adelaide Hospital, SA Pathology Adelaide, Adelaide, SA, Australia, 5006 France Hôpital de I´Archet- Centre Hospitalier Universitaire Nice Nice, France, 06202 Hôpital Pitié-Salpêtrière Paris Cedex 13, France, 75651 Germany Zentrum für Kinder- und Jugenmedizin Mainz, Rheinland-pfalz, Germany, 55131 United Kingdom Old Queen Elizabeth Hospital, Department of Medicine Birmingham, United Kingdom, B15 2TH Royal Free Hospital London, United Kingdom, NW3 2QG Salford Royal Hospital NHS Trust Salford, United Kingdom, M6 8HD 收起 << |
NCT00244621 | - | Completed | - | - | |
NCT01763827 | - | Completed | - | - | |
NCT01466374 | Crohn's Disease | Phase 2 | Completed | - | - |
NCT02273180 | - | Completed | - | - | |
NCT01230801 | - | Completed | - | - | |
NCT02273180 | Type 1 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01562899 | Metastatic Pancreatic Adenocar... 展开 >>cinoma BRAF Mutated Melanoma 收起 << | Phase 2 | Terminated(Study was withdrawn... 展开 >> due to scientific and business considerations.) 收起 << | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States, 02114 United States, Utah University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States, 84103 Australia, Victoria Novartis Investigative Site Parkville, Victoria, Australia, 3050 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, Ontario Novartis Investigative Site Toronto, Ontario, Canada, M5G 2M9 France Novartis Investigative Site Toulouse Cedex 9, France, 31059 Italy Novartis Investigative Site Napoli, Italy, 80131 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site Sutton, Surrey, United Kingdom, SM2 5PT 收起 << |
NCT00244621 | Hypertension | Phase 3 | Completed | - | - |
NCT02099058 | Advanced Solid Tumors Cancer | Phase 1 | Recruiting | October 13, 2019 | - |
NCT01636843 | Inflammation ... 展开 >>Rheumatoid Arthritis 收起 << | Phase 2 | Terminated | - | - |
NCT01475838 | Acquired Immunodeficiency Synd... 展开 >>rome HIV Infections 收起 << | Phase 3 | Completed | - | - |
NCT01471782 | - | Completed | - | - | |
NCT01471782 | Acute Lymphoblastic Leukemia | Phase 1 Phase 2 | Completed | - | - |
NCT01484977 | Epilepsy | Phase 3 | Completed | - | - |
NCT01484977 | - | Completed | - | - | |
NCT01485991 | Hepatitis C | Phase 3 | Completed | - | - |
NCT01485991 | - | Completed | - | - | |
NCT01980875 | - | Terminated | - | - | |
NCT01475838 | - | Completed | - | - | |
NCT00094029 | - | - | - | - | |
NCT01288573 | Ewing's Sarcoma/Soft Tissue Sa... 展开 >>rcoma Neuroblastoma Brain Tumors 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT01484275 | High-risk Smoldering Multiple ... 展开 >>Myeloma 收起 << | Phase 2 | Active, not recruiting | August 31, 2019 | - |
NCT01980875 | Chronic Lymphocytic Leukemia | Phase 3 | Terminated | - | United States, California ... 展开 >> Sansum Clinic Santa Barbara, California, United States, 93105 UCLA Jonsson Comprehensive Cancer Center Santa Monica, California, United States, 90404 Innovative Clinical Research Institute Whittier, California, United States, 90603 United States, Connecticut Cancer Center of Central Connecticut Southington, Connecticut, United States, 06489 United States, Ohio Gabrail Cancer Center Research Canton, Ohio, United States, 44718 United States, South Carolina Saint Francis Cancer Center Greenville, South Carolina, United States, 29607 Australia, New South Wales St Vincent Hospital, Sydney Darlinghurst, New South Wales, Australia, 2010 Belgium UZ Ghent- hematology Ghent, Belgium, 9000 Canada, Ontario Royal Victoria Regional Health Centre - Simcoe Musk Barrie, Ontario, Canada, L4M 6M2 France Centre Hospitalier du Mans Le Mans, France, 72037 Centre Hospitalier de Perpignan Perpignan Cedex 9, France, 66046-BP 49954 Poland Szpital Specjalistyczny w Brzozowie, Oddzial Hematologii Onkologicznej Brzozow, Podkarpackie, Poland, 36-200 Malopolskie Centrum Medyczne s.c. Krakow, Poland, 30-510 Wojewódzki Szpital Specjalistyczny w Legnicy Legnica, Poland, 59-220 Wojewodzki Szpital Specjalistyczny, im. M. Kopernika Klinika Hematologii Uniwersytetu Medycznego Lodz, Poland, 93-510 Samodzielny Publiczny Zaklad Opieki Zdrowotnej Ministerstwa Spraw Wewnetrznych z Warminsko-Mazurskim Centrum Onkologii w Olsztynie Oddzial Hematologii Olsztyn, Poland, 10-228 Spain Hospital Universitario de Salamanca Salamanca, Spain, 37007 United Kingdom East Kent Hospitals University NHS Foundation Trust Canterbury, Kent, United Kingdom, CT1 3NG 收起 << |
NCT01181128 | Severe Hemophilia A | Phase 3 | Completed | - | - |
NCT01990040 | - | Recruiting | May 31, 2029 | - | |
NCT00043875 | Epilepsy | Phase 2 | Completed | - | - |
NCT01183169 | Hepatitis C | Phase 2 | Completed | - | - |
NCT01181128 | - | Completed | - | - | |
NCT01513941 | Chronic Hepatitis C | Phase 3 | Completed | - | Australia ... 展开 >> Cairns, Australia Darlinghurst, Australia Melbourne, Australia Brazil Campinas, Brazil Rio De Janeiro, Brazil Santo André, Brazil Sao Paulo, Brazil France Le Kremlin Bicetre, France Marseille, France Nice N/A, France Paris Cedex 12, France Poland Bydgoszcz, Poland Myslowice, Poland Warszawa, Poland Russian Federation Krasnodar, Russian Federation Perm, Russian Federation Saint-Petersburg, Russian Federation Smolensk, Russian Federation St Petersburg, Russian Federation Voronezh, Russian Federation Spain Alicante, Spain Badalona, Spain Cordoba, Spain Elche, Spain Madrid, Spain San Sebastian, Spain Sevilla N/A, Spain Valencia, Spain Sweden Stockholm, Sweden United Kingdom Birmingham, United Kingdom Glasgow, United Kingdom London, United Kingdom 收起 << |
NCT01514461 | Familial Chylomicronemia Syndr... 展开 >>ome (FCS) 收起 << | Phase 3 | Completed | - | United States, Washington ... 展开 >> Novartis Investigative Site Seatlle, Washington, United States, 98104 Canada, Quebec Novartis Investigative Site Chicoutimi, Quebec, Canada, G7H 7P2 Novartis Investigative Site Ste-Foy, Quebec, Canada, G1V4M6 Canada Novartis Investigative Site Ouest-Montreal, Canada, H2W1R7 France Novartis Investigative Site Bron, France, 69677 Novartis Investigative Site Nantes, France, 44093 Novartis Investigative Site Paris Cedex 13, France, 75651 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Köln, Germany, 50937 Netherlands Novartis Investigative Site Meibergdreef 9, Netherlands, 1105 AZ South Africa Novartis Investigative Site Cape Town, South Africa, 7925 Spain Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 United Kingdom Novartis Investigative Site Manchester, United Kingdom, M13 9NT 收起 << |
NCT01183169 | - | Completed | - | - | |
NCT01514461 | - | Completed | - | - | |
NCT01855750 | Lymphoma | Phase 3 | Active, not recruiting | June 16, 2020 | - |
NCT01360840 | - | Completed | - | - | |
NCT01860638 | Glioblastoma | Phase 2 | Completed | - | - |
NCT00044278 | Epilepsy | Phase 2 | Completed | - | - |
NCT01381874 | Metastatic ER+ Her2- Breast Ca... 展开 >>ncer Postmenopausal 收起 << | Phase 2 | Completed | - | - |
NCT01360840 | Prostate Cancer Metastatic | Phase 2 | Completed | - | - |
NCT01381874 | - | Completed | - | - | |
NCT01397578 | Alzheimer's Disease | Phase 2 | Completed | - | - |
NCT00065507 | - | Completed | - | - | |
NCT01400503 | - | Completed | - | - | |
NCT01574326 | Hyperphosphatemia ... 展开 >> Chronic Kidney Disease 收起 << | Phase 2 | Completed | - | - |
NCT01252940 | HIV-1 Infection | Phase 3 | Completed | - | - |
NCT01574326 | - | Completed | - | - | |
NCT00065507 | Hepatitis B | Phase 3 | Completed | - | - |
NCT01400503 | Multicentric Castleman's Disea... 展开 >>se 收起 << | Phase 2 | Completed | - | - |
NCT01252940 | - | Completed | - | - | |
NCT01588496 | Homozygous Familial Hyperchole... 展开 >>sterolemia 收起 << | Phase 2 Phase 3 | Completed | - | United States, New York ... 展开 >> Research Site New York, New York, United States, 10032 United States, Ohio Research Site Cincinnati, Ohio, United States, 45227 Belgium Research Site Bruxelles, Belgium, 1200 Research Site La Louvière, Belgium, 7100 Canada, Ontario Research Site London, Ontario, Canada, N6A 5K8 Canada, Quebec Research Site Chicoutimi, Quebec, Canada, G7H 7K9 Czechia Research Site Brno, Czechia, 656 91 Research Site Hradec Kralove, Czechia, 500 05 Research Site Uherske Hradiste, Czechia, 686 01 France Research Site Dijon, France, 21000 Research Site Paris Cedex 13, France, 75651 Hong Kong Research Site New Territories, Hong Kong Italy Research Site Pisa, Italy, 56124 Lebanon Research Site Beirut, Lebanon, 0000 Netherlands Research Site Amsterdam, Netherlands, 1105 AZ New Zealand Research Site Christchurch, New Zealand, 8011 South Africa Research Site Johannesburg, Gauteng, South Africa, 2193 Research Site Observatory, Western Cape, South Africa, 7925 Spain Research Site Cordoba, Andalucía, Spain, 14004 Research Site Lugo, Galicia, Spain, 27003 Research Site Madrid, Spain, 28040 收起 << |
NCT01588496 | - | Completed | - | - | |
NCT02446899 | Active Systemic Lupus Erythema... 展开 >>tosus 收起 << | Phase 3 | Completed | - | - |
NCT01936532 | Newly Diagnosed Multiple Myelo... 展开 >>ma 收起 << | Phase 2 | Active, not recruiting | July 2020 | France ... 展开 >> CHRU - Hôpital du Haut Lévêque Bordeaux pessac, France, 33604 CHRU Dijon Dijon, France, 21000 Centre hospitalier départemental Vendée La Roche Sur Yon, France, 85925 CHRU - Hôpital Claude Huriez Lille, France, 59037 Nantes University Hospital Nantes, France, 44093 Hôpital Saint-Antoine Paris, France, 75 571 Centre Hospitalier Lyon sud Pierre Benite, France, 69495 Pole IUC Oncopole CHU Toulouse cedex 9, France, 31059 CHRU - Hôpital Bretonneau Tours, France, 37044 CHRU - Hôpitaux de Brabois Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT01611090 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma 收起 << | Phase 3 | Active, not recruiting | January 23, 2019 | - |
NCT01592370 | Non-Hodgkin's Lymphoma ... 展开 >> Hodgkin Lymphoma Multiple Myeloma 收起 << | Phase 1 Phase 2 | Recruiting | June 15, 2020 | - |
NCT01623115 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT01623115 | - | Completed | - | - | |
NCT02307513 | Behcet Syndrome | Phase 3 | Active, not recruiting | March 31, 2021 | - |
NCT01292473 | Chronic Idiopathic Urticaria | Phase 3 | Completed | - | - |
NCT01624142 | Severe Familial Hypercholester... 展开 >>olemia 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT01292473 | - | Completed | - | - | |
NCT01969123 | Alzheimer's Disease ... 展开 >> Dementia 收起 << | Phase 3 | Terminated(Study has been susp... 展开 >>ended due to clinical hold.) 收起 << | January 2017 | - |
NCT01968967 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT00630032 | Breast Cancer | Phase 3 | Active, not recruiting | September 2019 | - |
NCT01651143 | Systemic Sclerosis | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Investigational Site Number 840006 Scottsdale, Arizona, United States, 85259-5499 United States, District of Columbia Investigational Site Number 840003 Washington, District of Columbia, United States, 20007 United States, Maryland Investigational Site Number 840004 Baltimore, Maryland, United States, 21287 United States, Massachusetts Investigational Site Number 840001 Boston, Massachusetts, United States, 02118 United States, Michigan Investigational Site Number 840002 Ann Arbor, Michigan, United States, 48106 United States, New Jersey Investigational Site Number 840007 New Brunswick, New Jersey, United States, 08903 United States, Pennsylvania Investigational Site Number 840008 Pittsburgh, Pennsylvania, United States, 15213 France Investigational Site Number 250003 Lille, France, 59037 Investigational Site Number 250001 Paris Cedex 14, France, 75679 Italy Investigational Site Number 380001 Milano, Italy, 20122 Switzerland Investigational Site Number 756001 Zürich, Switzerland, 8091 United Kingdom Investigational Site Number 826001 London, United Kingdom Investigational Site Number 826002 Salford, United Kingdom, M6 8HD 收起 << |
NCT01646021 | Mantle Cell Lymphoma | Phase 3 | Completed | - | - |
NCT01968967 | - | Completed | - | - | |
NCT00847691 | - | Completed | - | France ... 展开 >> Departement de Pathologie de l'Institut Bergonié Bordeaux, France, 33076 Laboratoire de Biochimie et Biologie Moléculaire, CHRU de Lille Lille, France, 59037 Département d'Anantomie et de Cytologie Pathologie, Centre Léon Berard Lyon, France, 69373 Laboratoire de Génétique des Tumeurs Solides Nice, France, 06000 Institut Curie Paris Cedex 5, France, 75248 Service d'Anatomo-Pathologie, Centre Paul Strauss Strasbourg, France, 67065 Unité de Biologie Moléculaire, CHU de Hautepierre Strasbourg, France, 67098 Département de biologie et de pathologie médicales, Institut Gustave roussy Villejuif, France, 94805 收起 << | |
NCT01646021 | - | Completed | - | - | |
NCT02542631 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | - |
NCT01973244 | Growth Hormone Disorder ... 展开 >> Growth Hormone Deficiency in Children 收起 << | Phase 1 | Completed | - | Austria ... 展开 >> Novo Nordisk Investigational Site Graz, Austria, 8036 Novo Nordisk Investigational Site Linz, Austria, 4020 Novo Nordisk Investigational Site Wien, Austria, A 1090 Belgium Novo Nordisk Investigational Site Brussels, Belgium, 1090 Novo Nordisk Investigational Site Brussels, Belgium, 1200 France Novo Nordisk Investigational Site Paris, France, 75015 Novo Nordisk Investigational Site Toulouse cedex 9, France, 31059 Israel Novo Nordisk Investigational Site Haifa, Israel, 31096 Novo Nordisk Investigational Site Jerusalem, Israel, 91240 Novo Nordisk Investigational Site Kfar Saba, Israel, 44281 Novo Nordisk Investigational Site Petah Tikva, Israel, 49202 Novo Nordisk Investigational Site Tel Hashomer, Israel, 52621 Macedonia, The Former Yugoslav Republic of Novo Nordisk Investigational Site Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Norway Novo Nordisk Investigational Site Bergen, Norway, 5021 Slovenia Novo Nordisk Investigational Site Ljubljana, Slovenia, 1525 Spain Novo Nordisk Investigational Site Barcelona, Spain, 08035 Novo Nordisk Investigational Site Esplugues Llobregat(Barcelona), Spain, 08950 Novo Nordisk Investigational Site Santiago de Compostela, Spain, 15706 Novo Nordisk Investigational Site Vitoria, Spain, 01009 Sweden Novo Nordisk Investigational Site Stockholm, Sweden, 141 86 Switzerland Novo Nordisk Investigational Site Basel, Switzerland, 4031 Novo Nordisk Investigational Site Genève, Switzerland, 1211 收起 << |
NCT00078338 | Relapsing-remitting Multiple S... 展开 >>clerosis 收起 << | Phase 4 | Completed | - | - |
NCT02542631 | - | Completed | - | - | |
NCT01683695 | Lupus Arthritis, Systemic Lupu... 展开 >>s Erythematosus 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Los Angeles, California, United States, 90048 Research Site San Leandro, California, United States, 94578 United States, Connecticut Research Site Danbury, Connecticut, United States, 06810 United States, New York Research Site Manhasset, New York, United States, 11030 Australia, New South Wales Research Site St Leonards, New South Wales, Australia, 2065 Denmark Research Site Odense, Denmark, 5000 France Research Site Lille cedex 01, France, 59037 Germany Research Site Berlin, Germany, 10117 Malaysia Research Site Kuching, Sarawak, Malaysia, 93586 Research Site Kuala Lumpur, Wilayah Persekutuan, Malaysia, 59100 Taiwan Research Site Taipei, Taiwan, 10002 United Kingdom Research Site Birmingham, United Kingdom, B18 7QH Research Site London, United Kingdom, WC1E 6JF 收起 << |
NCT01441583 | Sinus Node Disease ... 展开 >> AV Block Heart Failure 收起 << | Not Applicable | Completed | - | Austria ... 展开 >> Wilhelminenspital Vienna, Austria, 1160 Landesklinikum Wiener Neustadt Wiener Neustadt, Austria, 2700 Belgium Clinique Universitaires Saint Luc Brussels, Belgium, 1200 Denmark Rigshospitalet Copenhagen Copenhagen, Denmark, 2100 Gentofte University Hospital Hellerup, Denmark, 2900 France NCN Nouvelles Cliniques Nantaises Nantes Cedex 2, France, 44277 Clinique Saint-Hilaire Rouen Rouen, France, 7600 Germany Krankenhaus Neu Bethlehem Göttingen, Germany, 37073 Heinrich Braun Krankenhaus Zwickau, Germany, 08060 Hong Kong Prince of Wales Hospital Shatin, New Territories, Hong Kong Italy Azienda Ospedaliera Mater Domini Policlinico Universitario Catanzaro, CZ, Italy, 88100 Policlinico Casilino Roma, RM, Italy, 00169 Malaysia Institut Jantung Negara Kuala Lumpur, Malaysia, 50400 Netherlands Amphia Ziekenhuis Breda, Netherlands, 4818 CK Rijnland Ziekenhuis Leiderdorp, Netherlands, 2353 GA Spain Hospital Clinico Y Provincial Barcelona, Spain, 08036 Clinica Universitaria de Navarra Pamplona, Spain, 31008 Sweden Sahlgrenska University Hospital Göteborg, Sweden, 41345 Karolinska Hospital Stockholm, Sweden, 17176 United Kingdom Golden Jubilee National Hospital Clydebank, United Kingdom, G81 4HX Northern General Hospital Sheffield, United Kingdom, S5 7AU 收起 << |
NCT00300781 | - | Completed | - | - | |
NCT02589665 | Ulcerative Colitis | Phase 2 | Active, not recruiting | December 31, 2018 | - |
NCT01462357 | Infections, Papillomavirus | Phase 3 | Completed | - | France ... 展开 >> GSK Investigational Site Dax, France, 40100 GSK Investigational Site Draguignan, France, 83300 GSK Investigational Site Essey les Nancy, France, 54270 GSK Investigational Site Le Havre, France, 76620 GSK Investigational Site Nice, France, 06300 GSK Investigational Site Paris cedex 20, France, 75970 GSK Investigational Site Rosiers d'Egletons, France, 19300 GSK Investigational Site Saint Cyr Sur Loir, France, 37540 GSK Investigational Site Seysses, France, 31600 GSK Investigational Site Tours, France, 37100 Hong Kong GSK Investigational Site Pokfulam, Hong Kong GSK Investigational Site Shatin, Hong Kong Singapore GSK Investigational Site Singapore, Singapore, 119074 GSK Investigational Site Singapore, Singapore, 169608 GSK Investigational Site Singapore, Singapore, 228510 GSK Investigational Site Singapore, Singapore, 229899 GSK Investigational Site Singapore, Singapore, 529889 GSK Investigational Site Singapore, Singapore, 768826 Sweden GSK Investigational Site Eskilstuna, Sweden, SE-631 88 GSK Investigational Site Linköping, Sweden, SE-581 85 GSK Investigational Site Örebro, Sweden, SE-701 16 收起 << |
NCT00078338 | - | Completed | - | - | |
NCT01462357 | - | Completed | - | - | |
NCT01709162 | Melanoma | Phase 2 | Terminated(Discontinued early ... 展开 >>due to enrollment challenges and changes in treatment standards) 收起 << | - | United States, Alabama ... 展开 >> Birmingham Hematology & Oncology Associates Llc Birmingham, Alabama, United States, 35205 United States, Colorado Rocky Mountain Cancer Centers Aurora, Colorado, United States, 80012 United States, Indiana Investigative Clinical Research Of Indiana, Llc Indianapolis, Indiana, United States, 46260 United States, Kansas Cancer Center Of Kansas Wichita, Kansas, United States, 67214 United States, Nevada Comprehensive Cancer Center Of Nevada Las Vegas, Nevada, United States, 89148 United States, Pennsylvania Lehigh Valley Hospital Allentown, Pennsylvania, United States, 18103 United States, Texas Texas Oncology Sammons Cancer Center Dallas, Texas, United States, 75246 Austria Local Institution Wien, Austria, A-1090 France Local Institution Bordeaux, France, 33075 Local Institution Nantes Cedex 1, France, 44093 Local Institution Paris, France, 75010 Germany Local Institution Erfurt, Germany, 99089 Local Institution Goettingen, Germany, 37075 Local Institution Heidelberg, Germany, 69115 Local Institution Kiel, Germany, 24105 Local Institution Koln, Germany, 50937 Italy Local Institution Siena, Italy, 53100 收起 << |
NCT01709162 | - | Terminated(Discontinued early ... 展开 >>due to enrollment challenges and changes in treatment standards) 收起 << | - | - | |
NCT00127283 | Acquired Bleeding Disorder ... 展开 >> Intracerebral Haemorrhage 收起 << | Phase 3 | Completed | - | - |
NCT00309023 | Tumors | Phase 1 Phase 2 | Terminated | - | United States, California ... 展开 >> City Of Hope National Medical Center Duarte, California, United States, 91010 United States, Connecticut Yale University School Of Medicine New Haven, Connecticut, United States, 06520 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, Pennsylvania Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15213 Canada, Ontario Local Institution Toronto, Ontario, Canada, M5G 2M9 France Local Institution Bordeaux, France, 33076 Local Institution Paris, France, 75004 Local Institution Paris, France, 75908 Local Institution Saint Herblain, France, 44805 Local Institution Villejuif Cedex, France, 94800 收起 << |
NCT01710358 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00300781 | Breast Neoplasms ... 展开 >> Neoplasms 收起 << | Phase 2 | Completed | - | - |
NCT01710358 | - | Completed | - | - | |
NCT00980330 | Hepatitis C | Phase 2 | Completed | - | - |
NCT02435680 | Advanced Triple Negative Breas... 展开 >>t Cancer (TNBC) With High TAMs 收起 << | Phase 2 | Active, not recruiting | December 19, 2018 | - |
NCT01206101 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 2 | Terminated(The decision to clo... 展开 >>se the NN2211-3619 trial was based on the very low recruitment rate as well as challenges relating to trial execution and study completion.) 收起 << | - | United States, California ... 展开 >> Novo Nordisk Investigational Site Duarte, California, United States, 91010 United States, Illinois Novo Nordisk Investigational Site Chicago, Illinois, United States, 60612 United States, Massachusetts Novo Nordisk Investigational Site Boston, Massachusetts, United States, 02114 United States, Wisconsin Novo Nordisk Investigational Site Madison, Wisconsin, United States, 53792-0001 Canada, Alberta Novo Nordisk Investigational Site Edmonton, Alberta, Canada, T6G 2C8 Canada, British Columbia Novo Nordisk Investigational Site Vancouver, British Columbia, Canada, V5Z 1M9 France Novo Nordisk Investigational Site Besancon, France, 25030 Novo Nordisk Investigational Site Grenoble, France, 38043 Novo Nordisk Investigational Site Lille, France, 59037 Novo Nordisk Investigational Site MONTPELLIER cedex 5, France, 34295 Novo Nordisk Investigational Site Strasbourg, France, 67091 Germany Novo Nordisk Investigational Site Dresden, Germany, 01307 Switzerland Novo Nordisk Investigational Site Genève 14, Switzerland, 1211 Novo Nordisk Investigational Site Zürich, Switzerland, 8091 United Kingdom Novo Nordisk Investigational Site Headington, United Kingdom, OX3 7LE Novo Nordisk Investigational Site London, United Kingdom, SE5 9RS 收起 << |
NCT00692770 | Carcinoma, Hepatocellular | Phase 3 | Completed | - | - |
NCT00692770 | - | Completed | - | - | |
NCT00551642 | - | Completed | - | - | |
NCT00627523 | - | Completed | - | - | |
NCT01206101 | - | Terminated(The decision to clo... 展开 >>se the NN2211-3619 trial was based on the very low recruitment rate as well as challenges relating to trial execution and study completion.) 收起 << | - | - | |
NCT00333788 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT00333788 | - | Completed | - | - | |
NCT00551642 | Lung Disease | Phase 3 | Completed | - | - |
NCT00561353 | Hepatitis C, Chronic | Phase 2 | Completed | - | Belgium ... 展开 >> Brugge, Belgium Brussels, Belgium Bruxelles, Belgium Edegem, Belgium Gent, Belgium France Clichy, France Lyon, France Marseille, France Paris Cedex 10, France Paris, France Pessac, France Vandoeuvre Les Nancy, France Germany Berlin, Germany Düsseldorf, Germany Freiburg, Germany Hamburg, Germany Hannover, Germany Kiel, Germany Munchen, Germany Netherlands Amsterdam Zuidoost, Netherlands Poland Bialystok, Poland Kielce, Poland Lodz, Poland Warszawa, Poland United Kingdom London, United Kingdom Plymouth, United Kingdom 收起 << |
NCT01244061 | - | Completed | - | - | |
NCT00562107 | Assess the Benefits From the A... 展开 >>AISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients. 收起 << | Phase 4 | Completed | - | United States, Massachusetts ... 展开 >> 736 Cambridge Street Brighton, Massachusetts, United States, MA 02135 France CHU - Hopital Sud Amiens, France, 80054 Centre hospitalier de Béthune Béthune, France, 62408 CHU - Hopital Michallon Grenoble, France, 38043 CHP Beauregard Marseille, France, 13012 CHU A de Villeneuve Montpellier, France, 34295 Clinique Bizet Paris cedex 16, France, 75116 CHU Hopital C. Nicolle Rouen, France, 76035 CCN Saint Denis, France, 93207 CHU - Hopital Nord Saint Etienne, France, 42055 CHU Hautepierre Strasbourg, France, 67098 Clinique Pasteur Toulouse, France, 31076 CHU Hopital Trousseau Tours, France, 37044 CHU de Nancy Vandoeuvre les Nancy, France, 54511 Germany Charite Virchow Berlin, Germany Bernau hospital Bernau, Germany Braunschweig hospital Braunschweig, Germany, 38100 Elisabeth KH Essen Essen, Germany, D-45138 Leipzig Uni Leipzig, Germany, 04103 Lübeck Uni Lübeck, Germany, D-23538 Lüdenscheid hospital Lüdenscheid, Germany, 58515 Mainz Uni Mainz, Germany, 55101 München Innenstadt München, Germany, 80336 Remscheid hospital Remscheid, Germany, 42859 Ulm Uni Ulm, Germany, 89081 Italy Clinica Villa Pini d'Abruzzo Chieti, Italy, 66100 Osp Civile di Montebelluna Conegliano, Italy, 31015 Ospedale Umberto I Mestre, Italy, 30173 Presidio Ospedaliero di Mirano Mirano, Italy, 30035 Azienda Ospedaliera S. Maria Terni, Italy, 05100 Spain Complejo Hospitalario Arquitecto Marcide Ferrol, Spain, 15405 Hospital Universitario de Madrid Madrid, Spain, 28041 Hospital Montecelo Mourente, Spain, 36071 Povisa Salamanca, Spain Hospital Clinico universitario de Santiago Santiago de Compostela, Spain, 15706 Complejo Hospitalario Xeral-Cies Vigo, Spain, 3204 United Kingdom William Harvey Hospital Ashford, United Kingdom, Kent TN24 OLZ 收起 << |
NCT00561353 | - | Completed | - | - | |
NCT00351468 | Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 << | Phase 3 | Completed | - | - |
NCT01847274 | Platinum Sensitive Ovarian Can... 展开 >>cer 收起 << | Phase 3 | Completed | - | - |
NCT02190604 | Cystic Fibrosis | Phase 1 Phase 2 | Terminated | - | - |
NCT00627523 | Infant, Small for Gestational ... 展开 >>Age 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> Universitair Ziekenhuis Brussel/Pediatrie Brussel, Belgium, 1090 Universitair Ziekenhuis Antwerpen / Pediatrie Edegem, Belgium, 2650 Czech Republic Fakultni nemocnice Olomouc Olomouc, Czech Republic, 775 20 Fakultni nemocnice Ostrava, Detska klinika Ostrava-Poruba, Czech Republic, 708 52 Fakultni nemocnice v Motole Praha 5, Czech Republic, 150 06 France CHU Toulouse, Hôpital des Enfants, Service Endocrinologie Toulouse Cedex 9, France, 31059 Germany Universitaetsklinikum Erlangen, Kinder- und Jugendklinik Erlangen, Germany, 91054 Italy Centro di Endocrinologia Pediatrica, Dipartimento di Pediatria Catania, Italy, 95125 Policlinico Universitario, Istituto di Clinica Pediatrica Messina, Italy, 98100 Dipartimento Materno Infantile, UO di Pediatria e Neonatologia Milano, Italy, 20132 Dipartimento di Medicina Pediatrica, UO di Endocrinologia e Diabetologia Roma, Italy, 00165 Netherlands Sophia Children's Hospital Rotterdam, Netherlands, 3015 GJ Spain Consorci Hospitalari Parc Tauli Sabadell, Barcelona, Spain, 08208 Hospital Virgen Del Camino Pamplona, Navarra, Spain, 31008 Hospital Miguel Servet Zaragoza, Spain, 50009 Sweden Drottning Silvias Barn och Ungdomssjukhus Göteborg, Sweden Switzerland Inselspital CH-3010 Bern, Switzerland 收起 << |
NCT00484536 | Multiple Sclerosis | Phase 2 | Terminated(The study was disco... 展开 >>ntinued due to unfavorable interim analysis) 收起 << | - | - |
NCT00612664 | Melanoma | Phase 2 | Completed | - | - |
NCT00351468 | - | Completed | - | - | |
NCT01244061 | Smoking Cessation | Phase 4 | Completed | - | - |
NCT00617175 | Heart Disease | Phase 4 | Completed | - | - |
NCT01602406 | Advanced HER2-positive Breast ... 展开 >>Cancer or Gastric Cancer 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Novartis Investigative Site Boston, Massachusetts, United States, 02114 United States, North Carolina Novartis Investigative Site Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19111 Belgium Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Saint Herblain cedex, France, 44805 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 03080 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1066 CX Spain Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 Taiwan Novartis Investigative Site Taipei, Taiwan, 10002 United Kingdom Novartis Investigative Site Oxford, United Kingdom, OX3 7LJ 收起 << |
NCT00634933 | Arthritis, Rheumatoid | Phase 2 | Terminated(The study was termi... 展开 >>nated on 21 June 2010 due to results not meeting the primary endpoint. No safety reasons contributed to the termination of the study.) 收起 << | - | - |
NCT00633789 | Advanced Non-small Cell Lung C... 展开 >>ancer Transitional Cell Carcinoma Soft Tissue Sarcoma Gastric/Esophageal Adenocarcinoma Pancreatic Cancer Including Ampulla of Vater 收起 << | Phase 2 | Completed | - | - |
NCT00658359 | Kidney Transplantation | Phase 2 | Completed | - | - |
NCT00634933 | - | Terminated(The study was termi... 展开 >>nated on 21 June 2010 due to results not meeting the primary endpoint. No safety reasons contributed to the termination of the study.) 收起 << | - | - | |
NCT02190604 | - | Terminated | - | - | |
NCT00617175 | - | Completed | - | - | |
NCT00660907 | - | Completed | - | - | |
NCT00655213 | Sinus Node Dysfunction ... 展开 >> Bradycardia-Tachycardia Syndrome Paroxysmal Atrioventricular Block 收起 << | Phase 4 | Completed | - | - |
NCT00812461 | Alcohol Dependence | Phase 3 | Completed | - | - |
NCT00812461 | - | Completed | - | - | |
NCT00660907 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT00035308 | Immunologic Diseases ... 展开 >> Autoimmune Diseases Systemic Lupus Erythematosus Lupus Nephritis Lupus Glomerulonephritis 收起 << | Phase 3 | Completed | - | - |
NCT01973231 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | - |
NCT00658359 | - | Completed | - | - | |
NCT01305460 | Myelodysplastic Syndrome | Phase 1 Phase 2 | Unknown | December 2016 | France ... 展开 >> Service d'Hématologie Clinique CHU Albert Michallon, Grenoble, France, 38043 CHU d'Amiens Amiens, France, 80054 Centre Hospitalier de La Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 CHU de Haut-Lévèque Bordeaux Pessac, France, 33604 Centre henri Mondor Creteil, France, 94010 Centre Hospitalier du Mans Le Mans cedex, France, 72037 Hôpital Huriez Lille, France, 59037 Hôpital Paoli Calmettes Marseille, France, 13273 Centre Hospitalier de Meaux Meaux, France, 77100 CHU Brabois Nancy, France, 54511 CHU de nantes Nantes, France, 44093 Hôpital l'Archet de Nice Nice, France, 06202 Hôpital Cochin Paris, France, 75004 Hôpital Saint Louis Paris, France, 75010 Hopital Saint Louis - AP-HP, Hematology Dpt Paris, France, 75475 CHU de Poitiers Poitiers, France, 86021 CHRU Annecy Hospital Pringy, France, 74374 Hôpital Pontchaillou Rennes, France, 35033 Hopital Purpan Service d'Hématologie Clinique Toulouse, France, 31059 CH de Valence Valence, France, 26953 收起 << |
NCT00708786 | Sleep Apnoea | Phase 4 | Completed | - | France ... 展开 >> CHRU Hopital de la cavale blanche Brest, France CHU Clermont Ferrand, France CHU - Hopital Michallon Grenoble, France, 38043 CHU Dupuytren Limoges, France Hopital cardiologique Lyon, France Hopital Saint Joseph et saint Luc Lyon, France Hopital Nord Marseille, France CHR Notre Dame de Bonsecours Metz, France CH Montpellier Montpellier, France Nouvelle Clinique Nantaise Nantes, France Clinique Bizet Paris cedex 16, France, 75116 Clinique Bizet Paris, France CH Pau Pau, France CHU Hopital la Milétrie Poitiers, France CHR Cardiologie A Rennes, France CHU Charles Nicolle Rouen, France Clinique Pasteur Toulouse, France CHRU Hopital Trousseau Tours, France Clinique Saint gatien Tours, France CHRU Brabois Vandoeuvre les Nancy, France Germany Herz-Kreislauf-Klinik Bevensen AG Bad Bevensen, Germany Universitatsklinikum Hamburg Eppendorf Hamburg, Germany Prof. Frey Praxis Starnberg Starnberg, Germany Greece Onassis Cardiac Surgery Center Athens, Greece Italy Ospedale Mellini Chiari (BS), Italy Osp. Civile Desio, Italy Casa di Cura Montevergine Mercogliano, Italy Policlinico de Modenna Modenna, Italy Instituto di Cura Pavia, Italy Hospitale civile Guglielmo da Saliceto Piacenza, Italy Policlinico San Donato San Donato, Italy 收起 << |
NCT00689377 | - | Completed | - | - | |
NCT01973231 | - | Completed | - | - | |
NCT02360943 | - | Recruiting | June 2020 | France ... 展开 >> CHU d'Angers Recruiting Angers, France, 49033 Contact: Pierre Marie ROY, MD PhD 02 41 35 37 18 ext +33 PMRoy@chu-angers.fr Principal Investigator: Pierre Marie ROY, MD PhD Sub-Investigator: Noémie LELOUP, MD Sub-Investigator: Caroline SOULIE-CHAVIGNON, MD Sub-Investigator: David HUGLA, MD Sub-Investigator: Bruno CARNEIRO, MD Sub-Investigator: David HAMDAN, MD Sub-Investigator: Antoine BRANGIER, MD Sub-Investigator: Betty MAZET, MD Sub-Investigator: Cédric ANNWEILER, MD PhD Sub-Investigator: Christian LAVIGNE, MD PhD Sub-Investigator: Guillaume DUVAL, MD Sub-Investigator: Jean BARRE, MD Sub-Investigator: Marie Rita ANDREU, MD Sub-Investigator: Pierre-Yves PARE, MD PhD Sub-Investigator: Raphaëlle HUREAUX-HUYNH, MD Sub-Investigator: Thomas MOUMNEH, MD Sub-Investigator: Angélique BACHELET, MD Sub-Investigator: Rosen CREN, MD Sub-Investigator: Emilie FRIOU, MD Sub-Investigator: Thibault SCHOTTE, MD Sub-Investigator: Hélène RIVIERE, MD Sub-Investigator: Pierre LOZAC'H, MD Sub-Investigator: Hélène MEYTADIER, MD Sub-Investigator: Vincent AZZOLA, MD Hôpital Universitaire Jean Minjoz Not yet recruiting Besancon, France, 25000 Contact: Nicolas MENNEVEAU, MD PhD 03 81 66 86 24 ext +33 nicolas.meneveau@univ-fcomte.fr Principal Investigator: Nicolas MENNEVEAU, MD PhD CHU de Brest Recruiting Brest, France, 29609 Contact: Dominique MOTTIER, MD PhD 02 98 34 73 36 ext +33 dominique.mottier@chu-brest.fr Sub-Investigator: Dominique MOTTIER, MD PhD Sub-Investigator: Karine LACUT, MD PhD Principal Investigator: Francis COUTURAUD, MD PhD Sub-Investigator: Aurélien DELLUC, MD Sub-Investigator: Cécile TROMEUR, MD Sub-Investigator: Grégoire LE GAL, MD PhD Sub-Investigator: Norbert ANDRE, MD Sub-Investigator: Aude BARNIER, MD Sub-Investigator: Amélie BAZIRE, MD Sub-Investigator: Christophe GUT-GOBERT, MD Sub-Investigator: Nolwenn ASTRUC, MD Sub-Investigator: Emmanuelle LE MOIGNE, MD Sub-Investigator: Laurent SIMONIN, MD Sub-Investigator: Raphaël LE MAO, MD Clinique du Parc - Castelnau Le Lez Recruiting Castelnau Le Lez, France, 34170 Contact: Dominique BRISOT, MD Principal Investigator: Dominique BRISOT, MD Sub-Investigator: Aurélie KHAU VAN KIEN, MD Sub-Investigator: Yoann THIBOUT, MD CHU Gabriel Montpied Active, not recruiting Clermont Ferrand, France, 63003 Hôpitaux Universitaires Louis Mourier Paris Nord Recruiting Colombes, France, 92700 Contact: Isabelle MAHE, MD PhD 01 47 60 64 90 ext +33 isabelle.mahe@lmr.aphp.fr Principal Investigator: Isabelle MAHE, MD PhD Sub-Investigator: Marie-Cécile COURTOIS, MD Sub-Investigator: Aude ROSSI, MD Sub-Investigator: Caroline FOURGEAUD, MD Sub-Investigator: Maxime DELRUE, MD Sub-Investigator: Sylvie GUINEMER, MD Sub-Investigator: Louis JOURNEAU, MD CHU de Dijon Not yet recruiting Dijon, France, 21079 Contact: Nicolas FALVO, MD 03 80 29 34 32 ext +33 Principal Investigator: Nicolas FALVO, MD Sub-Investigator: Sabine BERTHIER, MD CHU de Grenoble Not yet recruiting Grenoble, France, 38043 Contact: Gilles PERNOD, MD PhD 04 76 76 57 17 ext +33 GPernod@chu-grenoble.fr Principal Investigator: Gilles PERNOD, MD PhD Sub-Investigator: Maxime MAIGNAN, MD Sub-Investigator: Sophie BLAISE, MD Sub-Investigator: Anne LEDOYEN-JANKOWSKI, MD CHU de Limoges Recruiting Limoges, France, 87000 Contact: Philippe LACROIX, MD PhD Principal Investigator: Philippe LACROIX, MD PhD CHU de Montpellier Recruiting Montpellier, France, 34295 Contact: Isabelle QUERE, MD PhD 04.67.33.70.25 ext +33 i-quere@chu-montpellier.fr Principal Investigator: Isabelle QUERE, MD PhD Sub-Investigator: Aurore FANDOS BLANQUIER, MD Sub-Investigator: Emilie VALDELIEVRE, MD Sub-Investigator: Jean-Philippe GALANAUD, MD Sub-Investigator: Lorris LE COLLEN, MD Sub-Investigator: Pauline LHORTE, MD Sub-Investigator: Yacine RABAH, MD CHRU de Nantes Recruiting Nantes, France, 44093 Contact: Gilles BERRUT, MD PhD 02 40 68 66 68 ext +33 gilles.berrut@chu-nantes.fr Principal Investigator: Gilles BERRUT, MD PhD Sub-Investigator: Pascal CHEVALET, MD PhD Sub-Investigator: Typhaine RIAUDEL, MD Sub-Investigator: Marie-Hélène FIX, MD CHU de Nice Not yet recruiting Nice, France, 06002 Contact: Emile FERRARI, MD PhD 04.92.03.78.54 ext +33 ferrari.e@chu-nice.fr Principal Investigator: Emile FERRARI, MD PhD Sub-Investigator: Olivier CHICHE, MD Sub-Investigator: Priscille BOUVIER, MD Sub-Investigator: Nassim REDJIMI, MD Hôpital Europeen Georges Pompidou, APHP Recruiting Paris, France, 75015 Contact: Guy MEYER, MD PhD 01 56 09 34 62 ext +33 guy.meyer@egp.aphp.fr Sub-Investigator: Jean PASTRE, MD Sub-Investigator: Olivier SANCHEZ, MD PhD Sub-Investigator: Benjamin PLANQUETTE, MD Sub-Investigator: Aude GIBELIN, MD Sub-Investigator: Guillaume BRIEND, MD Principal Investigator: Guy MEYER, MD PhD Sub-Investigator: Jonathan MAREY, MD Sub-Investigator: Anne ROCHE, MD APHP Hôpital BROCA Recruiting Paris, France Contact: Olivier HANON, MD PhD (0)144083503 ext +33 olivier.hanon@brc.aphp.fr Principal Investigator: Olivier HANON, MD PhD Sub-Investigator: Clémence BOULLY, MD Sub-Investigator: Edouard CHAUSSADE, MD Sub-Investigator: Sophie CHAUVELIER, MD Sub-Investigator: Florian LABOUREE, MD Sub-Investigator: Laure CAILLARD, MD Centre Hospitalier Lyon Sud Recruiting Pierre Benite, France, 69310 Contact: Claire GRANGE, MD 04.78.86.14.63 ext +33 claire.grange@chu-lyon.fr Principal Investigator: Claire GRANGE, MD Sub-Investigator: Jean Christophe LEGA, MD CHU de Rouen Not yet recruiting Rouen, France, 76000 Contact: Ygal BENHAMOU, MD Principal Investigator: Ygal BENHAMOU, MD CHU de Saint Etienne Recruiting Saint Etienne Cedex, France, 42055 Contact: Patrick MISMETTI, MD PhD 0477120285 ext +33 patrick.mismetti@chu-st-etienne.fr Principal Investigator: Patrick MISMETTI, MD PhD Sub-Investigator: Laurent BERTOLETTI, MD PhD Sub-Investigator: Nathalie MOULIN, MD Sub-Investigator: Sandrine ACCASSAT, MD Sub-Investigator: Andréa BUCHMULLER, MD Sub-Investigator: Elodie DE MAGALHAES, MD Sub-Investigator: Cécile DUVILLARD, MD Sub-Investigator: Eric DICONNE, MD Sub-Investigator: Pierre LAFOND, MD Sub-Investigator: Bernard TARDY, MD PhD CHU de Strasbourg - Hôpital Civil Recruiting Strasbourg, France, 67000 Contact: Dominique STEPHAN, MD PhD Principal Investigator: Dominique STEPHAN, MD PhD Sub-Investigator: Alix-Marie FALLER, MD Sub-Investigator: Elena-Mihaela CORDEANU, MD Sub-Investigator: Sébastien GAERTNER, MD Centre Hospitalier Intercommunal Toulon La Seyne sur Mer Not yet recruiting Toulon, France, 83056 Contact: Antoine ELIAS, MD 04 94 14 52 35 ext +33 antoine.elias@free.fr Principal Investigator: Antoine ELIAS, MD Sub-Investigator: Marie ELIAS, MD Sub-Investigator: Colin RICHARD, MD Sub-Investigator: Anaïs CORNE, MD Sub-Investigator: Dimitri CORNAND, MD CHU Tours Recruiting Tours, France, 37000 Contact: Denis ANGOULVANT, MD PhD Principal Investigator: Denis ANGOULVANT, MD PhD Sub-Investigator: Fabrice IVANES, MD Sub-Investigator: Thibaud GENET, MD Sub-Investigator: Christophe SAINT-ETIENNE, MD 收起 << | |
NCT00561470 | - | Completed | - | - | |
NCT00561470 | Colorectal Neoplasms ... 展开 >> Neoplasm Metastasis 收起 << | Phase 3 | Completed | - | - |
NCT01013740 | Cancer | Phase 2 | Completed | - | - |
NCT01013740 | - | Completed | - | - | |
NCT02058147 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT00721409 | - | Completed | - | - | |
NCT00140049 | Glaucoma, Open Angle ... 展开 >> Ocular Hypertension 收起 << | Phase 4 | Completed | - | France ... 展开 >> Pfizer Investigational Site Caen, France, 14033 Pfizer Investigational Site Clermont-ferrand, France, 63003 Pfizer Investigational Site Lyon, France, 69437 Pfizer Investigational Site Marseille Cedex 05, France, 13385 Pfizer Investigational Site Saint Herblain, France, 44800 Germany Pfizer Investigational Site Darmstadt, Germany, 64283 Pfizer Investigational Site Darmstadt, Germany, 64297 Pfizer Investigational Site Landau / Pfalz, Germany, 76829 Pfizer Investigational Site Regenstauf, Germany, 93128 Pfizer Investigational Site Schorndorf, Germany, 73614 Pfizer Investigational Site Starnberg, Germany, 82319 Greece Pfizer Investigational Site Heraklion, Crete, Greece, 71110 Pfizer Investigational Site Thessaloniki, Macedonia, Greece, 546 36 Pfizer Investigational Site Alexandroupoli, Greece, 68100 Pfizer Investigational Site Larisa, Greece, 41110 Italy Pfizer Investigational Site Chieti, Italy, 66013 Pfizer Investigational Site Foggia, Italy, 71100 Pfizer Investigational Site Genova, Italy, 16132 Pfizer Investigational Site Milano, Italy, 20132 Pfizer Investigational Site Monza (MI), Italy, 20052 Pfizer Investigational Site Pisa, Italy, 56126 Sweden Pfizer Investigational Site Malmo, Sweden, 205 02 Pfizer Investigational Site Molndal, Sweden, 431 80 Pfizer Investigational Site Sundsvall, Sweden, 851 86 Pfizer Investigational Site örebro, Sweden, 703 61 收起 << |
NCT01461057 | Gastric Cancer | Phase 2 | Completed | - | Belgium ... 展开 >> Cliniques Universitaires St-Luc Bruxelles, Belgium, 1200 UZ Leuven Gasthuisberg Leuven, Belgium, 3000 Czechia Masaryk Memorial Cancer Institute; Oncological Clinic Brno, Czechia, 656 53 Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology Hradec Kralove, Czechia, 500 05 Fakultni nemocnice Olomouc; Onkologicka klinika Olomouc, Czechia, 779 00 Fakultní Nemocnice V Motole; Radioterapeuticko-Onkologicke Oddeleni Praha 5, Czechia, 150 06 University Hospital Na Bulovce; Institut of Radiation Oncology Praha 8, Czechia, 180 81 France Hopital Morvan Brest, France, 29200 CRLCC Val dAurelle Paul Lam Montpellier cedex 5, France, 34298 Hopital Robert Debre; DERMATOLOGIE Reims, France, 51092 Germany Charité-Universitätsm. Berlin; Med. Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunolo. Berlin, Germany, 10117 Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie Braunschweig, Germany, 38114 Krankenhaus Nordwest; Klinik f. Onkologie und Hämatologie Frankfurt, Germany, 60488 Klinikum Mannheim III. Medizinische Klinik Mannheim, Germany, 68167 Italy Campus Universitario S.Venuta; Centro Oncologico T.Campanella Catanzaro, Calabria, Italy, 88100 Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2 Milano, Lombardia, Italy, 20133 A.O. Universitaria Pisana; Oncologia Pisa, Toscana, Italy, 56100 Korea, Republic of Seoul National Uni Hospital; Dept. of Internal Medicine/Hematology/Oncology Seoul, Korea, Republic of, 03080 Yonsei Medical Center; Dept. of Medicine , Division of Hemato-Oncology Seoul, Korea, Republic of, 03722 Asan Medical Center; Medical Oncology Seoul, Korea, Republic of, 05505 Netherlands Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde Maastricht, Netherlands, 6229 HX Spain Hospital del Mar; Servicio de Oncologia Barcelona, Spain, 08003 Hospital Universitario La Paz; Servicio de Oncologia Madrid, Spain, 28046 Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia Valencia, Spain, 46010 收起 << |
NCT01541215 | - | Completed | - | - | |
NCT00777036 | Leukemia | Phase 2 | Active, not recruiting | September 23, 2021 | - |
NCT00721409 | Breast Cancer | Phase 2 | Completed | - | - |
NCT01461057 | - | Completed | - | - | |
NCT02058147 | - | Completed | - | - | |
NCT00777036 | - | Active, not recruiting | - | - | |
NCT00782067 | Leukemia | Phase 2 | Completed | - | - |
NCT00777153 | - | Completed | - | - | |
NCT01541215 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01071395 | Parkinson's Disease | Phase 4 | Completed | - | United States, Alabama ... 展开 >> University of Alabama-Birmingham (UAB) Birmingham, Alabama, United States, 35043 United States, Florida University of South Florida Tampa, Florida, United States, 33606 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Oregon Oregon Health & Science University (OHSU) Portland, Oregon, United States, 97239-9059 Austria Universitatsklinik fur Neurologie Innsbruck, Austria, 6020 Canada, Ontario Toronto Western Hospital (Movement Disorder Center) Toronto, Ontario, Canada, M5T2S8 France Centre d'investigation Clinique, CHU de Toulouse Toulouse Cedex 9, France, 31059 收起 << |
NCT00284518 | - | Completed | - | - | |
NCT01071395 | - | Completed | - | - | |
NCT00777153 | Recurrent Glioblastoma | Phase 3 | Completed | - | - |
NCT00798369 | Acute Gout | Phase 2 | Completed | - | - |
NCT00284518 | Benign Prostatic Hyperplasia | Phase 2 | Completed | - | Australia ... 展开 >> Murdoch, Australia Austria Vienna, Austria Canada, British Columbia Victoria, British Columbia, Canada Czech Republic Olomouc, Czech Republic France Paris Cedex 13, France Germany Braunschweig, Germany Italy Perugia, Italy Korea, Republic of Seoul, Korea, Republic of Slovakia Martin, Slovakia Taiwan Taipei, Taiwan United Kingdom London, United Kingdom 收起 << |
NCT00798369 | - | Completed | - | - | |
NCT00782067 | - | Completed | - | - | |
NCT01479868 | - | Completed | - | - | |
NCT01090427 | Psoriasis | Phase 3 | Completed | - | - |
NCT01479868 | Hepatitis C Virus Genotype-1 | Phase 3 | Completed | - | - |
NCT01101100 | Psoriasis | Phase 2 | Terminated(Sponsor Decision) | - | United States, Georgia ... 展开 >> Research Site Newnan, Georgia, United States, 30263 United States, Illinois Research Site Skokie, Illinois, United States, 60077 United States, Missouri Research Site St. Louis, Missouri, United States, 63117 United States, New Mexico Research Site Albuquerque, New Mexico, United States, 87106 United States, Texas Research Site Dallas, Texas, United States, 75246 Research Site Webster, Texas, United States, 77598 Australia, New South Wales Research Site Kogarah, New South Wales, Australia, 2217 Australia, South Australia Research Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Research Site Parkville, Victoria, Australia, 3050 Research Site Prahran, Victoria, Australia, 3181 Canada, Ontario Research Site Hamilton, Ontario, Canada, L8N 1V6 Research Site London, Ontario, Canada, N6A 3H7 Research Site Markham, Ontario, Canada, L3P 1A8 Research Site Waterloo, Ontario, Canada, N2J 1C4 Research Site Windsor, Ontario, Canada, N8W 1E6 Canada Research Site Quebec, Canada, G1V 4X7 Denmark Research Site Aarhus, Denmark, 8000 Research Site Hellerup, Denmark, 2900 France Research Site Besançon, France, 25030 Research Site Nice, France, 06200 Research Site Toulouse Cedex 9, France, 31059 收起 << |
NCT01090427 | - | Completed | - | - | |
NCT00960440 | Arthritis, Rheumatoid | Phase 3 | Completed | - | - |
NCT00309608 | - | Completed | - | - | |
NCT00960440 | - | Completed | - | - | |
NCT01519791 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00978380 | Congenital Bleeding Disorder ... 展开 >> Congenital FXIII Deficiency 收起 << | Phase 3 | Completed | - | - |
NCT01519791 | - | Completed | - | - | |
NCT00978380 | - | Completed | - | - | |
NCT00828919 | Solid Tumors | Not Applicable | Active, not recruiting | May 31, 2021 | - |
NCT01521923 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00818948 | Nephritis Sys... 展开 >>temic Lupus Erythematosus 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Research Site Phoenix, Arizona, United States, 85013 United States, Connecticut Research Site Danbury, Connecticut, United States, 06810 United States, Kansas Research Site Kansas City, Kansas, United States, 66160 United States, New York Research Site Manhasset, New York, United States, 11030 Research Site New York, New York, United States, 10003 United States, Pennsylvania Research Site Duncansville, Pennsylvania, United States, 16635 United States, Texas Research Site Amarillo, Texas, United States, 79106 Research Site Dallas, Texas, United States, 75231 France Research Site Paris Cedex 13, France, 75651 Hong Kong Research Site Hong Kong, Hong Kong Malaysia Research Site Kuala Lumpur, Wilayah Persekutuan, Malaysia, 50603 Mexico Research Site Mexico, Distrito Federal, Mexico, 14000 收起 << |
NCT00833417 | Basal Cell Carcinoma | Phase 2 | Completed | - | - |
NCT00833417 | - | Completed | - | - | |
NCT01266967 | Melanoma and Brain Metastases | Phase 2 | Completed | - | - |
NCT00984620 | - | Completed | - | - | |
NCT00545402 | Liver Transplantation | Phase 4 | Completed | - | France ... 展开 >> Besancon, France, 25030 Bordeaux, France, 33076 Caen, France, 14033 Clichy, France, 92118 Creteil, France, 94010 Grenoble, France, 38043 Lille, France, 59037 Lyon cedex 3, France, 69437 Lyon, France, 69317 Marseille, France, 13385 Montpellier, France, 34295 Nice, France, 06202 Paris, France, 75679 Rennes, France, 35033 Toulouse, France, 31059 Villejuif, France, 94804 收起 << |
NCT00841126 | Chronic Kidney Failure | Phase 3 | Terminated | July 2011 | - |
NCT00984620 | Hepatitis C | Phase 2 | Completed | - | - |
NCT01521923 | - | Completed | - | - | |
NCT00545402 | - | Completed | - | - | |
NCT00309608 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01560637 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Recruiting | August 2021 | - |
NCT01560624 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Completed | - | - |
NCT01779921 | - | Completed | - | United States, New Jersey ... 展开 >> Novo Nordisk Investigational Site Princeton, New Jersey, United States, 08540 France Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 Germany Novo Nordisk Investigational Site Mainz, Germany, 55127 Greece Novo Nordisk Investigational Site Vouliagment, Greece, 16671 Hong Kong Novo Nordisk Investigational Site Kowloon, Hong Kong India Novo Nordisk Investigational Site Bangalore, India, 560001 Iran, Islamic Republic of Novo Nordisk Investigational Site Teheran, Iran, Islamic Republic of Israel Novo Nordisk Investigational Site Kfar Saba, Israel, 44425 Italy Novo Nordisk Investigational Site Rome, Italy, 00144 Pakistan Novo Nordisk Investigational Site Karachi, Pakistan Serbia Novo Nordisk Investigational Site Belgrade, Serbia, 11070 Slovakia Novo Nordisk Investigational Site Bratislava, Slovakia, 811 05 Spain Novo Nordisk Investigational Site Madrid, Spain, 28033 Thailand Novo Nordisk Investigational Site Bangkok, Thailand, 10500 Turkey Novo Nordisk Investigational Site Istanbul, Turkey, 34335 Venezuela Novo Nordisk Investigational Site Caracas, Venezuela 收起 << | |
NCT01266967 | - | Completed | - | - | |
NCT00874770 | Hepatitis C Infection | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Alabama Liver & Digestive Specialists (Alds) Montgomery, Alabama, United States, 36116 United States, Colorado University Of Colorado Denver & Hospital Aurora, Colorado, United States, 80045 United States, Connecticut Yale University School Of Medicine New Haven, Connecticut, United States, 06520 United States, Maryland Mercy Medical Center Baltimore, Maryland, United States, 21202 United States, Massachusetts Llc Dba The Research Institute Springfield, Massachusetts, United States, 01107 United States, New York Veterans Affairs Medical Center Bronx, New York, United States, 10468 United States, North Carolina Carolinas Center For Liver Disease Statesville, North Carolina, United States, 28677 United States, Oklahoma Options Health Research, Llc Tulsa, Oklahoma, United States, 74104 Healthcare Research Consultants Tulsa, Oklahoma, United States, 74135 United States, Texas North Texas Research Institute Arlington, Texas, United States, 76012 United States, Virginia Metropolitan Research Fairfax, Virginia, United States, 22031 France Local Institution Creteil, France, 94010 Local Institution Paris Cedex 14, France, 75679 Local Institution Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT02581631 | Non-Hodgkin's Disease | Phase 1 Phase 2 | Recruiting | February 13, 2020 | - |
NCT00896480 | Melanoma | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Brussels, Belgium, 1200 GSK Investigational Site Brussel, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1180 GSK Investigational Site Liège, Belgium, 4000 GSK Investigational Site Wilrijk, Belgium, 2610 GSK Investigational Site Yvoir, Belgium, 5530 France GSK Investigational Site Caen, France, 14033 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Reims, France, 51092 GSK Investigational Site Villejuif, France, 94805 收起 << |
NCT00874770 | - | Completed | - | - | |
NCT00896051 | HIV Infections ... 展开 >> Acquired Immunodeficiency Syndrome 收起 << | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> Little Rock, Arkansas, United States United States, California Bakersfield, California, United States Beverly Hills, California, United States United States, Florida Orlando, Florida, United States Tampa, Florida, United States Vero Beach, Florida, United States West Palm Beach, Florida, United States United States, Georgia Macon, Georgia, United States United States, Texas Dallas, Texas, United States Houston, Texas, United States Argentina Buenos Aires, Argentina Cordoba, Argentina France Paris Cedex 10, France Paris, France Tourcoing, France South Africa Bloemfontein, South Africa Cape Town, South Africa George, South Africa Thailand Bangkok, Thailand 收起 << |
NCT00896051 | - | Completed | - | - | |
NCT01569295 | Chronic Lymphocytic Leukemia | Phase 3 | Active, not recruiting | November 2018 | - |
NCT02807844 | Triple Negative Breast Cancer ... 展开 >> Pancreatic Carcinoma Melanoma Endometrial Carcinoma 收起 << | Phase 1 Phase 2 | Recruiting | May 15, 2019 | United States, Massachusetts ... 展开 >> Novartis Investigative Site Recruiting Boston, Massachusetts, United States, 02215 Contact: Janice Russell 617-643-1820 Janice_Russell@DFCI.Harvard.edu Principal Investigator: F Stephen Hodi United States, Missouri Novartis Investigative Site Recruiting Saint Louis, Missouri, United States, 63123 United States, Tennessee Novartis Investigative Site Recruiting Germantown, Tennessee, United States, 38138 United States, Texas Novartis Investigative Site Recruiting Houston, Texas, United States, 77030 Contact: Lacey McQuinn 713-792-0007 lmcquinn@mdanderson.org Principal Investigator: Aung Naing Belgium Novartis Investigative Site Recruiting Wilrijk, Belgium, 2610 Finland Novartis Investigative Site Recruiting HUS, Finland, FIN-00029 France Novartis Investigative Site Recruiting Saint Herblain cedex, France, 44805 Germany Novartis Investigative Site Recruiting Frankfurt, Germany, 60590 Novartis Investigative Site Recruiting Ulm, Germany, 89081 Hong Kong Novartis Investigative Site Recruiting Hong Kong, Hong Kong Italy Novartis Investigative Site Recruiting Milano, MI, Italy, 20133 Novartis Investigative Site Recruiting Milano, MI, Italy, 20141 Japan Novartis Investigative Site Recruiting Koto-ku, Tokyo, Japan, 135 8550 Korea, Republic of Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 03080 Novartis Investigative Site Recruiting Seoul, Korea, Republic of, 05505 Spain Novartis Investigative Site Recruiting Valencia, Comunidad Valenciana, Spain, 46010 Novartis Investigative Site Recruiting Madrid, Spain, 28007 Switzerland Novartis Investigative Site Recruiting Chur, Switzerland, 7000 Novartis Investigative Site Recruiting Geneve 14, Switzerland, CH-1211 Novartis Investigative Site Recruiting Zuerich, Switzerland, 8091 收起 << |
NCT00760877 | CHRONIC MYELOGENOUS LEUKEMIA | Phase 3 | Completed | - | - |
NCT01569295 | - | Active, not recruiting | - | - | |
NCT00891046 | - | Completed | - | - | |
NCT00932100 | Acute Coronary Syndrome (ACS) | Phase 2 | Completed | - | - |
NCT00891046 | Systemic Juvenile Idiopathic A... 展开 >>rthritis 收起 << | Phase 3 | Completed | - | - |
NCT00760877 | - | Completed | - | - | |
NCT01149343 | Melanoma | Phase 1 | Completed | - | - |
NCT00939003 | Axial Spondyloarthritis | Phase 3 | Completed | - | - |
NCT00939003 | - | Completed | - | - | |
NCT01149343 | - | Completed | - | - | |
NCT01523587 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Completed | - | - |
NCT01243177 | Epilepsy Mono... 展开 >>therapy 收起 << | Phase 3 | Completed | - | - |
NCT01243177 | - | Completed | - | - | |
NCT00962741 | Arthritis, Juvenile Idiopathic | Phase 3 | Completed | - | - |
NCT01523587 | - | Completed | - | - | |
NCT00658775 | Gastroesophageal Reflux Diseas... 展开 >>e (GERD) 收起 << | Phase 3 | Completed | - | - |
NCT01644188 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02366143 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Active, not recruiting | December 22, 2019 | - |
NCT00962741 | - | Completed | - | - | |
NCT01684878 | - | Completed | - | - | |
NCT00658775 | - | Completed | - | - | |
NCT00980330 | - | Completed | - | - | |
NCT00992576 | Constipation | Phase 2 Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Hunter New England Area Health Service Newcastle, New South Wales, Australia, 2300 Austria AKH Wien - Universitätskliniken Wien, Austria, A-1090 Belgium Erasme Hospital Bruxelles, Belgium, 1070 Czech Republic Poradna pro lecbu bolesti Pribram, Czech Republic, 261-01 Denmark Speciallæge Michael Crawford København K., Denmark, 1100 Finland Oma Lääkäri Oy Kuopio, Finland, Fl-70100 France CHU - Hôpital Amiens Nord Amiens Cedex 1, France, 80054 Germany Universitaetsklinikum Jena Jena, Germany, 07747 Israel Tel-Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 Netherlands Diakonessenhuis, locatie Zeist Zeist, Netherlands, 3707HL Poland Szpital Uniwersytecki w Krakowie Zakład Badania Krakow, Poland, 31-531 Romania Spitalul Clinic Judetean de Urgenta Cluj Cluj-Napoca, Romania, 400006 Switzerland Kantonsspital Aarau Aarau, Switzerland, 5001 United Kingdom Avondale Surgery Chesterfield, United Kingdom, S40 4TF 收起 << |
NCT01684878 | Ovarian Cancer | Phase 3 | Completed | - | - |
NCT00994292 | Acute Coronary Syndrome | Phase 2 | Completed | - | - |
NCT00980655 | - | Completed | - | - | |
NCT01715896 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT02409342 | Non-Squamous Non-Small Cell Lu... 展开 >>ng Cancer, Squamous Non-Small Cell Lung Cancer 收起 << | Phase 3 | Active, not recruiting | April 23, 2020 | - |
NCT01715896 | - | Completed | - | - | |
NCT00714688 | Attention Deficit/ Hyperactivi... 展开 >>ty Disorder 收起 << | Phase 3 | Completed | - | - |
NCT01012037 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT00714688 | - | Completed | - | - | |
NCT01197755 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01056263 | - | Completed | - | United States, California ... 展开 >> Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, New York Pfizer Investigational Site New York, New York, United States, 10065 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 France Pfizer Investigational Site Paris Cedex 13, France, 75651 Germany Pfizer Investigational Site Hannover, Germany, 30625 收起 << | |
NCT01644188 | - | Completed | - | - | |
NCT01197755 | - | Completed | - | - | |
NCT01056263 | - | Completed | - | - | |
NCT00980655 | Vaccines, Pneumococcal Conjuga... 展开 >>te Vaccine 收起 << | Phase 3 | Completed | - | - |
NCT01067859 | Acute Heart Failure | Phase 2 | Terminated | - | - |
NCT00370877 | Postpartum Hemorrhage | Phase 4 | Completed | - | France ... 展开 >> Hôpital Antoine Béclère -APHP Clamart, France University Hospital, Lille Lille, France University Hospital of Montpellier Montpellier, France University Hospital, Nice Nice, France Laboratoire d'hématologie, Groupe Hospitalo-Universitaire Caremeau Nimes cedex 9, France, F-30029 Centre Hospital University of Nimes Nimes, France Maternite CHU de Cochin - APHP Paris, France Switzerland University Hospital, Geneva Geneva, Switzerland 收起 << |
NCT01012037 | - | Completed | - | - | |
NCT00094328 | - | Completed | - | - | |
NCT01058434 | Relapsed or Refractory Multipl... 展开 >>e Myeloma 收起 << | Phase 2 | Completed | - | - |
NCT00916513 | - | Completed | - | - | |
NCT00094328 | Puberty, Precocious | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Research Site Birmingham, Alabama, United States, 35233 United States, Florida Research Site Jacksonville, Florida, United States, 32207 United States, Indiana Research Site Indianapolis, Indiana, United States, 46202 United States, Minnesota Research Site Minneapolis, Minnesota, United States, 55416 United States, Oklahoma Research Site Tulsa, Oklahoma, United States, 74136 United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States, 19134 United States, South Carolina Research Site Greenville, South Carolina, United States, 29615 United States, Texas Research Site Temple, Texas, United States, 76508 United States, Washington Research Site Spokane, Washington, United States, 99204 Canada, Ontario Research Site London, Ontario, Canada, N6A 4G5 France Research Site Montpellier Cedex, France, 34295 India Research Site Chennai, India, 600020 Research Site New Dehli, India, 110029 Russian Federation Research Site Moscow, Russian Federation, 117036 United Kingdom Research Site London, United Kingdom, WC1N 3JH 收起 << |
NCT00864097 | Osteoarthritis | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01077362 | Arthritis, Psoriatic | Phase 3 | Completed | - | - |
NCT01082068 | Breast Cancer | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Investigational Site Number 1537 Los Angeles, California, United States, 90033 United States, Colorado Investigational Site Number 1601 Denver, Colorado, United States, 80262 United States, Florida Investigational Site Number 1238 Fort Meyers, Florida, United States, 33901 United States, Illinois Investigational Site Number 1441 Chicago, Illinois, United States, 60611 United States, Massachusetts Investigational Site Number 1138 Boston, Massachusetts, United States, 02115 United States, Michigan Investigational Site Number 1331 Ann Arbor, Michigan, United States, 48109 Investigational Site Number 1330 Detroit, Michigan, United States, 48201 United States, Missouri Investigational Site Number 5201 Columbia, Missouri, United States, 65201 United States, North Carolina Investigational Site Number 1252 Durham, North Carolina, United States, 27710 United States, Tennessee Investigational Site Number 1214 Nashville, Tennessee, United States, 37203 United States, Texas Investigational Site Number 5246 El Paso, Texas, United States, 79915 France Investigational Site Number 3321 Nantes Saint Herblain, France, 44805 Investigational Site Number 3324 Paris Cedex 05, France, 75231 Spain Investigational Site Number 3415 Barcelona, Spain, 08035 Investigational Site Number 3419 Barcelona, Spain, 08036 Investigational Site Number 3413 Madrid, Spain, 28041 Investigational Site Number 3420 Madrid, Spain, 28050 收起 << |
NCT01077362 | - | Completed | - | - | |
NCT03144674 | Lymphoma | Phase 2 | Recruiting | March 2022 | - |
NCT01242514 | Rheumatoid Arthritis | Phase 3 | Terminated(AZ decision to disc... 展开 >>ontinue fostamatinib development in RA; rights to fostamatinib returned to Rigel Pharmaceuticals.) 收起 << | January 2015 | - |
NCT01685060 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT01103596 | - | Completed | - | France ... 展开 >> Site Reference ID/Investigator# 27801 Angers, France, 49100 Site Reference ID/Investigator# 27799 Bordeaux, France, 33075 Site Reference ID/Investigator# 27790 Grenoble, France, 38043 Site Reference ID/Investigator# 27796 Lille, France, 59037 Site Reference ID/Investigator# 27786 Montpellier, France, 34295 Site Reference ID/Investigator# 27800 Nantes, France, 44093 Site Reference ID/Investigator# 27798 Nice, France, 06202 Site Reference ID/Investigator# 27792 Nimes, France, 30029 Site Reference ID/Investigator# 27797 Paris Cedex 12, France, 75571 Site Reference ID/Investigator# 5595 Paris, France, 75013 Site Reference ID/Investigator# 27787 Paris, France, 75475 Site Reference ID/Investigator# 27783 Paris, France, 75877 Site Reference ID/Investigator# 27802 Paris, France, 75908 Site Reference ID/Investigator# 27785 Paris, France, 75970 Site Reference ID/Investigator# 27791 Rennes, France, 35700 Site Reference ID/Investigator# 27788 Rouen, France, 76000 Site Reference ID/Investigator# 27789 Toulon, France, 83056 Site Reference ID/Investigator# 27794 Toulouse, France, 31000 Site Reference ID/Investigator# 27784 Villejuif, France, 94804 收起 << | |
NCT01381549 | - | Terminated(Microbiological fin... 展开 >>dings of resistance on therapy in patients with complicated urinary tract infection) 收起 << | - | - | |
NCT01242514 | - | Terminated(AZ decision to disc... 展开 >>ontinue fostamatinib development in RA; rights to fostamatinib returned to Rigel Pharmaceuticals.) 收起 << | - | - | |
NCT01381549 | Infections, Urinary Tract | Phase 2 | Terminated(Microbiological fin... 展开 >>dings of resistance on therapy in patients with complicated urinary tract infection) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90033 United States, Iowa GSK Investigational Site Council Bluffs, Iowa, United States, 51503 United States, Kansas GSK Investigational Site Topeka, Kansas, United States, 66604 United States, Texas GSK Investigational Site Corsicana, Texas, United States, 75110 Canada, Quebec GSK Investigational Site Chicoutimi, Quebec, Canada, G7H 5H6 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 France GSK Investigational Site Suresnes, France, 92151 GSK Investigational Site Toulouse cedex 9, France, 31059 Greece GSK Investigational Site Athens, Greece, 11527 GSK Investigational Site Chaidari, Greece, 12462 GSK Investigational Site Goudi, Athens, Greece, 11527 GSK Investigational Site Thessaloniki, Greece, 56429 Russian Federation GSK Investigational Site Irkutsk, Russian Federation, 664079 GSK Investigational Site Moscow, Russian Federation, 125367 GSK Investigational Site Rostov-on-Don, Russian Federation, 344022 GSK Investigational Site Smolensk, Russian Federation, 214018 GSK Investigational Site St'Petersburg, Russian Federation, 194354 Spain GSK Investigational Site Alicante, Spain, 03010 GSK Investigational Site Elche (Alicante), Spain, 03203 GSK Investigational Site Getafe/Madrid, Spain, 28905 GSK Investigational Site Granada, Spain, 18003 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Murcia, Spain GSK Investigational Site Pama de Mallorca, Spain, 07010 收起 << |
NCT01685060 | - | Completed | - | - | |
NCT00002426 | HIV Infections | Not Applicable | Completed | - | - |
NCT00134693 | Arthritis, Rheumatoid | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Darlinghurst, New South Wales, Australia, 2010 Australia, Queensland GSK Investigational Site Douglas, Queensland, Australia, 4814 GSK Investigational Site Woolloongabba, Queensland, Australia, 4102 Australia, South Australia GSK Investigational Site Daw Park, South Australia, Australia, 5041 GSK Investigational Site Woodville, South Australia, Australia, 5011 Australia, Tasmania GSK Investigational Site Hobart, Tasmania, Australia, 7000 Australia, Western Australia GSK Investigational Site Shenton Park, Western Australia, Australia, 6008 France GSK Investigational Site Amiens, Picardie, France, 80054 GSK Investigational Site Montpellier Cedex 5, France, 34295 Germany GSK Investigational Site Villingen-Schwenningen, Baden-Wuerttemberg, Germany, 78054 GSK Investigational Site Hildesheim, Niedersachsen, Germany, 31134 GSK Investigational Site Chemnitz, Sachsen, Germany, 09111 GSK Investigational Site Leipzig, Sachsen, Germany, 04107 GSK Investigational Site Leipzig, Sachsen, Germany, 04229 GSK Investigational Site Berlin, Germany, 12163 GSK Investigational Site Berlin, Germany, 13125 GSK Investigational Site Berlin, Germany, 14059 GSK Investigational Site Berlin, Germany, 14109 Russian Federation GSK Investigational Site Ekaterinburg, Russian Federation, 620102 GSK Investigational Site Moscow, Russian Federation, 115522 GSK Investigational Site Ryazan, Russian Federation, 390026 GSK Investigational Site Yaroslavl, Russian Federation, 150003 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ GSK Investigational Site Wigan, Lancashire, United Kingdom, WN6 9EP GSK Investigational Site Liverpool, Merseyside, United Kingdom, L9 7AL GSK Investigational Site Newcastle, Northumberland, United Kingdom, NE1 4LP GSK Investigational Site Oxford, United Kingdom, OX3 7LP GSK Investigational Site Sheffield, United Kingdom, S10 2RX 收起 << |
NCT00207740 | Asthma | Phase 2 | Completed | - | - |
NCT00175877 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00175877 | - | Completed | - | - | |
NCT02414958 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | - |
NCT00262522 | Human Immunodeficiency Virus I... 展开 >>nfections 收起 << | Phase 3 | Completed | - | - |
NCT02414958 | - | Completed | - | - | |
NCT01076010 | Advanced Renal Cell Carcinoma | Phase 3 | Completed | - | - |
NCT00262522 | - | Completed | - | - | |
NCT00207740 | - | Completed | - | - | |
NCT00042068 | Arthritis, Rheumatoid | Phase 3 | Completed | - | - |
NCT00763815 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT01030783 | Advanced Renal Cell Carcinoma | Phase 3 | Completed | - | - |
NCT00289978 | Relapsing-remitting Multiple S... 展开 >>clerosis 收起 << | Phase 3 | Completed | - | - |
NCT00789191 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00289978 | - | Completed | - | - | |
NCT01134536 | Pain, Postoperative ... 展开 >> Postoperative Pain 收起 << | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> Little Rock, Arkansas, United States United States, District of Columbia Washington, District of Columbia, United States United States, Idaho Meridian, Idaho, United States United States, Michigan Ann Arbor, Michigan, United States United States, New York Bronx, New York, United States United States, North Carolina Charlotte, North Carolina, United States Durham, North Carolina, United States United States, Ohio Toledo, Ohio, United States United States, Pennsylvania Pittsburgh, Pennsylvania, United States United States, Utah Salt Lake City, Utah, United States Canada, Ontario Hamilton, Ontario, Canada Ottawa, Ontario, Canada Canada, Quebec Sherbrooke, Quebec, Canada France F-75 730 Paris Cedex 15, France Rennes, France Spain Madrid N/A, Spain Madrid, Spain Valladolid, Spain 收起 << |
NCT00744900 | Lung Cancer | Phase 2 | Completed | - | France ... 展开 >> Centre Hôspitalier du Pays d'Aix, Service des Maladies Respiratoires Aix En Provence, France, 13616 CHU d'Angers, Service de Pneumologie Angers, France, 49033 Médecine 4, C.H.G. de la Fontonne Antibes Antibes, France, 06606 CHU brest, institut de cancérologie et d'hématologie Brest, France, 29200 Centre François Baclesse Caen, France, 14000 Centre Hospitalier René Dubos - Pontoise, Service d'Oncologie - Hématologie Clinique Cergy Pontoise, France, 95303 Centre Hospitalier, Service de Pneumologie Charleville, France, 08 000 CHI, Service de Pneumologie Creteil, France, 94010 Pneumologie, Centre hôspitalier, DRAGUIGNAN Draguignan, France, 83300 CH GAP GAP, France, 05000 Centre Hospitalier Départemental, Service de Pneumologie, La Roche Sur Yon, France, 85000 Hôpital A. Mignot, Service de Pneumologie Le Chesnay, France, 78157 Hopital de la Croix Rousse Lyon, France, 69317 Centre Hôspitalier, Service de Pneumo-Neuro Mantes La Jolie, France, 78200 Hôpital Sainte Margueritte Marseilles, France, 13274 Serv. de Pneumo-Allergo, CH de Martigues Martigues, France, 13695 Serv. de Pneumo - Hôpital St Antoine Paris, France, 75571 Service Pneumologie, Pavillon 1A, CH de Lyon-Sud Pierre-benite, France, 69495 Hôpital Pontchailloux, Service de Pneumologie. Rennes, France, 35033 CHG, Service de Pneumologie Roanne, France, 42300 Luc THIBERVILLE Rouen, France, 76031 CHU de ROUEN, Hôpital Bois Guillaume, Serv. de Pneumo. Rouen, France, 76233 Institut de Cancérologie de la Loire Saint-Priest en Jarez Cedex, France, 42271 CHU, Service du Pr. Carles Toulouse, France, 31059 Pneumologie, Centre Hospitalier VILLEFRANCHE sur SAONE, France, 69655 收起 << |
NCT00550004 | Pancreatic Cancer | Phase 2 | Terminated | - | - |
NCT00770744 | Schizophrenia | Phase 2 | Completed | - | Czech Republic ... 展开 >> CZ001 Ceske Budejovice, Czech Republic, 37087 CZ005 Litomerice, Czech Republic, 41201 CZ004 Lnare, Czech Republic, 38742 CZ002 Olomouc, Czech Republic, 77111 CZ003 Olomouc, Czech Republic, 77520 CZ006 Praha 8, Czech Republic, 18100 France FR001 Clermont-Ferrand, Cedex 1, France, 63003 FR002 Dole, France, 39100 FR003 Jonzac, France, 17503 Hong Kong HK001 Hong Kong, Hong Kong Indonesia ID001 Bangli, Indonesia, 80613 ID002 Jakarta, Indonesia, 10430 Philippines PH002 Baguio, Philippines, 2600 PH001 Mandaluyong City, Philippines, 1553 Poland PL003 Gdansk, Poland, 80-211 PL002 Lodz, Poland, 92-216 Spain ES001 Barcelona, Spain, 8025 ES002 Salamanca, Spain, 37003 ES004 Zamora, Spain, 49021 Thailand TH001 Bangkok, Thailand, 10330 TH002 Chiang Mai, Thailand, 50200 收起 << |
NCT01064414 | - | Completed | - | - | |
NCT00163163 | Hypercholesterolaemia | Phase 3 | Completed | - | - |
NCT01243424 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00789191 | - | Completed | - | - | |
NCT00139061 | Hyperlipidemia | Phase 3 | Completed | - | France ... 展开 >> Pfizer Investigational Site Angers, France, 49 000 Pfizer Investigational Site Angers, France, 49 100 Pfizer Investigational Site Bordeaux Cauderan, France, 33 200 Pfizer Investigational Site Briollay, France, 49125 Pfizer Investigational Site Dijon, France, 21000 Pfizer Investigational Site Hagondange, France, 57 300 Pfizer Investigational Site Haut Mauco, France, 40 280 Pfizer Investigational Site Jarny, France, 54800 Pfizer Investigational Site Lille, France, 59 037 Cedex Pfizer Investigational Site Mars LA Tour, France, 54800 Pfizer Investigational Site Metz, France, 57070 Pfizer Investigational Site Monguilhem, France, 32 240 Pfizer Investigational Site Mont de Marsan CEDEX, France, 40010 Pfizer Investigational Site Mont de Marsan, France, 40 010 cedex Pfizer Investigational Site Mont de Marsan, France, 40 010 Pfizer Investigational Site Mont de Marsan, France, 40000 Pfizer Investigational Site Moutiers, France, 54660 Pfizer Investigational Site Murs Erigne, France, 49610 Pfizer Investigational Site Nantes, France, 44 093 Cedex 01 Pfizer Investigational Site Pouilly en Auxois, France, 21 850 Pfizer Investigational Site Saint Justin, France, 40 240 Pfizer Investigational Site Saint Martin D'Oney, France, 40090 Pfizer Investigational Site Seysses, France, 31600 Pfizer Investigational Site Strasbourg, France, 67000 Pfizer Investigational Site Thouars, France, 79100 Pfizer Investigational Site Tierce, France, 49 125 收起 << |
NCT00865969 | Peripheral T-cell Lymphoma | Phase 2 | Completed | - | - |
NCT00265083 | - | Completed | - | - | |
NCT00274053 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | France ... 展开 >> Boehringer Ingelheim Investigational Site Aix les Bains, France, 73100 Hôpital Privé Antony Antony, France, 92166 Boehringer Ingelheim Investigational Site Bordeaux, France, 33100 Boehringer Ingelheim Investigational Site Cambo les Bains, France, 64250 Centre Médical Annie Enia Cambo les Bains, France, 64250 Boehringer Ingelheim Investigational Site Châlons sur Saône, France, 71100 Hôpital Gabriel Montpied Clermont Ferrand cedex 01, France, 63003 Boehringer Ingelheim Investigational Site Colmar, France, 68000 CH Laennec Creil, France, 60109 Boehringer Ingelheim Investigational Site Dole, France, 39100 Centre Hospitalier Longjumeau, France, 91160 Boehringer Ingelheim Investigational Site Luneville, France, 54300 MAPI CRO Lyon, France, 69003 Boehringer Ingelheim Investigational Site Maxeville, France, 54320 Boehringer Ingelheim Investigational Site Metz, France, 57000 Hôpital Notre Dame de Bon Secours Metz, France, 57038 Boehringer Ingelheim Investigational Site Montigny les Metz, France, 57950 Boehringer Ingelheim Investigational Site Mulhouse, France, 68100 Hôpital Pitié Salpétrière Paris, France, 75013 Hôpital Cochin Paris, France, 75679 Boehringer Ingelheim Investigational Site Poitiers, France, 86000 Hôpital Saint Charles Saint Dié des Vosges, France, 88187 Groupe Hospitalier Sud Réunion Saint Pierre, France, 97448 Boehringer Ingelheim Investigational Site Saint Quentin, France, 02100 Boehringer Ingelheim Investigational Site Toulouse, France, 31300 CH Toul Toul, France, 54201 Boehringer Ingelheim Investigational Site Vandoeuvre les Nancy, France, 54500 收起 << |
NCT00265083 | Spondylitis, Ankylosing | Phase 3 | Completed | - | - |
NCT00667823 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Active, not recruiting | September 15, 2021 | - |
NCT01064414 | Diabetes Mellitus, Type 2 ... 展开 >> Renal Insufficiency 收起 << | Phase 3 | Completed | - | - |
NCT01207648 | - | Completed | - | United States, Alabama ... 展开 >> Research Site Birmingham, Alabama, United States United States, California Research Site San Francisco, California, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, New York Research Site Buffalo, New York, United States Research Site Rochester, New York, United States Research Site Stoney Brook, New York, United States Argentina Research Site Buenos Aires, Argentina Canada Research Site Toronto, Canada France Research Site Le Kremlin Bicêtre Cedex, France Italy Research Site Bari, Italy Research Site Catania, Italy Research Site Gallarate, Italy Research Site Milan, Italy Research Site Rome, Italy Research Site Torino, Italy Russian Federation Research Site Moscow, Russian Federation Tunisia Research Site Tunis, Tunisia Venezuela Research Site Maracaibo, Venezuela 收起 << | |
NCT00241540 | GERD | Phase 3 | Completed | - | - |
NCT00910429 | Pulmonary Hypertension | Phase 3 | Active, not recruiting | January 31, 2019 | - |
NCT01390948 | High Grade Glioma | Phase 2 | Active, not recruiting | March 10, 2020 | - |
NCT00664911 | Solid Tumor Regardless of Loca... 展开 >>lization and Stage 收起 << | Phase 4 | Completed | - | France ... 展开 >> Centre Radiotherapie Oncologie Moyenne Garonne Agen, France, 47000 Centre Hospitalier de Castelluccio Ajaccio, France, 20176 Centre Hospitalier d'Ardeche Meridionale Aubenas, France, 07205 Centre Hospitalier d'Auxerre Auxerre, France, 89011 Institut Sainte Catherine Avignon, France, 84000 Hopital Duffaut Avignon, France, 84902 Centre Hospitalier de Beauvais Beauvais, France, 60021 Clinique des Cedres Cornebarrieu, France, 31700 Centre Medico-Chirurgical et Obstetrique d'Evry Evry, France, 91000 Hopital Clarac Fort de France Cedex, France, 97261 Centre Hospitalier Intercommunal des Alpes du Sud Gap, France, 05007 Centre Hospitalier de Lagny Lagny Sur Marne, France, 77405 Centre Hospitalier St. Joseph St. Luc Lyon, France, 69007 Hopital Prive Jean Mermoz Lyon, France, 69008 Centre Hospitalier Chanaux Macon, France, 71018 Centre Hospitalier de Montelimar Montelimar, France, 26200 Hopital Bichat - Claude Bernard Paris, France, 75018 Hopital de la Croix St. Simon Paris, France, 75020 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Hopital Rene Dubos Pontoise, France, 95300 Institut Jean Godinot Reims, France, 51056 Centre Hospitalier Prive Saint-Gregoire Saint-Gregoire, France, 35768 Centre Hospitalier de Saint-Quentin Saint-Quentin, France, 02321 Centre Hospitalier de Semur en Auxois Semur en Auxois, France, 21140 C.H. Senlis Senlis, France, 60309 Hopital Foch Suresnes, France, 92151 Centre hospitalier de Tonnerre Tonnerre, France, 89700 Centre Hospitalier Villeneuve Saint Georges Villeneuve Saint Georges, France, 94195 收起 << |
NCT01101087 | Peritonitis C... 展开 >>atheter-related Infections Renal Insufficiency 收起 << | Not Applicable | Completed | - | France ... 展开 >> CHU de Nîmes - Hôpital Universitaire Carémeau Nimes, Gard, France, 30029 CH d'Avignon - Centre Hospitalier Henri Duffaut Avignon, France, 84902 CHU de Caen - Hôpital Clemenceau Caen, France, 14033 CH de Chambéry Chambery, France, 73011 CH de Colmar - Hôpitaux Civils de Colmar Colmar, France, 68024 Association CALYDIAL Vienne Irigny, France, 69540 Centre Hospitalier Départemental Vendée - Site de la Roche sur Yon La Roche sur Yon, France, 85925 AIDER - Clinque Jacques Mirouze Montpellier, France, 34295 APHP - Groupe Hospitalier Pitié-Salpetrière Paris, France, 75651 CH Pontoise - Centre Hospitalier René Dubos Pontoise, France, 95300 Association AUB Santé Quimper Quimper, France, 29000 Centre Hospitalier Regional - Site Groupe Hospitalier Sud Réunion (GHSR) Saint Pierre, France, 97448 CH de Valenciennes - Hôpital Jean Bernard et Hôtel Dieu Valenciennes, France, 59322 ALTIR - Hôpital Brabois Vandoeuvre les Nancy Cedex, France, 54504 French Polynesia Association APURAD Paéa, French Polynesia, 98711 收起 << |
NCT00882778 | - | Completed | - | United States, New Jersey ... 展开 >> Novo Nordisk Investigational Site Princeton, New Jersey, United States, 08540 Argentina Novo Nordisk Investigational Site Prov. de Buenos Aires, Argentina, B1636DSU Canada Novo Nordisk Investigational Site Mississauga, Canada, L4W 4XI Croatia Novo Nordisk Investigational Site Zagreb, Croatia, 10 000 Czech Republic Novo Nordisk Investigational Site Prague, Czech Republic, 16000 France Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 Germany Novo Nordisk Investigational Site Mainz, Germany, 55127 Ireland Novo Nordisk Investigational Site Dublin 2, Ireland Italy Novo Nordisk Investigational Site Rome, Italy, 00144 Slovakia Novo Nordisk Investigational Site Bratislava, Slovakia, 811 05 Spain Novo Nordisk Investigational Site Madrid, Spain, 28033 Sweden Novo Nordisk Investigational Site Malmö, Sweden, 202 15 Switzerland Novo Nordisk Investigational Site Zurich, Switzerland, CH-8050 United Kingdom Novo Nordisk Investigational Site Crawley, United Kingdom, RH11 9RT 收起 << | |
NCT01207648 | - | Completed | - | - | |
NCT00882778 | - | Completed | - | - | |
NCT00265811 | Colorectal Cancer | Phase 3 | Completed | - | France ... 展开 >> Hopital Duffaut Avignon, France, 84902 CHU de Caen Caen, France, 14033 Hopital Robert Boulin Libourne, France, 33500 Hopital Bichat - Claude Bernard Paris, France, 75018 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Centre Hospitalier Yves Le Foll Saint Brieuc Cedex 1, France, BP 2367 Nouvelle Clinique Generale Valence, France, 26000 收起 << |
NCT00678535 | Gastric Cancer | Phase 3 | Completed | - | - |
NCT01390948 | - | Active, not recruiting | - | - | |
NCT00678535 | - | Completed | - | - | |
NCT00960128 | - | Completed | - | - | |
NCT00452010 | Chronic Low Back Pain ... 展开 >> Chronic Lumbo-radiculalgia 收起 << | Phase 4 | Completed | - | France ... 展开 >> CHU d'Amiens Amiens, France, 80000 CHU de Grenoble Grenoble, France, 38000 CHU de Limoges Limoges, France, 87000 Fondation Hôpital Saint Joseph - MARSEILLE Marseille, France, 13000 La Timone - MARSEILLE Marseille, France, 13000 Centre Catherine de Sienne - Nantes Nantes, France, 44000 CHU de Saint-Etienne Saint-Etienne Cedex 2, France, 42055 CH de Voiron Voiron, France, 38500 收起 << |
NCT00622245 | Depression in Patients With Bi... 展开 >>polar Disorder 收起 << | Phase 2 | Terminated(Human metabolite no... 展开 >>t yet covered sufficiently by nonclinical data) 收起 << | - | - |
NCT00184548 | Acquired Bleeding Disorder ... 展开 >> Trauma 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description) 收起 << | - | United States, New Jersey ... 展开 >> Novo Nordisk Clinical Trial Call Center Princeton, New Jersey, United States, 08540 Brazil Säo Paulo, Brazil, 05001-400 Czech Republic Prague, Czech Republic, 16000 France Paris La défense cedex, France, 92932 Germany Mainz, Germany, 55127 Greece Vouliagment, Greece, 16671 Hong Kong Kowloon, Hong Kong Hungary Budapest, Hungary, 1025 Italy Rome, Italy, 00144 Netherlands Alphen a/d Rijn, Netherlands South Africa Sandton, South Africa, 2146 Spain Madrid, Spain, 28033 Switzerland Zurich, Switzerland, CH-8050 United Kingdom Crawley, United Kingdom, RH11 9RT 收起 << |
NCT00659295 | - | Completed | - | - | |
NCT00703911 | - | Completed | - | Algeria ... 展开 >> Novo Nordisk Investigational Site Algiers, Algeria, 16035 Austria Novo Nordisk Investigational Site Vienna, Austria, A-1010 Belgium Novo Nordisk Investigational Site Brussels, Belgium, 1070 Czech Republic Novo Nordisk Investigational Site Prague, Czech Republic, 16000 France Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 Germany Novo Nordisk Investigational Site Mainz, Germany, 55127 Italy Novo Nordisk Investigational Site Rome, Italy, 00144 Netherlands Novo Nordisk Investigational Site Alphen a/d Rijn, Netherlands Poland Novo Nordisk Investigational Site Warszawa, Poland, PL-02-274 Portugal Novo Nordisk Investigational Site Paco de Arcos, Portugal, 2780-730 Saudi Arabia Novo Nordisk Investigational Site Riyadh, Saudi Arabia, 3542 South Africa Novo Nordisk Investigational Site Sandton, South Africa, 2146 Sweden Novo Nordisk Investigational Site Malmö, Sweden, 202 15 Turkey Novo Nordisk Investigational Site Istanbul, Turkey, 34335 United Kingdom Novo Nordisk Investigational Site Crawley, United Kingdom, RH11 9RT Venezuela Novo Nordisk Investigational Site Caracas, Venezuela 收起 << | |
NCT00659295 | - | Completed | - | Belgium ... 展开 >> Novo Nordisk Investigational Site Brussels, Belgium, 1070 Czech Republic Novo Nordisk Investigational Site Prague, Czech Republic, 16000 Denmark Novo Nordisk Investigational Site Copenhagen S, Denmark, 2300 Finland Novo Nordisk Investigational Site Espoo, Finland, FI-02600 France Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 Greece Novo Nordisk Investigational Site Vouliagment, Greece, 16671 Ireland Novo Nordisk Investigational Site Dublin 2, Ireland Israel Novo Nordisk Investigational Site Kfar Saba, Israel, 44425 Italy Novo Nordisk Investigational Site Rome, Italy, 00144 Korea, Republic of Novo Nordisk Investigational Site Seoul, Korea, Republic of, 137-920 Sweden Novo Nordisk Investigational Site Malmö, Sweden, 202 15 Turkey Novo Nordisk Investigational Site Istanbul, Turkey, 34335 United Kingdom Novo Nordisk Investigational Site Crawley, United Kingdom, RH11 9RT 收起 << | |
NCT00184548 | - | Terminated(See termination rea... 展开 >>son in detailed description) 收起 << | - | - | |
NCT01186939 | - | Completed | - | - | |
NCT01186939 | Myelodysplastic Syndromes | Phase 3 | Completed | - | Australia, Victoria ... 展开 >> East Melbourne, Victoria, Australia Australia Herston, Australia Perth, Australia Woolloongabba, Australia Bulgaria Plovdiv, Bulgaria France Aulnay Sous Bois Cedex, France Germany Berlin, Germany Dusseldorf, Germany Essen, Germany Kiel, Germany Greece Heraklio, Crete, Greece Haidari, Greece Hungary Budapest, Hungary Italy Bologna, Italy Firenze, Italy Genova, Italy Rome, Italy Netherlands Nijmegen, Netherlands Poland Lodz, Poland Spain Avda Campanar, Spain Leon, Spain United Kingdom London, United Kingdom 收起 << |
NCT00703911 | - | Completed | - | - | |
NCT00549198 | - | Completed | - | - | |
NCT00148356 | Coronary Disease ... 展开 >> Coronary Artery Disease Coronary Restenosis 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT00549198 | Infection, Human Immunodeficie... 展开 >>ncy Virus I HIV Infection 收起 << | Phase 4 | Completed | - | - |
NCT01476423 | - | Completed | - | United States, New Jersey ... 展开 >> Novo Nordisk Clinical Trial Call Center Princeton, New Jersey, United States, 08540 Algeria Algiers, Algeria, 16035 Austria Vienna, Austria, A-1010 Belgium Brussels, Belgium, 1070 Bulgaria Sofia, Bulgaria, 1407 France Paris La défense cedex, France, 92932 Germany Mainz, Germany, 55127 Hungary Budapest, Hungary, 1025 Italy Rome, Italy, 00144 Netherlands Alphen a/d Rijn, Netherlands Pakistan Karachi, Pakistan Spain Madrid, Spain, 28033 Sweden Malmö, Sweden, 202 15 Switzerland Zurich, Switzerland, CH-8050 United Kingdom Crawley, United Kingdom, RH11 9RT 收起 << | |
NCT01130493 | - | Completed | - | - | |
NCT00101608 | Transitional Cell Carcinoma ... 展开 >> Bladder Neoplasms Kidney Neoplasms Ureter Neoplasms Bladder Cancer Neoplasm, Bladder 收起 << | Phase 2 | Completed | - | - |
NCT00195676 | Psoriasis | Phase 3 | Completed | - | - |
NCT01507116 | - | Completed | - | - | |
NCT01130493 | Parkinson's Disease | Phase 3 | Completed | - | United States, California ... 展开 >> Margolin Brain Institute Fresno, California, United States, 93720 The Parkinson's Institute in Sunnyvale Sunnyvale, California, United States, 94085 United States, Florida UM Movement Disorders Center Miami, Florida, United States, 33136 Charlotte Neurological Services Port Charlotte, Florida, United States, 33980 USF Parkinson's and Movement Disorders Center Tampa, Florida, United States, 33606 United States, Michigan Quest Research Institute Bingham Farms, Michigan, United States, 48025 United States, Nevada University Health Systems Las Vegas, Nevada, United States, 89102 United States, New York Parkinson's Disease and Movement Disorders Center of Long Island Commack, New York, United States, 11725 Kingston Neurological Associates Kingston, New York, United States, 12401 United States, Ohio University Neurology, Inc Cincinnati, Ohio, United States, 45219 United States, Virginia Sentara Neurological Associates Virginia Beach, Virginia, United States, 23456 United States, Washington Booth Gardner Parkinson's Care Center Kirkland, Washington, United States, 98034 France Hôpital Gabriel Montpied-Service de Neurologie A- Clermont-Ferrand Cedex 1, France, 63003 Service de neurologie-Hôpital de la Timone- Marseille, France, 13385 Germany Praxis für Neurologie, Psychiatrie und Psychotherapie Achim Achim, Germany, 28832 Praxis Dres. Bitter/Schumann Bochum, Germany, 44805 Klinikum rechts der Isar der Technischen Universität München München, Germany, 81675 Klinik für Neurologie, Stadtroda Stadtroda, Germany, 07646 RKU, Neurologische Klinik der Universität Ulm Ulm, Germany, 89081 Italy Casa di Cura Villa Margherita Arcugnano, Italy, 36057 San Raffaele Cassino, San Raffaele Cassino, Cassino, Italy, 03043 Dipartimento di Oncologia e Neuroscienze, Università G. D'Annunzio Chieti, Italy, 66013 Ospedale della Misericordia Grosseto, Italy, 58100 IRCCS San Raffaele Pisana Roma, Italy, 163 收起 << |
NCT02227108 | B-Cell Pediatric ALL | Phase 2 | Terminated(The study was termi... 展开 >>nated prior to a planned interim analysis based on lack of required efficacy in the first 32 participants enrolled.) 收起 << | - | - |
NCT01234337 | Breast Cancer | Phase 3 | Completed | - | - |
NCT01234337 | - | Completed | - | - | |
NCT00401843 | Multiple Myeloma | Phase 2 | Active, not recruiting | September 1, 2020 | - |
NCT00401843 | - | Active, not recruiting | - | - | |
NCT00195676 | - | Completed | - | - | |
NCT01251640 | Pancreatic Neoplasms | Phase 1 Phase 2 | Completed | - | United States, Colorado ... 展开 >> Aurora, Colorado, United States, 80045 United States, Massachusetts Pittsfield, Massachusetts, United States, 01201 Belgium Bruxelles - Brussel, Belgium, 1070 Bruxelles - Brussel, Belgium, 1090 Edegem, Belgium, 2650 Czechia Brno, Czechia, 656 53 Olomouc, Czechia, 775 20 France CLERMONT-FERRAND Cedex 1, France, 63003 Germany Heilbronn, Baden-Württemberg, Germany, 74078 München, Bayern, Germany, 81377 Marburg, Hessen, Germany, 35033 Bochum, Nordrhein-Westfalen, Germany, 44892 Berlin, Germany, 13353 Italy Brescia, Lombardia, Italy, 25124 Ancona, Marche, Italy, 60126 Norway Oslo, Norway, 0310 Oslo, Norway Poland Bialystok, Poland, 15-027 Gdansk, Poland, 80-952 Warszawa, Poland, 02-781 United Kingdom London, United Kingdom, SE1 9RT London, United Kingdom, WC1E 6BT London, United Kingdom 收起 << |
NCT01626664 | Adult T-cell Leukemia-Lymphoma | Phase 2 | Completed | - | United States, California ... 展开 >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Florida University of Miami / Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Memorial Sloan Kettering New York, New York, United States, 10021 Columbia Presbyterian New York, New York, United States, 10032 Weill Cornell Medical College New York, New York, United States, 10065 Belgium Cliniques Universitaires Saint-Luc Bruxelles, Belgium, 1200 Brazil Hospital Universitario Professor Edgard Santos- UFBA Salvador, Bahia, Brazil, 40110-060 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo- SP, Brazil, CEP 05403-000 France CHU de Fort de France Fort De France Cedex, France, BP 632 97261 Hospital Necker Paris, France, 75743 Peru Hospital Nacional Edgardo Rebagliati Martins Lima, Peru, Lima11 Instituto Oncologico Miraflores Lima, Peru, Lima18 United Kingdom Guy's Hospital London, United Kingdom, SE1 9RT Imperial College London, United Kingdom, W2 1PG Sandwell General Hospital West Midlands, United Kingdom, B71 4HJ 收起 << |
NCT02227108 | - | Terminated(The study was termi... 展开 >>nated prior to a planned interim analysis based on lack of required efficacy in the first 32 participants enrolled.) 收起 << | - | - | |
NCT01626664 | - | Completed | - | - | |
NCT01202773 | Rheumatoid Arthritis | Phase 3 | Terminated(Terminated not base... 展开 >>d on safety concerns, but due to insufficient efficacy.) 收起 << | - | - |
NCT01231672 | - | Completed | - | France ... 展开 >> CHU de Clermont Ferrand - Hôpital Estaing Clermont Ferrand, France, 63003 APHM - Hôpital de la Conception Marseille, France, 13385 AP-HM Hôpital Nord Marseille, France, 13915 Centre Hospitalier Universitaire de Montpellier Montpellier, France CHU de Nice Nice, France Centre Hospitalier Universitaire de Nîmes Nîmes, France, 30029 CHU de Saint Etienne Saint Etienne cedex 2, France, 42055 收起 << | |
NCT01215942 | - | Terminated(Insufficient effica... 展开 >>cy observed in study BCDM (NCT01198002) and BCDV (NCT01202773).) 收起 << | - | - | |
NCT00073749 | Lymphoma, B-Cell | Phase 1 | Completed | - | United States, Alabama ... 展开 >> UAB CCC Clinical Studies Unit Birmingham, Alabama, United States, 35233 University of Alabama at Birmingham Kirklin Clinic Birmingham, Alabama, United States, 35233 UAB Russell Ambulatory Pharmacy Birmingham, Alabama, United States, 35294 University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Illinois Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Ohio The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030-4009 Belgium Universitair Ziekenhuis Gasthuisberg Leuven, Belgium, 3000 France Hopital Saint Louis Paris, France, 75010 Centre Hospitalier Lyon-Sud Pierre Benite Cedex, France, 69495 Germany Universitätsklinikum Bonn Bonn, NRW, Germany, 53105 Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Germany, 55131 Medizinische Klinik und Poliklinik III, Klinikum der Universitat Muenchen-Grosshadern Muenchen, Germany, 81377 Universitaet Muenchen Klinikum Grosshadern Muenchen, Germany, 81377 Spain Hospital de la Santa Creu I Sant Pau Barcelona, Spain, 08025 Hospital Clinic I Provincial Barcelona, Spain, 08036 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, 1011 United Kingdom St Bartholomew's Hospital London, United Kingdom, EC1A 7BE 收起 << |
NCT01202773 | - | Terminated(Terminated not base... 展开 >>d on safety concerns, but due to insufficient efficacy.) 收起 << | - | - | |
NCT01215942 | Rheumatoid Arthritis | Phase 3 | Terminated(Insufficient effica... 展开 >>cy observed in study BCDM (NCT01198002) and BCDV (NCT01202773).) 收起 << | - | - |
NCT01689519 | Malignant Melanoma | Phase 3 | Active, not recruiting | December 28, 2019 | - |
NCT00073749 | - | Completed | - | - | |
NCT01707992 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT02847728 | - | Recruiting | December 31, 2024 | - | |
NCT01689519 | - | Active, not recruiting | - | - | |
NCT01464827 | Chronic Hepatitis C ... 展开 >> Hepatitis C (HCV) Hepatitis C Genotype 1 收起 << | Phase 2 | Completed | - | - |
NCT00144755 | Diffuse Large Cell Lymphoma | Phase 3 | Completed | - | Belgium ... 展开 >> Université de Gent Gent, Belgium Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium France Polyclinique Bordeaux Nord Bordeaux, France, 33300 Hôpital Henri Mondor Créteil, France, 94010 Hématologie CHU de Lille Lille, France, 59000 Centre Léon Bérard Lyon, France, 69008 Hôpital Saint Louis Paris, France, 75010 Hématologie Adultes - Hôpital Necker Paris, France, 75743 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Hématologie CHU Purpan Toulouse, France, 31059 Institut Gustave Roussy Villejuif, France Switzerland Schweirische Arbeitsgruppe fur klinische Krebsforschung Lausanne, Switzerland 收起 << |
NCT00140582 | Follicular Lymphoma | Phase 3 | Completed | - | Argentina ... 展开 >> Fundaleu Hospital Buenos Aires, Argentina, CP C1114AAN Australia Australian Leukemia and Lymphoma Group Melbourne, Australia Belgium Université de Gent Gent, Belgium Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium Brazil Hospital Samaritano Sao Paulo, Brazil Colombia Fundación Santafé de Bogotá Bogota, Colombia Denmark Amtssygehuset i Herlev Herlev, Denmark France Polyclinique Bordeaux Nord Bordeaux, France, 33300 Hôpital Henri Mondor Créteil, France, 94010 Hématologie CHU de Lille Lille, France, 59000 Centre Léon Bérard Lyon, France, 69008 Institut Curie Paris, France, 75005 Hôpital Saint Louis Paris, France, 75010 Hématologie Adultes - Hôpital Necker Paris, France, 75743 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Hématologie CHU Purpan Toulouse, France, 31059 Institut Gustave Roussy Villejuif, France Netherlands HOVON Utrecht, Netherlands New Zealand Australia New Zealand Leukemia Lymphoma Group Auckland, New Zealand Peru Instituo Nacional de Enfermedades Neoplasicas Lima, Peru Spain Hospital Clinic Barcelona Barcelona, Spain Thailand King Chulalongkorn Memorial Hospital Bangkok, Thailand 收起 << |
NCT01464827 | - | Completed | - | - | |
NCT03256422 | HIV Infections | Phase 3 | Active, not recruiting | December 2020 | - |
NCT00789373 | Non-Small Cell Lung Cancer | Phase 3 | Completed | - | - |
NCT01220141 | - | Completed | - | Argentina ... 展开 >> Prov. de Buenos Aires, Argentina, B1636DSU Austria Vienna, Austria, A-1010 Belgium Brussels, Belgium, 1070 France Paris La défense cedex, France, 92932 Germany Mainz, Germany, 55127 Hungary Budapest, Hungary, 1025 Iran, Islamic Republic of Teheran, Iran, Islamic Republic of Ireland Dublin 2, Ireland Italy Rome, Italy, 00144 Poland Warszawa, Poland, PL-02-274 Portugal Paco de Arcos, Portugal, 2780-730 Slovakia Bratislava, Slovakia, 811 05 Sweden Malmö, Sweden, 202 15 United Kingdom Crawley, United Kingdom, RH11 9RT 收起 << | |
NCT00789373 | - | Completed | - | - | |
NCT00113607 | - | Completed | - | - | |
NCT00144807 | Diffuse Large Cell Lymphoma | Phase 2 | Completed | - | Belgium ... 展开 >> Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium France Polyclinique Bordeaux Nord Bordeaux, France, 33300 Hôpital Henri Mondor Créteil, France, 94010 Hématologie CHU de Lille Lille, France, 59000 Centre Léon Bérard Lyon, France, 69008 Hôpital Saint Louis Paris, France, 75010 Hématologie Adultes - Hôpital Necker Paris, France, 75743 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Hématologie CHU Purpan Toulouse, France, 31059 Institut Gustave Roussy Villejuif, France Switzerland Schweirische Arbeitsgruppe fur klinische Krebsforschung Lausanne, Switzerland 收起 << |
NCT00288249 | Breast Neoplasms ... 展开 >> Breast Cancer, Metastatic 收起 << | Phase 2 | Completed | - | Austria ... 展开 >> Wien, Austria, 1090 Wien, Austria, 1100 Belgium Brasschaat, Belgium, 2930 Bulgaria Plovdiv, Bulgaria, 4001 Sofia, Bulgaria, 01784 Varna, Bulgaria, 9000 France Angers, France, 49033 Bordeaux, France, 33076 Clermont Ferrand, France, 63011 Saint Herblain Cedex, France, 44805 Vandoeuvre les Nancy, France, 54500 Germany Berlin, Germany, 10117 Italy Forlì, FC, Italy, 47100 Milano, MI, Italy, 20162 Reggio Emilia, RE, Italy, 42100 Poland Olsztyn, Poland, 10-228 Warszawa, Poland, 02-781 Slovenia Ljubljana, Slovenia, 1000 Spain Madrid, Spain, 28040 Málaga, Spain, 29010 United Kingdom Manchester, Greater Manchester, United Kingdom, M20 4BX 收起 << |
NCT00751998 | Biliary Tract Diseases | Phase 4 | Completed | - | United States, California ... 展开 >> California Pacific Medical Center San Francisco, California, United States, 94120 United States, Colorado University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Indiana Indiana University Medical Center Indianapolis, Indiana, United States, 46202-5253 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905-0001 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15123 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-0001 Belgium Erasme Hospital - Belgium Brussels, Belgium, 1070 Denmark Bispebjerg Hospital, Denmark Kobenhavn NV, Denmark, 2400 France Hopital Edouard Herriot Lyon, Cedex 03, France, 69437 Germany Evangelisches Krankenhaus Dusseldorf Dusseldorf, Germany, D-40217 Italy Policlinico Agostino Gemelli Roma, Italy, 00161 收起 << |
NCT00113607 | Ovarian Cancer | Phase 3 | Completed | - | - |
NCT00138086 | B-Cell Lymphoma | Phase 2 | Completed | - | Belgium ... 展开 >> Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Hématologie CHU de Lille Lille, France, 59000 Institut Curie Paris, France, 75005 Hôpital Saint Louis Paris, France, 75010 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France Switzerland Schweirische Arbeitsgruppe fur klinische Krebsforschung Lausanne, Switzerland 收起 << |
NCT02005471 | Chronic Lymphocytic Leukemia | Phase 3 | Active, not recruiting | December 21, 2021 | - |
NCT00139295 | Osteoarthritis, Knee | Phase 3 | Completed | - | - |
NCT00359450 | Non-small Cell Lung Cancer | Phase 2 | Terminated | - | - |
NCT00140595 | Diffuse Large-Cell Lymphoma | Phase 3 | Completed | - | Belgium ... 展开 >> Groupe d'étude des lymphomes de l'adulte Yvoir, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Centre Léon Bérard Lyon, France, 69008 Hôpital Saint Louis Paris, France, 75010 Hématologie Adultes - Hôpital Necker Paris, France, 75743 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Hématologie CHU Purpan Toulouse, France, 31059 Institut Gustave Roussy Villejuif, France 收起 << |
NCT02005471 | - | Active, not recruiting | - | - | |
NCT00140660 | Diffuse Large Cell Lymphoma | Phase 3 | Terminated(Low acrual) | - | Belgium ... 展开 >> Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Hématologie CHU de Lille Lille, France, 59000 Hôpital Saint Louis Paris, France, 75010 Hématologie Adultes - Hôpital Necker Paris, France, 75743 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Hématologie CHU Purpan Toulouse, France, 31059 Institut Gustave Roussy Villejuif, France Switzerland Centre Pluridisciplinaire d'Oncologie, CHUV Lausanne, Switzerland, 1011 收起 << |
NCT00751998 | - | Completed | - | - | |
NCT02187861 | Follicular Lymphoma | Phase 2 | Completed | - | - |
NCT02657434 | Non-Small Cell Lung Cancer | Phase 3 | Recruiting | November 30, 2019 | - |
NCT02127788 | - | Completed | - | France ... 展开 >> Site Angers, France, 44933 Site Angers, France, 49933 Site Bordeaux, France, 33076 Site Brest, France, 29609 Site Béziers, France, 34525 Site Clermont Ferrand cedex 1, France, 63003 Site Lille, France, 59037 Site Limoges, France, 37042 Site Marseille, France, 13273 Site Marseille, France, 13385 Site Metz, France, 57038 Site Montpellier, France, 34295 Site Nantes, France, 44093 Site Paris, France, 75012 Site Paris, France, 75019 Site Saint-Denis la Réunion, France, 97400 Site Vandoeuvre-lès-Nancy, France, 54511 收起 << | |
NCT02187861 | - | Completed | - | - | |
NCT00048542 | Arthritis, Juvenile Idiopathic | Phase 3 | Completed | - | - |
NCT01342484 | - | Completed | - | - | |
NCT00048542 | - | Completed | - | - | |
NCT00673101 | - | Recruiting | December 2020 | France ... 展开 >> Hopital du Haut Leveque Recruiting Pessac, France, 33600 Contact: David Laharie, MD, PhD 33-557-656-439 david.laharie@chu-bordeaux.fr 收起 << | |
NCT02073682 | Venous Thromboembolism (VTE) ... 展开 >> Deep Vein Thrombosis (DVT) Pulmonary Embolism (PE) Cancer 收起 << | Phase 3 | Completed | - | United States, Florida ... 展开 >> Brandon, Florida, United States United States, Georgia Jonesboro, Georgia, United States United States, Michigan Detroit, Michigan, United States United States, Virginia Norfolk, Virginia, United States Belgium Leuven, Vlaams-Brabant, Belgium France Saint-Etienne cedex 2, France Hungary Debrecen, Hajdu-Bihar Megye, Hungary Italy Varese, Italy Netherlands Amsterdam, Netherlands 收起 << |
NCT00006114 | Prostate Cancer | Phase 2 | Unknown | - | France ... 展开 >> Hopital Saint-Louis Amiens, France, 80054 Cedex 1 Hopital Gouin Clichy, France, 92110 Hopital Perpetuel Secours Levallois-Perret, France, 92300 CHU de la Timone Marseille, France, 13385 Hopital Laennec Paris, France, 75007 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Polyclinique De Courlancy Reims, France, F-51100 C.H. Senlis Senlis, France, 60309 Centre Hospitalier Intercommunal Toulon - La Seyne/Mer Toulon - Cedex, France, 83056 收起 << |
NCT02900378 | Chronic Heart Failure With Red... 展开 >>uced Ejection Fraction 收起 << | Phase 3 | Completed | - | - |
NCT02073682 | - | Completed | - | - | |
NCT02397473 | Episodic Cluster Headache | Phase 3 | Completed | - | - |
NCT02438826 | Chronic Cluster Headache | Phase 3 | Active, not recruiting | July 22, 2019 | - |
NCT00140569 | Follicular Lymphoma | Phase 3 | Completed | - | Belgium ... 展开 >> Groupe d'atude des lymphome de l'adulte Yvoir, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Centre Léon Bérard Lyon, France, 69008 Hôpital Saint Louis Paris, France, 75010 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France 收起 << |
NCT00004583 | HIV Infections | Phase 3 | Completed | - | - |
NCT00004584 | HIV Infections | Phase 2 | Completed | - | - |
NCT00013897 | HIV Infections | Phase 3 | Completed | - | - |
NCT00104182 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00028301 | HIV Infections | Phase 3 | Completed | - | - |
NCT00274859 | Unspecified Adult Solid Tumor,... 展开 >> Protocol Specific 收起 << | Phase 2 | Unknown | - | France ... 展开 >> C.H.G. Beauvais Beauvais, France, 60021 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Centre Hospitalier Docteur Duchenne Boulogne Sur Mer, France, 62200 Centre Jean Perrin Clermont-Ferrand, France, 63011 Intercommunal Hospital Montfermeil, France, 93370 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Polyclinique De Courlancy Reims, France, F-51100 Centre Rene Huguenin Saint Cloud, France, 92210 Centre Hospitalier de Saint-Quentin Saint-Quentin, France, 02321 C.H. Senlis Senlis, France, 60309 Centre Paul Strauss Strasbourg, France, 67065 Centre Hospitalier Intercommunal Toulon - La Seyne Sur Mer Toulon - Cedex, France, 83056 Institut Gustave Roussy Villejuif, France, F-94805 收起 << |
NCT00086580 | B-Cell Chronic Lymphocytic Leu... 展开 >>kemia 收起 << | Phase 3 | Completed | - | - |
NCT00763815 | - | Completed | - | - | |
NCT00095290 | Albuminuria | Phase 4 | Completed | - | - |
NCT00004581 | HIV Infections | Phase 3 | Completed | - | - |
NCT00714090 | Unipolar Depression | Phase 3 | Completed | - | France ... 展开 >> C.H.U. Saint-Jacques - Service de Psychiatrie de l'Adulte Besançon, France, 25000 C.H. Le Vinatier - EA 4166, UCB Lyon 1 - Department of Psychiatry - Service du Pr d'AMATO Bron, France, 69500 C.H.U. Gabriel Montpied - Service de Psychiatrie et Psychologie Médicale - CMP A Clermont Ferrand, France, 63000 Hôpital Louis Mourier Colombes, France, 92700 C.H.U. Dijon, Hôpital Général - Service de Psychiatrie et d'Addictologie Dijon, France, 21000 C.H.U. de Grenoble, Hôpital sud - Département de Psychiatrie Grenoble, France, 38000 Hôpital Fontan - C.H.R.U. Lille Lille, France, 59000 ASM Limoux Lézignan-Corbières, France, 11200 C.H. Sainte Marguerite Marseille, France, 13000 CHU - Hôpital La Colombière Montpellier, France, 34000 Hôpital Pasteur - CHU Nice Nice, France, 06000 Hôpital Sainte Anne - Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique Paris, France, 75014 C.H.U. de POITIERS Poitiers, France, 86000 C.H.U. - C.H. Guillaume Régnier Rennes, France, 35000 C.H.U. Charles Nicolle - Service Hospitalo-Universitaire de Psychiatrie Rouen, France, 76000 EPS de Ville Evrard - Unité de Saint-Denis Saint-Denis, France, 93200 CHU St Etienne - Hôpital Nord St Etienne cedex, France, 42055 Monaco Centre Hospitalier Princesse Grace Monaco, Monaco, 98000 收起 << |
NCT00240474 | Hypertension | Phase 4 | Completed | - | - |
NCT00135499 | Lymphoma, Large-Cell, Diffuse | Phase 3 | Terminated(Recruitment too low... 展开 >>) 收起 << | - | Belgium ... 展开 >> Groupe d'Etude des Lymphomes de l'adulte Yvoir, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Hôpital Saint Louis Paris, France, 75010 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France Switzerland Schweirische Arbeitsgruppe fur klinische Krebsforschung Lausanne, Switzerland 收起 << |
NCT00086580 | - | Completed | - | - | |
NCT00076011 | Kidney Neoplasms | Phase 2 | Completed | - | United States, California ... 展开 >> Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111-2497 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 France Pfizer Investigational Site Paris Cedex 13, Paris, France, 75651 Germany Pfizer Investigational Site Hannover, Germany, 30625 收起 << |
NCT01471522 | Cardiovascular Diseases ... 展开 >> Coronary Disease Coronary Artery Disease Heart Diseases Myocardial Ischemia 收起 << | Not Applicable | Active, not recruiting | December 2019 | - |
NCT01310816 | Conventional Chondrosarcoma | Phase 2 | Completed | - | - |
NCT00076011 | - | Completed | - | - | |
NCT00054613 | Graft-versus-Host Disease | Phase 2 | Completed | - | - |
NCT01342484 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Texas ... 展开 >> 1218.56.01006 Boehringer Ingelheim Investigational Site San Antonio, Texas, United States United States, Virginia 1218.56.01004 Boehringer Ingelheim Investigational Site Norfolk, Virginia, United States Canada, Quebec 1218.56.11001 Boehringer Ingelheim Investigational Site Montreal, Quebec, Canada France 1218.56.33003 Boehringer Ingelheim Investigational Site Fort de France cedex, France 1218.56.33006 Boehringer Ingelheim Investigational Site Rouen, France Guatemala 1218.56.50202 Boehringer Ingelheim Investigational Site Guatemala, Guatemala 1218.56.50203 Boehringer Ingelheim Investigational Site Guatemala, Guatemala Italy 1218.56.39005 Boehringer Ingelheim Investigational Site Firenze, Italy Korea, Republic of 1218.56.82005 Boehringer Ingelheim Investigational Site Busan, Korea, Republic of 1218.56.82001 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1218.56.82002 Boehringer Ingelheim Investigational Site Seoul, Korea, Republic of 1218.56.82003 Boehringer Ingelheim Investigational Site Suwon, Korea, Republic of Mexico 1218.56.52008 Boehringer Ingelheim Investigational Site Chihuahua, Mexico 1218.56.52002 Boehringer Ingelheim Investigational Site Guadalajara, Mexico 1218.56.52001 Boehringer Ingelheim Investigational Site León, Mexico 1218.56.52003 Boehringer Ingelheim Investigational Site Monterrey, Mexico 1218.56.52004 Boehringer Ingelheim Investigational Site Oaxaca, Mexico Poland 1218.56.48002 Boehringer Ingelheim Investigational Site Gdansk, Poland 1218.56.48001 Boehringer Ingelheim Investigational Site Gliwice, Poland 1218.56.48004 Boehringer Ingelheim Investigational Site Warszawa, Poland 1218.56.48003 Boehringer Ingelheim Investigational Site Wroclaw, Poland Russian Federation 1218.56.70001 Boehringer Ingelheim Investigational Site Moscow, Russian Federation 1218.56.70003 Boehringer Ingelheim Investigational Site Saratov, Russian Federation 1218.56.70004 Boehringer Ingelheim Investigational Site Ufa, Russian Federation 1218.56.70006 Boehringer Ingelheim Investigational Site Yekaterinburg, Russian Federation 收起 << |
NCT00534313 | Psoriatic Arthritis | Phase 2 | Terminated(Lack of efficacy wi... 展开 >>th respect to skin-related lesions in the short-term phase) 收起 << | - | - |
NCT01225211 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT01225211 | - | Completed | - | - | |
NCT00094107 | Melanoma Skin... 展开 >> Neoplasms 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Pfizer Investigational Site Orange, California, United States, 92868 United States, Florida Pfizer Investigational Site Miami Beach, Florida, United States, 33140 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, Pennsylvania Pfizer Investigational Site Clairton, Pennsylvania, United States, 15025 Pfizer Investigational Site Greensburg, Pennsylvania, United States, 15601 Pfizer Investigational Site Johnstown, Pennsylvania, United States, 15901 Pfizer Investigational Site Pittsburgh, Pennsylvania, United States, 15232-1305 Pfizer Investigational Site Pittsburgh, Pennsylvania, United States, 15232 Pfizer Investigational Site Wexford, Pennsylvania, United States, 15090 France Pfizer Investigational Site Paris Cedex 13, France, 75651 收起 << |
NCT00982228 | - | Completed | - | - | |
NCT00534313 | - | Terminated(Lack of efficacy wi... 展开 >>th respect to skin-related lesions in the short-term phase) 收起 << | - | - | |
NCT00982228 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00094107 | - | Completed | - | - | |
NCT00094458 | Crohn Disease | Phase 3 | Completed | - | - |
NCT00171730 | Acromegaly | Phase 2 | Completed | - | United States, California ... 展开 >> Cedars Sinai Medical Center Dept. of Pituitary Ctr. Los Angeles, California, United States, 90048 United States, Michigan University of Michigan Health System StudyCoordinatorCSOM230B2201E1 Ann Arbor, Michigan, United States, 48109 United States, New York NYU / VA Medical Center New York, New York, United States, 10010 Australia, Queensland Novartis Investigative Site Woolloongabba, Queensland, Australia, 4102 Belgium Novartis Investigative Site Edegem, Belgium, 2650 France Novartis Investigative Site Toulouse Cédex 4, France, 31043 Germany Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Muenchen, Germany, 80336 Italy Novartis Investigative Site Napoli, Italy, 80131 Switzerland Novartis Investigative Site Lausanne, Switzerland, 1011 收起 << |
NCT00460408 | - | Completed | - | - | |
NCT00094458 | - | Completed | - | - | |
NCT00532675 | Multiple Myeloma | Phase 1 | Completed | - | United States, California ... 展开 >> UCSF Medical Center UCSF MC at Parnassus (SC) San Francisco, California, United States, 94143 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States, 30322 United States, New York St. Vincent's Comprehensive Cancer Center New York, New York, United States, 10011 Australia, Queensland Novartis Investigative Site South Brisbane, Queensland, Australia, 4101 Australia, Victoria Novartis Investigative Site Prahran, Victoria, Australia, 3181 France Novartis Investigative Site Lille, France, 59037 Novartis Investigative Site Montpellier cedex 5, France, 34295 Novartis Investigative Site Nantes, France, 44035 Spain Novartis Investigative Site Salamanca, Castilla Y Leon, Spain, 37007 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 收起 << |
NCT00517790 | Non-Small Cell Lung Cancer (NS... 展开 >>CLC) 收起 << | Phase 2 | Completed | - | - |
NCT00106353 | Adenocarcinoma ... 展开 >> Neoplasms 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT00660179 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Phase 3 | Completed | - | - |
NCT00106353 | - | Completed | - | - | |
NCT00371254 | Breast Cancer ... 展开 >> Metastasis 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Ucsf-Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Dana-Farber Cancer Inst Boston, Massachusetts, United States, 02115 United States, New York Montefiore Medical Center Bronx, New York, United States, 10461 United States, Texas University Of Texas Md Anderson Cancer Ctr Houston, Texas, United States, 77030 France Local Institution Paris, France, 75231 Local Institution Toulouse Cedex 3, France, 31052 Italy Local Institution Modena, Italy, 41100 Spain Local Institution Barcelona, Spain, 08035 Local Institution Lleida, Spain, 25198 收起 << |
NCT00660179 | - | Completed | - | - | |
NCT01877668 | - | Completed | - | - | |
NCT01877668 | Psoriatic Arthritis | Phase 3 | Completed | - | - |
NCT00371254 | - | Completed | - | - | |
NCT00134485 | Hypercholesterolemia, Familial... 展开 >> Hyperlipidemia 收起 << | Phase 3 | Completed | - | - |
NCT00460408 | - | Completed | - | - | |
NCT00279045 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01950650 | - | Completed | - | United States, New Jersey ... 展开 >> Novo Nordisk Investigational Site Princeton, New Jersey, United States, 08540 China, Beijing Novo Nordisk Investigational Site Beijing, Beijing, China, 100004 France Novo Nordisk Investigational Site Paris La défense cedex, France, 92932 Germany Novo Nordisk Investigational Site Mainz, Germany, 55127 India Novo Nordisk Investigational Site Bangalore, India, 560001 Japan Novo Nordisk Investigational Site Tokyo, Japan, 1000005 Russian Federation Novo Nordisk Investigational Site Moscow, Russian Federation, 119330 Spain Novo Nordisk Investigational Site Madrid, Spain, 28033 Turkey Novo Nordisk Investigational Site Istanbul, Turkey, 34335 United Kingdom Novo Nordisk Investigational Site Crawley, United Kingdom, RH11 9RT 收起 << | |
NCT00383214 | Systemic Lupus Erythematosus | Phase 3 | Terminated | - | - |
NCT00382837 | Systemic Lupus Erythematosus | Phase 3 | Withdrawn | - | - |
NCT00566254 | - | Completed | - | - | |
NCT00566254 | Epilepsy; Paediatric Partial O... 展开 >>nset Seizures 收起 << | Phase 3 | Completed | - | - |
NCT00290355 | Lung Cancer, Non-Small Cell | Phase 2 | Completed | - | - |
NCT00491829 | - | Completed | - | - | |
NCT00491829 | Sexual Dysfunctions, Psycholog... 展开 >>ical 收起 << | Phase 3 | Completed | - | - |
NCT01272232 | Metabolism and Nutrition Disor... 展开 >>der Obesity 收起 << | Phase 3 | Completed | - | - |
NCT00131066 | - | Completed | - | United States, Arkansas ... 展开 >> Dermatology Research Clinic Little Rock, Arkansas, United States, 72205 United States, Colorado Cherry Creek Dermatology Denver, Colorado, United States, 80246 United States, Georgia Atlanta Dermatology, Vein & Research Center, LLC Alpharetta, Georgia, United States, 30005 United States, Massachusetts Future Care Studies Springfield, Massachusetts, United States, 72205 United States, Missouri Washington University, Dermatology Clinical Trials Unit St. Louis, Missouri, United States, 63110 United States, Tennessee VA Medical Center Nashville, Tennessee, United States, 37212 United States, Washington Northwest Kinetics Tacoma, Washington, United States, 98405 Belgium Universitaur Ziekenhuis Gent Gent, Belgium, 185 CHU Centre Ville Liege, Belgium, 4020 Canada, Nova Scotia Capital District Health Authority, QE II Health Sciences Center Halifax, Nova Scotia, Canada, B3H1V7 Canada, Quebec International Dermatology Research Montreal, Quebec, Canada, H3H1V4 Canada Innovaderm Research Montreal, Canada, H2K 4L5 France Hotel Dieu/Clinque Dermatologique Nantes Cedex 1, France, F-44093 Hospital Saint-Louis Service de Dermatologie 1 Paris, France, F-75475 Hospital Haut Leveque CHU Sud -Service de Dermatologie Pessac, France, F-33600 Germany Universitataskilinkum der TU Dresden Dresden, Germany, D-01307 Universitatsklinikum Hautklinik Dusseldorf, Germany, D-40225 Klinikum de Johann - Wolfgang Goethe Universitate Frankfurt Frankfurt, Germany, D-60590 St. Urban, Dermatologie Freiburg, Germany, D-79104 Universitatsklinikum Hautklinik Tubingen, Germany, D-72076 Netherlands Academisch Medisch Centrum/Universiteit van Amsterdam (AMC/UvA) Amsterdam, Netherlands, 1105 收起 << | |
NCT00317642 | Acute Myelogenous Leukemia | Phase 3 | Completed | - | - |
NCT01272232 | - | Completed | - | - | |
NCT00424047 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00225589 | Hypercholesteremia | Phase 3 | Completed | - | - |
NCT00104429 | Infection, Human Immunodeficie... 展开 >>ncy Virus I HIV Infection 收起 << | Phase 2 | Terminated | - | - |
NCT00424047 | - | Completed | - | - | |
NCT00317642 | - | Completed | - | - | |
NCT00154427 | Acquired Bleeding Disorder ... 展开 >> Cardiac Surgery Requiring Cardiopulmonary Bypass 收起 << | Phase 2 | Terminated(Trial terminated af... 展开 >>ter recruiting 172 patients but without proceeding to the highest dosing cohort as this no longer reflects common clinical practice) 收起 << | - | - |
NCT00261495 | Pain | Phase 3 | Completed | - | - |
NCT01685138 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT00278915 | - | Active, not recruiting | - | - | |
NCT00113516 | Non-small Cell Lung Cancer | Phase 2 | Completed | - | - |
NCT01693614 | Diffuse Large B-cell Lymphoma,... 展开 >> Mantle Cell Lymphoma, Follicular Lymphoma 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Nebraska University of Nebraska Medical Center Univ Nebraska Omaha, Nebraska, United States, 68198 United States, New York Memorial Sloan Kettering Dept of Onc. New York, New York, United States, 10017 United States, South Carolina Medical University of South Carolina -Hollings Cancer Center Medical Univ of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas University of Texas MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(3) Houston, Texas, United States, 77030 Belgium Novartis Investigative Site Brugge, Belgium, 8000 Novartis Investigative Site Yvoir, Belgium, 5530 France Novartis Investigative Site Marseille, France, 13273 Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Novartis Investigative Site Rennes, France, 35019 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Wurzburg, Germany, 97080 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Milano, MI, Italy, 20141 Korea, Republic of Novartis Investigative Site Gyeonggi-do, Korea, Korea, Republic of, 10408 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Spain Novartis Investigative Site Salamanca, Castilla Y Leon, Spain, 37007 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 Turkey Novartis Investigative Site Izmir, Turkey, 35040 Novartis Investigative Site Samsun, Turkey, 55139 收起 << |
NCT00261495 | - | Completed | - | - | |
NCT01693614 | - | Completed | - | - | |
NCT00094653 | Melanoma Meta... 展开 >>stases 收起 << | Phase 3 | Completed | - | - |
NCT00306696 | Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT00278915 | Puberty, Precocious ... 展开 >> McCune-Albright Syndrome 收起 << | Phase 2 | Active, not recruiting | July 3, 2023 | United States, Alabama ... 展开 >> Research Site Birmingham, Alabama, United States, 35233 United States, Florida Research Site Miami, Florida, United States, 33136 United States, Kentucky Research Site Lexington, Kentucky, United States, 40536-0284 United States, Louisiana Research Site Baton Rouge, Louisiana, United States, 70808 United States, New York Research Site Bronx, New York, United States, 10467 United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States, 19104 United States, Utah Research Site Salt Lake City, Utah, United States, 84108 France Research Site Bordeaux, France Research Site Bron, France, 69677 Research Site Paris Cedex 12, France, 75571 Germany Research Site Erlangen, Germany, 91054 Research Site Osnabrück, Germany, 49082 Italy Research Site Torino, Italy, 10126 Russian Federation Research Site Moscow, Russian Federation, 117036 United Kingdom Research Site Liverpool, United Kingdom, L12 2AP Research Site London, United Kingdom, WC1N 3JH 收起 << |
NCT01852292 | Head and Neck Squamous Cell Ca... 展开 >>rcinoma 收起 << | Phase 2 | Terminated | - | - |
NCT01857193 | Breast Cancer | Phase 1 | Active, not recruiting | September 16, 2019 | United States, Arkansas ... 展开 >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Florida Sylvester Comprehensive Cancer Center Main Center Miami, Florida, United States, 33136 United States, Illinois Oncology Specialists, SC Dept.of Oncology Specialists Park Ridge, Illinois, United States, 60068-0736 United States, Massachusetts Massachusetts General Hospital Onc Dept Boston, Massachusetts, United States, 02114 United States, Michigan Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States, 48201 United States, Missouri St. Luke's Cancer Institute Kansas City, Missouri, United States, 64111 United States, New York Memorial Sloan Kettering Oncology Dept. New York, New York, United States, 10017 United States, Oregon Oregon Health and Science University SC-5 Portland, Oregon, United States, 97239 United States, Texas University of Texas MD Anderson Cancer Center Onc Dept Houston, Texas, United States, 77030 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 Belgium Novartis Investigative Site Wilrijk, Belgium, 2610 France Novartis Investigative Site Saint Herblain cedex, France, 44805 Hong Kong Novartis Investigative Site Hong Kong, Hong Kong Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site Hospitalet de LLobregat, Catalunya, Spain, 08907 收起 << |
NCT01852292 | - | Terminated | - | - | |
NCT01728805 | Cutaneous T-Cell Lymphoma | Phase 3 | Active, not recruiting | December 2018 | - |
NCT00162123 | Melanoma | Phase 2 | Completed | - | - |
NCT00094653 | - | Completed | - | - | |
NCT00162123 | - | Completed | - | - | |
NCT00207831 | Rectal Cancer ... 展开 >> Stage II/III T3 or T4 (Only Anal Extension) Rectal Cancer N0-2 M0 收起 << | Phase 3 | Terminated(Terminated after in... 展开 >>terim analysis) 收起 << | - | France ... 展开 >> Clinique Sainte Catherine Avignon, France, 84000 Hopital Avicenne Bobigny, France, 93 Institut de Cancérologie et d'Hématologie Brest, France, 29609 Centre Hospitalier Brive La Gaillarde, France, 19312 Centre d'Oncologie-radiothérapie d'Eure et Loir Chartres, France, 28006 Centre Jean Perrin Clermont Ferrand, France, 63011 Centre Médical République Clermont-ferrand, France, 63023 Clinique du Mail Grenoble, France, 38100 Centre Hospitalier Départemental La Roche Sur Yon, France, 85025 Centre Guillaume le Conquérant Le Havre, France, 76600 Centre Oscar Lambret Lille, France, 59020 Centre Hospitalier Lorient, France, 56322 Centre léon Bérard LYON Cedex 08, France, 69373 Centre Gray Maubeuge, France, 59600 Clinique du Pont de Chaume Montauban, France, 82017 Polyclinique St Roch Montpellier, France, 34967 Clinique Valdegour Nimes, France, 30900 Centre Hospitalier Niort, France, 79021 Centre Hospitalier Universitaire Poitiers, France, 86021 Centre Hospitalier de Cornouaille Quimper, France, 29000 Centre Eugène Marquis Rennes, France, 35042 Centre Hospitalier Rodez, France, 12027 Centre Frédéric Joliot Rouen, France, 76000 Clinique Armoricaine de Radiologie Saint Brieuc, France, 22015 Centre de Radiothérapie Strasbourg, France, 67000 Centre des Hautes Energies Toulouse, France, 31400 Clinique Fleming Tours, France, 37000 收起 << |
NCT00219583 | Ejaculation | Phase 2 Phase 3 | Completed | - | - |
NCT00219609 | Ejaculation | Phase 2 Phase 3 | Completed | - | - |
NCT00168844 | - | Completed | - | - | |
NCT00113516 | - | Completed | - | - | |
NCT00168844 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00885508 | Myelodysplastic Syndrome ... 展开 >> Chronic Myelomonocytic Leukemia Acute Myeloid Leukemia 收起 << | Phase 2 | Unknown | December 2015 | France ... 展开 >> CH Angers Angers, France, 49 000 hopital Victor Dupouy Argenteuil, France, 95107 Centre Hospitalier de La Cote Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93 000 CHU Haut-Lévèque Bordeaux, France, 33604 Centre hospitalier de Chambéry Chambéry, France, 73011 CHU de Clermont-Ferrand Clermont-Ferrand, France, 63058 Centre henri Mondor Creteil, France, 94010 Centre Hospitalier du Mans Le Mans cedex, France, 72037 Centre Hospitalier de Lens Lens, France, 32307 centre hospitalier de Lens Lens, France, 62307 Hôpital Limoges Limoges, France, 87046 Centre Hospitalier Lyon Sud Lyon, France, 69495 Institut Paoli Calmettes Marseille, France, 13009 CHU Brabois Nancy, France, 54511 CHU de nantes Nantes, France, 44093 Hôpital Archet1 Nice, France, 06202 Hoiptal St Louis Paris, France, 75475 Hopital Cochin-Hematology Paris, France, 75679 Centre Hospitalier Joffre Perpignan, France, 66046 Centre Henri Becquerel Rouen, France, 76038 Hôpital Hautepierre Strasbourg, France, 67098 Hopital Purpan Service d'Hématologie Clinique Toulouse, France, 31059 CH de Valence Valence, France, 26953 Institut gustave Roussy Villejuif, France, 94805 收起 << |
NCT03548220 | Pyruvate Kinase Deficiency ... 展开 >> Anemia, Hemolytic 收起 << | Phase 3 | Recruiting | January 2021 | - |
NCT01872260 | Breast Cancer | Phase 1 | Active, not recruiting | December 31, 2019 | - |
NCT00229697 | Breast Neoplasms | Phase 2 | Completed | - | - |
NCT03559699 | Pyruvate Kinase Deficiency ... 展开 >> Anemia, Hemolytic 收起 << | Phase 3 | Recruiting | May 2021 | United States, California ... 展开 >> UCSF Benioff Children's Hospital Recruiting Oakland, California, United States, 94609 Stanford University Not yet recruiting Palo Alto, California, United States, 94304 United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02115 Canada Toronto General Hospital, University Health Network Recruiting Toronto, Canada, M5G 2C4 Denmark University of Copenhagen, Herlev Hospital Recruiting Herlev, Denmark, 2730 France Hôpital de la Timone Not yet recruiting Marseille, Cedex 5, France, 13385 Ireland St James's Hospital Department of Haematolog Not yet recruiting Dublin, Ireland Italy Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Not yet recruiting Milano, Italy, 20122 AORN Cardarelli Not yet recruiting Napoli, Italy, 80131 Ospedale Galliera Not yet recruiting Napoli, Italy, 80131 AOU Policlinico, Università della Campania "Luigi Vanvitelli" Not yet recruiting Napoli, Italy, 80138 Ospedale Pediatrico Bambino Gesu Not yet recruiting Roma, Italy, 00165 Netherlands Universitair Medisch Centrum Utrecht Recruiting Utrecht, Netherlands, 3584 Spain Hospital Universitari Germans Trias i Pujol Not yet recruiting Badalona, Barcelona, Spain, 08916 Switzerland Centre Hospitalier Universitaire Vaudois (CHUV) Not yet recruiting Lausanne, Switzerland, 1011 Thailand Department of Paediatrics and Thalassaemia Center, Faculty of Medicine Siriraj Hospital, Mahidol University Not yet recruiting Bangkok, Thailand, 10700 United Kingdom Addenbrooke's Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Imperial College Healthcare NHS Trust, Hammersmith Hospital Recruiting London, United Kingdom, W12 0NN 收起 << |
NCT01911325 | Squamous Non-small Cell Lung C... 展开 >>ancer 收起 << | Phase 1 | Terminated(Review of safety an... 展开 >>d preliminary efficacy data showed marginal anti-tumor activity.) 收起 << | - | United States, Arkansas ... 展开 >> Highlands Oncology Group SC-1 Fayetteville, Arkansas, United States, 72703 United States, Florida H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt Tampa, Florida, United States, 33612 United States, Massachusetts Reliant Medical Group Reliant Medical Group Worcester, Massachusetts, United States, 01608 United States, Virginia Virginia Oncology Associates Virginia Oncology Assoc. (2) Norfolk, Virginia, United States, 23502 Belgium Novartis Investigative Site Charleroi, Belgium, 6000 Novartis Investigative Site Mons, Belgium, 7000 France Novartis Investigative Site Creteil, France, 94000 Novartis Investigative Site Saint Herblain cedex, France, 44805 Germany Novartis Investigative Site Frankfurt, Germany, 60590 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Mainz, Germany, 55131 Italy Novartis Investigative Site Monza, MB, Italy, 20900 Korea, Republic of Novartis Investigative Site Seoul, Korea, Korea, Republic of, 05505 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08036 Sweden Novartis Investigative Site Stockholm, Sweden, 171 76 收起 << |
NCT00685750 | Lung Cancer, Non-Small Cell | Not Applicable | Terminated(Slow enrolment over... 展开 >> the last 2 years with none in the past 1 year. No increase in the number of completed subjects for 1 year and no more ongoing study subjects) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90025 United States, Illinois GSK Investigational Site Park Ridge, Illinois, United States, 60068 United States, Missouri GSK Investigational Site St. Louis, Missouri, United States, 63110 United States, Utah GSK Investigational Site Murray, Utah, United States, 84107 France GSK Investigational Site Dijon, France, 21079 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Marseille, France, 13274 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Nantes, France, 44093 GSK Investigational Site Paris, France, 75012 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69126 GSK Investigational Site Mannheim, Baden-Wuerttemberg, Germany, 68167 GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72076 GSK Investigational Site Regensburg, Bayern, Germany, 93049 GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Greifswald, Mecklenburg-Vorpommern, Germany, 17487 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Ostercappeln, Niedersachsen, Germany, 49179 GSK Investigational Site Hemer, Nordrhein-Westfalen, Germany, 58675 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 51109 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Berlin, Germany, 12200 GSK Investigational Site Hamburg, Germany, 20246 Italy GSK Investigational Site Napoli, Campania, Italy, 80131 GSK Investigational Site Milano, Lombardia, Italy, 20141 GSK Investigational Site Siena, Toscana, Italy, 53100 GSK Investigational Site Padova, Veneto, Italy, 35128 Sweden GSK Investigational Site Göteborg, Sweden, SE-413 45 GSK Investigational Site Lund, Sweden, SE-221 85 GSK Investigational Site Stockholm, Sweden, SE-171 76 收起 << |
NCT01499082 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01499082 | - | Completed | - | - | |
NCT01499095 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00387127 | Neoplasms, Head and Neck | Phase 2 | Completed | - | - |
NCT00600171 | - | Completed | - | - | |
NCT00387127 | - | Completed | - | - | |
NCT01858532 | Diabetic Nephropathy | Phase 3 | Terminated(Strategic considera... 展开 >>tions) 收起 << | - | - |
NCT00395317 | Multiple Sclerosis | Phase 2 | Completed | - | - |
NCT00600171 | Asthma | Phase 2 | Completed | - | - |
NCT00761774 | - | Completed | - | - | |
NCT00354809 | Sleep Initiation and Maintenan... 展开 >>ce Disorders Insomnia 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> GSK Investigational Site Glendale, Arizona, United States, 85306 United States, California GSK Investigational Site Glendale, California, United States, 91204 United States, Florida GSK Investigational Site Hallandale Beach, Florida, United States, 33009 GSK Investigational Site Miami, Florida, United States, 33137 United States, Georgia GSK Investigational Site Fayetteville, Georgia, United States, 30214 GSK Investigational Site Hinesville, Georgia, United States, 31313 GSK Investigational Site Suwanee, Georgia, United States, 30024 United States, Kentucky GSK Investigational Site Crestview Hills, Kentucky, United States, 41017 United States, Louisiana GSK Investigational Site Baton Rouge, Louisiana, United States, 70809 GSK Investigational Site New Orleans, Louisiana, United States, 70115 United States, Massachusetts GSK Investigational Site Newton, Massachusetts, United States, 02459 United States, North Carolina GSK Investigational Site Fayetteville, North Carolina, United States, 28304 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73103 France GSK Investigational Site Clamart, France, 92140 GSK Investigational Site Paris Cedex 04, France, 75181 GSK Investigational Site Rouffach, France, 68250 Germany GSK Investigational Site Muenchen, Bayern, Germany, 81675 GSK Investigational Site Schwalmstadt, Hessen, Germany, 34613 GSK Investigational Site Schwerin, Mecklenburg-Vorpommern, Germany, 19053 GSK Investigational Site Goettingen, Niedersachsen, Germany, 37075 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Berlin, Germany, 10559 GSK Investigational Site Berlin, Germany, 13125 GSK Investigational Site Berlin, Germany, 14050 收起 << |
NCT00403767 | Atrial Fibrillation ... 展开 >> Stroke Embolism 收起 << | Phase 3 | Completed | - | - |
NCT00761774 | Epilepsy | Phase 3 | Completed | - | - |
NCT00420927 | - | Completed | - | - | |
NCT00431132 | Menopause Pos... 展开 >>tmenopausal Vaginal Atrophy 收起 << | Phase 3 | Completed | - | - |
NCT01499095 | - | Completed | - | - | |
NCT00403767 | - | Completed | - | - | |
NCT01889186 | Chronic Lymphocytic Leukemia ... 展开 >> 17 p Deletion Cancer of the Blood and Bone Marrow 收起 << | Phase 2 | Active, not recruiting | May 12, 2020 | - |
NCT00322595 | Generalized Anxiety Disorder | Phase 3 | Completed | - | - |
NCT00431132 | - | Completed | - | - | |
NCT00420927 | Rheumatoid Arthritis | Phase 4 | Completed | - | - |
NCT00206089 | Thromboembolism | Phase 3 | Terminated(Melagatran/ximelaga... 展开 >>tran was withdrawn from the market and clinical development in February 2006 in the interest of patient safety.) 收起 << | - | - |
NCT00443053 | Thrombosis, Venous | Phase 3 | Completed | - | - |
NCT00679731 | Psoriasis | Phase 3 | Completed | - | - |
NCT01676116 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01676116 | - | Completed | - | - | |
NCT00725283 | Leukaemia, Myelocytic, Acute | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Tampa, Florida, United States, 33612 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, Massachusetts GSK Investigational Site Worcester, Massachusetts, United States, 01655 United States, New York GSK Investigational Site Buffalo, New York, United States, 14263 GSK Investigational Site New York, New York, United States, 10032 United States, North Carolina GSK Investigational Site Winston-Salem, North Carolina, United States, 27157-1009 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98109-1023 France GSK Investigational Site Grenoble cedex 9, France, 38043 收起 << |
NCT00443053 | - | Completed | - | - | |
NCT00457626 | Hypertension | Phase 3 | Completed | - | - |
NCT00725283 | - | Completed | - | - | |
NCT00144248 | HIV Infections ... 展开 >> Hepatic Insufficiency 收起 << | Phase 4 | Completed | - | United States, California ... 展开 >> Boehringer Ingelheim Investigational Site Bakersfield, California, United States Boehringer Ingelheim Investigational Site San Francisco, California, United States California Pacific Medical Center San Francisco, California, United States United States, New York Albany Medical College, MC 142 Albany, New York, United States United States, Rhode Island Boehringer Ingelheim Investigational Site Providence, Rhode Island, United States France Hopital de l'Hotel Dieu Lyon cedex 02, France Hopital Pitie Salpetriere Paris, France Spain Hospital Clinico y Provincial de Barcelona - HIV Barcelona, Spain 收起 << |
NCT00158899 | Dyslipidaemias ... 展开 >> Dyslipidaemia 收起 << | Phase 2 | Completed | - | - |
NCT00492037 | Hyponatremia | Phase 3 | Completed | - | Belgium ... 展开 >> Bruxelles, Belgium Liege, Belgium Tournai, Belgium Finland Jyväskylä, Finland Turku, Finland France Garches, France Limoges, France Paris Cedex 10, France Germany Bad Nauheim, Germany Berlin, Germany Dresdan, Germany Göttingen, Germany Munchen, Germany Italy Ferrara, Italy Pavia, Italy Pisa, Italy Verona, Italy Netherlands Delft, Netherlands Groningen, Netherlands Leiden, Netherlands Nijmegen, Netherlands Poland Radomsko, Poland Warsaw, Poland Wroclaw, Poland Spain Barcelona, Spain Cordoba, Spain Madrid, Spain United Kingdom Cardiff, United Kingdom Manchester, United Kingdom 收起 << |
NCT00478881 | - | Completed | - | - | |
NCT01170611 | Sinus Node Dysfunction ... 展开 >> Brady Tachy Syndrome 收起 << | Phase 4 | Completed | - | - |
NCT00910910 | B-Cell Chronic Lymphocytic Leu... 展开 >>kemia 收起 << | Phase 3 | Active, not recruiting | April 30, 2018 | - |
NCT00478881 | Overactive Bladder ... 展开 >> Detrusor Overactivity 收起 << | Phase 2 | Completed | - | - |
NCT00387205 | Carcinoma, Renal Cell | Phase 1 | Completed | - | - |
NCT00404495 | Glioma Medull... 展开 >>oblastoma 收起 << | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> Pfizer Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Queensland Pfizer Investigational Site Herston, Queensland, Australia, 4029 Australia, Victoria Pfizer Investigational Site Parkville, Victoria, Australia, 3052 Belgium Pfizer Investigational Site Gent, Belgium, 9000 Pfizer Investigational Site Leuven, Belgium, 3000 Denmark Pfizer Investigational Site Aarhus N, Denmark, 8200 Pfizer Investigational Site Koebenhavn OE, Denmark, 2100 France Pfizer Investigational Site Angers, France, 49000 Pfizer Investigational Site Bordeaux, France, 33000 Pfizer Investigational Site Lille, France, 59020 Pfizer Investigational Site Lyon Cedex 08, France, 69373 Pfizer Investigational Site Marseille, France, 13385 Pfizer Investigational Site Paris, France, 75005 Pfizer Investigational Site Villejuif, France, 94805 Italy Pfizer Investigational Site Padova, Italy, 35100 Poland Pfizer Investigational Site Warszawa, Poland, 04-730 Spain Pfizer Investigational Site Esplugues de Llobregat, Barcelona, Spain, 08950 Pfizer Investigational Site El Palmar, Murcia, Spain, 30120 Pfizer Investigational Site Barcelona, Spain, 08035 Pfizer Investigational Site Madrid, Spain, 28009 Pfizer Investigational Site Sevilla, Spain, 41013 Pfizer Investigational Site Valencia, Spain, 46026 United Kingdom Pfizer Investigational Site Soouthampton, Hampshire, United Kingdom, SO16 6YD Pfizer Investigational Site Birmingham, United Kingdom, B4 6NH Pfizer Investigational Site Leeds, United Kingdom, LS9 7TF Pfizer Investigational Site Manchester, United Kingdom, M27 4HA Pfizer Investigational Site Newcastle Upon Tyne, United Kingdom, NE1 4LP Pfizer Investigational Site Nottingham, United Kingdom, NG7 2UH Pfizer Investigational Site Sutton, United Kingdom, SM2 5PT 收起 << |
NCT00645099 | - | Completed | - | - | |
NCT02078960 | Chronic Myeloid Leukemia | Phase 1 Phase 2 | Terminated(Inability to accrue... 展开 >> additional sites and enroll an adequate number of subjects.) 收起 << | - | United States, Georgia ... 展开 >> Teva Investigational Site 12550 Atlanta, Georgia, United States, 30322 United States, Indiana Teva Investigational Site 12543 Indianapolis, Indiana, United States, 46237 United States, New York Teva Investigational Site 12547 Buffalo, New York, United States, 14263 United States, Ohio Teva Investigational Site 12546 Cincinnati, Ohio, United States, 45219 United States, Texas Teva Investigational Site 12544 Houston, Texas, United States, 77030 Belgium Teva Investigational Site 37048 Gent, Belgium, 9000 Teva Investigational Site 37047 Leuven, Belgium, 3000 France Teva Investigational Site 35157 Pierre Benite Cedex, France, 69 495 Korea, Republic of Teva Investigational Site 87026 Seoul, Korea, Republic of, 137-701 收起 << |
NCT00645099 | Schizophrenia | Phase 3 | Completed | - | - |
NCT02246621 | Breast Cancer | Phase 3 | Active, not recruiting | July 2021 | - |
NCT01314716 | Bronchiectasis | Phase 3 | Completed | - | - |
NCT02246621 | - | Active, not recruiting | - | - | |
NCT01314716 | - | Completed | - | - | |
NCT00404495 | - | Completed | - | - | |
NCT00910910 | - | Active, not recruiting | - | - |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!